{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 173,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:57:49.309855Z",
     "start_time": "2019-05-17T23:57:49.305905Z"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:43.515725Z",
     "start_time": "2019-04-19T20:57:43.511898Z"
    }
   },
   "outputs": [],
   "source": [
    "COMPARE = False"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:43.896378Z",
     "start_time": "2019-04-19T20:57:43.519596Z"
    }
   },
   "outputs": [],
   "source": [
    "combined_sheet = pd.read_excel('results/hits_subgroup_effective.xlsx',sheet_name=\"all_subgroups+scores\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:43.968115Z",
     "start_time": "2019-04-19T20:57:43.898716Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>alectinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4324</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00075</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.467833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.707333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>gsk1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6400</td>\n",
       "      <td>True</td>\n",
       "      <td>0.64350</td>\n",
       "      <td>True</td>\n",
       "      <td>0.611000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.613667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>sb52334</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6185</td>\n",
       "      <td>True</td>\n",
       "      <td>0.64500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.576333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.597000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>tl-2-105</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6098</td>\n",
       "      <td>True</td>\n",
       "      <td>0.66050</td>\n",
       "      <td>False</td>\n",
       "      <td>0.194333</td>\n",
       "      <td>False</td>\n",
       "      <td>0.212000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ql-xii-61</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5997</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.30350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.187833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.196000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>vx-702</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5614</td>\n",
       "      <td>True</td>\n",
       "      <td>0.54675</td>\n",
       "      <td>True</td>\n",
       "      <td>0.519333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.527667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>gsk429286a</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4689</td>\n",
       "      <td>False</td>\n",
       "      <td>0.28825</td>\n",
       "      <td>False</td>\n",
       "      <td>0.186500</td>\n",
       "      <td>False</td>\n",
       "      <td>0.178333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>linsitinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5565</td>\n",
       "      <td>True</td>\n",
       "      <td>0.55850</td>\n",
       "      <td>True</td>\n",
       "      <td>0.528000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.534333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>bx-912</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5366</td>\n",
       "      <td>True</td>\n",
       "      <td>0.54125</td>\n",
       "      <td>True</td>\n",
       "      <td>0.337667</td>\n",
       "      <td>False</td>\n",
       "      <td>0.181333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>gw-2580</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5390</td>\n",
       "      <td>True</td>\n",
       "      <td>0.60825</td>\n",
       "      <td>True</td>\n",
       "      <td>0.586167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.583333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>tubastatin a</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5322</td>\n",
       "      <td>True</td>\n",
       "      <td>0.53075</td>\n",
       "      <td>False</td>\n",
       "      <td>0.317167</td>\n",
       "      <td>False</td>\n",
       "      <td>0.320333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>0.2085</td>\n",
       "      <td>True</td>\n",
       "      <td>0.50925</td>\n",
       "      <td>True</td>\n",
       "      <td>0.493000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.498667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>hg-5-88-01</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4726</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00175</td>\n",
       "      <td>True</td>\n",
       "      <td>0.280667</td>\n",
       "      <td>True</td>\n",
       "      <td>0.452000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>navitoclax</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4980</td>\n",
       "      <td>True</td>\n",
       "      <td>0.50300</td>\n",
       "      <td>True</td>\n",
       "      <td>0.479167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.489000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>amuvatinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4844</td>\n",
       "      <td>True</td>\n",
       "      <td>0.49125</td>\n",
       "      <td>True</td>\n",
       "      <td>0.443167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.450667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>xmd14-99</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3005</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.154000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.164000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>axitinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4639</td>\n",
       "      <td>False</td>\n",
       "      <td>0.18825</td>\n",
       "      <td>False</td>\n",
       "      <td>0.269833</td>\n",
       "      <td>False</td>\n",
       "      <td>0.283667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>xmd13-2</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4682</td>\n",
       "      <td>True</td>\n",
       "      <td>0.46550</td>\n",
       "      <td>True</td>\n",
       "      <td>0.281333</td>\n",
       "      <td>False</td>\n",
       "      <td>0.138000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>avrainvillamide</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4501</td>\n",
       "      <td>True</td>\n",
       "      <td>0.43325</td>\n",
       "      <td>True</td>\n",
       "      <td>0.391500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.396333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>ispinesib mesylate</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4449</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00525</td>\n",
       "      <td>False</td>\n",
       "      <td>0.126667</td>\n",
       "      <td>False</td>\n",
       "      <td>0.126333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>gsk319347a</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3663</td>\n",
       "      <td>True</td>\n",
       "      <td>0.45175</td>\n",
       "      <td>True</td>\n",
       "      <td>0.433000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.432000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>brd-k99006945</td>\n",
       "      <td>False</td>\n",
       "      <td>0.1698</td>\n",
       "      <td>True</td>\n",
       "      <td>0.42775</td>\n",
       "      <td>True</td>\n",
       "      <td>0.408667</td>\n",
       "      <td>True</td>\n",
       "      <td>0.409667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>staurosporine</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4296</td>\n",
       "      <td>True</td>\n",
       "      <td>0.39525</td>\n",
       "      <td>True</td>\n",
       "      <td>0.431333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.433333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>barasertib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4326</td>\n",
       "      <td>True</td>\n",
       "      <td>0.38700</td>\n",
       "      <td>True</td>\n",
       "      <td>0.382500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.402000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>ml239</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4117</td>\n",
       "      <td>True</td>\n",
       "      <td>0.41875</td>\n",
       "      <td>True</td>\n",
       "      <td>0.390333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.401000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>talazoparib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3229</td>\n",
       "      <td>True</td>\n",
       "      <td>0.40350</td>\n",
       "      <td>True</td>\n",
       "      <td>0.399000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.397667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>brd-k26531177</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4199</td>\n",
       "      <td>True</td>\n",
       "      <td>0.40025</td>\n",
       "      <td>True</td>\n",
       "      <td>0.387833</td>\n",
       "      <td>True</td>\n",
       "      <td>0.400000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>cct036477</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4262</td>\n",
       "      <td>True</td>\n",
       "      <td>0.41150</td>\n",
       "      <td>True</td>\n",
       "      <td>0.380000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.388333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>indisulam</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4307</td>\n",
       "      <td>True</td>\n",
       "      <td>0.39600</td>\n",
       "      <td>True</td>\n",
       "      <td>0.390000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.411667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>sb-505124</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4298</td>\n",
       "      <td>True</td>\n",
       "      <td>0.42475</td>\n",
       "      <td>False</td>\n",
       "      <td>0.131500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.131000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>642</th>\n",
       "      <td>tak-715</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4550</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47300</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.440667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.452000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>vismodegib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4632</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.46350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.450833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.460667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>z-llnle-cho</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4468</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47100</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.442333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.451667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>ro-3306</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.48925</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.455667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.462333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>bryostatin 1</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4688</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.49250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.451833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.455333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>bix02189</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4458</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.45725</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.438000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.454333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>sb216763</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4847</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.48225</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.442667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.448667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>681640</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5134</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.50800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.481833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.486000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>cp724714</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4834</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.483833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.488667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>651</th>\n",
       "      <td>rapamycin</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4941</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.49850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.469167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.482333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>dabrafenib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.3677</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.17675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.281333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.219000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>653</th>\n",
       "      <td>motesanib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5215</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.54250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.580167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.584333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>654</th>\n",
       "      <td>pelitinib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5073</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.51800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.502000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.505333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>az628</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5403</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.525167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.522333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>656</th>\n",
       "      <td>kin001-260</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.1158</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.29375</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.367500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.533000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>657</th>\n",
       "      <td>gnf-2</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5618</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.53325</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.544500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.555000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>658</th>\n",
       "      <td>qs11</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5340</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.54025</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.498333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.507000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>rtrail</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5347</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.55075</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.539833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.542667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>ql-xi-92</td>\n",
       "      <td>False</td>\n",
       "      <td>0.1165</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.28450</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.380333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.577000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>t0901317</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5112</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.560500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.593333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>pd173074</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5742</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.60550</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.574833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.579667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>nutlin-3a (-)</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5837</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.61000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.548833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.559667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>cetuximab</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5588</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56925</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.572000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.554000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665</th>\n",
       "      <td>y-39983</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.0167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.29850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.364333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.547333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>666</th>\n",
       "      <td>idelalisib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5366</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.55250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.547000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.552000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>wz-1-84</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5858</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.57850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.559333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.569000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>668</th>\n",
       "      <td>cyclopamine</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5977</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.59725</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.566167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.579333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>669</th>\n",
       "      <td>vx-11e</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5841</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.60225</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.598833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.603000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>670</th>\n",
       "      <td>gw441756</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.6208</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.63850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.589000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.607333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>671</th>\n",
       "      <td>vnlg/124</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.6492</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.65250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.628667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.640000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>672 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Name     G3  mean_score(G3)     G4  mean_score(G4)    SHH  \\\n",
       "0             alectinib   True          0.4324  False         0.00075  False   \n",
       "1            gsk1070916   True          0.6400   True         0.64350   True   \n",
       "2               sb52334   True          0.6185   True         0.64500   True   \n",
       "3              tl-2-105   True          0.6098   True         0.66050  False   \n",
       "4             ql-xii-61   True          0.5997  False        -0.30350  False   \n",
       "5                vx-702   True          0.5614   True         0.54675   True   \n",
       "6            gsk429286a   True          0.4689  False         0.28825  False   \n",
       "7            linsitinib   True          0.5565   True         0.55850   True   \n",
       "8                bx-912   True          0.5366   True         0.54125   True   \n",
       "9               gw-2580   True          0.5390   True         0.60825   True   \n",
       "10         tubastatin a   True          0.5322   True         0.53075  False   \n",
       "11            rucaparib  False          0.2085   True         0.50925   True   \n",
       "12           hg-5-88-01   True          0.4726  False         0.00175   True   \n",
       "13           navitoclax   True          0.4980   True         0.50300   True   \n",
       "14           amuvatinib   True          0.4844   True         0.49125   True   \n",
       "15             xmd14-99   True          0.3005  False         0.00675  False   \n",
       "16             axitinib   True          0.4639  False         0.18825  False   \n",
       "17              xmd13-2   True          0.4682   True         0.46550   True   \n",
       "18      avrainvillamide   True          0.4501   True         0.43325   True   \n",
       "19   ispinesib mesylate   True          0.4449  False         0.00525  False   \n",
       "20           gsk319347a   True          0.3663   True         0.45175   True   \n",
       "21        brd-k99006945  False          0.1698   True         0.42775   True   \n",
       "22        staurosporine   True          0.4296   True         0.39525   True   \n",
       "23           barasertib   True          0.4326   True         0.38700   True   \n",
       "24                ml239   True          0.4117   True         0.41875   True   \n",
       "25          talazoparib   True          0.3229   True         0.40350   True   \n",
       "26        brd-k26531177   True          0.4199   True         0.40025   True   \n",
       "27            cct036477   True          0.4262   True         0.41150   True   \n",
       "28            indisulam   True          0.4307   True         0.39600   True   \n",
       "29            sb-505124   True          0.4298   True         0.42475  False   \n",
       "..                  ...    ...             ...    ...             ...    ...   \n",
       "642             tak-715  False         -0.4550  False        -0.47300  False   \n",
       "643          vismodegib  False         -0.4632  False        -0.46350  False   \n",
       "644         z-llnle-cho  False         -0.4468  False        -0.47100  False   \n",
       "645             ro-3306  False         -0.4667  False        -0.48925  False   \n",
       "646        bryostatin 1  False         -0.4688  False        -0.49250  False   \n",
       "647            bix02189  False         -0.4458  False        -0.45725  False   \n",
       "648            sb216763  False         -0.4847  False        -0.48225  False   \n",
       "649              681640  False         -0.5134  False        -0.50800  False   \n",
       "650            cp724714  False         -0.4834  False        -0.47800  False   \n",
       "651           rapamycin  False         -0.4941  False        -0.49850  False   \n",
       "652          dabrafenib  False         -0.3677  False        -0.17675  False   \n",
       "653           motesanib  False         -0.5215  False        -0.54250  False   \n",
       "654           pelitinib  False         -0.5073  False        -0.51800  False   \n",
       "655               az628  False         -0.5403  False        -0.56350  False   \n",
       "656          kin001-260  False         -0.1158  False        -0.29375  False   \n",
       "657               gnf-2  False         -0.5618  False        -0.53325  False   \n",
       "658                qs11  False         -0.5340  False        -0.54025  False   \n",
       "659              rtrail  False         -0.5347  False        -0.55075  False   \n",
       "660            ql-xi-92  False          0.1165  False        -0.28450  False   \n",
       "661            t0901317  False         -0.5112  False        -0.56675  False   \n",
       "662            pd173074  False         -0.5742  False        -0.60550  False   \n",
       "663       nutlin-3a (-)  False         -0.5837  False        -0.61000  False   \n",
       "664           cetuximab  False         -0.5588  False        -0.56925  False   \n",
       "665             y-39983  False         -0.0167  False        -0.29850  False   \n",
       "666          idelalisib  False         -0.5366  False        -0.55250  False   \n",
       "667             wz-1-84  False         -0.5858  False        -0.57850  False   \n",
       "668         cyclopamine  False         -0.5977  False        -0.59725  False   \n",
       "669              vx-11e  False         -0.5841  False        -0.60225  False   \n",
       "670            gw441756  False         -0.6208  False        -0.63850  False   \n",
       "671            vnlg/124  False         -0.6492  False        -0.65250  False   \n",
       "\n",
       "     mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \n",
       "0          -0.467833    False            -0.707333  \n",
       "1           0.611000     True             0.613667  \n",
       "2           0.576333     True             0.597000  \n",
       "3           0.194333    False             0.212000  \n",
       "4          -0.187833    False            -0.196000  \n",
       "5           0.519333     True             0.527667  \n",
       "6           0.186500    False             0.178333  \n",
       "7           0.528000     True             0.534333  \n",
       "8           0.337667    False             0.181333  \n",
       "9           0.586167     True             0.583333  \n",
       "10          0.317167    False             0.320333  \n",
       "11          0.493000     True             0.498667  \n",
       "12          0.280667     True             0.452000  \n",
       "13          0.479167     True             0.489000  \n",
       "14          0.443167     True             0.450667  \n",
       "15         -0.154000    False            -0.164000  \n",
       "16          0.269833    False             0.283667  \n",
       "17          0.281333    False             0.138000  \n",
       "18          0.391500     True             0.396333  \n",
       "19          0.126667    False             0.126333  \n",
       "20          0.433000     True             0.432000  \n",
       "21          0.408667     True             0.409667  \n",
       "22          0.431333     True             0.433333  \n",
       "23          0.382500     True             0.402000  \n",
       "24          0.390333     True             0.401000  \n",
       "25          0.399000     True             0.397667  \n",
       "26          0.387833     True             0.400000  \n",
       "27          0.380000     True             0.388333  \n",
       "28          0.390000     True             0.411667  \n",
       "29          0.131500    False            -0.131000  \n",
       "..               ...      ...                  ...  \n",
       "642        -0.440667    False            -0.452000  \n",
       "643        -0.450833    False            -0.460667  \n",
       "644        -0.442333    False            -0.451667  \n",
       "645        -0.455667    False            -0.462333  \n",
       "646        -0.451833    False            -0.455333  \n",
       "647        -0.438000    False            -0.454333  \n",
       "648        -0.442667    False            -0.448667  \n",
       "649        -0.481833    False            -0.486000  \n",
       "650        -0.483833    False            -0.488667  \n",
       "651        -0.469167    False            -0.482333  \n",
       "652        -0.281333    False            -0.219000  \n",
       "653        -0.580167    False            -0.584333  \n",
       "654        -0.502000    False            -0.505333  \n",
       "655        -0.525167    False            -0.522333  \n",
       "656        -0.367500    False            -0.533000  \n",
       "657        -0.544500    False            -0.555000  \n",
       "658        -0.498333    False            -0.507000  \n",
       "659        -0.539833    False            -0.542667  \n",
       "660        -0.380333    False            -0.577000  \n",
       "661        -0.560500    False            -0.593333  \n",
       "662        -0.574833    False            -0.579667  \n",
       "663        -0.548833    False            -0.559667  \n",
       "664        -0.572000    False            -0.554000  \n",
       "665        -0.364333    False            -0.547333  \n",
       "666        -0.547000    False            -0.552000  \n",
       "667        -0.559333    False            -0.569000  \n",
       "668        -0.566167    False            -0.579333  \n",
       "669        -0.598833    False            -0.603000  \n",
       "670        -0.589000    False            -0.607333  \n",
       "671        -0.628667    False            -0.640000  \n",
       "\n",
       "[672 rows x 9 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combined_sheet "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:50.751457Z",
     "start_time": "2019-04-19T20:57:43.971345Z"
    }
   },
   "outputs": [],
   "source": [
    "# read sheet \"A. % viability (means)\" of \"screen_hits.xlsx\" we want \"drug_name, sbi_id, pubchem_cid\"\n",
    "\n",
    "screen_results = pd.read_excel('results/screen_hits.xlsx',sheet_name=\"A. % viability (means)\",header=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:50.787908Z",
     "start_time": "2019-04-19T20:57:50.753771Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_name</th>\n",
       "      <th>sbi_id</th>\n",
       "      <th>pubchem_cid</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(4-(p-(diethylamino)-alpha-phenylbenzylidene)-...</td>\n",
       "      <td>SBI-0653846.0001</td>\n",
       "      <td>12450.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>nvp-bgt226</td>\n",
       "      <td>SBI-0654465.P001</td>\n",
       "      <td>11978790.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>phenylmercuric acetate</td>\n",
       "      <td>SBI-0051573.P001</td>\n",
       "      <td>16682730.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>trichostatin a /// trichostatin a (tsa)</td>\n",
       "      <td>SBI-0646028.P001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>okadaic acid, prorocentrum sp.</td>\n",
       "      <td>SBI-0634592</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0637109.P001</td>\n",
       "      <td>6918811.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>nsc-3852</td>\n",
       "      <td>SBI-0053105.P002</td>\n",
       "      <td>19103.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>bortezomib</td>\n",
       "      <td>SBI-0634428.P001</td>\n",
       "      <td>387447.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>trichostatin a, streptomyces sp.</td>\n",
       "      <td>SBI-0634645</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>brefeldin a from penicillium brefeldianum</td>\n",
       "      <td>SBI-0050152.P002</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>idarubicin /// idarubicin hcl</td>\n",
       "      <td>SBI-0050582.P002</td>\n",
       "      <td>42890.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>mg-132 /// mg132</td>\n",
       "      <td>SBI-0207107</td>\n",
       "      <td>462382.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>oxamflatin</td>\n",
       "      <td>SBI-0646042.P001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>gambogic acid /// gambogic acid, garcinia hanb...</td>\n",
       "      <td>SBI-0052104.P001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0634389.P001</td>\n",
       "      <td>3085107.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>celastrol /// celastrol, celastrus scandens</td>\n",
       "      <td>SBI-0051253</td>\n",
       "      <td>122724.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>celastrol /// celastrol, celastrus scandens</td>\n",
       "      <td>SBI-0051253.P001</td>\n",
       "      <td>122724.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P007</td>\n",
       "      <td>4212.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0206677.P003</td>\n",
       "      <td>30323.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0206677.P002</td>\n",
       "      <td>30323.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>oleandrin</td>\n",
       "      <td>SBI-0052768.P001</td>\n",
       "      <td>6708811.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>m-344, histone deacetylase inhibitor iii</td>\n",
       "      <td>SBI-0634549.P002</td>\n",
       "      <td>3994.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P004</td>\n",
       "      <td>4212.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P002</td>\n",
       "      <td>4212.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>SBI-0051229.P002</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>k-strophanthin beta</td>\n",
       "      <td>SBI-0052688.P001</td>\n",
       "      <td>6708734.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>SBI-0051229</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>proscillaridin</td>\n",
       "      <td>SBI-0206671.P002</td>\n",
       "      <td>45114178.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>doxorubicin /// doxorubicin hydrochloride /// ...</td>\n",
       "      <td>SBI-0206890.P001</td>\n",
       "      <td>41867.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P003</td>\n",
       "      <td>4212.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7699</th>\n",
       "      <td>crenolanib (cp-868596)</td>\n",
       "      <td>SBI-0654437.P001</td>\n",
       "      <td>10366136.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7700</th>\n",
       "      <td>ctpb</td>\n",
       "      <td>SBI-0646041.P001</td>\n",
       "      <td>10311918.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7701</th>\n",
       "      <td>vatalanib /// vatalanib dihydrochloride (ptk787)</td>\n",
       "      <td>SBI-0636205.P002</td>\n",
       "      <td>151194.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7702</th>\n",
       "      <td>alsterpaullone</td>\n",
       "      <td>SBI-0086727.P003</td>\n",
       "      <td>5005498.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7703</th>\n",
       "      <td>telatinib (bay 57-9352)</td>\n",
       "      <td>SBI-0654411.P001</td>\n",
       "      <td>9808844.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7704</th>\n",
       "      <td>nepafenac</td>\n",
       "      <td>SBI-0654191.0001</td>\n",
       "      <td>151075.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7705</th>\n",
       "      <td>indirubin-3'-monoxime, 5-iodo-</td>\n",
       "      <td>SBI-0207163.P002</td>\n",
       "      <td>5472313.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7706</th>\n",
       "      <td>chir-98014</td>\n",
       "      <td>SBI-0654464.P001</td>\n",
       "      <td>53396311.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7707</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0637094.P001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7708</th>\n",
       "      <td>sodium valproate /// valproate sodium /// valp...</td>\n",
       "      <td>SBI-0050864.P008</td>\n",
       "      <td>3121.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7709</th>\n",
       "      <td>dcc-2036 (rebastinib)</td>\n",
       "      <td>SBI-0654390.P001</td>\n",
       "      <td>25066467.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7710</th>\n",
       "      <td>lapatinib ditosylate (tykerb)</td>\n",
       "      <td>SBI-0634417.P003</td>\n",
       "      <td>208908.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7711</th>\n",
       "      <td>prosultiamine</td>\n",
       "      <td>SBI-0654167.0001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7712</th>\n",
       "      <td>triacetylresveratrol</td>\n",
       "      <td>SBI-0052275.P002</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7713</th>\n",
       "      <td>syk inhibitor</td>\n",
       "      <td>SBI-0086712.P002</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7714</th>\n",
       "      <td>xl-184 free base (cabozantinib)</td>\n",
       "      <td>SBI-0646928.P001</td>\n",
       "      <td>25102847.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7715</th>\n",
       "      <td>met/flt-3/vegfr2 tyrosine kinase inhibitor</td>\n",
       "      <td>SBI-0637103.P001</td>\n",
       "      <td>21081761.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7716</th>\n",
       "      <td>aurora kinase inhibitor ii</td>\n",
       "      <td>SBI-0086659.P002</td>\n",
       "      <td>6610278.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7717</th>\n",
       "      <td>bms 777607</td>\n",
       "      <td>SBI-0654386.P001</td>\n",
       "      <td>24794418.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7718</th>\n",
       "      <td>bms-599626 (ac480)</td>\n",
       "      <td>SBI-0654332.P001</td>\n",
       "      <td>10437018.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7719</th>\n",
       "      <td>phthalazinone pyrazole</td>\n",
       "      <td>SBI-0654253.P001</td>\n",
       "      <td>11652621.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7720</th>\n",
       "      <td>bio /// gsk-3 inhibitor ix</td>\n",
       "      <td>SBI-0086755.P004</td>\n",
       "      <td>24906282.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7721</th>\n",
       "      <td>at9283</td>\n",
       "      <td>SBI-0654347.P001</td>\n",
       "      <td>56965909.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7722</th>\n",
       "      <td>bio /// gsk-3 inhibitor ix</td>\n",
       "      <td>SBI-0086755</td>\n",
       "      <td>24906282.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7723</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0633754.P001</td>\n",
       "      <td>24906282.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7724</th>\n",
       "      <td>sb590885</td>\n",
       "      <td>SBI-0639903.P002</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7725</th>\n",
       "      <td>abt-869 /// linifanib (abt-869)</td>\n",
       "      <td>SBI-0654273.P001</td>\n",
       "      <td>11485656.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7726</th>\n",
       "      <td>bms 794833</td>\n",
       "      <td>SBI-0654398.P001</td>\n",
       "      <td>44155856.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7727</th>\n",
       "      <td>chir99021</td>\n",
       "      <td>SBI-0654265.P001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7728</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0637085.P001</td>\n",
       "      <td>44251571.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>7729 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              drug_name            sbi_id  \\\n",
       "0     (4-(p-(diethylamino)-alpha-phenylbenzylidene)-...  SBI-0653846.0001   \n",
       "1                                            nvp-bgt226  SBI-0654465.P001   \n",
       "2                                phenylmercuric acetate  SBI-0051573.P001   \n",
       "3               trichostatin a /// trichostatin a (tsa)  SBI-0646028.P001   \n",
       "4                        okadaic acid, prorocentrum sp.       SBI-0634592   \n",
       "5                                                   NaN  SBI-0637109.P001   \n",
       "6                                              nsc-3852  SBI-0053105.P002   \n",
       "7                                            bortezomib  SBI-0634428.P001   \n",
       "8                      trichostatin a, streptomyces sp.       SBI-0634645   \n",
       "9             brefeldin a from penicillium brefeldianum  SBI-0050152.P002   \n",
       "10                        idarubicin /// idarubicin hcl  SBI-0050582.P002   \n",
       "11                                     mg-132 /// mg132       SBI-0207107   \n",
       "12                                           oxamflatin  SBI-0646042.P001   \n",
       "13    gambogic acid /// gambogic acid, garcinia hanb...  SBI-0052104.P001   \n",
       "14                           daunorubicin hydrochloride  SBI-0634389.P001   \n",
       "15          celastrol /// celastrol, celastrus scandens       SBI-0051253   \n",
       "16          celastrol /// celastrol, celastrus scandens  SBI-0051253.P001   \n",
       "17    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P007   \n",
       "18          daunorubicin /// daunorubicin hydrochloride  SBI-0206677.P003   \n",
       "19          daunorubicin /// daunorubicin hydrochloride  SBI-0206677.P002   \n",
       "20                                            oleandrin  SBI-0052768.P001   \n",
       "21             m-344, histone deacetylase inhibitor iii  SBI-0634549.P002   \n",
       "22    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P004   \n",
       "23    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P002   \n",
       "24                                         thapsigargin  SBI-0051229.P002   \n",
       "25                                  k-strophanthin beta  SBI-0052688.P001   \n",
       "26                                         thapsigargin       SBI-0051229   \n",
       "27                                       proscillaridin  SBI-0206671.P002   \n",
       "28    doxorubicin /// doxorubicin hydrochloride /// ...  SBI-0206890.P001   \n",
       "29    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P003   \n",
       "...                                                 ...               ...   \n",
       "7699                             crenolanib (cp-868596)  SBI-0654437.P001   \n",
       "7700                                               ctpb  SBI-0646041.P001   \n",
       "7701   vatalanib /// vatalanib dihydrochloride (ptk787)  SBI-0636205.P002   \n",
       "7702                                     alsterpaullone  SBI-0086727.P003   \n",
       "7703                            telatinib (bay 57-9352)  SBI-0654411.P001   \n",
       "7704                                          nepafenac  SBI-0654191.0001   \n",
       "7705                     indirubin-3'-monoxime, 5-iodo-  SBI-0207163.P002   \n",
       "7706                                         chir-98014  SBI-0654464.P001   \n",
       "7707                                                NaN  SBI-0637094.P001   \n",
       "7708  sodium valproate /// valproate sodium /// valp...  SBI-0050864.P008   \n",
       "7709                              dcc-2036 (rebastinib)  SBI-0654390.P001   \n",
       "7710                      lapatinib ditosylate (tykerb)  SBI-0634417.P003   \n",
       "7711                                      prosultiamine  SBI-0654167.0001   \n",
       "7712                               triacetylresveratrol  SBI-0052275.P002   \n",
       "7713                                      syk inhibitor  SBI-0086712.P002   \n",
       "7714                    xl-184 free base (cabozantinib)  SBI-0646928.P001   \n",
       "7715         met/flt-3/vegfr2 tyrosine kinase inhibitor  SBI-0637103.P001   \n",
       "7716                         aurora kinase inhibitor ii  SBI-0086659.P002   \n",
       "7717                                         bms 777607  SBI-0654386.P001   \n",
       "7718                                 bms-599626 (ac480)  SBI-0654332.P001   \n",
       "7719                             phthalazinone pyrazole  SBI-0654253.P001   \n",
       "7720                         bio /// gsk-3 inhibitor ix  SBI-0086755.P004   \n",
       "7721                                             at9283  SBI-0654347.P001   \n",
       "7722                         bio /// gsk-3 inhibitor ix       SBI-0086755   \n",
       "7723                                                NaN  SBI-0633754.P001   \n",
       "7724                                           sb590885  SBI-0639903.P002   \n",
       "7725                    abt-869 /// linifanib (abt-869)  SBI-0654273.P001   \n",
       "7726                                         bms 794833  SBI-0654398.P001   \n",
       "7727                                          chir99021  SBI-0654265.P001   \n",
       "7728                                                NaN  SBI-0637085.P001   \n",
       "\n",
       "      pubchem_cid  \n",
       "0         12450.0  \n",
       "1      11978790.0  \n",
       "2      16682730.0  \n",
       "3             NaN  \n",
       "4             NaN  \n",
       "5       6918811.0  \n",
       "6         19103.0  \n",
       "7        387447.0  \n",
       "8             NaN  \n",
       "9             NaN  \n",
       "10        42890.0  \n",
       "11       462382.0  \n",
       "12            NaN  \n",
       "13            NaN  \n",
       "14      3085107.0  \n",
       "15       122724.0  \n",
       "16       122724.0  \n",
       "17         4212.0  \n",
       "18        30323.0  \n",
       "19        30323.0  \n",
       "20      6708811.0  \n",
       "21         3994.0  \n",
       "22         4212.0  \n",
       "23         4212.0  \n",
       "24            NaN  \n",
       "25      6708734.0  \n",
       "26            NaN  \n",
       "27     45114178.0  \n",
       "28        41867.0  \n",
       "29         4212.0  \n",
       "...           ...  \n",
       "7699   10366136.0  \n",
       "7700   10311918.0  \n",
       "7701     151194.0  \n",
       "7702    5005498.0  \n",
       "7703    9808844.0  \n",
       "7704     151075.0  \n",
       "7705    5472313.0  \n",
       "7706   53396311.0  \n",
       "7707          NaN  \n",
       "7708       3121.0  \n",
       "7709   25066467.0  \n",
       "7710     208908.0  \n",
       "7711          NaN  \n",
       "7712          NaN  \n",
       "7713          NaN  \n",
       "7714   25102847.0  \n",
       "7715   21081761.0  \n",
       "7716    6610278.0  \n",
       "7717   24794418.0  \n",
       "7718   10437018.0  \n",
       "7719   11652621.0  \n",
       "7720   24906282.0  \n",
       "7721   56965909.0  \n",
       "7722   24906282.0  \n",
       "7723   24906282.0  \n",
       "7724          NaN  \n",
       "7725   11485656.0  \n",
       "7726   44155856.0  \n",
       "7727          NaN  \n",
       "7728   44251571.0  \n",
       "\n",
       "[7729 rows x 3 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_drugs = screen_results[['drug_name','sbi_id','pubchem_cid']]\n",
    "all_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:50.798366Z",
     "start_time": "2019-04-19T20:57:50.792227Z"
    }
   },
   "outputs": [],
   "source": [
    "def find_sbi_id(text,all_drugs=all_drugs):\n",
    "    text = str(text)\n",
    "    text_found = all_drugs[all_drugs['drug_name'].str.contains(text, regex=False,na=False)]\n",
    "    # text_found['pubchem_cid'] ## should return pubchem_cid\n",
    "    return list(text_found['sbi_id'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:50.815767Z",
     "start_time": "2019-04-19T20:57:50.803314Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['SBI-0646932.P001']"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "find_sbi_id('linsitinib')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:53.062634Z",
     "start_time": "2019-04-19T20:57:50.819187Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>alectinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4324</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00075</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.467833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.707333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>gsk1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6400</td>\n",
       "      <td>True</td>\n",
       "      <td>0.64350</td>\n",
       "      <td>True</td>\n",
       "      <td>0.611000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.613667</td>\n",
       "      <td>[SBI-0654453.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>sb52334</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6185</td>\n",
       "      <td>True</td>\n",
       "      <td>0.64500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.576333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.597000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>tl-2-105</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6098</td>\n",
       "      <td>True</td>\n",
       "      <td>0.66050</td>\n",
       "      <td>False</td>\n",
       "      <td>0.194333</td>\n",
       "      <td>False</td>\n",
       "      <td>0.212000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ql-xii-61</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5997</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.30350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.187833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.196000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>vx-702</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5614</td>\n",
       "      <td>True</td>\n",
       "      <td>0.54675</td>\n",
       "      <td>True</td>\n",
       "      <td>0.519333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.527667</td>\n",
       "      <td>[SBI-0654264.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>gsk429286a</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4689</td>\n",
       "      <td>False</td>\n",
       "      <td>0.28825</td>\n",
       "      <td>False</td>\n",
       "      <td>0.186500</td>\n",
       "      <td>False</td>\n",
       "      <td>0.178333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>linsitinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5565</td>\n",
       "      <td>True</td>\n",
       "      <td>0.55850</td>\n",
       "      <td>True</td>\n",
       "      <td>0.528000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.534333</td>\n",
       "      <td>[SBI-0646932.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>bx-912</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5366</td>\n",
       "      <td>True</td>\n",
       "      <td>0.54125</td>\n",
       "      <td>True</td>\n",
       "      <td>0.337667</td>\n",
       "      <td>False</td>\n",
       "      <td>0.181333</td>\n",
       "      <td>[SBI-0645949.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>gw-2580</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5390</td>\n",
       "      <td>True</td>\n",
       "      <td>0.60825</td>\n",
       "      <td>True</td>\n",
       "      <td>0.586167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.583333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>tubastatin a</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5322</td>\n",
       "      <td>True</td>\n",
       "      <td>0.53075</td>\n",
       "      <td>False</td>\n",
       "      <td>0.317167</td>\n",
       "      <td>False</td>\n",
       "      <td>0.320333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>0.2085</td>\n",
       "      <td>True</td>\n",
       "      <td>0.50925</td>\n",
       "      <td>True</td>\n",
       "      <td>0.493000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.498667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>hg-5-88-01</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4726</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00175</td>\n",
       "      <td>True</td>\n",
       "      <td>0.280667</td>\n",
       "      <td>True</td>\n",
       "      <td>0.452000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>navitoclax</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4980</td>\n",
       "      <td>True</td>\n",
       "      <td>0.50300</td>\n",
       "      <td>True</td>\n",
       "      <td>0.479167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.489000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>amuvatinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4844</td>\n",
       "      <td>True</td>\n",
       "      <td>0.49125</td>\n",
       "      <td>True</td>\n",
       "      <td>0.443167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.450667</td>\n",
       "      <td>[SBI-0654361.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>xmd14-99</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3005</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.154000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.164000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>axitinib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4639</td>\n",
       "      <td>False</td>\n",
       "      <td>0.18825</td>\n",
       "      <td>False</td>\n",
       "      <td>0.269833</td>\n",
       "      <td>False</td>\n",
       "      <td>0.283667</td>\n",
       "      <td>[SBI-0646925.P002]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>xmd13-2</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4682</td>\n",
       "      <td>True</td>\n",
       "      <td>0.46550</td>\n",
       "      <td>True</td>\n",
       "      <td>0.281333</td>\n",
       "      <td>False</td>\n",
       "      <td>0.138000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>avrainvillamide</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4501</td>\n",
       "      <td>True</td>\n",
       "      <td>0.43325</td>\n",
       "      <td>True</td>\n",
       "      <td>0.391500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.396333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>ispinesib mesylate</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4449</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00525</td>\n",
       "      <td>False</td>\n",
       "      <td>0.126667</td>\n",
       "      <td>False</td>\n",
       "      <td>0.126333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>gsk319347a</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3663</td>\n",
       "      <td>True</td>\n",
       "      <td>0.45175</td>\n",
       "      <td>True</td>\n",
       "      <td>0.433000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.432000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>brd-k99006945</td>\n",
       "      <td>False</td>\n",
       "      <td>0.1698</td>\n",
       "      <td>True</td>\n",
       "      <td>0.42775</td>\n",
       "      <td>True</td>\n",
       "      <td>0.408667</td>\n",
       "      <td>True</td>\n",
       "      <td>0.409667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>staurosporine</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4296</td>\n",
       "      <td>True</td>\n",
       "      <td>0.39525</td>\n",
       "      <td>True</td>\n",
       "      <td>0.431333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.433333</td>\n",
       "      <td>[SBI-0086710.P003, SBI-0061762.P001, SBI-00867...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>barasertib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4326</td>\n",
       "      <td>True</td>\n",
       "      <td>0.38700</td>\n",
       "      <td>True</td>\n",
       "      <td>0.382500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.402000</td>\n",
       "      <td>[SBI-0654349.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>ml239</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4117</td>\n",
       "      <td>True</td>\n",
       "      <td>0.41875</td>\n",
       "      <td>True</td>\n",
       "      <td>0.390333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.401000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>talazoparib</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3229</td>\n",
       "      <td>True</td>\n",
       "      <td>0.40350</td>\n",
       "      <td>True</td>\n",
       "      <td>0.399000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.397667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>brd-k26531177</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4199</td>\n",
       "      <td>True</td>\n",
       "      <td>0.40025</td>\n",
       "      <td>True</td>\n",
       "      <td>0.387833</td>\n",
       "      <td>True</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>cct036477</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4262</td>\n",
       "      <td>True</td>\n",
       "      <td>0.41150</td>\n",
       "      <td>True</td>\n",
       "      <td>0.380000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.388333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>indisulam</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4307</td>\n",
       "      <td>True</td>\n",
       "      <td>0.39600</td>\n",
       "      <td>True</td>\n",
       "      <td>0.390000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.411667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>sb-505124</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4298</td>\n",
       "      <td>True</td>\n",
       "      <td>0.42475</td>\n",
       "      <td>False</td>\n",
       "      <td>0.131500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.131000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>642</th>\n",
       "      <td>tak-715</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4550</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47300</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.440667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.452000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>vismodegib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4632</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.46350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.450833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.460667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>z-llnle-cho</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4468</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47100</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.442333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.451667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>ro-3306</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.48925</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.455667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.462333</td>\n",
       "      <td>[SBI-0207140.P002]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>bryostatin 1</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4688</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.49250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.451833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.455333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>bix02189</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4458</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.45725</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.438000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.454333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>sb216763</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4847</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.48225</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.442667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.448667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>681640</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5134</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.50800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.481833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.486000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>cp724714</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4834</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.483833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.488667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>651</th>\n",
       "      <td>rapamycin</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4941</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.49850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.469167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.482333</td>\n",
       "      <td>[SBI-0086706, SBI-0051883.P001, SBI-0051883.P0...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>dabrafenib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.3677</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.17675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.281333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.219000</td>\n",
       "      <td>[SBI-0654477.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>653</th>\n",
       "      <td>motesanib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5215</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.54250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.580167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.584333</td>\n",
       "      <td>[SBI-0654329.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>654</th>\n",
       "      <td>pelitinib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5073</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.51800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.502000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.505333</td>\n",
       "      <td>[SBI-0654367.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>az628</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5403</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.525167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.522333</td>\n",
       "      <td>[SBI-0654462.P001]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>656</th>\n",
       "      <td>kin001-260</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.1158</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.29375</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.367500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.533000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>657</th>\n",
       "      <td>gnf-2</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5618</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.53325</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.544500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.555000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>658</th>\n",
       "      <td>qs11</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5340</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.54025</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.498333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.507000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>rtrail</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5347</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.55075</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.539833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.542667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>ql-xi-92</td>\n",
       "      <td>False</td>\n",
       "      <td>0.1165</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.28450</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.380333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.577000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>t0901317</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5112</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.560500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.593333</td>\n",
       "      <td>[SBI-0634636]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>pd173074</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5742</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.60550</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.574833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.579667</td>\n",
       "      <td>[SBI-0647583.P002]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>nutlin-3a (-)</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5837</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.61000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.548833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.559667</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>cetuximab</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5588</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56925</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.572000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.554000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665</th>\n",
       "      <td>y-39983</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.0167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.29850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.364333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.547333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>666</th>\n",
       "      <td>idelalisib</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5366</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.55250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.547000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.552000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>wz-1-84</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5858</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.57850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.559333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.569000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>668</th>\n",
       "      <td>cyclopamine</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5977</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.59725</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.566167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.579333</td>\n",
       "      <td>[SBI-0634517]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>669</th>\n",
       "      <td>vx-11e</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5841</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.60225</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.598833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.603000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>670</th>\n",
       "      <td>gw441756</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.6208</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.63850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.589000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.607333</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>671</th>\n",
       "      <td>vnlg/124</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.6492</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.65250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.628667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.640000</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>672 rows × 10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Name     G3  mean_score(G3)     G4  mean_score(G4)    SHH  \\\n",
       "0             alectinib   True          0.4324  False         0.00075  False   \n",
       "1            gsk1070916   True          0.6400   True         0.64350   True   \n",
       "2               sb52334   True          0.6185   True         0.64500   True   \n",
       "3              tl-2-105   True          0.6098   True         0.66050  False   \n",
       "4             ql-xii-61   True          0.5997  False        -0.30350  False   \n",
       "5                vx-702   True          0.5614   True         0.54675   True   \n",
       "6            gsk429286a   True          0.4689  False         0.28825  False   \n",
       "7            linsitinib   True          0.5565   True         0.55850   True   \n",
       "8                bx-912   True          0.5366   True         0.54125   True   \n",
       "9               gw-2580   True          0.5390   True         0.60825   True   \n",
       "10         tubastatin a   True          0.5322   True         0.53075  False   \n",
       "11            rucaparib  False          0.2085   True         0.50925   True   \n",
       "12           hg-5-88-01   True          0.4726  False         0.00175   True   \n",
       "13           navitoclax   True          0.4980   True         0.50300   True   \n",
       "14           amuvatinib   True          0.4844   True         0.49125   True   \n",
       "15             xmd14-99   True          0.3005  False         0.00675  False   \n",
       "16             axitinib   True          0.4639  False         0.18825  False   \n",
       "17              xmd13-2   True          0.4682   True         0.46550   True   \n",
       "18      avrainvillamide   True          0.4501   True         0.43325   True   \n",
       "19   ispinesib mesylate   True          0.4449  False         0.00525  False   \n",
       "20           gsk319347a   True          0.3663   True         0.45175   True   \n",
       "21        brd-k99006945  False          0.1698   True         0.42775   True   \n",
       "22        staurosporine   True          0.4296   True         0.39525   True   \n",
       "23           barasertib   True          0.4326   True         0.38700   True   \n",
       "24                ml239   True          0.4117   True         0.41875   True   \n",
       "25          talazoparib   True          0.3229   True         0.40350   True   \n",
       "26        brd-k26531177   True          0.4199   True         0.40025   True   \n",
       "27            cct036477   True          0.4262   True         0.41150   True   \n",
       "28            indisulam   True          0.4307   True         0.39600   True   \n",
       "29            sb-505124   True          0.4298   True         0.42475  False   \n",
       "..                  ...    ...             ...    ...             ...    ...   \n",
       "642             tak-715  False         -0.4550  False        -0.47300  False   \n",
       "643          vismodegib  False         -0.4632  False        -0.46350  False   \n",
       "644         z-llnle-cho  False         -0.4468  False        -0.47100  False   \n",
       "645             ro-3306  False         -0.4667  False        -0.48925  False   \n",
       "646        bryostatin 1  False         -0.4688  False        -0.49250  False   \n",
       "647            bix02189  False         -0.4458  False        -0.45725  False   \n",
       "648            sb216763  False         -0.4847  False        -0.48225  False   \n",
       "649              681640  False         -0.5134  False        -0.50800  False   \n",
       "650            cp724714  False         -0.4834  False        -0.47800  False   \n",
       "651           rapamycin  False         -0.4941  False        -0.49850  False   \n",
       "652          dabrafenib  False         -0.3677  False        -0.17675  False   \n",
       "653           motesanib  False         -0.5215  False        -0.54250  False   \n",
       "654           pelitinib  False         -0.5073  False        -0.51800  False   \n",
       "655               az628  False         -0.5403  False        -0.56350  False   \n",
       "656          kin001-260  False         -0.1158  False        -0.29375  False   \n",
       "657               gnf-2  False         -0.5618  False        -0.53325  False   \n",
       "658                qs11  False         -0.5340  False        -0.54025  False   \n",
       "659              rtrail  False         -0.5347  False        -0.55075  False   \n",
       "660            ql-xi-92  False          0.1165  False        -0.28450  False   \n",
       "661            t0901317  False         -0.5112  False        -0.56675  False   \n",
       "662            pd173074  False         -0.5742  False        -0.60550  False   \n",
       "663       nutlin-3a (-)  False         -0.5837  False        -0.61000  False   \n",
       "664           cetuximab  False         -0.5588  False        -0.56925  False   \n",
       "665             y-39983  False         -0.0167  False        -0.29850  False   \n",
       "666          idelalisib  False         -0.5366  False        -0.55250  False   \n",
       "667             wz-1-84  False         -0.5858  False        -0.57850  False   \n",
       "668         cyclopamine  False         -0.5977  False        -0.59725  False   \n",
       "669              vx-11e  False         -0.5841  False        -0.60225  False   \n",
       "670            gw441756  False         -0.6208  False        -0.63850  False   \n",
       "671            vnlg/124  False         -0.6492  False        -0.65250  False   \n",
       "\n",
       "     mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \\\n",
       "0          -0.467833    False            -0.707333   \n",
       "1           0.611000     True             0.613667   \n",
       "2           0.576333     True             0.597000   \n",
       "3           0.194333    False             0.212000   \n",
       "4          -0.187833    False            -0.196000   \n",
       "5           0.519333     True             0.527667   \n",
       "6           0.186500    False             0.178333   \n",
       "7           0.528000     True             0.534333   \n",
       "8           0.337667    False             0.181333   \n",
       "9           0.586167     True             0.583333   \n",
       "10          0.317167    False             0.320333   \n",
       "11          0.493000     True             0.498667   \n",
       "12          0.280667     True             0.452000   \n",
       "13          0.479167     True             0.489000   \n",
       "14          0.443167     True             0.450667   \n",
       "15         -0.154000    False            -0.164000   \n",
       "16          0.269833    False             0.283667   \n",
       "17          0.281333    False             0.138000   \n",
       "18          0.391500     True             0.396333   \n",
       "19          0.126667    False             0.126333   \n",
       "20          0.433000     True             0.432000   \n",
       "21          0.408667     True             0.409667   \n",
       "22          0.431333     True             0.433333   \n",
       "23          0.382500     True             0.402000   \n",
       "24          0.390333     True             0.401000   \n",
       "25          0.399000     True             0.397667   \n",
       "26          0.387833     True             0.400000   \n",
       "27          0.380000     True             0.388333   \n",
       "28          0.390000     True             0.411667   \n",
       "29          0.131500    False            -0.131000   \n",
       "..               ...      ...                  ...   \n",
       "642        -0.440667    False            -0.452000   \n",
       "643        -0.450833    False            -0.460667   \n",
       "644        -0.442333    False            -0.451667   \n",
       "645        -0.455667    False            -0.462333   \n",
       "646        -0.451833    False            -0.455333   \n",
       "647        -0.438000    False            -0.454333   \n",
       "648        -0.442667    False            -0.448667   \n",
       "649        -0.481833    False            -0.486000   \n",
       "650        -0.483833    False            -0.488667   \n",
       "651        -0.469167    False            -0.482333   \n",
       "652        -0.281333    False            -0.219000   \n",
       "653        -0.580167    False            -0.584333   \n",
       "654        -0.502000    False            -0.505333   \n",
       "655        -0.525167    False            -0.522333   \n",
       "656        -0.367500    False            -0.533000   \n",
       "657        -0.544500    False            -0.555000   \n",
       "658        -0.498333    False            -0.507000   \n",
       "659        -0.539833    False            -0.542667   \n",
       "660        -0.380333    False            -0.577000   \n",
       "661        -0.560500    False            -0.593333   \n",
       "662        -0.574833    False            -0.579667   \n",
       "663        -0.548833    False            -0.559667   \n",
       "664        -0.572000    False            -0.554000   \n",
       "665        -0.364333    False            -0.547333   \n",
       "666        -0.547000    False            -0.552000   \n",
       "667        -0.559333    False            -0.569000   \n",
       "668        -0.566167    False            -0.579333   \n",
       "669        -0.598833    False            -0.603000   \n",
       "670        -0.589000    False            -0.607333   \n",
       "671        -0.628667    False            -0.640000   \n",
       "\n",
       "                                                   SBI  \n",
       "0                                                   []  \n",
       "1                                   [SBI-0654453.P001]  \n",
       "2                                                   []  \n",
       "3                                                   []  \n",
       "4                                                   []  \n",
       "5                                   [SBI-0654264.P001]  \n",
       "6                                                   []  \n",
       "7                                   [SBI-0646932.P001]  \n",
       "8                                   [SBI-0645949.P001]  \n",
       "9                                                   []  \n",
       "10                                                  []  \n",
       "11                                                  []  \n",
       "12                                                  []  \n",
       "13                                                  []  \n",
       "14                                  [SBI-0654361.P001]  \n",
       "15                                                  []  \n",
       "16                                  [SBI-0646925.P002]  \n",
       "17                                                  []  \n",
       "18                                                  []  \n",
       "19                                                  []  \n",
       "20                                                  []  \n",
       "21                                                  []  \n",
       "22   [SBI-0086710.P003, SBI-0061762.P001, SBI-00867...  \n",
       "23                                  [SBI-0654349.P001]  \n",
       "24                                                  []  \n",
       "25                                                  []  \n",
       "26                                                  []  \n",
       "27                                                  []  \n",
       "28                                                  []  \n",
       "29                                                  []  \n",
       "..                                                 ...  \n",
       "642                                                 []  \n",
       "643                                                 []  \n",
       "644                                                 []  \n",
       "645                                 [SBI-0207140.P002]  \n",
       "646                                                 []  \n",
       "647                                                 []  \n",
       "648                                                 []  \n",
       "649                                                 []  \n",
       "650                                                 []  \n",
       "651  [SBI-0086706, SBI-0051883.P001, SBI-0051883.P0...  \n",
       "652                                 [SBI-0654477.P001]  \n",
       "653                                 [SBI-0654329.P001]  \n",
       "654                                 [SBI-0654367.P001]  \n",
       "655                                 [SBI-0654462.P001]  \n",
       "656                                                 []  \n",
       "657                                                 []  \n",
       "658                                                 []  \n",
       "659                                                 []  \n",
       "660                                                 []  \n",
       "661                                      [SBI-0634636]  \n",
       "662                                 [SBI-0647583.P002]  \n",
       "663                                                 []  \n",
       "664                                                 []  \n",
       "665                                                 []  \n",
       "666                                                 []  \n",
       "667                                                 []  \n",
       "668                                      [SBI-0634517]  \n",
       "669                                                 []  \n",
       "670                                                 []  \n",
       "671                                                 []  \n",
       "\n",
       "[672 rows x 10 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "combined_sheet['SBI'] = combined_sheet['Name'].apply(find_sbi_id)\n",
    "combined_sheet"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:53.067919Z",
     "start_time": "2019-04-19T20:57:53.065131Z"
    }
   },
   "outputs": [],
   "source": [
    "# Split multiple SBI into identical rows!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:53.079528Z",
     "start_time": "2019-04-19T20:57:53.072611Z"
    }
   },
   "outputs": [],
   "source": [
    "# This is probably very slow, but with only 671 rows, it's not a big deal\n",
    "# if a drug has more than one SBI, create a repetaed row "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:53.087822Z",
     "start_time": "2019-04-19T20:57:53.083548Z"
    }
   },
   "outputs": [],
   "source": [
    "# def add_sbi(row):\n",
    "#     sbi_list = row['SBI']\n",
    "#     if len(sbi_list) == 0:\n",
    "#         row['sbi_id'] = 'NaN'\n",
    "#     elif len(sbi_list) == 1:\n",
    "#         row['sbi_id'] = sbi_list[0]\n",
    "#     else:\n",
    "#         row['sbi_id'] = len(sbi_list)\n",
    "#     return row"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:53.097376Z",
     "start_time": "2019-04-19T20:57:53.092315Z"
    },
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# combined_sheet.head(19).apply(add_sbi, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:56.000439Z",
     "start_time": "2019-04-19T20:57:53.100806Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['Name', 'G3', 'mean_score(G3)', 'G4', 'mean_score(G4)', 'SHH',\n",
      "       'mean_score(SHH)', 'SHH+p53', 'mean_score(SHH+p53)', 'SBI', 'sbi_id'],\n",
      "      dtype='object')\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>alectinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4324</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.467833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.707333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>gsk1070916</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6400</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.64350</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.611000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.613667</td>\n",
       "      <td>[SBI-0654453.P001]</td>\n",
       "      <td>SBI-0654453.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>sb52334</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6185</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.64500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.576333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.597000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>tl-2-105</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6098</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.66050</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.194333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.212000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ql-xii-61</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5997</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.30350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.187833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.196000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>vx-702</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5614</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54675</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.519333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.527667</td>\n",
       "      <td>[SBI-0654264.P001]</td>\n",
       "      <td>SBI-0654264.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>gsk429286a</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4689</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.28825</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.186500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.178333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>linsitinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5565</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.55850</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.528000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.534333</td>\n",
       "      <td>[SBI-0646932.P001]</td>\n",
       "      <td>SBI-0646932.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>bx-912</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5366</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54125</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.181333</td>\n",
       "      <td>[SBI-0645949.P001]</td>\n",
       "      <td>SBI-0645949.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>gw-2580</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5390</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.60825</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.586167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.583333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>tubastatin a</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5322</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.53075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.317167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.320333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2085</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.50925</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.493000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.498667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>hg-5-88-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4726</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00175</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.280667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.452000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>navitoclax</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4980</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.50300</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.479167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.489000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>amuvatinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4844</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.49125</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.443167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.450667</td>\n",
       "      <td>[SBI-0654361.P001]</td>\n",
       "      <td>SBI-0654361.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>xmd14-99</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3005</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00675</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.154000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.164000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>axitinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4639</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.18825</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.269833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.283667</td>\n",
       "      <td>[SBI-0646925.P002]</td>\n",
       "      <td>SBI-0646925.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>xmd13-2</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4682</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.46550</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.281333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.138000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>avrainvillamide</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4501</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.43325</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.391500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.396333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>ispinesib mesylate</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4449</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00525</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.126667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.126333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>gsk319347a</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3663</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.45175</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.433000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.432000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>brd-k99006945</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1698</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.42775</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.408667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.409667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>staurosporine</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4296</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.39525</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.431333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.433333</td>\n",
       "      <td>[SBI-0086710.P003, SBI-0061762.P001, SBI-00867...</td>\n",
       "      <td>SBI-0086710.P003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>barasertib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4326</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.38700</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.382500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.402000</td>\n",
       "      <td>[SBI-0654349.P001]</td>\n",
       "      <td>SBI-0654349.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>ml239</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4117</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.41875</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.390333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.401000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>talazoparib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3229</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.40350</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.399000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.397667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>brd-k26531177</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4199</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.40025</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.387833</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>cct036477</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4262</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.41150</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.380000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.388333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>indisulam</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4307</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.39600</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.390000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.411667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>sb-505124</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4298</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.42475</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.131500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.131000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>642</th>\n",
       "      <td>tak-715</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4550</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.47300</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.440667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.452000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>vismodegib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4632</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.46350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.450833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.460667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>z-llnle-cho</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4468</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.47100</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.442333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.451667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>ro-3306</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.48925</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.455667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.462333</td>\n",
       "      <td>[SBI-0207140.P002]</td>\n",
       "      <td>SBI-0207140.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>bryostatin 1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4688</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.49250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.451833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.455333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>bix02189</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4458</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.45725</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.438000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.454333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>sb216763</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4847</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.48225</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.442667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.448667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>681640</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5134</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.50800</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.481833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.486000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>cp724714</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4834</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.47800</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.483833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.488667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>651</th>\n",
       "      <td>rapamycin</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4941</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.49850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.469167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.482333</td>\n",
       "      <td>[SBI-0086706, SBI-0051883.P001, SBI-0051883.P0...</td>\n",
       "      <td>SBI-0086706</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>dabrafenib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.3677</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.17675</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.281333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.219000</td>\n",
       "      <td>[SBI-0654477.P001]</td>\n",
       "      <td>SBI-0654477.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>653</th>\n",
       "      <td>motesanib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5215</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.54250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.580167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.584333</td>\n",
       "      <td>[SBI-0654329.P001]</td>\n",
       "      <td>SBI-0654329.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>654</th>\n",
       "      <td>pelitinib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5073</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.51800</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.502000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.505333</td>\n",
       "      <td>[SBI-0654367.P001]</td>\n",
       "      <td>SBI-0654367.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>az628</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5403</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.56350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.525167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.522333</td>\n",
       "      <td>[SBI-0654462.P001]</td>\n",
       "      <td>SBI-0654462.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>656</th>\n",
       "      <td>kin001-260</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.1158</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.29375</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.367500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.533000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>657</th>\n",
       "      <td>gnf-2</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5618</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.53325</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.544500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.555000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>658</th>\n",
       "      <td>qs11</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5340</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.54025</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.498333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.507000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>rtrail</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5347</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.55075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.539833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.542667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>ql-xi-92</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1165</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.28450</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.380333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.577000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>t0901317</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5112</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.56675</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.560500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.593333</td>\n",
       "      <td>[SBI-0634636]</td>\n",
       "      <td>SBI-0634636</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>pd173074</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5742</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.60550</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.574833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.579667</td>\n",
       "      <td>[SBI-0647583.P002]</td>\n",
       "      <td>SBI-0647583.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>nutlin-3a (-)</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5837</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.61000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.548833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.559667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>cetuximab</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5588</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.56925</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.572000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.554000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665</th>\n",
       "      <td>y-39983</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.0167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.29850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.364333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.547333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>666</th>\n",
       "      <td>idelalisib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5366</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.55250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.547000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.552000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>wz-1-84</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5858</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.57850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.559333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.569000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>668</th>\n",
       "      <td>cyclopamine</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5977</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.59725</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.566167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.579333</td>\n",
       "      <td>[SBI-0634517]</td>\n",
       "      <td>SBI-0634517</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>669</th>\n",
       "      <td>vx-11e</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5841</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.60225</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.598833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.603000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>670</th>\n",
       "      <td>gw441756</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.6208</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.63850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.589000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.607333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>671</th>\n",
       "      <td>vnlg/124</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.6492</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.65250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.628667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.640000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>672 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  \\\n",
       "0             alectinib  1.0          0.4324  0.0         0.00075  0.0   \n",
       "1            gsk1070916  1.0          0.6400  1.0         0.64350  1.0   \n",
       "2               sb52334  1.0          0.6185  1.0         0.64500  1.0   \n",
       "3              tl-2-105  1.0          0.6098  1.0         0.66050  0.0   \n",
       "4             ql-xii-61  1.0          0.5997  0.0        -0.30350  0.0   \n",
       "5                vx-702  1.0          0.5614  1.0         0.54675  1.0   \n",
       "6            gsk429286a  1.0          0.4689  0.0         0.28825  0.0   \n",
       "7            linsitinib  1.0          0.5565  1.0         0.55850  1.0   \n",
       "8                bx-912  1.0          0.5366  1.0         0.54125  1.0   \n",
       "9               gw-2580  1.0          0.5390  1.0         0.60825  1.0   \n",
       "10         tubastatin a  1.0          0.5322  1.0         0.53075  0.0   \n",
       "11            rucaparib  0.0          0.2085  1.0         0.50925  1.0   \n",
       "12           hg-5-88-01  1.0          0.4726  0.0         0.00175  1.0   \n",
       "13           navitoclax  1.0          0.4980  1.0         0.50300  1.0   \n",
       "14           amuvatinib  1.0          0.4844  1.0         0.49125  1.0   \n",
       "15             xmd14-99  1.0          0.3005  0.0         0.00675  0.0   \n",
       "16             axitinib  1.0          0.4639  0.0         0.18825  0.0   \n",
       "17              xmd13-2  1.0          0.4682  1.0         0.46550  1.0   \n",
       "18      avrainvillamide  1.0          0.4501  1.0         0.43325  1.0   \n",
       "19   ispinesib mesylate  1.0          0.4449  0.0         0.00525  0.0   \n",
       "20           gsk319347a  1.0          0.3663  1.0         0.45175  1.0   \n",
       "21        brd-k99006945  0.0          0.1698  1.0         0.42775  1.0   \n",
       "22        staurosporine  1.0          0.4296  1.0         0.39525  1.0   \n",
       "23           barasertib  1.0          0.4326  1.0         0.38700  1.0   \n",
       "24                ml239  1.0          0.4117  1.0         0.41875  1.0   \n",
       "25          talazoparib  1.0          0.3229  1.0         0.40350  1.0   \n",
       "26        brd-k26531177  1.0          0.4199  1.0         0.40025  1.0   \n",
       "27            cct036477  1.0          0.4262  1.0         0.41150  1.0   \n",
       "28            indisulam  1.0          0.4307  1.0         0.39600  1.0   \n",
       "29            sb-505124  1.0          0.4298  1.0         0.42475  0.0   \n",
       "..                  ...  ...             ...  ...             ...  ...   \n",
       "642             tak-715  0.0         -0.4550  0.0        -0.47300  0.0   \n",
       "643          vismodegib  0.0         -0.4632  0.0        -0.46350  0.0   \n",
       "644         z-llnle-cho  0.0         -0.4468  0.0        -0.47100  0.0   \n",
       "645             ro-3306  0.0         -0.4667  0.0        -0.48925  0.0   \n",
       "646        bryostatin 1  0.0         -0.4688  0.0        -0.49250  0.0   \n",
       "647            bix02189  0.0         -0.4458  0.0        -0.45725  0.0   \n",
       "648            sb216763  0.0         -0.4847  0.0        -0.48225  0.0   \n",
       "649              681640  0.0         -0.5134  0.0        -0.50800  0.0   \n",
       "650            cp724714  0.0         -0.4834  0.0        -0.47800  0.0   \n",
       "651           rapamycin  0.0         -0.4941  0.0        -0.49850  0.0   \n",
       "652          dabrafenib  0.0         -0.3677  0.0        -0.17675  0.0   \n",
       "653           motesanib  0.0         -0.5215  0.0        -0.54250  0.0   \n",
       "654           pelitinib  0.0         -0.5073  0.0        -0.51800  0.0   \n",
       "655               az628  0.0         -0.5403  0.0        -0.56350  0.0   \n",
       "656          kin001-260  0.0         -0.1158  0.0        -0.29375  0.0   \n",
       "657               gnf-2  0.0         -0.5618  0.0        -0.53325  0.0   \n",
       "658                qs11  0.0         -0.5340  0.0        -0.54025  0.0   \n",
       "659              rtrail  0.0         -0.5347  0.0        -0.55075  0.0   \n",
       "660            ql-xi-92  0.0          0.1165  0.0        -0.28450  0.0   \n",
       "661            t0901317  0.0         -0.5112  0.0        -0.56675  0.0   \n",
       "662            pd173074  0.0         -0.5742  0.0        -0.60550  0.0   \n",
       "663       nutlin-3a (-)  0.0         -0.5837  0.0        -0.61000  0.0   \n",
       "664           cetuximab  0.0         -0.5588  0.0        -0.56925  0.0   \n",
       "665             y-39983  0.0         -0.0167  0.0        -0.29850  0.0   \n",
       "666          idelalisib  0.0         -0.5366  0.0        -0.55250  0.0   \n",
       "667             wz-1-84  0.0         -0.5858  0.0        -0.57850  0.0   \n",
       "668         cyclopamine  0.0         -0.5977  0.0        -0.59725  0.0   \n",
       "669              vx-11e  0.0         -0.5841  0.0        -0.60225  0.0   \n",
       "670            gw441756  0.0         -0.6208  0.0        -0.63850  0.0   \n",
       "671            vnlg/124  0.0         -0.6492  0.0        -0.65250  0.0   \n",
       "\n",
       "     mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \\\n",
       "0          -0.467833      0.0            -0.707333   \n",
       "1           0.611000      1.0             0.613667   \n",
       "2           0.576333      1.0             0.597000   \n",
       "3           0.194333      0.0             0.212000   \n",
       "4          -0.187833      0.0            -0.196000   \n",
       "5           0.519333      1.0             0.527667   \n",
       "6           0.186500      0.0             0.178333   \n",
       "7           0.528000      1.0             0.534333   \n",
       "8           0.337667      0.0             0.181333   \n",
       "9           0.586167      1.0             0.583333   \n",
       "10          0.317167      0.0             0.320333   \n",
       "11          0.493000      1.0             0.498667   \n",
       "12          0.280667      1.0             0.452000   \n",
       "13          0.479167      1.0             0.489000   \n",
       "14          0.443167      1.0             0.450667   \n",
       "15         -0.154000      0.0            -0.164000   \n",
       "16          0.269833      0.0             0.283667   \n",
       "17          0.281333      0.0             0.138000   \n",
       "18          0.391500      1.0             0.396333   \n",
       "19          0.126667      0.0             0.126333   \n",
       "20          0.433000      1.0             0.432000   \n",
       "21          0.408667      1.0             0.409667   \n",
       "22          0.431333      1.0             0.433333   \n",
       "23          0.382500      1.0             0.402000   \n",
       "24          0.390333      1.0             0.401000   \n",
       "25          0.399000      1.0             0.397667   \n",
       "26          0.387833      1.0             0.400000   \n",
       "27          0.380000      1.0             0.388333   \n",
       "28          0.390000      1.0             0.411667   \n",
       "29          0.131500      0.0            -0.131000   \n",
       "..               ...      ...                  ...   \n",
       "642        -0.440667      0.0            -0.452000   \n",
       "643        -0.450833      0.0            -0.460667   \n",
       "644        -0.442333      0.0            -0.451667   \n",
       "645        -0.455667      0.0            -0.462333   \n",
       "646        -0.451833      0.0            -0.455333   \n",
       "647        -0.438000      0.0            -0.454333   \n",
       "648        -0.442667      0.0            -0.448667   \n",
       "649        -0.481833      0.0            -0.486000   \n",
       "650        -0.483833      0.0            -0.488667   \n",
       "651        -0.469167      0.0            -0.482333   \n",
       "652        -0.281333      0.0            -0.219000   \n",
       "653        -0.580167      0.0            -0.584333   \n",
       "654        -0.502000      0.0            -0.505333   \n",
       "655        -0.525167      0.0            -0.522333   \n",
       "656        -0.367500      0.0            -0.533000   \n",
       "657        -0.544500      0.0            -0.555000   \n",
       "658        -0.498333      0.0            -0.507000   \n",
       "659        -0.539833      0.0            -0.542667   \n",
       "660        -0.380333      0.0            -0.577000   \n",
       "661        -0.560500      0.0            -0.593333   \n",
       "662        -0.574833      0.0            -0.579667   \n",
       "663        -0.548833      0.0            -0.559667   \n",
       "664        -0.572000      0.0            -0.554000   \n",
       "665        -0.364333      0.0            -0.547333   \n",
       "666        -0.547000      0.0            -0.552000   \n",
       "667        -0.559333      0.0            -0.569000   \n",
       "668        -0.566167      0.0            -0.579333   \n",
       "669        -0.598833      0.0            -0.603000   \n",
       "670        -0.589000      0.0            -0.607333   \n",
       "671        -0.628667      0.0            -0.640000   \n",
       "\n",
       "                                                   SBI            sbi_id  \n",
       "0                                                   []               NaN  \n",
       "1                                   [SBI-0654453.P001]  SBI-0654453.P001  \n",
       "2                                                   []               NaN  \n",
       "3                                                   []               NaN  \n",
       "4                                                   []               NaN  \n",
       "5                                   [SBI-0654264.P001]  SBI-0654264.P001  \n",
       "6                                                   []               NaN  \n",
       "7                                   [SBI-0646932.P001]  SBI-0646932.P001  \n",
       "8                                   [SBI-0645949.P001]  SBI-0645949.P001  \n",
       "9                                                   []               NaN  \n",
       "10                                                  []               NaN  \n",
       "11                                                  []               NaN  \n",
       "12                                                  []               NaN  \n",
       "13                                                  []               NaN  \n",
       "14                                  [SBI-0654361.P001]  SBI-0654361.P001  \n",
       "15                                                  []               NaN  \n",
       "16                                  [SBI-0646925.P002]  SBI-0646925.P002  \n",
       "17                                                  []               NaN  \n",
       "18                                                  []               NaN  \n",
       "19                                                  []               NaN  \n",
       "20                                                  []               NaN  \n",
       "21                                                  []               NaN  \n",
       "22   [SBI-0086710.P003, SBI-0061762.P001, SBI-00867...  SBI-0086710.P003  \n",
       "23                                  [SBI-0654349.P001]  SBI-0654349.P001  \n",
       "24                                                  []               NaN  \n",
       "25                                                  []               NaN  \n",
       "26                                                  []               NaN  \n",
       "27                                                  []               NaN  \n",
       "28                                                  []               NaN  \n",
       "29                                                  []               NaN  \n",
       "..                                                 ...               ...  \n",
       "642                                                 []               NaN  \n",
       "643                                                 []               NaN  \n",
       "644                                                 []               NaN  \n",
       "645                                 [SBI-0207140.P002]  SBI-0207140.P002  \n",
       "646                                                 []               NaN  \n",
       "647                                                 []               NaN  \n",
       "648                                                 []               NaN  \n",
       "649                                                 []               NaN  \n",
       "650                                                 []               NaN  \n",
       "651  [SBI-0086706, SBI-0051883.P001, SBI-0051883.P0...       SBI-0086706  \n",
       "652                                 [SBI-0654477.P001]  SBI-0654477.P001  \n",
       "653                                 [SBI-0654329.P001]  SBI-0654329.P001  \n",
       "654                                 [SBI-0654367.P001]  SBI-0654367.P001  \n",
       "655                                 [SBI-0654462.P001]  SBI-0654462.P001  \n",
       "656                                                 []               NaN  \n",
       "657                                                 []               NaN  \n",
       "658                                                 []               NaN  \n",
       "659                                                 []               NaN  \n",
       "660                                                 []               NaN  \n",
       "661                                      [SBI-0634636]       SBI-0634636  \n",
       "662                                 [SBI-0647583.P002]  SBI-0647583.P002  \n",
       "663                                                 []               NaN  \n",
       "664                                                 []               NaN  \n",
       "665                                                 []               NaN  \n",
       "666                                                 []               NaN  \n",
       "667                                                 []               NaN  \n",
       "668                                      [SBI-0634517]       SBI-0634517  \n",
       "669                                                 []               NaN  \n",
       "670                                                 []               NaN  \n",
       "671                                                 []               NaN  \n",
       "\n",
       "[672 rows x 11 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_drugs_from_exp = pd.DataFrame()\n",
    "temp = combined_sheet\n",
    "temp['sbi_id'] = temp['SBI']\n",
    "col_order = temp.columns\n",
    "print(col_order)\n",
    "for index,row in combined_sheet.iterrows():\n",
    "    row = row[col_order]\n",
    "    sbi_list = row['SBI']\n",
    "    if len(sbi_list) == 0:\n",
    "        row['sbi_id'] = 'NaN'\n",
    "    elif len(sbi_list) == 1:\n",
    "        row['sbi_id'] = sbi_list[0]\n",
    "    else:\n",
    "        if COMPARE:\n",
    "            # there are multiple SBIs, so row will be a dataframe, not a series\n",
    "            old_row = row\n",
    "            row = pd.DataFrame()\n",
    "            for curr_sbi in sbi_list:\n",
    "                old_row['sbi_id'] = curr_sbi\n",
    "                row = row.append(old_row)\n",
    "        else:\n",
    "            row['sbi_id'] = sbi_list[0] \n",
    "    all_drugs_from_exp = all_drugs_from_exp.append(row)\n",
    "all_drugs_from_exp.reset_index(drop=True,inplace=True)\n",
    "all_drugs_from_exp = all_drugs_from_exp[col_order]\n",
    "all_drugs_from_exp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:56.114588Z",
     "start_time": "2019-04-19T20:57:56.003799Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>alectinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4324</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.467833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.707333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>gsk1070916</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6400</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.64350</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.611000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.613667</td>\n",
       "      <td>[SBI-0654453.P001]</td>\n",
       "      <td>SBI-0654453.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>sb52334</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6185</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.64500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.576333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.597000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>tl-2-105</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6098</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.66050</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.194333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.212000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ql-xii-61</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5997</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.30350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.187833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.196000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>vx-702</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5614</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54675</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.519333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.527667</td>\n",
       "      <td>[SBI-0654264.P001]</td>\n",
       "      <td>SBI-0654264.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>gsk429286a</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4689</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.28825</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.186500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.178333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>linsitinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5565</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.55850</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.528000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.534333</td>\n",
       "      <td>[SBI-0646932.P001]</td>\n",
       "      <td>SBI-0646932.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>bx-912</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5366</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54125</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.181333</td>\n",
       "      <td>[SBI-0645949.P001]</td>\n",
       "      <td>SBI-0645949.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>gw-2580</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5390</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.60825</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.586167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.583333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>tubastatin a</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5322</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.53075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.317167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.320333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2085</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.50925</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.493000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.498667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>hg-5-88-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4726</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00175</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.280667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.452000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>navitoclax</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4980</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.50300</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.479167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.489000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>amuvatinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4844</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.49125</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.443167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.450667</td>\n",
       "      <td>[SBI-0654361.P001]</td>\n",
       "      <td>SBI-0654361.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>xmd14-99</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3005</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00675</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.154000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.164000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>axitinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4639</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.18825</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.269833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.283667</td>\n",
       "      <td>[SBI-0646925.P002]</td>\n",
       "      <td>SBI-0646925.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>xmd13-2</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4682</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.46550</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.281333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.138000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>avrainvillamide</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4501</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.43325</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.391500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.396333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>ispinesib mesylate</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4449</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00525</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.126667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.126333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>gsk319347a</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3663</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.45175</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.433000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.432000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>brd-k99006945</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1698</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.42775</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.408667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.409667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>staurosporine</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4296</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.39525</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.431333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.433333</td>\n",
       "      <td>[SBI-0086710.P003, SBI-0061762.P001, SBI-00867...</td>\n",
       "      <td>SBI-0086710.P003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>barasertib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4326</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.38700</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.382500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.402000</td>\n",
       "      <td>[SBI-0654349.P001]</td>\n",
       "      <td>SBI-0654349.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>ml239</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4117</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.41875</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.390333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.401000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>talazoparib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3229</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.40350</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.399000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.397667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>brd-k26531177</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4199</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.40025</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.387833</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.400000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>cct036477</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4262</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.41150</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.380000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.388333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>indisulam</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4307</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.39600</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.390000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.411667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>sb-505124</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4298</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.42475</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.131500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.131000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>pifithrin-mu</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.2710</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31900</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.117500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.321667</td>\n",
       "      <td>[SBI-0633799, SBI-0633799.P001]</td>\n",
       "      <td>SBI-0633799</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>compound 23 citrate</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3343</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.33025</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.304333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.327667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>brd-k75293299</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3212</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30650</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.317167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.327333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>nsc95397</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3278</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.32025</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.311833</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.328333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>tg-100-115</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3437</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.34000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.338500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.334333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>mgcd-265</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3455</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.32775</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.331833</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.348000</td>\n",
       "      <td>[SBI-0654365.P001]</td>\n",
       "      <td>SBI-0654365.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>brd-k84807411</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3369</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.34550</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.345167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.347667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>brd-k61166597</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3347</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.122667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>hg-5-113-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3341</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00825</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.297167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.313667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>itraconazole</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3575</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.34275</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.217167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.329000</td>\n",
       "      <td>[SBI-0206914.P001, SBI-0634168.P001, SBI-06341...</td>\n",
       "      <td>SBI-0206914.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>necrostatin-1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3355</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.32450</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.323167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.329667</td>\n",
       "      <td>[SBI-0207171.P002]</td>\n",
       "      <td>SBI-0207171.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>sgx-523</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3289</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31550</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.310667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.316000</td>\n",
       "      <td>[SBI-0654344.P001]</td>\n",
       "      <td>SBI-0654344.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>jw-55</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3580</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.35525</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.359333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.371333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>brd-k02251932</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.2854</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.32350</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.327667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.348667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>ml006</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3352</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31875</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.308500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.323667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3370</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30800</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.102167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.210333</td>\n",
       "      <td>[SBI-0634430.P003, SBI-0634430.P001, SBI-06344...</td>\n",
       "      <td>SBI-0634430.P003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>brd-k66532283</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3238</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.32250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.298333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.311000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>at-406</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3246</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.32475</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.317167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.319667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>elocalcitol</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3469</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.33575</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.323833</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.331667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>lomeguatrib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3345</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.32350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.118167</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.334000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>sildenafil</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3252</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.324000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.342667</td>\n",
       "      <td>[SBI-0051920.P004, SBI-0051920.P002, SBI-00519...</td>\n",
       "      <td>SBI-0051920.P004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>plx-4032</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3262</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.33125</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.311667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.317667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>brd-k44224150</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3213</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.32500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.327500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>jw-480</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3246</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31925</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.311667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.320333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>ml083</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2622</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.31775</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.299333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.310000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>brivanib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3277</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30400</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.313500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.324000</td>\n",
       "      <td>[SBI-0654443.P001, SBI-0654440.P001]</td>\n",
       "      <td>SBI-0654443.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>brd8899</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3303</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30725</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.312000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.324667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>hc-067047</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3319</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31825</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.308333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.326333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>pyr-41</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3107</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30200</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.304333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.320333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>fsc231</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1339</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31025</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.215500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.346000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>159 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                    Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  \\\n",
       "0              alectinib  1.0          0.4324  0.0         0.00075  0.0   \n",
       "1             gsk1070916  1.0          0.6400  1.0         0.64350  1.0   \n",
       "2                sb52334  1.0          0.6185  1.0         0.64500  1.0   \n",
       "3               tl-2-105  1.0          0.6098  1.0         0.66050  0.0   \n",
       "4              ql-xii-61  1.0          0.5997  0.0        -0.30350  0.0   \n",
       "5                 vx-702  1.0          0.5614  1.0         0.54675  1.0   \n",
       "6             gsk429286a  1.0          0.4689  0.0         0.28825  0.0   \n",
       "7             linsitinib  1.0          0.5565  1.0         0.55850  1.0   \n",
       "8                 bx-912  1.0          0.5366  1.0         0.54125  1.0   \n",
       "9                gw-2580  1.0          0.5390  1.0         0.60825  1.0   \n",
       "10          tubastatin a  1.0          0.5322  1.0         0.53075  0.0   \n",
       "11             rucaparib  0.0          0.2085  1.0         0.50925  1.0   \n",
       "12            hg-5-88-01  1.0          0.4726  0.0         0.00175  1.0   \n",
       "13            navitoclax  1.0          0.4980  1.0         0.50300  1.0   \n",
       "14            amuvatinib  1.0          0.4844  1.0         0.49125  1.0   \n",
       "15              xmd14-99  1.0          0.3005  0.0         0.00675  0.0   \n",
       "16              axitinib  1.0          0.4639  0.0         0.18825  0.0   \n",
       "17               xmd13-2  1.0          0.4682  1.0         0.46550  1.0   \n",
       "18       avrainvillamide  1.0          0.4501  1.0         0.43325  1.0   \n",
       "19    ispinesib mesylate  1.0          0.4449  0.0         0.00525  0.0   \n",
       "20            gsk319347a  1.0          0.3663  1.0         0.45175  1.0   \n",
       "21         brd-k99006945  0.0          0.1698  1.0         0.42775  1.0   \n",
       "22         staurosporine  1.0          0.4296  1.0         0.39525  1.0   \n",
       "23            barasertib  1.0          0.4326  1.0         0.38700  1.0   \n",
       "24                 ml239  1.0          0.4117  1.0         0.41875  1.0   \n",
       "25           talazoparib  1.0          0.3229  1.0         0.40350  1.0   \n",
       "26         brd-k26531177  1.0          0.4199  1.0         0.40025  1.0   \n",
       "27             cct036477  1.0          0.4262  1.0         0.41150  1.0   \n",
       "28             indisulam  1.0          0.4307  1.0         0.39600  1.0   \n",
       "29             sb-505124  1.0          0.4298  1.0         0.42475  0.0   \n",
       "..                   ...  ...             ...  ...             ...  ...   \n",
       "129         pifithrin-mu  1.0          0.2710  0.0         0.31900  0.0   \n",
       "130  compound 23 citrate  1.0          0.3343  1.0         0.33025  1.0   \n",
       "131        brd-k75293299  0.0          0.3212  0.0         0.30650  1.0   \n",
       "132             nsc95397  0.0          0.3278  0.0         0.32025  1.0   \n",
       "133           tg-100-115  1.0          0.3437  1.0         0.34000  1.0   \n",
       "134             mgcd-265  1.0          0.3455  1.0         0.32775  1.0   \n",
       "135        brd-k84807411  0.0          0.3369  1.0         0.34550  1.0   \n",
       "136        brd-k61166597  1.0          0.3347  0.0         0.31075  0.0   \n",
       "137          hg-5-113-01  1.0          0.3341  0.0         0.00825  0.0   \n",
       "138         itraconazole  1.0          0.3575  1.0         0.34275  0.0   \n",
       "139        necrostatin-1  1.0          0.3355  1.0         0.32450  1.0   \n",
       "140              sgx-523  0.0          0.3289  0.0         0.31550  1.0   \n",
       "141                jw-55  1.0          0.3580  1.0         0.35525  1.0   \n",
       "142        brd-k02251932  1.0          0.2854  0.0         0.32350  1.0   \n",
       "143                ml006  0.0          0.3352  0.0         0.31875  1.0   \n",
       "144           vorinostat  1.0          0.3370  0.0         0.30800  0.0   \n",
       "145        brd-k66532283  0.0          0.3238  1.0         0.32250  0.0   \n",
       "146               at-406  0.0          0.3246  1.0         0.32475  1.0   \n",
       "147          elocalcitol  1.0          0.3469  1.0         0.33575  1.0   \n",
       "148          lomeguatrib  1.0          0.3345  0.0         0.32350  0.0   \n",
       "149           sildenafil  0.0          0.3252  0.0         0.31000  1.0   \n",
       "150             plx-4032  0.0          0.3262  1.0         0.33125  1.0   \n",
       "151        brd-k44224150  0.0          0.3213  0.0         0.32500  1.0   \n",
       "152               jw-480  0.0          0.3246  0.0         0.31925  1.0   \n",
       "153                ml083  0.0          0.2622  1.0         0.31775  0.0   \n",
       "154             brivanib  0.0          0.3277  0.0         0.30400  1.0   \n",
       "155              brd8899  0.0          0.3303  0.0         0.30725  1.0   \n",
       "156            hc-067047  0.0          0.3319  0.0         0.31825  1.0   \n",
       "157               pyr-41  0.0          0.3107  0.0         0.30200  1.0   \n",
       "158               fsc231  0.0          0.1339  0.0         0.31025  1.0   \n",
       "\n",
       "     mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \\\n",
       "0          -0.467833      0.0            -0.707333   \n",
       "1           0.611000      1.0             0.613667   \n",
       "2           0.576333      1.0             0.597000   \n",
       "3           0.194333      0.0             0.212000   \n",
       "4          -0.187833      0.0            -0.196000   \n",
       "5           0.519333      1.0             0.527667   \n",
       "6           0.186500      0.0             0.178333   \n",
       "7           0.528000      1.0             0.534333   \n",
       "8           0.337667      0.0             0.181333   \n",
       "9           0.586167      1.0             0.583333   \n",
       "10          0.317167      0.0             0.320333   \n",
       "11          0.493000      1.0             0.498667   \n",
       "12          0.280667      1.0             0.452000   \n",
       "13          0.479167      1.0             0.489000   \n",
       "14          0.443167      1.0             0.450667   \n",
       "15         -0.154000      0.0            -0.164000   \n",
       "16          0.269833      0.0             0.283667   \n",
       "17          0.281333      0.0             0.138000   \n",
       "18          0.391500      1.0             0.396333   \n",
       "19          0.126667      0.0             0.126333   \n",
       "20          0.433000      1.0             0.432000   \n",
       "21          0.408667      1.0             0.409667   \n",
       "22          0.431333      1.0             0.433333   \n",
       "23          0.382500      1.0             0.402000   \n",
       "24          0.390333      1.0             0.401000   \n",
       "25          0.399000      1.0             0.397667   \n",
       "26          0.387833      1.0             0.400000   \n",
       "27          0.380000      1.0             0.388333   \n",
       "28          0.390000      1.0             0.411667   \n",
       "29          0.131500      0.0            -0.131000   \n",
       "..               ...      ...                  ...   \n",
       "129         0.117500      0.0             0.321667   \n",
       "130         0.304333      1.0             0.327667   \n",
       "131         0.317167      0.0             0.327333   \n",
       "132         0.311833      1.0             0.328333   \n",
       "133         0.338500      1.0             0.334333   \n",
       "134         0.331833      1.0             0.348000   \n",
       "135         0.345167      1.0             0.347667   \n",
       "136         0.122667      1.0             0.337333   \n",
       "137         0.297167      0.0             0.313667   \n",
       "138         0.217167      0.0             0.329000   \n",
       "139         0.323167      1.0             0.329667   \n",
       "140         0.310667      1.0             0.316000   \n",
       "141         0.359333      1.0             0.371333   \n",
       "142         0.327667      1.0             0.348667   \n",
       "143         0.308500      1.0             0.323667   \n",
       "144         0.102167      0.0             0.210333   \n",
       "145         0.298333      0.0             0.311000   \n",
       "146         0.317167      0.0             0.319667   \n",
       "147         0.323833      1.0             0.331667   \n",
       "148         0.118167      1.0             0.334000   \n",
       "149         0.324000      1.0             0.342667   \n",
       "150         0.311667      1.0             0.317667   \n",
       "151         0.327500      1.0             0.337333   \n",
       "152         0.311667      0.0             0.320333   \n",
       "153         0.299333      0.0             0.310000   \n",
       "154         0.313500      1.0             0.324000   \n",
       "155         0.312000      1.0             0.324667   \n",
       "156         0.308333      1.0             0.326333   \n",
       "157         0.304333      1.0             0.320333   \n",
       "158         0.215500      1.0             0.346000   \n",
       "\n",
       "                                                   SBI            sbi_id  \n",
       "0                                                   []               NaN  \n",
       "1                                   [SBI-0654453.P001]  SBI-0654453.P001  \n",
       "2                                                   []               NaN  \n",
       "3                                                   []               NaN  \n",
       "4                                                   []               NaN  \n",
       "5                                   [SBI-0654264.P001]  SBI-0654264.P001  \n",
       "6                                                   []               NaN  \n",
       "7                                   [SBI-0646932.P001]  SBI-0646932.P001  \n",
       "8                                   [SBI-0645949.P001]  SBI-0645949.P001  \n",
       "9                                                   []               NaN  \n",
       "10                                                  []               NaN  \n",
       "11                                                  []               NaN  \n",
       "12                                                  []               NaN  \n",
       "13                                                  []               NaN  \n",
       "14                                  [SBI-0654361.P001]  SBI-0654361.P001  \n",
       "15                                                  []               NaN  \n",
       "16                                  [SBI-0646925.P002]  SBI-0646925.P002  \n",
       "17                                                  []               NaN  \n",
       "18                                                  []               NaN  \n",
       "19                                                  []               NaN  \n",
       "20                                                  []               NaN  \n",
       "21                                                  []               NaN  \n",
       "22   [SBI-0086710.P003, SBI-0061762.P001, SBI-00867...  SBI-0086710.P003  \n",
       "23                                  [SBI-0654349.P001]  SBI-0654349.P001  \n",
       "24                                                  []               NaN  \n",
       "25                                                  []               NaN  \n",
       "26                                                  []               NaN  \n",
       "27                                                  []               NaN  \n",
       "28                                                  []               NaN  \n",
       "29                                                  []               NaN  \n",
       "..                                                 ...               ...  \n",
       "129                    [SBI-0633799, SBI-0633799.P001]       SBI-0633799  \n",
       "130                                                 []               NaN  \n",
       "131                                                 []               NaN  \n",
       "132                                                 []               NaN  \n",
       "133                                                 []               NaN  \n",
       "134                                 [SBI-0654365.P001]  SBI-0654365.P001  \n",
       "135                                                 []               NaN  \n",
       "136                                                 []               NaN  \n",
       "137                                                 []               NaN  \n",
       "138  [SBI-0206914.P001, SBI-0634168.P001, SBI-06341...  SBI-0206914.P001  \n",
       "139                                 [SBI-0207171.P002]  SBI-0207171.P002  \n",
       "140                                 [SBI-0654344.P001]  SBI-0654344.P001  \n",
       "141                                                 []               NaN  \n",
       "142                                                 []               NaN  \n",
       "143                                                 []               NaN  \n",
       "144  [SBI-0634430.P003, SBI-0634430.P001, SBI-06344...  SBI-0634430.P003  \n",
       "145                                                 []               NaN  \n",
       "146                                                 []               NaN  \n",
       "147                                                 []               NaN  \n",
       "148                                                 []               NaN  \n",
       "149  [SBI-0051920.P004, SBI-0051920.P002, SBI-00519...  SBI-0051920.P004  \n",
       "150                                                 []               NaN  \n",
       "151                                                 []               NaN  \n",
       "152                                                 []               NaN  \n",
       "153                                                 []               NaN  \n",
       "154               [SBI-0654443.P001, SBI-0654440.P001]  SBI-0654443.P001  \n",
       "155                                                 []               NaN  \n",
       "156                                                 []               NaN  \n",
       "157                                                 []               NaN  \n",
       "158                                                 []               NaN  \n",
       "\n",
       "[159 rows x 11 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effective_exp = all_drugs_from_exp[all_drugs_from_exp.apply(lambda x: any([x['G3'],x['G4'],x['SHH']]), axis=1)]\n",
    "effective_exp = effective_exp.reset_index(drop=True)\n",
    "effective_exp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-01-05T04:08:12.782056Z",
     "start_time": "2019-01-05T04:08:11.956Z"
    }
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:57:56.228469Z",
     "start_time": "2019-04-19T20:57:56.119644Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_name</th>\n",
       "      <th>sbi_id</th>\n",
       "      <th>pubchem_cid</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>BT084</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>MB002</th>\n",
       "      <th>...</th>\n",
       "      <th>MED411</th>\n",
       "      <th>RCMB20</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>RCMB40</th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>RCMB38</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(4-(p-(diethylamino)-alpha-phenylbenzylidene)-...</td>\n",
       "      <td>SBI-0653846.0001</td>\n",
       "      <td>12450.0</td>\n",
       "      <td>3.481889</td>\n",
       "      <td>3.828240</td>\n",
       "      <td>7.610323</td>\n",
       "      <td>3.065455</td>\n",
       "      <td>8.250944</td>\n",
       "      <td>3.937452</td>\n",
       "      <td>4.197368</td>\n",
       "      <td>...</td>\n",
       "      <td>24.699474</td>\n",
       "      <td>5.161500</td>\n",
       "      <td>3.557933</td>\n",
       "      <td>6.509765</td>\n",
       "      <td>6.840454</td>\n",
       "      <td>4.733371</td>\n",
       "      <td>2.981917</td>\n",
       "      <td>4.951227</td>\n",
       "      <td>7.378294</td>\n",
       "      <td>6.650917</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>nvp-bgt226</td>\n",
       "      <td>SBI-0654465.P001</td>\n",
       "      <td>11978790.0</td>\n",
       "      <td>7.272578</td>\n",
       "      <td>6.186267</td>\n",
       "      <td>7.566144</td>\n",
       "      <td>10.415518</td>\n",
       "      <td>12.210541</td>\n",
       "      <td>40.567737</td>\n",
       "      <td>3.739998</td>\n",
       "      <td>...</td>\n",
       "      <td>9.025518</td>\n",
       "      <td>12.670348</td>\n",
       "      <td>14.144575</td>\n",
       "      <td>5.951729</td>\n",
       "      <td>21.422257</td>\n",
       "      <td>4.975142</td>\n",
       "      <td>49.141068</td>\n",
       "      <td>6.528873</td>\n",
       "      <td>22.220716</td>\n",
       "      <td>7.506924</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>phenylmercuric acetate</td>\n",
       "      <td>SBI-0051573.P001</td>\n",
       "      <td>16682730.0</td>\n",
       "      <td>37.762308</td>\n",
       "      <td>9.225441</td>\n",
       "      <td>29.516886</td>\n",
       "      <td>73.820655</td>\n",
       "      <td>23.049054</td>\n",
       "      <td>45.852417</td>\n",
       "      <td>14.474181</td>\n",
       "      <td>...</td>\n",
       "      <td>1.747090</td>\n",
       "      <td>22.626782</td>\n",
       "      <td>21.370519</td>\n",
       "      <td>4.448983</td>\n",
       "      <td>23.018599</td>\n",
       "      <td>15.108849</td>\n",
       "      <td>2.507212</td>\n",
       "      <td>2.349719</td>\n",
       "      <td>1.933107</td>\n",
       "      <td>7.096385</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>trichostatin a /// trichostatin a (tsa)</td>\n",
       "      <td>SBI-0646028.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32.683160</td>\n",
       "      <td>8.237700</td>\n",
       "      <td>12.750988</td>\n",
       "      <td>34.286193</td>\n",
       "      <td>35.394355</td>\n",
       "      <td>48.409684</td>\n",
       "      <td>3.765314</td>\n",
       "      <td>...</td>\n",
       "      <td>5.227074</td>\n",
       "      <td>16.744563</td>\n",
       "      <td>10.233100</td>\n",
       "      <td>8.876335</td>\n",
       "      <td>13.646809</td>\n",
       "      <td>6.754617</td>\n",
       "      <td>52.846806</td>\n",
       "      <td>27.046102</td>\n",
       "      <td>26.572230</td>\n",
       "      <td>15.326381</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>okadaic acid, prorocentrum sp.</td>\n",
       "      <td>SBI-0634592</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7.450082</td>\n",
       "      <td>11.974682</td>\n",
       "      <td>10.173365</td>\n",
       "      <td>24.579803</td>\n",
       "      <td>13.991793</td>\n",
       "      <td>29.452688</td>\n",
       "      <td>39.378469</td>\n",
       "      <td>...</td>\n",
       "      <td>9.200899</td>\n",
       "      <td>56.970600</td>\n",
       "      <td>20.717944</td>\n",
       "      <td>16.974388</td>\n",
       "      <td>12.516104</td>\n",
       "      <td>17.638380</td>\n",
       "      <td>32.528280</td>\n",
       "      <td>27.588029</td>\n",
       "      <td>21.240651</td>\n",
       "      <td>26.758357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0637109.P001</td>\n",
       "      <td>6918811.0</td>\n",
       "      <td>20.074210</td>\n",
       "      <td>13.028794</td>\n",
       "      <td>14.183187</td>\n",
       "      <td>14.041306</td>\n",
       "      <td>28.425341</td>\n",
       "      <td>60.122885</td>\n",
       "      <td>14.619912</td>\n",
       "      <td>...</td>\n",
       "      <td>14.110818</td>\n",
       "      <td>24.070025</td>\n",
       "      <td>9.088454</td>\n",
       "      <td>9.819705</td>\n",
       "      <td>20.895311</td>\n",
       "      <td>5.109335</td>\n",
       "      <td>41.421995</td>\n",
       "      <td>35.920239</td>\n",
       "      <td>14.822742</td>\n",
       "      <td>39.726392</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>nsc-3852</td>\n",
       "      <td>SBI-0053105.P002</td>\n",
       "      <td>19103.0</td>\n",
       "      <td>4.070117</td>\n",
       "      <td>4.813542</td>\n",
       "      <td>6.962432</td>\n",
       "      <td>46.562295</td>\n",
       "      <td>77.233449</td>\n",
       "      <td>78.831142</td>\n",
       "      <td>31.711066</td>\n",
       "      <td>...</td>\n",
       "      <td>5.030922</td>\n",
       "      <td>13.493590</td>\n",
       "      <td>6.921222</td>\n",
       "      <td>9.421569</td>\n",
       "      <td>8.250854</td>\n",
       "      <td>5.733644</td>\n",
       "      <td>46.949368</td>\n",
       "      <td>17.173463</td>\n",
       "      <td>11.537894</td>\n",
       "      <td>7.622506</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>bortezomib</td>\n",
       "      <td>SBI-0634428.P001</td>\n",
       "      <td>387447.0</td>\n",
       "      <td>28.904780</td>\n",
       "      <td>9.289674</td>\n",
       "      <td>11.687265</td>\n",
       "      <td>58.398635</td>\n",
       "      <td>40.209213</td>\n",
       "      <td>47.164608</td>\n",
       "      <td>8.513036</td>\n",
       "      <td>...</td>\n",
       "      <td>5.753374</td>\n",
       "      <td>44.619036</td>\n",
       "      <td>6.707559</td>\n",
       "      <td>15.824040</td>\n",
       "      <td>7.743592</td>\n",
       "      <td>6.238729</td>\n",
       "      <td>38.131601</td>\n",
       "      <td>15.405000</td>\n",
       "      <td>17.688189</td>\n",
       "      <td>25.994153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>trichostatin a, streptomyces sp.</td>\n",
       "      <td>SBI-0634645</td>\n",
       "      <td>NaN</td>\n",
       "      <td>34.251740</td>\n",
       "      <td>10.313395</td>\n",
       "      <td>19.266798</td>\n",
       "      <td>38.302093</td>\n",
       "      <td>32.594430</td>\n",
       "      <td>43.375099</td>\n",
       "      <td>7.174994</td>\n",
       "      <td>...</td>\n",
       "      <td>5.655566</td>\n",
       "      <td>34.063590</td>\n",
       "      <td>16.760022</td>\n",
       "      <td>15.749824</td>\n",
       "      <td>20.469380</td>\n",
       "      <td>8.018375</td>\n",
       "      <td>47.622812</td>\n",
       "      <td>28.822322</td>\n",
       "      <td>29.981218</td>\n",
       "      <td>14.373842</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>brefeldin a from penicillium brefeldianum</td>\n",
       "      <td>SBI-0050152.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>26.211358</td>\n",
       "      <td>7.986145</td>\n",
       "      <td>27.318862</td>\n",
       "      <td>24.682452</td>\n",
       "      <td>30.237049</td>\n",
       "      <td>13.940191</td>\n",
       "      <td>5.615528</td>\n",
       "      <td>...</td>\n",
       "      <td>7.957869</td>\n",
       "      <td>45.801626</td>\n",
       "      <td>23.978652</td>\n",
       "      <td>14.783029</td>\n",
       "      <td>33.108746</td>\n",
       "      <td>7.990721</td>\n",
       "      <td>35.917460</td>\n",
       "      <td>10.392108</td>\n",
       "      <td>31.786618</td>\n",
       "      <td>27.650176</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>idarubicin /// idarubicin hcl</td>\n",
       "      <td>SBI-0050582.P002</td>\n",
       "      <td>42890.0</td>\n",
       "      <td>4.711210</td>\n",
       "      <td>6.341952</td>\n",
       "      <td>11.029932</td>\n",
       "      <td>82.114429</td>\n",
       "      <td>86.559684</td>\n",
       "      <td>85.529118</td>\n",
       "      <td>21.544355</td>\n",
       "      <td>...</td>\n",
       "      <td>3.407843</td>\n",
       "      <td>21.898447</td>\n",
       "      <td>5.109860</td>\n",
       "      <td>9.966233</td>\n",
       "      <td>6.333221</td>\n",
       "      <td>6.086391</td>\n",
       "      <td>38.907633</td>\n",
       "      <td>32.246601</td>\n",
       "      <td>15.874748</td>\n",
       "      <td>17.335612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>mg-132 /// mg132</td>\n",
       "      <td>SBI-0207107</td>\n",
       "      <td>462382.0</td>\n",
       "      <td>30.220261</td>\n",
       "      <td>6.442114</td>\n",
       "      <td>18.652017</td>\n",
       "      <td>59.592301</td>\n",
       "      <td>47.466466</td>\n",
       "      <td>60.360104</td>\n",
       "      <td>10.046581</td>\n",
       "      <td>...</td>\n",
       "      <td>8.314901</td>\n",
       "      <td>52.168530</td>\n",
       "      <td>9.984477</td>\n",
       "      <td>13.397539</td>\n",
       "      <td>6.558522</td>\n",
       "      <td>7.835103</td>\n",
       "      <td>35.620538</td>\n",
       "      <td>18.474456</td>\n",
       "      <td>23.196315</td>\n",
       "      <td>24.863853</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>oxamflatin</td>\n",
       "      <td>SBI-0646042.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>39.161261</td>\n",
       "      <td>15.036119</td>\n",
       "      <td>13.713638</td>\n",
       "      <td>38.550641</td>\n",
       "      <td>57.283319</td>\n",
       "      <td>49.916785</td>\n",
       "      <td>7.303958</td>\n",
       "      <td>...</td>\n",
       "      <td>21.311176</td>\n",
       "      <td>31.503111</td>\n",
       "      <td>38.811669</td>\n",
       "      <td>14.132360</td>\n",
       "      <td>33.531015</td>\n",
       "      <td>11.961115</td>\n",
       "      <td>44.938544</td>\n",
       "      <td>28.998735</td>\n",
       "      <td>42.975647</td>\n",
       "      <td>11.331546</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>gambogic acid /// gambogic acid, garcinia hanb...</td>\n",
       "      <td>SBI-0052104.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>35.711384</td>\n",
       "      <td>13.152295</td>\n",
       "      <td>53.407399</td>\n",
       "      <td>33.226965</td>\n",
       "      <td>44.673777</td>\n",
       "      <td>49.967211</td>\n",
       "      <td>5.330060</td>\n",
       "      <td>...</td>\n",
       "      <td>13.440698</td>\n",
       "      <td>11.564723</td>\n",
       "      <td>16.792869</td>\n",
       "      <td>75.120368</td>\n",
       "      <td>7.576626</td>\n",
       "      <td>47.151280</td>\n",
       "      <td>78.280303</td>\n",
       "      <td>3.118636</td>\n",
       "      <td>23.386999</td>\n",
       "      <td>41.016382</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0634389.P001</td>\n",
       "      <td>3085107.0</td>\n",
       "      <td>15.491566</td>\n",
       "      <td>11.677736</td>\n",
       "      <td>12.307656</td>\n",
       "      <td>84.232665</td>\n",
       "      <td>78.712706</td>\n",
       "      <td>88.271432</td>\n",
       "      <td>17.899099</td>\n",
       "      <td>...</td>\n",
       "      <td>4.737159</td>\n",
       "      <td>33.178226</td>\n",
       "      <td>7.262092</td>\n",
       "      <td>8.592953</td>\n",
       "      <td>9.799952</td>\n",
       "      <td>6.759306</td>\n",
       "      <td>58.194855</td>\n",
       "      <td>42.100265</td>\n",
       "      <td>32.653348</td>\n",
       "      <td>37.038002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>celastrol /// celastrol, celastrus scandens</td>\n",
       "      <td>SBI-0051253</td>\n",
       "      <td>122724.0</td>\n",
       "      <td>9.337936</td>\n",
       "      <td>14.054296</td>\n",
       "      <td>29.417953</td>\n",
       "      <td>27.181584</td>\n",
       "      <td>38.872772</td>\n",
       "      <td>96.993641</td>\n",
       "      <td>27.831428</td>\n",
       "      <td>...</td>\n",
       "      <td>3.811108</td>\n",
       "      <td>68.132295</td>\n",
       "      <td>30.925061</td>\n",
       "      <td>39.633985</td>\n",
       "      <td>14.882522</td>\n",
       "      <td>11.571085</td>\n",
       "      <td>31.487798</td>\n",
       "      <td>23.000208</td>\n",
       "      <td>24.640859</td>\n",
       "      <td>21.468049</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>celastrol /// celastrol, celastrus scandens</td>\n",
       "      <td>SBI-0051253.P001</td>\n",
       "      <td>122724.0</td>\n",
       "      <td>22.636450</td>\n",
       "      <td>35.592458</td>\n",
       "      <td>68.149036</td>\n",
       "      <td>28.898380</td>\n",
       "      <td>17.063320</td>\n",
       "      <td>31.886237</td>\n",
       "      <td>11.909786</td>\n",
       "      <td>...</td>\n",
       "      <td>3.893565</td>\n",
       "      <td>14.430553</td>\n",
       "      <td>14.891219</td>\n",
       "      <td>96.620827</td>\n",
       "      <td>11.357228</td>\n",
       "      <td>47.427337</td>\n",
       "      <td>106.024275</td>\n",
       "      <td>7.093396</td>\n",
       "      <td>66.807203</td>\n",
       "      <td>71.110414</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P007</td>\n",
       "      <td>4212.0</td>\n",
       "      <td>37.036119</td>\n",
       "      <td>8.316659</td>\n",
       "      <td>12.457651</td>\n",
       "      <td>84.279397</td>\n",
       "      <td>95.313356</td>\n",
       "      <td>91.927876</td>\n",
       "      <td>34.322822</td>\n",
       "      <td>...</td>\n",
       "      <td>46.836295</td>\n",
       "      <td>20.791157</td>\n",
       "      <td>9.479611</td>\n",
       "      <td>26.540828</td>\n",
       "      <td>9.243692</td>\n",
       "      <td>7.930590</td>\n",
       "      <td>57.704618</td>\n",
       "      <td>22.457214</td>\n",
       "      <td>35.989782</td>\n",
       "      <td>48.758791</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0206677.P003</td>\n",
       "      <td>30323.0</td>\n",
       "      <td>55.629873</td>\n",
       "      <td>33.557970</td>\n",
       "      <td>12.803056</td>\n",
       "      <td>82.684510</td>\n",
       "      <td>78.464315</td>\n",
       "      <td>75.759625</td>\n",
       "      <td>19.855923</td>\n",
       "      <td>...</td>\n",
       "      <td>8.996225</td>\n",
       "      <td>18.943203</td>\n",
       "      <td>7.897596</td>\n",
       "      <td>8.960341</td>\n",
       "      <td>16.216291</td>\n",
       "      <td>5.146765</td>\n",
       "      <td>67.598865</td>\n",
       "      <td>53.344896</td>\n",
       "      <td>47.952810</td>\n",
       "      <td>50.793033</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0206677.P002</td>\n",
       "      <td>30323.0</td>\n",
       "      <td>19.260041</td>\n",
       "      <td>15.135673</td>\n",
       "      <td>35.553832</td>\n",
       "      <td>100.118341</td>\n",
       "      <td>99.462988</td>\n",
       "      <td>98.354917</td>\n",
       "      <td>38.609729</td>\n",
       "      <td>...</td>\n",
       "      <td>36.803189</td>\n",
       "      <td>40.305462</td>\n",
       "      <td>5.260710</td>\n",
       "      <td>7.899596</td>\n",
       "      <td>11.127905</td>\n",
       "      <td>6.888940</td>\n",
       "      <td>70.926375</td>\n",
       "      <td>10.362168</td>\n",
       "      <td>35.250908</td>\n",
       "      <td>43.828153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>oleandrin</td>\n",
       "      <td>SBI-0052768.P001</td>\n",
       "      <td>6708811.0</td>\n",
       "      <td>40.468801</td>\n",
       "      <td>15.855284</td>\n",
       "      <td>41.094254</td>\n",
       "      <td>31.068708</td>\n",
       "      <td>35.525735</td>\n",
       "      <td>28.123865</td>\n",
       "      <td>12.269748</td>\n",
       "      <td>...</td>\n",
       "      <td>21.640957</td>\n",
       "      <td>18.001032</td>\n",
       "      <td>25.317958</td>\n",
       "      <td>22.293480</td>\n",
       "      <td>44.930271</td>\n",
       "      <td>27.663442</td>\n",
       "      <td>77.186973</td>\n",
       "      <td>81.028695</td>\n",
       "      <td>62.805935</td>\n",
       "      <td>70.770525</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>m-344, histone deacetylase inhibitor iii</td>\n",
       "      <td>SBI-0634549.P002</td>\n",
       "      <td>3994.0</td>\n",
       "      <td>44.134435</td>\n",
       "      <td>11.620595</td>\n",
       "      <td>28.273389</td>\n",
       "      <td>55.726328</td>\n",
       "      <td>45.420346</td>\n",
       "      <td>58.077390</td>\n",
       "      <td>7.488277</td>\n",
       "      <td>...</td>\n",
       "      <td>18.296099</td>\n",
       "      <td>44.014181</td>\n",
       "      <td>51.404995</td>\n",
       "      <td>36.730689</td>\n",
       "      <td>51.684425</td>\n",
       "      <td>12.999663</td>\n",
       "      <td>64.181028</td>\n",
       "      <td>46.975889</td>\n",
       "      <td>44.362622</td>\n",
       "      <td>18.764625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P004</td>\n",
       "      <td>4212.0</td>\n",
       "      <td>15.408423</td>\n",
       "      <td>13.185432</td>\n",
       "      <td>18.500567</td>\n",
       "      <td>93.470182</td>\n",
       "      <td>98.704520</td>\n",
       "      <td>101.927531</td>\n",
       "      <td>39.733566</td>\n",
       "      <td>...</td>\n",
       "      <td>12.273326</td>\n",
       "      <td>36.904710</td>\n",
       "      <td>6.778478</td>\n",
       "      <td>20.587582</td>\n",
       "      <td>6.861337</td>\n",
       "      <td>12.908048</td>\n",
       "      <td>66.193436</td>\n",
       "      <td>12.797780</td>\n",
       "      <td>55.549180</td>\n",
       "      <td>48.773468</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P002</td>\n",
       "      <td>4212.0</td>\n",
       "      <td>38.570951</td>\n",
       "      <td>14.041546</td>\n",
       "      <td>32.542556</td>\n",
       "      <td>97.304156</td>\n",
       "      <td>97.086938</td>\n",
       "      <td>93.821447</td>\n",
       "      <td>43.236084</td>\n",
       "      <td>...</td>\n",
       "      <td>10.892298</td>\n",
       "      <td>28.413971</td>\n",
       "      <td>8.585473</td>\n",
       "      <td>19.171389</td>\n",
       "      <td>14.329695</td>\n",
       "      <td>7.311943</td>\n",
       "      <td>61.550139</td>\n",
       "      <td>24.154938</td>\n",
       "      <td>40.453340</td>\n",
       "      <td>45.035805</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>SBI-0051229.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30.726614</td>\n",
       "      <td>21.670773</td>\n",
       "      <td>22.001627</td>\n",
       "      <td>40.818123</td>\n",
       "      <td>39.766451</td>\n",
       "      <td>53.157795</td>\n",
       "      <td>12.844309</td>\n",
       "      <td>...</td>\n",
       "      <td>26.954452</td>\n",
       "      <td>73.296854</td>\n",
       "      <td>60.419586</td>\n",
       "      <td>56.546536</td>\n",
       "      <td>39.151118</td>\n",
       "      <td>15.058070</td>\n",
       "      <td>58.630681</td>\n",
       "      <td>31.779608</td>\n",
       "      <td>58.543396</td>\n",
       "      <td>37.339925</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>k-strophanthin beta</td>\n",
       "      <td>SBI-0052688.P001</td>\n",
       "      <td>6708734.0</td>\n",
       "      <td>43.425285</td>\n",
       "      <td>21.054448</td>\n",
       "      <td>46.811867</td>\n",
       "      <td>30.001264</td>\n",
       "      <td>30.627884</td>\n",
       "      <td>27.183112</td>\n",
       "      <td>11.362777</td>\n",
       "      <td>...</td>\n",
       "      <td>20.993617</td>\n",
       "      <td>16.344916</td>\n",
       "      <td>23.581933</td>\n",
       "      <td>28.035154</td>\n",
       "      <td>52.297926</td>\n",
       "      <td>25.251559</td>\n",
       "      <td>82.830693</td>\n",
       "      <td>93.137768</td>\n",
       "      <td>58.322500</td>\n",
       "      <td>82.810175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>SBI-0051229</td>\n",
       "      <td>NaN</td>\n",
       "      <td>33.896903</td>\n",
       "      <td>15.871167</td>\n",
       "      <td>25.072326</td>\n",
       "      <td>39.162679</td>\n",
       "      <td>42.973505</td>\n",
       "      <td>56.376160</td>\n",
       "      <td>13.714061</td>\n",
       "      <td>...</td>\n",
       "      <td>32.105775</td>\n",
       "      <td>69.829008</td>\n",
       "      <td>61.596025</td>\n",
       "      <td>65.476011</td>\n",
       "      <td>37.594391</td>\n",
       "      <td>13.920720</td>\n",
       "      <td>60.285571</td>\n",
       "      <td>32.173435</td>\n",
       "      <td>60.665603</td>\n",
       "      <td>44.716184</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>proscillaridin</td>\n",
       "      <td>SBI-0206671.P002</td>\n",
       "      <td>45114178.0</td>\n",
       "      <td>37.304771</td>\n",
       "      <td>26.038242</td>\n",
       "      <td>35.354755</td>\n",
       "      <td>37.667090</td>\n",
       "      <td>26.974275</td>\n",
       "      <td>23.895405</td>\n",
       "      <td>12.644327</td>\n",
       "      <td>...</td>\n",
       "      <td>44.383987</td>\n",
       "      <td>38.778814</td>\n",
       "      <td>24.872443</td>\n",
       "      <td>30.698141</td>\n",
       "      <td>45.070482</td>\n",
       "      <td>25.493474</td>\n",
       "      <td>87.550639</td>\n",
       "      <td>72.843361</td>\n",
       "      <td>59.986058</td>\n",
       "      <td>81.834454</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>doxorubicin /// doxorubicin hydrochloride /// ...</td>\n",
       "      <td>SBI-0206890.P001</td>\n",
       "      <td>41867.0</td>\n",
       "      <td>25.113222</td>\n",
       "      <td>34.906473</td>\n",
       "      <td>44.348666</td>\n",
       "      <td>87.327303</td>\n",
       "      <td>95.609563</td>\n",
       "      <td>96.973512</td>\n",
       "      <td>48.605145</td>\n",
       "      <td>...</td>\n",
       "      <td>6.253082</td>\n",
       "      <td>59.692592</td>\n",
       "      <td>6.725501</td>\n",
       "      <td>9.279795</td>\n",
       "      <td>12.460868</td>\n",
       "      <td>6.150391</td>\n",
       "      <td>71.474747</td>\n",
       "      <td>28.658155</td>\n",
       "      <td>53.485339</td>\n",
       "      <td>44.112874</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P003</td>\n",
       "      <td>4212.0</td>\n",
       "      <td>18.326153</td>\n",
       "      <td>42.880240</td>\n",
       "      <td>16.633303</td>\n",
       "      <td>88.708414</td>\n",
       "      <td>102.822277</td>\n",
       "      <td>102.025764</td>\n",
       "      <td>48.976575</td>\n",
       "      <td>...</td>\n",
       "      <td>12.399732</td>\n",
       "      <td>37.027750</td>\n",
       "      <td>7.657137</td>\n",
       "      <td>21.811150</td>\n",
       "      <td>9.434569</td>\n",
       "      <td>9.346062</td>\n",
       "      <td>79.538201</td>\n",
       "      <td>14.383852</td>\n",
       "      <td>58.315662</td>\n",
       "      <td>47.276387</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7699</th>\n",
       "      <td>crenolanib (cp-868596)</td>\n",
       "      <td>SBI-0654437.P001</td>\n",
       "      <td>10366136.0</td>\n",
       "      <td>97.636071</td>\n",
       "      <td>123.856128</td>\n",
       "      <td>107.158272</td>\n",
       "      <td>107.856126</td>\n",
       "      <td>105.202053</td>\n",
       "      <td>103.911241</td>\n",
       "      <td>92.813910</td>\n",
       "      <td>...</td>\n",
       "      <td>105.073248</td>\n",
       "      <td>98.013910</td>\n",
       "      <td>100.232942</td>\n",
       "      <td>101.952755</td>\n",
       "      <td>101.024180</td>\n",
       "      <td>150.851143</td>\n",
       "      <td>98.088354</td>\n",
       "      <td>107.208574</td>\n",
       "      <td>110.059086</td>\n",
       "      <td>102.287428</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7700</th>\n",
       "      <td>ctpb</td>\n",
       "      <td>SBI-0646041.P001</td>\n",
       "      <td>10311918.0</td>\n",
       "      <td>102.081986</td>\n",
       "      <td>112.165715</td>\n",
       "      <td>102.809375</td>\n",
       "      <td>106.406017</td>\n",
       "      <td>104.453794</td>\n",
       "      <td>97.154642</td>\n",
       "      <td>110.717902</td>\n",
       "      <td>...</td>\n",
       "      <td>99.707239</td>\n",
       "      <td>113.989907</td>\n",
       "      <td>115.224499</td>\n",
       "      <td>99.355410</td>\n",
       "      <td>105.725337</td>\n",
       "      <td>129.310522</td>\n",
       "      <td>100.060033</td>\n",
       "      <td>102.099406</td>\n",
       "      <td>104.881913</td>\n",
       "      <td>100.303069</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7701</th>\n",
       "      <td>vatalanib /// vatalanib dihydrochloride (ptk787)</td>\n",
       "      <td>SBI-0636205.P002</td>\n",
       "      <td>151194.0</td>\n",
       "      <td>102.000314</td>\n",
       "      <td>103.168482</td>\n",
       "      <td>106.836793</td>\n",
       "      <td>115.112484</td>\n",
       "      <td>106.224398</td>\n",
       "      <td>86.494869</td>\n",
       "      <td>119.013144</td>\n",
       "      <td>...</td>\n",
       "      <td>106.555468</td>\n",
       "      <td>100.473291</td>\n",
       "      <td>107.414972</td>\n",
       "      <td>103.915562</td>\n",
       "      <td>112.289340</td>\n",
       "      <td>120.303843</td>\n",
       "      <td>105.729901</td>\n",
       "      <td>105.869066</td>\n",
       "      <td>102.771608</td>\n",
       "      <td>111.225608</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7702</th>\n",
       "      <td>alsterpaullone</td>\n",
       "      <td>SBI-0086727.P003</td>\n",
       "      <td>5005498.0</td>\n",
       "      <td>102.539210</td>\n",
       "      <td>123.565241</td>\n",
       "      <td>106.618214</td>\n",
       "      <td>99.457990</td>\n",
       "      <td>106.562322</td>\n",
       "      <td>102.848093</td>\n",
       "      <td>100.189862</td>\n",
       "      <td>...</td>\n",
       "      <td>106.905599</td>\n",
       "      <td>107.774842</td>\n",
       "      <td>107.110734</td>\n",
       "      <td>111.207340</td>\n",
       "      <td>98.862829</td>\n",
       "      <td>121.172919</td>\n",
       "      <td>97.655716</td>\n",
       "      <td>104.493446</td>\n",
       "      <td>99.864829</td>\n",
       "      <td>102.287753</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7703</th>\n",
       "      <td>telatinib (bay 57-9352)</td>\n",
       "      <td>SBI-0654411.P001</td>\n",
       "      <td>9808844.0</td>\n",
       "      <td>107.861708</td>\n",
       "      <td>110.366202</td>\n",
       "      <td>102.809394</td>\n",
       "      <td>103.746245</td>\n",
       "      <td>103.172311</td>\n",
       "      <td>102.106052</td>\n",
       "      <td>109.107359</td>\n",
       "      <td>...</td>\n",
       "      <td>107.898183</td>\n",
       "      <td>109.397736</td>\n",
       "      <td>110.744995</td>\n",
       "      <td>100.456651</td>\n",
       "      <td>103.681114</td>\n",
       "      <td>126.271843</td>\n",
       "      <td>103.526407</td>\n",
       "      <td>105.295979</td>\n",
       "      <td>104.410089</td>\n",
       "      <td>109.193978</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7704</th>\n",
       "      <td>nepafenac</td>\n",
       "      <td>SBI-0654191.0001</td>\n",
       "      <td>151075.0</td>\n",
       "      <td>108.276546</td>\n",
       "      <td>114.765733</td>\n",
       "      <td>104.627136</td>\n",
       "      <td>106.735799</td>\n",
       "      <td>102.316638</td>\n",
       "      <td>107.678167</td>\n",
       "      <td>110.396360</td>\n",
       "      <td>...</td>\n",
       "      <td>112.919808</td>\n",
       "      <td>104.014048</td>\n",
       "      <td>114.405489</td>\n",
       "      <td>105.915309</td>\n",
       "      <td>100.937681</td>\n",
       "      <td>107.748709</td>\n",
       "      <td>105.586762</td>\n",
       "      <td>104.638976</td>\n",
       "      <td>105.328034</td>\n",
       "      <td>103.553534</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7705</th>\n",
       "      <td>indirubin-3'-monoxime, 5-iodo-</td>\n",
       "      <td>SBI-0207163.P002</td>\n",
       "      <td>5472313.0</td>\n",
       "      <td>102.857173</td>\n",
       "      <td>125.247964</td>\n",
       "      <td>113.254217</td>\n",
       "      <td>101.671980</td>\n",
       "      <td>101.986290</td>\n",
       "      <td>118.913356</td>\n",
       "      <td>97.011378</td>\n",
       "      <td>...</td>\n",
       "      <td>98.306723</td>\n",
       "      <td>106.878239</td>\n",
       "      <td>112.957052</td>\n",
       "      <td>110.524654</td>\n",
       "      <td>106.054933</td>\n",
       "      <td>103.925747</td>\n",
       "      <td>102.119789</td>\n",
       "      <td>107.734045</td>\n",
       "      <td>94.542989</td>\n",
       "      <td>105.925164</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7706</th>\n",
       "      <td>chir-98014</td>\n",
       "      <td>SBI-0654464.P001</td>\n",
       "      <td>53396311.0</td>\n",
       "      <td>110.186442</td>\n",
       "      <td>116.725426</td>\n",
       "      <td>102.914311</td>\n",
       "      <td>97.848085</td>\n",
       "      <td>104.856249</td>\n",
       "      <td>103.617009</td>\n",
       "      <td>102.157902</td>\n",
       "      <td>...</td>\n",
       "      <td>103.802794</td>\n",
       "      <td>101.071874</td>\n",
       "      <td>107.727366</td>\n",
       "      <td>108.267101</td>\n",
       "      <td>104.781855</td>\n",
       "      <td>102.959563</td>\n",
       "      <td>100.299489</td>\n",
       "      <td>103.006891</td>\n",
       "      <td>97.449178</td>\n",
       "      <td>102.712533</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7707</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0637094.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>104.625401</td>\n",
       "      <td>110.779854</td>\n",
       "      <td>109.162122</td>\n",
       "      <td>104.402558</td>\n",
       "      <td>99.992940</td>\n",
       "      <td>105.466713</td>\n",
       "      <td>105.740786</td>\n",
       "      <td>...</td>\n",
       "      <td>105.835150</td>\n",
       "      <td>103.349863</td>\n",
       "      <td>106.307722</td>\n",
       "      <td>108.628845</td>\n",
       "      <td>105.411550</td>\n",
       "      <td>116.885260</td>\n",
       "      <td>100.390758</td>\n",
       "      <td>101.789694</td>\n",
       "      <td>109.670438</td>\n",
       "      <td>101.022304</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7708</th>\n",
       "      <td>sodium valproate /// valproate sodium /// valp...</td>\n",
       "      <td>SBI-0050864.P008</td>\n",
       "      <td>3121.0</td>\n",
       "      <td>106.982731</td>\n",
       "      <td>105.252519</td>\n",
       "      <td>108.047007</td>\n",
       "      <td>103.946688</td>\n",
       "      <td>105.302246</td>\n",
       "      <td>104.928658</td>\n",
       "      <td>104.647205</td>\n",
       "      <td>...</td>\n",
       "      <td>105.071767</td>\n",
       "      <td>111.082555</td>\n",
       "      <td>105.568633</td>\n",
       "      <td>102.351395</td>\n",
       "      <td>106.847673</td>\n",
       "      <td>113.700390</td>\n",
       "      <td>104.108685</td>\n",
       "      <td>107.993331</td>\n",
       "      <td>109.836023</td>\n",
       "      <td>120.077297</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7709</th>\n",
       "      <td>dcc-2036 (rebastinib)</td>\n",
       "      <td>SBI-0654390.P001</td>\n",
       "      <td>25066467.0</td>\n",
       "      <td>98.172328</td>\n",
       "      <td>108.921884</td>\n",
       "      <td>106.903948</td>\n",
       "      <td>112.187286</td>\n",
       "      <td>110.818961</td>\n",
       "      <td>107.906115</td>\n",
       "      <td>104.440627</td>\n",
       "      <td>...</td>\n",
       "      <td>96.802077</td>\n",
       "      <td>101.878845</td>\n",
       "      <td>116.705042</td>\n",
       "      <td>97.371062</td>\n",
       "      <td>101.613409</td>\n",
       "      <td>126.676242</td>\n",
       "      <td>103.899786</td>\n",
       "      <td>107.904098</td>\n",
       "      <td>102.155169</td>\n",
       "      <td>107.276844</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7710</th>\n",
       "      <td>lapatinib ditosylate (tykerb)</td>\n",
       "      <td>SBI-0634417.P003</td>\n",
       "      <td>208908.0</td>\n",
       "      <td>99.640131</td>\n",
       "      <td>102.716856</td>\n",
       "      <td>100.223690</td>\n",
       "      <td>110.194006</td>\n",
       "      <td>105.076621</td>\n",
       "      <td>108.177404</td>\n",
       "      <td>117.937851</td>\n",
       "      <td>...</td>\n",
       "      <td>101.633139</td>\n",
       "      <td>112.140697</td>\n",
       "      <td>110.654108</td>\n",
       "      <td>100.446498</td>\n",
       "      <td>113.510729</td>\n",
       "      <td>121.390473</td>\n",
       "      <td>106.994234</td>\n",
       "      <td>100.679536</td>\n",
       "      <td>107.790071</td>\n",
       "      <td>109.844034</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7711</th>\n",
       "      <td>prosultiamine</td>\n",
       "      <td>SBI-0654167.0001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>108.697557</td>\n",
       "      <td>107.441076</td>\n",
       "      <td>106.830147</td>\n",
       "      <td>102.560137</td>\n",
       "      <td>102.854841</td>\n",
       "      <td>100.930305</td>\n",
       "      <td>110.682483</td>\n",
       "      <td>...</td>\n",
       "      <td>114.009035</td>\n",
       "      <td>105.372629</td>\n",
       "      <td>112.376203</td>\n",
       "      <td>108.307655</td>\n",
       "      <td>104.769492</td>\n",
       "      <td>108.148950</td>\n",
       "      <td>109.299527</td>\n",
       "      <td>112.217943</td>\n",
       "      <td>105.114958</td>\n",
       "      <td>102.479100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7712</th>\n",
       "      <td>triacetylresveratrol</td>\n",
       "      <td>SBI-0052275.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>101.676297</td>\n",
       "      <td>111.494381</td>\n",
       "      <td>107.417081</td>\n",
       "      <td>112.976389</td>\n",
       "      <td>108.407377</td>\n",
       "      <td>123.646664</td>\n",
       "      <td>108.673899</td>\n",
       "      <td>...</td>\n",
       "      <td>106.967370</td>\n",
       "      <td>103.562435</td>\n",
       "      <td>111.768399</td>\n",
       "      <td>95.450488</td>\n",
       "      <td>104.385676</td>\n",
       "      <td>115.052288</td>\n",
       "      <td>98.207675</td>\n",
       "      <td>99.527455</td>\n",
       "      <td>102.392087</td>\n",
       "      <td>110.462352</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7713</th>\n",
       "      <td>syk inhibitor</td>\n",
       "      <td>SBI-0086712.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>104.822096</td>\n",
       "      <td>119.977971</td>\n",
       "      <td>107.242596</td>\n",
       "      <td>98.770601</td>\n",
       "      <td>96.244199</td>\n",
       "      <td>109.780905</td>\n",
       "      <td>103.549273</td>\n",
       "      <td>...</td>\n",
       "      <td>101.933198</td>\n",
       "      <td>101.490282</td>\n",
       "      <td>105.329540</td>\n",
       "      <td>117.655845</td>\n",
       "      <td>100.202078</td>\n",
       "      <td>143.373628</td>\n",
       "      <td>94.665091</td>\n",
       "      <td>96.670602</td>\n",
       "      <td>110.760842</td>\n",
       "      <td>96.536981</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7714</th>\n",
       "      <td>xl-184 free base (cabozantinib)</td>\n",
       "      <td>SBI-0646928.P001</td>\n",
       "      <td>25102847.0</td>\n",
       "      <td>90.930426</td>\n",
       "      <td>98.659808</td>\n",
       "      <td>107.007358</td>\n",
       "      <td>105.993090</td>\n",
       "      <td>103.120769</td>\n",
       "      <td>102.692916</td>\n",
       "      <td>112.241459</td>\n",
       "      <td>...</td>\n",
       "      <td>109.448740</td>\n",
       "      <td>78.543171</td>\n",
       "      <td>112.302186</td>\n",
       "      <td>109.366831</td>\n",
       "      <td>110.373515</td>\n",
       "      <td>155.338244</td>\n",
       "      <td>73.476549</td>\n",
       "      <td>106.656751</td>\n",
       "      <td>117.943292</td>\n",
       "      <td>107.589170</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7715</th>\n",
       "      <td>met/flt-3/vegfr2 tyrosine kinase inhibitor</td>\n",
       "      <td>SBI-0637103.P001</td>\n",
       "      <td>21081761.0</td>\n",
       "      <td>93.552868</td>\n",
       "      <td>101.812112</td>\n",
       "      <td>104.101054</td>\n",
       "      <td>105.325377</td>\n",
       "      <td>100.948627</td>\n",
       "      <td>110.936304</td>\n",
       "      <td>105.926851</td>\n",
       "      <td>...</td>\n",
       "      <td>104.406124</td>\n",
       "      <td>110.037696</td>\n",
       "      <td>113.603228</td>\n",
       "      <td>102.282793</td>\n",
       "      <td>116.501264</td>\n",
       "      <td>149.617704</td>\n",
       "      <td>101.737096</td>\n",
       "      <td>106.320904</td>\n",
       "      <td>105.652591</td>\n",
       "      <td>105.269511</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7716</th>\n",
       "      <td>aurora kinase inhibitor ii</td>\n",
       "      <td>SBI-0086659.P002</td>\n",
       "      <td>6610278.0</td>\n",
       "      <td>101.566951</td>\n",
       "      <td>101.943280</td>\n",
       "      <td>102.721430</td>\n",
       "      <td>101.792193</td>\n",
       "      <td>97.828545</td>\n",
       "      <td>105.622539</td>\n",
       "      <td>112.949864</td>\n",
       "      <td>...</td>\n",
       "      <td>105.304797</td>\n",
       "      <td>104.738203</td>\n",
       "      <td>103.194617</td>\n",
       "      <td>107.314343</td>\n",
       "      <td>107.237625</td>\n",
       "      <td>122.032505</td>\n",
       "      <td>99.219912</td>\n",
       "      <td>107.209664</td>\n",
       "      <td>108.782904</td>\n",
       "      <td>152.634760</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7717</th>\n",
       "      <td>bms 777607</td>\n",
       "      <td>SBI-0654386.P001</td>\n",
       "      <td>24794418.0</td>\n",
       "      <td>103.816509</td>\n",
       "      <td>89.862038</td>\n",
       "      <td>101.006832</td>\n",
       "      <td>107.717904</td>\n",
       "      <td>101.492450</td>\n",
       "      <td>112.334698</td>\n",
       "      <td>112.201203</td>\n",
       "      <td>...</td>\n",
       "      <td>105.770422</td>\n",
       "      <td>105.799191</td>\n",
       "      <td>114.376341</td>\n",
       "      <td>108.982503</td>\n",
       "      <td>113.322747</td>\n",
       "      <td>146.998892</td>\n",
       "      <td>103.860612</td>\n",
       "      <td>100.650779</td>\n",
       "      <td>103.764861</td>\n",
       "      <td>107.076952</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7718</th>\n",
       "      <td>bms-599626 (ac480)</td>\n",
       "      <td>SBI-0654332.P001</td>\n",
       "      <td>10437018.0</td>\n",
       "      <td>107.397133</td>\n",
       "      <td>113.918380</td>\n",
       "      <td>111.839423</td>\n",
       "      <td>109.481306</td>\n",
       "      <td>102.693356</td>\n",
       "      <td>107.971218</td>\n",
       "      <td>111.130149</td>\n",
       "      <td>...</td>\n",
       "      <td>102.800649</td>\n",
       "      <td>111.805716</td>\n",
       "      <td>111.580731</td>\n",
       "      <td>100.700651</td>\n",
       "      <td>112.194424</td>\n",
       "      <td>108.515049</td>\n",
       "      <td>108.832062</td>\n",
       "      <td>106.251429</td>\n",
       "      <td>103.100165</td>\n",
       "      <td>109.550473</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7719</th>\n",
       "      <td>phthalazinone pyrazole</td>\n",
       "      <td>SBI-0654253.P001</td>\n",
       "      <td>11652621.0</td>\n",
       "      <td>93.181226</td>\n",
       "      <td>94.799401</td>\n",
       "      <td>95.309428</td>\n",
       "      <td>105.400123</td>\n",
       "      <td>100.000621</td>\n",
       "      <td>103.870195</td>\n",
       "      <td>107.003049</td>\n",
       "      <td>...</td>\n",
       "      <td>109.603056</td>\n",
       "      <td>111.845341</td>\n",
       "      <td>113.937702</td>\n",
       "      <td>101.104867</td>\n",
       "      <td>113.640542</td>\n",
       "      <td>138.909939</td>\n",
       "      <td>100.674024</td>\n",
       "      <td>102.286399</td>\n",
       "      <td>90.575053</td>\n",
       "      <td>98.205833</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7720</th>\n",
       "      <td>bio /// gsk-3 inhibitor ix</td>\n",
       "      <td>SBI-0086755.P004</td>\n",
       "      <td>24906282.0</td>\n",
       "      <td>99.060170</td>\n",
       "      <td>104.260044</td>\n",
       "      <td>107.127597</td>\n",
       "      <td>100.245301</td>\n",
       "      <td>105.476259</td>\n",
       "      <td>121.051245</td>\n",
       "      <td>98.136553</td>\n",
       "      <td>...</td>\n",
       "      <td>104.846036</td>\n",
       "      <td>111.575650</td>\n",
       "      <td>117.939710</td>\n",
       "      <td>97.856751</td>\n",
       "      <td>107.616508</td>\n",
       "      <td>122.772108</td>\n",
       "      <td>100.009089</td>\n",
       "      <td>100.660188</td>\n",
       "      <td>96.274669</td>\n",
       "      <td>100.041573</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7721</th>\n",
       "      <td>at9283</td>\n",
       "      <td>SBI-0654347.P001</td>\n",
       "      <td>56965909.0</td>\n",
       "      <td>87.002793</td>\n",
       "      <td>137.590326</td>\n",
       "      <td>91.225081</td>\n",
       "      <td>103.712056</td>\n",
       "      <td>105.314169</td>\n",
       "      <td>101.061366</td>\n",
       "      <td>94.542925</td>\n",
       "      <td>...</td>\n",
       "      <td>78.680953</td>\n",
       "      <td>113.915441</td>\n",
       "      <td>98.557235</td>\n",
       "      <td>101.382853</td>\n",
       "      <td>109.362981</td>\n",
       "      <td>158.380785</td>\n",
       "      <td>98.176744</td>\n",
       "      <td>108.488429</td>\n",
       "      <td>89.180081</td>\n",
       "      <td>106.528460</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7722</th>\n",
       "      <td>bio /// gsk-3 inhibitor ix</td>\n",
       "      <td>SBI-0086755</td>\n",
       "      <td>24906282.0</td>\n",
       "      <td>115.914238</td>\n",
       "      <td>118.469267</td>\n",
       "      <td>106.249510</td>\n",
       "      <td>105.626256</td>\n",
       "      <td>105.001992</td>\n",
       "      <td>109.160173</td>\n",
       "      <td>94.822685</td>\n",
       "      <td>...</td>\n",
       "      <td>101.273719</td>\n",
       "      <td>108.891203</td>\n",
       "      <td>118.143704</td>\n",
       "      <td>102.874571</td>\n",
       "      <td>111.977438</td>\n",
       "      <td>126.370252</td>\n",
       "      <td>123.180458</td>\n",
       "      <td>100.326964</td>\n",
       "      <td>100.677130</td>\n",
       "      <td>105.404765</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7723</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0633754.P001</td>\n",
       "      <td>24906282.0</td>\n",
       "      <td>115.101465</td>\n",
       "      <td>117.976723</td>\n",
       "      <td>111.301239</td>\n",
       "      <td>107.967972</td>\n",
       "      <td>109.937796</td>\n",
       "      <td>123.217327</td>\n",
       "      <td>90.312484</td>\n",
       "      <td>...</td>\n",
       "      <td>101.701592</td>\n",
       "      <td>115.763047</td>\n",
       "      <td>128.422838</td>\n",
       "      <td>106.724947</td>\n",
       "      <td>103.961055</td>\n",
       "      <td>133.545036</td>\n",
       "      <td>105.640165</td>\n",
       "      <td>99.936194</td>\n",
       "      <td>90.843124</td>\n",
       "      <td>112.827384</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7724</th>\n",
       "      <td>sb590885</td>\n",
       "      <td>SBI-0639903.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>107.433028</td>\n",
       "      <td>108.467892</td>\n",
       "      <td>113.898643</td>\n",
       "      <td>113.367500</td>\n",
       "      <td>107.554135</td>\n",
       "      <td>101.535076</td>\n",
       "      <td>109.971967</td>\n",
       "      <td>...</td>\n",
       "      <td>103.128965</td>\n",
       "      <td>108.838502</td>\n",
       "      <td>108.959393</td>\n",
       "      <td>111.853976</td>\n",
       "      <td>105.693738</td>\n",
       "      <td>155.693166</td>\n",
       "      <td>103.466104</td>\n",
       "      <td>101.835443</td>\n",
       "      <td>117.035604</td>\n",
       "      <td>108.450515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7725</th>\n",
       "      <td>abt-869 /// linifanib (abt-869)</td>\n",
       "      <td>SBI-0654273.P001</td>\n",
       "      <td>11485656.0</td>\n",
       "      <td>102.515996</td>\n",
       "      <td>110.262345</td>\n",
       "      <td>100.697138</td>\n",
       "      <td>117.774259</td>\n",
       "      <td>116.736912</td>\n",
       "      <td>105.073632</td>\n",
       "      <td>100.968865</td>\n",
       "      <td>...</td>\n",
       "      <td>102.343165</td>\n",
       "      <td>114.046181</td>\n",
       "      <td>123.427025</td>\n",
       "      <td>112.373954</td>\n",
       "      <td>107.598564</td>\n",
       "      <td>207.599034</td>\n",
       "      <td>108.683281</td>\n",
       "      <td>107.577848</td>\n",
       "      <td>110.940239</td>\n",
       "      <td>109.617023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7726</th>\n",
       "      <td>bms 794833</td>\n",
       "      <td>SBI-0654398.P001</td>\n",
       "      <td>44155856.0</td>\n",
       "      <td>113.494691</td>\n",
       "      <td>107.214759</td>\n",
       "      <td>104.042627</td>\n",
       "      <td>112.514661</td>\n",
       "      <td>101.802235</td>\n",
       "      <td>104.051698</td>\n",
       "      <td>106.958039</td>\n",
       "      <td>...</td>\n",
       "      <td>108.982346</td>\n",
       "      <td>109.194844</td>\n",
       "      <td>113.257614</td>\n",
       "      <td>117.268694</td>\n",
       "      <td>106.327277</td>\n",
       "      <td>183.434452</td>\n",
       "      <td>111.241727</td>\n",
       "      <td>103.500417</td>\n",
       "      <td>116.638976</td>\n",
       "      <td>106.148544</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7727</th>\n",
       "      <td>chir99021</td>\n",
       "      <td>SBI-0654265.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>119.886190</td>\n",
       "      <td>135.908737</td>\n",
       "      <td>110.797270</td>\n",
       "      <td>109.022639</td>\n",
       "      <td>109.878511</td>\n",
       "      <td>102.075384</td>\n",
       "      <td>103.732734</td>\n",
       "      <td>...</td>\n",
       "      <td>98.544410</td>\n",
       "      <td>112.518988</td>\n",
       "      <td>113.074672</td>\n",
       "      <td>117.321394</td>\n",
       "      <td>103.238553</td>\n",
       "      <td>129.701536</td>\n",
       "      <td>113.449488</td>\n",
       "      <td>110.694704</td>\n",
       "      <td>109.199895</td>\n",
       "      <td>105.842650</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7728</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0637085.P001</td>\n",
       "      <td>44251571.0</td>\n",
       "      <td>135.970753</td>\n",
       "      <td>102.787861</td>\n",
       "      <td>126.232325</td>\n",
       "      <td>112.246793</td>\n",
       "      <td>107.420145</td>\n",
       "      <td>94.245835</td>\n",
       "      <td>104.600773</td>\n",
       "      <td>...</td>\n",
       "      <td>118.075732</td>\n",
       "      <td>138.582396</td>\n",
       "      <td>112.321065</td>\n",
       "      <td>118.792603</td>\n",
       "      <td>117.784448</td>\n",
       "      <td>161.899631</td>\n",
       "      <td>108.152470</td>\n",
       "      <td>117.995779</td>\n",
       "      <td>97.337138</td>\n",
       "      <td>120.754876</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>7729 rows × 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              drug_name            sbi_id  \\\n",
       "0     (4-(p-(diethylamino)-alpha-phenylbenzylidene)-...  SBI-0653846.0001   \n",
       "1                                            nvp-bgt226  SBI-0654465.P001   \n",
       "2                                phenylmercuric acetate  SBI-0051573.P001   \n",
       "3               trichostatin a /// trichostatin a (tsa)  SBI-0646028.P001   \n",
       "4                        okadaic acid, prorocentrum sp.       SBI-0634592   \n",
       "5                                                   NaN  SBI-0637109.P001   \n",
       "6                                              nsc-3852  SBI-0053105.P002   \n",
       "7                                            bortezomib  SBI-0634428.P001   \n",
       "8                      trichostatin a, streptomyces sp.       SBI-0634645   \n",
       "9             brefeldin a from penicillium brefeldianum  SBI-0050152.P002   \n",
       "10                        idarubicin /// idarubicin hcl  SBI-0050582.P002   \n",
       "11                                     mg-132 /// mg132       SBI-0207107   \n",
       "12                                           oxamflatin  SBI-0646042.P001   \n",
       "13    gambogic acid /// gambogic acid, garcinia hanb...  SBI-0052104.P001   \n",
       "14                           daunorubicin hydrochloride  SBI-0634389.P001   \n",
       "15          celastrol /// celastrol, celastrus scandens       SBI-0051253   \n",
       "16          celastrol /// celastrol, celastrus scandens  SBI-0051253.P001   \n",
       "17    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P007   \n",
       "18          daunorubicin /// daunorubicin hydrochloride  SBI-0206677.P003   \n",
       "19          daunorubicin /// daunorubicin hydrochloride  SBI-0206677.P002   \n",
       "20                                            oleandrin  SBI-0052768.P001   \n",
       "21             m-344, histone deacetylase inhibitor iii  SBI-0634549.P002   \n",
       "22    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P004   \n",
       "23    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P002   \n",
       "24                                         thapsigargin  SBI-0051229.P002   \n",
       "25                                  k-strophanthin beta  SBI-0052688.P001   \n",
       "26                                         thapsigargin       SBI-0051229   \n",
       "27                                       proscillaridin  SBI-0206671.P002   \n",
       "28    doxorubicin /// doxorubicin hydrochloride /// ...  SBI-0206890.P001   \n",
       "29    mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P003   \n",
       "...                                                 ...               ...   \n",
       "7699                             crenolanib (cp-868596)  SBI-0654437.P001   \n",
       "7700                                               ctpb  SBI-0646041.P001   \n",
       "7701   vatalanib /// vatalanib dihydrochloride (ptk787)  SBI-0636205.P002   \n",
       "7702                                     alsterpaullone  SBI-0086727.P003   \n",
       "7703                            telatinib (bay 57-9352)  SBI-0654411.P001   \n",
       "7704                                          nepafenac  SBI-0654191.0001   \n",
       "7705                     indirubin-3'-monoxime, 5-iodo-  SBI-0207163.P002   \n",
       "7706                                         chir-98014  SBI-0654464.P001   \n",
       "7707                                                NaN  SBI-0637094.P001   \n",
       "7708  sodium valproate /// valproate sodium /// valp...  SBI-0050864.P008   \n",
       "7709                              dcc-2036 (rebastinib)  SBI-0654390.P001   \n",
       "7710                      lapatinib ditosylate (tykerb)  SBI-0634417.P003   \n",
       "7711                                      prosultiamine  SBI-0654167.0001   \n",
       "7712                               triacetylresveratrol  SBI-0052275.P002   \n",
       "7713                                      syk inhibitor  SBI-0086712.P002   \n",
       "7714                    xl-184 free base (cabozantinib)  SBI-0646928.P001   \n",
       "7715         met/flt-3/vegfr2 tyrosine kinase inhibitor  SBI-0637103.P001   \n",
       "7716                         aurora kinase inhibitor ii  SBI-0086659.P002   \n",
       "7717                                         bms 777607  SBI-0654386.P001   \n",
       "7718                                 bms-599626 (ac480)  SBI-0654332.P001   \n",
       "7719                             phthalazinone pyrazole  SBI-0654253.P001   \n",
       "7720                         bio /// gsk-3 inhibitor ix  SBI-0086755.P004   \n",
       "7721                                             at9283  SBI-0654347.P001   \n",
       "7722                         bio /// gsk-3 inhibitor ix       SBI-0086755   \n",
       "7723                                                NaN  SBI-0633754.P001   \n",
       "7724                                           sb590885  SBI-0639903.P002   \n",
       "7725                    abt-869 /// linifanib (abt-869)  SBI-0654273.P001   \n",
       "7726                                         bms 794833  SBI-0654398.P001   \n",
       "7727                                          chir99021  SBI-0654265.P001   \n",
       "7728                                                NaN  SBI-0637085.P001   \n",
       "\n",
       "      pubchem_cid      RCMB32     MED1712      RCMB24      RCMB18       BT084  \\\n",
       "0         12450.0    3.481889    3.828240    7.610323    3.065455    8.250944   \n",
       "1      11978790.0    7.272578    6.186267    7.566144   10.415518   12.210541   \n",
       "2      16682730.0   37.762308    9.225441   29.516886   73.820655   23.049054   \n",
       "3             NaN   32.683160    8.237700   12.750988   34.286193   35.394355   \n",
       "4             NaN    7.450082   11.974682   10.173365   24.579803   13.991793   \n",
       "5       6918811.0   20.074210   13.028794   14.183187   14.041306   28.425341   \n",
       "6         19103.0    4.070117    4.813542    6.962432   46.562295   77.233449   \n",
       "7        387447.0   28.904780    9.289674   11.687265   58.398635   40.209213   \n",
       "8             NaN   34.251740   10.313395   19.266798   38.302093   32.594430   \n",
       "9             NaN   26.211358    7.986145   27.318862   24.682452   30.237049   \n",
       "10        42890.0    4.711210    6.341952   11.029932   82.114429   86.559684   \n",
       "11       462382.0   30.220261    6.442114   18.652017   59.592301   47.466466   \n",
       "12            NaN   39.161261   15.036119   13.713638   38.550641   57.283319   \n",
       "13            NaN   35.711384   13.152295   53.407399   33.226965   44.673777   \n",
       "14      3085107.0   15.491566   11.677736   12.307656   84.232665   78.712706   \n",
       "15       122724.0    9.337936   14.054296   29.417953   27.181584   38.872772   \n",
       "16       122724.0   22.636450   35.592458   68.149036   28.898380   17.063320   \n",
       "17         4212.0   37.036119    8.316659   12.457651   84.279397   95.313356   \n",
       "18        30323.0   55.629873   33.557970   12.803056   82.684510   78.464315   \n",
       "19        30323.0   19.260041   15.135673   35.553832  100.118341   99.462988   \n",
       "20      6708811.0   40.468801   15.855284   41.094254   31.068708   35.525735   \n",
       "21         3994.0   44.134435   11.620595   28.273389   55.726328   45.420346   \n",
       "22         4212.0   15.408423   13.185432   18.500567   93.470182   98.704520   \n",
       "23         4212.0   38.570951   14.041546   32.542556   97.304156   97.086938   \n",
       "24            NaN   30.726614   21.670773   22.001627   40.818123   39.766451   \n",
       "25      6708734.0   43.425285   21.054448   46.811867   30.001264   30.627884   \n",
       "26            NaN   33.896903   15.871167   25.072326   39.162679   42.973505   \n",
       "27     45114178.0   37.304771   26.038242   35.354755   37.667090   26.974275   \n",
       "28        41867.0   25.113222   34.906473   44.348666   87.327303   95.609563   \n",
       "29         4212.0   18.326153   42.880240   16.633303   88.708414  102.822277   \n",
       "...           ...         ...         ...         ...         ...         ...   \n",
       "7699   10366136.0   97.636071  123.856128  107.158272  107.856126  105.202053   \n",
       "7700   10311918.0  102.081986  112.165715  102.809375  106.406017  104.453794   \n",
       "7701     151194.0  102.000314  103.168482  106.836793  115.112484  106.224398   \n",
       "7702    5005498.0  102.539210  123.565241  106.618214   99.457990  106.562322   \n",
       "7703    9808844.0  107.861708  110.366202  102.809394  103.746245  103.172311   \n",
       "7704     151075.0  108.276546  114.765733  104.627136  106.735799  102.316638   \n",
       "7705    5472313.0  102.857173  125.247964  113.254217  101.671980  101.986290   \n",
       "7706   53396311.0  110.186442  116.725426  102.914311   97.848085  104.856249   \n",
       "7707          NaN  104.625401  110.779854  109.162122  104.402558   99.992940   \n",
       "7708       3121.0  106.982731  105.252519  108.047007  103.946688  105.302246   \n",
       "7709   25066467.0   98.172328  108.921884  106.903948  112.187286  110.818961   \n",
       "7710     208908.0   99.640131  102.716856  100.223690  110.194006  105.076621   \n",
       "7711          NaN  108.697557  107.441076  106.830147  102.560137  102.854841   \n",
       "7712          NaN  101.676297  111.494381  107.417081  112.976389  108.407377   \n",
       "7713          NaN  104.822096  119.977971  107.242596   98.770601   96.244199   \n",
       "7714   25102847.0   90.930426   98.659808  107.007358  105.993090  103.120769   \n",
       "7715   21081761.0   93.552868  101.812112  104.101054  105.325377  100.948627   \n",
       "7716    6610278.0  101.566951  101.943280  102.721430  101.792193   97.828545   \n",
       "7717   24794418.0  103.816509   89.862038  101.006832  107.717904  101.492450   \n",
       "7718   10437018.0  107.397133  113.918380  111.839423  109.481306  102.693356   \n",
       "7719   11652621.0   93.181226   94.799401   95.309428  105.400123  100.000621   \n",
       "7720   24906282.0   99.060170  104.260044  107.127597  100.245301  105.476259   \n",
       "7721   56965909.0   87.002793  137.590326   91.225081  103.712056  105.314169   \n",
       "7722   24906282.0  115.914238  118.469267  106.249510  105.626256  105.001992   \n",
       "7723   24906282.0  115.101465  117.976723  111.301239  107.967972  109.937796   \n",
       "7724          NaN  107.433028  108.467892  113.898643  113.367500  107.554135   \n",
       "7725   11485656.0  102.515996  110.262345  100.697138  117.774259  116.736912   \n",
       "7726   44155856.0  113.494691  107.214759  104.042627  112.514661  101.802235   \n",
       "7727          NaN  119.886190  135.908737  110.797270  109.022639  109.878511   \n",
       "7728   44251571.0  135.970753  102.787861  126.232325  112.246793  107.420145   \n",
       "\n",
       "          ICB984       MB002     ...          MED411      RCMB20      RCMB28  \\\n",
       "0       3.937452    4.197368     ...       24.699474    5.161500    3.557933   \n",
       "1      40.567737    3.739998     ...        9.025518   12.670348   14.144575   \n",
       "2      45.852417   14.474181     ...        1.747090   22.626782   21.370519   \n",
       "3      48.409684    3.765314     ...        5.227074   16.744563   10.233100   \n",
       "4      29.452688   39.378469     ...        9.200899   56.970600   20.717944   \n",
       "5      60.122885   14.619912     ...       14.110818   24.070025    9.088454   \n",
       "6      78.831142   31.711066     ...        5.030922   13.493590    6.921222   \n",
       "7      47.164608    8.513036     ...        5.753374   44.619036    6.707559   \n",
       "8      43.375099    7.174994     ...        5.655566   34.063590   16.760022   \n",
       "9      13.940191    5.615528     ...        7.957869   45.801626   23.978652   \n",
       "10     85.529118   21.544355     ...        3.407843   21.898447    5.109860   \n",
       "11     60.360104   10.046581     ...        8.314901   52.168530    9.984477   \n",
       "12     49.916785    7.303958     ...       21.311176   31.503111   38.811669   \n",
       "13     49.967211    5.330060     ...       13.440698   11.564723   16.792869   \n",
       "14     88.271432   17.899099     ...        4.737159   33.178226    7.262092   \n",
       "15     96.993641   27.831428     ...        3.811108   68.132295   30.925061   \n",
       "16     31.886237   11.909786     ...        3.893565   14.430553   14.891219   \n",
       "17     91.927876   34.322822     ...       46.836295   20.791157    9.479611   \n",
       "18     75.759625   19.855923     ...        8.996225   18.943203    7.897596   \n",
       "19     98.354917   38.609729     ...       36.803189   40.305462    5.260710   \n",
       "20     28.123865   12.269748     ...       21.640957   18.001032   25.317958   \n",
       "21     58.077390    7.488277     ...       18.296099   44.014181   51.404995   \n",
       "22    101.927531   39.733566     ...       12.273326   36.904710    6.778478   \n",
       "23     93.821447   43.236084     ...       10.892298   28.413971    8.585473   \n",
       "24     53.157795   12.844309     ...       26.954452   73.296854   60.419586   \n",
       "25     27.183112   11.362777     ...       20.993617   16.344916   23.581933   \n",
       "26     56.376160   13.714061     ...       32.105775   69.829008   61.596025   \n",
       "27     23.895405   12.644327     ...       44.383987   38.778814   24.872443   \n",
       "28     96.973512   48.605145     ...        6.253082   59.692592    6.725501   \n",
       "29    102.025764   48.976575     ...       12.399732   37.027750    7.657137   \n",
       "...          ...         ...     ...             ...         ...         ...   \n",
       "7699  103.911241   92.813910     ...      105.073248   98.013910  100.232942   \n",
       "7700   97.154642  110.717902     ...       99.707239  113.989907  115.224499   \n",
       "7701   86.494869  119.013144     ...      106.555468  100.473291  107.414972   \n",
       "7702  102.848093  100.189862     ...      106.905599  107.774842  107.110734   \n",
       "7703  102.106052  109.107359     ...      107.898183  109.397736  110.744995   \n",
       "7704  107.678167  110.396360     ...      112.919808  104.014048  114.405489   \n",
       "7705  118.913356   97.011378     ...       98.306723  106.878239  112.957052   \n",
       "7706  103.617009  102.157902     ...      103.802794  101.071874  107.727366   \n",
       "7707  105.466713  105.740786     ...      105.835150  103.349863  106.307722   \n",
       "7708  104.928658  104.647205     ...      105.071767  111.082555  105.568633   \n",
       "7709  107.906115  104.440627     ...       96.802077  101.878845  116.705042   \n",
       "7710  108.177404  117.937851     ...      101.633139  112.140697  110.654108   \n",
       "7711  100.930305  110.682483     ...      114.009035  105.372629  112.376203   \n",
       "7712  123.646664  108.673899     ...      106.967370  103.562435  111.768399   \n",
       "7713  109.780905  103.549273     ...      101.933198  101.490282  105.329540   \n",
       "7714  102.692916  112.241459     ...      109.448740   78.543171  112.302186   \n",
       "7715  110.936304  105.926851     ...      104.406124  110.037696  113.603228   \n",
       "7716  105.622539  112.949864     ...      105.304797  104.738203  103.194617   \n",
       "7717  112.334698  112.201203     ...      105.770422  105.799191  114.376341   \n",
       "7718  107.971218  111.130149     ...      102.800649  111.805716  111.580731   \n",
       "7719  103.870195  107.003049     ...      109.603056  111.845341  113.937702   \n",
       "7720  121.051245   98.136553     ...      104.846036  111.575650  117.939710   \n",
       "7721  101.061366   94.542925     ...       78.680953  113.915441   98.557235   \n",
       "7722  109.160173   94.822685     ...      101.273719  108.891203  118.143704   \n",
       "7723  123.217327   90.312484     ...      101.701592  115.763047  128.422838   \n",
       "7724  101.535076  109.971967     ...      103.128965  108.838502  108.959393   \n",
       "7725  105.073632  100.968865     ...      102.343165  114.046181  123.427025   \n",
       "7726  104.051698  106.958039     ...      108.982346  109.194844  113.257614   \n",
       "7727  102.075384  103.732734     ...       98.544410  112.518988  113.074672   \n",
       "7728   94.245835  104.600773     ...      118.075732  138.582396  112.321065   \n",
       "\n",
       "          RCMB40     ICB1299     ICB1572     ICB1487      DMB006     MED2312  \\\n",
       "0       6.509765    6.840454    4.733371    2.981917    4.951227    7.378294   \n",
       "1       5.951729   21.422257    4.975142   49.141068    6.528873   22.220716   \n",
       "2       4.448983   23.018599   15.108849    2.507212    2.349719    1.933107   \n",
       "3       8.876335   13.646809    6.754617   52.846806   27.046102   26.572230   \n",
       "4      16.974388   12.516104   17.638380   32.528280   27.588029   21.240651   \n",
       "5       9.819705   20.895311    5.109335   41.421995   35.920239   14.822742   \n",
       "6       9.421569    8.250854    5.733644   46.949368   17.173463   11.537894   \n",
       "7      15.824040    7.743592    6.238729   38.131601   15.405000   17.688189   \n",
       "8      15.749824   20.469380    8.018375   47.622812   28.822322   29.981218   \n",
       "9      14.783029   33.108746    7.990721   35.917460   10.392108   31.786618   \n",
       "10      9.966233    6.333221    6.086391   38.907633   32.246601   15.874748   \n",
       "11     13.397539    6.558522    7.835103   35.620538   18.474456   23.196315   \n",
       "12     14.132360   33.531015   11.961115   44.938544   28.998735   42.975647   \n",
       "13     75.120368    7.576626   47.151280   78.280303    3.118636   23.386999   \n",
       "14      8.592953    9.799952    6.759306   58.194855   42.100265   32.653348   \n",
       "15     39.633985   14.882522   11.571085   31.487798   23.000208   24.640859   \n",
       "16     96.620827   11.357228   47.427337  106.024275    7.093396   66.807203   \n",
       "17     26.540828    9.243692    7.930590   57.704618   22.457214   35.989782   \n",
       "18      8.960341   16.216291    5.146765   67.598865   53.344896   47.952810   \n",
       "19      7.899596   11.127905    6.888940   70.926375   10.362168   35.250908   \n",
       "20     22.293480   44.930271   27.663442   77.186973   81.028695   62.805935   \n",
       "21     36.730689   51.684425   12.999663   64.181028   46.975889   44.362622   \n",
       "22     20.587582    6.861337   12.908048   66.193436   12.797780   55.549180   \n",
       "23     19.171389   14.329695    7.311943   61.550139   24.154938   40.453340   \n",
       "24     56.546536   39.151118   15.058070   58.630681   31.779608   58.543396   \n",
       "25     28.035154   52.297926   25.251559   82.830693   93.137768   58.322500   \n",
       "26     65.476011   37.594391   13.920720   60.285571   32.173435   60.665603   \n",
       "27     30.698141   45.070482   25.493474   87.550639   72.843361   59.986058   \n",
       "28      9.279795   12.460868    6.150391   71.474747   28.658155   53.485339   \n",
       "29     21.811150    9.434569    9.346062   79.538201   14.383852   58.315662   \n",
       "...          ...         ...         ...         ...         ...         ...   \n",
       "7699  101.952755  101.024180  150.851143   98.088354  107.208574  110.059086   \n",
       "7700   99.355410  105.725337  129.310522  100.060033  102.099406  104.881913   \n",
       "7701  103.915562  112.289340  120.303843  105.729901  105.869066  102.771608   \n",
       "7702  111.207340   98.862829  121.172919   97.655716  104.493446   99.864829   \n",
       "7703  100.456651  103.681114  126.271843  103.526407  105.295979  104.410089   \n",
       "7704  105.915309  100.937681  107.748709  105.586762  104.638976  105.328034   \n",
       "7705  110.524654  106.054933  103.925747  102.119789  107.734045   94.542989   \n",
       "7706  108.267101  104.781855  102.959563  100.299489  103.006891   97.449178   \n",
       "7707  108.628845  105.411550  116.885260  100.390758  101.789694  109.670438   \n",
       "7708  102.351395  106.847673  113.700390  104.108685  107.993331  109.836023   \n",
       "7709   97.371062  101.613409  126.676242  103.899786  107.904098  102.155169   \n",
       "7710  100.446498  113.510729  121.390473  106.994234  100.679536  107.790071   \n",
       "7711  108.307655  104.769492  108.148950  109.299527  112.217943  105.114958   \n",
       "7712   95.450488  104.385676  115.052288   98.207675   99.527455  102.392087   \n",
       "7713  117.655845  100.202078  143.373628   94.665091   96.670602  110.760842   \n",
       "7714  109.366831  110.373515  155.338244   73.476549  106.656751  117.943292   \n",
       "7715  102.282793  116.501264  149.617704  101.737096  106.320904  105.652591   \n",
       "7716  107.314343  107.237625  122.032505   99.219912  107.209664  108.782904   \n",
       "7717  108.982503  113.322747  146.998892  103.860612  100.650779  103.764861   \n",
       "7718  100.700651  112.194424  108.515049  108.832062  106.251429  103.100165   \n",
       "7719  101.104867  113.640542  138.909939  100.674024  102.286399   90.575053   \n",
       "7720   97.856751  107.616508  122.772108  100.009089  100.660188   96.274669   \n",
       "7721  101.382853  109.362981  158.380785   98.176744  108.488429   89.180081   \n",
       "7722  102.874571  111.977438  126.370252  123.180458  100.326964  100.677130   \n",
       "7723  106.724947  103.961055  133.545036  105.640165   99.936194   90.843124   \n",
       "7724  111.853976  105.693738  155.693166  103.466104  101.835443  117.035604   \n",
       "7725  112.373954  107.598564  207.599034  108.683281  107.577848  110.940239   \n",
       "7726  117.268694  106.327277  183.434452  111.241727  103.500417  116.638976   \n",
       "7727  117.321394  103.238553  129.701536  113.449488  110.694704  109.199895   \n",
       "7728  118.792603  117.784448  161.899631  108.152470  117.995779   97.337138   \n",
       "\n",
       "          RCMB38  \n",
       "0       6.650917  \n",
       "1       7.506924  \n",
       "2       7.096385  \n",
       "3      15.326381  \n",
       "4      26.758357  \n",
       "5      39.726392  \n",
       "6       7.622506  \n",
       "7      25.994153  \n",
       "8      14.373842  \n",
       "9      27.650176  \n",
       "10     17.335612  \n",
       "11     24.863853  \n",
       "12     11.331546  \n",
       "13     41.016382  \n",
       "14     37.038002  \n",
       "15     21.468049  \n",
       "16     71.110414  \n",
       "17     48.758791  \n",
       "18     50.793033  \n",
       "19     43.828153  \n",
       "20     70.770525  \n",
       "21     18.764625  \n",
       "22     48.773468  \n",
       "23     45.035805  \n",
       "24     37.339925  \n",
       "25     82.810175  \n",
       "26     44.716184  \n",
       "27     81.834454  \n",
       "28     44.112874  \n",
       "29     47.276387  \n",
       "...          ...  \n",
       "7699  102.287428  \n",
       "7700  100.303069  \n",
       "7701  111.225608  \n",
       "7702  102.287753  \n",
       "7703  109.193978  \n",
       "7704  103.553534  \n",
       "7705  105.925164  \n",
       "7706  102.712533  \n",
       "7707  101.022304  \n",
       "7708  120.077297  \n",
       "7709  107.276844  \n",
       "7710  109.844034  \n",
       "7711  102.479100  \n",
       "7712  110.462352  \n",
       "7713   96.536981  \n",
       "7714  107.589170  \n",
       "7715  105.269511  \n",
       "7716  152.634760  \n",
       "7717  107.076952  \n",
       "7718  109.550473  \n",
       "7719   98.205833  \n",
       "7720  100.041573  \n",
       "7721  106.528460  \n",
       "7722  105.404765  \n",
       "7723  112.827384  \n",
       "7724  108.450515  \n",
       "7725  109.617023  \n",
       "7726  106.148544  \n",
       "7727  105.842650  \n",
       "7728  120.754876  \n",
       "\n",
       "[7729 rows x 23 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "screen_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:02.861572Z",
     "start_time": "2019-04-19T20:57:56.231876Z"
    }
   },
   "outputs": [],
   "source": [
    "effective_screen = pd.read_excel('results/screen_hits.xlsx',sheet_name=\"E. Effective drugs per subgroup\",header=6)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:02.916558Z",
     "start_time": "2019-04-19T20:58:02.864986Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_name</th>\n",
       "      <th>sbi_id</th>\n",
       "      <th>pubchem_cid</th>\n",
       "      <th>G3</th>\n",
       "      <th>SHH</th>\n",
       "      <th>G4</th>\n",
       "      <th>class</th>\n",
       "      <th>subclass</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(4-(p-(diethylamino)-alpha-phenylbenzylidene)-...</td>\n",
       "      <td>SBI-0653846.0001</td>\n",
       "      <td>12450.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>topical antiseptic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>nvp-bgt226</td>\n",
       "      <td>SBI-0654465.P001</td>\n",
       "      <td>11978790.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>phenylmercuric acetate</td>\n",
       "      <td>SBI-0051573.P001</td>\n",
       "      <td>16682730.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>anti-fungal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>okadaic acid, prorocentrum sp.</td>\n",
       "      <td>SBI-0634592</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>phosphatase inhibitor</td>\n",
       "      <td>inhibitor of PP2A and PP1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>SBI-0637109.P001</td>\n",
       "      <td>6918811.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>other</td>\n",
       "      <td>BCL2 inhibitor II, disrupts its interaction wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>nsc-3852</td>\n",
       "      <td>SBI-0053105.P002</td>\n",
       "      <td>19103.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>bortezomib</td>\n",
       "      <td>SBI-0634428.P001</td>\n",
       "      <td>387447.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>proteasome inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>trichostatin a, streptomyces sp.</td>\n",
       "      <td>SBI-0634645</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>brefeldin a from penicillium brefeldianum</td>\n",
       "      <td>SBI-0050152.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>ER protein transport inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>idarubicin /// idarubicin hcl</td>\n",
       "      <td>SBI-0050582.P002</td>\n",
       "      <td>42890.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>mg-132 /// mg132</td>\n",
       "      <td>SBI-0207107</td>\n",
       "      <td>462382.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>oxamflatin</td>\n",
       "      <td>SBI-0646042.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>gambogic acid /// gambogic acid, garcinia hanb...</td>\n",
       "      <td>SBI-0052104.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>proteasome inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>celastrol /// celastrol, celastrus scandens</td>\n",
       "      <td>SBI-0051253</td>\n",
       "      <td>122724.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>natural product</td>\n",
       "      <td>multiple mechanisms of action</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0206677.P003</td>\n",
       "      <td>30323.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>SBI-0206677.P002</td>\n",
       "      <td>30323.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>oleandrin</td>\n",
       "      <td>SBI-0052768.P001</td>\n",
       "      <td>6708811.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>m-344, histone deacetylase inhibitor iii</td>\n",
       "      <td>SBI-0634549.P002</td>\n",
       "      <td>3994.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>SBI-0050757.P002</td>\n",
       "      <td>4212.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>SBI-0051229.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>natural product</td>\n",
       "      <td>multiple mechanisms of action</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>k-strophanthin beta</td>\n",
       "      <td>SBI-0052688.P001</td>\n",
       "      <td>6708734.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>SBI-0051229</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>natural product</td>\n",
       "      <td>multiple mechanisms of action</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>proscillaridin</td>\n",
       "      <td>SBI-0206671.P002</td>\n",
       "      <td>45114178.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>(-)-ouabain /// ouabain /// ouabain, octahydrate</td>\n",
       "      <td>SBI-0050917.P002</td>\n",
       "      <td>439501.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>periplocymarin</td>\n",
       "      <td>SBI-0052579.P001</td>\n",
       "      <td>6708762.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>strophanthidin /// strophantidin</td>\n",
       "      <td>SBI-0051578.P001</td>\n",
       "      <td>5702136.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>cymarin</td>\n",
       "      <td>SBI-0052634.P001</td>\n",
       "      <td>6708764.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>a-674563</td>\n",
       "      <td>SBI-0654421.P001</td>\n",
       "      <td>11314340.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>doxorubicin /// doxorubicin hydrochloride /// ...</td>\n",
       "      <td>SBI-0206795.P001</td>\n",
       "      <td>6916127.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>intercalates into DNA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>digoxin</td>\n",
       "      <td>SBI-0052454.P001</td>\n",
       "      <td>5702042.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>ac-93253 iodide</td>\n",
       "      <td>SBI-0633717.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>SIRT2 deacetylase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>actinomycin d</td>\n",
       "      <td>SBI-0052701.P001</td>\n",
       "      <td>4035263.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>inhibits RNA synthesis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>emetine dihydrochloride hydrate /// emetine·2hcl</td>\n",
       "      <td>SBI-0050445.P002</td>\n",
       "      <td>10219.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>protein synthesis inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>nigericin sodium /// nigericin, sodium salt, s...</td>\n",
       "      <td>SBI-0051855</td>\n",
       "      <td>6708472.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>gitoxigenin diacetate</td>\n",
       "      <td>SBI-0052060.P001</td>\n",
       "      <td>6708551.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>bergapten /// bergaptene</td>\n",
       "      <td>SBI-0051583.P001</td>\n",
       "      <td>2355.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>natural product</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>dihydrogambogic acid</td>\n",
       "      <td>SBI-0052206.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>proteasome inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>gentian violet</td>\n",
       "      <td>SBI-0051393.P001</td>\n",
       "      <td>3468.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>topical antiseptic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>teniposide</td>\n",
       "      <td>SBI-0052684.P001</td>\n",
       "      <td>6708778.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>causes DNA strand breaks</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>pdk1/akt/flt dual pathway inhibitor</td>\n",
       "      <td>SBI-0086695.P002</td>\n",
       "      <td>5113385.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>Receptor tyrosine kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>salinomycin /// salinomycin, sodium</td>\n",
       "      <td>SBI-0051829.P002</td>\n",
       "      <td>6602450.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>pf-04691502</td>\n",
       "      <td>SBI-0654438.P001</td>\n",
       "      <td>25033539.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>scriptaid</td>\n",
       "      <td>SBI-0634614.P002</td>\n",
       "      <td>5186.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>vorinostat (saha, mk0683)</td>\n",
       "      <td>SBI-0634430.P003</td>\n",
       "      <td>5311.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>puromycin /// puromycin hydrochloride</td>\n",
       "      <td>SBI-0052817.P001</td>\n",
       "      <td>5702164.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>protein synthesis inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>sarmentogenin</td>\n",
       "      <td>SBI-0052083.P001</td>\n",
       "      <td>6708600.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>akt inhibitor iv</td>\n",
       "      <td>SBI-0086656.P002</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>dihydroouabain</td>\n",
       "      <td>SBI-0050343.P002</td>\n",
       "      <td>11957513.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>pha-848125</td>\n",
       "      <td>SBI-0654461.P001</td>\n",
       "      <td>16718576.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>CDK inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>10-hydroxycamptothecin /// 10-hydroxycamtothecin</td>\n",
       "      <td>SBI-0052834.P001</td>\n",
       "      <td>97226.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>homoharringtonine</td>\n",
       "      <td>SBI-0634352.P001</td>\n",
       "      <td>16219462.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>protein synthesis inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>torin 2</td>\n",
       "      <td>SBI-0654478.P001</td>\n",
       "      <td>51358113.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>hesperadin</td>\n",
       "      <td>SBI-0654379.P001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>Aurora kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>valinomycin, streptomyces fulvissimus</td>\n",
       "      <td>SBI-0634653</td>\n",
       "      <td>5649.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>amsacrine</td>\n",
       "      <td>SBI-0206714.P001</td>\n",
       "      <td>3926765.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>topotecan /// topotecan hcl /// topotecan hydr...</td>\n",
       "      <td>SBI-0055592.P003</td>\n",
       "      <td>60700.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>vincristine sulfate</td>\n",
       "      <td>SBI-0053517.P002</td>\n",
       "      <td>5978.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>microtubule regulators</td>\n",
       "      <td>Inhibits microtubule polymerization and causes...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>monensin sodium salt</td>\n",
       "      <td>SBI-0635892.P001</td>\n",
       "      <td>441145.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>dinaciclib (sch727965)</td>\n",
       "      <td>SBI-0654457.P001</td>\n",
       "      <td>46926350.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>CDK inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Total effective drugs</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>63</td>\n",
       "      <td>48</td>\n",
       "      <td>22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>76 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            drug_name            sbi_id  \\\n",
       "0   (4-(p-(diethylamino)-alpha-phenylbenzylidene)-...  SBI-0653846.0001   \n",
       "1                                          nvp-bgt226  SBI-0654465.P001   \n",
       "2                              phenylmercuric acetate  SBI-0051573.P001   \n",
       "3                      okadaic acid, prorocentrum sp.       SBI-0634592   \n",
       "4                                                 NaN  SBI-0637109.P001   \n",
       "5                                            nsc-3852  SBI-0053105.P002   \n",
       "6                                          bortezomib  SBI-0634428.P001   \n",
       "7                    trichostatin a, streptomyces sp.       SBI-0634645   \n",
       "8           brefeldin a from penicillium brefeldianum  SBI-0050152.P002   \n",
       "9                       idarubicin /// idarubicin hcl  SBI-0050582.P002   \n",
       "10                                   mg-132 /// mg132       SBI-0207107   \n",
       "11                                         oxamflatin  SBI-0646042.P001   \n",
       "12  gambogic acid /// gambogic acid, garcinia hanb...  SBI-0052104.P001   \n",
       "13        celastrol /// celastrol, celastrus scandens       SBI-0051253   \n",
       "14        daunorubicin /// daunorubicin hydrochloride  SBI-0206677.P003   \n",
       "15        daunorubicin /// daunorubicin hydrochloride  SBI-0206677.P002   \n",
       "16                                          oleandrin  SBI-0052768.P001   \n",
       "17           m-344, histone deacetylase inhibitor iii  SBI-0634549.P002   \n",
       "18  mitoxanthrone hydrochloride /// mitoxantrone /...  SBI-0050757.P002   \n",
       "19                                       thapsigargin  SBI-0051229.P002   \n",
       "20                                k-strophanthin beta  SBI-0052688.P001   \n",
       "21                                       thapsigargin       SBI-0051229   \n",
       "22                                     proscillaridin  SBI-0206671.P002   \n",
       "23   (-)-ouabain /// ouabain /// ouabain, octahydrate  SBI-0050917.P002   \n",
       "24                                     periplocymarin  SBI-0052579.P001   \n",
       "25                   strophanthidin /// strophantidin  SBI-0051578.P001   \n",
       "26                                            cymarin  SBI-0052634.P001   \n",
       "27                                           a-674563  SBI-0654421.P001   \n",
       "28  doxorubicin /// doxorubicin hydrochloride /// ...  SBI-0206795.P001   \n",
       "29                                            digoxin  SBI-0052454.P001   \n",
       "..                                                ...               ...   \n",
       "46                                    ac-93253 iodide  SBI-0633717.P001   \n",
       "47                                      actinomycin d  SBI-0052701.P001   \n",
       "48   emetine dihydrochloride hydrate /// emetine·2hcl  SBI-0050445.P002   \n",
       "49  nigericin sodium /// nigericin, sodium salt, s...       SBI-0051855   \n",
       "50                              gitoxigenin diacetate  SBI-0052060.P001   \n",
       "51                           bergapten /// bergaptene  SBI-0051583.P001   \n",
       "52                               dihydrogambogic acid  SBI-0052206.P001   \n",
       "53                                     gentian violet  SBI-0051393.P001   \n",
       "54                                         teniposide  SBI-0052684.P001   \n",
       "55                pdk1/akt/flt dual pathway inhibitor  SBI-0086695.P002   \n",
       "56                salinomycin /// salinomycin, sodium  SBI-0051829.P002   \n",
       "57                                        pf-04691502  SBI-0654438.P001   \n",
       "58                                          scriptaid  SBI-0634614.P002   \n",
       "59                          vorinostat (saha, mk0683)  SBI-0634430.P003   \n",
       "60              puromycin /// puromycin hydrochloride  SBI-0052817.P001   \n",
       "61                                      sarmentogenin  SBI-0052083.P001   \n",
       "62                                   akt inhibitor iv  SBI-0086656.P002   \n",
       "63                                     dihydroouabain  SBI-0050343.P002   \n",
       "64                                         pha-848125  SBI-0654461.P001   \n",
       "65   10-hydroxycamptothecin /// 10-hydroxycamtothecin  SBI-0052834.P001   \n",
       "66                                  homoharringtonine  SBI-0634352.P001   \n",
       "67                                            torin 2  SBI-0654478.P001   \n",
       "68                                         hesperadin  SBI-0654379.P001   \n",
       "69              valinomycin, streptomyces fulvissimus       SBI-0634653   \n",
       "70                                          amsacrine  SBI-0206714.P001   \n",
       "71  topotecan /// topotecan hcl /// topotecan hydr...  SBI-0055592.P003   \n",
       "72                                vincristine sulfate  SBI-0053517.P002   \n",
       "73                               monensin sodium salt  SBI-0635892.P001   \n",
       "74                             dinaciclib (sch727965)  SBI-0654457.P001   \n",
       "75                              Total effective drugs               NaN   \n",
       "\n",
       "    pubchem_cid  G3  SHH  G4                        class  \\\n",
       "0       12450.0   1    1   1               anti-infective   \n",
       "1    11978790.0   1    1   1             kinase inhibitor   \n",
       "2    16682730.0   1    1   1               anti-infective   \n",
       "3           NaN   1    1   1        phosphatase inhibitor   \n",
       "4     6918811.0   1    1   1                        other   \n",
       "5       19103.0   1    0   1         epigenetic regulator   \n",
       "6      387447.0   1    1   1       proteostasis regulator   \n",
       "7           NaN   1    1   1         epigenetic regulator   \n",
       "8           NaN   1    1   1       proteostasis regulator   \n",
       "9       42890.0   1    0   1  DNA/RNA synthesis inhibitor   \n",
       "10     462382.0   1    1   1       proteostasis regulator   \n",
       "11          NaN   1    1   1         epigenetic regulator   \n",
       "12          NaN   1    1   0       proteostasis regulator   \n",
       "13     122724.0   1    1   1              natural product   \n",
       "14      30323.0   0    0   1  DNA/RNA synthesis inhibitor   \n",
       "15      30323.0   1    0   0  DNA/RNA synthesis inhibitor   \n",
       "16    6708811.0   1    1   0            cardiac glycoside   \n",
       "17       3994.0   1    1   1         epigenetic regulator   \n",
       "18       4212.0   1    0   1  DNA/RNA synthesis inhibitor   \n",
       "19          NaN   1    0   0              natural product   \n",
       "20    6708734.0   1    1   0            cardiac glycoside   \n",
       "21          NaN   0    1   1              natural product   \n",
       "22   45114178.0   1    1   0            cardiac glycoside   \n",
       "23     439501.0   1    1   0            cardiac glycoside   \n",
       "24    6708762.0   1    1   0            cardiac glycoside   \n",
       "25    5702136.0   1    1   0            cardiac glycoside   \n",
       "26    6708764.0   1    1   0            cardiac glycoside   \n",
       "27   11314340.0   1    1   0             kinase inhibitor   \n",
       "28    6916127.0   1    0   0  DNA/RNA synthesis inhibitor   \n",
       "29    5702042.0   1    1   0            cardiac glycoside   \n",
       "..          ...  ..  ...  ..                          ...   \n",
       "46          NaN   1    1   1         epigenetic regulator   \n",
       "47    4035263.0   1    0   0  DNA/RNA synthesis inhibitor   \n",
       "48      10219.0   1    1   0       proteostasis regulator   \n",
       "49    6708472.0   1    1   0                ion regulator   \n",
       "50    6708551.0   1    0   0            cardiac glycoside   \n",
       "51       2355.0   0    0   1              natural product   \n",
       "52          NaN   1    0   0       proteostasis regulator   \n",
       "53       3468.0   1    1   0               anti-infective   \n",
       "54    6708778.0   1    0   0  DNA/RNA synthesis inhibitor   \n",
       "55    5113385.0   0    0   1             kinase inhibitor   \n",
       "56    6602450.0   0    1   0                ion regulator   \n",
       "57   25033539.0   1    0   0             kinase inhibitor   \n",
       "58       5186.0   1    1   0         epigenetic regulator   \n",
       "59       5311.0   1    0   0         epigenetic regulator   \n",
       "60    5702164.0   0    1   0       proteostasis regulator   \n",
       "61    6708600.0   1    0   0            cardiac glycoside   \n",
       "62          NaN   0    1   0             kinase inhibitor   \n",
       "63   11957513.0   1    0   0            cardiac glycoside   \n",
       "64   16718576.0   1    0   0             kinase inhibitor   \n",
       "65      97226.0   1    0   0  DNA/RNA synthesis inhibitor   \n",
       "66   16219462.0   0    1   0       proteostasis regulator   \n",
       "67   51358113.0   1    0   0             kinase inhibitor   \n",
       "68          NaN   0    1   0             kinase inhibitor   \n",
       "69       5649.0   0    1   0                ion regulator   \n",
       "70    3926765.0   1    0   0  DNA/RNA synthesis inhibitor   \n",
       "71      60700.0   1    0   0  DNA/RNA synthesis inhibitor   \n",
       "72       5978.0   1    0   0       microtubule regulators   \n",
       "73     441145.0   0    1   0                ion regulator   \n",
       "74   46926350.0   0    1   0             kinase inhibitor   \n",
       "75          NaN  63   48  22                          NaN   \n",
       "\n",
       "                                             subclass  \n",
       "0                                  topical antiseptic  \n",
       "1                           PI3K, AKT, MTOR inhibitor  \n",
       "2                                         anti-fungal  \n",
       "3                           inhibitor of PP2A and PP1  \n",
       "4   BCL2 inhibitor II, disrupts its interaction wi...  \n",
       "5                                      HDAC inhibitor  \n",
       "6                                proteasome inhibitor  \n",
       "7                                      HDAC inhibitor  \n",
       "8                      ER protein transport inhibitor  \n",
       "9                             Topoisomerase inhibitor  \n",
       "10                                                NaN  \n",
       "11                                     HDAC inhibitor  \n",
       "12                               proteasome inhibitor  \n",
       "13                      multiple mechanisms of action  \n",
       "14                            Topoisomerase inhibitor  \n",
       "15                            Topoisomerase inhibitor  \n",
       "16                                                NaN  \n",
       "17                                     HDAC inhibitor  \n",
       "18                            Topoisomerase inhibitor  \n",
       "19                      multiple mechanisms of action  \n",
       "20                                                NaN  \n",
       "21                      multiple mechanisms of action  \n",
       "22                                                NaN  \n",
       "23                                                NaN  \n",
       "24                                                NaN  \n",
       "25                                                NaN  \n",
       "26                                                NaN  \n",
       "27                          PI3K, AKT, MTOR inhibitor  \n",
       "28                              intercalates into DNA  \n",
       "29                                                NaN  \n",
       "..                                                ...  \n",
       "46                        SIRT2 deacetylase inhibitor  \n",
       "47                             inhibits RNA synthesis  \n",
       "48                        protein synthesis inhibitor  \n",
       "49                  anti-infective, unknown mechanism  \n",
       "50                                                NaN  \n",
       "51                                            unknown  \n",
       "52                               proteasome inhibitor  \n",
       "53                                 topical antiseptic  \n",
       "54                           causes DNA strand breaks  \n",
       "55                 Receptor tyrosine kinase inhibitor  \n",
       "56                  anti-infective, unknown mechanism  \n",
       "57                          PI3K, AKT, MTOR inhibitor  \n",
       "58                                     HDAC inhibitor  \n",
       "59                                     HDAC inhibitor  \n",
       "60                        protein synthesis inhibitor  \n",
       "61                                                NaN  \n",
       "62                          PI3K, AKT, MTOR inhibitor  \n",
       "63                                                NaN  \n",
       "64                                     CDK inhibitors  \n",
       "65                            Topoisomerase inhibitor  \n",
       "66                        protein synthesis inhibitor  \n",
       "67                          PI3K, AKT, MTOR inhibitor  \n",
       "68                            Aurora kinase inhibitor  \n",
       "69                  anti-infective, unknown mechanism  \n",
       "70                            Topoisomerase inhibitor  \n",
       "71                            Topoisomerase inhibitor  \n",
       "72  Inhibits microtubule polymerization and causes...  \n",
       "73                  anti-infective, unknown mechanism  \n",
       "74                                     CDK inhibitors  \n",
       "75                                                NaN  \n",
       "\n",
       "[76 rows x 8 columns]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effective_screen"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:02.926364Z",
     "start_time": "2019-04-19T20:58:02.920701Z"
    }
   },
   "outputs": [],
   "source": [
    "# Finding some overlap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:02.957941Z",
     "start_time": "2019-04-19T20:58:02.929775Z"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_name</th>\n",
       "      <th>pubchem_cid</th>\n",
       "      <th>G3</th>\n",
       "      <th>SHH</th>\n",
       "      <th>G4</th>\n",
       "      <th>class</th>\n",
       "      <th>subclass</th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sbi_id</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>SBI-0634430.P003</th>\n",
       "      <td>vorinostat (saha, mk0683)</td>\n",
       "      <td>5311.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>vorinostat</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.308</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.102167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.210333</td>\n",
       "      <td>[SBI-0634430.P003, SBI-0634430.P001, SBI-06344...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  drug_name  pubchem_cid  G3  SHH  G4  \\\n",
       "sbi_id                                                                  \n",
       "SBI-0634430.P003  vorinostat (saha, mk0683)       5311.0   1    0   0   \n",
       "\n",
       "                                 class        subclass        Name   G3  \\\n",
       "sbi_id                                                                    \n",
       "SBI-0634430.P003  epigenetic regulator  HDAC inhibitor  vorinostat  1.0   \n",
       "\n",
       "                  mean_score(G3)   G4  mean_score(G4)  SHH  mean_score(SHH)  \\\n",
       "sbi_id                                                                        \n",
       "SBI-0634430.P003           0.337  0.0           0.308  0.0         0.102167   \n",
       "\n",
       "                  SHH+p53  mean_score(SHH+p53)  \\\n",
       "sbi_id                                           \n",
       "SBI-0634430.P003      0.0             0.210333   \n",
       "\n",
       "                                                                SBI  \n",
       "sbi_id                                                               \n",
       "SBI-0634430.P003  [SBI-0634430.P003, SBI-0634430.P001, SBI-06344...  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.concat([effective_screen.set_index('sbi_id'),effective_exp.set_index('sbi_id')], axis=1, join='inner')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.039063Z",
     "start_time": "2019-04-19T20:58:02.961080Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_name</th>\n",
       "      <th>pubchem_cid</th>\n",
       "      <th>G3_screen</th>\n",
       "      <th>SHH_screen</th>\n",
       "      <th>G4_screen</th>\n",
       "      <th>class</th>\n",
       "      <th>subclass</th>\n",
       "      <th>Name</th>\n",
       "      <th>G3_exp</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4_exp</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH_exp</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sbi_id</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>SBI-0050152.P002</th>\n",
       "      <td>brefeldin a from penicillium brefeldianum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>ER protein transport inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0050242.P007</th>\n",
       "      <td>chlorothiazide</td>\n",
       "      <td>2720.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>Diuretic; Carbonic anhydrase inhibitor; Na/Cl ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0050343.P002</th>\n",
       "      <td>dihydroouabain</td>\n",
       "      <td>11957513.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0050445.P002</th>\n",
       "      <td>emetine dihydrochloride hydrate /// emetine·2hcl</td>\n",
       "      <td>10219.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>protein synthesis inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0050582.P002</th>\n",
       "      <td>idarubicin /// idarubicin hcl</td>\n",
       "      <td>42890.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0050757.P002</th>\n",
       "      <td>mitoxanthrone hydrochloride /// mitoxantrone /...</td>\n",
       "      <td>4212.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0050917.P002</th>\n",
       "      <td>(-)-ouabain /// ouabain /// ouabain, octahydrate</td>\n",
       "      <td>439501.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051229</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>natural product</td>\n",
       "      <td>multiple mechanisms of action</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051229.P002</th>\n",
       "      <td>thapsigargin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>natural product</td>\n",
       "      <td>multiple mechanisms of action</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051253</th>\n",
       "      <td>celastrol /// celastrol, celastrus scandens</td>\n",
       "      <td>122724.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>natural product</td>\n",
       "      <td>multiple mechanisms of action</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051348.P003</th>\n",
       "      <td>digitoxin</td>\n",
       "      <td>441207.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051393.P001</th>\n",
       "      <td>gentian violet</td>\n",
       "      <td>3468.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>topical antiseptic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051532.P004</th>\n",
       "      <td>thimerosal</td>\n",
       "      <td>67361.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>anti-fungal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051573.P001</th>\n",
       "      <td>phenylmercuric acetate</td>\n",
       "      <td>16682730.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>anti-fungal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051578.P001</th>\n",
       "      <td>strophanthidin /// strophantidin</td>\n",
       "      <td>5702136.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051583.P001</th>\n",
       "      <td>bergapten /// bergaptene</td>\n",
       "      <td>2355.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>natural product</td>\n",
       "      <td>unknown</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051642.P001</th>\n",
       "      <td>peruvoside</td>\n",
       "      <td>5702166.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051650.P001</th>\n",
       "      <td>neriifolin</td>\n",
       "      <td>441867.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051829.P001</th>\n",
       "      <td>salinomycin /// salinomycin, sodium</td>\n",
       "      <td>6602450.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051829.P002</th>\n",
       "      <td>salinomycin /// salinomycin, sodium</td>\n",
       "      <td>6602450.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051852</th>\n",
       "      <td>anisomycin /// anisomycin, streptomyces griseolus</td>\n",
       "      <td>253602.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>protein synthesis inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051855</th>\n",
       "      <td>nigericin sodium /// nigericin, sodium salt, s...</td>\n",
       "      <td>6708472.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051941.P001</th>\n",
       "      <td>convallatoxin</td>\n",
       "      <td>6708765.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0051950.P001</th>\n",
       "      <td>lanatoside c</td>\n",
       "      <td>5702228.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0052060.P001</th>\n",
       "      <td>gitoxigenin diacetate</td>\n",
       "      <td>6708551.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0052083.P001</th>\n",
       "      <td>sarmentogenin</td>\n",
       "      <td>6708600.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0052086.P001</th>\n",
       "      <td>digoxigenin</td>\n",
       "      <td>608640.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0052089.P001</th>\n",
       "      <td>strophanthidinic acid lactone acetate</td>\n",
       "      <td>5194698.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0052104.P001</th>\n",
       "      <td>gambogic acid /// gambogic acid, garcinia hanb...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>proteasome inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0052200.P001</th>\n",
       "      <td>digitoxigenin acetate</td>\n",
       "      <td>6708536.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>cardiac glycoside</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0206677.P002</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>30323.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0206677.P003</th>\n",
       "      <td>daunorubicin /// daunorubicin hydrochloride</td>\n",
       "      <td>30323.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0206714.P001</th>\n",
       "      <td>amsacrine</td>\n",
       "      <td>3926765.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>Topoisomerase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0206795.P001</th>\n",
       "      <td>doxorubicin /// doxorubicin hydrochloride /// ...</td>\n",
       "      <td>6916127.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>DNA/RNA synthesis inhibitor</td>\n",
       "      <td>intercalates into DNA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0207107</th>\n",
       "      <td>mg-132 /// mg132</td>\n",
       "      <td>462382.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0633717.P001</th>\n",
       "      <td>ac-93253 iodide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>SIRT2 deacetylase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0633783.P003</th>\n",
       "      <td>auranofin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>broad</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634352.P001</th>\n",
       "      <td>homoharringtonine</td>\n",
       "      <td>16219462.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>protein synthesis inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634428.P001</th>\n",
       "      <td>bortezomib</td>\n",
       "      <td>387447.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>proteostasis regulator</td>\n",
       "      <td>proteasome inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634430.P003</th>\n",
       "      <td>vorinostat (saha, mk0683)</td>\n",
       "      <td>5311.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>vorinostat</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.308</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.102167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.210333</td>\n",
       "      <td>[SBI-0634430.P003, SBI-0634430.P001, SBI-06344...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634549.P002</th>\n",
       "      <td>m-344, histone deacetylase inhibitor iii</td>\n",
       "      <td>3994.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634592</th>\n",
       "      <td>okadaic acid, prorocentrum sp.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>phosphatase inhibitor</td>\n",
       "      <td>inhibitor of PP2A and PP1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634614.P002</th>\n",
       "      <td>scriptaid</td>\n",
       "      <td>5186.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634645</th>\n",
       "      <td>trichostatin a, streptomyces sp.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0634653</th>\n",
       "      <td>valinomycin, streptomyces fulvissimus</td>\n",
       "      <td>5649.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0635892.P001</th>\n",
       "      <td>monensin sodium salt</td>\n",
       "      <td>441145.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>ion regulator</td>\n",
       "      <td>anti-infective, unknown mechanism</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0637109.P001</th>\n",
       "      <td>NaN</td>\n",
       "      <td>6918811.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>other</td>\n",
       "      <td>BCL2 inhibitor II, disrupts its interaction wi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0646042.P001</th>\n",
       "      <td>oxamflatin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0646047.P001</th>\n",
       "      <td>bml-281</td>\n",
       "      <td>24951314.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>epigenetic regulator</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0653846.0001</th>\n",
       "      <td>(4-(p-(diethylamino)-alpha-phenylbenzylidene)-...</td>\n",
       "      <td>12450.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>anti-infective</td>\n",
       "      <td>topical antiseptic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654379.P001</th>\n",
       "      <td>hesperadin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>Aurora kinase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654406.P001</th>\n",
       "      <td>gsk2126458</td>\n",
       "      <td>25167777.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654421.P001</th>\n",
       "      <td>a-674563</td>\n",
       "      <td>11314340.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654430.P001</th>\n",
       "      <td>tak-901</td>\n",
       "      <td>16124208.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>Aurora kinase inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654438.P001</th>\n",
       "      <td>pf-04691502</td>\n",
       "      <td>25033539.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654457.P001</th>\n",
       "      <td>dinaciclib (sch727965)</td>\n",
       "      <td>46926350.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>CDK inhibitors</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654461.P001</th>\n",
       "      <td>pha-848125</td>\n",
       "      <td>16718576.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>CDK inhibitors</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654465.P001</th>\n",
       "      <td>nvp-bgt226</td>\n",
       "      <td>11978790.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SBI-0654478.P001</th>\n",
       "      <td>torin 2</td>\n",
       "      <td>51358113.0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>kinase inhibitor</td>\n",
       "      <td>PI3K, AKT, MTOR inhibitor</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NaN</th>\n",
       "      <td>Total effective drugs</td>\n",
       "      <td>NaN</td>\n",
       "      <td>63</td>\n",
       "      <td>48</td>\n",
       "      <td>22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>76 rows × 17 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                          drug_name  \\\n",
       "sbi_id                                                                \n",
       "SBI-0050152.P002          brefeldin a from penicillium brefeldianum   \n",
       "SBI-0050242.P007                                     chlorothiazide   \n",
       "SBI-0050343.P002                                     dihydroouabain   \n",
       "SBI-0050445.P002   emetine dihydrochloride hydrate /// emetine·2hcl   \n",
       "SBI-0050582.P002                      idarubicin /// idarubicin hcl   \n",
       "SBI-0050757.P002  mitoxanthrone hydrochloride /// mitoxantrone /...   \n",
       "SBI-0050917.P002   (-)-ouabain /// ouabain /// ouabain, octahydrate   \n",
       "SBI-0051229                                            thapsigargin   \n",
       "SBI-0051229.P002                                       thapsigargin   \n",
       "SBI-0051253             celastrol /// celastrol, celastrus scandens   \n",
       "SBI-0051348.P003                                          digitoxin   \n",
       "SBI-0051393.P001                                     gentian violet   \n",
       "SBI-0051532.P004                                         thimerosal   \n",
       "SBI-0051573.P001                             phenylmercuric acetate   \n",
       "SBI-0051578.P001                   strophanthidin /// strophantidin   \n",
       "SBI-0051583.P001                           bergapten /// bergaptene   \n",
       "SBI-0051642.P001                                         peruvoside   \n",
       "SBI-0051650.P001                                         neriifolin   \n",
       "SBI-0051829.P001                salinomycin /// salinomycin, sodium   \n",
       "SBI-0051829.P002                salinomycin /// salinomycin, sodium   \n",
       "SBI-0051852       anisomycin /// anisomycin, streptomyces griseolus   \n",
       "SBI-0051855       nigericin sodium /// nigericin, sodium salt, s...   \n",
       "SBI-0051941.P001                                      convallatoxin   \n",
       "SBI-0051950.P001                                       lanatoside c   \n",
       "SBI-0052060.P001                              gitoxigenin diacetate   \n",
       "SBI-0052083.P001                                      sarmentogenin   \n",
       "SBI-0052086.P001                                        digoxigenin   \n",
       "SBI-0052089.P001              strophanthidinic acid lactone acetate   \n",
       "SBI-0052104.P001  gambogic acid /// gambogic acid, garcinia hanb...   \n",
       "SBI-0052200.P001                              digitoxigenin acetate   \n",
       "...                                                             ...   \n",
       "SBI-0206677.P002        daunorubicin /// daunorubicin hydrochloride   \n",
       "SBI-0206677.P003        daunorubicin /// daunorubicin hydrochloride   \n",
       "SBI-0206714.P001                                          amsacrine   \n",
       "SBI-0206795.P001  doxorubicin /// doxorubicin hydrochloride /// ...   \n",
       "SBI-0207107                                        mg-132 /// mg132   \n",
       "SBI-0633717.P001                                    ac-93253 iodide   \n",
       "SBI-0633783.P003                                          auranofin   \n",
       "SBI-0634352.P001                                  homoharringtonine   \n",
       "SBI-0634428.P001                                         bortezomib   \n",
       "SBI-0634430.P003                          vorinostat (saha, mk0683)   \n",
       "SBI-0634549.P002           m-344, histone deacetylase inhibitor iii   \n",
       "SBI-0634592                          okadaic acid, prorocentrum sp.   \n",
       "SBI-0634614.P002                                          scriptaid   \n",
       "SBI-0634645                        trichostatin a, streptomyces sp.   \n",
       "SBI-0634653                   valinomycin, streptomyces fulvissimus   \n",
       "SBI-0635892.P001                               monensin sodium salt   \n",
       "SBI-0637109.P001                                                NaN   \n",
       "SBI-0646042.P001                                         oxamflatin   \n",
       "SBI-0646047.P001                                            bml-281   \n",
       "SBI-0653846.0001  (4-(p-(diethylamino)-alpha-phenylbenzylidene)-...   \n",
       "SBI-0654379.P001                                         hesperadin   \n",
       "SBI-0654406.P001                                         gsk2126458   \n",
       "SBI-0654421.P001                                           a-674563   \n",
       "SBI-0654430.P001                                            tak-901   \n",
       "SBI-0654438.P001                                        pf-04691502   \n",
       "SBI-0654457.P001                             dinaciclib (sch727965)   \n",
       "SBI-0654461.P001                                         pha-848125   \n",
       "SBI-0654465.P001                                         nvp-bgt226   \n",
       "SBI-0654478.P001                                            torin 2   \n",
       "NaN                                           Total effective drugs   \n",
       "\n",
       "                  pubchem_cid  G3_screen  SHH_screen  G4_screen  \\\n",
       "sbi_id                                                            \n",
       "SBI-0050152.P002          NaN          1           1          1   \n",
       "SBI-0050242.P007       2720.0          1           1          0   \n",
       "SBI-0050343.P002   11957513.0          1           0          0   \n",
       "SBI-0050445.P002      10219.0          1           1          0   \n",
       "SBI-0050582.P002      42890.0          1           0          1   \n",
       "SBI-0050757.P002       4212.0          1           0          1   \n",
       "SBI-0050917.P002     439501.0          1           1          0   \n",
       "SBI-0051229               NaN          0           1          1   \n",
       "SBI-0051229.P002          NaN          1           0          0   \n",
       "SBI-0051253          122724.0          1           1          1   \n",
       "SBI-0051348.P003     441207.0          1           1          0   \n",
       "SBI-0051393.P001       3468.0          1           1          0   \n",
       "SBI-0051532.P004      67361.0          1           0          1   \n",
       "SBI-0051573.P001   16682730.0          1           1          1   \n",
       "SBI-0051578.P001    5702136.0          1           1          0   \n",
       "SBI-0051583.P001       2355.0          0           0          1   \n",
       "SBI-0051642.P001    5702166.0          1           1          0   \n",
       "SBI-0051650.P001     441867.0          1           1          0   \n",
       "SBI-0051829.P001    6602450.0          1           0          0   \n",
       "SBI-0051829.P002    6602450.0          0           1          0   \n",
       "SBI-0051852          253602.0          1           1          0   \n",
       "SBI-0051855         6708472.0          1           1          0   \n",
       "SBI-0051941.P001    6708765.0          1           1          0   \n",
       "SBI-0051950.P001    5702228.0          1           1          0   \n",
       "SBI-0052060.P001    6708551.0          1           0          0   \n",
       "SBI-0052083.P001    6708600.0          1           0          0   \n",
       "SBI-0052086.P001     608640.0          1           1          0   \n",
       "SBI-0052089.P001    5194698.0          1           1          0   \n",
       "SBI-0052104.P001          NaN          1           1          0   \n",
       "SBI-0052200.P001    6708536.0          1           1          0   \n",
       "...                       ...        ...         ...        ...   \n",
       "SBI-0206677.P002      30323.0          1           0          0   \n",
       "SBI-0206677.P003      30323.0          0           0          1   \n",
       "SBI-0206714.P001    3926765.0          1           0          0   \n",
       "SBI-0206795.P001    6916127.0          1           0          0   \n",
       "SBI-0207107          462382.0          1           1          1   \n",
       "SBI-0633717.P001          NaN          1           1          1   \n",
       "SBI-0633783.P003          NaN          1           0          1   \n",
       "SBI-0634352.P001   16219462.0          0           1          0   \n",
       "SBI-0634428.P001     387447.0          1           1          1   \n",
       "SBI-0634430.P003       5311.0          1           0          0   \n",
       "SBI-0634549.P002       3994.0          1           1          1   \n",
       "SBI-0634592               NaN          1           1          1   \n",
       "SBI-0634614.P002       5186.0          1           1          0   \n",
       "SBI-0634645               NaN          1           1          1   \n",
       "SBI-0634653            5649.0          0           1          0   \n",
       "SBI-0635892.P001     441145.0          0           1          0   \n",
       "SBI-0637109.P001    6918811.0          1           1          1   \n",
       "SBI-0646042.P001          NaN          1           1          1   \n",
       "SBI-0646047.P001   24951314.0          1           1          0   \n",
       "SBI-0653846.0001      12450.0          1           1          1   \n",
       "SBI-0654379.P001          NaN          0           1          0   \n",
       "SBI-0654406.P001   25167777.0          1           1          0   \n",
       "SBI-0654421.P001   11314340.0          1           1          0   \n",
       "SBI-0654430.P001   16124208.0          1           0          0   \n",
       "SBI-0654438.P001   25033539.0          1           0          0   \n",
       "SBI-0654457.P001   46926350.0          0           1          0   \n",
       "SBI-0654461.P001   16718576.0          1           0          0   \n",
       "SBI-0654465.P001   11978790.0          1           1          1   \n",
       "SBI-0654478.P001   51358113.0          1           0          0   \n",
       "NaN                       NaN         63          48         22   \n",
       "\n",
       "                                        class  \\\n",
       "sbi_id                                          \n",
       "SBI-0050152.P002       proteostasis regulator   \n",
       "SBI-0050242.P007                ion regulator   \n",
       "SBI-0050343.P002            cardiac glycoside   \n",
       "SBI-0050445.P002       proteostasis regulator   \n",
       "SBI-0050582.P002  DNA/RNA synthesis inhibitor   \n",
       "SBI-0050757.P002  DNA/RNA synthesis inhibitor   \n",
       "SBI-0050917.P002            cardiac glycoside   \n",
       "SBI-0051229                   natural product   \n",
       "SBI-0051229.P002              natural product   \n",
       "SBI-0051253                   natural product   \n",
       "SBI-0051348.P003            cardiac glycoside   \n",
       "SBI-0051393.P001               anti-infective   \n",
       "SBI-0051532.P004               anti-infective   \n",
       "SBI-0051573.P001               anti-infective   \n",
       "SBI-0051578.P001            cardiac glycoside   \n",
       "SBI-0051583.P001              natural product   \n",
       "SBI-0051642.P001            cardiac glycoside   \n",
       "SBI-0051650.P001            cardiac glycoside   \n",
       "SBI-0051829.P001                ion regulator   \n",
       "SBI-0051829.P002                ion regulator   \n",
       "SBI-0051852            proteostasis regulator   \n",
       "SBI-0051855                     ion regulator   \n",
       "SBI-0051941.P001            cardiac glycoside   \n",
       "SBI-0051950.P001            cardiac glycoside   \n",
       "SBI-0052060.P001            cardiac glycoside   \n",
       "SBI-0052083.P001            cardiac glycoside   \n",
       "SBI-0052086.P001            cardiac glycoside   \n",
       "SBI-0052089.P001            cardiac glycoside   \n",
       "SBI-0052104.P001       proteostasis regulator   \n",
       "SBI-0052200.P001            cardiac glycoside   \n",
       "...                                       ...   \n",
       "SBI-0206677.P002  DNA/RNA synthesis inhibitor   \n",
       "SBI-0206677.P003  DNA/RNA synthesis inhibitor   \n",
       "SBI-0206714.P001  DNA/RNA synthesis inhibitor   \n",
       "SBI-0206795.P001  DNA/RNA synthesis inhibitor   \n",
       "SBI-0207107            proteostasis regulator   \n",
       "SBI-0633717.P001         epigenetic regulator   \n",
       "SBI-0633783.P003               anti-infective   \n",
       "SBI-0634352.P001       proteostasis regulator   \n",
       "SBI-0634428.P001       proteostasis regulator   \n",
       "SBI-0634430.P003         epigenetic regulator   \n",
       "SBI-0634549.P002         epigenetic regulator   \n",
       "SBI-0634592             phosphatase inhibitor   \n",
       "SBI-0634614.P002         epigenetic regulator   \n",
       "SBI-0634645              epigenetic regulator   \n",
       "SBI-0634653                     ion regulator   \n",
       "SBI-0635892.P001                ion regulator   \n",
       "SBI-0637109.P001                        other   \n",
       "SBI-0646042.P001         epigenetic regulator   \n",
       "SBI-0646047.P001         epigenetic regulator   \n",
       "SBI-0653846.0001               anti-infective   \n",
       "SBI-0654379.P001             kinase inhibitor   \n",
       "SBI-0654406.P001             kinase inhibitor   \n",
       "SBI-0654421.P001             kinase inhibitor   \n",
       "SBI-0654430.P001             kinase inhibitor   \n",
       "SBI-0654438.P001             kinase inhibitor   \n",
       "SBI-0654457.P001             kinase inhibitor   \n",
       "SBI-0654461.P001             kinase inhibitor   \n",
       "SBI-0654465.P001             kinase inhibitor   \n",
       "SBI-0654478.P001             kinase inhibitor   \n",
       "NaN                                       NaN   \n",
       "\n",
       "                                                           subclass  \\\n",
       "sbi_id                                                                \n",
       "SBI-0050152.P002                     ER protein transport inhibitor   \n",
       "SBI-0050242.P007  Diuretic; Carbonic anhydrase inhibitor; Na/Cl ...   \n",
       "SBI-0050343.P002                                                NaN   \n",
       "SBI-0050445.P002                        protein synthesis inhibitor   \n",
       "SBI-0050582.P002                            Topoisomerase inhibitor   \n",
       "SBI-0050757.P002                            Topoisomerase inhibitor   \n",
       "SBI-0050917.P002                                                NaN   \n",
       "SBI-0051229                           multiple mechanisms of action   \n",
       "SBI-0051229.P002                      multiple mechanisms of action   \n",
       "SBI-0051253                           multiple mechanisms of action   \n",
       "SBI-0051348.P003                                                NaN   \n",
       "SBI-0051393.P001                                 topical antiseptic   \n",
       "SBI-0051532.P004                                        anti-fungal   \n",
       "SBI-0051573.P001                                        anti-fungal   \n",
       "SBI-0051578.P001                                                NaN   \n",
       "SBI-0051583.P001                                            unknown   \n",
       "SBI-0051642.P001                                                NaN   \n",
       "SBI-0051650.P001                                                NaN   \n",
       "SBI-0051829.P001                  anti-infective, unknown mechanism   \n",
       "SBI-0051829.P002                  anti-infective, unknown mechanism   \n",
       "SBI-0051852                             protein synthesis inhibitor   \n",
       "SBI-0051855                       anti-infective, unknown mechanism   \n",
       "SBI-0051941.P001                                                NaN   \n",
       "SBI-0051950.P001                                                NaN   \n",
       "SBI-0052060.P001                                                NaN   \n",
       "SBI-0052083.P001                                                NaN   \n",
       "SBI-0052086.P001                                                NaN   \n",
       "SBI-0052089.P001                                                NaN   \n",
       "SBI-0052104.P001                               proteasome inhibitor   \n",
       "SBI-0052200.P001                                                NaN   \n",
       "...                                                             ...   \n",
       "SBI-0206677.P002                            Topoisomerase inhibitor   \n",
       "SBI-0206677.P003                            Topoisomerase inhibitor   \n",
       "SBI-0206714.P001                            Topoisomerase inhibitor   \n",
       "SBI-0206795.P001                              intercalates into DNA   \n",
       "SBI-0207107                                                     NaN   \n",
       "SBI-0633717.P001                        SIRT2 deacetylase inhibitor   \n",
       "SBI-0633783.P003                                              broad   \n",
       "SBI-0634352.P001                        protein synthesis inhibitor   \n",
       "SBI-0634428.P001                               proteasome inhibitor   \n",
       "SBI-0634430.P003                                     HDAC inhibitor   \n",
       "SBI-0634549.P002                                     HDAC inhibitor   \n",
       "SBI-0634592                               inhibitor of PP2A and PP1   \n",
       "SBI-0634614.P002                                     HDAC inhibitor   \n",
       "SBI-0634645                                          HDAC inhibitor   \n",
       "SBI-0634653                       anti-infective, unknown mechanism   \n",
       "SBI-0635892.P001                  anti-infective, unknown mechanism   \n",
       "SBI-0637109.P001  BCL2 inhibitor II, disrupts its interaction wi...   \n",
       "SBI-0646042.P001                                     HDAC inhibitor   \n",
       "SBI-0646047.P001                                     HDAC inhibitor   \n",
       "SBI-0653846.0001                                 topical antiseptic   \n",
       "SBI-0654379.P001                            Aurora kinase inhibitor   \n",
       "SBI-0654406.P001                          PI3K, AKT, MTOR inhibitor   \n",
       "SBI-0654421.P001                          PI3K, AKT, MTOR inhibitor   \n",
       "SBI-0654430.P001                            Aurora kinase inhibitor   \n",
       "SBI-0654438.P001                          PI3K, AKT, MTOR inhibitor   \n",
       "SBI-0654457.P001                                     CDK inhibitors   \n",
       "SBI-0654461.P001                                     CDK inhibitors   \n",
       "SBI-0654465.P001                          PI3K, AKT, MTOR inhibitor   \n",
       "SBI-0654478.P001                          PI3K, AKT, MTOR inhibitor   \n",
       "NaN                                                             NaN   \n",
       "\n",
       "                        Name  G3_exp  mean_score(G3)  G4_exp  mean_score(G4)  \\\n",
       "sbi_id                                                                         \n",
       "SBI-0050152.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0050242.P007         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0050343.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0050445.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0050582.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0050757.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0050917.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051229              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051229.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051253              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051348.P003         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051393.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051532.P004         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051573.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051578.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051583.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051642.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051650.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051829.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051829.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051852              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051855              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051941.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0051950.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0052060.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0052083.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0052086.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0052089.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0052104.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0052200.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "...                      ...     ...             ...     ...             ...   \n",
       "SBI-0206677.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0206677.P003         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0206714.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0206795.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0207107              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0633717.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0633783.P003         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0634352.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0634428.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0634430.P003  vorinostat     1.0           0.337     0.0           0.308   \n",
       "SBI-0634549.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0634592              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0634614.P002         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0634645              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0634653              NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0635892.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0637109.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0646042.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0646047.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0653846.0001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654379.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654406.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654421.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654430.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654438.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654457.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654461.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654465.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "SBI-0654478.P001         NaN     NaN             NaN     NaN             NaN   \n",
       "NaN                      NaN     NaN             NaN     NaN             NaN   \n",
       "\n",
       "                  SHH_exp  mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \\\n",
       "sbi_id                                                                     \n",
       "SBI-0050152.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0050242.P007      NaN              NaN      NaN                  NaN   \n",
       "SBI-0050343.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0050445.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0050582.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0050757.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0050917.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051229           NaN              NaN      NaN                  NaN   \n",
       "SBI-0051229.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051253           NaN              NaN      NaN                  NaN   \n",
       "SBI-0051348.P003      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051393.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051532.P004      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051573.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051578.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051583.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051642.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051650.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051829.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051829.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051852           NaN              NaN      NaN                  NaN   \n",
       "SBI-0051855           NaN              NaN      NaN                  NaN   \n",
       "SBI-0051941.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0051950.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0052060.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0052083.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0052086.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0052089.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0052104.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0052200.P001      NaN              NaN      NaN                  NaN   \n",
       "...                   ...              ...      ...                  ...   \n",
       "SBI-0206677.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0206677.P003      NaN              NaN      NaN                  NaN   \n",
       "SBI-0206714.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0206795.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0207107           NaN              NaN      NaN                  NaN   \n",
       "SBI-0633717.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0633783.P003      NaN              NaN      NaN                  NaN   \n",
       "SBI-0634352.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0634428.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0634430.P003      0.0         0.102167      0.0             0.210333   \n",
       "SBI-0634549.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0634592           NaN              NaN      NaN                  NaN   \n",
       "SBI-0634614.P002      NaN              NaN      NaN                  NaN   \n",
       "SBI-0634645           NaN              NaN      NaN                  NaN   \n",
       "SBI-0634653           NaN              NaN      NaN                  NaN   \n",
       "SBI-0635892.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0637109.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0646042.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0646047.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0653846.0001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654379.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654406.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654421.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654430.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654438.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654457.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654461.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654465.P001      NaN              NaN      NaN                  NaN   \n",
       "SBI-0654478.P001      NaN              NaN      NaN                  NaN   \n",
       "NaN                   NaN              NaN      NaN                  NaN   \n",
       "\n",
       "                                                                SBI  \n",
       "sbi_id                                                               \n",
       "SBI-0050152.P002                                                NaN  \n",
       "SBI-0050242.P007                                                NaN  \n",
       "SBI-0050343.P002                                                NaN  \n",
       "SBI-0050445.P002                                                NaN  \n",
       "SBI-0050582.P002                                                NaN  \n",
       "SBI-0050757.P002                                                NaN  \n",
       "SBI-0050917.P002                                                NaN  \n",
       "SBI-0051229                                                     NaN  \n",
       "SBI-0051229.P002                                                NaN  \n",
       "SBI-0051253                                                     NaN  \n",
       "SBI-0051348.P003                                                NaN  \n",
       "SBI-0051393.P001                                                NaN  \n",
       "SBI-0051532.P004                                                NaN  \n",
       "SBI-0051573.P001                                                NaN  \n",
       "SBI-0051578.P001                                                NaN  \n",
       "SBI-0051583.P001                                                NaN  \n",
       "SBI-0051642.P001                                                NaN  \n",
       "SBI-0051650.P001                                                NaN  \n",
       "SBI-0051829.P001                                                NaN  \n",
       "SBI-0051829.P002                                                NaN  \n",
       "SBI-0051852                                                     NaN  \n",
       "SBI-0051855                                                     NaN  \n",
       "SBI-0051941.P001                                                NaN  \n",
       "SBI-0051950.P001                                                NaN  \n",
       "SBI-0052060.P001                                                NaN  \n",
       "SBI-0052083.P001                                                NaN  \n",
       "SBI-0052086.P001                                                NaN  \n",
       "SBI-0052089.P001                                                NaN  \n",
       "SBI-0052104.P001                                                NaN  \n",
       "SBI-0052200.P001                                                NaN  \n",
       "...                                                             ...  \n",
       "SBI-0206677.P002                                                NaN  \n",
       "SBI-0206677.P003                                                NaN  \n",
       "SBI-0206714.P001                                                NaN  \n",
       "SBI-0206795.P001                                                NaN  \n",
       "SBI-0207107                                                     NaN  \n",
       "SBI-0633717.P001                                                NaN  \n",
       "SBI-0633783.P003                                                NaN  \n",
       "SBI-0634352.P001                                                NaN  \n",
       "SBI-0634428.P001                                                NaN  \n",
       "SBI-0634430.P003  [SBI-0634430.P003, SBI-0634430.P001, SBI-06344...  \n",
       "SBI-0634549.P002                                                NaN  \n",
       "SBI-0634592                                                     NaN  \n",
       "SBI-0634614.P002                                                NaN  \n",
       "SBI-0634645                                                     NaN  \n",
       "SBI-0634653                                                     NaN  \n",
       "SBI-0635892.P001                                                NaN  \n",
       "SBI-0637109.P001                                                NaN  \n",
       "SBI-0646042.P001                                                NaN  \n",
       "SBI-0646047.P001                                                NaN  \n",
       "SBI-0653846.0001                                                NaN  \n",
       "SBI-0654379.P001                                                NaN  \n",
       "SBI-0654406.P001                                                NaN  \n",
       "SBI-0654421.P001                                                NaN  \n",
       "SBI-0654430.P001                                                NaN  \n",
       "SBI-0654438.P001                                                NaN  \n",
       "SBI-0654457.P001                                                NaN  \n",
       "SBI-0654461.P001                                                NaN  \n",
       "SBI-0654465.P001                                                NaN  \n",
       "SBI-0654478.P001                                                NaN  \n",
       "NaN                                                             NaN  \n",
       "\n",
       "[76 rows x 17 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effective_screen.set_index('sbi_id').join(effective_exp.set_index('sbi_id'),lsuffix='_screen',rsuffix='_exp')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Finding the drugs from the paper:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.046428Z",
     "start_time": "2019-04-19T20:58:03.042419Z"
    }
   },
   "outputs": [],
   "source": [
    "def find_name():\n",
    "    return"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.152164Z",
     "start_time": "2019-04-19T20:58:03.050680Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>nsc-87877</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.3543</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00450</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.144833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.136000</td>\n",
       "      <td>[SBI-0055430, SBI-0634841.0001]</td>\n",
       "      <td>SBI-0055430</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>brd-k49290616</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1506</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.014000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.381333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>tivantinib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3391</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.273000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.303333</td>\n",
       "      <td>[SBI-0654487.P001]</td>\n",
       "      <td>SBI-0654487.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>necrosulfonamide</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3200</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.194833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.296667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>triazolothiadiazine</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3294</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30200</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.293500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.314333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>rita</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1370</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.00300</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.327333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.336667</td>\n",
       "      <td>[SBI-0051053.P002, SBI-0051053.P003, SBI-00535...</td>\n",
       "      <td>SBI-0051053.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>parbendazole</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3242</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.29350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.289167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.313333</td>\n",
       "      <td>[SBI-0636144.P001]</td>\n",
       "      <td>SBI-0636144.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>cediranib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3232</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30475</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.304167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.300667</td>\n",
       "      <td>[SBI-0654326.P001]</td>\n",
       "      <td>SBI-0654326.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>cil70</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3263</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.298000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.311667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>fgin-1-27</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3342</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31450</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.319333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.318667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>gw-843682x</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3242</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.29975</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.298333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.321000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>vincristine</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3092</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.28775</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.271167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.295333</td>\n",
       "      <td>[SBI-0053517.P002, SBI-0206815.P001, SBI-00511...</td>\n",
       "      <td>SBI-0053517.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>daporinad</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3255</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31550</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.287333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.303000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>pl-di</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3202</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.199000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.301333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>cimetidine</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3135</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.29525</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.273667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.277667</td>\n",
       "      <td>[SBI-0050281.P002, SBI-0050281.P007, SBI-00502...</td>\n",
       "      <td>SBI-0050281.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>stf-31</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3162</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.29400</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.266333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.288333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>tpca-1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2515</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.02900</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.002000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.060667</td>\n",
       "      <td>[SBI-0086762.P002]</td>\n",
       "      <td>SBI-0086762.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>cucurbitacin i</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3185</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31400</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.286667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.303000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>erastin</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3258</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.28950</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.299000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.311333</td>\n",
       "      <td>[SBI-0051861.P002, SBI-0051861.P001, SBI-06345...</td>\n",
       "      <td>SBI-0051861.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>brd-k86535717</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2474</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.31425</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.294000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.307667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>yk 4-279</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3159</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.29900</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.293833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.309667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>sn-38</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0968</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.07575</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.146167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.002000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>etp-46464</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3161</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.28850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.278667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.293667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>kx2-391</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3035</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.28200</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.273000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.291667</td>\n",
       "      <td>[SBI-0654429.P001]</td>\n",
       "      <td>SBI-0654429.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>mps-1-in-1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3229</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30875</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.095500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.099000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>decitabine</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3201</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.15525</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.016000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.316667</td>\n",
       "      <td>[SBI-0634423.P001, SBI-0634491.P002, SBI-0634491]</td>\n",
       "      <td>SBI-0634423.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>mi-2</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3114</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.30575</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.012833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.319667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>rigosertib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3050</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.28175</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.269667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.278667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>brd-k34222889</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3068</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.27975</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.278000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.293667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>fqi-2</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.3128</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.29200</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.281667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.306667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>483</th>\n",
       "      <td>tak-715</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4550</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.47300</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.440667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.452000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>484</th>\n",
       "      <td>vismodegib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4632</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.46350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.450833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.460667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>485</th>\n",
       "      <td>z-llnle-cho</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4468</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.47100</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.442333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.451667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>486</th>\n",
       "      <td>ro-3306</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.48925</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.455667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.462333</td>\n",
       "      <td>[SBI-0207140.P002]</td>\n",
       "      <td>SBI-0207140.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>487</th>\n",
       "      <td>bryostatin 1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4688</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.49250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.451833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.455333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>488</th>\n",
       "      <td>bix02189</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4458</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.45725</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.438000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.454333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>489</th>\n",
       "      <td>sb216763</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4847</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.48225</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.442667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.448667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>490</th>\n",
       "      <td>681640</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5134</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.50800</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.481833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.486000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>491</th>\n",
       "      <td>cp724714</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4834</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.47800</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.483833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.488667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>492</th>\n",
       "      <td>rapamycin</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.4941</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.49850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.469167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.482333</td>\n",
       "      <td>[SBI-0086706, SBI-0051883.P001, SBI-0051883.P0...</td>\n",
       "      <td>SBI-0086706</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>493</th>\n",
       "      <td>dabrafenib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.3677</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.17675</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.281333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.219000</td>\n",
       "      <td>[SBI-0654477.P001]</td>\n",
       "      <td>SBI-0654477.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>motesanib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5215</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.54250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.580167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.584333</td>\n",
       "      <td>[SBI-0654329.P001]</td>\n",
       "      <td>SBI-0654329.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>pelitinib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5073</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.51800</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.502000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.505333</td>\n",
       "      <td>[SBI-0654367.P001]</td>\n",
       "      <td>SBI-0654367.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>az628</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5403</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.56350</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.525167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.522333</td>\n",
       "      <td>[SBI-0654462.P001]</td>\n",
       "      <td>SBI-0654462.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>kin001-260</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.1158</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.29375</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.367500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.533000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>498</th>\n",
       "      <td>gnf-2</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5618</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.53325</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.544500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.555000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>499</th>\n",
       "      <td>qs11</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5340</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.54025</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.498333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.507000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>rtrail</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5347</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.55075</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.539833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.542667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>501</th>\n",
       "      <td>ql-xi-92</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1165</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.28450</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.380333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.577000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>502</th>\n",
       "      <td>t0901317</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5112</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.56675</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.560500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.593333</td>\n",
       "      <td>[SBI-0634636]</td>\n",
       "      <td>SBI-0634636</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>503</th>\n",
       "      <td>pd173074</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5742</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.60550</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.574833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.579667</td>\n",
       "      <td>[SBI-0647583.P002]</td>\n",
       "      <td>SBI-0647583.P002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>504</th>\n",
       "      <td>nutlin-3a (-)</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5837</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.61000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.548833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.559667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>505</th>\n",
       "      <td>cetuximab</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5588</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.56925</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.572000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.554000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>506</th>\n",
       "      <td>y-39983</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.0167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.29850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.364333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.547333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>507</th>\n",
       "      <td>idelalisib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5366</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.55250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.547000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.552000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>508</th>\n",
       "      <td>wz-1-84</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5858</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.57850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.559333</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.569000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>509</th>\n",
       "      <td>cyclopamine</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5977</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.59725</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.566167</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.579333</td>\n",
       "      <td>[SBI-0634517]</td>\n",
       "      <td>SBI-0634517</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>510</th>\n",
       "      <td>vx-11e</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.5841</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.60225</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.598833</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.603000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>511</th>\n",
       "      <td>gw441756</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.6208</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.63850</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.589000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.607333</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512</th>\n",
       "      <td>vnlg/124</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.6492</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.65250</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.628667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.640000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>513 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                    Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  \\\n",
       "0              nsc-87877  0.0         -0.3543  0.0         0.00450  0.0   \n",
       "1          brd-k49290616  0.0          0.1506  0.0         0.00250  0.0   \n",
       "2             tivantinib  0.0          0.3391  0.0         0.30250  0.0   \n",
       "3       necrosulfonamide  0.0          0.3200  0.0         0.30075  0.0   \n",
       "4    triazolothiadiazine  0.0          0.3294  0.0         0.30200  0.0   \n",
       "5                   rita  0.0          0.1370  0.0         0.00300  0.0   \n",
       "6           parbendazole  0.0          0.3242  0.0         0.29350  0.0   \n",
       "7              cediranib  0.0          0.3232  0.0         0.30475  0.0   \n",
       "8                  cil70  0.0          0.3263  0.0         0.30350  0.0   \n",
       "9              fgin-1-27  0.0          0.3342  0.0         0.31450  0.0   \n",
       "10            gw-843682x  0.0          0.3242  0.0         0.29975  0.0   \n",
       "11           vincristine  0.0          0.3092  0.0         0.28775  0.0   \n",
       "12             daporinad  0.0          0.3255  0.0         0.31550  0.0   \n",
       "13                 pl-di  0.0          0.3202  0.0         0.30850  0.0   \n",
       "14            cimetidine  0.0          0.3135  0.0         0.29525  0.0   \n",
       "15                stf-31  0.0          0.3162  0.0         0.29400  0.0   \n",
       "16                tpca-1  0.0          0.2515  0.0         0.02900  0.0   \n",
       "17        cucurbitacin i  0.0          0.3185  0.0         0.31400  0.0   \n",
       "18               erastin  0.0          0.3258  0.0         0.28950  0.0   \n",
       "19         brd-k86535717  0.0          0.2474  0.0         0.31425  0.0   \n",
       "20              yk 4-279  0.0          0.3159  0.0         0.29900  0.0   \n",
       "21                 sn-38  0.0          0.0968  0.0         0.07575  0.0   \n",
       "22             etp-46464  0.0          0.3161  0.0         0.28850  0.0   \n",
       "23               kx2-391  0.0          0.3035  0.0         0.28200  0.0   \n",
       "24            mps-1-in-1  0.0          0.3229  0.0         0.30875  0.0   \n",
       "25            decitabine  0.0          0.3201  0.0         0.15525  0.0   \n",
       "26                  mi-2  0.0          0.3114  0.0         0.30575  0.0   \n",
       "27            rigosertib  0.0          0.3050  0.0         0.28175  0.0   \n",
       "28         brd-k34222889  0.0          0.3068  0.0         0.27975  0.0   \n",
       "29                 fqi-2  0.0          0.3128  0.0         0.29200  0.0   \n",
       "..                   ...  ...             ...  ...             ...  ...   \n",
       "483              tak-715  0.0         -0.4550  0.0        -0.47300  0.0   \n",
       "484           vismodegib  0.0         -0.4632  0.0        -0.46350  0.0   \n",
       "485          z-llnle-cho  0.0         -0.4468  0.0        -0.47100  0.0   \n",
       "486              ro-3306  0.0         -0.4667  0.0        -0.48925  0.0   \n",
       "487         bryostatin 1  0.0         -0.4688  0.0        -0.49250  0.0   \n",
       "488             bix02189  0.0         -0.4458  0.0        -0.45725  0.0   \n",
       "489             sb216763  0.0         -0.4847  0.0        -0.48225  0.0   \n",
       "490               681640  0.0         -0.5134  0.0        -0.50800  0.0   \n",
       "491             cp724714  0.0         -0.4834  0.0        -0.47800  0.0   \n",
       "492            rapamycin  0.0         -0.4941  0.0        -0.49850  0.0   \n",
       "493           dabrafenib  0.0         -0.3677  0.0        -0.17675  0.0   \n",
       "494            motesanib  0.0         -0.5215  0.0        -0.54250  0.0   \n",
       "495            pelitinib  0.0         -0.5073  0.0        -0.51800  0.0   \n",
       "496                az628  0.0         -0.5403  0.0        -0.56350  0.0   \n",
       "497           kin001-260  0.0         -0.1158  0.0        -0.29375  0.0   \n",
       "498                gnf-2  0.0         -0.5618  0.0        -0.53325  0.0   \n",
       "499                 qs11  0.0         -0.5340  0.0        -0.54025  0.0   \n",
       "500               rtrail  0.0         -0.5347  0.0        -0.55075  0.0   \n",
       "501             ql-xi-92  0.0          0.1165  0.0        -0.28450  0.0   \n",
       "502             t0901317  0.0         -0.5112  0.0        -0.56675  0.0   \n",
       "503             pd173074  0.0         -0.5742  0.0        -0.60550  0.0   \n",
       "504        nutlin-3a (-)  0.0         -0.5837  0.0        -0.61000  0.0   \n",
       "505            cetuximab  0.0         -0.5588  0.0        -0.56925  0.0   \n",
       "506              y-39983  0.0         -0.0167  0.0        -0.29850  0.0   \n",
       "507           idelalisib  0.0         -0.5366  0.0        -0.55250  0.0   \n",
       "508              wz-1-84  0.0         -0.5858  0.0        -0.57850  0.0   \n",
       "509          cyclopamine  0.0         -0.5977  0.0        -0.59725  0.0   \n",
       "510               vx-11e  0.0         -0.5841  0.0        -0.60225  0.0   \n",
       "511             gw441756  0.0         -0.6208  0.0        -0.63850  0.0   \n",
       "512             vnlg/124  0.0         -0.6492  0.0        -0.65250  0.0   \n",
       "\n",
       "     mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \\\n",
       "0           0.144833      0.0             0.136000   \n",
       "1          -0.014000      0.0            -0.381333   \n",
       "2           0.273000      0.0             0.303333   \n",
       "3           0.194833      0.0             0.296667   \n",
       "4           0.293500      0.0             0.314333   \n",
       "5          -0.327333      0.0            -0.336667   \n",
       "6           0.289167      0.0             0.313333   \n",
       "7           0.304167      0.0             0.300667   \n",
       "8           0.298000      0.0             0.311667   \n",
       "9           0.319333      0.0             0.318667   \n",
       "10          0.298333      0.0             0.321000   \n",
       "11          0.271167      0.0             0.295333   \n",
       "12          0.287333      0.0             0.303000   \n",
       "13          0.199000      0.0             0.301333   \n",
       "14          0.273667      0.0             0.277667   \n",
       "15          0.266333      0.0             0.288333   \n",
       "16         -0.002000      0.0            -0.060667   \n",
       "17          0.286667      0.0             0.303000   \n",
       "18          0.299000      0.0             0.311333   \n",
       "19          0.294000      0.0             0.307667   \n",
       "20          0.293833      0.0             0.309667   \n",
       "21          0.146167      0.0             0.002000   \n",
       "22          0.278667      0.0             0.293667   \n",
       "23          0.273000      0.0             0.291667   \n",
       "24          0.095500      0.0             0.099000   \n",
       "25          0.016000      0.0             0.316667   \n",
       "26          0.012833      0.0             0.319667   \n",
       "27          0.269667      0.0             0.278667   \n",
       "28          0.278000      0.0             0.293667   \n",
       "29          0.281667      0.0             0.306667   \n",
       "..               ...      ...                  ...   \n",
       "483        -0.440667      0.0            -0.452000   \n",
       "484        -0.450833      0.0            -0.460667   \n",
       "485        -0.442333      0.0            -0.451667   \n",
       "486        -0.455667      0.0            -0.462333   \n",
       "487        -0.451833      0.0            -0.455333   \n",
       "488        -0.438000      0.0            -0.454333   \n",
       "489        -0.442667      0.0            -0.448667   \n",
       "490        -0.481833      0.0            -0.486000   \n",
       "491        -0.483833      0.0            -0.488667   \n",
       "492        -0.469167      0.0            -0.482333   \n",
       "493        -0.281333      0.0            -0.219000   \n",
       "494        -0.580167      0.0            -0.584333   \n",
       "495        -0.502000      0.0            -0.505333   \n",
       "496        -0.525167      0.0            -0.522333   \n",
       "497        -0.367500      0.0            -0.533000   \n",
       "498        -0.544500      0.0            -0.555000   \n",
       "499        -0.498333      0.0            -0.507000   \n",
       "500        -0.539833      0.0            -0.542667   \n",
       "501        -0.380333      0.0            -0.577000   \n",
       "502        -0.560500      0.0            -0.593333   \n",
       "503        -0.574833      0.0            -0.579667   \n",
       "504        -0.548833      0.0            -0.559667   \n",
       "505        -0.572000      0.0            -0.554000   \n",
       "506        -0.364333      0.0            -0.547333   \n",
       "507        -0.547000      0.0            -0.552000   \n",
       "508        -0.559333      0.0            -0.569000   \n",
       "509        -0.566167      0.0            -0.579333   \n",
       "510        -0.598833      0.0            -0.603000   \n",
       "511        -0.589000      0.0            -0.607333   \n",
       "512        -0.628667      0.0            -0.640000   \n",
       "\n",
       "                                                   SBI            sbi_id  \n",
       "0                      [SBI-0055430, SBI-0634841.0001]       SBI-0055430  \n",
       "1                                                   []               NaN  \n",
       "2                                   [SBI-0654487.P001]  SBI-0654487.P001  \n",
       "3                                                   []               NaN  \n",
       "4                                                   []               NaN  \n",
       "5    [SBI-0051053.P002, SBI-0051053.P003, SBI-00535...  SBI-0051053.P002  \n",
       "6                                   [SBI-0636144.P001]  SBI-0636144.P001  \n",
       "7                                   [SBI-0654326.P001]  SBI-0654326.P001  \n",
       "8                                                   []               NaN  \n",
       "9                                                   []               NaN  \n",
       "10                                                  []               NaN  \n",
       "11   [SBI-0053517.P002, SBI-0206815.P001, SBI-00511...  SBI-0053517.P002  \n",
       "12                                                  []               NaN  \n",
       "13                                                  []               NaN  \n",
       "14   [SBI-0050281.P002, SBI-0050281.P007, SBI-00502...  SBI-0050281.P002  \n",
       "15                                                  []               NaN  \n",
       "16                                  [SBI-0086762.P002]  SBI-0086762.P002  \n",
       "17                                                  []               NaN  \n",
       "18   [SBI-0051861.P002, SBI-0051861.P001, SBI-06345...  SBI-0051861.P002  \n",
       "19                                                  []               NaN  \n",
       "20                                                  []               NaN  \n",
       "21                                                  []               NaN  \n",
       "22                                                  []               NaN  \n",
       "23                                  [SBI-0654429.P001]  SBI-0654429.P001  \n",
       "24                                                  []               NaN  \n",
       "25   [SBI-0634423.P001, SBI-0634491.P002, SBI-0634491]  SBI-0634423.P001  \n",
       "26                                                  []               NaN  \n",
       "27                                                  []               NaN  \n",
       "28                                                  []               NaN  \n",
       "29                                                  []               NaN  \n",
       "..                                                 ...               ...  \n",
       "483                                                 []               NaN  \n",
       "484                                                 []               NaN  \n",
       "485                                                 []               NaN  \n",
       "486                                 [SBI-0207140.P002]  SBI-0207140.P002  \n",
       "487                                                 []               NaN  \n",
       "488                                                 []               NaN  \n",
       "489                                                 []               NaN  \n",
       "490                                                 []               NaN  \n",
       "491                                                 []               NaN  \n",
       "492  [SBI-0086706, SBI-0051883.P001, SBI-0051883.P0...       SBI-0086706  \n",
       "493                                 [SBI-0654477.P001]  SBI-0654477.P001  \n",
       "494                                 [SBI-0654329.P001]  SBI-0654329.P001  \n",
       "495                                 [SBI-0654367.P001]  SBI-0654367.P001  \n",
       "496                                 [SBI-0654462.P001]  SBI-0654462.P001  \n",
       "497                                                 []               NaN  \n",
       "498                                                 []               NaN  \n",
       "499                                                 []               NaN  \n",
       "500                                                 []               NaN  \n",
       "501                                                 []               NaN  \n",
       "502                                      [SBI-0634636]       SBI-0634636  \n",
       "503                                 [SBI-0647583.P002]  SBI-0647583.P002  \n",
       "504                                                 []               NaN  \n",
       "505                                                 []               NaN  \n",
       "506                                                 []               NaN  \n",
       "507                                                 []               NaN  \n",
       "508                                                 []               NaN  \n",
       "509                                      [SBI-0634517]       SBI-0634517  \n",
       "510                                                 []               NaN  \n",
       "511                                                 []               NaN  \n",
       "512                                                 []               NaN  \n",
       "\n",
       "[513 rows x 11 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ineffective_exp = all_drugs_from_exp[all_drugs_from_exp.apply(lambda x: all([not x['G3'], not x['G4'], not x['SHH']]), axis=1)]\n",
    "ineffective_exp = ineffective_exp.reset_index(drop=True)\n",
    "ineffective_exp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.181669Z",
     "start_time": "2019-04-19T20:58:03.155816Z"
    }
   },
   "outputs": [],
   "source": [
    "writer = pd.ExcelWriter('results/drugs_to_validate.xlsx', engine='xlsxwriter')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### G3 (and others)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.191925Z",
     "start_time": "2019-04-19T20:58:03.183864Z"
    }
   },
   "outputs": [],
   "source": [
    "d_names = [\n",
    "'monafide',\n",
    "'bx-912',\n",
    "'linsitinib',\n",
    "'ABT-737',\n",
    "'anisomycin',\n",
    "'GSK1070916',\n",
    "'topotecan',\n",
    "'etoposide'\n",
    "]\n",
    "\n",
    "d_names = [x.lower() for x in d_names]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.222776Z",
     "start_time": "2019-04-19T20:58:03.195718Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>gsk1070916</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6400</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.64350</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.611000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.613667</td>\n",
       "      <td>[SBI-0654453.P001]</td>\n",
       "      <td>SBI-0654453.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>linsitinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5565</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.55850</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.528000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.534333</td>\n",
       "      <td>[SBI-0646932.P001]</td>\n",
       "      <td>SBI-0646932.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>bx-912</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5366</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54125</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.181333</td>\n",
       "      <td>[SBI-0645949.P001]</td>\n",
       "      <td>SBI-0645949.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>abt-737</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4227</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.41675</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.396667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.408000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  \\\n",
       "1   gsk1070916  1.0          0.6400  1.0         0.64350  1.0   \n",
       "7   linsitinib  1.0          0.5565  1.0         0.55850  1.0   \n",
       "8       bx-912  1.0          0.5366  1.0         0.54125  1.0   \n",
       "31     abt-737  1.0          0.4227  1.0         0.41675  1.0   \n",
       "\n",
       "    mean_score(SHH)  SHH+p53  mean_score(SHH+p53)                 SBI  \\\n",
       "1          0.611000      1.0             0.613667  [SBI-0654453.P001]   \n",
       "7          0.528000      1.0             0.534333  [SBI-0646932.P001]   \n",
       "8          0.337667      0.0             0.181333  [SBI-0645949.P001]   \n",
       "31         0.396667      1.0             0.408000                  []   \n",
       "\n",
       "              sbi_id  \n",
       "1   SBI-0654453.P001  \n",
       "7   SBI-0646932.P001  \n",
       "8   SBI-0645949.P001  \n",
       "31               NaN  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.238389Z",
     "start_time": "2019-04-19T20:58:03.226531Z"
    }
   },
   "outputs": [],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)].to_excel(writer,sheet_name=f'G3_effective')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.265047Z",
     "start_time": "2019-04-19T20:58:03.242384Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>etoposide</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2413</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.15525</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.147500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.049000</td>\n",
       "      <td>[SBI-0634393.P001, SBI-0634371.P001, SBI-00519...</td>\n",
       "      <td>SBI-0634393.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>topotecan</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2718</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.16600</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.072667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.109333</td>\n",
       "      <td>[SBI-0055592.P003, SBI-0055592.P005, SBI-00555...</td>\n",
       "      <td>SBI-0055592.P003</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  \\\n",
       "89   etoposide  0.0          0.2413  0.0         0.15525  0.0   \n",
       "158  topotecan  0.0          0.2718  0.0         0.16600  0.0   \n",
       "\n",
       "     mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \\\n",
       "89          0.147500      0.0             0.049000   \n",
       "158         0.072667      0.0             0.109333   \n",
       "\n",
       "                                                   SBI            sbi_id  \n",
       "89   [SBI-0634393.P001, SBI-0634371.P001, SBI-00519...  SBI-0634393.P001  \n",
       "158  [SBI-0055592.P003, SBI-0055592.P005, SBI-00555...  SBI-0055592.P003  "
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ineffective_exp[ineffective_exp['Name'].isin(d_names)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.275778Z",
     "start_time": "2019-04-19T20:58:03.267947Z"
    }
   },
   "outputs": [],
   "source": [
    "ineffective_exp[ineffective_exp['Name'].isin(d_names)].to_excel(writer,sheet_name=f'G3_ineffective')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## not G3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.283137Z",
     "start_time": "2019-04-19T20:58:03.278802Z"
    }
   },
   "outputs": [],
   "source": [
    "d_names = [\n",
    "    'Alisertib',\n",
    "    'vx-702']\n",
    "d_names = [x.lower() for x in d_names]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.308299Z",
     "start_time": "2019-04-19T20:58:03.287007Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>vx-702</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5614</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54675</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.519333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.527667</td>\n",
       "      <td>[SBI-0654264.P001]</td>\n",
       "      <td>SBI-0654264.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>alisertib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3872</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.34575</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.363667</td>\n",
       "      <td>[SBI-0646927.P001]</td>\n",
       "      <td>SBI-0646927.P001</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  mean_score(SHH)  \\\n",
       "5      vx-702  1.0          0.5614  1.0         0.54675  1.0         0.519333   \n",
       "37  alisertib  1.0          0.3872  1.0         0.34575  1.0         0.337333   \n",
       "\n",
       "    SHH+p53  mean_score(SHH+p53)                 SBI            sbi_id  \n",
       "5       1.0             0.527667  [SBI-0654264.P001]  SBI-0654264.P001  \n",
       "37      1.0             0.363667  [SBI-0646927.P001]  SBI-0646927.P001  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.320073Z",
     "start_time": "2019-04-19T20:58:03.311784Z"
    }
   },
   "outputs": [],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)].to_excel(writer,sheet_name=f'notG3_effective')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.336884Z",
     "start_time": "2019-04-19T20:58:03.323300Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [Name, G3, mean_score(G3), G4, mean_score(G4), SHH, mean_score(SHH), SHH+p53, mean_score(SHH+p53), SBI, sbi_id]\n",
       "Index: []"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ineffective_exp[ineffective_exp['Name'].isin(d_names)]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## SHH"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.345695Z",
     "start_time": "2019-04-19T20:58:03.340157Z"
    }
   },
   "outputs": [],
   "source": [
    "d_names = [\n",
    "    'Olaparib',\n",
    "    'Rucaparib']\n",
    "d_names = [x.lower() for x in d_names]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.372819Z",
     "start_time": "2019-04-19T20:58:03.348763Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2085</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.50925</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4930</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.498667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>olaparib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1674</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.18825</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3965</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.411667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  mean_score(SHH)  \\\n",
       "11  rucaparib  0.0          0.2085  1.0         0.50925  1.0           0.4930   \n",
       "38   olaparib  0.0          0.1674  0.0         0.18825  1.0           0.3965   \n",
       "\n",
       "    SHH+p53  mean_score(SHH+p53) SBI sbi_id  \n",
       "11      1.0             0.498667  []    NaN  \n",
       "38      1.0             0.411667  []    NaN  "
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.384155Z",
     "start_time": "2019-04-19T20:58:03.375721Z"
    }
   },
   "outputs": [],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)].to_excel(writer,sheet_name=f'SHH_effective')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.399379Z",
     "start_time": "2019-04-19T20:58:03.386771Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [Name, G3, mean_score(G3), G4, mean_score(G4), SHH, mean_score(SHH), SHH+p53, mean_score(SHH+p53), SBI, sbi_id]\n",
       "Index: []"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ineffective_exp[ineffective_exp['Name'].isin(d_names)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.409830Z",
     "start_time": "2019-04-19T20:58:03.402303Z"
    }
   },
   "outputs": [],
   "source": [
    "d_names = [\n",
    "'monafide',\n",
    "'bx-912',\n",
    "'linsitinib',\n",
    "'ABT-737',\n",
    "'anisomycin',\n",
    "'GSK1070916',\n",
    "'topotecan',\n",
    "'etoposide',\n",
    "'Alisertib',\n",
    "'vx-702',\n",
    "'Olaparib',\n",
    "'Rucaparib'\n",
    "]\n",
    "\n",
    "d_names = [x.lower() for x in d_names]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.443872Z",
     "start_time": "2019-04-19T20:58:03.412690Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "      <th>SBI</th>\n",
       "      <th>sbi_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>gsk1070916</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.6400</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.64350</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.611000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.613667</td>\n",
       "      <td>[SBI-0654453.P001]</td>\n",
       "      <td>SBI-0654453.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>vx-702</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5614</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54675</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.519333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.527667</td>\n",
       "      <td>[SBI-0654264.P001]</td>\n",
       "      <td>SBI-0654264.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>linsitinib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5565</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.55850</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.528000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.534333</td>\n",
       "      <td>[SBI-0646932.P001]</td>\n",
       "      <td>SBI-0646932.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>bx-912</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.5366</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.54125</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.181333</td>\n",
       "      <td>[SBI-0645949.P001]</td>\n",
       "      <td>SBI-0645949.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2085</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.50925</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.493000</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.498667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>abt-737</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.4227</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.41675</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.396667</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.408000</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>alisertib</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.3872</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.34575</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.337333</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.363667</td>\n",
       "      <td>[SBI-0646927.P001]</td>\n",
       "      <td>SBI-0646927.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>olaparib</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1674</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.18825</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.396500</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.411667</td>\n",
       "      <td>[]</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>etoposide</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2413</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.15525</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.147500</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.049000</td>\n",
       "      <td>[SBI-0634393.P001, SBI-0634371.P001, SBI-00519...</td>\n",
       "      <td>SBI-0634393.P001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>topotecan</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.2718</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.16600</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.072667</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.109333</td>\n",
       "      <td>[SBI-0055592.P003, SBI-0055592.P005, SBI-00555...</td>\n",
       "      <td>SBI-0055592.P003</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           Name   G3  mean_score(G3)   G4  mean_score(G4)  SHH  \\\n",
       "1    gsk1070916  1.0          0.6400  1.0         0.64350  1.0   \n",
       "5        vx-702  1.0          0.5614  1.0         0.54675  1.0   \n",
       "7    linsitinib  1.0          0.5565  1.0         0.55850  1.0   \n",
       "8        bx-912  1.0          0.5366  1.0         0.54125  1.0   \n",
       "11    rucaparib  0.0          0.2085  1.0         0.50925  1.0   \n",
       "31      abt-737  1.0          0.4227  1.0         0.41675  1.0   \n",
       "37    alisertib  1.0          0.3872  1.0         0.34575  1.0   \n",
       "38     olaparib  0.0          0.1674  0.0         0.18825  1.0   \n",
       "89    etoposide  0.0          0.2413  0.0         0.15525  0.0   \n",
       "158   topotecan  0.0          0.2718  0.0         0.16600  0.0   \n",
       "\n",
       "     mean_score(SHH)  SHH+p53  mean_score(SHH+p53)  \\\n",
       "1           0.611000      1.0             0.613667   \n",
       "5           0.519333      1.0             0.527667   \n",
       "7           0.528000      1.0             0.534333   \n",
       "8           0.337667      0.0             0.181333   \n",
       "11          0.493000      1.0             0.498667   \n",
       "31          0.396667      1.0             0.408000   \n",
       "37          0.337333      1.0             0.363667   \n",
       "38          0.396500      1.0             0.411667   \n",
       "89          0.147500      0.0             0.049000   \n",
       "158         0.072667      0.0             0.109333   \n",
       "\n",
       "                                                   SBI            sbi_id  \n",
       "1                                   [SBI-0654453.P001]  SBI-0654453.P001  \n",
       "5                                   [SBI-0654264.P001]  SBI-0654264.P001  \n",
       "7                                   [SBI-0646932.P001]  SBI-0646932.P001  \n",
       "8                                   [SBI-0645949.P001]  SBI-0645949.P001  \n",
       "11                                                  []               NaN  \n",
       "31                                                  []               NaN  \n",
       "37                                  [SBI-0646927.P001]  SBI-0646927.P001  \n",
       "38                                                  []               NaN  \n",
       "89   [SBI-0634393.P001, SBI-0634371.P001, SBI-00519...  SBI-0634393.P001  \n",
       "158  [SBI-0055592.P003, SBI-0055592.P005, SBI-00555...  SBI-0055592.P003  "
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)].append(ineffective_exp[ineffective_exp['Name'].isin(d_names)])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.457950Z",
     "start_time": "2019-04-19T20:58:03.446761Z"
    }
   },
   "outputs": [],
   "source": [
    "effective_exp[effective_exp['Name'].isin(d_names)].append(ineffective_exp[ineffective_exp['Name'].isin(d_names)]).to_excel(writer,sheet_name=f'all_drugs_present')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.470190Z",
     "start_time": "2019-04-19T20:58:03.460978Z"
    }
   },
   "outputs": [],
   "source": [
    "drugs_in_DiSCoVER = list(effective_exp[effective_exp['Name'].isin(d_names)].append(ineffective_exp[ineffective_exp['Name'].isin(d_names)])['Name'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.478103Z",
     "start_time": "2019-04-19T20:58:03.473417Z"
    }
   },
   "outputs": [],
   "source": [
    "drugs_NOT_in_DiSCoVER = list(set(d_names).difference(set(drugs_in_DiSCoVER)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.486012Z",
     "start_time": "2019-04-19T20:58:03.480689Z"
    }
   },
   "outputs": [],
   "source": [
    "pd.DataFrame({'not_found':drugs_NOT_in_DiSCoVER}).to_excel(writer,sheet_name=f'not_in_DiSCoVER')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-04-19T20:58:03.522380Z",
     "start_time": "2019-04-19T20:58:03.489739Z"
    }
   },
   "outputs": [],
   "source": [
    "writer.save()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Comparing to drug validation results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 174,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:58:00.495793Z",
     "start_time": "2019-05-17T23:58:00.492692Z"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T17:18:27.675217Z",
     "start_time": "2019-05-17T17:18:26.103846Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>moa</th>\n",
       "      <th>drug</th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>MED1911</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED411</th>\n",
       "      <th>RCMB20</th>\n",
       "      <th>...</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>BT084</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>RCMB18</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>alectinib</th>\n",
       "      <td>ALK inhibitor, used to treat non-small-cell lu...</td>\n",
       "      <td>gdsc_Alectinib</td>\n",
       "      <td>0.715</td>\n",
       "      <td>-0.686</td>\n",
       "      <td>0.719</td>\n",
       "      <td>0.732</td>\n",
       "      <td>0.686</td>\n",
       "      <td>-0.709</td>\n",
       "      <td>0.703</td>\n",
       "      <td>0.684</td>\n",
       "      <td>...</td>\n",
       "      <td>0.698</td>\n",
       "      <td>0.719</td>\n",
       "      <td>-0.701</td>\n",
       "      <td>-0.713</td>\n",
       "      <td>-0.710</td>\n",
       "      <td>0.700</td>\n",
       "      <td>-0.675</td>\n",
       "      <td>-0.722</td>\n",
       "      <td>-0.704</td>\n",
       "      <td>-0.696</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_GSK1070916</td>\n",
       "      <td>0.652</td>\n",
       "      <td>0.626</td>\n",
       "      <td>0.616</td>\n",
       "      <td>0.664</td>\n",
       "      <td>0.646</td>\n",
       "      <td>0.614</td>\n",
       "      <td>0.632</td>\n",
       "      <td>0.644</td>\n",
       "      <td>...</td>\n",
       "      <td>0.666</td>\n",
       "      <td>0.645</td>\n",
       "      <td>0.633</td>\n",
       "      <td>0.630</td>\n",
       "      <td>0.593</td>\n",
       "      <td>0.631</td>\n",
       "      <td>0.601</td>\n",
       "      <td>0.606</td>\n",
       "      <td>0.618</td>\n",
       "      <td>0.617</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb52334</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_SB52334</td>\n",
       "      <td>0.640</td>\n",
       "      <td>0.562</td>\n",
       "      <td>0.594</td>\n",
       "      <td>0.635</td>\n",
       "      <td>0.625</td>\n",
       "      <td>0.612</td>\n",
       "      <td>0.607</td>\n",
       "      <td>0.617</td>\n",
       "      <td>...</td>\n",
       "      <td>0.663</td>\n",
       "      <td>0.631</td>\n",
       "      <td>0.623</td>\n",
       "      <td>0.663</td>\n",
       "      <td>0.534</td>\n",
       "      <td>0.549</td>\n",
       "      <td>0.584</td>\n",
       "      <td>0.622</td>\n",
       "      <td>0.572</td>\n",
       "      <td>0.597</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tl-2-105</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_TL-2-105</td>\n",
       "      <td>0.637</td>\n",
       "      <td>0.548</td>\n",
       "      <td>0.574</td>\n",
       "      <td>0.628</td>\n",
       "      <td>0.626</td>\n",
       "      <td>0.624</td>\n",
       "      <td>0.594</td>\n",
       "      <td>0.569</td>\n",
       "      <td>...</td>\n",
       "      <td>0.663</td>\n",
       "      <td>0.653</td>\n",
       "      <td>0.639</td>\n",
       "      <td>0.687</td>\n",
       "      <td>-0.633</td>\n",
       "      <td>0.553</td>\n",
       "      <td>0.610</td>\n",
       "      <td>0.646</td>\n",
       "      <td>-0.624</td>\n",
       "      <td>0.614</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ql-xii-61</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_QL-XII-61</td>\n",
       "      <td>0.605</td>\n",
       "      <td>0.570</td>\n",
       "      <td>0.593</td>\n",
       "      <td>0.610</td>\n",
       "      <td>0.623</td>\n",
       "      <td>0.599</td>\n",
       "      <td>0.593</td>\n",
       "      <td>0.592</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.580</td>\n",
       "      <td>0.561</td>\n",
       "      <td>-0.602</td>\n",
       "      <td>-0.593</td>\n",
       "      <td>-0.545</td>\n",
       "      <td>0.576</td>\n",
       "      <td>-0.570</td>\n",
       "      <td>0.594</td>\n",
       "      <td>-0.594</td>\n",
       "      <td>-0.588</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_VX-702</td>\n",
       "      <td>0.578</td>\n",
       "      <td>0.552</td>\n",
       "      <td>0.566</td>\n",
       "      <td>0.583</td>\n",
       "      <td>0.574</td>\n",
       "      <td>0.522</td>\n",
       "      <td>0.607</td>\n",
       "      <td>0.562</td>\n",
       "      <td>...</td>\n",
       "      <td>0.555</td>\n",
       "      <td>0.539</td>\n",
       "      <td>0.522</td>\n",
       "      <td>0.571</td>\n",
       "      <td>0.509</td>\n",
       "      <td>0.503</td>\n",
       "      <td>0.521</td>\n",
       "      <td>0.531</td>\n",
       "      <td>0.536</td>\n",
       "      <td>0.516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk429286a</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_GSK429286A</td>\n",
       "      <td>0.572</td>\n",
       "      <td>0.556</td>\n",
       "      <td>0.593</td>\n",
       "      <td>0.594</td>\n",
       "      <td>0.603</td>\n",
       "      <td>-0.587</td>\n",
       "      <td>0.583</td>\n",
       "      <td>0.553</td>\n",
       "      <td>...</td>\n",
       "      <td>0.607</td>\n",
       "      <td>0.567</td>\n",
       "      <td>0.587</td>\n",
       "      <td>-0.608</td>\n",
       "      <td>-0.503</td>\n",
       "      <td>0.541</td>\n",
       "      <td>0.546</td>\n",
       "      <td>0.548</td>\n",
       "      <td>-0.554</td>\n",
       "      <td>0.541</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>ctrp_linsitinib</td>\n",
       "      <td>0.572</td>\n",
       "      <td>0.527</td>\n",
       "      <td>0.522</td>\n",
       "      <td>0.592</td>\n",
       "      <td>0.563</td>\n",
       "      <td>0.562</td>\n",
       "      <td>0.555</td>\n",
       "      <td>0.538</td>\n",
       "      <td>...</td>\n",
       "      <td>0.561</td>\n",
       "      <td>0.547</td>\n",
       "      <td>0.542</td>\n",
       "      <td>0.584</td>\n",
       "      <td>0.520</td>\n",
       "      <td>0.507</td>\n",
       "      <td>0.538</td>\n",
       "      <td>0.552</td>\n",
       "      <td>0.528</td>\n",
       "      <td>0.523</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_BX-912</td>\n",
       "      <td>0.549</td>\n",
       "      <td>0.505</td>\n",
       "      <td>0.505</td>\n",
       "      <td>0.553</td>\n",
       "      <td>0.541</td>\n",
       "      <td>0.510</td>\n",
       "      <td>0.549</td>\n",
       "      <td>0.546</td>\n",
       "      <td>...</td>\n",
       "      <td>0.551</td>\n",
       "      <td>0.556</td>\n",
       "      <td>0.519</td>\n",
       "      <td>0.539</td>\n",
       "      <td>0.471</td>\n",
       "      <td>0.505</td>\n",
       "      <td>0.506</td>\n",
       "      <td>0.535</td>\n",
       "      <td>-0.500</td>\n",
       "      <td>0.509</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gw-2580</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_GW-2580</td>\n",
       "      <td>0.546</td>\n",
       "      <td>0.548</td>\n",
       "      <td>0.512</td>\n",
       "      <td>0.613</td>\n",
       "      <td>0.510</td>\n",
       "      <td>0.527</td>\n",
       "      <td>0.535</td>\n",
       "      <td>0.490</td>\n",
       "      <td>...</td>\n",
       "      <td>0.582</td>\n",
       "      <td>0.584</td>\n",
       "      <td>0.647</td>\n",
       "      <td>0.620</td>\n",
       "      <td>0.598</td>\n",
       "      <td>0.597</td>\n",
       "      <td>0.572</td>\n",
       "      <td>0.552</td>\n",
       "      <td>0.619</td>\n",
       "      <td>0.579</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tubastatin a</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>ctrp_tubastatin A</td>\n",
       "      <td>0.525</td>\n",
       "      <td>0.520</td>\n",
       "      <td>0.540</td>\n",
       "      <td>0.542</td>\n",
       "      <td>0.550</td>\n",
       "      <td>0.524</td>\n",
       "      <td>0.528</td>\n",
       "      <td>0.509</td>\n",
       "      <td>...</td>\n",
       "      <td>0.536</td>\n",
       "      <td>0.528</td>\n",
       "      <td>0.523</td>\n",
       "      <td>0.536</td>\n",
       "      <td>-0.074</td>\n",
       "      <td>0.486</td>\n",
       "      <td>0.530</td>\n",
       "      <td>0.536</td>\n",
       "      <td>-0.087</td>\n",
       "      <td>0.512</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>gdsc_Rucaparib</td>\n",
       "      <td>0.506</td>\n",
       "      <td>0.456</td>\n",
       "      <td>-0.459</td>\n",
       "      <td>-0.489</td>\n",
       "      <td>0.503</td>\n",
       "      <td>0.482</td>\n",
       "      <td>0.528</td>\n",
       "      <td>-0.462</td>\n",
       "      <td>...</td>\n",
       "      <td>0.515</td>\n",
       "      <td>0.519</td>\n",
       "      <td>0.505</td>\n",
       "      <td>0.498</td>\n",
       "      <td>0.486</td>\n",
       "      <td>0.472</td>\n",
       "      <td>0.504</td>\n",
       "      <td>0.519</td>\n",
       "      <td>0.486</td>\n",
       "      <td>0.491</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>hg-5-88-01</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_HG-5-88-01</td>\n",
       "      <td>0.499</td>\n",
       "      <td>0.439</td>\n",
       "      <td>0.478</td>\n",
       "      <td>0.498</td>\n",
       "      <td>0.467</td>\n",
       "      <td>0.426</td>\n",
       "      <td>0.472</td>\n",
       "      <td>0.472</td>\n",
       "      <td>...</td>\n",
       "      <td>0.462</td>\n",
       "      <td>0.450</td>\n",
       "      <td>-0.437</td>\n",
       "      <td>-0.468</td>\n",
       "      <td>0.376</td>\n",
       "      <td>0.393</td>\n",
       "      <td>-0.441</td>\n",
       "      <td>0.466</td>\n",
       "      <td>0.456</td>\n",
       "      <td>0.434</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>navitoclax</th>\n",
       "      <td>Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and ...</td>\n",
       "      <td>ctrp_navitoclax</td>\n",
       "      <td>0.495</td>\n",
       "      <td>0.487</td>\n",
       "      <td>0.472</td>\n",
       "      <td>0.511</td>\n",
       "      <td>0.523</td>\n",
       "      <td>0.489</td>\n",
       "      <td>0.495</td>\n",
       "      <td>0.482</td>\n",
       "      <td>...</td>\n",
       "      <td>0.504</td>\n",
       "      <td>0.496</td>\n",
       "      <td>0.500</td>\n",
       "      <td>0.512</td>\n",
       "      <td>0.468</td>\n",
       "      <td>0.477</td>\n",
       "      <td>0.463</td>\n",
       "      <td>0.509</td>\n",
       "      <td>0.480</td>\n",
       "      <td>0.478</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>amuvatinib</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Amuvatinib</td>\n",
       "      <td>0.489</td>\n",
       "      <td>0.461</td>\n",
       "      <td>0.449</td>\n",
       "      <td>0.504</td>\n",
       "      <td>0.500</td>\n",
       "      <td>0.472</td>\n",
       "      <td>0.495</td>\n",
       "      <td>0.472</td>\n",
       "      <td>...</td>\n",
       "      <td>0.494</td>\n",
       "      <td>0.471</td>\n",
       "      <td>0.493</td>\n",
       "      <td>0.507</td>\n",
       "      <td>0.412</td>\n",
       "      <td>0.440</td>\n",
       "      <td>0.455</td>\n",
       "      <td>0.455</td>\n",
       "      <td>0.440</td>\n",
       "      <td>0.457</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd14-99</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_XMD14-99</td>\n",
       "      <td>0.487</td>\n",
       "      <td>-0.492</td>\n",
       "      <td>0.472</td>\n",
       "      <td>0.539</td>\n",
       "      <td>0.499</td>\n",
       "      <td>-0.472</td>\n",
       "      <td>0.470</td>\n",
       "      <td>0.467</td>\n",
       "      <td>...</td>\n",
       "      <td>0.525</td>\n",
       "      <td>0.527</td>\n",
       "      <td>-0.498</td>\n",
       "      <td>-0.527</td>\n",
       "      <td>-0.476</td>\n",
       "      <td>0.495</td>\n",
       "      <td>-0.451</td>\n",
       "      <td>0.481</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.477</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>axitinib</th>\n",
       "      <td>VEGFR, c-KIT and PDGFR inhibitor</td>\n",
       "      <td>ctrp_axitinib</td>\n",
       "      <td>0.470</td>\n",
       "      <td>0.474</td>\n",
       "      <td>0.432</td>\n",
       "      <td>0.483</td>\n",
       "      <td>0.473</td>\n",
       "      <td>0.456</td>\n",
       "      <td>0.462</td>\n",
       "      <td>0.462</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.077</td>\n",
       "      <td>0.449</td>\n",
       "      <td>-0.079</td>\n",
       "      <td>0.460</td>\n",
       "      <td>-0.099</td>\n",
       "      <td>0.410</td>\n",
       "      <td>0.457</td>\n",
       "      <td>0.471</td>\n",
       "      <td>-0.062</td>\n",
       "      <td>0.442</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd13-2</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_XMD13-2</td>\n",
       "      <td>0.466</td>\n",
       "      <td>0.444</td>\n",
       "      <td>0.449</td>\n",
       "      <td>0.499</td>\n",
       "      <td>0.459</td>\n",
       "      <td>0.451</td>\n",
       "      <td>0.462</td>\n",
       "      <td>0.465</td>\n",
       "      <td>...</td>\n",
       "      <td>0.471</td>\n",
       "      <td>0.465</td>\n",
       "      <td>0.470</td>\n",
       "      <td>0.456</td>\n",
       "      <td>0.406</td>\n",
       "      <td>0.433</td>\n",
       "      <td>0.435</td>\n",
       "      <td>0.450</td>\n",
       "      <td>-0.461</td>\n",
       "      <td>0.425</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avrainvillamide</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>ctrp_avrainvillamide</td>\n",
       "      <td>0.460</td>\n",
       "      <td>0.431</td>\n",
       "      <td>0.416</td>\n",
       "      <td>0.437</td>\n",
       "      <td>0.444</td>\n",
       "      <td>0.456</td>\n",
       "      <td>0.480</td>\n",
       "      <td>0.460</td>\n",
       "      <td>...</td>\n",
       "      <td>0.428</td>\n",
       "      <td>0.416</td>\n",
       "      <td>0.407</td>\n",
       "      <td>0.482</td>\n",
       "      <td>0.385</td>\n",
       "      <td>0.350</td>\n",
       "      <td>0.425</td>\n",
       "      <td>0.395</td>\n",
       "      <td>0.404</td>\n",
       "      <td>0.390</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ispinesib mesylate</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Ispinesib Mesylate</td>\n",
       "      <td>0.451</td>\n",
       "      <td>0.403</td>\n",
       "      <td>0.440</td>\n",
       "      <td>0.462</td>\n",
       "      <td>0.435</td>\n",
       "      <td>0.405</td>\n",
       "      <td>0.460</td>\n",
       "      <td>0.459</td>\n",
       "      <td>...</td>\n",
       "      <td>0.452</td>\n",
       "      <td>0.424</td>\n",
       "      <td>-0.417</td>\n",
       "      <td>-0.438</td>\n",
       "      <td>-0.422</td>\n",
       "      <td>0.392</td>\n",
       "      <td>0.411</td>\n",
       "      <td>0.417</td>\n",
       "      <td>-0.424</td>\n",
       "      <td>0.386</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk319347a</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_GSK319347A</td>\n",
       "      <td>0.446</td>\n",
       "      <td>0.411</td>\n",
       "      <td>-0.422</td>\n",
       "      <td>0.463</td>\n",
       "      <td>0.468</td>\n",
       "      <td>0.487</td>\n",
       "      <td>0.457</td>\n",
       "      <td>0.448</td>\n",
       "      <td>...</td>\n",
       "      <td>0.438</td>\n",
       "      <td>0.439</td>\n",
       "      <td>0.449</td>\n",
       "      <td>0.481</td>\n",
       "      <td>0.445</td>\n",
       "      <td>0.388</td>\n",
       "      <td>0.469</td>\n",
       "      <td>0.412</td>\n",
       "      <td>0.455</td>\n",
       "      <td>0.429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>brd-k99006945</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>ctrp_BRD-K99006945</td>\n",
       "      <td>0.445</td>\n",
       "      <td>0.396</td>\n",
       "      <td>-0.370</td>\n",
       "      <td>0.427</td>\n",
       "      <td>0.425</td>\n",
       "      <td>-0.427</td>\n",
       "      <td>-0.380</td>\n",
       "      <td>0.387</td>\n",
       "      <td>...</td>\n",
       "      <td>0.437</td>\n",
       "      <td>0.429</td>\n",
       "      <td>0.404</td>\n",
       "      <td>0.441</td>\n",
       "      <td>0.417</td>\n",
       "      <td>0.417</td>\n",
       "      <td>0.389</td>\n",
       "      <td>0.421</td>\n",
       "      <td>0.403</td>\n",
       "      <td>0.405</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>staurosporine</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>ctrp_staurosporine</td>\n",
       "      <td>0.445</td>\n",
       "      <td>0.385</td>\n",
       "      <td>0.460</td>\n",
       "      <td>0.413</td>\n",
       "      <td>0.419</td>\n",
       "      <td>0.422</td>\n",
       "      <td>0.451</td>\n",
       "      <td>0.447</td>\n",
       "      <td>...</td>\n",
       "      <td>0.408</td>\n",
       "      <td>0.397</td>\n",
       "      <td>0.412</td>\n",
       "      <td>0.364</td>\n",
       "      <td>0.440</td>\n",
       "      <td>0.414</td>\n",
       "      <td>0.434</td>\n",
       "      <td>0.426</td>\n",
       "      <td>0.465</td>\n",
       "      <td>0.409</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>ctrp_barasertib</td>\n",
       "      <td>0.443</td>\n",
       "      <td>0.393</td>\n",
       "      <td>0.418</td>\n",
       "      <td>0.424</td>\n",
       "      <td>0.430</td>\n",
       "      <td>0.457</td>\n",
       "      <td>0.464</td>\n",
       "      <td>0.431</td>\n",
       "      <td>...</td>\n",
       "      <td>0.382</td>\n",
       "      <td>0.382</td>\n",
       "      <td>0.353</td>\n",
       "      <td>0.431</td>\n",
       "      <td>0.370</td>\n",
       "      <td>0.340</td>\n",
       "      <td>0.379</td>\n",
       "      <td>0.399</td>\n",
       "      <td>0.434</td>\n",
       "      <td>0.373</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ml239</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>ctrp_ML239</td>\n",
       "      <td>0.442</td>\n",
       "      <td>0.360</td>\n",
       "      <td>0.401</td>\n",
       "      <td>0.424</td>\n",
       "      <td>0.397</td>\n",
       "      <td>0.428</td>\n",
       "      <td>0.431</td>\n",
       "      <td>0.407</td>\n",
       "      <td>...</td>\n",
       "      <td>0.428</td>\n",
       "      <td>0.392</td>\n",
       "      <td>0.410</td>\n",
       "      <td>0.445</td>\n",
       "      <td>0.376</td>\n",
       "      <td>0.370</td>\n",
       "      <td>0.393</td>\n",
       "      <td>0.412</td>\n",
       "      <td>0.425</td>\n",
       "      <td>0.366</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>talazoparib</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Talazoparib</td>\n",
       "      <td>0.440</td>\n",
       "      <td>0.361</td>\n",
       "      <td>0.367</td>\n",
       "      <td>0.408</td>\n",
       "      <td>0.418</td>\n",
       "      <td>-0.383</td>\n",
       "      <td>0.409</td>\n",
       "      <td>0.380</td>\n",
       "      <td>...</td>\n",
       "      <td>0.414</td>\n",
       "      <td>0.409</td>\n",
       "      <td>0.404</td>\n",
       "      <td>0.387</td>\n",
       "      <td>0.400</td>\n",
       "      <td>0.382</td>\n",
       "      <td>0.419</td>\n",
       "      <td>0.397</td>\n",
       "      <td>0.393</td>\n",
       "      <td>0.403</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>brd-k26531177</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>ctrp_BRD-K26531177</td>\n",
       "      <td>0.437</td>\n",
       "      <td>0.385</td>\n",
       "      <td>0.414</td>\n",
       "      <td>0.403</td>\n",
       "      <td>0.414</td>\n",
       "      <td>0.439</td>\n",
       "      <td>0.428</td>\n",
       "      <td>0.409</td>\n",
       "      <td>...</td>\n",
       "      <td>0.394</td>\n",
       "      <td>0.403</td>\n",
       "      <td>0.383</td>\n",
       "      <td>0.421</td>\n",
       "      <td>0.365</td>\n",
       "      <td>0.370</td>\n",
       "      <td>0.392</td>\n",
       "      <td>0.421</td>\n",
       "      <td>0.392</td>\n",
       "      <td>0.387</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cct036477</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>ctrp_CCT036477</td>\n",
       "      <td>0.437</td>\n",
       "      <td>0.408</td>\n",
       "      <td>0.387</td>\n",
       "      <td>0.443</td>\n",
       "      <td>0.433</td>\n",
       "      <td>0.431</td>\n",
       "      <td>0.437</td>\n",
       "      <td>0.426</td>\n",
       "      <td>...</td>\n",
       "      <td>0.409</td>\n",
       "      <td>0.429</td>\n",
       "      <td>0.393</td>\n",
       "      <td>0.415</td>\n",
       "      <td>0.377</td>\n",
       "      <td>0.367</td>\n",
       "      <td>0.371</td>\n",
       "      <td>0.394</td>\n",
       "      <td>0.389</td>\n",
       "      <td>0.382</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>indisulam</th>\n",
       "      <td>carbonic anhydrase inibitor and  CDK inhibitor...</td>\n",
       "      <td>ctrp_indisulam</td>\n",
       "      <td>0.433</td>\n",
       "      <td>0.378</td>\n",
       "      <td>0.425</td>\n",
       "      <td>0.428</td>\n",
       "      <td>0.411</td>\n",
       "      <td>0.458</td>\n",
       "      <td>0.459</td>\n",
       "      <td>0.415</td>\n",
       "      <td>...</td>\n",
       "      <td>0.396</td>\n",
       "      <td>0.383</td>\n",
       "      <td>0.378</td>\n",
       "      <td>0.427</td>\n",
       "      <td>0.364</td>\n",
       "      <td>0.345</td>\n",
       "      <td>0.396</td>\n",
       "      <td>0.437</td>\n",
       "      <td>0.420</td>\n",
       "      <td>0.378</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb-505124</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_SB-505124</td>\n",
       "      <td>0.432</td>\n",
       "      <td>0.425</td>\n",
       "      <td>0.418</td>\n",
       "      <td>0.435</td>\n",
       "      <td>0.415</td>\n",
       "      <td>0.430</td>\n",
       "      <td>0.439</td>\n",
       "      <td>0.440</td>\n",
       "      <td>...</td>\n",
       "      <td>0.445</td>\n",
       "      <td>0.397</td>\n",
       "      <td>0.424</td>\n",
       "      <td>0.433</td>\n",
       "      <td>0.384</td>\n",
       "      <td>0.389</td>\n",
       "      <td>0.409</td>\n",
       "      <td>0.384</td>\n",
       "      <td>-0.378</td>\n",
       "      <td>-0.399</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tak-715</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_TAK-715</td>\n",
       "      <td>-0.457</td>\n",
       "      <td>-0.451</td>\n",
       "      <td>-0.449</td>\n",
       "      <td>-0.470</td>\n",
       "      <td>-0.469</td>\n",
       "      <td>-0.454</td>\n",
       "      <td>-0.435</td>\n",
       "      <td>-0.432</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.475</td>\n",
       "      <td>-0.456</td>\n",
       "      <td>-0.468</td>\n",
       "      <td>-0.493</td>\n",
       "      <td>-0.466</td>\n",
       "      <td>-0.393</td>\n",
       "      <td>-0.429</td>\n",
       "      <td>-0.428</td>\n",
       "      <td>-0.485</td>\n",
       "      <td>-0.443</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vismodegib</th>\n",
       "      <td>Hedgehog (Smoothened) antagonist (GDC-0449)</td>\n",
       "      <td>gdsc_Vismodegib</td>\n",
       "      <td>-0.461</td>\n",
       "      <td>-0.456</td>\n",
       "      <td>-0.422</td>\n",
       "      <td>-0.491</td>\n",
       "      <td>-0.487</td>\n",
       "      <td>-0.458</td>\n",
       "      <td>-0.445</td>\n",
       "      <td>-0.447</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.467</td>\n",
       "      <td>-0.457</td>\n",
       "      <td>-0.451</td>\n",
       "      <td>-0.479</td>\n",
       "      <td>-0.439</td>\n",
       "      <td>-0.442</td>\n",
       "      <td>-0.442</td>\n",
       "      <td>-0.464</td>\n",
       "      <td>-0.457</td>\n",
       "      <td>-0.461</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>z-llnle-cho</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Z-LLNle-CHO</td>\n",
       "      <td>-0.466</td>\n",
       "      <td>-0.411</td>\n",
       "      <td>-0.411</td>\n",
       "      <td>-0.472</td>\n",
       "      <td>-0.456</td>\n",
       "      <td>-0.460</td>\n",
       "      <td>-0.439</td>\n",
       "      <td>-0.432</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.481</td>\n",
       "      <td>-0.449</td>\n",
       "      <td>-0.457</td>\n",
       "      <td>-0.497</td>\n",
       "      <td>-0.422</td>\n",
       "      <td>-0.411</td>\n",
       "      <td>-0.466</td>\n",
       "      <td>-0.467</td>\n",
       "      <td>-0.440</td>\n",
       "      <td>-0.448</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ro-3306</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_RO-3306</td>\n",
       "      <td>-0.469</td>\n",
       "      <td>-0.436</td>\n",
       "      <td>-0.434</td>\n",
       "      <td>-0.498</td>\n",
       "      <td>-0.492</td>\n",
       "      <td>-0.445</td>\n",
       "      <td>-0.456</td>\n",
       "      <td>-0.479</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.513</td>\n",
       "      <td>-0.465</td>\n",
       "      <td>-0.482</td>\n",
       "      <td>-0.497</td>\n",
       "      <td>-0.426</td>\n",
       "      <td>-0.454</td>\n",
       "      <td>-0.467</td>\n",
       "      <td>-0.462</td>\n",
       "      <td>-0.479</td>\n",
       "      <td>-0.446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bryostatin 1</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Bryostatin 1</td>\n",
       "      <td>-0.479</td>\n",
       "      <td>-0.451</td>\n",
       "      <td>-0.413</td>\n",
       "      <td>-0.517</td>\n",
       "      <td>-0.486</td>\n",
       "      <td>-0.455</td>\n",
       "      <td>-0.464</td>\n",
       "      <td>-0.464</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.480</td>\n",
       "      <td>-0.482</td>\n",
       "      <td>-0.503</td>\n",
       "      <td>-0.505</td>\n",
       "      <td>-0.447</td>\n",
       "      <td>-0.427</td>\n",
       "      <td>-0.471</td>\n",
       "      <td>-0.452</td>\n",
       "      <td>-0.450</td>\n",
       "      <td>-0.464</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bix02189</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_BIX02189</td>\n",
       "      <td>-0.483</td>\n",
       "      <td>-0.434</td>\n",
       "      <td>-0.403</td>\n",
       "      <td>-0.435</td>\n",
       "      <td>-0.466</td>\n",
       "      <td>-0.439</td>\n",
       "      <td>-0.447</td>\n",
       "      <td>-0.428</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.463</td>\n",
       "      <td>-0.436</td>\n",
       "      <td>-0.472</td>\n",
       "      <td>-0.458</td>\n",
       "      <td>-0.438</td>\n",
       "      <td>-0.375</td>\n",
       "      <td>-0.452</td>\n",
       "      <td>-0.446</td>\n",
       "      <td>-0.462</td>\n",
       "      <td>-0.455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb216763</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_SB216763</td>\n",
       "      <td>-0.487</td>\n",
       "      <td>-0.473</td>\n",
       "      <td>-0.477</td>\n",
       "      <td>-0.529</td>\n",
       "      <td>-0.479</td>\n",
       "      <td>-0.476</td>\n",
       "      <td>-0.463</td>\n",
       "      <td>-0.460</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.500</td>\n",
       "      <td>-0.458</td>\n",
       "      <td>-0.475</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.418</td>\n",
       "      <td>-0.453</td>\n",
       "      <td>-0.439</td>\n",
       "      <td>-0.464</td>\n",
       "      <td>-0.435</td>\n",
       "      <td>-0.447</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681640</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_681640</td>\n",
       "      <td>-0.494</td>\n",
       "      <td>-0.518</td>\n",
       "      <td>-0.499</td>\n",
       "      <td>-0.562</td>\n",
       "      <td>-0.506</td>\n",
       "      <td>-0.495</td>\n",
       "      <td>-0.500</td>\n",
       "      <td>-0.506</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.533</td>\n",
       "      <td>-0.488</td>\n",
       "      <td>-0.485</td>\n",
       "      <td>-0.526</td>\n",
       "      <td>-0.470</td>\n",
       "      <td>-0.480</td>\n",
       "      <td>-0.483</td>\n",
       "      <td>-0.495</td>\n",
       "      <td>-0.467</td>\n",
       "      <td>-0.496</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cp724714</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_CP724714</td>\n",
       "      <td>-0.498</td>\n",
       "      <td>-0.492</td>\n",
       "      <td>-0.425</td>\n",
       "      <td>-0.570</td>\n",
       "      <td>-0.466</td>\n",
       "      <td>-0.451</td>\n",
       "      <td>-0.456</td>\n",
       "      <td>-0.479</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.476</td>\n",
       "      <td>-0.483</td>\n",
       "      <td>-0.478</td>\n",
       "      <td>-0.475</td>\n",
       "      <td>-0.469</td>\n",
       "      <td>-0.489</td>\n",
       "      <td>-0.479</td>\n",
       "      <td>-0.481</td>\n",
       "      <td>-0.483</td>\n",
       "      <td>-0.502</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rapamycin</th>\n",
       "      <td>rapamycin, mTOR inhibitor</td>\n",
       "      <td>gdsc_Rapamycin</td>\n",
       "      <td>-0.503</td>\n",
       "      <td>-0.460</td>\n",
       "      <td>-0.453</td>\n",
       "      <td>-0.524</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.504</td>\n",
       "      <td>-0.503</td>\n",
       "      <td>-0.469</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.487</td>\n",
       "      <td>-0.480</td>\n",
       "      <td>-0.490</td>\n",
       "      <td>-0.537</td>\n",
       "      <td>-0.441</td>\n",
       "      <td>-0.447</td>\n",
       "      <td>-0.480</td>\n",
       "      <td>-0.486</td>\n",
       "      <td>-0.469</td>\n",
       "      <td>-0.492</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dabrafenib</th>\n",
       "      <td>Braf (V600E) inhibitor</td>\n",
       "      <td>gdsc_Dabrafenib</td>\n",
       "      <td>-0.510</td>\n",
       "      <td>-0.049</td>\n",
       "      <td>-0.466</td>\n",
       "      <td>-0.057</td>\n",
       "      <td>-0.051</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.526</td>\n",
       "      <td>-0.494</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.060</td>\n",
       "      <td>-0.052</td>\n",
       "      <td>-0.068</td>\n",
       "      <td>-0.527</td>\n",
       "      <td>-0.475</td>\n",
       "      <td>-0.084</td>\n",
       "      <td>-0.472</td>\n",
       "      <td>-0.087</td>\n",
       "      <td>-0.488</td>\n",
       "      <td>-0.082</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>motesanib</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Motesanib</td>\n",
       "      <td>-0.513</td>\n",
       "      <td>-0.441</td>\n",
       "      <td>-0.533</td>\n",
       "      <td>-0.560</td>\n",
       "      <td>-0.511</td>\n",
       "      <td>-0.559</td>\n",
       "      <td>-0.476</td>\n",
       "      <td>-0.529</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.539</td>\n",
       "      <td>-0.547</td>\n",
       "      <td>-0.540</td>\n",
       "      <td>-0.544</td>\n",
       "      <td>-0.646</td>\n",
       "      <td>-0.503</td>\n",
       "      <td>-0.579</td>\n",
       "      <td>-0.639</td>\n",
       "      <td>-0.584</td>\n",
       "      <td>-0.530</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pelitinib</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Pelitinib</td>\n",
       "      <td>-0.516</td>\n",
       "      <td>-0.519</td>\n",
       "      <td>-0.485</td>\n",
       "      <td>-0.494</td>\n",
       "      <td>-0.519</td>\n",
       "      <td>-0.526</td>\n",
       "      <td>-0.494</td>\n",
       "      <td>-0.492</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.524</td>\n",
       "      <td>-0.497</td>\n",
       "      <td>-0.502</td>\n",
       "      <td>-0.549</td>\n",
       "      <td>-0.506</td>\n",
       "      <td>-0.472</td>\n",
       "      <td>-0.518</td>\n",
       "      <td>-0.512</td>\n",
       "      <td>-0.498</td>\n",
       "      <td>-0.506</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>az628</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_AZ628</td>\n",
       "      <td>-0.535</td>\n",
       "      <td>-0.470</td>\n",
       "      <td>-0.520</td>\n",
       "      <td>-0.565</td>\n",
       "      <td>-0.565</td>\n",
       "      <td>-0.566</td>\n",
       "      <td>-0.540</td>\n",
       "      <td>-0.508</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.567</td>\n",
       "      <td>-0.547</td>\n",
       "      <td>-0.551</td>\n",
       "      <td>-0.589</td>\n",
       "      <td>-0.507</td>\n",
       "      <td>-0.534</td>\n",
       "      <td>-0.543</td>\n",
       "      <td>-0.529</td>\n",
       "      <td>-0.506</td>\n",
       "      <td>-0.532</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>kin001-260</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_KIN001-260</td>\n",
       "      <td>-0.539</td>\n",
       "      <td>-0.560</td>\n",
       "      <td>0.514</td>\n",
       "      <td>0.525</td>\n",
       "      <td>-0.536</td>\n",
       "      <td>-0.528</td>\n",
       "      <td>-0.513</td>\n",
       "      <td>0.473</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.583</td>\n",
       "      <td>0.506</td>\n",
       "      <td>-0.557</td>\n",
       "      <td>-0.541</td>\n",
       "      <td>-0.551</td>\n",
       "      <td>0.502</td>\n",
       "      <td>-0.557</td>\n",
       "      <td>-0.528</td>\n",
       "      <td>-0.557</td>\n",
       "      <td>-0.514</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gnf-2</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_GNF-2</td>\n",
       "      <td>-0.541</td>\n",
       "      <td>-0.538</td>\n",
       "      <td>-0.536</td>\n",
       "      <td>-0.558</td>\n",
       "      <td>-0.557</td>\n",
       "      <td>-0.577</td>\n",
       "      <td>-0.590</td>\n",
       "      <td>-0.545</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.520</td>\n",
       "      <td>-0.518</td>\n",
       "      <td>-0.519</td>\n",
       "      <td>-0.576</td>\n",
       "      <td>-0.537</td>\n",
       "      <td>-0.519</td>\n",
       "      <td>-0.546</td>\n",
       "      <td>-0.578</td>\n",
       "      <td>-0.544</td>\n",
       "      <td>-0.543</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>qs11</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_QS11</td>\n",
       "      <td>-0.544</td>\n",
       "      <td>-0.517</td>\n",
       "      <td>-0.495</td>\n",
       "      <td>-0.540</td>\n",
       "      <td>-0.559</td>\n",
       "      <td>-0.531</td>\n",
       "      <td>-0.546</td>\n",
       "      <td>-0.520</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.548</td>\n",
       "      <td>-0.524</td>\n",
       "      <td>-0.553</td>\n",
       "      <td>-0.536</td>\n",
       "      <td>-0.460</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.513</td>\n",
       "      <td>-0.505</td>\n",
       "      <td>-0.500</td>\n",
       "      <td>-0.516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rtrail</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_rTRAIL</td>\n",
       "      <td>-0.545</td>\n",
       "      <td>-0.516</td>\n",
       "      <td>-0.501</td>\n",
       "      <td>-0.536</td>\n",
       "      <td>-0.555</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.549</td>\n",
       "      <td>-0.533</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.540</td>\n",
       "      <td>-0.559</td>\n",
       "      <td>-0.540</td>\n",
       "      <td>-0.564</td>\n",
       "      <td>-0.544</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.571</td>\n",
       "      <td>-0.574</td>\n",
       "      <td>-0.526</td>\n",
       "      <td>-0.528</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ql-xi-92</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_QL-XI-92</td>\n",
       "      <td>-0.548</td>\n",
       "      <td>-0.518</td>\n",
       "      <td>0.545</td>\n",
       "      <td>0.582</td>\n",
       "      <td>-0.559</td>\n",
       "      <td>-0.604</td>\n",
       "      <td>0.548</td>\n",
       "      <td>0.568</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.581</td>\n",
       "      <td>0.569</td>\n",
       "      <td>-0.561</td>\n",
       "      <td>-0.565</td>\n",
       "      <td>-0.557</td>\n",
       "      <td>0.568</td>\n",
       "      <td>-0.562</td>\n",
       "      <td>-0.558</td>\n",
       "      <td>-0.586</td>\n",
       "      <td>-0.587</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>t0901317</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_T0901317</td>\n",
       "      <td>-0.554</td>\n",
       "      <td>-0.389</td>\n",
       "      <td>-0.489</td>\n",
       "      <td>-0.514</td>\n",
       "      <td>-0.510</td>\n",
       "      <td>-0.499</td>\n",
       "      <td>-0.551</td>\n",
       "      <td>-0.478</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.569</td>\n",
       "      <td>-0.579</td>\n",
       "      <td>-0.582</td>\n",
       "      <td>-0.537</td>\n",
       "      <td>-0.533</td>\n",
       "      <td>-0.521</td>\n",
       "      <td>-0.529</td>\n",
       "      <td>-0.576</td>\n",
       "      <td>-0.622</td>\n",
       "      <td>-0.582</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pd173074</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_PD173074</td>\n",
       "      <td>-0.563</td>\n",
       "      <td>-0.618</td>\n",
       "      <td>-0.521</td>\n",
       "      <td>-0.609</td>\n",
       "      <td>-0.577</td>\n",
       "      <td>-0.606</td>\n",
       "      <td>-0.538</td>\n",
       "      <td>-0.522</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.640</td>\n",
       "      <td>-0.586</td>\n",
       "      <td>-0.598</td>\n",
       "      <td>-0.598</td>\n",
       "      <td>-0.583</td>\n",
       "      <td>-0.529</td>\n",
       "      <td>-0.598</td>\n",
       "      <td>-0.577</td>\n",
       "      <td>-0.590</td>\n",
       "      <td>-0.572</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nutlin-3a (-)</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Nutlin-3a (-)</td>\n",
       "      <td>-0.572</td>\n",
       "      <td>-0.564</td>\n",
       "      <td>-0.529</td>\n",
       "      <td>-0.604</td>\n",
       "      <td>-0.623</td>\n",
       "      <td>-0.571</td>\n",
       "      <td>-0.595</td>\n",
       "      <td>-0.560</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.629</td>\n",
       "      <td>-0.560</td>\n",
       "      <td>-0.626</td>\n",
       "      <td>-0.625</td>\n",
       "      <td>-0.543</td>\n",
       "      <td>-0.521</td>\n",
       "      <td>-0.550</td>\n",
       "      <td>-0.563</td>\n",
       "      <td>-0.550</td>\n",
       "      <td>-0.566</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cetuximab</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Cetuximab</td>\n",
       "      <td>-0.573</td>\n",
       "      <td>-0.520</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.629</td>\n",
       "      <td>-0.530</td>\n",
       "      <td>-0.496</td>\n",
       "      <td>-0.572</td>\n",
       "      <td>-0.546</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.580</td>\n",
       "      <td>-0.587</td>\n",
       "      <td>-0.538</td>\n",
       "      <td>-0.572</td>\n",
       "      <td>-0.575</td>\n",
       "      <td>-0.580</td>\n",
       "      <td>-0.615</td>\n",
       "      <td>-0.578</td>\n",
       "      <td>-0.559</td>\n",
       "      <td>-0.525</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>y-39983</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Y-39983</td>\n",
       "      <td>-0.587</td>\n",
       "      <td>-0.565</td>\n",
       "      <td>0.532</td>\n",
       "      <td>0.549</td>\n",
       "      <td>-0.558</td>\n",
       "      <td>-0.574</td>\n",
       "      <td>0.516</td>\n",
       "      <td>0.547</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.586</td>\n",
       "      <td>0.564</td>\n",
       "      <td>-0.582</td>\n",
       "      <td>-0.590</td>\n",
       "      <td>-0.523</td>\n",
       "      <td>0.541</td>\n",
       "      <td>-0.562</td>\n",
       "      <td>-0.542</td>\n",
       "      <td>-0.536</td>\n",
       "      <td>-0.564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>idelalisib</th>\n",
       "      <td>Idelalisib,  PI3K/p110δ inhibitor</td>\n",
       "      <td>gdsc_Idelalisib</td>\n",
       "      <td>-0.591</td>\n",
       "      <td>-0.548</td>\n",
       "      <td>-0.500</td>\n",
       "      <td>-0.526</td>\n",
       "      <td>-0.566</td>\n",
       "      <td>-0.547</td>\n",
       "      <td>-0.488</td>\n",
       "      <td>-0.510</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.538</td>\n",
       "      <td>-0.530</td>\n",
       "      <td>-0.568</td>\n",
       "      <td>-0.574</td>\n",
       "      <td>-0.569</td>\n",
       "      <td>-0.519</td>\n",
       "      <td>-0.538</td>\n",
       "      <td>-0.537</td>\n",
       "      <td>-0.569</td>\n",
       "      <td>-0.550</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz-1-84</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_WZ-1-84</td>\n",
       "      <td>-0.593</td>\n",
       "      <td>-0.512</td>\n",
       "      <td>-0.578</td>\n",
       "      <td>-0.611</td>\n",
       "      <td>-0.594</td>\n",
       "      <td>-0.573</td>\n",
       "      <td>-0.563</td>\n",
       "      <td>-0.585</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.585</td>\n",
       "      <td>-0.582</td>\n",
       "      <td>-0.556</td>\n",
       "      <td>-0.591</td>\n",
       "      <td>-0.547</td>\n",
       "      <td>-0.543</td>\n",
       "      <td>-0.559</td>\n",
       "      <td>-0.576</td>\n",
       "      <td>-0.547</td>\n",
       "      <td>-0.584</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cyclopamine</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_Cyclopamine</td>\n",
       "      <td>-0.610</td>\n",
       "      <td>-0.557</td>\n",
       "      <td>-0.589</td>\n",
       "      <td>-0.615</td>\n",
       "      <td>-0.617</td>\n",
       "      <td>-0.633</td>\n",
       "      <td>-0.585</td>\n",
       "      <td>-0.584</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.603</td>\n",
       "      <td>-0.562</td>\n",
       "      <td>-0.593</td>\n",
       "      <td>-0.631</td>\n",
       "      <td>-0.540</td>\n",
       "      <td>-0.553</td>\n",
       "      <td>-0.566</td>\n",
       "      <td>-0.577</td>\n",
       "      <td>-0.572</td>\n",
       "      <td>-0.589</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-11e</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_VX-11e</td>\n",
       "      <td>-0.624</td>\n",
       "      <td>-0.583</td>\n",
       "      <td>-0.559</td>\n",
       "      <td>-0.576</td>\n",
       "      <td>-0.572</td>\n",
       "      <td>-0.584</td>\n",
       "      <td>-0.593</td>\n",
       "      <td>-0.590</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.586</td>\n",
       "      <td>-0.586</td>\n",
       "      <td>-0.625</td>\n",
       "      <td>-0.612</td>\n",
       "      <td>-0.613</td>\n",
       "      <td>-0.592</td>\n",
       "      <td>-0.579</td>\n",
       "      <td>-0.604</td>\n",
       "      <td>-0.606</td>\n",
       "      <td>-0.599</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gw441756</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_GW441756</td>\n",
       "      <td>-0.637</td>\n",
       "      <td>-0.639</td>\n",
       "      <td>-0.568</td>\n",
       "      <td>-0.654</td>\n",
       "      <td>-0.646</td>\n",
       "      <td>-0.543</td>\n",
       "      <td>-0.600</td>\n",
       "      <td>-0.621</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.650</td>\n",
       "      <td>-0.617</td>\n",
       "      <td>-0.628</td>\n",
       "      <td>-0.659</td>\n",
       "      <td>-0.591</td>\n",
       "      <td>-0.551</td>\n",
       "      <td>-0.570</td>\n",
       "      <td>-0.615</td>\n",
       "      <td>-0.610</td>\n",
       "      <td>-0.597</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vnlg/124</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>gdsc_VNLG/124</td>\n",
       "      <td>-0.650</td>\n",
       "      <td>-0.625</td>\n",
       "      <td>-0.630</td>\n",
       "      <td>-0.714</td>\n",
       "      <td>-0.620</td>\n",
       "      <td>-0.658</td>\n",
       "      <td>-0.685</td>\n",
       "      <td>-0.591</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.608</td>\n",
       "      <td>-0.684</td>\n",
       "      <td>-0.689</td>\n",
       "      <td>-0.629</td>\n",
       "      <td>-0.668</td>\n",
       "      <td>-0.583</td>\n",
       "      <td>-0.601</td>\n",
       "      <td>-0.636</td>\n",
       "      <td>-0.658</td>\n",
       "      <td>-0.626</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>672 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                  moa  \\\n",
       "alectinib           ALK inhibitor, used to treat non-small-cell lu...   \n",
       "gsk1070916                                    Not Clinically Relevant   \n",
       "sb52334                                       Not Clinically Relevant   \n",
       "tl-2-105                                      Not Clinically Relevant   \n",
       "ql-xii-61                                     Not Clinically Relevant   \n",
       "vx-702                                        Not Clinically Relevant   \n",
       "gsk429286a                                    Not Clinically Relevant   \n",
       "linsitinib                                           IGF-1R inhibitor   \n",
       "bx-912                                        Not Clinically Relevant   \n",
       "gw-2580                                       Not Clinically Relevant   \n",
       "tubastatin a                                  Not Clinically Relevant   \n",
       "rucaparib                         PARP inhibitor, inhibits DNA repair   \n",
       "hg-5-88-01                                    Not Clinically Relevant   \n",
       "navitoclax          Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and ...   \n",
       "amuvatinib                                    Not Clinically Relevant   \n",
       "xmd14-99                                      Not Clinically Relevant   \n",
       "axitinib                             VEGFR, c-KIT and PDGFR inhibitor   \n",
       "xmd13-2                                       Not Clinically Relevant   \n",
       "avrainvillamide                               Not Clinically Relevant   \n",
       "ispinesib mesylate                            Not Clinically Relevant   \n",
       "gsk319347a                                    Not Clinically Relevant   \n",
       "brd-k99006945                                 Not Clinically Relevant   \n",
       "staurosporine                                 Not Clinically Relevant   \n",
       "barasertib                 highly selective Aurora B kinase inhibitor   \n",
       "ml239                                         Not Clinically Relevant   \n",
       "talazoparib                                   Not Clinically Relevant   \n",
       "brd-k26531177                                 Not Clinically Relevant   \n",
       "cct036477                                     Not Clinically Relevant   \n",
       "indisulam           carbonic anhydrase inibitor and  CDK inhibitor...   \n",
       "sb-505124                                     Not Clinically Relevant   \n",
       "...                                                               ...   \n",
       "tak-715                                       Not Clinically Relevant   \n",
       "vismodegib                Hedgehog (Smoothened) antagonist (GDC-0449)   \n",
       "z-llnle-cho                                   Not Clinically Relevant   \n",
       "ro-3306                                       Not Clinically Relevant   \n",
       "bryostatin 1                                  Not Clinically Relevant   \n",
       "bix02189                                      Not Clinically Relevant   \n",
       "sb216763                                      Not Clinically Relevant   \n",
       "681640                                        Not Clinically Relevant   \n",
       "cp724714                                      Not Clinically Relevant   \n",
       "rapamycin                                   rapamycin, mTOR inhibitor   \n",
       "dabrafenib                                     Braf (V600E) inhibitor   \n",
       "motesanib                                     Not Clinically Relevant   \n",
       "pelitinib                                     Not Clinically Relevant   \n",
       "az628                                         Not Clinically Relevant   \n",
       "kin001-260                                    Not Clinically Relevant   \n",
       "gnf-2                                         Not Clinically Relevant   \n",
       "qs11                                          Not Clinically Relevant   \n",
       "rtrail                                        Not Clinically Relevant   \n",
       "ql-xi-92                                      Not Clinically Relevant   \n",
       "t0901317                                      Not Clinically Relevant   \n",
       "pd173074                                      Not Clinically Relevant   \n",
       "nutlin-3a (-)                                 Not Clinically Relevant   \n",
       "cetuximab                                     Not Clinically Relevant   \n",
       "y-39983                                       Not Clinically Relevant   \n",
       "idelalisib                          Idelalisib,  PI3K/p110δ inhibitor   \n",
       "wz-1-84                                       Not Clinically Relevant   \n",
       "cyclopamine                                   Not Clinically Relevant   \n",
       "vx-11e                                        Not Clinically Relevant   \n",
       "gw441756                                      Not Clinically Relevant   \n",
       "vnlg/124                                      Not Clinically Relevant   \n",
       "\n",
       "                                       drug  ICB1299  ICB1572  MB002  MB009  \\\n",
       "alectinib                    gdsc_Alectinib    0.715   -0.686  0.719  0.732   \n",
       "gsk1070916                  gdsc_GSK1070916    0.652    0.626  0.616  0.664   \n",
       "sb52334                        gdsc_SB52334    0.640    0.562  0.594  0.635   \n",
       "tl-2-105                      gdsc_TL-2-105    0.637    0.548  0.574  0.628   \n",
       "ql-xii-61                    gdsc_QL-XII-61    0.605    0.570  0.593  0.610   \n",
       "vx-702                          gdsc_VX-702    0.578    0.552  0.566  0.583   \n",
       "gsk429286a                  gdsc_GSK429286A    0.572    0.556  0.593  0.594   \n",
       "linsitinib                  ctrp_linsitinib    0.572    0.527  0.522  0.592   \n",
       "bx-912                          gdsc_BX-912    0.549    0.505  0.505  0.553   \n",
       "gw-2580                        gdsc_GW-2580    0.546    0.548  0.512  0.613   \n",
       "tubastatin a              ctrp_tubastatin A    0.525    0.520  0.540  0.542   \n",
       "rucaparib                    gdsc_Rucaparib    0.506    0.456 -0.459 -0.489   \n",
       "hg-5-88-01                  gdsc_HG-5-88-01    0.499    0.439  0.478  0.498   \n",
       "navitoclax                  ctrp_navitoclax    0.495    0.487  0.472  0.511   \n",
       "amuvatinib                  gdsc_Amuvatinib    0.489    0.461  0.449  0.504   \n",
       "xmd14-99                      gdsc_XMD14-99    0.487   -0.492  0.472  0.539   \n",
       "axitinib                      ctrp_axitinib    0.470    0.474  0.432  0.483   \n",
       "xmd13-2                        gdsc_XMD13-2    0.466    0.444  0.449  0.499   \n",
       "avrainvillamide        ctrp_avrainvillamide    0.460    0.431  0.416  0.437   \n",
       "ispinesib mesylate  gdsc_Ispinesib Mesylate    0.451    0.403  0.440  0.462   \n",
       "gsk319347a                  gdsc_GSK319347A    0.446    0.411 -0.422  0.463   \n",
       "brd-k99006945            ctrp_BRD-K99006945    0.445    0.396 -0.370  0.427   \n",
       "staurosporine            ctrp_staurosporine    0.445    0.385  0.460  0.413   \n",
       "barasertib                  ctrp_barasertib    0.443    0.393  0.418  0.424   \n",
       "ml239                            ctrp_ML239    0.442    0.360  0.401  0.424   \n",
       "talazoparib                gdsc_Talazoparib    0.440    0.361  0.367  0.408   \n",
       "brd-k26531177            ctrp_BRD-K26531177    0.437    0.385  0.414  0.403   \n",
       "cct036477                    ctrp_CCT036477    0.437    0.408  0.387  0.443   \n",
       "indisulam                    ctrp_indisulam    0.433    0.378  0.425  0.428   \n",
       "sb-505124                    gdsc_SB-505124    0.432    0.425  0.418  0.435   \n",
       "...                                     ...      ...      ...    ...    ...   \n",
       "tak-715                        gdsc_TAK-715   -0.457   -0.451 -0.449 -0.470   \n",
       "vismodegib                  gdsc_Vismodegib   -0.461   -0.456 -0.422 -0.491   \n",
       "z-llnle-cho                gdsc_Z-LLNle-CHO   -0.466   -0.411 -0.411 -0.472   \n",
       "ro-3306                        gdsc_RO-3306   -0.469   -0.436 -0.434 -0.498   \n",
       "bryostatin 1              gdsc_Bryostatin 1   -0.479   -0.451 -0.413 -0.517   \n",
       "bix02189                      gdsc_BIX02189   -0.483   -0.434 -0.403 -0.435   \n",
       "sb216763                      gdsc_SB216763   -0.487   -0.473 -0.477 -0.529   \n",
       "681640                          gdsc_681640   -0.494   -0.518 -0.499 -0.562   \n",
       "cp724714                      gdsc_CP724714   -0.498   -0.492 -0.425 -0.570   \n",
       "rapamycin                    gdsc_Rapamycin   -0.503   -0.460 -0.453 -0.524   \n",
       "dabrafenib                  gdsc_Dabrafenib   -0.510   -0.049 -0.466 -0.057   \n",
       "motesanib                    gdsc_Motesanib   -0.513   -0.441 -0.533 -0.560   \n",
       "pelitinib                    gdsc_Pelitinib   -0.516   -0.519 -0.485 -0.494   \n",
       "az628                            gdsc_AZ628   -0.535   -0.470 -0.520 -0.565   \n",
       "kin001-260                  gdsc_KIN001-260   -0.539   -0.560  0.514  0.525   \n",
       "gnf-2                            gdsc_GNF-2   -0.541   -0.538 -0.536 -0.558   \n",
       "qs11                              gdsc_QS11   -0.544   -0.517 -0.495 -0.540   \n",
       "rtrail                          gdsc_rTRAIL   -0.545   -0.516 -0.501 -0.536   \n",
       "ql-xi-92                      gdsc_QL-XI-92   -0.548   -0.518  0.545  0.582   \n",
       "t0901317                      gdsc_T0901317   -0.554   -0.389 -0.489 -0.514   \n",
       "pd173074                      gdsc_PD173074   -0.563   -0.618 -0.521 -0.609   \n",
       "nutlin-3a (-)            gdsc_Nutlin-3a (-)   -0.572   -0.564 -0.529 -0.604   \n",
       "cetuximab                    gdsc_Cetuximab   -0.573   -0.520 -0.496 -0.629   \n",
       "y-39983                        gdsc_Y-39983   -0.587   -0.565  0.532  0.549   \n",
       "idelalisib                  gdsc_Idelalisib   -0.591   -0.548 -0.500 -0.526   \n",
       "wz-1-84                        gdsc_WZ-1-84   -0.593   -0.512 -0.578 -0.611   \n",
       "cyclopamine                gdsc_Cyclopamine   -0.610   -0.557 -0.589 -0.615   \n",
       "vx-11e                          gdsc_VX-11e   -0.624   -0.583 -0.559 -0.576   \n",
       "gw441756                      gdsc_GW441756   -0.637   -0.639 -0.568 -0.654   \n",
       "vnlg/124                      gdsc_VNLG/124   -0.650   -0.625 -0.630 -0.714   \n",
       "\n",
       "                    MED1911  MED211  MED411  RCMB20   ...    ICB1487  MED2312  \\\n",
       "alectinib             0.686  -0.709   0.703   0.684   ...      0.698    0.719   \n",
       "gsk1070916            0.646   0.614   0.632   0.644   ...      0.666    0.645   \n",
       "sb52334               0.625   0.612   0.607   0.617   ...      0.663    0.631   \n",
       "tl-2-105              0.626   0.624   0.594   0.569   ...      0.663    0.653   \n",
       "ql-xii-61             0.623   0.599   0.593   0.592   ...     -0.580    0.561   \n",
       "vx-702                0.574   0.522   0.607   0.562   ...      0.555    0.539   \n",
       "gsk429286a            0.603  -0.587   0.583   0.553   ...      0.607    0.567   \n",
       "linsitinib            0.563   0.562   0.555   0.538   ...      0.561    0.547   \n",
       "bx-912                0.541   0.510   0.549   0.546   ...      0.551    0.556   \n",
       "gw-2580               0.510   0.527   0.535   0.490   ...      0.582    0.584   \n",
       "tubastatin a          0.550   0.524   0.528   0.509   ...      0.536    0.528   \n",
       "rucaparib             0.503   0.482   0.528  -0.462   ...      0.515    0.519   \n",
       "hg-5-88-01            0.467   0.426   0.472   0.472   ...      0.462    0.450   \n",
       "navitoclax            0.523   0.489   0.495   0.482   ...      0.504    0.496   \n",
       "amuvatinib            0.500   0.472   0.495   0.472   ...      0.494    0.471   \n",
       "xmd14-99              0.499  -0.472   0.470   0.467   ...      0.525    0.527   \n",
       "axitinib              0.473   0.456   0.462   0.462   ...     -0.077    0.449   \n",
       "xmd13-2               0.459   0.451   0.462   0.465   ...      0.471    0.465   \n",
       "avrainvillamide       0.444   0.456   0.480   0.460   ...      0.428    0.416   \n",
       "ispinesib mesylate    0.435   0.405   0.460   0.459   ...      0.452    0.424   \n",
       "gsk319347a            0.468   0.487   0.457   0.448   ...      0.438    0.439   \n",
       "brd-k99006945         0.425  -0.427  -0.380   0.387   ...      0.437    0.429   \n",
       "staurosporine         0.419   0.422   0.451   0.447   ...      0.408    0.397   \n",
       "barasertib            0.430   0.457   0.464   0.431   ...      0.382    0.382   \n",
       "ml239                 0.397   0.428   0.431   0.407   ...      0.428    0.392   \n",
       "talazoparib           0.418  -0.383   0.409   0.380   ...      0.414    0.409   \n",
       "brd-k26531177         0.414   0.439   0.428   0.409   ...      0.394    0.403   \n",
       "cct036477             0.433   0.431   0.437   0.426   ...      0.409    0.429   \n",
       "indisulam             0.411   0.458   0.459   0.415   ...      0.396    0.383   \n",
       "sb-505124             0.415   0.430   0.439   0.440   ...      0.445    0.397   \n",
       "...                     ...     ...     ...     ...   ...        ...      ...   \n",
       "tak-715              -0.469  -0.454  -0.435  -0.432   ...     -0.475   -0.456   \n",
       "vismodegib           -0.487  -0.458  -0.445  -0.447   ...     -0.467   -0.457   \n",
       "z-llnle-cho          -0.456  -0.460  -0.439  -0.432   ...     -0.481   -0.449   \n",
       "ro-3306              -0.492  -0.445  -0.456  -0.479   ...     -0.513   -0.465   \n",
       "bryostatin 1         -0.486  -0.455  -0.464  -0.464   ...     -0.480   -0.482   \n",
       "bix02189             -0.466  -0.439  -0.447  -0.428   ...     -0.463   -0.436   \n",
       "sb216763             -0.479  -0.476  -0.463  -0.460   ...     -0.500   -0.458   \n",
       "681640               -0.506  -0.495  -0.500  -0.506   ...     -0.533   -0.488   \n",
       "cp724714             -0.466  -0.451  -0.456  -0.479   ...     -0.476   -0.483   \n",
       "rapamycin            -0.496  -0.504  -0.503  -0.469   ...     -0.487   -0.480   \n",
       "dabrafenib           -0.051  -0.496  -0.526  -0.494   ...     -0.060   -0.052   \n",
       "motesanib            -0.511  -0.559  -0.476  -0.529   ...     -0.539   -0.547   \n",
       "pelitinib            -0.519  -0.526  -0.494  -0.492   ...     -0.524   -0.497   \n",
       "az628                -0.565  -0.566  -0.540  -0.508   ...     -0.567   -0.547   \n",
       "kin001-260           -0.536  -0.528  -0.513   0.473   ...     -0.583    0.506   \n",
       "gnf-2                -0.557  -0.577  -0.590  -0.545   ...     -0.520   -0.518   \n",
       "qs11                 -0.559  -0.531  -0.546  -0.520   ...     -0.548   -0.524   \n",
       "rtrail               -0.555  -0.496  -0.549  -0.533   ...     -0.540   -0.559   \n",
       "ql-xi-92             -0.559  -0.604   0.548   0.568   ...     -0.581    0.569   \n",
       "t0901317             -0.510  -0.499  -0.551  -0.478   ...     -0.569   -0.579   \n",
       "pd173074             -0.577  -0.606  -0.538  -0.522   ...     -0.640   -0.586   \n",
       "nutlin-3a (-)        -0.623  -0.571  -0.595  -0.560   ...     -0.629   -0.560   \n",
       "cetuximab            -0.530  -0.496  -0.572  -0.546   ...     -0.580   -0.587   \n",
       "y-39983              -0.558  -0.574   0.516   0.547   ...     -0.586    0.564   \n",
       "idelalisib           -0.566  -0.547  -0.488  -0.510   ...     -0.538   -0.530   \n",
       "wz-1-84              -0.594  -0.573  -0.563  -0.585   ...     -0.585   -0.582   \n",
       "cyclopamine          -0.617  -0.633  -0.585  -0.584   ...     -0.603   -0.562   \n",
       "vx-11e               -0.572  -0.584  -0.593  -0.590   ...     -0.586   -0.586   \n",
       "gw441756             -0.646  -0.543  -0.600  -0.621   ...     -0.650   -0.617   \n",
       "vnlg/124             -0.620  -0.658  -0.685  -0.591   ...     -0.608   -0.684   \n",
       "\n",
       "                    RCMB38  DMB006  MED1712  RCMB24  RCMB32  BT084  ICB984  \\\n",
       "alectinib           -0.701  -0.713   -0.710   0.700  -0.675 -0.722  -0.704   \n",
       "gsk1070916           0.633   0.630    0.593   0.631   0.601  0.606   0.618   \n",
       "sb52334              0.623   0.663    0.534   0.549   0.584  0.622   0.572   \n",
       "tl-2-105             0.639   0.687   -0.633   0.553   0.610  0.646  -0.624   \n",
       "ql-xii-61           -0.602  -0.593   -0.545   0.576  -0.570  0.594  -0.594   \n",
       "vx-702               0.522   0.571    0.509   0.503   0.521  0.531   0.536   \n",
       "gsk429286a           0.587  -0.608   -0.503   0.541   0.546  0.548  -0.554   \n",
       "linsitinib           0.542   0.584    0.520   0.507   0.538  0.552   0.528   \n",
       "bx-912               0.519   0.539    0.471   0.505   0.506  0.535  -0.500   \n",
       "gw-2580              0.647   0.620    0.598   0.597   0.572  0.552   0.619   \n",
       "tubastatin a         0.523   0.536   -0.074   0.486   0.530  0.536  -0.087   \n",
       "rucaparib            0.505   0.498    0.486   0.472   0.504  0.519   0.486   \n",
       "hg-5-88-01          -0.437  -0.468    0.376   0.393  -0.441  0.466   0.456   \n",
       "navitoclax           0.500   0.512    0.468   0.477   0.463  0.509   0.480   \n",
       "amuvatinib           0.493   0.507    0.412   0.440   0.455  0.455   0.440   \n",
       "xmd14-99            -0.498  -0.527   -0.476   0.495  -0.451  0.481  -0.496   \n",
       "axitinib            -0.079   0.460   -0.099   0.410   0.457  0.471  -0.062   \n",
       "xmd13-2              0.470   0.456    0.406   0.433   0.435  0.450  -0.461   \n",
       "avrainvillamide      0.407   0.482    0.385   0.350   0.425  0.395   0.404   \n",
       "ispinesib mesylate  -0.417  -0.438   -0.422   0.392   0.411  0.417  -0.424   \n",
       "gsk319347a           0.449   0.481    0.445   0.388   0.469  0.412   0.455   \n",
       "brd-k99006945        0.404   0.441    0.417   0.417   0.389  0.421   0.403   \n",
       "staurosporine        0.412   0.364    0.440   0.414   0.434  0.426   0.465   \n",
       "barasertib           0.353   0.431    0.370   0.340   0.379  0.399   0.434   \n",
       "ml239                0.410   0.445    0.376   0.370   0.393  0.412   0.425   \n",
       "talazoparib          0.404   0.387    0.400   0.382   0.419  0.397   0.393   \n",
       "brd-k26531177        0.383   0.421    0.365   0.370   0.392  0.421   0.392   \n",
       "cct036477            0.393   0.415    0.377   0.367   0.371  0.394   0.389   \n",
       "indisulam            0.378   0.427    0.364   0.345   0.396  0.437   0.420   \n",
       "sb-505124            0.424   0.433    0.384   0.389   0.409  0.384  -0.378   \n",
       "...                    ...     ...      ...     ...     ...    ...     ...   \n",
       "tak-715             -0.468  -0.493   -0.466  -0.393  -0.429 -0.428  -0.485   \n",
       "vismodegib          -0.451  -0.479   -0.439  -0.442  -0.442 -0.464  -0.457   \n",
       "z-llnle-cho         -0.457  -0.497   -0.422  -0.411  -0.466 -0.467  -0.440   \n",
       "ro-3306             -0.482  -0.497   -0.426  -0.454  -0.467 -0.462  -0.479   \n",
       "bryostatin 1        -0.503  -0.505   -0.447  -0.427  -0.471 -0.452  -0.450   \n",
       "bix02189            -0.472  -0.458   -0.438  -0.375  -0.452 -0.446  -0.462   \n",
       "sb216763            -0.475  -0.496   -0.418  -0.453  -0.439 -0.464  -0.435   \n",
       "681640              -0.485  -0.526   -0.470  -0.480  -0.483 -0.495  -0.467   \n",
       "cp724714            -0.478  -0.475   -0.469  -0.489  -0.479 -0.481  -0.483   \n",
       "rapamycin           -0.490  -0.537   -0.441  -0.447  -0.480 -0.486  -0.469   \n",
       "dabrafenib          -0.068  -0.527   -0.475  -0.084  -0.472 -0.087  -0.488   \n",
       "motesanib           -0.540  -0.544   -0.646  -0.503  -0.579 -0.639  -0.584   \n",
       "pelitinib           -0.502  -0.549   -0.506  -0.472  -0.518 -0.512  -0.498   \n",
       "az628               -0.551  -0.589   -0.507  -0.534  -0.543 -0.529  -0.506   \n",
       "kin001-260          -0.557  -0.541   -0.551   0.502  -0.557 -0.528  -0.557   \n",
       "gnf-2               -0.519  -0.576   -0.537  -0.519  -0.546 -0.578  -0.544   \n",
       "qs11                -0.553  -0.536   -0.460  -0.496  -0.513 -0.505  -0.500   \n",
       "rtrail              -0.540  -0.564   -0.544  -0.496  -0.571 -0.574  -0.526   \n",
       "ql-xi-92            -0.561  -0.565   -0.557   0.568  -0.562 -0.558  -0.586   \n",
       "t0901317            -0.582  -0.537   -0.533  -0.521  -0.529 -0.576  -0.622   \n",
       "pd173074            -0.598  -0.598   -0.583  -0.529  -0.598 -0.577  -0.590   \n",
       "nutlin-3a (-)       -0.626  -0.625   -0.543  -0.521  -0.550 -0.563  -0.550   \n",
       "cetuximab           -0.538  -0.572   -0.575  -0.580  -0.615 -0.578  -0.559   \n",
       "y-39983             -0.582  -0.590   -0.523   0.541  -0.562 -0.542  -0.536   \n",
       "idelalisib          -0.568  -0.574   -0.569  -0.519  -0.538 -0.537  -0.569   \n",
       "wz-1-84             -0.556  -0.591   -0.547  -0.543  -0.559 -0.576  -0.547   \n",
       "cyclopamine         -0.593  -0.631   -0.540  -0.553  -0.566 -0.577  -0.572   \n",
       "vx-11e              -0.625  -0.612   -0.613  -0.592  -0.579 -0.604  -0.606   \n",
       "gw441756            -0.628  -0.659   -0.591  -0.551  -0.570 -0.615  -0.610   \n",
       "vnlg/124            -0.689  -0.629   -0.668  -0.583  -0.601 -0.636  -0.658   \n",
       "\n",
       "                    RCMB18  \n",
       "alectinib           -0.696  \n",
       "gsk1070916           0.617  \n",
       "sb52334              0.597  \n",
       "tl-2-105             0.614  \n",
       "ql-xii-61           -0.588  \n",
       "vx-702               0.516  \n",
       "gsk429286a           0.541  \n",
       "linsitinib           0.523  \n",
       "bx-912               0.509  \n",
       "gw-2580              0.579  \n",
       "tubastatin a         0.512  \n",
       "rucaparib            0.491  \n",
       "hg-5-88-01           0.434  \n",
       "navitoclax           0.478  \n",
       "amuvatinib           0.457  \n",
       "xmd14-99            -0.477  \n",
       "axitinib             0.442  \n",
       "xmd13-2              0.425  \n",
       "avrainvillamide      0.390  \n",
       "ispinesib mesylate   0.386  \n",
       "gsk319347a           0.429  \n",
       "brd-k99006945        0.405  \n",
       "staurosporine        0.409  \n",
       "barasertib           0.373  \n",
       "ml239                0.366  \n",
       "talazoparib          0.403  \n",
       "brd-k26531177        0.387  \n",
       "cct036477            0.382  \n",
       "indisulam            0.378  \n",
       "sb-505124           -0.399  \n",
       "...                    ...  \n",
       "tak-715             -0.443  \n",
       "vismodegib          -0.461  \n",
       "z-llnle-cho         -0.448  \n",
       "ro-3306             -0.446  \n",
       "bryostatin 1        -0.464  \n",
       "bix02189            -0.455  \n",
       "sb216763            -0.447  \n",
       "681640              -0.496  \n",
       "cp724714            -0.502  \n",
       "rapamycin           -0.492  \n",
       "dabrafenib          -0.082  \n",
       "motesanib           -0.530  \n",
       "pelitinib           -0.506  \n",
       "az628               -0.532  \n",
       "kin001-260          -0.514  \n",
       "gnf-2               -0.543  \n",
       "qs11                -0.516  \n",
       "rtrail              -0.528  \n",
       "ql-xi-92            -0.587  \n",
       "t0901317            -0.582  \n",
       "pd173074            -0.572  \n",
       "nutlin-3a (-)       -0.566  \n",
       "cetuximab           -0.525  \n",
       "y-39983             -0.564  \n",
       "idelalisib          -0.550  \n",
       "wz-1-84             -0.584  \n",
       "cyclopamine         -0.589  \n",
       "vx-11e              -0.599  \n",
       "gw441756            -0.597  \n",
       "vnlg/124            -0.626  \n",
       "\n",
       "[672 rows x 22 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_pdx = pd.read_excel('results/subgroup_effective_drugs_from_expression.xlsx',sheet_name=\"DiSCoVER_scores\")\n",
    "all_pdx"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T18:53:02.992171Z",
     "start_time": "2019-05-17T18:53:02.532278Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Name</th>\n",
       "      <th>MoA</th>\n",
       "      <th>G3</th>\n",
       "      <th>mean_score(G3)</th>\n",
       "      <th>G4</th>\n",
       "      <th>mean_score(G4)</th>\n",
       "      <th>SHH</th>\n",
       "      <th>mean_score(SHH)</th>\n",
       "      <th>SHH+p53</th>\n",
       "      <th>mean_score(SHH+p53)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>alectinib</td>\n",
       "      <td>ALK inhibitor, used to treat non-small-cell lu...</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4324</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00075</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.467833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.707333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>gsk1070916</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6400</td>\n",
       "      <td>True</td>\n",
       "      <td>0.64350</td>\n",
       "      <td>True</td>\n",
       "      <td>0.611000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.613667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>sb52334</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6185</td>\n",
       "      <td>True</td>\n",
       "      <td>0.64500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.576333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.597000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>tl-2-105</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.6098</td>\n",
       "      <td>True</td>\n",
       "      <td>0.66050</td>\n",
       "      <td>False</td>\n",
       "      <td>0.194333</td>\n",
       "      <td>False</td>\n",
       "      <td>0.212000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ql-xii-61</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5997</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.30350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.187833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.196000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>vx-702</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5614</td>\n",
       "      <td>True</td>\n",
       "      <td>0.54675</td>\n",
       "      <td>True</td>\n",
       "      <td>0.519333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.527667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>gsk429286a</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4689</td>\n",
       "      <td>False</td>\n",
       "      <td>0.28825</td>\n",
       "      <td>False</td>\n",
       "      <td>0.186500</td>\n",
       "      <td>False</td>\n",
       "      <td>0.178333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>linsitinib</td>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5565</td>\n",
       "      <td>True</td>\n",
       "      <td>0.55850</td>\n",
       "      <td>True</td>\n",
       "      <td>0.528000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.534333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>bx-912</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5366</td>\n",
       "      <td>True</td>\n",
       "      <td>0.54125</td>\n",
       "      <td>True</td>\n",
       "      <td>0.337667</td>\n",
       "      <td>False</td>\n",
       "      <td>0.181333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>gw-2580</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5390</td>\n",
       "      <td>True</td>\n",
       "      <td>0.60825</td>\n",
       "      <td>True</td>\n",
       "      <td>0.586167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.583333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>tubastatin a</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.5322</td>\n",
       "      <td>True</td>\n",
       "      <td>0.53075</td>\n",
       "      <td>False</td>\n",
       "      <td>0.317167</td>\n",
       "      <td>False</td>\n",
       "      <td>0.320333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>False</td>\n",
       "      <td>0.2085</td>\n",
       "      <td>True</td>\n",
       "      <td>0.50925</td>\n",
       "      <td>True</td>\n",
       "      <td>0.493000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.498667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>hg-5-88-01</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4726</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00175</td>\n",
       "      <td>True</td>\n",
       "      <td>0.280667</td>\n",
       "      <td>True</td>\n",
       "      <td>0.452000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>navitoclax</td>\n",
       "      <td>Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and ...</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4980</td>\n",
       "      <td>True</td>\n",
       "      <td>0.50300</td>\n",
       "      <td>True</td>\n",
       "      <td>0.479167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.489000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>amuvatinib</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4844</td>\n",
       "      <td>True</td>\n",
       "      <td>0.49125</td>\n",
       "      <td>True</td>\n",
       "      <td>0.443167</td>\n",
       "      <td>True</td>\n",
       "      <td>0.450667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>xmd14-99</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3005</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.154000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.164000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>axitinib</td>\n",
       "      <td>VEGFR, c-KIT and PDGFR inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4639</td>\n",
       "      <td>False</td>\n",
       "      <td>0.18825</td>\n",
       "      <td>False</td>\n",
       "      <td>0.269833</td>\n",
       "      <td>False</td>\n",
       "      <td>0.283667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>xmd13-2</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4682</td>\n",
       "      <td>True</td>\n",
       "      <td>0.46550</td>\n",
       "      <td>True</td>\n",
       "      <td>0.281333</td>\n",
       "      <td>False</td>\n",
       "      <td>0.138000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>avrainvillamide</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4501</td>\n",
       "      <td>True</td>\n",
       "      <td>0.43325</td>\n",
       "      <td>True</td>\n",
       "      <td>0.391500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.396333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>ispinesib mesylate</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4449</td>\n",
       "      <td>False</td>\n",
       "      <td>0.00525</td>\n",
       "      <td>False</td>\n",
       "      <td>0.126667</td>\n",
       "      <td>False</td>\n",
       "      <td>0.126333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>gsk319347a</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3663</td>\n",
       "      <td>True</td>\n",
       "      <td>0.45175</td>\n",
       "      <td>True</td>\n",
       "      <td>0.433000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.432000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>brd-k99006945</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>0.1698</td>\n",
       "      <td>True</td>\n",
       "      <td>0.42775</td>\n",
       "      <td>True</td>\n",
       "      <td>0.408667</td>\n",
       "      <td>True</td>\n",
       "      <td>0.409667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>staurosporine</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4296</td>\n",
       "      <td>True</td>\n",
       "      <td>0.39525</td>\n",
       "      <td>True</td>\n",
       "      <td>0.431333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.433333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>barasertib</td>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4326</td>\n",
       "      <td>True</td>\n",
       "      <td>0.38700</td>\n",
       "      <td>True</td>\n",
       "      <td>0.382500</td>\n",
       "      <td>True</td>\n",
       "      <td>0.402000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>ml239</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4117</td>\n",
       "      <td>True</td>\n",
       "      <td>0.41875</td>\n",
       "      <td>True</td>\n",
       "      <td>0.390333</td>\n",
       "      <td>True</td>\n",
       "      <td>0.401000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>talazoparib</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.3229</td>\n",
       "      <td>True</td>\n",
       "      <td>0.40350</td>\n",
       "      <td>True</td>\n",
       "      <td>0.399000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.397667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>brd-k26531177</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4199</td>\n",
       "      <td>True</td>\n",
       "      <td>0.40025</td>\n",
       "      <td>True</td>\n",
       "      <td>0.387833</td>\n",
       "      <td>True</td>\n",
       "      <td>0.400000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>cct036477</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4262</td>\n",
       "      <td>True</td>\n",
       "      <td>0.41150</td>\n",
       "      <td>True</td>\n",
       "      <td>0.380000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.388333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>indisulam</td>\n",
       "      <td>carbonic anhydrase inibitor and  CDK inhibitor...</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4307</td>\n",
       "      <td>True</td>\n",
       "      <td>0.39600</td>\n",
       "      <td>True</td>\n",
       "      <td>0.390000</td>\n",
       "      <td>True</td>\n",
       "      <td>0.411667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>sb-505124</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>0.4298</td>\n",
       "      <td>True</td>\n",
       "      <td>0.42475</td>\n",
       "      <td>False</td>\n",
       "      <td>0.131500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.131000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>642</th>\n",
       "      <td>tak-715</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4550</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47300</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.440667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.452000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>vismodegib</td>\n",
       "      <td>Hedgehog (Smoothened) antagonist (GDC-0449)</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4632</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.46350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.450833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.460667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>z-llnle-cho</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4468</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47100</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.442333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.451667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>ro-3306</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.48925</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.455667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.462333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>646</th>\n",
       "      <td>bryostatin 1</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4688</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.49250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.451833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.455333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>bix02189</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4458</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.45725</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.438000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.454333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>sb216763</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4847</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.48225</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.442667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.448667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>681640</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5134</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.50800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.481833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.486000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>650</th>\n",
       "      <td>cp724714</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4834</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.47800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.483833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.488667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>651</th>\n",
       "      <td>rapamycin</td>\n",
       "      <td>rapamycin, mTOR inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.4941</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.49850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.469167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.482333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>dabrafenib</td>\n",
       "      <td>Braf (V600E) inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.3677</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.17675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.281333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.219000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>653</th>\n",
       "      <td>motesanib</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5215</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.54250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.580167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.584333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>654</th>\n",
       "      <td>pelitinib</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5073</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.51800</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.502000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.505333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>az628</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5403</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56350</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.525167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.522333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>656</th>\n",
       "      <td>kin001-260</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.1158</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.29375</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.367500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.533000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>657</th>\n",
       "      <td>gnf-2</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5618</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.53325</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.544500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.555000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>658</th>\n",
       "      <td>qs11</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5340</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.54025</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.498333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.507000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>659</th>\n",
       "      <td>rtrail</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5347</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.55075</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.539833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.542667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>660</th>\n",
       "      <td>ql-xi-92</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>0.1165</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.28450</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.380333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.577000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>661</th>\n",
       "      <td>t0901317</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5112</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56675</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.560500</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.593333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>662</th>\n",
       "      <td>pd173074</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5742</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.60550</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.574833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.579667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>663</th>\n",
       "      <td>nutlin-3a (-)</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5837</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.61000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.548833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.559667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>664</th>\n",
       "      <td>cetuximab</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5588</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.56925</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.572000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.554000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>665</th>\n",
       "      <td>y-39983</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.0167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.29850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.364333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.547333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>666</th>\n",
       "      <td>idelalisib</td>\n",
       "      <td>Idelalisib,  PI3K/p110δ inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5366</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.55250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.547000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.552000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>wz-1-84</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5858</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.57850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.559333</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.569000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>668</th>\n",
       "      <td>cyclopamine</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5977</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.59725</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.566167</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.579333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>669</th>\n",
       "      <td>vx-11e</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.5841</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.60225</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.598833</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.603000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>670</th>\n",
       "      <td>gw441756</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.6208</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.63850</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.589000</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.607333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>671</th>\n",
       "      <td>vnlg/124</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.6492</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.65250</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.628667</td>\n",
       "      <td>False</td>\n",
       "      <td>-0.640000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>672 rows × 10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   Name                                                MoA  \\\n",
       "0             alectinib  ALK inhibitor, used to treat non-small-cell lu...   \n",
       "1            gsk1070916                            Not Clinically Relevant   \n",
       "2               sb52334                            Not Clinically Relevant   \n",
       "3              tl-2-105                            Not Clinically Relevant   \n",
       "4             ql-xii-61                            Not Clinically Relevant   \n",
       "5                vx-702                            Not Clinically Relevant   \n",
       "6            gsk429286a                            Not Clinically Relevant   \n",
       "7            linsitinib                                   IGF-1R inhibitor   \n",
       "8                bx-912                            Not Clinically Relevant   \n",
       "9               gw-2580                            Not Clinically Relevant   \n",
       "10         tubastatin a                            Not Clinically Relevant   \n",
       "11            rucaparib                PARP inhibitor, inhibits DNA repair   \n",
       "12           hg-5-88-01                            Not Clinically Relevant   \n",
       "13           navitoclax  Bcl-2 family inhibitor: esp Bcl-xL, Bcl-2 and ...   \n",
       "14           amuvatinib                            Not Clinically Relevant   \n",
       "15             xmd14-99                            Not Clinically Relevant   \n",
       "16             axitinib                   VEGFR, c-KIT and PDGFR inhibitor   \n",
       "17              xmd13-2                            Not Clinically Relevant   \n",
       "18      avrainvillamide                            Not Clinically Relevant   \n",
       "19   ispinesib mesylate                            Not Clinically Relevant   \n",
       "20           gsk319347a                            Not Clinically Relevant   \n",
       "21        brd-k99006945                            Not Clinically Relevant   \n",
       "22        staurosporine                            Not Clinically Relevant   \n",
       "23           barasertib         highly selective Aurora B kinase inhibitor   \n",
       "24                ml239                            Not Clinically Relevant   \n",
       "25          talazoparib                            Not Clinically Relevant   \n",
       "26        brd-k26531177                            Not Clinically Relevant   \n",
       "27            cct036477                            Not Clinically Relevant   \n",
       "28            indisulam  carbonic anhydrase inibitor and  CDK inhibitor...   \n",
       "29            sb-505124                            Not Clinically Relevant   \n",
       "..                  ...                                                ...   \n",
       "642             tak-715                            Not Clinically Relevant   \n",
       "643          vismodegib        Hedgehog (Smoothened) antagonist (GDC-0449)   \n",
       "644         z-llnle-cho                            Not Clinically Relevant   \n",
       "645             ro-3306                            Not Clinically Relevant   \n",
       "646        bryostatin 1                            Not Clinically Relevant   \n",
       "647            bix02189                            Not Clinically Relevant   \n",
       "648            sb216763                            Not Clinically Relevant   \n",
       "649              681640                            Not Clinically Relevant   \n",
       "650            cp724714                            Not Clinically Relevant   \n",
       "651           rapamycin                          rapamycin, mTOR inhibitor   \n",
       "652          dabrafenib                             Braf (V600E) inhibitor   \n",
       "653           motesanib                            Not Clinically Relevant   \n",
       "654           pelitinib                            Not Clinically Relevant   \n",
       "655               az628                            Not Clinically Relevant   \n",
       "656          kin001-260                            Not Clinically Relevant   \n",
       "657               gnf-2                            Not Clinically Relevant   \n",
       "658                qs11                            Not Clinically Relevant   \n",
       "659              rtrail                            Not Clinically Relevant   \n",
       "660            ql-xi-92                            Not Clinically Relevant   \n",
       "661            t0901317                            Not Clinically Relevant   \n",
       "662            pd173074                            Not Clinically Relevant   \n",
       "663       nutlin-3a (-)                            Not Clinically Relevant   \n",
       "664           cetuximab                            Not Clinically Relevant   \n",
       "665             y-39983                            Not Clinically Relevant   \n",
       "666          idelalisib                  Idelalisib,  PI3K/p110δ inhibitor   \n",
       "667             wz-1-84                            Not Clinically Relevant   \n",
       "668         cyclopamine                            Not Clinically Relevant   \n",
       "669              vx-11e                            Not Clinically Relevant   \n",
       "670            gw441756                            Not Clinically Relevant   \n",
       "671            vnlg/124                            Not Clinically Relevant   \n",
       "\n",
       "        G3  mean_score(G3)     G4  mean_score(G4)    SHH  mean_score(SHH)  \\\n",
       "0     True          0.4324  False         0.00075  False        -0.467833   \n",
       "1     True          0.6400   True         0.64350   True         0.611000   \n",
       "2     True          0.6185   True         0.64500   True         0.576333   \n",
       "3     True          0.6098   True         0.66050  False         0.194333   \n",
       "4     True          0.5997  False        -0.30350  False        -0.187833   \n",
       "5     True          0.5614   True         0.54675   True         0.519333   \n",
       "6     True          0.4689  False         0.28825  False         0.186500   \n",
       "7     True          0.5565   True         0.55850   True         0.528000   \n",
       "8     True          0.5366   True         0.54125   True         0.337667   \n",
       "9     True          0.5390   True         0.60825   True         0.586167   \n",
       "10    True          0.5322   True         0.53075  False         0.317167   \n",
       "11   False          0.2085   True         0.50925   True         0.493000   \n",
       "12    True          0.4726  False         0.00175   True         0.280667   \n",
       "13    True          0.4980   True         0.50300   True         0.479167   \n",
       "14    True          0.4844   True         0.49125   True         0.443167   \n",
       "15    True          0.3005  False         0.00675  False        -0.154000   \n",
       "16    True          0.4639  False         0.18825  False         0.269833   \n",
       "17    True          0.4682   True         0.46550   True         0.281333   \n",
       "18    True          0.4501   True         0.43325   True         0.391500   \n",
       "19    True          0.4449  False         0.00525  False         0.126667   \n",
       "20    True          0.3663   True         0.45175   True         0.433000   \n",
       "21   False          0.1698   True         0.42775   True         0.408667   \n",
       "22    True          0.4296   True         0.39525   True         0.431333   \n",
       "23    True          0.4326   True         0.38700   True         0.382500   \n",
       "24    True          0.4117   True         0.41875   True         0.390333   \n",
       "25    True          0.3229   True         0.40350   True         0.399000   \n",
       "26    True          0.4199   True         0.40025   True         0.387833   \n",
       "27    True          0.4262   True         0.41150   True         0.380000   \n",
       "28    True          0.4307   True         0.39600   True         0.390000   \n",
       "29    True          0.4298   True         0.42475  False         0.131500   \n",
       "..     ...             ...    ...             ...    ...              ...   \n",
       "642  False         -0.4550  False        -0.47300  False        -0.440667   \n",
       "643  False         -0.4632  False        -0.46350  False        -0.450833   \n",
       "644  False         -0.4468  False        -0.47100  False        -0.442333   \n",
       "645  False         -0.4667  False        -0.48925  False        -0.455667   \n",
       "646  False         -0.4688  False        -0.49250  False        -0.451833   \n",
       "647  False         -0.4458  False        -0.45725  False        -0.438000   \n",
       "648  False         -0.4847  False        -0.48225  False        -0.442667   \n",
       "649  False         -0.5134  False        -0.50800  False        -0.481833   \n",
       "650  False         -0.4834  False        -0.47800  False        -0.483833   \n",
       "651  False         -0.4941  False        -0.49850  False        -0.469167   \n",
       "652  False         -0.3677  False        -0.17675  False        -0.281333   \n",
       "653  False         -0.5215  False        -0.54250  False        -0.580167   \n",
       "654  False         -0.5073  False        -0.51800  False        -0.502000   \n",
       "655  False         -0.5403  False        -0.56350  False        -0.525167   \n",
       "656  False         -0.1158  False        -0.29375  False        -0.367500   \n",
       "657  False         -0.5618  False        -0.53325  False        -0.544500   \n",
       "658  False         -0.5340  False        -0.54025  False        -0.498333   \n",
       "659  False         -0.5347  False        -0.55075  False        -0.539833   \n",
       "660  False          0.1165  False        -0.28450  False        -0.380333   \n",
       "661  False         -0.5112  False        -0.56675  False        -0.560500   \n",
       "662  False         -0.5742  False        -0.60550  False        -0.574833   \n",
       "663  False         -0.5837  False        -0.61000  False        -0.548833   \n",
       "664  False         -0.5588  False        -0.56925  False        -0.572000   \n",
       "665  False         -0.0167  False        -0.29850  False        -0.364333   \n",
       "666  False         -0.5366  False        -0.55250  False        -0.547000   \n",
       "667  False         -0.5858  False        -0.57850  False        -0.559333   \n",
       "668  False         -0.5977  False        -0.59725  False        -0.566167   \n",
       "669  False         -0.5841  False        -0.60225  False        -0.598833   \n",
       "670  False         -0.6208  False        -0.63850  False        -0.589000   \n",
       "671  False         -0.6492  False        -0.65250  False        -0.628667   \n",
       "\n",
       "     SHH+p53  mean_score(SHH+p53)  \n",
       "0      False            -0.707333  \n",
       "1       True             0.613667  \n",
       "2       True             0.597000  \n",
       "3      False             0.212000  \n",
       "4      False            -0.196000  \n",
       "5       True             0.527667  \n",
       "6      False             0.178333  \n",
       "7       True             0.534333  \n",
       "8      False             0.181333  \n",
       "9       True             0.583333  \n",
       "10     False             0.320333  \n",
       "11      True             0.498667  \n",
       "12      True             0.452000  \n",
       "13      True             0.489000  \n",
       "14      True             0.450667  \n",
       "15     False            -0.164000  \n",
       "16     False             0.283667  \n",
       "17     False             0.138000  \n",
       "18      True             0.396333  \n",
       "19     False             0.126333  \n",
       "20      True             0.432000  \n",
       "21      True             0.409667  \n",
       "22      True             0.433333  \n",
       "23      True             0.402000  \n",
       "24      True             0.401000  \n",
       "25      True             0.397667  \n",
       "26      True             0.400000  \n",
       "27      True             0.388333  \n",
       "28      True             0.411667  \n",
       "29     False            -0.131000  \n",
       "..       ...                  ...  \n",
       "642    False            -0.452000  \n",
       "643    False            -0.460667  \n",
       "644    False            -0.451667  \n",
       "645    False            -0.462333  \n",
       "646    False            -0.455333  \n",
       "647    False            -0.454333  \n",
       "648    False            -0.448667  \n",
       "649    False            -0.486000  \n",
       "650    False            -0.488667  \n",
       "651    False            -0.482333  \n",
       "652    False            -0.219000  \n",
       "653    False            -0.584333  \n",
       "654    False            -0.505333  \n",
       "655    False            -0.522333  \n",
       "656    False            -0.533000  \n",
       "657    False            -0.555000  \n",
       "658    False            -0.507000  \n",
       "659    False            -0.542667  \n",
       "660    False            -0.577000  \n",
       "661    False            -0.593333  \n",
       "662    False            -0.579667  \n",
       "663    False            -0.559667  \n",
       "664    False            -0.554000  \n",
       "665    False            -0.547333  \n",
       "666    False            -0.552000  \n",
       "667    False            -0.569000  \n",
       "668    False            -0.579333  \n",
       "669    False            -0.603000  \n",
       "670    False            -0.607333  \n",
       "671    False            -0.640000  \n",
       "\n",
       "[672 rows x 10 columns]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "subgroup_effective_predicted = pd.read_excel('results/subgroup_effective_drugs_from_expression.xlsx',sheet_name = 'all_subgroups+scores')\n",
    "subgroup_effective_predicted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Limmiting to these drugs/categories:\n",
    "\n",
    "Drug:\n",
    "NVP-BGT226\n",
    "BKM120\n",
    "GSK2126458\n",
    "PRIMAmet\n",
    "JQ1\n",
    "iBET762\n",
    "GSK1070916\n",
    "Barasertib\n",
    "Alisertib\n",
    "Palbociclib\n",
    "Dinaciclib\n",
    "Prexacertib\n",
    "GSK126\n",
    "Panobinostat\n",
    "Trichostatin A\n",
    "Apicidin\n",
    "ABT-737\n",
    "TW-37\n",
    "bx-912\n",
    "SB525334\n",
    "vx-702\n",
    "Rucaparib\n",
    "Olaparib\n",
    "Linsitinib\n",
    "\n",
    "Category:\n",
    "p13k/mTOR/Akt inhibitor\n",
    "p13k/mTOR/Akt inhibitor\n",
    "p13k/mTOR/Akt inhibitor\n",
    "p53 activator\n",
    "BET inhibitor\n",
    "BET inhibitor\n",
    "Aurora inhibitor\n",
    "Aurora inhibitor\n",
    "Aurora inhibitor\n",
    "CDK4/6 or CDK2,5,1,9 inhibitor\n",
    "CDK4/6 or CDK2,5,1,9 inhibitor\n",
    "CHK inhibitor\n",
    "EZH2 inhibitor\n",
    "HDAC inhibitor\n",
    "HDAC inhibitor\n",
    "HDAC inhibitor\n",
    "BCL2 inhibitor\n",
    "BCL2 inhibitor\n",
    "BCL2 inhibitor\n",
    "TGFbetaR1\n",
    "TGFbetaR1\n",
    "PARP Inhibitors\n",
    "PARP Inhibitors\n",
    "PARP Inhibitors\n",
    "\n",
    "\n",
    "And later to this PDXs:\n",
    "ICB-1299\tMB002\tMB009\tRCMB28\tMED211\tMED511\tICb-1572\tHepaRG\tMED2312\tDMB006\tRCMB38\tICb-1487\tHepaRG\tICb-984\tBT084\tRCMB18\tMED1712\tRCMB24\tRCMB32"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T17:18:29.711756Z",
     "start_time": "2019-05-17T17:18:29.701984Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 24 drugs\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['nvp-bgt226',\n",
       " 'bkm120',\n",
       " 'gsk2126458',\n",
       " 'primamet',\n",
       " 'jq1',\n",
       " 'ibet762',\n",
       " 'gsk1070916',\n",
       " 'barasertib',\n",
       " 'alisertib',\n",
       " 'palbociclib',\n",
       " 'dinaciclib',\n",
       " 'prexacertib',\n",
       " 'gsk126',\n",
       " 'panobinostat',\n",
       " 'trichostatin a',\n",
       " 'apicidin',\n",
       " 'abt-737',\n",
       " 'tw-37',\n",
       " 'bx-912',\n",
       " 'sb525334',\n",
       " 'vx-702',\n",
       " 'rucaparib',\n",
       " 'olaparib',\n",
       " 'linsitinib']"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_list = \"\"\"NVP-BGT226\n",
    "BKM120\n",
    "GSK2126458\n",
    "PRIMAmet\n",
    "JQ1\n",
    "iBET762\n",
    "GSK1070916\n",
    "Barasertib\n",
    "Alisertib\n",
    "Palbociclib\n",
    "Dinaciclib\n",
    "Prexacertib\n",
    "GSK126\n",
    "Panobinostat\n",
    "Trichostatin A\n",
    "Apicidin\n",
    "ABT-737\n",
    "TW-37\n",
    "bx-912\n",
    "SB525334\n",
    "vx-702\n",
    "Rucaparib\n",
    "Olaparib\n",
    "Linsitinib\"\"\"\n",
    "drug_list = drug_list.split('\\n')\n",
    "lower_drugs = [x.lower() for x in drug_list]\n",
    "print(f'There are {len(lower_drugs)} drugs')\n",
    "lower_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:04:31.013314Z",
     "start_time": "2019-05-17T19:04:30.463823Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>MED1911</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED411</th>\n",
       "      <th>RCMB20</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>RCMB40</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>BT084</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>RCMB18</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>alectinib</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb52334</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tl-2-105</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ql-xii-61</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk429286a</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gw-2580</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tubastatin a</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>hg-5-88-01</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>navitoclax</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>amuvatinib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd14-99</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>axitinib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd13-2</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avrainvillamide</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ispinesib mesylate</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk319347a</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>brd-k99006945</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>staurosporine</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ml239</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>talazoparib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>brd-k26531177</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cct036477</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>indisulam</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb-505124</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tak-715</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vismodegib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>z-llnle-cho</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ro-3306</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bryostatin 1</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bix02189</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb216763</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681640</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cp724714</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rapamycin</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dabrafenib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>motesanib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pelitinib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>az628</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>kin001-260</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gnf-2</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>qs11</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rtrail</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ql-xi-92</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>t0901317</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pd173074</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nutlin-3a (-)</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cetuximab</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>y-39983</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>idelalisib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz-1-84</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cyclopamine</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-11e</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gw441756</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vnlg/124</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>672 rows × 20 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                    ICB1299  ICB1572  MB002  MB009  MED1911  MED211  MED411  \\\n",
       "Name                                                                          \n",
       "alectinib              True    False   True   True     True   False    True   \n",
       "gsk1070916             True     True   True   True     True    True    True   \n",
       "sb52334                True     True   True   True     True    True    True   \n",
       "tl-2-105               True     True   True   True     True    True    True   \n",
       "ql-xii-61              True     True   True   True     True    True    True   \n",
       "vx-702                 True     True   True   True     True    True    True   \n",
       "gsk429286a             True     True   True   True     True   False    True   \n",
       "linsitinib             True     True   True   True     True    True    True   \n",
       "bx-912                 True     True   True   True     True    True    True   \n",
       "gw-2580                True     True   True   True     True    True    True   \n",
       "tubastatin a           True     True   True   True     True    True    True   \n",
       "rucaparib              True     True  False  False     True    True    True   \n",
       "hg-5-88-01             True     True   True   True     True    True    True   \n",
       "navitoclax             True     True   True   True     True    True    True   \n",
       "amuvatinib             True     True   True   True     True    True    True   \n",
       "xmd14-99               True    False   True   True     True   False    True   \n",
       "axitinib               True     True   True   True     True    True    True   \n",
       "xmd13-2                True     True   True   True     True    True    True   \n",
       "avrainvillamide        True     True   True   True     True    True    True   \n",
       "ispinesib mesylate     True     True   True   True     True    True    True   \n",
       "gsk319347a             True     True  False   True     True    True    True   \n",
       "brd-k99006945          True     True  False   True     True   False   False   \n",
       "staurosporine          True     True   True   True     True    True    True   \n",
       "barasertib             True     True   True   True     True    True    True   \n",
       "ml239                  True     True   True   True     True    True    True   \n",
       "talazoparib            True     True   True   True     True   False    True   \n",
       "brd-k26531177          True     True   True   True     True    True    True   \n",
       "cct036477              True     True   True   True     True    True    True   \n",
       "indisulam              True     True   True   True     True    True    True   \n",
       "sb-505124              True     True   True   True     True    True    True   \n",
       "...                     ...      ...    ...    ...      ...     ...     ...   \n",
       "tak-715               False    False  False  False    False   False   False   \n",
       "vismodegib            False    False  False  False    False   False   False   \n",
       "z-llnle-cho           False    False  False  False    False   False   False   \n",
       "ro-3306               False    False  False  False    False   False   False   \n",
       "bryostatin 1          False    False  False  False    False   False   False   \n",
       "bix02189              False    False  False  False    False   False   False   \n",
       "sb216763              False    False  False  False    False   False   False   \n",
       "681640                False    False  False  False    False   False   False   \n",
       "cp724714              False    False  False  False    False   False   False   \n",
       "rapamycin             False    False  False  False    False   False   False   \n",
       "dabrafenib            False    False  False  False    False   False   False   \n",
       "motesanib             False    False  False  False    False   False   False   \n",
       "pelitinib             False    False  False  False    False   False   False   \n",
       "az628                 False    False  False  False    False   False   False   \n",
       "kin001-260            False    False   True   True    False   False   False   \n",
       "gnf-2                 False    False  False  False    False   False   False   \n",
       "qs11                  False    False  False  False    False   False   False   \n",
       "rtrail                False    False  False  False    False   False   False   \n",
       "ql-xi-92              False    False   True   True    False   False    True   \n",
       "t0901317              False    False  False  False    False   False   False   \n",
       "pd173074              False    False  False  False    False   False   False   \n",
       "nutlin-3a (-)         False    False  False  False    False   False   False   \n",
       "cetuximab             False    False  False  False    False   False   False   \n",
       "y-39983               False    False   True   True    False   False    True   \n",
       "idelalisib            False    False  False  False    False   False   False   \n",
       "wz-1-84               False    False  False  False    False   False   False   \n",
       "cyclopamine           False    False  False  False    False   False   False   \n",
       "vx-11e                False    False  False  False    False   False   False   \n",
       "gw441756              False    False  False  False    False   False   False   \n",
       "vnlg/124              False    False  False  False    False   False   False   \n",
       "\n",
       "                    RCMB20  RCMB28  RCMB40  ICB1487  MED2312  RCMB38  DMB006  \\\n",
       "Name                                                                           \n",
       "alectinib             True    True    True     True     True   False   False   \n",
       "gsk1070916            True    True    True     True     True    True    True   \n",
       "sb52334               True    True    True     True     True    True    True   \n",
       "tl-2-105              True    True    True     True     True    True    True   \n",
       "ql-xii-61             True    True    True    False     True   False   False   \n",
       "vx-702                True    True    True     True     True    True    True   \n",
       "gsk429286a            True    True    True     True     True    True   False   \n",
       "linsitinib            True    True    True     True     True    True    True   \n",
       "bx-912                True    True    True     True     True    True    True   \n",
       "gw-2580               True    True    True     True     True    True    True   \n",
       "tubastatin a          True    True    True     True     True    True    True   \n",
       "rucaparib            False    True    True     True     True    True    True   \n",
       "hg-5-88-01            True    True    True     True     True   False   False   \n",
       "navitoclax            True    True    True     True     True    True    True   \n",
       "amuvatinib            True    True    True     True     True    True    True   \n",
       "xmd14-99              True    True    True     True     True   False   False   \n",
       "axitinib              True    True    True    False     True   False    True   \n",
       "xmd13-2               True    True    True     True     True    True    True   \n",
       "avrainvillamide       True    True    True     True     True    True    True   \n",
       "ispinesib mesylate    True    True    True     True     True   False   False   \n",
       "gsk319347a            True    True    True     True     True    True    True   \n",
       "brd-k99006945         True    True    True     True     True    True    True   \n",
       "staurosporine         True    True    True     True     True    True    True   \n",
       "barasertib            True    True    True     True     True    True    True   \n",
       "ml239                 True    True    True     True     True    True    True   \n",
       "talazoparib           True    True    True     True     True    True    True   \n",
       "brd-k26531177         True    True    True     True     True    True    True   \n",
       "cct036477             True    True    True     True     True    True    True   \n",
       "indisulam             True    True    True     True     True    True    True   \n",
       "sb-505124             True    True    True     True     True    True    True   \n",
       "...                    ...     ...     ...      ...      ...     ...     ...   \n",
       "tak-715              False   False   False    False    False   False   False   \n",
       "vismodegib           False   False   False    False    False   False   False   \n",
       "z-llnle-cho          False   False   False    False    False   False   False   \n",
       "ro-3306              False   False   False    False    False   False   False   \n",
       "bryostatin 1         False   False   False    False    False   False   False   \n",
       "bix02189             False   False   False    False    False   False   False   \n",
       "sb216763             False   False   False    False    False   False   False   \n",
       "681640               False   False   False    False    False   False   False   \n",
       "cp724714             False   False   False    False    False   False   False   \n",
       "rapamycin            False   False   False    False    False   False   False   \n",
       "dabrafenib           False   False   False    False    False   False   False   \n",
       "motesanib            False   False   False    False    False   False   False   \n",
       "pelitinib            False   False   False    False    False   False   False   \n",
       "az628                False   False   False    False    False   False   False   \n",
       "kin001-260            True    True   False    False     True   False   False   \n",
       "gnf-2                False   False   False    False    False   False   False   \n",
       "qs11                 False   False   False    False    False   False   False   \n",
       "rtrail               False   False   False    False    False   False   False   \n",
       "ql-xi-92              True    True    True    False     True   False   False   \n",
       "t0901317             False   False   False    False    False   False   False   \n",
       "pd173074             False   False   False    False    False   False   False   \n",
       "nutlin-3a (-)        False   False   False    False    False   False   False   \n",
       "cetuximab            False   False   False    False    False   False   False   \n",
       "y-39983               True    True   False    False     True   False   False   \n",
       "idelalisib           False   False   False    False    False   False   False   \n",
       "wz-1-84              False   False   False    False    False   False   False   \n",
       "cyclopamine          False   False   False    False    False   False   False   \n",
       "vx-11e               False   False   False    False    False   False   False   \n",
       "gw441756             False   False   False    False    False   False   False   \n",
       "vnlg/124             False   False   False    False    False   False   False   \n",
       "\n",
       "                    MED1712  RCMB24  RCMB32  BT084  ICB984  RCMB18  \n",
       "Name                                                                \n",
       "alectinib             False    True   False  False   False   False  \n",
       "gsk1070916             True    True    True   True    True    True  \n",
       "sb52334                True    True    True   True    True    True  \n",
       "tl-2-105              False    True    True   True   False    True  \n",
       "ql-xii-61             False    True   False   True   False   False  \n",
       "vx-702                 True    True    True   True    True    True  \n",
       "gsk429286a            False    True    True   True   False    True  \n",
       "linsitinib             True    True    True   True    True    True  \n",
       "bx-912                 True    True    True   True   False    True  \n",
       "gw-2580                True    True    True   True    True    True  \n",
       "tubastatin a          False    True    True   True   False    True  \n",
       "rucaparib              True    True    True   True    True    True  \n",
       "hg-5-88-01             True    True   False   True    True    True  \n",
       "navitoclax             True    True    True   True    True    True  \n",
       "amuvatinib             True    True    True   True    True    True  \n",
       "xmd14-99              False    True   False   True   False   False  \n",
       "axitinib              False    True    True   True   False    True  \n",
       "xmd13-2                True    True    True   True   False    True  \n",
       "avrainvillamide        True    True    True   True    True    True  \n",
       "ispinesib mesylate    False    True    True   True   False    True  \n",
       "gsk319347a             True    True    True   True    True    True  \n",
       "brd-k99006945          True    True    True   True    True    True  \n",
       "staurosporine          True    True    True   True    True    True  \n",
       "barasertib             True    True    True   True    True    True  \n",
       "ml239                  True    True    True   True    True    True  \n",
       "talazoparib            True    True    True   True    True    True  \n",
       "brd-k26531177          True    True    True   True    True    True  \n",
       "cct036477              True    True    True   True    True    True  \n",
       "indisulam              True    True    True   True    True    True  \n",
       "sb-505124              True    True    True   True   False   False  \n",
       "...                     ...     ...     ...    ...     ...     ...  \n",
       "tak-715               False   False   False  False   False   False  \n",
       "vismodegib            False   False   False  False   False   False  \n",
       "z-llnle-cho           False   False   False  False   False   False  \n",
       "ro-3306               False   False   False  False   False   False  \n",
       "bryostatin 1          False   False   False  False   False   False  \n",
       "bix02189              False   False   False  False   False   False  \n",
       "sb216763              False   False   False  False   False   False  \n",
       "681640                False   False   False  False   False   False  \n",
       "cp724714              False   False   False  False   False   False  \n",
       "rapamycin             False   False   False  False   False   False  \n",
       "dabrafenib            False   False   False  False   False   False  \n",
       "motesanib             False   False   False  False   False   False  \n",
       "pelitinib             False   False   False  False   False   False  \n",
       "az628                 False   False   False  False   False   False  \n",
       "kin001-260            False    True   False  False   False   False  \n",
       "gnf-2                 False   False   False  False   False   False  \n",
       "qs11                  False   False   False  False   False   False  \n",
       "rtrail                False   False   False  False   False   False  \n",
       "ql-xi-92              False    True   False  False   False   False  \n",
       "t0901317              False   False   False  False   False   False  \n",
       "pd173074              False   False   False  False   False   False  \n",
       "nutlin-3a (-)         False   False   False  False   False   False  \n",
       "cetuximab             False   False   False  False   False   False  \n",
       "y-39983               False    True   False  False   False   False  \n",
       "idelalisib            False   False   False  False   False   False  \n",
       "wz-1-84               False   False   False  False   False   False  \n",
       "cyclopamine           False   False   False  False   False   False  \n",
       "vx-11e                False   False   False  False   False   False  \n",
       "gw441756              False   False   False  False   False   False  \n",
       "vnlg/124              False   False   False  False   False   False  \n",
       "\n",
       "[672 rows x 20 columns]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hits_per_pdf = pd.read_excel('results/hits_per_pdx.xlsx',sheet_name = 'Effective Drugs')\n",
    "hits_per_pdf\n",
    "hits_per_pdf.index = hits_per_pdf['Name']\n",
    "hits_per_pdf = hits_per_pdf.drop('Name', axis=1)\n",
    "hits_per_pdf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:03:14.508781Z",
     "start_time": "2019-05-17T19:03:14.502384Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "nvp-bgt226                                               NaN\n",
       "bkm120                                                   NaN\n",
       "gsk2126458                                               NaN\n",
       "primamet                                                 NaN\n",
       "jq1                                  Not Clinically Relevant\n",
       "ibet762                                                  NaN\n",
       "gsk1070916                           Not Clinically Relevant\n",
       "barasertib        highly selective Aurora B kinase inhibitor\n",
       "alisertib                          Aurora A kinase inhibitor\n",
       "palbociclib                                 CDK4/6 inhibitor\n",
       "dinaciclib              CDK inhibitor, esp CDK1, 2, 5, and 9\n",
       "prexacertib                                              NaN\n",
       "gsk126                                                   NaN\n",
       "panobinostat                                  HDAC inhibitor\n",
       "trichostatin a                                           NaN\n",
       "apicidin                             Not Clinically Relevant\n",
       "abt-737                               Bcl-2/Bcl-xL inhibitor\n",
       "tw-37                                Not Clinically Relevant\n",
       "bx-912                               Not Clinically Relevant\n",
       "sb525334                                                 NaN\n",
       "vx-702                               Not Clinically Relevant\n",
       "rucaparib                PARP inhibitor, inhibits DNA repair\n",
       "olaparib                                      PARP Inhibitor\n",
       "linsitinib                                  IGF-1R inhibitor\n",
       "Name: moa, dtype: object"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T18:59:31.460845Z",
     "start_time": "2019-05-17T18:59:31.349828Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>MED1911</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED411</th>\n",
       "      <th>RCMB20</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>RCMB40</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>BT084</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>RCMB18</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "              ICB1299  ICB1572  MB002  MB009  MED1911  MED211  MED411  RCMB20  \\\n",
       "Name                                                                            \n",
       "jq1             False    False  False  False    False   False   False   False   \n",
       "jq12            False    False  False  False    False   False   False   False   \n",
       "gsk1070916       True     True   True   True     True    True    True    True   \n",
       "barasertib       True     True   True   True     True    True    True    True   \n",
       "alisertib        True     True   True   True     True    True    True    True   \n",
       "palbociclib     False    False  False  False    False   False   False   False   \n",
       "dinaciclib      False    False  False  False    False   False   False   False   \n",
       "panobinostat    False    False  False  False    False   False   False   False   \n",
       "apicidin         True     True   True   True     True    True    True    True   \n",
       "abt-737          True     True   True   True     True    True    True    True   \n",
       "tw-37           False    False  False  False    False   False   False   False   \n",
       "bx-912           True     True   True   True     True    True    True    True   \n",
       "vx-702           True     True   True   True     True    True    True    True   \n",
       "rucaparib        True     True  False  False     True    True    True   False   \n",
       "olaparib         True    False  False  False     True   False    True   False   \n",
       "linsitinib       True     True   True   True     True    True    True    True   \n",
       "\n",
       "              RCMB28  RCMB40  ICB1487  MED2312  RCMB38  DMB006  MED1712  \\\n",
       "Name                                                                      \n",
       "jq1            False   False    False    False   False   False    False   \n",
       "jq12           False   False    False    False   False   False    False   \n",
       "gsk1070916      True    True     True     True    True    True     True   \n",
       "barasertib      True    True     True     True    True    True     True   \n",
       "alisertib       True    True     True     True    True    True     True   \n",
       "palbociclib    False   False    False    False   False   False    False   \n",
       "dinaciclib     False   False    False    False   False   False    False   \n",
       "panobinostat   False   False    False    False   False   False    False   \n",
       "apicidin        True    True     True     True    True    True     True   \n",
       "abt-737         True    True     True     True    True    True     True   \n",
       "tw-37          False   False    False    False   False   False    False   \n",
       "bx-912          True    True     True     True    True    True     True   \n",
       "vx-702          True    True     True     True    True    True     True   \n",
       "rucaparib       True    True     True     True    True    True     True   \n",
       "olaparib       False    True     True     True   False   False     True   \n",
       "linsitinib      True    True     True     True    True    True     True   \n",
       "\n",
       "              RCMB24  RCMB32  BT084  ICB984  RCMB18  \n",
       "Name                                                 \n",
       "jq1            False   False  False   False   False  \n",
       "jq12           False   False  False   False   False  \n",
       "gsk1070916      True    True   True    True    True  \n",
       "barasertib      True    True   True    True    True  \n",
       "alisertib      False    True   True    True    True  \n",
       "palbociclib    False   False  False   False   False  \n",
       "dinaciclib     False   False  False   False   False  \n",
       "panobinostat   False   False  False   False   False  \n",
       "apicidin        True    True   True    True    True  \n",
       "abt-737         True    True   True    True    True  \n",
       "tw-37          False   False  False   False   False  \n",
       "bx-912          True    True   True   False    True  \n",
       "vx-702          True    True   True    True    True  \n",
       "rucaparib       True    True   True    True    True  \n",
       "olaparib        True    True   True    True    True  \n",
       "linsitinib      True    True   True    True    True  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exact_drugs = pd.DataFrame()\n",
    "for drug in lower_drugs:\n",
    "    exact_drugs = exact_drugs.append(hits_per_pdf[hits_per_pdf.index.str.contains(drug,case=False)])\n",
    "exact_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:04:57.913809Z",
     "start_time": "2019-05-17T19:04:57.852095Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>MED1911</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED411</th>\n",
       "      <th>RCMB20</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>RCMB40</th>\n",
       "      <th>...</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>BT084</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>moa</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>PARP Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>16 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              ICB1299  ICB1572  MB002  MB009  MED1911  MED211  MED411  RCMB20  \\\n",
       "Name                                                                            \n",
       "jq1             False    False  False  False    False   False   False   False   \n",
       "jq12            False    False  False  False    False   False   False   False   \n",
       "gsk1070916       True     True   True   True     True    True    True    True   \n",
       "barasertib       True     True   True   True     True    True    True    True   \n",
       "alisertib        True     True   True   True     True    True    True    True   \n",
       "palbociclib     False    False  False  False    False   False   False   False   \n",
       "dinaciclib      False    False  False  False    False   False   False   False   \n",
       "panobinostat    False    False  False  False    False   False   False   False   \n",
       "apicidin         True     True   True   True     True    True    True    True   \n",
       "abt-737          True     True   True   True     True    True    True    True   \n",
       "tw-37           False    False  False  False    False   False   False   False   \n",
       "bx-912           True     True   True   True     True    True    True    True   \n",
       "vx-702           True     True   True   True     True    True    True    True   \n",
       "rucaparib        True     True  False  False     True    True    True   False   \n",
       "olaparib         True    False  False  False     True   False    True   False   \n",
       "linsitinib       True     True   True   True     True    True    True    True   \n",
       "\n",
       "              RCMB28  RCMB40                     ...                      \\\n",
       "Name                                             ...                       \n",
       "jq1            False   False                     ...                       \n",
       "jq12           False   False                     ...                       \n",
       "gsk1070916      True    True                     ...                       \n",
       "barasertib      True    True                     ...                       \n",
       "alisertib       True    True                     ...                       \n",
       "palbociclib    False   False                     ...                       \n",
       "dinaciclib     False   False                     ...                       \n",
       "panobinostat   False   False                     ...                       \n",
       "apicidin        True    True                     ...                       \n",
       "abt-737         True    True                     ...                       \n",
       "tw-37          False   False                     ...                       \n",
       "bx-912          True    True                     ...                       \n",
       "vx-702          True    True                     ...                       \n",
       "rucaparib       True    True                     ...                       \n",
       "olaparib       False    True                     ...                       \n",
       "linsitinib      True    True                     ...                       \n",
       "\n",
       "              MED2312  RCMB38  DMB006  MED1712  RCMB24  RCMB32  BT084  ICB984  \\\n",
       "Name                                                                            \n",
       "jq1             False   False   False    False   False   False  False   False   \n",
       "jq12            False   False   False    False   False   False  False   False   \n",
       "gsk1070916       True    True    True     True    True    True   True    True   \n",
       "barasertib       True    True    True     True    True    True   True    True   \n",
       "alisertib        True    True    True     True   False    True   True    True   \n",
       "palbociclib     False   False   False    False   False   False  False   False   \n",
       "dinaciclib      False   False   False    False   False   False  False   False   \n",
       "panobinostat    False   False   False    False   False   False  False   False   \n",
       "apicidin         True    True    True     True    True    True   True    True   \n",
       "abt-737          True    True    True     True    True    True   True    True   \n",
       "tw-37           False   False   False    False   False   False  False   False   \n",
       "bx-912           True    True    True     True    True    True   True   False   \n",
       "vx-702           True    True    True     True    True    True   True    True   \n",
       "rucaparib        True    True    True     True    True    True   True    True   \n",
       "olaparib         True   False   False     True    True    True   True    True   \n",
       "linsitinib       True    True    True     True    True    True   True    True   \n",
       "\n",
       "              RCMB18                                         moa  \n",
       "Name                                                              \n",
       "jq1            False                     Not Clinically Relevant  \n",
       "jq12           False                                         NaN  \n",
       "gsk1070916      True                     Not Clinically Relevant  \n",
       "barasertib      True  highly selective Aurora B kinase inhibitor  \n",
       "alisertib       True                   Aurora A kinase inhibitor  \n",
       "palbociclib    False                            CDK4/6 inhibitor  \n",
       "dinaciclib     False        CDK inhibitor, esp CDK1, 2, 5, and 9  \n",
       "panobinostat   False                              HDAC inhibitor  \n",
       "apicidin        True                     Not Clinically Relevant  \n",
       "abt-737         True                      Bcl-2/Bcl-xL inhibitor  \n",
       "tw-37          False                     Not Clinically Relevant  \n",
       "bx-912          True                     Not Clinically Relevant  \n",
       "vx-702          True                     Not Clinically Relevant  \n",
       "rucaparib       True         PARP inhibitor, inhibits DNA repair  \n",
       "olaparib        True                              PARP Inhibitor  \n",
       "linsitinib      True                            IGF-1R inhibitor  \n",
       "\n",
       "[16 rows x 21 columns]"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exact_drugs['moa'] = all_pdx['moa'].reindex(lower_drugs)\n",
    "exact_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:31:17.799390Z",
     "start_time": "2019-05-17T23:31:17.796173Z"
    },
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# exact_drugs = pd.DataFrame()\n",
    "# for drug in lower_drugs:\n",
    "#     exact_drugs = exact_drugs.append(all_pdx[all_pdx.index.str.contains(drug)])\n",
    "# exact_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:11:03.090607Z",
     "start_time": "2019-05-17T19:11:03.085698Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['moa',\n",
       " 'ICB1299',\n",
       " 'MB002',\n",
       " 'MB009',\n",
       " 'RCMB28',\n",
       " 'MED211',\n",
       " 'MED511',\n",
       " 'ICB1572',\n",
       " 'MED2312',\n",
       " 'DMB006',\n",
       " 'RCMB38',\n",
       " 'ICB1487',\n",
       " 'ICB984',\n",
       " 'BT084',\n",
       " 'RCMB18',\n",
       " 'MED1712',\n",
       " 'RCMB24',\n",
       " 'RCMB32']"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "subset_pdx = \"moa\\tICB1299\tMB002\tMB009\tRCMB28\tMED211\tMED511\tICB1572\tMED2312\tDMB006\tRCMB38\tICB1487\tICB984\tBT084\tRCMB18\tMED1712\tRCMB24\tRCMB32\".split('\\t')\n",
    "subset_pdx"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:13:53.263560Z",
     "start_time": "2019-05-17T19:13:53.217960Z"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>moa</th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED511</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>BT084</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                     moa  ICB1299  MB002  \\\n",
       "Name                                                                       \n",
       "jq1                              Not Clinically Relevant    False  False   \n",
       "jq12                                                 NaN    False  False   \n",
       "gsk1070916                       Not Clinically Relevant     True   True   \n",
       "barasertib    highly selective Aurora B kinase inhibitor     True   True   \n",
       "alisertib                      Aurora A kinase inhibitor     True   True   \n",
       "palbociclib                             CDK4/6 inhibitor    False  False   \n",
       "dinaciclib          CDK inhibitor, esp CDK1, 2, 5, and 9    False  False   \n",
       "panobinostat                              HDAC inhibitor    False  False   \n",
       "apicidin                         Not Clinically Relevant     True   True   \n",
       "abt-737                           Bcl-2/Bcl-xL inhibitor     True   True   \n",
       "tw-37                            Not Clinically Relevant    False  False   \n",
       "bx-912                           Not Clinically Relevant     True   True   \n",
       "vx-702                           Not Clinically Relevant     True   True   \n",
       "rucaparib            PARP inhibitor, inhibits DNA repair     True  False   \n",
       "olaparib                                  PARP Inhibitor     True  False   \n",
       "linsitinib                              IGF-1R inhibitor     True   True   \n",
       "\n",
       "              MB009  RCMB28  MED211  MED511  ICB1572  MED2312  DMB006  RCMB38  \\\n",
       "Name                                                                            \n",
       "jq1           False   False   False     NaN    False    False   False   False   \n",
       "jq12          False   False   False     NaN    False    False   False   False   \n",
       "gsk1070916     True    True    True     NaN     True     True    True    True   \n",
       "barasertib     True    True    True     NaN     True     True    True    True   \n",
       "alisertib      True    True    True     NaN     True     True    True    True   \n",
       "palbociclib   False   False   False     NaN    False    False   False   False   \n",
       "dinaciclib    False   False   False     NaN    False    False   False   False   \n",
       "panobinostat  False   False   False     NaN    False    False   False   False   \n",
       "apicidin       True    True    True     NaN     True     True    True    True   \n",
       "abt-737        True    True    True     NaN     True     True    True    True   \n",
       "tw-37         False   False   False     NaN    False    False   False   False   \n",
       "bx-912         True    True    True     NaN     True     True    True    True   \n",
       "vx-702         True    True    True     NaN     True     True    True    True   \n",
       "rucaparib     False    True    True     NaN     True     True    True    True   \n",
       "olaparib      False   False   False     NaN    False     True   False   False   \n",
       "linsitinib     True    True    True     NaN     True     True    True    True   \n",
       "\n",
       "              ICB1487  ICB984  BT084  RCMB18  MED1712  RCMB24  RCMB32  \n",
       "Name                                                                   \n",
       "jq1             False   False  False   False    False   False   False  \n",
       "jq12            False   False  False   False    False   False   False  \n",
       "gsk1070916       True    True   True    True     True    True    True  \n",
       "barasertib       True    True   True    True     True    True    True  \n",
       "alisertib        True    True   True    True     True   False    True  \n",
       "palbociclib     False   False  False   False    False   False   False  \n",
       "dinaciclib      False   False  False   False    False   False   False  \n",
       "panobinostat    False   False  False   False    False   False   False  \n",
       "apicidin         True    True   True    True     True    True    True  \n",
       "abt-737          True    True   True    True     True    True    True  \n",
       "tw-37           False   False  False   False    False   False   False  \n",
       "bx-912           True   False   True    True     True    True    True  \n",
       "vx-702           True    True   True    True     True    True    True  \n",
       "rucaparib        True    True   True    True     True    True    True  \n",
       "olaparib         True    True   True    True     True    True    True  \n",
       "linsitinib       True    True   True    True     True    True    True  "
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exact_drugs = exact_drugs.reindex(subset_pdx,axis=1)\n",
    "exact_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:13:54.956582Z",
     "start_time": "2019-05-17T19:13:54.922485Z"
    }
   },
   "outputs": [],
   "source": [
    "exact_drugs.to_excel('predicted_drugs_validated_PDX.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:25:59.598091Z",
     "start_time": "2019-05-17T23:25:59.210859Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Category</th>\n",
       "      <th>Drug</th>\n",
       "      <th>ICB-1299</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED511</th>\n",
       "      <th>ICb-1572</th>\n",
       "      <th>HepaRG</th>\n",
       "      <th>...</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>ICb-1487</th>\n",
       "      <th>HepaRG.1</th>\n",
       "      <th>ICb-984</th>\n",
       "      <th>BT084</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>24 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                          Category            Drug ICB-1299 MB002 MB009  \\\n",
       "0          p13k/mTOR/Akt inhibitor      NVP-BGT226       --    --  True   \n",
       "1          p13k/mTOR/Akt inhibitor          BKM120       --    --  True   \n",
       "2          p13k/mTOR/Akt inhibitor      GSK2126458       --    --  True   \n",
       "3                    p53 activator        PRIMAmet       --  True  True   \n",
       "4                    BET inhibitor             JQ1        F  True    --   \n",
       "5                    BET inhibitor         iBET762        F     F    --   \n",
       "6                 Aurora inhibitor      GSK1070916     True  True    --   \n",
       "7                 Aurora inhibitor      Barasertib        F     F    --   \n",
       "8                 Aurora inhibitor       Alisertib        F     F    --   \n",
       "9   CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib       --  True    --   \n",
       "10  CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib       --  True    --   \n",
       "11                   CHK inhibitor     Prexacertib       --  True    --   \n",
       "12                  EZH2 inhibitor          GSK126       --     F    --   \n",
       "13                  HDAC inhibitor    Panobinostat       --  True    --   \n",
       "14                  HDAC inhibitor  Trichostatin A       --  True    --   \n",
       "15                  HDAC inhibitor        Apicidin       --  True    --   \n",
       "16                  BCL2 inhibitor         ABT-737       --  True    --   \n",
       "17                  BCL2 inhibitor           TW-37       --  True    --   \n",
       "18                  BCL2 inhibitor          bx-912       --  True    --   \n",
       "19                       TGFbetaR1        SB525334       --     F    --   \n",
       "20                       TGFbetaR1          vx-702       --     F    --   \n",
       "21                 PARP Inhibitors       Rucaparib       --     F    --   \n",
       "22                 PARP Inhibitors        Olaparib       --     F    --   \n",
       "23                 PARP Inhibitors      Linsitinib       --  True    --   \n",
       "\n",
       "   RCMB28 MED211 MED511 ICb-1572 HepaRG  ...   DMB006 RCMB38 ICb-1487  \\\n",
       "0    True   True   True     True   True  ...     True   True     True   \n",
       "1    True   True   True     True   True  ...        F   True        F   \n",
       "2    True   True   True     True   True  ...     True   True     True   \n",
       "3    True   True   True     True      F  ...     True   True     True   \n",
       "4       F   True   True     True      F  ...        F      F        F   \n",
       "5       F   True      F     True      F  ...        F      F        F   \n",
       "6    True   True   True     True      F  ...     True   True     True   \n",
       "7       F   True      F     True      F  ...        F      F        F   \n",
       "8       F   True      F     True      F  ...        F      F        F   \n",
       "9    True   True   True     True   True  ...        F      F        F   \n",
       "10      F      F   True     True      F  ...        F      F        F   \n",
       "11      F   True   True     True      F  ...        F      F        F   \n",
       "12      F   True      F     True      F  ...     True      F     True   \n",
       "13   True   True   True     True   True  ...     True   True     True   \n",
       "14   True   True   True     True   True  ...     True   True     True   \n",
       "15   True   True   True     True   True  ...     True   True     True   \n",
       "16   True   True   True     True      F  ...        F   True     True   \n",
       "17   True      T      T     True      F  ...     True   True     True   \n",
       "18   True      T      T     True      F  ...        F      F        F   \n",
       "19      F      F      F     True      F  ...        F      F        F   \n",
       "20      F      F      F        F      F  ...        F      F        F   \n",
       "21      F   True      F        F      F  ...        F      F        F   \n",
       "22      F   True      F     True      F  ...        F      F        F   \n",
       "23   True   True   True     True      F  ...        F      F        F   \n",
       "\n",
       "   HepaRG.1 ICb-984 BT084 RCMB18 MED1712 RCMB24 RCMB32  \n",
       "0      True    True  True   True    True   True   True  \n",
       "1      True    True     F      F    True   True   True  \n",
       "2      True    True  True      F    True   True   True  \n",
       "3         F    True  True   True    True   True   True  \n",
       "4         F       F     F      F       F   True   True  \n",
       "5         F       F     F      F       F      F      F  \n",
       "6         F    True  True      F    True     --     --  \n",
       "7         F       F     F      F       F      F      F  \n",
       "8         F       F     F      F       F      F      F  \n",
       "9      True    True     F      F       F   True   True  \n",
       "10        F       F     F      F    True      F      F  \n",
       "11        F    True     F      F    True      F   True  \n",
       "12        F       F     F      F       F      F      F  \n",
       "13     True    True  True   True    True   True   True  \n",
       "14     True    True  True   True    True   True   True  \n",
       "15     True    True  True   True    True   True     --  \n",
       "16        F    True  True   True    True   True   True  \n",
       "17        F    True  True   True    True   True     --  \n",
       "18        F       F     F      F    True      F     --  \n",
       "19        F       F     F      F       F      F     --  \n",
       "20        F       F     F      F       F      F     --  \n",
       "21        F       F     F      F       F      F     --  \n",
       "22        F       F     F      F       F      F     --  \n",
       "23        F       F     F      F       F   True     --  \n",
       "\n",
       "[24 rows x 21 columns]"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_df = pd.read_excel('data/preprocessed/Drug validation summary.xlsx',sheet_name='Fig2_summary_to_read')\n",
    "val_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:13.461516Z",
     "start_time": "2019-05-17T23:26:13.401660Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Category-Val</th>\n",
       "      <th>Drug-Val</th>\n",
       "      <th>ICB-1299-Val</th>\n",
       "      <th>MB002-Val</th>\n",
       "      <th>MB009-Val</th>\n",
       "      <th>RCMB28-Val</th>\n",
       "      <th>MED211-Val</th>\n",
       "      <th>MED511-Val</th>\n",
       "      <th>ICb-1572-Val</th>\n",
       "      <th>HepaRG-Val</th>\n",
       "      <th>...</th>\n",
       "      <th>DMB006-Val</th>\n",
       "      <th>RCMB38-Val</th>\n",
       "      <th>ICb-1487-Val</th>\n",
       "      <th>HepaRG.1-Val</th>\n",
       "      <th>ICb-984-Val</th>\n",
       "      <th>BT084-Val</th>\n",
       "      <th>RCMB18-Val</th>\n",
       "      <th>MED1712-Val</th>\n",
       "      <th>RCMB24-Val</th>\n",
       "      <th>RCMB32-Val</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>24 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                      Category-Val        Drug-Val ICB-1299-Val MB002-Val  \\\n",
       "0          p13k/mTOR/Akt inhibitor      NVP-BGT226           --        --   \n",
       "1          p13k/mTOR/Akt inhibitor          BKM120           --        --   \n",
       "2          p13k/mTOR/Akt inhibitor      GSK2126458           --        --   \n",
       "3                    p53 activator        PRIMAmet           --      True   \n",
       "4                    BET inhibitor             JQ1            F      True   \n",
       "5                    BET inhibitor         iBET762            F         F   \n",
       "6                 Aurora inhibitor      GSK1070916         True      True   \n",
       "7                 Aurora inhibitor      Barasertib            F         F   \n",
       "8                 Aurora inhibitor       Alisertib            F         F   \n",
       "9   CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib           --      True   \n",
       "10  CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib           --      True   \n",
       "11                   CHK inhibitor     Prexacertib           --      True   \n",
       "12                  EZH2 inhibitor          GSK126           --         F   \n",
       "13                  HDAC inhibitor    Panobinostat           --      True   \n",
       "14                  HDAC inhibitor  Trichostatin A           --      True   \n",
       "15                  HDAC inhibitor        Apicidin           --      True   \n",
       "16                  BCL2 inhibitor         ABT-737           --      True   \n",
       "17                  BCL2 inhibitor           TW-37           --      True   \n",
       "18                  BCL2 inhibitor          bx-912           --      True   \n",
       "19                       TGFbetaR1        SB525334           --         F   \n",
       "20                       TGFbetaR1          vx-702           --         F   \n",
       "21                 PARP Inhibitors       Rucaparib           --         F   \n",
       "22                 PARP Inhibitors        Olaparib           --         F   \n",
       "23                 PARP Inhibitors      Linsitinib           --      True   \n",
       "\n",
       "   MB009-Val RCMB28-Val MED211-Val MED511-Val ICb-1572-Val HepaRG-Val  \\\n",
       "0       True       True       True       True         True       True   \n",
       "1       True       True       True       True         True       True   \n",
       "2       True       True       True       True         True       True   \n",
       "3       True       True       True       True         True          F   \n",
       "4         --          F       True       True         True          F   \n",
       "5         --          F       True          F         True          F   \n",
       "6         --       True       True       True         True          F   \n",
       "7         --          F       True          F         True          F   \n",
       "8         --          F       True          F         True          F   \n",
       "9         --       True       True       True         True       True   \n",
       "10        --          F          F       True         True          F   \n",
       "11        --          F       True       True         True          F   \n",
       "12        --          F       True          F         True          F   \n",
       "13        --       True       True       True         True       True   \n",
       "14        --       True       True       True         True       True   \n",
       "15        --       True       True       True         True       True   \n",
       "16        --       True       True       True         True          F   \n",
       "17        --       True          T          T         True          F   \n",
       "18        --       True          T          T         True          F   \n",
       "19        --          F          F          F         True          F   \n",
       "20        --          F          F          F            F          F   \n",
       "21        --          F       True          F            F          F   \n",
       "22        --          F       True          F         True          F   \n",
       "23        --       True       True       True         True          F   \n",
       "\n",
       "      ...     DMB006-Val RCMB38-Val ICb-1487-Val HepaRG.1-Val ICb-984-Val  \\\n",
       "0     ...           True       True         True         True        True   \n",
       "1     ...              F       True            F         True        True   \n",
       "2     ...           True       True         True         True        True   \n",
       "3     ...           True       True         True            F        True   \n",
       "4     ...              F          F            F            F           F   \n",
       "5     ...              F          F            F            F           F   \n",
       "6     ...           True       True         True            F        True   \n",
       "7     ...              F          F            F            F           F   \n",
       "8     ...              F          F            F            F           F   \n",
       "9     ...              F          F            F         True        True   \n",
       "10    ...              F          F            F            F           F   \n",
       "11    ...              F          F            F            F        True   \n",
       "12    ...           True          F         True            F           F   \n",
       "13    ...           True       True         True         True        True   \n",
       "14    ...           True       True         True         True        True   \n",
       "15    ...           True       True         True         True        True   \n",
       "16    ...              F       True         True            F        True   \n",
       "17    ...           True       True         True            F        True   \n",
       "18    ...              F          F            F            F           F   \n",
       "19    ...              F          F            F            F           F   \n",
       "20    ...              F          F            F            F           F   \n",
       "21    ...              F          F            F            F           F   \n",
       "22    ...              F          F            F            F           F   \n",
       "23    ...              F          F            F            F           F   \n",
       "\n",
       "   BT084-Val RCMB18-Val MED1712-Val RCMB24-Val RCMB32-Val  \n",
       "0       True       True        True       True       True  \n",
       "1          F          F        True       True       True  \n",
       "2       True          F        True       True       True  \n",
       "3       True       True        True       True       True  \n",
       "4          F          F           F       True       True  \n",
       "5          F          F           F          F          F  \n",
       "6       True          F        True         --         --  \n",
       "7          F          F           F          F          F  \n",
       "8          F          F           F          F          F  \n",
       "9          F          F           F       True       True  \n",
       "10         F          F        True          F          F  \n",
       "11         F          F        True          F       True  \n",
       "12         F          F           F          F          F  \n",
       "13      True       True        True       True       True  \n",
       "14      True       True        True       True       True  \n",
       "15      True       True        True       True         --  \n",
       "16      True       True        True       True       True  \n",
       "17      True       True        True       True         --  \n",
       "18         F          F        True          F         --  \n",
       "19         F          F           F          F         --  \n",
       "20         F          F           F          F         --  \n",
       "21         F          F           F          F         --  \n",
       "22         F          F           F          F         --  \n",
       "23         F          F           F       True         --  \n",
       "\n",
       "[24 rows x 21 columns]"
      ]
     },
     "execution_count": 126,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_df.columns = [i+'-Val' for i in val_df.columns]\n",
    "val_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:17.195811Z",
     "start_time": "2019-05-17T23:26:17.190764Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Category-Val',\n",
       " 'Drug-Val',\n",
       " 'ICB-1299-Val',\n",
       " 'MB002-Val',\n",
       " 'MB009-Val',\n",
       " 'RCMB28-Val',\n",
       " 'MED211-Val',\n",
       " 'MED511-Val',\n",
       " 'ICb-1572-Val',\n",
       " 'HepaRG-Val',\n",
       " 'MED2312-Val',\n",
       " 'DMB006-Val',\n",
       " 'RCMB38-Val',\n",
       " 'ICb-1487-Val',\n",
       " 'HepaRG.1-Val',\n",
       " 'ICb-984-Val',\n",
       " 'BT084-Val',\n",
       " 'RCMB18-Val',\n",
       " 'MED1712-Val',\n",
       " 'RCMB24-Val',\n",
       " 'RCMB32-Val']"
      ]
     },
     "execution_count": 127,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(val_df.columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:19.195398Z",
     "start_time": "2019-05-17T23:26:19.189396Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['moa',\n",
       " 'ICB1299',\n",
       " 'MB002',\n",
       " 'MB009',\n",
       " 'RCMB28',\n",
       " 'MED211',\n",
       " 'MED511',\n",
       " 'ICB1572',\n",
       " 'MED2312',\n",
       " 'DMB006',\n",
       " 'RCMB38',\n",
       " 'ICB1487',\n",
       " 'ICB984',\n",
       " 'BT084',\n",
       " 'RCMB18',\n",
       " 'MED1712',\n",
       " 'RCMB24',\n",
       " 'RCMB32']"
      ]
     },
     "execution_count": 128,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(exact_drugs.columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:20.339729Z",
     "start_time": "2019-05-17T23:26:20.333531Z"
    }
   },
   "outputs": [],
   "source": [
    "g3 =[   'Category-Val',\n",
    "        'Drug-Val',\n",
    "        'moa',\n",
    "        'ICB1299',\n",
    "        'ICB-1299-Val',\n",
    "        'MB002',\n",
    "        'MB002-Val',\n",
    "        'MB009',\n",
    "        'MB009-Val',\n",
    "        'RCMB28',\n",
    "        'RCMB28-Val',\n",
    "        'MED211',\n",
    "        'MED211-Val',\n",
    "        'MED511',\n",
    "        'MED511-Val',\n",
    "        'ICB1572',\n",
    "        'ICb-1572-Val',]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:20.654576Z",
     "start_time": "2019-05-17T23:26:20.648439Z"
    }
   },
   "outputs": [],
   "source": [
    "g4 = ['Category-Val',\n",
    "       'Drug-Val',\n",
    "       'moa',\n",
    "       'MED2312',\n",
    "       'MED2312-Val',\n",
    "       'DMB006',\n",
    "       'DMB006-Val',\n",
    "       'RCMB38',\n",
    "       'RCMB38-Val',\n",
    "       'ICB1487',\n",
    "       'ICb-1487-Val',\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 131,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:21.028582Z",
     "start_time": "2019-05-17T23:26:21.022979Z"
    }
   },
   "outputs": [],
   "source": [
    "shh = ['Category-Val',\n",
    "       'Drug-Val',\n",
    "       'moa',\n",
    "       'ICB984',\n",
    "       'ICb-984-Val',\n",
    "       'BT084',\n",
    "       'BT084-Val',\n",
    "       'RCMB18',\n",
    "       'RCMB18-Val',\n",
    "       'MED1712',\n",
    "       'MED1712-Val',\n",
    "       'RCMB24',\n",
    "       'RCMB24-Val',\n",
    "       'RCMB32',\n",
    "       'RCMB32-Val',]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 132,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:22.368360Z",
     "start_time": "2019-05-17T23:26:22.347703Z"
    }
   },
   "outputs": [],
   "source": [
    "new_cols= ['Category-Val',\n",
    "           'Drug-Val',\n",
    "           'moa',\n",
    "           'ICB1299',\n",
    "           'ICB-1299-Val',\n",
    "           'MB002',\n",
    "           'MB002-Val',\n",
    "           'MB009',\n",
    "           'MB009-Val',\n",
    "           'RCMB28',\n",
    "           'RCMB28-Val',\n",
    "           'MED211',\n",
    "           'MED211-Val',\n",
    "           'MED511',\n",
    "           'MED511-Val',\n",
    "           'ICB1572',\n",
    "           'ICb-1572-Val',\n",
    "           \n",
    "           'MED2312',\n",
    "           'MED2312-Val',\n",
    "           'DMB006',\n",
    "           'DMB006-Val',\n",
    "           'RCMB38',\n",
    "           'RCMB38-Val',\n",
    "           'ICB1487',\n",
    "           'ICb-1487-Val',\n",
    "           \n",
    "           'ICB984',\n",
    "           'ICb-984-Val',\n",
    "           'BT084',\n",
    "           'BT084-Val',\n",
    "           'RCMB18',\n",
    "           'RCMB18-Val',\n",
    "           'MED1712',\n",
    "           'MED1712-Val',\n",
    "           'RCMB24',\n",
    "           'RCMB24-Val',\n",
    "           'RCMB32',\n",
    "           'RCMB32-Val',\n",
    "           \n",
    "           'HepaRG-Val',]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:26.595382Z",
     "start_time": "2019-05-17T23:26:26.542542Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Category-Val</th>\n",
       "      <th>Drug-Val</th>\n",
       "      <th>ICB-1299-Val</th>\n",
       "      <th>MB002-Val</th>\n",
       "      <th>MB009-Val</th>\n",
       "      <th>RCMB28-Val</th>\n",
       "      <th>MED211-Val</th>\n",
       "      <th>MED511-Val</th>\n",
       "      <th>ICb-1572-Val</th>\n",
       "      <th>HepaRG-Val</th>\n",
       "      <th>...</th>\n",
       "      <th>DMB006-Val</th>\n",
       "      <th>RCMB38-Val</th>\n",
       "      <th>ICb-1487-Val</th>\n",
       "      <th>HepaRG.1-Val</th>\n",
       "      <th>ICb-984-Val</th>\n",
       "      <th>BT084-Val</th>\n",
       "      <th>RCMB18-Val</th>\n",
       "      <th>MED1712-Val</th>\n",
       "      <th>RCMB24-Val</th>\n",
       "      <th>RCMB32-Val</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>nvp-bgt226</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bkm120</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk2126458</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>primamet</th>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ibet762</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>prexacertib</th>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk126</th>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>trichostatin a</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb525334</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>24 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  Category-Val        Drug-Val ICB-1299-Val  \\\n",
       "drug                                                                          \n",
       "nvp-bgt226             p13k/mTOR/Akt inhibitor      NVP-BGT226           --   \n",
       "bkm120                 p13k/mTOR/Akt inhibitor          BKM120           --   \n",
       "gsk2126458             p13k/mTOR/Akt inhibitor      GSK2126458           --   \n",
       "primamet                         p53 activator        PRIMAmet           --   \n",
       "jq1                              BET inhibitor             JQ1            F   \n",
       "ibet762                          BET inhibitor         iBET762            F   \n",
       "gsk1070916                    Aurora inhibitor      GSK1070916         True   \n",
       "barasertib                    Aurora inhibitor      Barasertib            F   \n",
       "alisertib                     Aurora inhibitor       Alisertib            F   \n",
       "palbociclib     CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib           --   \n",
       "dinaciclib      CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib           --   \n",
       "prexacertib                      CHK inhibitor     Prexacertib           --   \n",
       "gsk126                          EZH2 inhibitor          GSK126           --   \n",
       "panobinostat                    HDAC inhibitor    Panobinostat           --   \n",
       "trichostatin a                  HDAC inhibitor  Trichostatin A           --   \n",
       "apicidin                        HDAC inhibitor        Apicidin           --   \n",
       "abt-737                         BCL2 inhibitor         ABT-737           --   \n",
       "tw-37                           BCL2 inhibitor           TW-37           --   \n",
       "bx-912                          BCL2 inhibitor          bx-912           --   \n",
       "sb525334                             TGFbetaR1        SB525334           --   \n",
       "vx-702                               TGFbetaR1          vx-702           --   \n",
       "rucaparib                      PARP Inhibitors       Rucaparib           --   \n",
       "olaparib                       PARP Inhibitors        Olaparib           --   \n",
       "linsitinib                     PARP Inhibitors      Linsitinib           --   \n",
       "\n",
       "               MB002-Val MB009-Val RCMB28-Val MED211-Val MED511-Val  \\\n",
       "drug                                                                  \n",
       "nvp-bgt226            --      True       True       True       True   \n",
       "bkm120                --      True       True       True       True   \n",
       "gsk2126458            --      True       True       True       True   \n",
       "primamet            True      True       True       True       True   \n",
       "jq1                 True        --          F       True       True   \n",
       "ibet762                F        --          F       True          F   \n",
       "gsk1070916          True        --       True       True       True   \n",
       "barasertib             F        --          F       True          F   \n",
       "alisertib              F        --          F       True          F   \n",
       "palbociclib         True        --       True       True       True   \n",
       "dinaciclib          True        --          F          F       True   \n",
       "prexacertib         True        --          F       True       True   \n",
       "gsk126                 F        --          F       True          F   \n",
       "panobinostat        True        --       True       True       True   \n",
       "trichostatin a      True        --       True       True       True   \n",
       "apicidin            True        --       True       True       True   \n",
       "abt-737             True        --       True       True       True   \n",
       "tw-37               True        --       True          T          T   \n",
       "bx-912              True        --       True          T          T   \n",
       "sb525334               F        --          F          F          F   \n",
       "vx-702                 F        --          F          F          F   \n",
       "rucaparib              F        --          F       True          F   \n",
       "olaparib               F        --          F       True          F   \n",
       "linsitinib          True        --       True       True       True   \n",
       "\n",
       "               ICb-1572-Val HepaRG-Val    ...     DMB006-Val RCMB38-Val  \\\n",
       "drug                                      ...                             \n",
       "nvp-bgt226             True       True    ...           True       True   \n",
       "bkm120                 True       True    ...              F       True   \n",
       "gsk2126458             True       True    ...           True       True   \n",
       "primamet               True          F    ...           True       True   \n",
       "jq1                    True          F    ...              F          F   \n",
       "ibet762                True          F    ...              F          F   \n",
       "gsk1070916             True          F    ...           True       True   \n",
       "barasertib             True          F    ...              F          F   \n",
       "alisertib              True          F    ...              F          F   \n",
       "palbociclib            True       True    ...              F          F   \n",
       "dinaciclib             True          F    ...              F          F   \n",
       "prexacertib            True          F    ...              F          F   \n",
       "gsk126                 True          F    ...           True          F   \n",
       "panobinostat           True       True    ...           True       True   \n",
       "trichostatin a         True       True    ...           True       True   \n",
       "apicidin               True       True    ...           True       True   \n",
       "abt-737                True          F    ...              F       True   \n",
       "tw-37                  True          F    ...           True       True   \n",
       "bx-912                 True          F    ...              F          F   \n",
       "sb525334               True          F    ...              F          F   \n",
       "vx-702                    F          F    ...              F          F   \n",
       "rucaparib                 F          F    ...              F          F   \n",
       "olaparib               True          F    ...              F          F   \n",
       "linsitinib             True          F    ...              F          F   \n",
       "\n",
       "               ICb-1487-Val HepaRG.1-Val ICb-984-Val BT084-Val RCMB18-Val  \\\n",
       "drug                                                                        \n",
       "nvp-bgt226             True         True        True      True       True   \n",
       "bkm120                    F         True        True         F          F   \n",
       "gsk2126458             True         True        True      True          F   \n",
       "primamet               True            F        True      True       True   \n",
       "jq1                       F            F           F         F          F   \n",
       "ibet762                   F            F           F         F          F   \n",
       "gsk1070916             True            F        True      True          F   \n",
       "barasertib                F            F           F         F          F   \n",
       "alisertib                 F            F           F         F          F   \n",
       "palbociclib               F         True        True         F          F   \n",
       "dinaciclib                F            F           F         F          F   \n",
       "prexacertib               F            F        True         F          F   \n",
       "gsk126                 True            F           F         F          F   \n",
       "panobinostat           True         True        True      True       True   \n",
       "trichostatin a         True         True        True      True       True   \n",
       "apicidin               True         True        True      True       True   \n",
       "abt-737                True            F        True      True       True   \n",
       "tw-37                  True            F        True      True       True   \n",
       "bx-912                    F            F           F         F          F   \n",
       "sb525334                  F            F           F         F          F   \n",
       "vx-702                    F            F           F         F          F   \n",
       "rucaparib                 F            F           F         F          F   \n",
       "olaparib                  F            F           F         F          F   \n",
       "linsitinib                F            F           F         F          F   \n",
       "\n",
       "               MED1712-Val RCMB24-Val RCMB32-Val  \n",
       "drug                                              \n",
       "nvp-bgt226            True       True       True  \n",
       "bkm120                True       True       True  \n",
       "gsk2126458            True       True       True  \n",
       "primamet              True       True       True  \n",
       "jq1                      F       True       True  \n",
       "ibet762                  F          F          F  \n",
       "gsk1070916            True         --         --  \n",
       "barasertib               F          F          F  \n",
       "alisertib                F          F          F  \n",
       "palbociclib              F       True       True  \n",
       "dinaciclib            True          F          F  \n",
       "prexacertib           True          F       True  \n",
       "gsk126                   F          F          F  \n",
       "panobinostat          True       True       True  \n",
       "trichostatin a        True       True       True  \n",
       "apicidin              True       True         --  \n",
       "abt-737               True       True       True  \n",
       "tw-37                 True       True         --  \n",
       "bx-912                True          F         --  \n",
       "sb525334                 F          F         --  \n",
       "vx-702                   F          F         --  \n",
       "rucaparib                F          F         --  \n",
       "olaparib                 F          F         --  \n",
       "linsitinib               F       True         --  \n",
       "\n",
       "[24 rows x 21 columns]"
      ]
     },
     "execution_count": 133,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_df['drug'] = val_df['Drug-Val'].str.lower()\n",
    "val_df.index = val_df['drug']\n",
    "val_df = val_df.drop('drug',axis=1)\n",
    "val_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:31:10.001556Z",
     "start_time": "2019-05-17T19:31:09.959248Z"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>moa</th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED511</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>BT084</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                     moa  ICB1299  MB002  \\\n",
       "Name                                                                       \n",
       "jq1                              Not Clinically Relevant    False  False   \n",
       "jq12                                                 NaN    False  False   \n",
       "gsk1070916                       Not Clinically Relevant     True   True   \n",
       "barasertib    highly selective Aurora B kinase inhibitor     True   True   \n",
       "alisertib                      Aurora A kinase inhibitor     True   True   \n",
       "palbociclib                             CDK4/6 inhibitor    False  False   \n",
       "dinaciclib          CDK inhibitor, esp CDK1, 2, 5, and 9    False  False   \n",
       "panobinostat                              HDAC inhibitor    False  False   \n",
       "apicidin                         Not Clinically Relevant     True   True   \n",
       "abt-737                           Bcl-2/Bcl-xL inhibitor     True   True   \n",
       "tw-37                            Not Clinically Relevant    False  False   \n",
       "bx-912                           Not Clinically Relevant     True   True   \n",
       "vx-702                           Not Clinically Relevant     True   True   \n",
       "rucaparib            PARP inhibitor, inhibits DNA repair     True  False   \n",
       "olaparib                                  PARP Inhibitor     True  False   \n",
       "linsitinib                              IGF-1R inhibitor     True   True   \n",
       "\n",
       "              MB009  RCMB28  MED211  MED511  ICB1572  MED2312  DMB006  RCMB38  \\\n",
       "Name                                                                            \n",
       "jq1           False   False   False     NaN    False    False   False   False   \n",
       "jq12          False   False   False     NaN    False    False   False   False   \n",
       "gsk1070916     True    True    True     NaN     True     True    True    True   \n",
       "barasertib     True    True    True     NaN     True     True    True    True   \n",
       "alisertib      True    True    True     NaN     True     True    True    True   \n",
       "palbociclib   False   False   False     NaN    False    False   False   False   \n",
       "dinaciclib    False   False   False     NaN    False    False   False   False   \n",
       "panobinostat  False   False   False     NaN    False    False   False   False   \n",
       "apicidin       True    True    True     NaN     True     True    True    True   \n",
       "abt-737        True    True    True     NaN     True     True    True    True   \n",
       "tw-37         False   False   False     NaN    False    False   False   False   \n",
       "bx-912         True    True    True     NaN     True     True    True    True   \n",
       "vx-702         True    True    True     NaN     True     True    True    True   \n",
       "rucaparib     False    True    True     NaN     True     True    True    True   \n",
       "olaparib      False   False   False     NaN    False     True   False   False   \n",
       "linsitinib     True    True    True     NaN     True     True    True    True   \n",
       "\n",
       "              ICB1487  ICB984  BT084  RCMB18  MED1712  RCMB24  RCMB32  \n",
       "Name                                                                   \n",
       "jq1             False   False  False   False    False   False   False  \n",
       "jq12            False   False  False   False    False   False   False  \n",
       "gsk1070916       True    True   True    True     True    True    True  \n",
       "barasertib       True    True   True    True     True    True    True  \n",
       "alisertib        True    True   True    True     True   False    True  \n",
       "palbociclib     False   False  False   False    False   False   False  \n",
       "dinaciclib      False   False  False   False    False   False   False  \n",
       "panobinostat    False   False  False   False    False   False   False  \n",
       "apicidin         True    True   True    True     True    True    True  \n",
       "abt-737          True    True   True    True     True    True    True  \n",
       "tw-37           False   False  False   False    False   False   False  \n",
       "bx-912           True   False   True    True     True    True    True  \n",
       "vx-702           True    True   True    True     True    True    True  \n",
       "rucaparib        True    True   True    True     True    True    True  \n",
       "olaparib         True    True   True    True     True    True    True  \n",
       "linsitinib       True    True   True    True     True    True    True  "
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exact_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:46:40.196374Z",
     "start_time": "2019-05-17T19:46:40.075335Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Category-Val</th>\n",
       "      <th>Drug-Val</th>\n",
       "      <th>moa</th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB-1299-Val</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB002-Val</th>\n",
       "      <th>MB009</th>\n",
       "      <th>MB009-Val</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>...</th>\n",
       "      <th>BT084-Val</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>RCMB18-Val</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>MED1712-Val</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB24-Val</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>RCMB32-Val</th>\n",
       "      <th>HepaRG-Val</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bkm120</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk126</th>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk2126458</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ibet762</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nvp-bgt226</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>PARP Inhibitor</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>prexacertib</th>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>primamet</th>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>F</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb525334</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>trichostatin a</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>F</td>\n",
       "      <td>True</td>\n",
       "      <td>--</td>\n",
       "      <td>F</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>25 rows × 38 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  Category-Val        Drug-Val  \\\n",
       "abt-737                         BCL2 inhibitor         ABT-737   \n",
       "alisertib                     Aurora inhibitor       Alisertib   \n",
       "apicidin                        HDAC inhibitor        Apicidin   \n",
       "barasertib                    Aurora inhibitor      Barasertib   \n",
       "bkm120                 p13k/mTOR/Akt inhibitor          BKM120   \n",
       "bx-912                          BCL2 inhibitor          bx-912   \n",
       "dinaciclib      CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib   \n",
       "gsk1070916                    Aurora inhibitor      GSK1070916   \n",
       "gsk126                          EZH2 inhibitor          GSK126   \n",
       "gsk2126458             p13k/mTOR/Akt inhibitor      GSK2126458   \n",
       "ibet762                          BET inhibitor         iBET762   \n",
       "jq1                              BET inhibitor             JQ1   \n",
       "jq12                                       NaN             NaN   \n",
       "linsitinib                     PARP Inhibitors      Linsitinib   \n",
       "nvp-bgt226             p13k/mTOR/Akt inhibitor      NVP-BGT226   \n",
       "olaparib                       PARP Inhibitors        Olaparib   \n",
       "palbociclib     CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib   \n",
       "panobinostat                    HDAC inhibitor    Panobinostat   \n",
       "prexacertib                      CHK inhibitor     Prexacertib   \n",
       "primamet                         p53 activator        PRIMAmet   \n",
       "rucaparib                      PARP Inhibitors       Rucaparib   \n",
       "sb525334                             TGFbetaR1        SB525334   \n",
       "trichostatin a                  HDAC inhibitor  Trichostatin A   \n",
       "tw-37                           BCL2 inhibitor           TW-37   \n",
       "vx-702                               TGFbetaR1          vx-702   \n",
       "\n",
       "                                                       moa ICB1299  \\\n",
       "abt-737                             Bcl-2/Bcl-xL inhibitor    True   \n",
       "alisertib                        Aurora A kinase inhibitor    True   \n",
       "apicidin                           Not Clinically Relevant    True   \n",
       "barasertib      highly selective Aurora B kinase inhibitor    True   \n",
       "bkm120                                                 NaN     NaN   \n",
       "bx-912                             Not Clinically Relevant    True   \n",
       "dinaciclib            CDK inhibitor, esp CDK1, 2, 5, and 9   False   \n",
       "gsk1070916                         Not Clinically Relevant    True   \n",
       "gsk126                                                 NaN     NaN   \n",
       "gsk2126458                                             NaN     NaN   \n",
       "ibet762                                                NaN     NaN   \n",
       "jq1                                Not Clinically Relevant   False   \n",
       "jq12                                                   NaN   False   \n",
       "linsitinib                                IGF-1R inhibitor    True   \n",
       "nvp-bgt226                                             NaN     NaN   \n",
       "olaparib                                    PARP Inhibitor    True   \n",
       "palbociclib                               CDK4/6 inhibitor   False   \n",
       "panobinostat                                HDAC inhibitor   False   \n",
       "prexacertib                                            NaN     NaN   \n",
       "primamet                                               NaN     NaN   \n",
       "rucaparib              PARP inhibitor, inhibits DNA repair    True   \n",
       "sb525334                                               NaN     NaN   \n",
       "trichostatin a                                         NaN     NaN   \n",
       "tw-37                              Not Clinically Relevant   False   \n",
       "vx-702                             Not Clinically Relevant    True   \n",
       "\n",
       "               ICB-1299-Val  MB002 MB002-Val  MB009 MB009-Val RCMB28  \\\n",
       "abt-737                  --   True      True   True        --   True   \n",
       "alisertib                 F   True         F   True        --   True   \n",
       "apicidin                 --   True      True   True        --   True   \n",
       "barasertib                F   True         F   True        --   True   \n",
       "bkm120                   --    NaN        --    NaN      True    NaN   \n",
       "bx-912                   --   True      True   True        --   True   \n",
       "dinaciclib               --  False      True  False        --  False   \n",
       "gsk1070916             True   True      True   True        --   True   \n",
       "gsk126                   --    NaN         F    NaN        --    NaN   \n",
       "gsk2126458               --    NaN        --    NaN      True    NaN   \n",
       "ibet762                   F    NaN         F    NaN        --    NaN   \n",
       "jq1                       F  False      True  False        --  False   \n",
       "jq12                    NaN  False       NaN  False       NaN  False   \n",
       "linsitinib               --   True      True   True        --   True   \n",
       "nvp-bgt226               --    NaN        --    NaN      True    NaN   \n",
       "olaparib                 --  False         F  False        --  False   \n",
       "palbociclib              --  False      True  False        --  False   \n",
       "panobinostat             --  False      True  False        --  False   \n",
       "prexacertib              --    NaN      True    NaN        --    NaN   \n",
       "primamet                 --    NaN      True    NaN      True    NaN   \n",
       "rucaparib                --  False         F  False        --   True   \n",
       "sb525334                 --    NaN         F    NaN        --    NaN   \n",
       "trichostatin a           --    NaN      True    NaN        --    NaN   \n",
       "tw-37                    --  False      True  False        --  False   \n",
       "vx-702                   --   True         F   True        --   True   \n",
       "\n",
       "                  ...     BT084-Val RCMB18 RCMB18-Val  MED1712 MED1712-Val  \\\n",
       "abt-737           ...          True   True       True     True        True   \n",
       "alisertib         ...             F   True          F     True           F   \n",
       "apicidin          ...          True   True       True     True        True   \n",
       "barasertib        ...             F   True          F     True           F   \n",
       "bkm120            ...             F    NaN          F      NaN        True   \n",
       "bx-912            ...             F   True          F     True        True   \n",
       "dinaciclib        ...             F  False          F    False        True   \n",
       "gsk1070916        ...          True   True          F     True        True   \n",
       "gsk126            ...             F    NaN          F      NaN           F   \n",
       "gsk2126458        ...          True    NaN          F      NaN        True   \n",
       "ibet762           ...             F    NaN          F      NaN           F   \n",
       "jq1               ...             F  False          F    False           F   \n",
       "jq12              ...           NaN  False        NaN    False         NaN   \n",
       "linsitinib        ...             F   True          F     True           F   \n",
       "nvp-bgt226        ...          True    NaN       True      NaN        True   \n",
       "olaparib          ...             F   True          F     True           F   \n",
       "palbociclib       ...             F  False          F    False           F   \n",
       "panobinostat      ...          True  False       True    False        True   \n",
       "prexacertib       ...             F    NaN          F      NaN        True   \n",
       "primamet          ...          True    NaN       True      NaN        True   \n",
       "rucaparib         ...             F   True          F     True           F   \n",
       "sb525334          ...             F    NaN          F      NaN           F   \n",
       "trichostatin a    ...          True    NaN       True      NaN        True   \n",
       "tw-37             ...          True  False       True    False        True   \n",
       "vx-702            ...             F   True          F     True           F   \n",
       "\n",
       "               RCMB24 RCMB24-Val RCMB32 RCMB32-Val HepaRG-Val  \n",
       "abt-737          True       True   True       True          F  \n",
       "alisertib       False          F   True          F          F  \n",
       "apicidin         True       True   True         --       True  \n",
       "barasertib       True          F   True          F          F  \n",
       "bkm120            NaN       True    NaN       True       True  \n",
       "bx-912           True          F   True         --          F  \n",
       "dinaciclib      False          F  False          F          F  \n",
       "gsk1070916       True         --   True         --          F  \n",
       "gsk126            NaN          F    NaN          F          F  \n",
       "gsk2126458        NaN       True    NaN       True       True  \n",
       "ibet762           NaN          F    NaN          F          F  \n",
       "jq1             False       True  False       True          F  \n",
       "jq12            False        NaN  False        NaN        NaN  \n",
       "linsitinib       True       True   True         --          F  \n",
       "nvp-bgt226        NaN       True    NaN       True       True  \n",
       "olaparib         True          F   True         --          F  \n",
       "palbociclib     False       True  False       True       True  \n",
       "panobinostat    False       True  False       True       True  \n",
       "prexacertib       NaN          F    NaN       True          F  \n",
       "primamet          NaN       True    NaN       True          F  \n",
       "rucaparib        True          F   True         --          F  \n",
       "sb525334          NaN          F    NaN         --          F  \n",
       "trichostatin a    NaN       True    NaN       True       True  \n",
       "tw-37           False       True  False         --          F  \n",
       "vx-702           True          F   True         --          F  \n",
       "\n",
       "[25 rows x 38 columns]"
      ]
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "concatenated = pd.concat([val_df,exact_drugs],axis=1)\n",
    "concatenated.loc[:,new_cols].to_excel('drugs_validated_exact_PDX.xlsx')\n",
    "concatenated.loc[:,new_cols]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T19:49:04.590192Z",
     "start_time": "2019-05-17T19:49:04.482147Z"
    }
   },
   "outputs": [],
   "source": [
    "concatenated.loc[:,g3].to_excel('drugs_validated_exact_PDX_g3.xlsx')\n",
    "concatenated.loc[:,g4].to_excel('drugs_validated_exact_PDX_g4.xlsx')\n",
    "concatenated.loc[:,shh].to_excel('drugs_validated_exact_PDX_shh.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 176,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:58:42.074411Z",
     "start_time": "2019-05-17T23:58:41.681458Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>CATEGORY</th>\n",
       "      <th>DRUG</th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED511</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>HEPARG</th>\n",
       "      <th>...</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>HEPARG.1</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>BT084</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bkm120</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk126</th>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk2126458</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nvp-bgt226</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>primamet</th>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>prexacertib</th>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb525334</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>trichostatin a</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ibet762</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>24 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      CATEGORY            DRUG ICB1299  MB002  \\\n",
       "drug                                                                            \n",
       "abt-737                         BCL2 inhibitor         ABT-737     NaN   True   \n",
       "alisertib                     Aurora inhibitor       Alisertib   False  False   \n",
       "apicidin                        HDAC inhibitor        Apicidin     NaN   True   \n",
       "bkm120                 p13k/mTOR/Akt inhibitor          BKM120     NaN    NaN   \n",
       "barasertib                    Aurora inhibitor      Barasertib   False  False   \n",
       "dinaciclib      CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib     NaN   True   \n",
       "gsk1070916                    Aurora inhibitor      GSK1070916    True   True   \n",
       "gsk126                          EZH2 inhibitor          GSK126     NaN  False   \n",
       "gsk2126458             p13k/mTOR/Akt inhibitor      GSK2126458     NaN    NaN   \n",
       "jq1                              BET inhibitor             JQ1   False   True   \n",
       "linsitinib                     PARP Inhibitors      Linsitinib     NaN   True   \n",
       "nvp-bgt226             p13k/mTOR/Akt inhibitor      NVP-BGT226     NaN    NaN   \n",
       "olaparib                       PARP Inhibitors        Olaparib     NaN  False   \n",
       "primamet                         p53 activator        PRIMAmet     NaN   True   \n",
       "palbociclib     CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib     NaN   True   \n",
       "panobinostat                    HDAC inhibitor    Panobinostat     NaN   True   \n",
       "prexacertib                      CHK inhibitor     Prexacertib     NaN   True   \n",
       "rucaparib                      PARP Inhibitors       Rucaparib     NaN  False   \n",
       "sb525334                             TGFbetaR1        SB525334     NaN  False   \n",
       "tw-37                           BCL2 inhibitor           TW-37     NaN   True   \n",
       "trichostatin a                  HDAC inhibitor  Trichostatin A     NaN   True   \n",
       "bx-912                          BCL2 inhibitor          bx-912     NaN   True   \n",
       "ibet762                          BET inhibitor         iBET762   False  False   \n",
       "vx-702                               TGFbetaR1          vx-702     NaN  False   \n",
       "\n",
       "               MB009  RCMB28  MED211  MED511  ICB1572  HEPARG  ...   DMB006  \\\n",
       "drug                                                           ...            \n",
       "abt-737          NaN    True    True    True     True   False  ...    False   \n",
       "alisertib        NaN   False    True   False     True   False  ...    False   \n",
       "apicidin         NaN    True    True    True     True    True  ...     True   \n",
       "bkm120          True    True    True    True     True    True  ...    False   \n",
       "barasertib       NaN   False    True   False     True   False  ...    False   \n",
       "dinaciclib       NaN   False   False    True     True   False  ...    False   \n",
       "gsk1070916       NaN    True    True    True     True   False  ...     True   \n",
       "gsk126           NaN   False    True   False     True   False  ...     True   \n",
       "gsk2126458      True    True    True    True     True    True  ...     True   \n",
       "jq1              NaN   False    True    True     True   False  ...    False   \n",
       "linsitinib       NaN    True    True    True     True   False  ...    False   \n",
       "nvp-bgt226      True    True    True    True     True    True  ...     True   \n",
       "olaparib         NaN   False    True   False     True   False  ...    False   \n",
       "primamet        True    True    True    True     True   False  ...     True   \n",
       "palbociclib      NaN    True    True    True     True    True  ...    False   \n",
       "panobinostat     NaN    True    True    True     True    True  ...     True   \n",
       "prexacertib      NaN   False    True    True     True   False  ...    False   \n",
       "rucaparib        NaN   False    True   False    False   False  ...    False   \n",
       "sb525334         NaN   False   False   False     True   False  ...    False   \n",
       "tw-37            NaN    True    True    True     True   False  ...     True   \n",
       "trichostatin a   NaN    True    True    True     True    True  ...     True   \n",
       "bx-912           NaN    True    True    True     True   False  ...    False   \n",
       "ibet762          NaN   False    True   False     True   False  ...    False   \n",
       "vx-702           NaN   False   False   False    False   False  ...    False   \n",
       "\n",
       "                RCMB38  ICB1487  HEPARG.1  ICB984  BT084  RCMB18  MED1712  \\\n",
       "drug                                                                        \n",
       "abt-737           True     True     False    True   True    True     True   \n",
       "alisertib        False    False     False   False  False   False    False   \n",
       "apicidin          True     True      True    True   True    True     True   \n",
       "bkm120            True    False      True    True  False   False     True   \n",
       "barasertib       False    False     False   False  False   False    False   \n",
       "dinaciclib       False    False     False   False  False   False     True   \n",
       "gsk1070916        True     True     False    True   True   False     True   \n",
       "gsk126           False     True     False   False  False   False    False   \n",
       "gsk2126458        True     True      True    True   True   False     True   \n",
       "jq1              False    False     False   False  False   False    False   \n",
       "linsitinib       False    False     False   False  False   False    False   \n",
       "nvp-bgt226        True     True      True    True   True    True     True   \n",
       "olaparib         False    False     False   False  False   False    False   \n",
       "primamet          True     True     False    True   True    True     True   \n",
       "palbociclib      False    False      True    True  False   False    False   \n",
       "panobinostat      True     True      True    True   True    True     True   \n",
       "prexacertib      False    False     False    True  False   False     True   \n",
       "rucaparib        False    False     False   False  False   False    False   \n",
       "sb525334         False    False     False   False  False   False    False   \n",
       "tw-37             True     True     False    True   True    True     True   \n",
       "trichostatin a    True     True      True    True   True    True     True   \n",
       "bx-912           False    False     False   False  False   False     True   \n",
       "ibet762          False    False     False   False  False   False    False   \n",
       "vx-702           False    False     False   False  False   False    False   \n",
       "\n",
       "                RCMB24 RCMB32  \n",
       "drug                           \n",
       "abt-737           True   True  \n",
       "alisertib        False  False  \n",
       "apicidin          True    NaN  \n",
       "bkm120            True   True  \n",
       "barasertib       False  False  \n",
       "dinaciclib       False  False  \n",
       "gsk1070916         NaN    NaN  \n",
       "gsk126           False  False  \n",
       "gsk2126458        True   True  \n",
       "jq1               True   True  \n",
       "linsitinib        True    NaN  \n",
       "nvp-bgt226        True   True  \n",
       "olaparib         False    NaN  \n",
       "primamet          True   True  \n",
       "palbociclib       True   True  \n",
       "panobinostat      True   True  \n",
       "prexacertib      False   True  \n",
       "rucaparib        False    NaN  \n",
       "sb525334         False    NaN  \n",
       "tw-37             True    NaN  \n",
       "trichostatin a    True   True  \n",
       "bx-912           False    NaN  \n",
       "ibet762          False  False  \n",
       "vx-702           False    NaN  \n",
       "\n",
       "[24 rows x 21 columns]"
      ]
     },
     "execution_count": 176,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_df = pd.read_excel('data/preprocessed/Drug validation summary.xlsx',sheet_name='Fig2_summary_to_read')\n",
    "val_df.columns = [i+'-Val' for i in val_df.columns]\n",
    "val_df['drug'] = val_df['Drug-Val'].str.lower()\n",
    "val_df.index = val_df['drug']\n",
    "val_df = val_df.drop('drug',axis=1)\n",
    "val_df = val_df.sort_values(by='Drug-Val')\n",
    "val_df.columns = [i.strip('-Val').replace('-','').upper() for i in val_df.columns]\n",
    "val_df = val_df.replace(to_replace='F',value=False)\n",
    "val_df = val_df.replace(to_replace='T',value=True)\n",
    "val_df = val_df.replace(to_replace='False',value=False)\n",
    "val_df = val_df.replace(to_replace='True',value=True)\n",
    "val_df = val_df.replace(to_replace='--',value=np.nan)\n",
    "val_df = val_df.replace(to_replace='NaN',value=np.nan)\n",
    "val_df\n",
    "val_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:26:45.303836Z",
     "start_time": "2019-05-17T23:26:45.249931Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>CATEGORY</th>\n",
       "      <th>DRUG</th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED511</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>HEPARG</th>\n",
       "      <th>...</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>ICB1487</th>\n",
       "      <th>HEPARG.1</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>BT084</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bkm120</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk126</th>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk2126458</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nvp-bgt226</th>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>primamet</th>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>prexacertib</th>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb525334</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>trichostatin a</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>T</td>\n",
       "      <td>T</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ibet762</th>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>24 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      CATEGORY            DRUG ICB1299  MB002  \\\n",
       "drug                                                                            \n",
       "abt-737                         BCL2 inhibitor         ABT-737     NaN   True   \n",
       "alisertib                     Aurora inhibitor       Alisertib   False  False   \n",
       "apicidin                        HDAC inhibitor        Apicidin     NaN   True   \n",
       "bkm120                 p13k/mTOR/Akt inhibitor          BKM120     NaN    NaN   \n",
       "barasertib                    Aurora inhibitor      Barasertib   False  False   \n",
       "dinaciclib      CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib     NaN   True   \n",
       "gsk1070916                    Aurora inhibitor      GSK1070916    True   True   \n",
       "gsk126                          EZH2 inhibitor          GSK126     NaN  False   \n",
       "gsk2126458             p13k/mTOR/Akt inhibitor      GSK2126458     NaN    NaN   \n",
       "jq1                              BET inhibitor             JQ1   False   True   \n",
       "linsitinib                     PARP Inhibitors      Linsitinib     NaN   True   \n",
       "nvp-bgt226             p13k/mTOR/Akt inhibitor      NVP-BGT226     NaN    NaN   \n",
       "olaparib                       PARP Inhibitors        Olaparib     NaN  False   \n",
       "primamet                         p53 activator        PRIMAmet     NaN   True   \n",
       "palbociclib     CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib     NaN   True   \n",
       "panobinostat                    HDAC inhibitor    Panobinostat     NaN   True   \n",
       "prexacertib                      CHK inhibitor     Prexacertib     NaN   True   \n",
       "rucaparib                      PARP Inhibitors       Rucaparib     NaN  False   \n",
       "sb525334                             TGFbetaR1        SB525334     NaN  False   \n",
       "tw-37                           BCL2 inhibitor           TW-37     NaN   True   \n",
       "trichostatin a                  HDAC inhibitor  Trichostatin A     NaN   True   \n",
       "bx-912                          BCL2 inhibitor          bx-912     NaN   True   \n",
       "ibet762                          BET inhibitor         iBET762   False  False   \n",
       "vx-702                               TGFbetaR1          vx-702     NaN  False   \n",
       "\n",
       "               MB009  RCMB28 MED211 MED511  ICB1572  HEPARG  ...   DMB006  \\\n",
       "drug                                                         ...            \n",
       "abt-737          NaN    True   True   True     True   False  ...    False   \n",
       "alisertib        NaN   False   True  False     True   False  ...    False   \n",
       "apicidin         NaN    True   True   True     True    True  ...     True   \n",
       "bkm120          True    True   True   True     True    True  ...    False   \n",
       "barasertib       NaN   False   True  False     True   False  ...    False   \n",
       "dinaciclib       NaN   False  False   True     True   False  ...    False   \n",
       "gsk1070916       NaN    True   True   True     True   False  ...     True   \n",
       "gsk126           NaN   False   True  False     True   False  ...     True   \n",
       "gsk2126458      True    True   True   True     True    True  ...     True   \n",
       "jq1              NaN   False   True   True     True   False  ...    False   \n",
       "linsitinib       NaN    True   True   True     True   False  ...    False   \n",
       "nvp-bgt226      True    True   True   True     True    True  ...     True   \n",
       "olaparib         NaN   False   True  False     True   False  ...    False   \n",
       "primamet        True    True   True   True     True   False  ...     True   \n",
       "palbociclib      NaN    True   True   True     True    True  ...    False   \n",
       "panobinostat     NaN    True   True   True     True    True  ...     True   \n",
       "prexacertib      NaN   False   True   True     True   False  ...    False   \n",
       "rucaparib        NaN   False   True  False    False   False  ...    False   \n",
       "sb525334         NaN   False  False  False     True   False  ...    False   \n",
       "tw-37            NaN    True      T      T     True   False  ...     True   \n",
       "trichostatin a   NaN    True   True   True     True    True  ...     True   \n",
       "bx-912           NaN    True      T      T     True   False  ...    False   \n",
       "ibet762          NaN   False   True  False     True   False  ...    False   \n",
       "vx-702           NaN   False  False  False    False   False  ...    False   \n",
       "\n",
       "                RCMB38  ICB1487  HEPARG.1  ICB984  BT084  RCMB18  MED1712  \\\n",
       "drug                                                                        \n",
       "abt-737           True     True     False    True   True    True     True   \n",
       "alisertib        False    False     False   False  False   False    False   \n",
       "apicidin          True     True      True    True   True    True     True   \n",
       "bkm120            True    False      True    True  False   False     True   \n",
       "barasertib       False    False     False   False  False   False    False   \n",
       "dinaciclib       False    False     False   False  False   False     True   \n",
       "gsk1070916        True     True     False    True   True   False     True   \n",
       "gsk126           False     True     False   False  False   False    False   \n",
       "gsk2126458        True     True      True    True   True   False     True   \n",
       "jq1              False    False     False   False  False   False    False   \n",
       "linsitinib       False    False     False   False  False   False    False   \n",
       "nvp-bgt226        True     True      True    True   True    True     True   \n",
       "olaparib         False    False     False   False  False   False    False   \n",
       "primamet          True     True     False    True   True    True     True   \n",
       "palbociclib      False    False      True    True  False   False    False   \n",
       "panobinostat      True     True      True    True   True    True     True   \n",
       "prexacertib      False    False     False    True  False   False     True   \n",
       "rucaparib        False    False     False   False  False   False    False   \n",
       "sb525334         False    False     False   False  False   False    False   \n",
       "tw-37             True     True     False    True   True    True     True   \n",
       "trichostatin a    True     True      True    True   True    True     True   \n",
       "bx-912           False    False     False   False  False   False     True   \n",
       "ibet762          False    False     False   False  False   False    False   \n",
       "vx-702           False    False     False   False  False   False    False   \n",
       "\n",
       "                RCMB24 RCMB32  \n",
       "drug                           \n",
       "abt-737           True   True  \n",
       "alisertib        False  False  \n",
       "apicidin          True    NaN  \n",
       "bkm120            True   True  \n",
       "barasertib       False  False  \n",
       "dinaciclib       False  False  \n",
       "gsk1070916         NaN    NaN  \n",
       "gsk126           False  False  \n",
       "gsk2126458        True   True  \n",
       "jq1               True   True  \n",
       "linsitinib        True    NaN  \n",
       "nvp-bgt226        True   True  \n",
       "olaparib         False    NaN  \n",
       "primamet          True   True  \n",
       "palbociclib       True   True  \n",
       "panobinostat      True   True  \n",
       "prexacertib      False   True  \n",
       "rucaparib        False    NaN  \n",
       "sb525334         False    NaN  \n",
       "tw-37             True    NaN  \n",
       "trichostatin a    True   True  \n",
       "bx-912           False    NaN  \n",
       "ibet762          False  False  \n",
       "vx-702           False    NaN  \n",
       "\n",
       "[24 rows x 21 columns]"
      ]
     },
     "execution_count": 135,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:59:06.493588Z",
     "start_time": "2019-05-17T23:59:06.439352Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>MED1911</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED411</th>\n",
       "      <th>RCMB20</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>RCMB40</th>\n",
       "      <th>...</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>BT084</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>moa</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>PARP Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>16 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              ICB1299  ICB1572  MB002  MB009  MED1911  MED211  MED411  RCMB20  \\\n",
       "Name                                                                            \n",
       "abt-737          True     True   True   True     True    True    True    True   \n",
       "alisertib        True     True   True   True     True    True    True    True   \n",
       "apicidin         True     True   True   True     True    True    True    True   \n",
       "barasertib       True     True   True   True     True    True    True    True   \n",
       "bx-912           True     True   True   True     True    True    True    True   \n",
       "dinaciclib      False    False  False  False    False   False   False   False   \n",
       "gsk1070916       True     True   True   True     True    True    True    True   \n",
       "jq1             False    False  False  False    False   False   False   False   \n",
       "jq12            False    False  False  False    False   False   False   False   \n",
       "linsitinib       True     True   True   True     True    True    True    True   \n",
       "olaparib         True    False  False  False     True   False    True   False   \n",
       "palbociclib     False    False  False  False    False   False   False   False   \n",
       "panobinostat    False    False  False  False    False   False   False   False   \n",
       "rucaparib        True     True  False  False     True    True    True   False   \n",
       "tw-37           False    False  False  False    False   False   False   False   \n",
       "vx-702           True     True   True   True     True    True    True    True   \n",
       "\n",
       "              RCMB28  RCMB40                     ...                      \\\n",
       "Name                                             ...                       \n",
       "abt-737         True    True                     ...                       \n",
       "alisertib       True    True                     ...                       \n",
       "apicidin        True    True                     ...                       \n",
       "barasertib      True    True                     ...                       \n",
       "bx-912          True    True                     ...                       \n",
       "dinaciclib     False   False                     ...                       \n",
       "gsk1070916      True    True                     ...                       \n",
       "jq1            False   False                     ...                       \n",
       "jq12           False   False                     ...                       \n",
       "linsitinib      True    True                     ...                       \n",
       "olaparib       False    True                     ...                       \n",
       "palbociclib    False   False                     ...                       \n",
       "panobinostat   False   False                     ...                       \n",
       "rucaparib       True    True                     ...                       \n",
       "tw-37          False   False                     ...                       \n",
       "vx-702          True    True                     ...                       \n",
       "\n",
       "              MED2312  RCMB38  DMB006  MED1712  RCMB24  RCMB32  BT084  ICB984  \\\n",
       "Name                                                                            \n",
       "abt-737          True    True    True     True    True    True   True    True   \n",
       "alisertib        True    True    True     True   False    True   True    True   \n",
       "apicidin         True    True    True     True    True    True   True    True   \n",
       "barasertib       True    True    True     True    True    True   True    True   \n",
       "bx-912           True    True    True     True    True    True   True   False   \n",
       "dinaciclib      False   False   False    False   False   False  False   False   \n",
       "gsk1070916       True    True    True     True    True    True   True    True   \n",
       "jq1             False   False   False    False   False   False  False   False   \n",
       "jq12            False   False   False    False   False   False  False   False   \n",
       "linsitinib       True    True    True     True    True    True   True    True   \n",
       "olaparib         True   False   False     True    True    True   True    True   \n",
       "palbociclib     False   False   False    False   False   False  False   False   \n",
       "panobinostat    False   False   False    False   False   False  False   False   \n",
       "rucaparib        True    True    True     True    True    True   True    True   \n",
       "tw-37           False   False   False    False   False   False  False   False   \n",
       "vx-702           True    True    True     True    True    True   True    True   \n",
       "\n",
       "              RCMB18                                         moa  \n",
       "Name                                                              \n",
       "abt-737         True                      Bcl-2/Bcl-xL inhibitor  \n",
       "alisertib       True                   Aurora A kinase inhibitor  \n",
       "apicidin        True                     Not Clinically Relevant  \n",
       "barasertib      True  highly selective Aurora B kinase inhibitor  \n",
       "bx-912          True                     Not Clinically Relevant  \n",
       "dinaciclib     False        CDK inhibitor, esp CDK1, 2, 5, and 9  \n",
       "gsk1070916      True                     Not Clinically Relevant  \n",
       "jq1            False                     Not Clinically Relevant  \n",
       "jq12           False                                         NaN  \n",
       "linsitinib      True                            IGF-1R inhibitor  \n",
       "olaparib        True                              PARP Inhibitor  \n",
       "palbociclib    False                            CDK4/6 inhibitor  \n",
       "panobinostat   False                              HDAC inhibitor  \n",
       "rucaparib       True         PARP inhibitor, inhibits DNA repair  \n",
       "tw-37          False                     Not Clinically Relevant  \n",
       "vx-702          True                     Not Clinically Relevant  \n",
       "\n",
       "[16 rows x 21 columns]"
      ]
     },
     "execution_count": 177,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exact_drugs = exact_drugs.sort_index()\n",
    "exact_drugs = exact_drugs.replace(to_replace='False',value=False)\n",
    "exact_drugs = exact_drugs.replace(to_replace='True',value=True)\n",
    "exact_drugs = exact_drugs.replace(to_replace='NaN',value=np.nan)\n",
    "exact_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:38:06.074355Z",
     "start_time": "2019-05-17T23:38:06.069232Z"
    }
   },
   "outputs": [],
   "source": [
    "val_g3 =['ICB1299',\n",
    "    'MB002',\n",
    "    'MB009',\n",
    "    'RCMB28',\n",
    "    'MED211',\n",
    "    'MED511',\n",
    "    'ICB1572',]\n",
    "val_g4 = ['MED2312',\n",
    "       'DMB006',\n",
    "       'RCMB38',\n",
    "       'ICB1487']\n",
    "val_shh = ['ICB984',\n",
    "       'BT084',\n",
    "       'RCMB18',\n",
    "       'MED1712',\n",
    "       'RCMB24',\n",
    "       'RCMB32',]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:36:43.848006Z",
     "start_time": "2019-05-17T23:36:43.844131Z"
    }
   },
   "outputs": [],
   "source": [
    "pre_g3 = 'ICB1299\tICB1572\tMB002\tMB009\tMED1911\tMED211\tMED411\tRCMB20\tRCMB28\tRCMB40'.split('\\t')\n",
    "pre_g4 = 'ICB1487\tMED2312\tRCMB38\tDMB006'.split('\\t')\n",
    "pre_shh = 'MED1712\tRCMB24\tRCMB32\tBT084\tICB984\tRCMB18'.split('\\t')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 178,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:59:23.879182Z",
     "start_time": "2019-05-17T23:59:23.769842Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ICB1299</th>\n",
       "      <th>ICB1572</th>\n",
       "      <th>MB002</th>\n",
       "      <th>MB009</th>\n",
       "      <th>MED1911</th>\n",
       "      <th>MED211</th>\n",
       "      <th>MED411</th>\n",
       "      <th>RCMB20</th>\n",
       "      <th>RCMB28</th>\n",
       "      <th>RCMB40</th>\n",
       "      <th>...</th>\n",
       "      <th>MED2312</th>\n",
       "      <th>RCMB38</th>\n",
       "      <th>DMB006</th>\n",
       "      <th>MED1712</th>\n",
       "      <th>RCMB24</th>\n",
       "      <th>RCMB32</th>\n",
       "      <th>BT084</th>\n",
       "      <th>ICB984</th>\n",
       "      <th>RCMB18</th>\n",
       "      <th>moa</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>PARP Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>...</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>16 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              ICB1299  ICB1572  MB002  MB009  MED1911  MED211  MED411  RCMB20  \\\n",
       "Name                                                                            \n",
       "abt-737          True     True   True   True     True    True    True    True   \n",
       "alisertib        True     True   True   True     True    True    True    True   \n",
       "apicidin         True     True   True   True     True    True    True    True   \n",
       "barasertib       True     True   True   True     True    True    True    True   \n",
       "bx-912           True     True   True   True     True    True    True    True   \n",
       "dinaciclib      False    False  False  False    False   False   False   False   \n",
       "gsk1070916       True     True   True   True     True    True    True    True   \n",
       "jq1             False    False  False  False    False   False   False   False   \n",
       "jq12            False    False  False  False    False   False   False   False   \n",
       "linsitinib       True     True   True   True     True    True    True    True   \n",
       "olaparib         True    False  False  False     True   False    True   False   \n",
       "palbociclib     False    False  False  False    False   False   False   False   \n",
       "panobinostat    False    False  False  False    False   False   False   False   \n",
       "rucaparib        True     True  False  False     True    True    True   False   \n",
       "tw-37           False    False  False  False    False   False   False   False   \n",
       "vx-702           True     True   True   True     True    True    True    True   \n",
       "\n",
       "              RCMB28  RCMB40                     ...                      \\\n",
       "Name                                             ...                       \n",
       "abt-737         True    True                     ...                       \n",
       "alisertib       True    True                     ...                       \n",
       "apicidin        True    True                     ...                       \n",
       "barasertib      True    True                     ...                       \n",
       "bx-912          True    True                     ...                       \n",
       "dinaciclib     False   False                     ...                       \n",
       "gsk1070916      True    True                     ...                       \n",
       "jq1            False   False                     ...                       \n",
       "jq12           False   False                     ...                       \n",
       "linsitinib      True    True                     ...                       \n",
       "olaparib       False    True                     ...                       \n",
       "palbociclib    False   False                     ...                       \n",
       "panobinostat   False   False                     ...                       \n",
       "rucaparib       True    True                     ...                       \n",
       "tw-37          False   False                     ...                       \n",
       "vx-702          True    True                     ...                       \n",
       "\n",
       "              MED2312  RCMB38  DMB006  MED1712  RCMB24  RCMB32  BT084  ICB984  \\\n",
       "Name                                                                            \n",
       "abt-737          True    True    True     True    True    True   True    True   \n",
       "alisertib        True    True    True     True   False    True   True    True   \n",
       "apicidin         True    True    True     True    True    True   True    True   \n",
       "barasertib       True    True    True     True    True    True   True    True   \n",
       "bx-912           True    True    True     True    True    True   True   False   \n",
       "dinaciclib      False   False   False    False   False   False  False   False   \n",
       "gsk1070916       True    True    True     True    True    True   True    True   \n",
       "jq1             False   False   False    False   False   False  False   False   \n",
       "jq12            False   False   False    False   False   False  False   False   \n",
       "linsitinib       True    True    True     True    True    True   True    True   \n",
       "olaparib         True   False   False     True    True    True   True    True   \n",
       "palbociclib     False   False   False    False   False   False  False   False   \n",
       "panobinostat    False   False   False    False   False   False  False   False   \n",
       "rucaparib        True    True    True     True    True    True   True    True   \n",
       "tw-37           False   False   False    False   False   False  False   False   \n",
       "vx-702           True    True    True     True    True    True   True    True   \n",
       "\n",
       "              RCMB18                                         moa  \n",
       "Name                                                              \n",
       "abt-737         True                      Bcl-2/Bcl-xL inhibitor  \n",
       "alisertib       True                   Aurora A kinase inhibitor  \n",
       "apicidin        True                     Not Clinically Relevant  \n",
       "barasertib      True  highly selective Aurora B kinase inhibitor  \n",
       "bx-912          True                     Not Clinically Relevant  \n",
       "dinaciclib     False        CDK inhibitor, esp CDK1, 2, 5, and 9  \n",
       "gsk1070916      True                     Not Clinically Relevant  \n",
       "jq1            False                     Not Clinically Relevant  \n",
       "jq12           False                                         NaN  \n",
       "linsitinib      True                            IGF-1R inhibitor  \n",
       "olaparib        True                              PARP Inhibitor  \n",
       "palbociclib    False                            CDK4/6 inhibitor  \n",
       "panobinostat   False                              HDAC inhibitor  \n",
       "rucaparib       True         PARP inhibitor, inhibits DNA repair  \n",
       "tw-37          False                     Not Clinically Relevant  \n",
       "vx-702          True                     Not Clinically Relevant  \n",
       "\n",
       "[16 rows x 21 columns]"
      ]
     },
     "execution_count": 178,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "exact_drugs = pd.DataFrame()\n",
    "for drug in lower_drugs:\n",
    "    exact_drugs = exact_drugs.append(hits_per_pdf[hits_per_pdf.index.str.contains(drug,case=False)])\n",
    "exact_drugs['moa'] = all_pdx['moa'].reindex(lower_drugs)\n",
    "exact_drugs = exact_drugs.sort_index()\n",
    "exact_drugs = exact_drugs.replace(to_replace='False',value=False)\n",
    "exact_drugs = exact_drugs.replace(to_replace='True',value=True)\n",
    "exact_drugs = exact_drugs.replace(to_replace='NaN',value=np.nan)\n",
    "exact_drugs"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:36:58.311526Z",
     "start_time": "2019-05-17T23:36:58.308828Z"
    }
   },
   "source": [
    "### G3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 221,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:09:51.827583Z",
     "start_time": "2019-05-18T00:09:51.821316Z"
    }
   },
   "outputs": [],
   "source": [
    "val_df_g3 = val_df.loc[:,['CATEGORY','DRUG']+val_g3]\n",
    "pre_df_g3 = exact_drugs.loc[:,['moa']+pre_g3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 180,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:59:33.596741Z",
     "start_time": "2019-05-17T23:59:33.588784Z"
    }
   },
   "outputs": [],
   "source": [
    "# Subgroup effective drugs are defined as:\n",
    "# A criterion was needed for designating drug as effective or ineffective in each subgroup. \n",
    "# Requiring the same number of hits across subgroups would unduly favor larger subgroups, \n",
    "# while requiring the same fraction of hits would unduly favor smaller subgroups. \n",
    "# Instead we required that it be effective in enough samples to achieve a specified confidence that, \n",
    "# in the limit, the frequency of efficacy in similar samples would exceed a given threshold. \n",
    "# The required number of hits is k = F^{-1}(1- \\alpha; n, p), \n",
    "# where F(k;n,p)= \\sum_{i=0}^{k}{ \\binom{n}{i}p^i (1-p)^{(n-i)}} is the cumulative distribution of the \n",
    "# binomial distribution and n is the number of tumors of the subgroup in question. \n",
    "# We chose =0.05, corresponding to 95% confidence, and p=0.5. \n",
    "\n",
    "# **This required efficacy in 8 of 10 G3 tumors, 4 of 4 G4 tumors, and 5 of 6 SHH tumors,.**\n",
    "pre_min_hits = pd.Series(data=[8,4,5], index=['G3','G4','SHH'])\n",
    "pre_min_hits\n",
    "\n",
    "## More generally:\n",
    "# 10,9,8,7,6,5,4,3,2,1\n",
    "# 8,7,6,6,5,4,4,3,2,1\n",
    "min_hits={\n",
    "    10:8,\n",
    "    9:7,\n",
    "    8:6,\n",
    "    7:6,\n",
    "    6:5,\n",
    "    5:4,\n",
    "    4:4,\n",
    "    3:3,\n",
    "    2:2,\n",
    "    1:1\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 181,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T23:59:35.304104Z",
     "start_time": "2019-05-17T23:59:35.292886Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "CATEGORY    BCL2 inhibitor\n",
       "DRUG               ABT-737\n",
       "ICB1299                NaN\n",
       "MB002                 True\n",
       "MB009                  NaN\n",
       "RCMB28                True\n",
       "MED211                True\n",
       "MED511                True\n",
       "ICB1572               True\n",
       "Name: abt-737, dtype: object"
      ]
     },
     "execution_count": 181,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "row = val_df_g3.iloc[0,:]\n",
    "row"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 217,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:09:06.058397Z",
     "start_time": "2019-05-18T00:09:06.050302Z"
    }
   },
   "outputs": [],
   "source": [
    "min_hits={\n",
    "    10:8,\n",
    "    9:7,\n",
    "    8:6,\n",
    "    7:6,\n",
    "    6:5,\n",
    "    5:4,\n",
    "    4:4,\n",
    "    3:3,\n",
    "    2:2,\n",
    "    1:1\n",
    "}\n",
    "def subgroup_effective(row,cols):\n",
    "    pdxs = len(row[cols].dropna())\n",
    "    hits = sum(row[cols].dropna())\n",
    "    return hits >= min_hits[pdxs]\n",
    "\n",
    "# subgroup_effective(val_df_g3.iloc[,:],val_g3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 234,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:18:23.362672Z",
     "start_time": "2019-05-18T00:18:23.358998Z"
    }
   },
   "outputs": [],
   "source": [
    "def validate(row,col1,col2):\n",
    "    return row[col1]==row[col2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 244,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:26:29.800157Z",
     "start_time": "2019-05-18T00:26:29.689411Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>moa</th>\n",
       "      <th>CATEGORY</th>\n",
       "      <th>DRUG</th>\n",
       "      <th>G3_effective_val</th>\n",
       "      <th>G3_effective</th>\n",
       "      <th>Validated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bkm120</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk126</th>\n",
       "      <td>NaN</td>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk2126458</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ibet762</th>\n",
       "      <td>NaN</td>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nvp-bgt226</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitor</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>prexacertib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>primamet</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb525334</th>\n",
       "      <td>NaN</td>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>trichostatin a</th>\n",
       "      <td>NaN</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                       moa  \\\n",
       "abt-737                             Bcl-2/Bcl-xL inhibitor   \n",
       "alisertib                        Aurora A kinase inhibitor   \n",
       "apicidin                           Not Clinically Relevant   \n",
       "barasertib      highly selective Aurora B kinase inhibitor   \n",
       "bkm120                                                 NaN   \n",
       "bx-912                             Not Clinically Relevant   \n",
       "dinaciclib            CDK inhibitor, esp CDK1, 2, 5, and 9   \n",
       "gsk1070916                         Not Clinically Relevant   \n",
       "gsk126                                                 NaN   \n",
       "gsk2126458                                             NaN   \n",
       "ibet762                                                NaN   \n",
       "jq1                                Not Clinically Relevant   \n",
       "jq12                                                   NaN   \n",
       "linsitinib                                IGF-1R inhibitor   \n",
       "nvp-bgt226                                             NaN   \n",
       "olaparib                                    PARP Inhibitor   \n",
       "palbociclib                               CDK4/6 inhibitor   \n",
       "panobinostat                                HDAC inhibitor   \n",
       "prexacertib                                            NaN   \n",
       "primamet                                               NaN   \n",
       "rucaparib              PARP inhibitor, inhibits DNA repair   \n",
       "sb525334                                               NaN   \n",
       "trichostatin a                                         NaN   \n",
       "tw-37                              Not Clinically Relevant   \n",
       "vx-702                             Not Clinically Relevant   \n",
       "\n",
       "                                      CATEGORY            DRUG  \\\n",
       "abt-737                         BCL2 inhibitor         ABT-737   \n",
       "alisertib                     Aurora inhibitor       Alisertib   \n",
       "apicidin                        HDAC inhibitor        Apicidin   \n",
       "barasertib                    Aurora inhibitor      Barasertib   \n",
       "bkm120                 p13k/mTOR/Akt inhibitor          BKM120   \n",
       "bx-912                          BCL2 inhibitor          bx-912   \n",
       "dinaciclib      CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib   \n",
       "gsk1070916                    Aurora inhibitor      GSK1070916   \n",
       "gsk126                          EZH2 inhibitor          GSK126   \n",
       "gsk2126458             p13k/mTOR/Akt inhibitor      GSK2126458   \n",
       "ibet762                          BET inhibitor         iBET762   \n",
       "jq1                              BET inhibitor             JQ1   \n",
       "jq12                                       NaN             NaN   \n",
       "linsitinib                     PARP Inhibitors      Linsitinib   \n",
       "nvp-bgt226             p13k/mTOR/Akt inhibitor      NVP-BGT226   \n",
       "olaparib                       PARP Inhibitors        Olaparib   \n",
       "palbociclib     CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib   \n",
       "panobinostat                    HDAC inhibitor    Panobinostat   \n",
       "prexacertib                      CHK inhibitor     Prexacertib   \n",
       "primamet                         p53 activator        PRIMAmet   \n",
       "rucaparib                      PARP Inhibitors       Rucaparib   \n",
       "sb525334                             TGFbetaR1        SB525334   \n",
       "trichostatin a                  HDAC inhibitor  Trichostatin A   \n",
       "tw-37                           BCL2 inhibitor           TW-37   \n",
       "vx-702                               TGFbetaR1          vx-702   \n",
       "\n",
       "               G3_effective_val G3_effective  Validated  \n",
       "abt-737                    True         True       True  \n",
       "alisertib                 False         True      False  \n",
       "apicidin                   True         True       True  \n",
       "barasertib                False         True      False  \n",
       "bkm120                     True          NaN      False  \n",
       "bx-912                     True         True       True  \n",
       "dinaciclib                False        False       True  \n",
       "gsk1070916                 True         True       True  \n",
       "gsk126                    False          NaN      False  \n",
       "gsk2126458                 True          NaN      False  \n",
       "ibet762                   False          NaN      False  \n",
       "jq1                       False        False       True  \n",
       "jq12                        NaN        False      False  \n",
       "linsitinib                 True         True       True  \n",
       "nvp-bgt226                 True          NaN      False  \n",
       "olaparib                  False        False       True  \n",
       "palbociclib                True        False      False  \n",
       "panobinostat               True        False      False  \n",
       "prexacertib                True          NaN      False  \n",
       "primamet                   True          NaN      False  \n",
       "rucaparib                 False        False       True  \n",
       "sb525334                  False          NaN      False  \n",
       "trichostatin a             True          NaN      False  \n",
       "tw-37                      True        False      False  \n",
       "vx-702                    False         True      False  "
      ]
     },
     "execution_count": 244,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_df_g3 = val_df.loc[:,['CATEGORY','DRUG']+val_g3]\n",
    "pre_df_g3 = exact_drugs.loc[:,['moa']+pre_g3]\n",
    "val_df_g3['G3_effective_val'] = val_df_g3.apply(lambda x: subgroup_effective(x,val_g3),axis=1)\n",
    "# val_df_g3\n",
    "pre_df_g3['G3_effective'] = pre_df_g3.apply(lambda x: subgroup_effective(x,pre_g3),axis=1)\n",
    "# pre_df_g3\n",
    "g3_concat = pd.concat([val_df_g3.loc[:,['CATEGORY','DRUG','G3_effective_val']],pre_df_g3.loc[:,['G3_effective','moa']]],axis=1)\n",
    "g3_concat['Validated'] = g3_concat.apply(lambda x: validate(x,'G3_effective_val','G3_effective'),axis=1)\n",
    "g3_concat = g3_concat[['moa','CATEGORY','DRUG','G3_effective_val','G3_effective','Validated']]\n",
    "g3_concat"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:10:21.559016Z",
     "start_time": "2019-05-18T00:10:21.493213Z"
    }
   },
   "source": [
    "### G4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 245,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:26:46.363509Z",
     "start_time": "2019-05-18T00:26:46.252665Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>moa</th>\n",
       "      <th>CATEGORY</th>\n",
       "      <th>DRUG</th>\n",
       "      <th>G4_effective_val</th>\n",
       "      <th>G4_effective</th>\n",
       "      <th>Validated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bkm120</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk126</th>\n",
       "      <td>NaN</td>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk2126458</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ibet762</th>\n",
       "      <td>NaN</td>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nvp-bgt226</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitor</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>prexacertib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>primamet</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb525334</th>\n",
       "      <td>NaN</td>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>trichostatin a</th>\n",
       "      <td>NaN</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                       moa  \\\n",
       "abt-737                             Bcl-2/Bcl-xL inhibitor   \n",
       "alisertib                        Aurora A kinase inhibitor   \n",
       "apicidin                           Not Clinically Relevant   \n",
       "barasertib      highly selective Aurora B kinase inhibitor   \n",
       "bkm120                                                 NaN   \n",
       "bx-912                             Not Clinically Relevant   \n",
       "dinaciclib            CDK inhibitor, esp CDK1, 2, 5, and 9   \n",
       "gsk1070916                         Not Clinically Relevant   \n",
       "gsk126                                                 NaN   \n",
       "gsk2126458                                             NaN   \n",
       "ibet762                                                NaN   \n",
       "jq1                                Not Clinically Relevant   \n",
       "jq12                                                   NaN   \n",
       "linsitinib                                IGF-1R inhibitor   \n",
       "nvp-bgt226                                             NaN   \n",
       "olaparib                                    PARP Inhibitor   \n",
       "palbociclib                               CDK4/6 inhibitor   \n",
       "panobinostat                                HDAC inhibitor   \n",
       "prexacertib                                            NaN   \n",
       "primamet                                               NaN   \n",
       "rucaparib              PARP inhibitor, inhibits DNA repair   \n",
       "sb525334                                               NaN   \n",
       "trichostatin a                                         NaN   \n",
       "tw-37                              Not Clinically Relevant   \n",
       "vx-702                             Not Clinically Relevant   \n",
       "\n",
       "                                      CATEGORY            DRUG  \\\n",
       "abt-737                         BCL2 inhibitor         ABT-737   \n",
       "alisertib                     Aurora inhibitor       Alisertib   \n",
       "apicidin                        HDAC inhibitor        Apicidin   \n",
       "barasertib                    Aurora inhibitor      Barasertib   \n",
       "bkm120                 p13k/mTOR/Akt inhibitor          BKM120   \n",
       "bx-912                          BCL2 inhibitor          bx-912   \n",
       "dinaciclib      CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib   \n",
       "gsk1070916                    Aurora inhibitor      GSK1070916   \n",
       "gsk126                          EZH2 inhibitor          GSK126   \n",
       "gsk2126458             p13k/mTOR/Akt inhibitor      GSK2126458   \n",
       "ibet762                          BET inhibitor         iBET762   \n",
       "jq1                              BET inhibitor             JQ1   \n",
       "jq12                                       NaN             NaN   \n",
       "linsitinib                     PARP Inhibitors      Linsitinib   \n",
       "nvp-bgt226             p13k/mTOR/Akt inhibitor      NVP-BGT226   \n",
       "olaparib                       PARP Inhibitors        Olaparib   \n",
       "palbociclib     CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib   \n",
       "panobinostat                    HDAC inhibitor    Panobinostat   \n",
       "prexacertib                      CHK inhibitor     Prexacertib   \n",
       "primamet                         p53 activator        PRIMAmet   \n",
       "rucaparib                      PARP Inhibitors       Rucaparib   \n",
       "sb525334                             TGFbetaR1        SB525334   \n",
       "trichostatin a                  HDAC inhibitor  Trichostatin A   \n",
       "tw-37                           BCL2 inhibitor           TW-37   \n",
       "vx-702                               TGFbetaR1          vx-702   \n",
       "\n",
       "               G4_effective_val G4_effective  Validated  \n",
       "abt-737                   False         True      False  \n",
       "alisertib                 False         True      False  \n",
       "apicidin                   True         True       True  \n",
       "barasertib                False         True      False  \n",
       "bkm120                    False          NaN      False  \n",
       "bx-912                    False         True      False  \n",
       "dinaciclib                False        False       True  \n",
       "gsk1070916                 True         True       True  \n",
       "gsk126                    False          NaN      False  \n",
       "gsk2126458                 True          NaN      False  \n",
       "ibet762                   False          NaN      False  \n",
       "jq1                       False        False       True  \n",
       "jq12                        NaN        False      False  \n",
       "linsitinib                False         True      False  \n",
       "nvp-bgt226                 True          NaN      False  \n",
       "olaparib                  False        False       True  \n",
       "palbociclib               False        False       True  \n",
       "panobinostat               True        False      False  \n",
       "prexacertib               False          NaN      False  \n",
       "primamet                   True          NaN      False  \n",
       "rucaparib                 False         True      False  \n",
       "sb525334                  False          NaN      False  \n",
       "trichostatin a             True          NaN      False  \n",
       "tw-37                      True        False      False  \n",
       "vx-702                    False         True      False  "
      ]
     },
     "execution_count": 245,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_df_g4 = val_df.loc[:,['CATEGORY','DRUG']+val_g4]\n",
    "pre_df_g4 = exact_drugs.loc[:,['moa']+pre_g4]\n",
    "val_df_g4['G4_effective_val'] = val_df_g4.apply(lambda x: subgroup_effective(x,val_g4),axis=1)\n",
    "# val_df_g4\n",
    "pre_df_g4['G4_effective'] = pre_df_g4.apply(lambda x: subgroup_effective(x,pre_g4),axis=1)\n",
    "# pre_df_g4\n",
    "g4_concat = pd.concat([val_df_g4.loc[:,['CATEGORY','DRUG','G4_effective_val']],pre_df_g4.loc[:,['G4_effective','moa']]],axis=1)\n",
    "g4_concat['Validated'] = g4_concat.apply(lambda x: validate(x,'G4_effective_val','G4_effective'),axis=1)\n",
    "g4_concat = g4_concat[['moa','CATEGORY','DRUG','G4_effective_val','G4_effective','Validated']]\n",
    "g4_concat"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### SHH"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 246,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:27:01.502370Z",
     "start_time": "2019-05-18T00:27:01.398618Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>moa</th>\n",
       "      <th>CATEGORY</th>\n",
       "      <th>DRUG</th>\n",
       "      <th>SHH_effective_val</th>\n",
       "      <th>SHH_effective</th>\n",
       "      <th>Validated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>Bcl-2/Bcl-xL inhibitor</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>Aurora A kinase inhibitor</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Alisertib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Apicidin</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>barasertib</th>\n",
       "      <td>highly selective Aurora B kinase inhibitor</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>Barasertib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bkm120</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>BKM120</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bx-912</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>bx-912</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dinaciclib</th>\n",
       "      <td>CDK inhibitor, esp CDK1, 2, 5, and 9</td>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Dinaciclib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk1070916</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>Aurora inhibitor</td>\n",
       "      <td>GSK1070916</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk126</th>\n",
       "      <td>NaN</td>\n",
       "      <td>EZH2 inhibitor</td>\n",
       "      <td>GSK126</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gsk2126458</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>GSK2126458</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ibet762</th>\n",
       "      <td>NaN</td>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>iBET762</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq1</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BET inhibitor</td>\n",
       "      <td>JQ1</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>jq12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>linsitinib</th>\n",
       "      <td>IGF-1R inhibitor</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Linsitinib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nvp-bgt226</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p13k/mTOR/Akt inhibitor</td>\n",
       "      <td>NVP-BGT226</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>olaparib</th>\n",
       "      <td>PARP Inhibitor</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>palbociclib</th>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>CDK4/6 or CDK2,5,1,9 inhibitor</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>panobinostat</th>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Panobinostat</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>prexacertib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>Prexacertib</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>primamet</th>\n",
       "      <td>NaN</td>\n",
       "      <td>p53 activator</td>\n",
       "      <td>PRIMAmet</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>rucaparib</th>\n",
       "      <td>PARP inhibitor, inhibits DNA repair</td>\n",
       "      <td>PARP Inhibitors</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>sb525334</th>\n",
       "      <td>NaN</td>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>SB525334</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>trichostatin a</th>\n",
       "      <td>NaN</td>\n",
       "      <td>HDAC inhibitor</td>\n",
       "      <td>Trichostatin A</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tw-37</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>BCL2 inhibitor</td>\n",
       "      <td>TW-37</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>Not Clinically Relevant</td>\n",
       "      <td>TGFbetaR1</td>\n",
       "      <td>vx-702</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                       moa  \\\n",
       "abt-737                             Bcl-2/Bcl-xL inhibitor   \n",
       "alisertib                        Aurora A kinase inhibitor   \n",
       "apicidin                           Not Clinically Relevant   \n",
       "barasertib      highly selective Aurora B kinase inhibitor   \n",
       "bkm120                                                 NaN   \n",
       "bx-912                             Not Clinically Relevant   \n",
       "dinaciclib            CDK inhibitor, esp CDK1, 2, 5, and 9   \n",
       "gsk1070916                         Not Clinically Relevant   \n",
       "gsk126                                                 NaN   \n",
       "gsk2126458                                             NaN   \n",
       "ibet762                                                NaN   \n",
       "jq1                                Not Clinically Relevant   \n",
       "jq12                                                   NaN   \n",
       "linsitinib                                IGF-1R inhibitor   \n",
       "nvp-bgt226                                             NaN   \n",
       "olaparib                                    PARP Inhibitor   \n",
       "palbociclib                               CDK4/6 inhibitor   \n",
       "panobinostat                                HDAC inhibitor   \n",
       "prexacertib                                            NaN   \n",
       "primamet                                               NaN   \n",
       "rucaparib              PARP inhibitor, inhibits DNA repair   \n",
       "sb525334                                               NaN   \n",
       "trichostatin a                                         NaN   \n",
       "tw-37                              Not Clinically Relevant   \n",
       "vx-702                             Not Clinically Relevant   \n",
       "\n",
       "                                      CATEGORY            DRUG  \\\n",
       "abt-737                         BCL2 inhibitor         ABT-737   \n",
       "alisertib                     Aurora inhibitor       Alisertib   \n",
       "apicidin                        HDAC inhibitor        Apicidin   \n",
       "barasertib                    Aurora inhibitor      Barasertib   \n",
       "bkm120                 p13k/mTOR/Akt inhibitor          BKM120   \n",
       "bx-912                          BCL2 inhibitor          bx-912   \n",
       "dinaciclib      CDK4/6 or CDK2,5,1,9 inhibitor      Dinaciclib   \n",
       "gsk1070916                    Aurora inhibitor      GSK1070916   \n",
       "gsk126                          EZH2 inhibitor          GSK126   \n",
       "gsk2126458             p13k/mTOR/Akt inhibitor      GSK2126458   \n",
       "ibet762                          BET inhibitor         iBET762   \n",
       "jq1                              BET inhibitor             JQ1   \n",
       "jq12                                       NaN             NaN   \n",
       "linsitinib                     PARP Inhibitors      Linsitinib   \n",
       "nvp-bgt226             p13k/mTOR/Akt inhibitor      NVP-BGT226   \n",
       "olaparib                       PARP Inhibitors        Olaparib   \n",
       "palbociclib     CDK4/6 or CDK2,5,1,9 inhibitor     Palbociclib   \n",
       "panobinostat                    HDAC inhibitor    Panobinostat   \n",
       "prexacertib                      CHK inhibitor     Prexacertib   \n",
       "primamet                         p53 activator        PRIMAmet   \n",
       "rucaparib                      PARP Inhibitors       Rucaparib   \n",
       "sb525334                             TGFbetaR1        SB525334   \n",
       "trichostatin a                  HDAC inhibitor  Trichostatin A   \n",
       "tw-37                           BCL2 inhibitor           TW-37   \n",
       "vx-702                               TGFbetaR1          vx-702   \n",
       "\n",
       "               SHH_effective_val SHH_effective  Validated  \n",
       "abt-737                     True          True       True  \n",
       "alisertib                  False          True      False  \n",
       "apicidin                    True          True       True  \n",
       "barasertib                 False          True      False  \n",
       "bkm120                     False           NaN      False  \n",
       "bx-912                     False          True      False  \n",
       "dinaciclib                 False         False       True  \n",
       "gsk1070916                 False          True      False  \n",
       "gsk126                     False           NaN      False  \n",
       "gsk2126458                  True           NaN      False  \n",
       "ibet762                    False           NaN      False  \n",
       "jq1                        False         False       True  \n",
       "jq12                         NaN         False      False  \n",
       "linsitinib                 False          True      False  \n",
       "nvp-bgt226                  True           NaN      False  \n",
       "olaparib                   False          True      False  \n",
       "palbociclib                False         False       True  \n",
       "panobinostat                True         False      False  \n",
       "prexacertib                False           NaN      False  \n",
       "primamet                    True           NaN      False  \n",
       "rucaparib                  False          True      False  \n",
       "sb525334                   False           NaN      False  \n",
       "trichostatin a              True           NaN      False  \n",
       "tw-37                       True         False      False  \n",
       "vx-702                     False          True      False  "
      ]
     },
     "execution_count": 246,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_df_shh = val_df.loc[:,['CATEGORY','DRUG']+val_shh]\n",
    "pre_df_shh = exact_drugs.loc[:,['moa']+pre_shh]\n",
    "val_df_shh['SHH_effective_val'] = val_df_shh.apply(lambda x: subgroup_effective(x,val_shh),axis=1)\n",
    "# val_df_shh\n",
    "pre_df_shh['SHH_effective'] = pre_df_shh.apply(lambda x: subgroup_effective(x,pre_shh),axis=1)\n",
    "# pre_df_shh\n",
    "shh_concat = pd.concat([val_df_shh.loc[:,['CATEGORY','DRUG','SHH_effective_val']],pre_df_shh.loc[:,['SHH_effective','moa']]],axis=1)\n",
    "shh_concat['Validated'] = shh_concat.apply(lambda x: validate(x,'SHH_effective_val','SHH_effective'),axis=1)\n",
    "shh_concat = shh_concat[['moa','CATEGORY','DRUG','SHH_effective_val','SHH_effective','Validated']]\n",
    "shh_concat"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 249,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-18T00:33:43.073800Z",
     "start_time": "2019-05-18T00:33:43.001797Z"
    }
   },
   "outputs": [],
   "source": [
    "writer = pd.ExcelWriter('results/drug_validation_per_subgroup.xlsx', engine='xlsxwriter')\n",
    "\n",
    "# Convert the dataframe to an XlsxWriter Excel object.\n",
    "g3_concat.fillna('NaN').to_excel(writer, sheet_name='G3')\n",
    "g4_concat.fillna('NaN').to_excel(writer, sheet_name='G4')\n",
    "shh_concat.fillna('NaN').to_excel(writer, sheet_name='SHH')\n",
    "writer.save()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "heading_collapsed": true
   },
   "source": [
    "## failed attempts. Delete."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "hidden": true
   },
   "source": [
    "from:\n",
    "http://drugcentral.org/download\n",
    "on 2019-05-16 at 15:00:01\n",
    "http://unmtid-shinyapps.net/download/drug.target.interaction.tsv.gz\n",
    "\n",
    "we got the file."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T22:02:12.942493Z",
     "start_time": "2019-05-16T22:02:12.688977Z"
    },
    "hidden": true,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>DRUG_NAME</th>\n",
       "      <th>STRUCT_ID</th>\n",
       "      <th>TARGET_NAME</th>\n",
       "      <th>TARGET_CLASS</th>\n",
       "      <th>ACCESSION</th>\n",
       "      <th>GENE</th>\n",
       "      <th>SWISSPROT</th>\n",
       "      <th>ACT_VALUE</th>\n",
       "      <th>ACT_UNIT</th>\n",
       "      <th>ACT_TYPE</th>\n",
       "      <th>ACT_COMMENT</th>\n",
       "      <th>ACT_SOURCE</th>\n",
       "      <th>RELATION</th>\n",
       "      <th>MOA</th>\n",
       "      <th>MOA_SOURCE</th>\n",
       "      <th>ACT_SOURCE_URL</th>\n",
       "      <th>MOA_SOURCE_URL</th>\n",
       "      <th>ACTION_TYPE</th>\n",
       "      <th>TDL</th>\n",
       "      <th>ORGANISM</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Sodium channel protein type 4 subunit alpha</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>P35499</td>\n",
       "      <td>SCN4A</td>\n",
       "      <td>SCN4A_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>BLOCKER</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Cytochrome P450 2D6</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P10635</td>\n",
       "      <td>CYP2D6</td>\n",
       "      <td>CP2D6_HUMAN</td>\n",
       "      <td>6.706859</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>DRUGMATRIX: CYP450, 2D6 enzyme inhibition (sub...</td>\n",
       "      <td>DRUG MATRIX</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Potassium voltage-gated channel subfamily H me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q12809</td>\n",
       "      <td>KCNH2</td>\n",
       "      <td>KCNH2_HUMAN</td>\n",
       "      <td>4.890000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of wild-type human ERG channel expr...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Potassium voltage-gated channel subfamily D me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q9UK17</td>\n",
       "      <td>KCND3</td>\n",
       "      <td>KCND3_HUMAN</td>\n",
       "      <td>4.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Prostaglandin E2 receptor EP1 subtype</td>\n",
       "      <td>GPCR</td>\n",
       "      <td>P34995</td>\n",
       "      <td>PTGER1</td>\n",
       "      <td>PE2R1_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Sodium channel protein type 1 subunit alpha</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>P35498</td>\n",
       "      <td>SCN1A</td>\n",
       "      <td>SCN1A_HUMAN</td>\n",
       "      <td>5.790000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Potassium voltage-gated channel subfamily A me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>P22460</td>\n",
       "      <td>KCNA5</td>\n",
       "      <td>KCNA5_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>5-hydroxytryptamine receptor 3A</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>P46098</td>\n",
       "      <td>HTR3A</td>\n",
       "      <td>5HT3A_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>(S)-nicardipine</td>\n",
       "      <td>5</td>\n",
       "      <td>Voltage-gated L-type calcium channel</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q01668|Q13936</td>\n",
       "      <td>CACNA1C|CACNA1D</td>\n",
       "      <td>CAC1C_HUMAN|CAC1D_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mechanism of Action</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>BLOCKER</td>\n",
       "      <td>Tclin|Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>(S)-nitrendipine</td>\n",
       "      <td>6</td>\n",
       "      <td>Intermediate conductance calcium-activated pot...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>O15554</td>\n",
       "      <td>KCNN4</td>\n",
       "      <td>KCNN4_HUMAN</td>\n",
       "      <td>7.600000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BLOCKER</td>\n",
       "      <td>Tchem</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>(S)-nitrendipine</td>\n",
       "      <td>6</td>\n",
       "      <td>Voltage-dependent L-type calcium channel subun...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>O60840</td>\n",
       "      <td>CACNA1F</td>\n",
       "      <td>CAC1F_HUMAN</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NEGATIVE MODULATOR</td>\n",
       "      <td>Tchem</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>(S)-nitrendipine</td>\n",
       "      <td>6</td>\n",
       "      <td>Voltage-dependent L-type calcium channel subun...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>P22002</td>\n",
       "      <td>Cacna1c</td>\n",
       "      <td>CAC1C_RAT</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NEGATIVE MODULATOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Rattus norvegicus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>(S)-nitrendipine</td>\n",
       "      <td>6</td>\n",
       "      <td>Voltage-dependent L-type calcium channel subun...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q02485</td>\n",
       "      <td>Cacna1s</td>\n",
       "      <td>CAC1S_RAT</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NEGATIVE MODULATOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Rattus norvegicus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>(S)-nitrendipine</td>\n",
       "      <td>6</td>\n",
       "      <td>Voltage-dependent L-type calcium channel subun...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q01668</td>\n",
       "      <td>CACNA1D</td>\n",
       "      <td>CAC1D_HUMAN</td>\n",
       "      <td>8.400000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Mechanism of Action</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>BLOCKER</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>(S)-nitrendipine</td>\n",
       "      <td>6</td>\n",
       "      <td>Voltage-dependent L-type calcium channel subun...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q13936</td>\n",
       "      <td>CACNA1C</td>\n",
       "      <td>CAC1C_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mechanism of Action</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/17276408</td>\n",
       "      <td>BLOCKER</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>levdobutamine</td>\n",
       "      <td>13</td>\n",
       "      <td>Beta-1 adrenergic receptor</td>\n",
       "      <td>GPCR</td>\n",
       "      <td>P08588</td>\n",
       "      <td>ADRB1</td>\n",
       "      <td>ADRB1_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DRUGBANK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>AGONIST</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>aminopterin</td>\n",
       "      <td>21</td>\n",
       "      <td>Dihydrofolate reductase</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P00381</td>\n",
       "      <td>folA</td>\n",
       "      <td>DYR_LACCA</td>\n",
       "      <td>8.300000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of dihydrofolate reductase in Lacto...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lactobacillus casei</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>aminopterin</td>\n",
       "      <td>21</td>\n",
       "      <td>Dihydrofolate reductase</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P00374</td>\n",
       "      <td>DHFR</td>\n",
       "      <td>DYR_HUMAN</td>\n",
       "      <td>9.680000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ki</td>\n",
       "      <td>Inhibitory activity against Leu22-Phe mutant h...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>aminopterin</td>\n",
       "      <td>21</td>\n",
       "      <td>Dihydrofolate reductase</td>\n",
       "      <td>Unclassified</td>\n",
       "      <td>B0BL08</td>\n",
       "      <td>dfrA17</td>\n",
       "      <td>B0BL08_ECOLX</td>\n",
       "      <td>7.960000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of dihydrofolate reductase in Esche...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Escherichia coli</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>aminopterin</td>\n",
       "      <td>21</td>\n",
       "      <td>Dihydrofolate reductase</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P00375</td>\n",
       "      <td>Dhfr</td>\n",
       "      <td>DYR_MOUSE</td>\n",
       "      <td>8.700000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibitory activity against dihydrofolate redu...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mus musculus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>aminopterin</td>\n",
       "      <td>21</td>\n",
       "      <td>Folylpoly-gamma-glutamate synthetase</td>\n",
       "      <td>Unclassified</td>\n",
       "      <td>P48760</td>\n",
       "      <td>Fpgs</td>\n",
       "      <td>FOLC_MOUSE</td>\n",
       "      <td>4.750000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ki</td>\n",
       "      <td>Compound was tested for its ability to inhibit...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mus musculus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>phenylbutanoic acid</td>\n",
       "      <td>24</td>\n",
       "      <td>glutamine</td>\n",
       "      <td>Amino acid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mechanism of Action</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>phenylbutanoic acid</td>\n",
       "      <td>24</td>\n",
       "      <td>Histone deacetylase 8</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q9BY41</td>\n",
       "      <td>HDAC8</td>\n",
       "      <td>HDAC8_HUMAN</td>\n",
       "      <td>4.030000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of human recombinant HDAC8</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>phenylbutanoic acid</td>\n",
       "      <td>24</td>\n",
       "      <td>Histone deacetylase 1</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q13547</td>\n",
       "      <td>HDAC1</td>\n",
       "      <td>HDAC1_HUMAN</td>\n",
       "      <td>4.190000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of human recombinant HDAC1</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>phenylbutanoic acid</td>\n",
       "      <td>24</td>\n",
       "      <td>Histone deacetylase 2</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q92769</td>\n",
       "      <td>HDAC2</td>\n",
       "      <td>HDAC2_HUMAN</td>\n",
       "      <td>4.190000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of human recombinant HDAC2</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>phenylbutanoic acid</td>\n",
       "      <td>24</td>\n",
       "      <td>Aldose reductase</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P15121</td>\n",
       "      <td>AKR1B1</td>\n",
       "      <td>ALDR_HUMAN</td>\n",
       "      <td>4.020000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of aldose reductase</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>azacitidine</td>\n",
       "      <td>25</td>\n",
       "      <td>DNA (cytosine-5)-methyltransferase 1</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P26358</td>\n",
       "      <td>DNMT1</td>\n",
       "      <td>DNMT1_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DRUGBANK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>http://www.drugbank.ca/drugs/DB00928</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>azacitidine</td>\n",
       "      <td>25</td>\n",
       "      <td>DNA (cytosine-5)-methyltransferase 3A</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q9Y6K1</td>\n",
       "      <td>DNMT3A</td>\n",
       "      <td>DNM3A_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mechanism of Action; CHEMBL1992; SINGLE PROTEIN</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>fluorouracil</td>\n",
       "      <td>26</td>\n",
       "      <td>Thymidylate synthase</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P04818</td>\n",
       "      <td>TYMS</td>\n",
       "      <td>TYSY_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>fluorouracil</td>\n",
       "      <td>26</td>\n",
       "      <td>Thymidylate synthase</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P07607</td>\n",
       "      <td>Tyms</td>\n",
       "      <td>TYSY_MOUSE</td>\n",
       "      <td>7.700000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of thymidylate synthase in mouse L1...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mus musculus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16560</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 3</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q9Y6F1</td>\n",
       "      <td>PARP3</td>\n",
       "      <td>PARP3_HUMAN</td>\n",
       "      <td>6.390000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16561</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 4</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q9UKK3</td>\n",
       "      <td>PARP4</td>\n",
       "      <td>PARP4_HUMAN</td>\n",
       "      <td>6.080000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16562</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Tankyrase-1</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>O95271</td>\n",
       "      <td>TNKS</td>\n",
       "      <td>TNKS1_HUMAN</td>\n",
       "      <td>6.840000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tchem</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16563</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Tankyrase-2</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q9H2K2</td>\n",
       "      <td>TNKS2</td>\n",
       "      <td>TNKS2_HUMAN</td>\n",
       "      <td>6.050000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tchem</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16564</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 10</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q53GL7</td>\n",
       "      <td>PARP10</td>\n",
       "      <td>PAR10_HUMAN</td>\n",
       "      <td>6.250000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16565</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 12</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q9H0J9</td>\n",
       "      <td>PARP12</td>\n",
       "      <td>PAR12_HUMAN</td>\n",
       "      <td>5.180000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16566</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 14</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q460N5</td>\n",
       "      <td>PARP14</td>\n",
       "      <td>PAR14_HUMAN</td>\n",
       "      <td>5.050000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16567</th>\n",
       "      <td>rucaparib</td>\n",
       "      <td>5203</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 15</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q460N3</td>\n",
       "      <td>PARP15</td>\n",
       "      <td>PAR15_HUMAN</td>\n",
       "      <td>4.490000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://dx.doi.org/10.1021/acs.jmedchem.6b00990</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16568</th>\n",
       "      <td>plecanatide</td>\n",
       "      <td>5208</td>\n",
       "      <td>Heat-stable enterotoxin receptor</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P25092</td>\n",
       "      <td>GUCY2C</td>\n",
       "      <td>GUC2C_HUMAN</td>\n",
       "      <td>6.721246</td>\n",
       "      <td>NaN</td>\n",
       "      <td>EC50</td>\n",
       "      <td>Stimulation of cGMP synthesis in T84 cells</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/26558155</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>AGONIST</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16569</th>\n",
       "      <td>icotinib</td>\n",
       "      <td>5209</td>\n",
       "      <td>Epidermal growth factor receptor</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P00533</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR_HUMAN</td>\n",
       "      <td>8.698970</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/22959248</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/22088449</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16570</th>\n",
       "      <td>olmutinib</td>\n",
       "      <td>5210</td>\n",
       "      <td>Epidermal growth factor receptor</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P00533</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR_HUMAN</td>\n",
       "      <td>8.036212</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>HCC827 cells expressing EGFR(DEL19)</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/27357069</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/27357069</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16571</th>\n",
       "      <td>apatinib</td>\n",
       "      <td>5211</td>\n",
       "      <td>Vascular endothelial growth factor receptor 2</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P35968</td>\n",
       "      <td>KDR</td>\n",
       "      <td>VGFR2_HUMAN</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/21443688</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/21443688</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16572</th>\n",
       "      <td>apatinib</td>\n",
       "      <td>5211</td>\n",
       "      <td>Mast/stem cell growth factor receptor Kit</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P10721</td>\n",
       "      <td>KIT</td>\n",
       "      <td>KIT_HUMAN</td>\n",
       "      <td>6.367543</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/21443688</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16573</th>\n",
       "      <td>apatinib</td>\n",
       "      <td>5211</td>\n",
       "      <td>Proto-oncogene tyrosine-protein kinase recepto...</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P07949</td>\n",
       "      <td>RET</td>\n",
       "      <td>RET_HUMAN</td>\n",
       "      <td>7.886056</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/21443688</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16574</th>\n",
       "      <td>apatinib</td>\n",
       "      <td>5211</td>\n",
       "      <td>Proto-oncogene tyrosine-protein kinase Src</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P12931</td>\n",
       "      <td>SRC</td>\n",
       "      <td>SRC_HUMAN</td>\n",
       "      <td>6.275724</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/21443688</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16575</th>\n",
       "      <td>apatinib</td>\n",
       "      <td>5211</td>\n",
       "      <td>Tyrosine-protein kinase CSK</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P41240</td>\n",
       "      <td>CSK</td>\n",
       "      <td>CSK_HUMAN</td>\n",
       "      <td>6.280000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Assay used apatinib mesylate (YN968D1)</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tchem</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16576</th>\n",
       "      <td>telotristat ethyl</td>\n",
       "      <td>5214</td>\n",
       "      <td>Tryptophan 5-hydroxylase 1</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P17752</td>\n",
       "      <td>TPH1</td>\n",
       "      <td>TPH1_HUMAN</td>\n",
       "      <td>7.795880</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/28041831</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tchem</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16577</th>\n",
       "      <td>beclabuvir</td>\n",
       "      <td>5215</td>\n",
       "      <td>Potassium voltage-gated channel subfamily H me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q12809</td>\n",
       "      <td>KCNH2</td>\n",
       "      <td>KCNH2_HUMAN</td>\n",
       "      <td>4.610000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16578</th>\n",
       "      <td>crisantaspase</td>\n",
       "      <td>5216</td>\n",
       "      <td>aspargine</td>\n",
       "      <td>Amino acid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mechanism of Action</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>HYDROLYTIC ENZYME</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16579</th>\n",
       "      <td>ribociclib</td>\n",
       "      <td>5218</td>\n",
       "      <td>Cyclin-dependent kinase 4</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P11802</td>\n",
       "      <td>CDK4</td>\n",
       "      <td>CDK4_HUMAN</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/25941111</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16580</th>\n",
       "      <td>ribociclib</td>\n",
       "      <td>5218</td>\n",
       "      <td>Cyclin-dependent kinase 6</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>Q00534</td>\n",
       "      <td>CDK6</td>\n",
       "      <td>CDK6_HUMAN</td>\n",
       "      <td>7.408936</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/25941111</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16581</th>\n",
       "      <td>naldemedine</td>\n",
       "      <td>5220</td>\n",
       "      <td>Mu-type opioid receptor</td>\n",
       "      <td>GPCR</td>\n",
       "      <td>P35372</td>\n",
       "      <td>OPRM1</td>\n",
       "      <td>OPRM_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>ANTAGONIST</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16582</th>\n",
       "      <td>avelumab</td>\n",
       "      <td>5221</td>\n",
       "      <td>Programmed cell death 1 ligand 1</td>\n",
       "      <td>CD molecules</td>\n",
       "      <td>Q9NZQ7</td>\n",
       "      <td>CD274</td>\n",
       "      <td>PD1L1_HUMAN</td>\n",
       "      <td>10.100000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "      <td>ANTIBODY BINDING</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16583</th>\n",
       "      <td>niraparib</td>\n",
       "      <td>5222</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 1</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P09874</td>\n",
       "      <td>PARP1</td>\n",
       "      <td>PARP1_HUMAN</td>\n",
       "      <td>8.400000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16584</th>\n",
       "      <td>niraparib</td>\n",
       "      <td>5222</td>\n",
       "      <td>Poly [ADP-ribose] polymerase 2</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>Q9UGN5</td>\n",
       "      <td>PARP2</td>\n",
       "      <td>PARP2_HUMAN</td>\n",
       "      <td>8.700000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16585</th>\n",
       "      <td>ocrelizumab</td>\n",
       "      <td>5223</td>\n",
       "      <td>B-lymphocyte antigen CD20</td>\n",
       "      <td>Surface antigen</td>\n",
       "      <td>P11836</td>\n",
       "      <td>MS4A1</td>\n",
       "      <td>CD20_HUMAN</td>\n",
       "      <td>9.100000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Kd</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>ANTIBODY BINDING</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16586</th>\n",
       "      <td>dupilumab</td>\n",
       "      <td>5224</td>\n",
       "      <td>Interleukin-4 receptor subunit alpha</td>\n",
       "      <td>Membrane receptor</td>\n",
       "      <td>P24394</td>\n",
       "      <td>IL4R</td>\n",
       "      <td>IL4RA_HUMAN</td>\n",
       "      <td>11.100000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>ANTIBODY BINDING</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16587</th>\n",
       "      <td>deutetrabenazine</td>\n",
       "      <td>5226</td>\n",
       "      <td>Synaptic vesicular amine transporter</td>\n",
       "      <td>Transporter</td>\n",
       "      <td>Q05940</td>\n",
       "      <td>SLC18A2</td>\n",
       "      <td>VMAT2_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16588</th>\n",
       "      <td>valbenazine</td>\n",
       "      <td>5227</td>\n",
       "      <td>Synaptic vesicular amine transporter</td>\n",
       "      <td>Transporter</td>\n",
       "      <td>Q05940</td>\n",
       "      <td>SLC18A2</td>\n",
       "      <td>VMAT2_HUMAN</td>\n",
       "      <td>8.522879</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ki</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16589</th>\n",
       "      <td>valbenazine</td>\n",
       "      <td>5227</td>\n",
       "      <td>Synaptic vesicular amine transporter</td>\n",
       "      <td>Transporter</td>\n",
       "      <td>Q01827</td>\n",
       "      <td>Slc18a2</td>\n",
       "      <td>VMAT2_RAT</td>\n",
       "      <td>6.730000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ki</td>\n",
       "      <td>Displacement binding assay using rat brain hom...</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.guidetopharmacology.org/GRAC/Ligand...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Rattus norvegicus</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>16590 rows × 20 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                 DRUG_NAME  STRUCT_ID  \\\n",
       "0          levobupivacaine          4   \n",
       "1          levobupivacaine          4   \n",
       "2          levobupivacaine          4   \n",
       "3          levobupivacaine          4   \n",
       "4          levobupivacaine          4   \n",
       "5          levobupivacaine          4   \n",
       "6          levobupivacaine          4   \n",
       "7          levobupivacaine          4   \n",
       "8          (S)-nicardipine          5   \n",
       "9         (S)-nitrendipine          6   \n",
       "10        (S)-nitrendipine          6   \n",
       "11        (S)-nitrendipine          6   \n",
       "12        (S)-nitrendipine          6   \n",
       "13        (S)-nitrendipine          6   \n",
       "14        (S)-nitrendipine          6   \n",
       "15           levdobutamine         13   \n",
       "16             aminopterin         21   \n",
       "17             aminopterin         21   \n",
       "18             aminopterin         21   \n",
       "19             aminopterin         21   \n",
       "20             aminopterin         21   \n",
       "21     phenylbutanoic acid         24   \n",
       "22     phenylbutanoic acid         24   \n",
       "23     phenylbutanoic acid         24   \n",
       "24     phenylbutanoic acid         24   \n",
       "25     phenylbutanoic acid         24   \n",
       "26             azacitidine         25   \n",
       "27             azacitidine         25   \n",
       "28            fluorouracil         26   \n",
       "29            fluorouracil         26   \n",
       "...                    ...        ...   \n",
       "16560            rucaparib       5203   \n",
       "16561            rucaparib       5203   \n",
       "16562            rucaparib       5203   \n",
       "16563            rucaparib       5203   \n",
       "16564            rucaparib       5203   \n",
       "16565            rucaparib       5203   \n",
       "16566            rucaparib       5203   \n",
       "16567            rucaparib       5203   \n",
       "16568          plecanatide       5208   \n",
       "16569             icotinib       5209   \n",
       "16570            olmutinib       5210   \n",
       "16571             apatinib       5211   \n",
       "16572             apatinib       5211   \n",
       "16573             apatinib       5211   \n",
       "16574             apatinib       5211   \n",
       "16575             apatinib       5211   \n",
       "16576    telotristat ethyl       5214   \n",
       "16577           beclabuvir       5215   \n",
       "16578        crisantaspase       5216   \n",
       "16579           ribociclib       5218   \n",
       "16580           ribociclib       5218   \n",
       "16581          naldemedine       5220   \n",
       "16582             avelumab       5221   \n",
       "16583            niraparib       5222   \n",
       "16584            niraparib       5222   \n",
       "16585          ocrelizumab       5223   \n",
       "16586            dupilumab       5224   \n",
       "16587     deutetrabenazine       5226   \n",
       "16588          valbenazine       5227   \n",
       "16589          valbenazine       5227   \n",
       "\n",
       "                                             TARGET_NAME       TARGET_CLASS  \\\n",
       "0            Sodium channel protein type 4 subunit alpha        Ion channel   \n",
       "1                                    Cytochrome P450 2D6             Enzyme   \n",
       "2      Potassium voltage-gated channel subfamily H me...        Ion channel   \n",
       "3      Potassium voltage-gated channel subfamily D me...        Ion channel   \n",
       "4                  Prostaglandin E2 receptor EP1 subtype               GPCR   \n",
       "5            Sodium channel protein type 1 subunit alpha        Ion channel   \n",
       "6      Potassium voltage-gated channel subfamily A me...        Ion channel   \n",
       "7                        5-hydroxytryptamine receptor 3A        Ion channel   \n",
       "8                   Voltage-gated L-type calcium channel        Ion channel   \n",
       "9      Intermediate conductance calcium-activated pot...        Ion channel   \n",
       "10     Voltage-dependent L-type calcium channel subun...        Ion channel   \n",
       "11     Voltage-dependent L-type calcium channel subun...        Ion channel   \n",
       "12     Voltage-dependent L-type calcium channel subun...        Ion channel   \n",
       "13     Voltage-dependent L-type calcium channel subun...        Ion channel   \n",
       "14     Voltage-dependent L-type calcium channel subun...        Ion channel   \n",
       "15                            Beta-1 adrenergic receptor               GPCR   \n",
       "16                               Dihydrofolate reductase             Enzyme   \n",
       "17                               Dihydrofolate reductase             Enzyme   \n",
       "18                               Dihydrofolate reductase       Unclassified   \n",
       "19                               Dihydrofolate reductase             Enzyme   \n",
       "20                  Folylpoly-gamma-glutamate synthetase       Unclassified   \n",
       "21                                             glutamine         Amino acid   \n",
       "22                                 Histone deacetylase 8             Enzyme   \n",
       "23                                 Histone deacetylase 1             Enzyme   \n",
       "24                                 Histone deacetylase 2             Enzyme   \n",
       "25                                      Aldose reductase             Enzyme   \n",
       "26                  DNA (cytosine-5)-methyltransferase 1             Enzyme   \n",
       "27                 DNA (cytosine-5)-methyltransferase 3A             Enzyme   \n",
       "28                                  Thymidylate synthase             Enzyme   \n",
       "29                                  Thymidylate synthase             Enzyme   \n",
       "...                                                  ...                ...   \n",
       "16560                     Poly [ADP-ribose] polymerase 3             Enzyme   \n",
       "16561                     Poly [ADP-ribose] polymerase 4             Enzyme   \n",
       "16562                                        Tankyrase-1             Enzyme   \n",
       "16563                                        Tankyrase-2             Enzyme   \n",
       "16564                    Poly [ADP-ribose] polymerase 10             Enzyme   \n",
       "16565                    Poly [ADP-ribose] polymerase 12             Enzyme   \n",
       "16566                    Poly [ADP-ribose] polymerase 14             Enzyme   \n",
       "16567                    Poly [ADP-ribose] polymerase 15             Enzyme   \n",
       "16568                   Heat-stable enterotoxin receptor             Enzyme   \n",
       "16569                   Epidermal growth factor receptor             Kinase   \n",
       "16570                   Epidermal growth factor receptor             Kinase   \n",
       "16571      Vascular endothelial growth factor receptor 2             Kinase   \n",
       "16572          Mast/stem cell growth factor receptor Kit             Kinase   \n",
       "16573  Proto-oncogene tyrosine-protein kinase recepto...             Kinase   \n",
       "16574         Proto-oncogene tyrosine-protein kinase Src             Kinase   \n",
       "16575                        Tyrosine-protein kinase CSK             Kinase   \n",
       "16576                         Tryptophan 5-hydroxylase 1             Enzyme   \n",
       "16577  Potassium voltage-gated channel subfamily H me...        Ion channel   \n",
       "16578                                          aspargine         Amino acid   \n",
       "16579                          Cyclin-dependent kinase 4             Kinase   \n",
       "16580                          Cyclin-dependent kinase 6             Kinase   \n",
       "16581                            Mu-type opioid receptor               GPCR   \n",
       "16582                   Programmed cell death 1 ligand 1       CD molecules   \n",
       "16583                     Poly [ADP-ribose] polymerase 1             Enzyme   \n",
       "16584                     Poly [ADP-ribose] polymerase 2             Enzyme   \n",
       "16585                          B-lymphocyte antigen CD20    Surface antigen   \n",
       "16586               Interleukin-4 receptor subunit alpha  Membrane receptor   \n",
       "16587               Synaptic vesicular amine transporter        Transporter   \n",
       "16588               Synaptic vesicular amine transporter        Transporter   \n",
       "16589               Synaptic vesicular amine transporter        Transporter   \n",
       "\n",
       "           ACCESSION             GENE                SWISSPROT  ACT_VALUE  \\\n",
       "0             P35499            SCN4A              SCN4A_HUMAN        NaN   \n",
       "1             P10635           CYP2D6              CP2D6_HUMAN   6.706859   \n",
       "2             Q12809            KCNH2              KCNH2_HUMAN   4.890000   \n",
       "3             Q9UK17            KCND3              KCND3_HUMAN   4.500000   \n",
       "4             P34995           PTGER1              PE2R1_HUMAN        NaN   \n",
       "5             P35498            SCN1A              SCN1A_HUMAN   5.790000   \n",
       "6             P22460            KCNA5              KCNA5_HUMAN        NaN   \n",
       "7             P46098            HTR3A              5HT3A_HUMAN        NaN   \n",
       "8      Q01668|Q13936  CACNA1C|CACNA1D  CAC1C_HUMAN|CAC1D_HUMAN        NaN   \n",
       "9             O15554            KCNN4              KCNN4_HUMAN   7.600000   \n",
       "10            O60840          CACNA1F              CAC1F_HUMAN   6.000000   \n",
       "11            P22002          Cacna1c                CAC1C_RAT   6.000000   \n",
       "12            Q02485          Cacna1s                CAC1S_RAT   6.000000   \n",
       "13            Q01668          CACNA1D              CAC1D_HUMAN   8.400000   \n",
       "14            Q13936          CACNA1C              CAC1C_HUMAN        NaN   \n",
       "15            P08588            ADRB1              ADRB1_HUMAN        NaN   \n",
       "16            P00381             folA                DYR_LACCA   8.300000   \n",
       "17            P00374             DHFR                DYR_HUMAN   9.680000   \n",
       "18            B0BL08           dfrA17             B0BL08_ECOLX   7.960000   \n",
       "19            P00375             Dhfr                DYR_MOUSE   8.700000   \n",
       "20            P48760             Fpgs               FOLC_MOUSE   4.750000   \n",
       "21               NaN              NaN                      NaN        NaN   \n",
       "22            Q9BY41            HDAC8              HDAC8_HUMAN   4.030000   \n",
       "23            Q13547            HDAC1              HDAC1_HUMAN   4.190000   \n",
       "24            Q92769            HDAC2              HDAC2_HUMAN   4.190000   \n",
       "25            P15121           AKR1B1               ALDR_HUMAN   4.020000   \n",
       "26            P26358            DNMT1              DNMT1_HUMAN        NaN   \n",
       "27            Q9Y6K1           DNMT3A              DNM3A_HUMAN        NaN   \n",
       "28            P04818             TYMS               TYSY_HUMAN        NaN   \n",
       "29            P07607             Tyms               TYSY_MOUSE   7.700000   \n",
       "...              ...              ...                      ...        ...   \n",
       "16560         Q9Y6F1            PARP3              PARP3_HUMAN   6.390000   \n",
       "16561         Q9UKK3            PARP4              PARP4_HUMAN   6.080000   \n",
       "16562         O95271             TNKS              TNKS1_HUMAN   6.840000   \n",
       "16563         Q9H2K2            TNKS2              TNKS2_HUMAN   6.050000   \n",
       "16564         Q53GL7           PARP10              PAR10_HUMAN   6.250000   \n",
       "16565         Q9H0J9           PARP12              PAR12_HUMAN   5.180000   \n",
       "16566         Q460N5           PARP14              PAR14_HUMAN   5.050000   \n",
       "16567         Q460N3           PARP15              PAR15_HUMAN   4.490000   \n",
       "16568         P25092           GUCY2C              GUC2C_HUMAN   6.721246   \n",
       "16569         P00533             EGFR               EGFR_HUMAN   8.698970   \n",
       "16570         P00533             EGFR               EGFR_HUMAN   8.036212   \n",
       "16571         P35968              KDR              VGFR2_HUMAN   9.000000   \n",
       "16572         P10721              KIT                KIT_HUMAN   6.367543   \n",
       "16573         P07949              RET                RET_HUMAN   7.886056   \n",
       "16574         P12931              SRC                SRC_HUMAN   6.275724   \n",
       "16575         P41240              CSK                CSK_HUMAN   6.280000   \n",
       "16576         P17752             TPH1               TPH1_HUMAN   7.795880   \n",
       "16577         Q12809            KCNH2              KCNH2_HUMAN   4.610000   \n",
       "16578            NaN              NaN                      NaN        NaN   \n",
       "16579         P11802             CDK4               CDK4_HUMAN   8.000000   \n",
       "16580         Q00534             CDK6               CDK6_HUMAN   7.408936   \n",
       "16581         P35372            OPRM1               OPRM_HUMAN        NaN   \n",
       "16582         Q9NZQ7            CD274              PD1L1_HUMAN  10.100000   \n",
       "16583         P09874            PARP1              PARP1_HUMAN   8.400000   \n",
       "16584         Q9UGN5            PARP2              PARP2_HUMAN   8.700000   \n",
       "16585         P11836            MS4A1               CD20_HUMAN   9.100000   \n",
       "16586         P24394             IL4R              IL4RA_HUMAN  11.100000   \n",
       "16587         Q05940          SLC18A2              VMAT2_HUMAN        NaN   \n",
       "16588         Q05940          SLC18A2              VMAT2_HUMAN   8.522879   \n",
       "16589         Q01827          Slc18a2                VMAT2_RAT   6.730000   \n",
       "\n",
       "       ACT_UNIT ACT_TYPE                                        ACT_COMMENT  \\\n",
       "0           NaN      NaN                                                NaN   \n",
       "1           NaN     IC50  DRUGMATRIX: CYP450, 2D6 enzyme inhibition (sub...   \n",
       "2           NaN     IC50  Inhibition of wild-type human ERG channel expr...   \n",
       "3           NaN     IC50                                                NaN   \n",
       "4           NaN      NaN                                                NaN   \n",
       "5           NaN     IC50                                                NaN   \n",
       "6           NaN      NaN                                                NaN   \n",
       "7           NaN      NaN                                                NaN   \n",
       "8           NaN      NaN                                Mechanism of Action   \n",
       "9           NaN     IC50                                                NaN   \n",
       "10          NaN     IC50                                                NaN   \n",
       "11          NaN     IC50                                                NaN   \n",
       "12          NaN     IC50                                                NaN   \n",
       "13          NaN     IC50                                Mechanism of Action   \n",
       "14          NaN      NaN                                Mechanism of Action   \n",
       "15          NaN      NaN                                                NaN   \n",
       "16          NaN     IC50  Inhibition of dihydrofolate reductase in Lacto...   \n",
       "17          NaN       Ki  Inhibitory activity against Leu22-Phe mutant h...   \n",
       "18          NaN     IC50  Inhibition of dihydrofolate reductase in Esche...   \n",
       "19          NaN     IC50  Inhibitory activity against dihydrofolate redu...   \n",
       "20          NaN       Ki  Compound was tested for its ability to inhibit...   \n",
       "21          NaN      NaN                                Mechanism of Action   \n",
       "22          NaN     IC50              Inhibition of human recombinant HDAC8   \n",
       "23          NaN     IC50              Inhibition of human recombinant HDAC1   \n",
       "24          NaN     IC50              Inhibition of human recombinant HDAC2   \n",
       "25          NaN     IC50                     Inhibition of aldose reductase   \n",
       "26          NaN      NaN                                                NaN   \n",
       "27          NaN      NaN    Mechanism of Action; CHEMBL1992; SINGLE PROTEIN   \n",
       "28          NaN      NaN                                                NaN   \n",
       "29          NaN     IC50  Inhibition of thymidylate synthase in mouse L1...   \n",
       "...         ...      ...                                                ...   \n",
       "16560       NaN     IC50                                                NaN   \n",
       "16561       NaN     IC50                                                NaN   \n",
       "16562       NaN     IC50                                                NaN   \n",
       "16563       NaN     IC50                                                NaN   \n",
       "16564       NaN     IC50                                                NaN   \n",
       "16565       NaN     IC50                                                NaN   \n",
       "16566       NaN     IC50                                                NaN   \n",
       "16567       NaN     IC50                                                NaN   \n",
       "16568       NaN     EC50         Stimulation of cGMP synthesis in T84 cells   \n",
       "16569       NaN     IC50                                                NaN   \n",
       "16570       NaN     IC50                HCC827 cells expressing EGFR(DEL19)   \n",
       "16571       NaN     IC50                                                NaN   \n",
       "16572       NaN     IC50                                                NaN   \n",
       "16573       NaN     IC50                                                NaN   \n",
       "16574       NaN     IC50                                                NaN   \n",
       "16575       NaN     IC50             Assay used apatinib mesylate (YN968D1)   \n",
       "16576       NaN     IC50                                                NaN   \n",
       "16577       NaN     IC50                                                NaN   \n",
       "16578       NaN      NaN                                Mechanism of Action   \n",
       "16579       NaN     IC50                                                NaN   \n",
       "16580       NaN     IC50                                                NaN   \n",
       "16581       NaN      NaN                                                NaN   \n",
       "16582       NaN     IC50                                                NaN   \n",
       "16583       NaN     IC50                                                NaN   \n",
       "16584       NaN     IC50                                                NaN   \n",
       "16585       NaN       Kd                                                NaN   \n",
       "16586       NaN     IC50                                                NaN   \n",
       "16587       NaN      NaN                                                NaN   \n",
       "16588       NaN       Ki                                                NaN   \n",
       "16589       NaN       Ki  Displacement binding assay using rat brain hom...   \n",
       "\n",
       "                  ACT_SOURCE RELATION  MOA             MOA_SOURCE  \\\n",
       "0                  WOMBAT-PK      NaN  1.0                 CHEMBL   \n",
       "1                DRUG MATRIX        =  NaN                    NaN   \n",
       "2                     CHEMBL        =  NaN                    NaN   \n",
       "3                  WOMBAT-PK        =  NaN                    NaN   \n",
       "4                  WOMBAT-PK      NaN  NaN                    NaN   \n",
       "5                  WOMBAT-PK        =  NaN                    NaN   \n",
       "6                  WOMBAT-PK      NaN  NaN                    NaN   \n",
       "7                  WOMBAT-PK      NaN  NaN                    NaN   \n",
       "8                 DRUG LABEL      NaN  1.0             DRUG LABEL   \n",
       "9                     IUPHAR        =  NaN                    NaN   \n",
       "10                    IUPHAR        =  NaN                    NaN   \n",
       "11                    IUPHAR        =  NaN                    NaN   \n",
       "12                    IUPHAR        =  NaN                    NaN   \n",
       "13                    IUPHAR        =  1.0                 IUPHAR   \n",
       "14     SCIENTIFIC LITERATURE      NaN  1.0  SCIENTIFIC LITERATURE   \n",
       "15                  DRUGBANK      NaN  1.0                 CHEMBL   \n",
       "16                    CHEMBL        =  NaN                    NaN   \n",
       "17                    CHEMBL        =  NaN                    NaN   \n",
       "18                    CHEMBL        =  NaN                    NaN   \n",
       "19                    CHEMBL        =  NaN                    NaN   \n",
       "20                    CHEMBL        =  NaN                    NaN   \n",
       "21                DRUG LABEL      NaN  1.0             DRUG LABEL   \n",
       "22                    CHEMBL        =  NaN                    NaN   \n",
       "23                    CHEMBL        =  NaN                    NaN   \n",
       "24                    CHEMBL        =  NaN                    NaN   \n",
       "25                    CHEMBL        =  NaN                    NaN   \n",
       "26                  DRUGBANK      NaN  1.0                 CHEMBL   \n",
       "27                    CHEMBL      NaN  1.0                 CHEMBL   \n",
       "28                 WOMBAT-PK      NaN  1.0                 CHEMBL   \n",
       "29                    CHEMBL        =  NaN                    NaN   \n",
       "...                      ...      ...  ...                    ...   \n",
       "16560  SCIENTIFIC LITERATURE        =  1.0             DRUG LABEL   \n",
       "16561  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16562  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16563  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16564  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16565  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16566  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16567  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16568  SCIENTIFIC LITERATURE        =  1.0             DRUG LABEL   \n",
       "16569  SCIENTIFIC LITERATURE        =  1.0  SCIENTIFIC LITERATURE   \n",
       "16570  SCIENTIFIC LITERATURE        =  1.0  SCIENTIFIC LITERATURE   \n",
       "16571  SCIENTIFIC LITERATURE        =  1.0  SCIENTIFIC LITERATURE   \n",
       "16572  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16573  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16574  SCIENTIFIC LITERATURE        =  NaN                    NaN   \n",
       "16575                 IUPHAR        =  NaN                    NaN   \n",
       "16576  SCIENTIFIC LITERATURE        =  1.0             DRUG LABEL   \n",
       "16577                 CHEMBL        =  NaN                    NaN   \n",
       "16578             DRUG LABEL      NaN  1.0             DRUG LABEL   \n",
       "16579  SCIENTIFIC LITERATURE        =  1.0             DRUG LABEL   \n",
       "16580  SCIENTIFIC LITERATURE        =  1.0             DRUG LABEL   \n",
       "16581                UNKNOWN      NaN  1.0             DRUG LABEL   \n",
       "16582                 IUPHAR        =  1.0             DRUG LABEL   \n",
       "16583                 IUPHAR        =  1.0             DRUG LABEL   \n",
       "16584                 IUPHAR        =  1.0             DRUG LABEL   \n",
       "16585                 IUPHAR        =  1.0             DRUG LABEL   \n",
       "16586                 IUPHAR        =  1.0             DRUG LABEL   \n",
       "16587                UNKNOWN      NaN  1.0             DRUG LABEL   \n",
       "16588             DRUG LABEL        =  1.0             DRUG LABEL   \n",
       "16589                 IUPHAR        =  NaN                    NaN   \n",
       "\n",
       "                                          ACT_SOURCE_URL  \\\n",
       "0                                                    NaN   \n",
       "1                                                    NaN   \n",
       "2      https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "3                                                    NaN   \n",
       "4                                                    NaN   \n",
       "5                                                    NaN   \n",
       "6                                                    NaN   \n",
       "7                                                    NaN   \n",
       "8      http://www.accessdata.fda.gov/drugsatfda_docs/...   \n",
       "9      http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "10     http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "11     http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "12     http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "13     http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "14                                                   NaN   \n",
       "15                                                   NaN   \n",
       "16     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "17     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "18     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "19     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "20     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "21                                                   NaN   \n",
       "22     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "23     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "24     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "25     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "26                  http://www.drugbank.ca/drugs/DB00928   \n",
       "27     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "28                                                   NaN   \n",
       "29     https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "...                                                  ...   \n",
       "16560     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16561     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16562     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16563     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16564     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16565     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16566     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16567     http://dx.doi.org/10.1021/acs.jmedchem.6b00990   \n",
       "16568        http://www.ncbi.nlm.nih.gov/pubmed/26558155   \n",
       "16569        http://www.ncbi.nlm.nih.gov/pubmed/22959248   \n",
       "16570        http://www.ncbi.nlm.nih.gov/pubmed/27357069   \n",
       "16571        http://www.ncbi.nlm.nih.gov/pubmed/21443688   \n",
       "16572        http://www.ncbi.nlm.nih.gov/pubmed/21443688   \n",
       "16573        http://www.ncbi.nlm.nih.gov/pubmed/21443688   \n",
       "16574        http://www.ncbi.nlm.nih.gov/pubmed/21443688   \n",
       "16575  http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "16576        http://www.ncbi.nlm.nih.gov/pubmed/28041831   \n",
       "16577  https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "16578                                                NaN   \n",
       "16579        http://www.ncbi.nlm.nih.gov/pubmed/25941111   \n",
       "16580        http://www.ncbi.nlm.nih.gov/pubmed/25941111   \n",
       "16581                                                NaN   \n",
       "16582  http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "16583  http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "16584  http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "16585  http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "16586  http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "16587                                                NaN   \n",
       "16588  https://www.accessdata.fda.gov/drugsatfda_docs...   \n",
       "16589  http://www.guidetopharmacology.org/GRAC/Ligand...   \n",
       "\n",
       "                                          MOA_SOURCE_URL         ACTION_TYPE  \\\n",
       "0      https://www.ebi.ac.uk/chembl/compound/inspect/...             BLOCKER   \n",
       "1                                                    NaN                 NaN   \n",
       "2                                                    NaN                 NaN   \n",
       "3                                                    NaN                 NaN   \n",
       "4                                                    NaN                 NaN   \n",
       "5                                                    NaN                 NaN   \n",
       "6                                                    NaN                 NaN   \n",
       "7                                                    NaN                 NaN   \n",
       "8      http://www.accessdata.fda.gov/drugsatfda_docs/...             BLOCKER   \n",
       "9                                                    NaN             BLOCKER   \n",
       "10                                                   NaN  NEGATIVE MODULATOR   \n",
       "11                                                   NaN  NEGATIVE MODULATOR   \n",
       "12                                                   NaN  NEGATIVE MODULATOR   \n",
       "13     http://www.guidetopharmacology.org/GRAC/Ligand...             BLOCKER   \n",
       "14           http://www.ncbi.nlm.nih.gov/pubmed/17276408             BLOCKER   \n",
       "15     https://www.ebi.ac.uk/chembl/compound/inspect/...             AGONIST   \n",
       "16                                                   NaN                 NaN   \n",
       "17                                                   NaN                 NaN   \n",
       "18                                                   NaN                 NaN   \n",
       "19                                                   NaN                 NaN   \n",
       "20                                                   NaN                 NaN   \n",
       "21     http://www.accessdata.fda.gov/drugsatfda_docs/...               OTHER   \n",
       "22                                                   NaN                 NaN   \n",
       "23                                                   NaN                 NaN   \n",
       "24                                                   NaN                 NaN   \n",
       "25                                                   NaN                 NaN   \n",
       "26     https://www.ebi.ac.uk/chembl/compound/inspect/...           INHIBITOR   \n",
       "27     https://www.ebi.ac.uk/chembl/compound/inspect/...           INHIBITOR   \n",
       "28     https://www.ebi.ac.uk/chembl/compound/inspect/...           INHIBITOR   \n",
       "29                                                   NaN                 NaN   \n",
       "...                                                  ...                 ...   \n",
       "16560  http://www.accessdata.fda.gov/drugsatfda_docs/...           INHIBITOR   \n",
       "16561                                                NaN           INHIBITOR   \n",
       "16562                                                NaN           INHIBITOR   \n",
       "16563                                                NaN           INHIBITOR   \n",
       "16564                                                NaN           INHIBITOR   \n",
       "16565                                                NaN           INHIBITOR   \n",
       "16566                                                NaN           INHIBITOR   \n",
       "16567                                                NaN           INHIBITOR   \n",
       "16568  http://www.accessdata.fda.gov/drugsatfda_docs/...             AGONIST   \n",
       "16569        http://www.ncbi.nlm.nih.gov/pubmed/22088449           INHIBITOR   \n",
       "16570        http://www.ncbi.nlm.nih.gov/pubmed/27357069           INHIBITOR   \n",
       "16571        http://www.ncbi.nlm.nih.gov/pubmed/21443688           INHIBITOR   \n",
       "16572                                                NaN           INHIBITOR   \n",
       "16573                                                NaN           INHIBITOR   \n",
       "16574                                                NaN           INHIBITOR   \n",
       "16575                                                NaN           INHIBITOR   \n",
       "16576  http://www.accessdata.fda.gov/drugsatfda_docs/...           INHIBITOR   \n",
       "16577                                                NaN                 NaN   \n",
       "16578  http://www.accessdata.fda.gov/drugsatfda_docs/...   HYDROLYTIC ENZYME   \n",
       "16579  http://www.accessdata.fda.gov/drugsatfda_docs/...           INHIBITOR   \n",
       "16580  http://www.accessdata.fda.gov/drugsatfda_docs/...           INHIBITOR   \n",
       "16581  https://www.accessdata.fda.gov/drugsatfda_docs...          ANTAGONIST   \n",
       "16582  http://www.accessdata.fda.gov/drugsatfda_docs/...    ANTIBODY BINDING   \n",
       "16583  https://www.accessdata.fda.gov/drugsatfda_docs...           INHIBITOR   \n",
       "16584  https://www.accessdata.fda.gov/drugsatfda_docs...           INHIBITOR   \n",
       "16585  https://www.accessdata.fda.gov/drugsatfda_docs...    ANTIBODY BINDING   \n",
       "16586  https://www.accessdata.fda.gov/drugsatfda_docs...    ANTIBODY BINDING   \n",
       "16587  https://www.accessdata.fda.gov/drugsatfda_docs...           INHIBITOR   \n",
       "16588  https://www.accessdata.fda.gov/drugsatfda_docs...           INHIBITOR   \n",
       "16589                                                NaN           INHIBITOR   \n",
       "\n",
       "               TDL             ORGANISM  \n",
       "0            Tclin         Homo sapiens  \n",
       "1            Tclin         Homo sapiens  \n",
       "2            Tclin         Homo sapiens  \n",
       "3            Tclin         Homo sapiens  \n",
       "4            Tclin         Homo sapiens  \n",
       "5            Tclin         Homo sapiens  \n",
       "6            Tclin         Homo sapiens  \n",
       "7            Tclin         Homo sapiens  \n",
       "8      Tclin|Tclin         Homo sapiens  \n",
       "9            Tchem         Homo sapiens  \n",
       "10           Tchem         Homo sapiens  \n",
       "11             NaN    Rattus norvegicus  \n",
       "12             NaN    Rattus norvegicus  \n",
       "13           Tclin         Homo sapiens  \n",
       "14           Tclin         Homo sapiens  \n",
       "15           Tclin         Homo sapiens  \n",
       "16             NaN  Lactobacillus casei  \n",
       "17           Tclin         Homo sapiens  \n",
       "18             NaN     Escherichia coli  \n",
       "19             NaN         Mus musculus  \n",
       "20             NaN         Mus musculus  \n",
       "21             NaN                  NaN  \n",
       "22           Tclin         Homo sapiens  \n",
       "23           Tclin         Homo sapiens  \n",
       "24           Tclin         Homo sapiens  \n",
       "25           Tclin         Homo sapiens  \n",
       "26           Tclin         Homo sapiens  \n",
       "27           Tclin         Homo sapiens  \n",
       "28           Tclin         Homo sapiens  \n",
       "29             NaN         Mus musculus  \n",
       "...            ...                  ...  \n",
       "16560        Tclin         Homo sapiens  \n",
       "16561          NaN         Homo sapiens  \n",
       "16562        Tchem         Homo sapiens  \n",
       "16563        Tchem         Homo sapiens  \n",
       "16564          NaN         Homo sapiens  \n",
       "16565          NaN         Homo sapiens  \n",
       "16566          NaN         Homo sapiens  \n",
       "16567          NaN         Homo sapiens  \n",
       "16568        Tclin         Homo sapiens  \n",
       "16569        Tclin         Homo sapiens  \n",
       "16570        Tclin         Homo sapiens  \n",
       "16571        Tclin         Homo sapiens  \n",
       "16572        Tclin         Homo sapiens  \n",
       "16573        Tclin         Homo sapiens  \n",
       "16574        Tclin         Homo sapiens  \n",
       "16575        Tchem         Homo sapiens  \n",
       "16576        Tchem         Homo sapiens  \n",
       "16577        Tclin         Homo sapiens  \n",
       "16578          NaN                  NaN  \n",
       "16579        Tclin         Homo sapiens  \n",
       "16580        Tclin         Homo sapiens  \n",
       "16581        Tclin         Homo sapiens  \n",
       "16582        Tclin         Homo sapiens  \n",
       "16583        Tclin         Homo sapiens  \n",
       "16584        Tclin         Homo sapiens  \n",
       "16585        Tclin         Homo sapiens  \n",
       "16586        Tclin         Homo sapiens  \n",
       "16587        Tclin         Homo sapiens  \n",
       "16588        Tclin         Homo sapiens  \n",
       "16589          NaN    Rattus norvegicus  \n",
       "\n",
       "[16590 rows x 20 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drugcentral = pd.read_table('data/raw/drug.target.interaction.tsv',sep='\\t')\n",
    "drugcentral"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T22:11:56.606709Z",
     "start_time": "2019-05-16T22:11:56.564360Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>DRUG_NAME</th>\n",
       "      <th>STRUCT_ID</th>\n",
       "      <th>TARGET_NAME</th>\n",
       "      <th>TARGET_CLASS</th>\n",
       "      <th>ACCESSION</th>\n",
       "      <th>GENE</th>\n",
       "      <th>SWISSPROT</th>\n",
       "      <th>ACT_VALUE</th>\n",
       "      <th>ACT_UNIT</th>\n",
       "      <th>ACT_TYPE</th>\n",
       "      <th>ACT_COMMENT</th>\n",
       "      <th>ACT_SOURCE</th>\n",
       "      <th>RELATION</th>\n",
       "      <th>MOA</th>\n",
       "      <th>MOA_SOURCE</th>\n",
       "      <th>ACT_SOURCE_URL</th>\n",
       "      <th>MOA_SOURCE_URL</th>\n",
       "      <th>ACTION_TYPE</th>\n",
       "      <th>TDL</th>\n",
       "      <th>ORGANISM</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [DRUG_NAME, STRUCT_ID, TARGET_NAME, TARGET_CLASS, ACCESSION, GENE, SWISSPROT, ACT_VALUE, ACT_UNIT, ACT_TYPE, ACT_COMMENT, ACT_SOURCE, RELATION, MOA, MOA_SOURCE, ACT_SOURCE_URL, MOA_SOURCE_URL, ACTION_TYPE, TDL, ORGANISM]\n",
       "Index: []"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drugcentral[drugcentral['DRUG_NAME'].str.contains('ibet')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": [
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T22:40:26.618364Z",
     "start_time": "2019-05-16T22:40:26.614518Z"
    },
    "hidden": true
   },
   "outputs": [],
   "source": [
    "from common_imports import *"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T22:47:42.449082Z",
     "start_time": "2019-05-16T22:47:42.396535Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'gdsc_BMS-536924': [11353973, 10390396, 49830981, 22021328, 68925359],\n",
       " 'gdsc_GSK269962A': [16095342],\n",
       " 'gdsc_Bicalutamide': [2375],\n",
       " 'gdsc_CHIR-99021': [9956119],\n",
       " 'gdsc_AZD6482': [44137675],\n",
       " 'gdsc_JQ1': [46907787],\n",
       " 'gdsc_AKT inhibitor VIII': [10196499],\n",
       " 'gdsc_Avagacestat': [46883536],\n",
       " 'gdsc_UNC0638': [46224516],\n",
       " 'gdsc_Refametinib': [44182295],\n",
       " 'gdsc_Olaparib': [23725625],\n",
       " 'gdsc_Afatinib': [10184653],\n",
       " 'gdsc_PLX-4720': [24180719],\n",
       " 'gdsc_Pictilisib': [17755052],\n",
       " 'gdsc_Selumetinib': [10127622],\n",
       " 'gdsc_Erlotinib': [176870],\n",
       " 'gdsc_Rapamycin': [5284616],\n",
       " 'gdsc_Sunitinib': [5329102],\n",
       " 'gdsc_PHA-665752': [10461815],\n",
       " 'gdsc_MG-132': [462382],\n",
       " 'gdsc_Paclitaxel': [36314],\n",
       " 'gdsc_Cyclopamine': [442972,\n",
       "  46783360,\n",
       "  66577043,\n",
       "  4113848,\n",
       "  44118238,\n",
       "  86287406,\n",
       "  102004827,\n",
       "  20518,\n",
       "  122130428],\n",
       " 'gdsc_AZ628': [11676786],\n",
       " 'gdsc_Sorafenib': [216239],\n",
       " 'gdsc_Tozasertib': [5494449],\n",
       " 'gdsc_Imatinib': [5291],\n",
       " 'gdsc_NVP-TAE684': [16038120],\n",
       " 'gdsc_Crizotinib': [11626560],\n",
       " 'gdsc_Saracatinib': [10302451],\n",
       " 'gdsc_S-Trityl-L-cysteine': [76044],\n",
       " 'gdsc_Z-LLNle-CHO': [16760646],\n",
       " 'gdsc_Dasatinib': [3062316],\n",
       " 'gdsc_GNF-2': [5311510],\n",
       " 'gdsc_CGP-60474': [644215],\n",
       " 'gdsc_CGP-082996': [24825971],\n",
       " 'gdsc_A-770041': [9549184],\n",
       " 'gdsc_WH-4-023': [11844351],\n",
       " 'gdsc_BI-2536': [11364421],\n",
       " 'gdsc_BMS-509744': [11467730],\n",
       " 'gdsc_CMK': [16663089],\n",
       " 'gdsc_Pyrimethamine': [4993],\n",
       " 'gdsc_A-443654': [10172943],\n",
       " 'gdsc_GW843682X': [9826308],\n",
       " 'gdsc_Entinostat': [4261],\n",
       " 'gdsc_Parthenolide': [7251185,\n",
       "  6473881,\n",
       "  5420804,\n",
       "  5420805,\n",
       "  108068,\n",
       "  4692,\n",
       "  5353864,\n",
       "  927704,\n",
       "  5320420,\n",
       "  11972532,\n",
       "  5702252,\n",
       "  91873711,\n",
       "  23631982,\n",
       "  73759808,\n",
       "  123134657],\n",
       " 'gdsc_GSK319347A': [11626927],\n",
       " 'gdsc_TGX221': [9907093],\n",
       " 'gdsc_Bortezomib': [387447],\n",
       " 'gdsc_Seliciclib': [160355],\n",
       " 'gdsc_Salubrinal': [5717801],\n",
       " 'gdsc_Lapatinib': [208908],\n",
       " 'gdsc_Doxorubicin': [31703],\n",
       " 'gdsc_Etoposide': [36462],\n",
       " 'gdsc_Gemcitabine': [60750],\n",
       " 'gdsc_Mitomycin-C': [5746],\n",
       " 'gdsc_Vinorelbine': [5311497, 60780, 13200033, 44424639, 71752961],\n",
       " 'gdsc_NSC-87877': [5459322, 9576093, 91896131],\n",
       " 'gdsc_QS11': [42623900],\n",
       " 'gdsc_CP466722': [44551660],\n",
       " 'gdsc_Midostaurin': [9829523],\n",
       " 'gdsc_Ponatinib': [24826799],\n",
       " 'gdsc_JNK-9L': [25222038],\n",
       " 'gdsc_PF-562271': [11713159],\n",
       " 'gdsc_HG6-64-1': [53302361],\n",
       " 'gdsc_DMOG': [560326],\n",
       " 'gdsc_FTI-277': [3005532],\n",
       " 'gdsc_OSU-03012': [10027278],\n",
       " 'gdsc_Shikonin': [479503],\n",
       " 'gdsc_Embelin': [3218],\n",
       " 'gdsc_FH535': [3463933],\n",
       " 'gdsc_PAC-1': [6851947, 5344054, 6753378],\n",
       " 'gdsc_IPA-3': [521106],\n",
       " 'gdsc_GSK650394': [25022668],\n",
       " 'gdsc_BAY-61-3606': [11784504],\n",
       " 'gdsc_5-Fluorouracil': [3385],\n",
       " 'gdsc_Thapsigargin': [446378],\n",
       " 'gdsc_Obatoclax Mesylate': [16681698,\n",
       "  16727411,\n",
       "  46930996,\n",
       "  56843157,\n",
       "  70700268,\n",
       "  71816154,\n",
       "  56973712],\n",
       " 'gdsc_BMS-754807': [24785538],\n",
       " 'gdsc_Linsitinib': [11640390],\n",
       " 'gdsc_Bexarotene': [82146],\n",
       " 'gdsc_Bleomycin': [5360373,\n",
       "  5460769,\n",
       "  46930981,\n",
       "  456190,\n",
       "  72466,\n",
       "  84068,\n",
       "  54608728],\n",
       " 'gdsc_LFM-A13': [54676905],\n",
       " 'gdsc_GW-2580': [11617559],\n",
       " 'gdsc_Luminespib': [10096043],\n",
       " 'gdsc_Phenformin': [8249],\n",
       " 'gdsc_Bryostatin 1': [5280757,\n",
       "  22524140,\n",
       "  433902,\n",
       "  44277532,\n",
       "  5458769,\n",
       "  5477635,\n",
       "  6473739,\n",
       "  16760328,\n",
       "  6435419,\n",
       "  122173102,\n",
       "  124918436],\n",
       " 'gdsc_Pazopanib': [10113978],\n",
       " 'gdsc_Dacinostat': [6445533],\n",
       " 'gdsc_Epothilone B': [448013],\n",
       " 'gdsc_GSK1904529A': [25124816],\n",
       " 'gdsc_BMS-345541': [9926054, 9813758],\n",
       " 'gdsc_Tipifarnib': [159324],\n",
       " 'gdsc_Ruxolitinib': [25126798],\n",
       " 'gdsc_AS601245': [10109823],\n",
       " 'gdsc_Ispinesib Mesylate': [6450816],\n",
       " 'gdsc_AT-7519': [11338033],\n",
       " 'gdsc_TAK-715': [9952773],\n",
       " 'gdsc_BX-912': [11754511],\n",
       " 'gdsc_ZSTK474': [11647372],\n",
       " 'gdsc_AS605240': [5289247],\n",
       " 'gdsc_GSK1070916': [46885626],\n",
       " 'gdsc_Enzastaurin': [176167],\n",
       " 'gdsc_GSK429286A': [11373846],\n",
       " 'gdsc_FMK': [644243],\n",
       " 'gdsc_Idelalisib': [11625818],\n",
       " 'gdsc_Cabozantinib': [25102847],\n",
       " 'gdsc_Quizartinib': [24889392],\n",
       " 'gdsc_CP724714': [9874913],\n",
       " 'gdsc_STF-62247': [704473],\n",
       " 'gdsc_NG-25': [53340664],\n",
       " 'gdsc_VX-11e': [11634725],\n",
       " 'gdsc_FR-180204': [11493598],\n",
       " 'gdsc_Tubastatin A': [49850262],\n",
       " 'gdsc_Zibotentan': [9910224],\n",
       " 'gdsc_Sepantronium bromide': [11178236],\n",
       " 'gdsc_NSC-207895': [42640],\n",
       " 'gdsc_AR-42': [6918848],\n",
       " 'gdsc_CUDC-101': [24756910],\n",
       " 'gdsc_Belinostat': [6918638],\n",
       " 'gdsc_I-BET-762': [46943432],\n",
       " 'gdsc_CAY10603': [24951314],\n",
       " 'gdsc_Linifanib': [11485656],\n",
       " 'gdsc_BIX02189': [46931012],\n",
       " 'gdsc_Alectinib': [49806720],\n",
       " 'gdsc_Pelitinib': [6445562],\n",
       " 'gdsc_Omipalisib': [25167777],\n",
       " 'gdsc_WHI-P97': [3796],\n",
       " 'gdsc_Masitinib': [10074640],\n",
       " 'gdsc_Amuvatinib': [11282283],\n",
       " 'gdsc_NVP-BHG712': [16747388],\n",
       " 'gdsc_OSI-930': [9868037],\n",
       " 'gdsc_OSI-027': [44224160, 71307533],\n",
       " 'gdsc_CX-5461': [25257557],\n",
       " 'gdsc_PHA-793887': [46191454],\n",
       " 'gdsc_PI-103': [9884685],\n",
       " 'gdsc_PIK-93': [6852167],\n",
       " 'gdsc_TPCA-1': [9903786],\n",
       " 'gdsc_Fedratinib': [16722836],\n",
       " 'gdsc_WIKI4': [2984337],\n",
       " 'gdsc_Y-39983': [11507964, 9810884, 20601328],\n",
       " 'gdsc_YM201636': [9956222],\n",
       " 'gdsc_Tivozanib': [9911830],\n",
       " 'gdsc_GSK690693': [16725726],\n",
       " 'gdsc_SNX-2112': [24772860],\n",
       " 'gdsc_T0901317': [447912],\n",
       " 'gdsc_Selisistat': [5113032],\n",
       " 'gdsc_AICA Ribonucleotide': [65110],\n",
       " 'gdsc_Camptothecin': [24360],\n",
       " 'gdsc_Vinblastine': [13342, 241903, 6710780, 44417235, 3823887],\n",
       " 'gdsc_Cytarabine': [6253],\n",
       " 'gdsc_Docetaxel': [148124],\n",
       " 'gdsc_Methotrexate': [126941],\n",
       " 'gdsc_Tretinoin': [444795],\n",
       " 'gdsc_Gefitinib': [123631],\n",
       " 'gdsc_Navitoclax': [24978538],\n",
       " 'gdsc_Vorinostat': [5311],\n",
       " 'gdsc_Nilotinib': [644241],\n",
       " 'gdsc_CI-1040': [6918454],\n",
       " 'gdsc_Temsirolimus': [6918289,\n",
       "  18293306,\n",
       "  23724530,\n",
       "  53486199,\n",
       "  23375915,\n",
       "  71433778,\n",
       "  86277830,\n",
       "  148191,\n",
       "  122362113,\n",
       "  9876533,\n",
       "  24847874,\n",
       "  54608508,\n",
       "  71296107,\n",
       "  71312019,\n",
       "  86287409,\n",
       "  101179914,\n",
       "  129317846,\n",
       "  132274070],\n",
       " 'gdsc_Veliparib': [11960529],\n",
       " 'gdsc_Bosutinib': [5328940],\n",
       " 'gdsc_Lenalidomide': [216326],\n",
       " 'gdsc_Axitinib': [6450551],\n",
       " 'gdsc_AZD7762': [11152667],\n",
       " 'gdsc_GW441756': [9943465, 16219401],\n",
       " 'gdsc_SB216763': [176158],\n",
       " 'gdsc_Tanespimycin': [6505803],\n",
       " 'gdsc_VX-702': [10341154],\n",
       " 'gdsc_Motesanib': [11667893],\n",
       " 'gdsc_KU-55933': [5278396],\n",
       " 'gdsc_Elesclomol': [300471],\n",
       " 'gdsc_Vismodegib': [24776445],\n",
       " 'gdsc_NU7441': [11327430],\n",
       " 'gdsc_SL0101': [10459196],\n",
       " 'gdsc_Doramapimod': [156422],\n",
       " 'gdsc_JNK Inhibitor VIII': [11624601],\n",
       " 'gdsc_PD173074': [1401],\n",
       " 'gdsc_ZM447439': [9914412],\n",
       " 'gdsc_RO-3306': [11631681, 44450571, 71433937],\n",
       " 'gdsc_MK-2206': [24964624],\n",
       " 'gdsc_Palbociclib': [5330286],\n",
       " 'gdsc_Dactolisib': [11977753],\n",
       " 'gdsc_AZD8055': [25262965],\n",
       " 'gdsc_PD0325901': [9826528],\n",
       " 'gdsc_SB590885': [11465183, 11316960],\n",
       " 'gdsc_CCT007093': [2314623, 2314621, 2314622, 2806572, 6929779],\n",
       " 'gdsc_EHT-1864': [9938202],\n",
       " 'gdsc_PF-4708671': [51371303],\n",
       " 'gdsc_Serdemetan': [11609586],\n",
       " 'gdsc_TW 37': [11455910],\n",
       " 'gdsc_XMD8-92': [46843772],\n",
       " 'gdsc_CCT-018159': [5327091],\n",
       " 'gdsc_Rucaparib': [9931954],\n",
       " 'gdsc_SB-505124': [9858940],\n",
       " 'gdsc_Tamoxifen': [2733526],\n",
       " 'gdsc_PFI-1': [71271629],\n",
       " 'gdsc_IOX2': [54685215],\n",
       " 'gdsc_YK-4-279': [44632017],\n",
       " 'gdsc_(5Z)-7-Oxozeaenol': [9863776],\n",
       " 'gdsc_Piperlongumine': [637858],\n",
       " 'gdsc_Daporinad': [6914657],\n",
       " 'gdsc_Talazoparib': [44819241],\n",
       " 'gdsc_UNC1215': [57339144],\n",
       " 'gdsc_SGC0946': [56962337],\n",
       " 'gdsc_XAV939': [2726824],\n",
       " 'gdsc_Trametinib': [11707110],\n",
       " 'gdsc_Dabrafenib': [44462760],\n",
       " 'gdsc_Temozolomide': [5394],\n",
       " 'gdsc_SN-38': [104842],\n",
       " 'gdsc_Pevonedistat': [16720766],\n",
       " 'ctrp_ML311': [3384730],\n",
       " 'ctrp_zebularine': [100016],\n",
       " 'ctrp_importazole': [2949965],\n",
       " 'ctrp_SR8278': [53393127],\n",
       " 'ctrp_elocalcitol': [11396600],\n",
       " 'ctrp_docetaxel': [148124],\n",
       " 'ctrp_cyclophosphamide': [2907],\n",
       " 'ctrp_3-Cl-AHPC': [9866186],\n",
       " 'ctrp_nutlin-3': [216345],\n",
       " 'ctrp_NVP-231': [4096211],\n",
       " 'ctrp_triptolide': [107985],\n",
       " 'ctrp_avicin D': [44566777],\n",
       " 'ctrp_Bax channel blocker': [2729026, 16760310, 2729027],\n",
       " 'ctrp_CCT036477': [3634881],\n",
       " 'ctrp_erastin': [11214940],\n",
       " 'ctrp_cucurbitacin I': [5281321],\n",
       " 'ctrp_paclitaxel': [36314],\n",
       " 'ctrp_hyperforin': [441298],\n",
       " 'ctrp_brefeldin A': [5287620,\n",
       "  5351204,\n",
       "  6364669,\n",
       "  2430,\n",
       "  6436187,\n",
       "  24123450,\n",
       "  5362868,\n",
       "  71308166,\n",
       "  5353446,\n",
       "  25102665,\n",
       "  657314],\n",
       " 'ctrp_tigecycline': [54686904],\n",
       " 'ctrp_itraconazole': [55283, 3793, 6917738, 14179013, 45039617],\n",
       " 'ctrp_dexamethasone': [5743],\n",
       " 'ctrp_teniposide': [452548,\n",
       "  5396,\n",
       "  275784,\n",
       "  34698,\n",
       "  5284623,\n",
       "  6708778,\n",
       "  23724511,\n",
       "  107642,\n",
       "  54610154,\n",
       "  71752354,\n",
       "  90659141,\n",
       "  92212925,\n",
       "  122172961],\n",
       " 'ctrp_ML162': [3689413],\n",
       " 'ctrp_necrostatin-1': [2828334],\n",
       " 'ctrp_SN-38': [104842],\n",
       " 'ctrp_ciclosporin': [5284373],\n",
       " 'ctrp_TGX-221': [9907093],\n",
       " 'ctrp_bleomycin A2': [5460769, 5360373, 102601374, 84068, 456190],\n",
       " 'ctrp_fluvastatin': [446155, 1548972, 5353627, 6347538],\n",
       " 'ctrp_PX-12': [219104],\n",
       " 'ctrp_PD318088': [10231331],\n",
       " 'ctrp_COL-3': [54678924],\n",
       " 'ctrp_YK 4-279': [44632017],\n",
       " 'ctrp_fumonisin B1': [2733487, 3431, 62314, 14077784, 16760030],\n",
       " 'ctrp_ifosfamide': [3690],\n",
       " 'ctrp_salermide': [42626405],\n",
       " 'ctrp_isoevodiamine': [151289],\n",
       " 'ctrp_lovastatin': [53232],\n",
       " 'ctrp_blebbistatin': [3476986],\n",
       " 'ctrp_myriocin': [6438394],\n",
       " 'ctrp_NSC23766': [409805, 16759159, 54603599],\n",
       " 'ctrp_oligomycin A': [5281899,\n",
       "  46930990,\n",
       "  52947716,\n",
       "  4591,\n",
       "  5472285,\n",
       "  44634687,\n",
       "  71312254,\n",
       "  92813,\n",
       "  25162984,\n",
       "  52947560,\n",
       "  66649023,\n",
       "  91885493,\n",
       "  98042588,\n",
       "  102602671,\n",
       "  131674035,\n",
       "  131750278],\n",
       " 'ctrp_ML258': [53301938],\n",
       " 'ctrp_ML050': [3136844],\n",
       " 'ctrp_fulvestrant': [104741],\n",
       " 'ctrp_CID-5951923': [5951923],\n",
       " 'ctrp_FQI-1': [656346],\n",
       " 'ctrp_thalidomide': [5426],\n",
       " 'ctrp_temozolomide': [5394],\n",
       " 'ctrp_RITA': [374536],\n",
       " 'ctrp_tubastatin A': [49850262],\n",
       " 'ctrp_ML239': [49843203],\n",
       " 'ctrp_LRRK2-IN-1': [46843906],\n",
       " 'ctrp_pyrazolanthrone': [8515],\n",
       " 'ctrp_NVP-BSK805': [46398810],\n",
       " 'ctrp_olaparib': [23725625],\n",
       " 'ctrp_LBH-589': [6918837],\n",
       " 'ctrp_parbendazole': [26596],\n",
       " 'ctrp_QS-11': [42623900],\n",
       " 'ctrp_AT-406': [25022340],\n",
       " 'ctrp_SU11274': [9549297],\n",
       " 'ctrp_HC-067047': [2742550],\n",
       " 'ctrp_azacitidine': [9444],\n",
       " 'ctrp_foretinib': [42642645],\n",
       " 'ctrp_BIBR-1532': [9927531, 53440640],\n",
       " 'ctrp_BMS-270394': [445455],\n",
       " 'ctrp_GSK-3 inhibitor IX': [5287844],\n",
       " 'ctrp_triazolothiadiazine': [67156097],\n",
       " 'ctrp_BRD9647': [1242560],\n",
       " 'ctrp_PDMP': [3129, 6610216, 16219895],\n",
       " 'ctrp_LE-135': [10410894],\n",
       " 'ctrp_GSK1059615': [23582824],\n",
       " 'ctrp_narciclasine': [72376],\n",
       " 'ctrp_AM-580': [2126],\n",
       " 'ctrp_GSK525762A': [46943432],\n",
       " 'ctrp_temsirolimus': [6918289,\n",
       "  18293306,\n",
       "  23724530,\n",
       "  53486199,\n",
       "  23375915,\n",
       "  71433778,\n",
       "  86277830,\n",
       "  148191,\n",
       "  122362113,\n",
       "  9876533,\n",
       "  24847874,\n",
       "  54608508,\n",
       "  71296107,\n",
       "  71312019,\n",
       "  86287409,\n",
       "  101179914,\n",
       "  129317846,\n",
       "  132274070],\n",
       " 'ctrp_SID 26681509': [16725315],\n",
       " 'ctrp_linsitinib': [11640390],\n",
       " 'ctrp_C6-ceramide': [5702613],\n",
       " 'ctrp_GANT-61': [421610],\n",
       " 'ctrp_KU 0060648': [11964036],\n",
       " 'ctrp_FGIN-1-27': [132496],\n",
       " 'ctrp_PRL-3 inhibitor I': [11983303, 71434048, 73707371],\n",
       " 'ctrp_dabrafenib': [44462760],\n",
       " 'ctrp_avrainvillamide': [11719255],\n",
       " 'ctrp_GW-405833': [9911463],\n",
       " 'ctrp_B02': [5738263, 2942111],\n",
       " 'ctrp_CIL56': [654092],\n",
       " 'ctrp_AT7867': [11175137],\n",
       " 'ctrp_NVP-BEZ235': [11977753],\n",
       " 'ctrp_trametinib': [11707110],\n",
       " 'ctrp_TG-101348': [16722836],\n",
       " 'ctrp_valdecoxib': [119607],\n",
       " 'ctrp_procarbazine': [4915],\n",
       " 'ctrp_ciclopirox': [2749],\n",
       " 'ctrp_BMS-754807': [24785538],\n",
       " 'ctrp_BMS-345541': [9926054, 9813758],\n",
       " 'ctrp_dinaciclib': [46926350],\n",
       " 'ctrp_R428': [46215462],\n",
       " 'ctrp_gemcitabine': [60750],\n",
       " 'ctrp_NVP-ADW742': [9825149],\n",
       " 'ctrp_PRIMA-1': [322968],\n",
       " 'ctrp_phloretin': [4788],\n",
       " 'ctrp_obatoclax': [16681698, 11404337, 60145994],\n",
       " 'ctrp_CHIR-99021': [9956119],\n",
       " 'ctrp_PLX-4720': [24180719],\n",
       " 'ctrp_regorafenib': [11167602],\n",
       " 'ctrp_sotrastaurin': [10296883],\n",
       " 'ctrp_bendamustine': [65628],\n",
       " 'ctrp_SCH-79797': [4259181],\n",
       " 'ctrp_HLI 373': [435678, 72193867],\n",
       " 'ctrp_indisulam': [216468],\n",
       " 'ctrp_belinostat': [6918638],\n",
       " 'ctrp_staurosporine': [44259,\n",
       "  5279,\n",
       "  451705,\n",
       "  5311103,\n",
       "  5459111,\n",
       "  6419748,\n",
       "  9956178,\n",
       "  6711321,\n",
       "  44299148,\n",
       "  42610657,\n",
       "  49831000],\n",
       " 'ctrp_birinapant': [49836020],\n",
       " 'ctrp_MK-0752': [9803433],\n",
       " 'ctrp_gossypol': [3503],\n",
       " 'ctrp_prochlorperazine': [4917],\n",
       " 'ctrp_sitagliptin': [4369359],\n",
       " 'ctrp_SGX-523': [24779724],\n",
       " 'ctrp_saracatinib': [10302451],\n",
       " 'ctrp_lapatinib': [208908],\n",
       " 'ctrp_erismodegib': [24775005],\n",
       " 'ctrp_MST-312': [10385095],\n",
       " 'ctrp_tamatinib': [11213558],\n",
       " 'ctrp_KW-2449': [11427553],\n",
       " 'ctrp_RO4929097': [49867930],\n",
       " 'ctrp_simvastatin': [54454],\n",
       " 'ctrp_STF-31': [984333],\n",
       " 'ctrp_sorafenib': [216239],\n",
       " 'ctrp_piperlongumine': [637858],\n",
       " 'ctrp_SCH-529074': [12001922],\n",
       " 'ctrp_ETP-46464': [72199292],\n",
       " 'ctrp_fluorouracil': [3385],\n",
       " 'ctrp_KU-55933': [5278396],\n",
       " 'ctrp_OSI-930': [9868037],\n",
       " 'ctrp_CD-1530': [13290751],\n",
       " 'ctrp_austocystin D': [5470400],\n",
       " 'ctrp_PD 153035': [4705, 11246488],\n",
       " 'ctrp_cytochalasin B': [5311281,\n",
       "  2919,\n",
       "  5368686,\n",
       "  5836499,\n",
       "  2724383,\n",
       "  6364615,\n",
       "  24870911,\n",
       "  44634701,\n",
       "  6433621],\n",
       " 'ctrp_BIX-01294': [25150857],\n",
       " 'ctrp_leptomycin B': [6917907,\n",
       "  435143,\n",
       "  5458861,\n",
       "  6436291,\n",
       "  57459335,\n",
       "  71684517,\n",
       "  121232734],\n",
       " 'ctrp_lomeguatrib': [3025944],\n",
       " 'ctrp_TW-37': [11455910],\n",
       " 'ctrp_AZD4547': [51039095],\n",
       " 'ctrp_brivanib': [11234052],\n",
       " 'ctrp_CD-437': [135411],\n",
       " 'ctrp_PIK-93': [6852167],\n",
       " 'ctrp_chlorambucil': [2708],\n",
       " 'ctrp_NSC30930': [81146],\n",
       " 'ctrp_axitinib': [6450551],\n",
       " 'ctrp_KX2-391': [23635314],\n",
       " 'ctrp_ceranib-2': [122388991],\n",
       " 'ctrp_VER-155008': [25195348],\n",
       " 'ctrp_AGK-2': [2130404],\n",
       " 'ctrp_cytarabine hydrochloride': [6252, 5351180, 69621045, 124080914],\n",
       " 'ctrp_tivantinib': [11494412],\n",
       " 'ctrp_isoliquiritigenin': [638278],\n",
       " 'ctrp_clofarabine': [119182],\n",
       " 'ctrp_cimetidine': [2756],\n",
       " 'ctrp_BMS-536924': [11353973, 10390396, 49830981, 22021328, 68925359],\n",
       " 'ctrp_dacarbazine': [5353562, 5351166, 5281007],\n",
       " 'ctrp_ouabain': [439501],\n",
       " 'ctrp_BRD6340': [1641662],\n",
       " 'ctrp_darinaparsin': [11683005],\n",
       " 'ctrp_niclosamide': [4477],\n",
       " 'ctrp_KU-60019': [15953870],\n",
       " 'ctrp_I-BET151': [52912189],\n",
       " 'ctrp_StemRegenin 1': [46199207],\n",
       " 'ctrp_SB-525334': [9967941],\n",
       " 'ctrp_PF-3758309': [25227462],\n",
       " 'ctrp_etoposide': [36462],\n",
       " 'ctrp_LY-2183240': [11507802],\n",
       " 'ctrp_nakiterpiosin': [11966550, 54613361],\n",
       " 'ctrp_ML031': [2113511],\n",
       " 'ctrp_NSC19630': [227681],\n",
       " 'ctrp_lenvatinib': [9823820],\n",
       " 'ctrp_NSC 74859': [252682],\n",
       " 'ctrp_palmostatin B': [45100481],\n",
       " 'ctrp_sunitinib': [5329102],\n",
       " 'ctrp_myricetin': [5281672],\n",
       " 'ctrp_SNS-032': [3025986],\n",
       " 'ctrp_MLN2480': [25161177],\n",
       " 'ctrp_PF-4800567 hydrochloride': [71751553],\n",
       " 'ctrp_WP1130': [11222830],\n",
       " 'ctrp_ML083': [650361],\n",
       " 'ctrp_pandacostat': [44543714],\n",
       " 'ctrp_betulinic acid': [64971],\n",
       " 'ctrp_NSC48300': [241158],\n",
       " 'ctrp_IU1': [675434],\n",
       " 'ctrp_BMS-195614': [445091],\n",
       " 'ctrp_Ki8751': [11317348],\n",
       " 'ctrp_GMX-1778': [148198],\n",
       " 'ctrp_SR1001': [44241473],\n",
       " 'ctrp_nintedanib': [9809715],\n",
       " 'ctrp_GSK2636771': [56949517],\n",
       " 'ctrp_dasatinib': [3062316],\n",
       " 'ctrp_PRIMA-1-Met': [52918385],\n",
       " 'ctrp_abiraterone': [132971],\n",
       " 'ctrp_sildenafil': [5212],\n",
       " 'ctrp_NVP-TAE684': [16038120],\n",
       " 'ctrp_necrostatin-7': [1239801],\n",
       " 'ctrp_canertinib': [156414],\n",
       " 'ctrp_HBX-41108': [16065773],\n",
       " 'ctrp_cabozantinib': [25102847],\n",
       " 'ctrp_TPCA-1': [9903786],\n",
       " 'ctrp_CAY10576': [11626927],\n",
       " 'ctrp_cerulenin': [5282054],\n",
       " 'ctrp_tacedinaline': [2746],\n",
       " 'ctrp_AZD7545': [16741245],\n",
       " 'ctrp_GDC-0941': [17755052],\n",
       " 'ctrp_JW-55': [2946601],\n",
       " 'ctrp_tivozanib': [9911830],\n",
       " 'ctrp_BEC': [9877608, 2306],\n",
       " 'ctrp_SRT-1720': [24180125],\n",
       " 'ctrp_neuronal differentiation inducer III': [19582717],\n",
       " 'ctrp_ruxolitinib': [25126798],\n",
       " 'ctrp_MK-1775': [24856436],\n",
       " 'ctrp_JQ-1': [46907787],\n",
       " 'ctrp_WAY-362450': [10026128],\n",
       " 'ctrp_BYL-719': [56649450],\n",
       " 'ctrp_SZ4TA2': [11657048],\n",
       " 'ctrp_rigosertib': [6918736],\n",
       " 'ctrp_isonicotinohydroxamic acid': [72967],\n",
       " 'ctrp_epigallocatechin-3-monogallate': [65064],\n",
       " 'ctrp_topotecan': [60700],\n",
       " 'ctrp_MGCD-265': [24901704],\n",
       " 'ctrp_ABT-737': [11228183],\n",
       " 'ctrp_PLX-4032': [42611257],\n",
       " 'ctrp_selumetinib': [10127622],\n",
       " 'ctrp_marinopyrrole A': [24797083],\n",
       " 'ctrp_AT13387': [11955716],\n",
       " 'ctrp_daporinad': [6914657],\n",
       " 'ctrp_AZD6482': [44137675],\n",
       " 'ctrp_AZ-3146': [56973724],\n",
       " 'ctrp_DBeQ': [676352],\n",
       " 'ctrp_VX-680': [5494449],\n",
       " 'ctrp_bardoxolone methyl': [400769, 70700216, 24896135, 53315588, 131632414],\n",
       " 'ctrp_methotrexate': [126941],\n",
       " 'ctrp_mitomycin': [5746],\n",
       " 'ctrp_ML029': [2858522, 2858523],\n",
       " 'ctrp_serdemetan': [11609586],\n",
       " 'ctrp_MG-132': [462382],\n",
       " 'ctrp_PYR-41': [5335621],\n",
       " 'ctrp_CAL-101': [11625818],\n",
       " 'ctrp_Mdivi-1': [3825829],\n",
       " 'ctrp_SB-225002': [3854666],\n",
       " 'ctrp_CAY10594': [25105715],\n",
       " 'ctrp_SB-743921': [9936388, 49867937],\n",
       " 'ctrp_ABT-199': [49846579],\n",
       " 'ctrp_neopeltolide': [16115403, 23661650],\n",
       " 'ctrp_ZSTK474': [11647372],\n",
       " 'ctrp_barasertib': [11497983],\n",
       " 'ctrp_gefitinib': [123631],\n",
       " 'ctrp_necrosulfonamide': [1566236],\n",
       " 'ctrp_apicidin': [6918328, 467801, 57568978, 21922507, 44593387, 59274521],\n",
       " 'ctrp_tretinoin': [444795],\n",
       " 'ctrp_Ko-143': [10322450],\n",
       " 'ctrp_TG-100-115': [10427712],\n",
       " 'ctrp_PHA-793887': [46191454],\n",
       " 'ctrp_BI-2536': [11364421],\n",
       " 'ctrp_semagacestat': [9843750],\n",
       " 'ctrp_AZD1480': [16659841],\n",
       " 'ctrp_afatinib': [10184653],\n",
       " 'ctrp_KH-CB19': [44237094],\n",
       " 'ctrp_pifithrin-alpha': [9929138],\n",
       " 'ctrp_SB-431542': [4521392],\n",
       " 'ctrp_KU-0063794': [16736978],\n",
       " 'ctrp_GDC-0879': [11717001],\n",
       " 'ctrp_pevonedistat': [16720766],\n",
       " 'ctrp_PI-103': [9884685],\n",
       " 'ctrp_MK-2206': [24964624],\n",
       " 'ctrp_NSC95397': [262093],\n",
       " 'ctrp_alvocidib': [5287969],\n",
       " 'ctrp_tacrolimus': [445643],\n",
       " 'ctrp_AZD8055': [25262965],\n",
       " 'ctrp_ibrutinib': [24821094],\n",
       " 'ctrp_erlotinib': [176870],\n",
       " 'ctrp_masitinib': [10074640],\n",
       " 'ctrp_SNX-2112': [24772860],\n",
       " 'ctrp_KPT185': [53495165],\n",
       " 'ctrp_Ch-55': [6184667],\n",
       " 'ctrp_N9-isopropylolomoucine': [6610355],\n",
       " 'ctrp_WZ4002': [44607530],\n",
       " 'ctrp_purmorphamine': [5284329],\n",
       " 'ctrp_BIRB-796': [156422],\n",
       " 'ctrp_curcumin': [969516],\n",
       " 'ctrp_UNC0321': [46901937],\n",
       " 'ctrp_NSC632839': [5351362],\n",
       " 'ctrp_pazopanib': [10113978],\n",
       " 'ctrp_alisertib': [24771867],\n",
       " 'ctrp_XL765': [49867926],\n",
       " 'ctrp_IC-87114': [9908783],\n",
       " 'ctrp_omacetaxine mepesuccinate': [285033],\n",
       " 'ctrp_YM-155': [11178236],\n",
       " 'ctrp_A-804598': [53325874],\n",
       " 'ctrp_EX-527': [5113032],\n",
       " 'ctrp_vandetanib': [3081361],\n",
       " 'ctrp_entinostat': [4261],\n",
       " 'ctrp_LY-2157299': [10090485],\n",
       " 'ctrp_crizotinib': [11626560],\n",
       " 'ctrp_manumycin A': [6438330, 4010, 53230011, 11981008, 71684620],\n",
       " 'ctrp_MLN2238': [25183872],\n",
       " 'ctrp_GSK4112': [50905018],\n",
       " 'ctrp_KHS101': [71304818],\n",
       " 'ctrp_PF-573228': [11612883],\n",
       " 'ctrp_decitabine': [451668],\n",
       " 'ctrp_PF-543': [66577038],\n",
       " 'ctrp_ML203': [44543605],\n",
       " 'ctrp_etomoxir': [9840324, 123823, 60765],\n",
       " 'ctrp_vorinostat': [5311],\n",
       " 'ctrp_silmitasertib': [24748573],\n",
       " 'ctrp_tanespimycin': [6505803],\n",
       " 'ctrp_nilotinib': [644241],\n",
       " 'ctrp_parthenolide': [7251185,\n",
       "  6473881,\n",
       "  5420804,\n",
       "  5420805,\n",
       "  108068,\n",
       "  4692,\n",
       "  5353864,\n",
       "  927704,\n",
       "  5320420,\n",
       "  11972532,\n",
       "  5702252,\n",
       "  91873711,\n",
       "  23631982,\n",
       "  73759808,\n",
       "  123134657],\n",
       " 'ctrp_WZ8040': [44607531],\n",
       " 'ctrp_vincristine': [5978],\n",
       " 'ctrp_navitoclax': [24978538],\n",
       " 'ctrp_PF-750': [25154868],\n",
       " 'ctrp_skepinone-L': [45279963],\n",
       " 'ctrp_nelarabine': [3011155],\n",
       " 'ctrp_sirolimus': [5284616],\n",
       " 'ctrp_spautin-1': [51037431],\n",
       " 'ctrp_neratinib': [9915743],\n",
       " 'ctrp_AZD7762': [11152667],\n",
       " 'ctrp_BRD4132': [7326481],\n",
       " 'ctrp_bafilomycin A1': [6436223,\n",
       "  5702538,\n",
       "  2287,\n",
       "  5385089,\n",
       "  53321987,\n",
       "  5353429,\n",
       "  90656913,\n",
       "  5458921,\n",
       "  129012189,\n",
       "  72947,\n",
       "  21159502,\n",
       "  90479784,\n",
       "  131863036],\n",
       " 'ctrp_UNC0638': [46224516],\n",
       " 'ctrp_cediranib': [9933475],\n",
       " 'ctrp_OSI-027': [44224160, 71307533],\n",
       " 'ctrp_veliparib': [11960529],\n",
       " 'ctrp_L-685458': [5479543],\n",
       " 'ctrp_momelotinib': [25062766],\n",
       " 'ctrp_istradefylline': [5311037],\n",
       " 'ctrp_fingolimod': [107970],\n",
       " 'ctrp_bortezomib': [387447],\n",
       " 'ctrp_CI-976': [122327],\n",
       " 'ctrp_tandutinib': [3038522],\n",
       " 'ctrp_BRD9876': [613000],\n",
       " 'ctrp_RG-108': [702558, 344265],\n",
       " 'ctrp_ML006': [2842253],\n",
       " 'ctrp_trifluoperazine': [5566],\n",
       " 'ctrp_GW-843682X': [9826308],\n",
       " 'ctrp_bosutinib': [5328940],\n",
       " 'ctrp_MI-2': [54765302],\n",
       " 'ctrp_O-6-benzylguanine': [4578],\n",
       " 'ctrp_doxorubicin': [31703],\n",
       " 'ctrp_tosedostat': [15547703],\n",
       " 'ctrp_GSK461364': [15983966],\n",
       " 'ctrp_bexarotene': [82146],\n",
       " 'ctrp_imatinib': [5291],\n",
       " 'ctrp_SMER-3': [568763],\n",
       " 'ctrp_PAC-1': [6851947, 5344054, 6753378],\n",
       " 'ctrp_SJ-172550': [1317464],\n",
       " 'ctrp_RAF265': [11656518],\n",
       " 'ctrp_AC55649': [1714884],\n",
       " 'ctrp_vorapaxar': [10077130],\n",
       " 'ctrp_tamoxifen': [2733526],\n",
       " 'ctrp_quizartinib': [24889392],\n",
       " 'ctrp_CHM-1': [375860],\n",
       " 'ctrp_pifithrin-mu': [327653],\n",
       " 'ctrp_GSK-J4': [71729975],\n",
       " 'ctrp_pluripotin': [12003241],\n",
       " 'ctrp_JW-480': [57330099],\n",
       " 'ctrp_linifanib': [11485656],\n",
       " 'ccle_17-AAG': [6505803,\n",
       "  6440175,\n",
       "  151069,\n",
       "  5458730,\n",
       "  433449,\n",
       "  5477572,\n",
       "  24870925,\n",
       "  131750287,\n",
       "  131954773],\n",
       " 'ccle_AEW541': [11476171],\n",
       " 'ccle_AZD0530': [10302451],\n",
       " 'ccle_AZD6244': [10127622],\n",
       " 'ccle_Erlotinib': [176870],\n",
       " 'ccle_Irinotecan': [60838],\n",
       " 'ccle_L-685458': [5479543],\n",
       " 'ccle_LBW242': [11503417],\n",
       " 'ccle_Lapatinib': [208908],\n",
       " 'ccle_Nilotinib': [644241],\n",
       " 'ccle_Nutlin-3': [216345],\n",
       " 'ccle_PD-0325901': [9826528],\n",
       " 'ccle_PD-0332991': [5330286],\n",
       " 'ccle_PF2341066': [11626560],\n",
       " 'ccle_PHA-665752': [10461815],\n",
       " 'ccle_PLX4720': [24180719],\n",
       " 'ccle_Paclitaxel': [36314],\n",
       " 'ccle_Panobinostat': [6918837],\n",
       " 'ccle_RAF265': [11656518],\n",
       " 'ccle_Sorafenib': [216239],\n",
       " 'ccle_TAE684': [16038120],\n",
       " 'ccle_TKI258': [9886808, 49830557],\n",
       " 'ccle_Topotecan': [60700],\n",
       " 'ccle_ZD-6474': [3081361]}"
      ]
     },
     "execution_count": 89,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from discover_temp.discover import load_discover_drug_to_cids\n",
    "disco2cid = load_discover_drug_to_cids()\n",
    "disco2cid"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T22:51:21.937188Z",
     "start_time": "2019-05-16T22:51:21.911765Z"
    },
    "hidden": true
   },
   "outputs": [],
   "source": [
    "import pubchempy as pcp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:01:26.999908Z",
     "start_time": "2019-05-16T23:01:26.466653Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Compound(176870)"
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "c = pcp.Compound.from_cid(176870)\n",
    "c"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:01:36.481321Z",
     "start_time": "2019-05-16T23:01:36.425729Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'atom_stereo_count': 0,\n",
       " 'atoms': [{'aid': 1, 'number': 8, 'element': 'O', 'y': 0.3372, 'x': 5.4641},\n",
       "  {'aid': 2, 'number': 8, 'element': 'O', 'y': 2.3372, 'x': 5.4641},\n",
       "  {'aid': 3, 'number': 8, 'element': 'O', 'y': 0.8372, 'x': 2.866},\n",
       "  {'aid': 4, 'number': 8, 'element': 'O', 'y': 4.8372, 'x': 4.5981},\n",
       "  {'aid': 5, 'number': 7, 'element': 'N', 'y': -0.6974, 'x': 8.9446},\n",
       "  {'aid': 6, 'number': 7, 'element': 'N', 'y': 2.3718, 'x': 8.9561},\n",
       "  {'aid': 7, 'number': 7, 'element': 'N', 'y': 0.8163, 'x': 9.8622},\n",
       "  {'aid': 8, 'number': 6, 'element': 'C', 'y': 0.8372, 'x': 8.0622},\n",
       "  {'aid': 9, 'number': 6, 'element': 'C', 'y': 1.8372, 'x': 8.0622},\n",
       "  {'aid': 10, 'number': 6, 'element': 'C', 'y': 0.8372, 'x': 6.3301},\n",
       "  {'aid': 11, 'number': 6, 'element': 'C', 'y': 1.8372, 'x': 6.3301},\n",
       "  {'aid': 12, 'number': 6, 'element': 'C', 'y': 0.3372, 'x': 7.1962},\n",
       "  {'aid': 13, 'number': 6, 'element': 'C', 'y': 0.3025, 'x': 8.9561},\n",
       "  {'aid': 14, 'number': 6, 'element': 'C', 'y': 2.3372, 'x': 7.1962},\n",
       "  {'aid': 15, 'number': 6, 'element': 'C', 'y': 0.8372, 'x': 4.5981},\n",
       "  {'aid': 16, 'number': 6, 'element': 'C', 'y': -1.2074, 'x': 9.8047},\n",
       "  {'aid': 17, 'number': 6, 'element': 'C', 'y': 3.3372, 'x': 5.4641},\n",
       "  {'aid': 18, 'number': 6, 'element': 'C', 'y': 1.858, 'x': 9.8622},\n",
       "  {'aid': 19, 'number': 6, 'element': 'C', 'y': 0.3372, 'x': 3.732},\n",
       "  {'aid': 20, 'number': 6, 'element': 'C', 'y': 3.8372, 'x': 4.5981},\n",
       "  {'aid': 21, 'number': 6, 'element': 'C', 'y': -2.2074, 'x': 9.7932},\n",
       "  {'aid': 22, 'number': 6, 'element': 'C', 'y': -0.7175, 'x': 10.6765},\n",
       "  {'aid': 23, 'number': 6, 'element': 'C', 'y': -2.7173, 'x': 10.6534},\n",
       "  {'aid': 24, 'number': 6, 'element': 'C', 'y': -1.2274, 'x': 11.5367},\n",
       "  {'aid': 25, 'number': 6, 'element': 'C', 'y': -2.2274, 'x': 11.5251},\n",
       "  {'aid': 26, 'number': 6, 'element': 'C', 'y': 0.3372, 'x': 2},\n",
       "  {'aid': 27, 'number': 6, 'element': 'C', 'y': 5.3372, 'x': 3.732},\n",
       "  {'aid': 28, 'number': 6, 'element': 'C', 'y': -3.7173, 'x': 10.6418},\n",
       "  {'aid': 29, 'number': 6, 'element': 'C', 'y': -4.7172, 'x': 10.6302},\n",
       "  {'aid': 30, 'number': 1, 'element': 'H', 'y': -0.2828, 'x': 7.1962},\n",
       "  {'aid': 31, 'number': 1, 'element': 'H', 'y': 2.9572, 'x': 7.1962},\n",
       "  {'aid': 32, 'number': 1, 'element': 'H', 'y': -1.0012, 'x': 8.4041},\n",
       "  {'aid': 33, 'number': 1, 'element': 'H', 'y': 1.3121, 'x': 4.9966},\n",
       "  {'aid': 34, 'number': 1, 'element': 'H', 'y': 1.3121, 'x': 4.1996},\n",
       "  {'aid': 35, 'number': 1, 'element': 'H', 'y': 3.2295, 'x': 6.0747},\n",
       "  {'aid': 36, 'number': 1, 'element': 'H', 'y': 3.9198, 'x': 5.6762},\n",
       "  {'aid': 37, 'number': 1, 'element': 'H', 'y': 2.17, 'x': 10.3979},\n",
       "  {'aid': 38, 'number': 1, 'element': 'H', 'y': -0.1378, 'x': 3.3335},\n",
       "  {'aid': 39, 'number': 1, 'element': 'H', 'y': -0.1378, 'x': 4.1306},\n",
       "  {'aid': 40, 'number': 1, 'element': 'H', 'y': 3.9448, 'x': 3.9875},\n",
       "  {'aid': 41, 'number': 1, 'element': 'H', 'y': 3.2546, 'x': 4.386},\n",
       "  {'aid': 42, 'number': 1, 'element': 'H', 'y': -2.5111, 'x': 9.2527},\n",
       "  {'aid': 43, 'number': 1, 'element': 'H', 'y': -0.0975, 'x': 10.6837},\n",
       "  {'aid': 44, 'number': 1, 'element': 'H', 'y': -0.9237, 'x': 12.0772},\n",
       "  {'aid': 45, 'number': 1, 'element': 'H', 'y': -2.5436, 'x': 12.0584},\n",
       "  {'aid': 46, 'number': 1, 'element': 'H', 'y': 0.8741, 'x': 1.69},\n",
       "  {'aid': 47, 'number': 1, 'element': 'H', 'y': 0.0272, 'x': 1.4631},\n",
       "  {'aid': 48, 'number': 1, 'element': 'H', 'y': -0.1998, 'x': 2.31},\n",
       "  {'aid': 49, 'number': 1, 'element': 'H', 'y': 5.8741, 'x': 4.042},\n",
       "  {'aid': 50, 'number': 1, 'element': 'H', 'y': 5.6472, 'x': 3.1951},\n",
       "  {'aid': 51, 'number': 1, 'element': 'H', 'y': 4.8002, 'x': 3.422},\n",
       "  {'aid': 52, 'number': 1, 'element': 'H', 'y': -5.3372, 'x': 10.6231}],\n",
       " 'bond_stereo_count': 0,\n",
       " 'bonds': [{'aid1': 1, 'aid2': 10, 'order': 1},\n",
       "  {'aid1': 1, 'aid2': 15, 'order': 1},\n",
       "  {'aid1': 2, 'aid2': 11, 'order': 1},\n",
       "  {'aid1': 2, 'aid2': 17, 'order': 1},\n",
       "  {'aid1': 3, 'aid2': 19, 'order': 1},\n",
       "  {'aid1': 3, 'aid2': 26, 'order': 1},\n",
       "  {'aid1': 4, 'aid2': 20, 'order': 1},\n",
       "  {'aid1': 4, 'aid2': 27, 'order': 1},\n",
       "  {'aid1': 5, 'aid2': 13, 'order': 1},\n",
       "  {'aid1': 5, 'aid2': 16, 'order': 1},\n",
       "  {'aid1': 5, 'aid2': 32, 'order': 1},\n",
       "  {'aid1': 6, 'aid2': 9, 'order': 1, 'style': 8},\n",
       "  {'aid1': 6, 'aid2': 18, 'order': 2, 'style': 8},\n",
       "  {'aid1': 7, 'aid2': 13, 'order': 2, 'style': 8},\n",
       "  {'aid1': 7, 'aid2': 18, 'order': 1, 'style': 8},\n",
       "  {'aid1': 8, 'aid2': 9, 'order': 1, 'style': 8},\n",
       "  {'aid1': 8, 'aid2': 12, 'order': 2, 'style': 8},\n",
       "  {'aid1': 8, 'aid2': 13, 'order': 1, 'style': 8},\n",
       "  {'aid1': 9, 'aid2': 14, 'order': 2, 'style': 8},\n",
       "  {'aid1': 10, 'aid2': 11, 'order': 2, 'style': 8},\n",
       "  {'aid1': 10, 'aid2': 12, 'order': 1, 'style': 8},\n",
       "  {'aid1': 11, 'aid2': 14, 'order': 1, 'style': 8},\n",
       "  {'aid1': 12, 'aid2': 30, 'order': 1},\n",
       "  {'aid1': 14, 'aid2': 31, 'order': 1},\n",
       "  {'aid1': 15, 'aid2': 19, 'order': 1},\n",
       "  {'aid1': 15, 'aid2': 33, 'order': 1},\n",
       "  {'aid1': 15, 'aid2': 34, 'order': 1},\n",
       "  {'aid1': 16, 'aid2': 21, 'order': 1, 'style': 8},\n",
       "  {'aid1': 16, 'aid2': 22, 'order': 2, 'style': 8},\n",
       "  {'aid1': 17, 'aid2': 20, 'order': 1},\n",
       "  {'aid1': 17, 'aid2': 35, 'order': 1},\n",
       "  {'aid1': 17, 'aid2': 36, 'order': 1},\n",
       "  {'aid1': 18, 'aid2': 37, 'order': 1},\n",
       "  {'aid1': 19, 'aid2': 38, 'order': 1},\n",
       "  {'aid1': 19, 'aid2': 39, 'order': 1},\n",
       "  {'aid1': 20, 'aid2': 40, 'order': 1},\n",
       "  {'aid1': 20, 'aid2': 41, 'order': 1},\n",
       "  {'aid1': 21, 'aid2': 23, 'order': 2, 'style': 8},\n",
       "  {'aid1': 21, 'aid2': 42, 'order': 1},\n",
       "  {'aid1': 22, 'aid2': 24, 'order': 1, 'style': 8},\n",
       "  {'aid1': 22, 'aid2': 43, 'order': 1},\n",
       "  {'aid1': 23, 'aid2': 25, 'order': 1, 'style': 8},\n",
       "  {'aid1': 23, 'aid2': 28, 'order': 1},\n",
       "  {'aid1': 24, 'aid2': 25, 'order': 2, 'style': 8},\n",
       "  {'aid1': 24, 'aid2': 44, 'order': 1},\n",
       "  {'aid1': 25, 'aid2': 45, 'order': 1},\n",
       "  {'aid1': 26, 'aid2': 46, 'order': 1},\n",
       "  {'aid1': 26, 'aid2': 47, 'order': 1},\n",
       "  {'aid1': 26, 'aid2': 48, 'order': 1},\n",
       "  {'aid1': 27, 'aid2': 49, 'order': 1},\n",
       "  {'aid1': 27, 'aid2': 50, 'order': 1},\n",
       "  {'aid1': 27, 'aid2': 51, 'order': 1},\n",
       "  {'aid1': 28, 'aid2': 29, 'order': 3},\n",
       "  {'aid1': 29, 'aid2': 52, 'order': 1}],\n",
       " 'cactvs_fingerprint': '11100000011110110011100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001111000110000010000000000000000000000000000000000000000000000000000000101100011111010000000000000000000001111000000000000100000000000000000000000000000000110000001100101000011001111000000110001101111111011011110110110010000001010000000000111000000001101100100110011000110110010000001000100000101000100000101001001100010010001010100000000010011101100000100000001111101110110010011000100011010010111011100010110001001111100111011011100001100011110000101010111011101101000000011011110010101110100000100111101100001101000000010011000011100010000001000000000000010100001000000000000000100100000000000000010000001000000000000010100001000000000000000100100000000000000000000000000000000000000000000000000000000',\n",
       " 'canonical_smiles': 'COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC',\n",
       " 'charge': 0,\n",
       " 'cid': 176870,\n",
       " 'complexity': 525,\n",
       " 'conformer_id_3d': None,\n",
       " 'conformer_rmsd_3d': None,\n",
       " 'coordinate_type': '2d',\n",
       " 'covalent_unit_count': 1,\n",
       " 'defined_atom_stereo_count': 0,\n",
       " 'defined_bond_stereo_count': 0,\n",
       " 'effective_rotor_count_3d': None,\n",
       " 'elements': ['O',\n",
       "  'O',\n",
       "  'O',\n",
       "  'O',\n",
       "  'N',\n",
       "  'N',\n",
       "  'N',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'C',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H',\n",
       "  'H'],\n",
       " 'exact_mass': 393.169,\n",
       " 'feature_selfoverlap_3d': None,\n",
       " 'fingerprint': '00000371E07B38000000000000000000000000000000000000003C6080000000000000B1F400001E00100000000C0CA19E0637F6F6C81400E01B266364088288293122A009D8203EEC988D2EE2C4F9DB863C2AEED01BCAE827B0D0130E20400142000240004080028400048000000000000000',\n",
       " 'h_bond_acceptor_count': 7,\n",
       " 'h_bond_donor_count': 1,\n",
       " 'heavy_atom_count': 29,\n",
       " 'inchi': 'InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)',\n",
       " 'inchikey': 'AAKJLRGGTJKAMG-UHFFFAOYSA-N',\n",
       " 'isomeric_smiles': 'COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC',\n",
       " 'isotope_atom_count': 0,\n",
       " 'iupac_name': 'N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine',\n",
       " 'mmff94_energy_3d': None,\n",
       " 'mmff94_partial_charges_3d': None,\n",
       " 'molecular_formula': 'C22H23N3O4',\n",
       " 'molecular_weight': 393.443,\n",
       " 'monoisotopic_mass': 393.169,\n",
       " 'multipoles_3d': None,\n",
       " 'pharmacophore_features_3d': None,\n",
       " 'record': {'id': {'id': {'cid': 176870}},\n",
       "  'atoms': {'aid': [1,\n",
       "    2,\n",
       "    3,\n",
       "    4,\n",
       "    5,\n",
       "    6,\n",
       "    7,\n",
       "    8,\n",
       "    9,\n",
       "    10,\n",
       "    11,\n",
       "    12,\n",
       "    13,\n",
       "    14,\n",
       "    15,\n",
       "    16,\n",
       "    17,\n",
       "    18,\n",
       "    19,\n",
       "    20,\n",
       "    21,\n",
       "    22,\n",
       "    23,\n",
       "    24,\n",
       "    25,\n",
       "    26,\n",
       "    27,\n",
       "    28,\n",
       "    29,\n",
       "    30,\n",
       "    31,\n",
       "    32,\n",
       "    33,\n",
       "    34,\n",
       "    35,\n",
       "    36,\n",
       "    37,\n",
       "    38,\n",
       "    39,\n",
       "    40,\n",
       "    41,\n",
       "    42,\n",
       "    43,\n",
       "    44,\n",
       "    45,\n",
       "    46,\n",
       "    47,\n",
       "    48,\n",
       "    49,\n",
       "    50,\n",
       "    51,\n",
       "    52],\n",
       "   'element': [8,\n",
       "    8,\n",
       "    8,\n",
       "    8,\n",
       "    7,\n",
       "    7,\n",
       "    7,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    6,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1]},\n",
       "  'bonds': {'aid1': [1,\n",
       "    1,\n",
       "    2,\n",
       "    2,\n",
       "    3,\n",
       "    3,\n",
       "    4,\n",
       "    4,\n",
       "    5,\n",
       "    5,\n",
       "    5,\n",
       "    6,\n",
       "    6,\n",
       "    7,\n",
       "    7,\n",
       "    8,\n",
       "    8,\n",
       "    8,\n",
       "    9,\n",
       "    10,\n",
       "    10,\n",
       "    11,\n",
       "    12,\n",
       "    14,\n",
       "    15,\n",
       "    15,\n",
       "    15,\n",
       "    16,\n",
       "    16,\n",
       "    17,\n",
       "    17,\n",
       "    17,\n",
       "    18,\n",
       "    19,\n",
       "    19,\n",
       "    20,\n",
       "    20,\n",
       "    21,\n",
       "    21,\n",
       "    22,\n",
       "    22,\n",
       "    23,\n",
       "    23,\n",
       "    24,\n",
       "    24,\n",
       "    25,\n",
       "    26,\n",
       "    26,\n",
       "    26,\n",
       "    27,\n",
       "    27,\n",
       "    27,\n",
       "    28,\n",
       "    29],\n",
       "   'aid2': [10,\n",
       "    15,\n",
       "    11,\n",
       "    17,\n",
       "    19,\n",
       "    26,\n",
       "    20,\n",
       "    27,\n",
       "    13,\n",
       "    16,\n",
       "    32,\n",
       "    9,\n",
       "    18,\n",
       "    13,\n",
       "    18,\n",
       "    9,\n",
       "    12,\n",
       "    13,\n",
       "    14,\n",
       "    11,\n",
       "    12,\n",
       "    14,\n",
       "    30,\n",
       "    31,\n",
       "    19,\n",
       "    33,\n",
       "    34,\n",
       "    21,\n",
       "    22,\n",
       "    20,\n",
       "    35,\n",
       "    36,\n",
       "    37,\n",
       "    38,\n",
       "    39,\n",
       "    40,\n",
       "    41,\n",
       "    23,\n",
       "    42,\n",
       "    24,\n",
       "    43,\n",
       "    25,\n",
       "    28,\n",
       "    25,\n",
       "    44,\n",
       "    45,\n",
       "    46,\n",
       "    47,\n",
       "    48,\n",
       "    49,\n",
       "    50,\n",
       "    51,\n",
       "    29,\n",
       "    52],\n",
       "   'order': [1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    2,\n",
       "    2,\n",
       "    1,\n",
       "    1,\n",
       "    2,\n",
       "    1,\n",
       "    2,\n",
       "    2,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    2,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    2,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    2,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    1,\n",
       "    3,\n",
       "    1]},\n",
       "  'coords': [{'type': [1, 5, 255],\n",
       "    'aid': [1,\n",
       "     2,\n",
       "     3,\n",
       "     4,\n",
       "     5,\n",
       "     6,\n",
       "     7,\n",
       "     8,\n",
       "     9,\n",
       "     10,\n",
       "     11,\n",
       "     12,\n",
       "     13,\n",
       "     14,\n",
       "     15,\n",
       "     16,\n",
       "     17,\n",
       "     18,\n",
       "     19,\n",
       "     20,\n",
       "     21,\n",
       "     22,\n",
       "     23,\n",
       "     24,\n",
       "     25,\n",
       "     26,\n",
       "     27,\n",
       "     28,\n",
       "     29,\n",
       "     30,\n",
       "     31,\n",
       "     32,\n",
       "     33,\n",
       "     34,\n",
       "     35,\n",
       "     36,\n",
       "     37,\n",
       "     38,\n",
       "     39,\n",
       "     40,\n",
       "     41,\n",
       "     42,\n",
       "     43,\n",
       "     44,\n",
       "     45,\n",
       "     46,\n",
       "     47,\n",
       "     48,\n",
       "     49,\n",
       "     50,\n",
       "     51,\n",
       "     52],\n",
       "    'conformers': [{'x': [5.4641,\n",
       "       5.4641,\n",
       "       2.866,\n",
       "       4.5981,\n",
       "       8.9446,\n",
       "       8.9561,\n",
       "       9.8622,\n",
       "       8.0622,\n",
       "       8.0622,\n",
       "       6.3301,\n",
       "       6.3301,\n",
       "       7.1962,\n",
       "       8.9561,\n",
       "       7.1962,\n",
       "       4.5981,\n",
       "       9.8047,\n",
       "       5.4641,\n",
       "       9.8622,\n",
       "       3.732,\n",
       "       4.5981,\n",
       "       9.7932,\n",
       "       10.6765,\n",
       "       10.6534,\n",
       "       11.5367,\n",
       "       11.5251,\n",
       "       2,\n",
       "       3.732,\n",
       "       10.6418,\n",
       "       10.6302,\n",
       "       7.1962,\n",
       "       7.1962,\n",
       "       8.4041,\n",
       "       4.9966,\n",
       "       4.1996,\n",
       "       6.0747,\n",
       "       5.6762,\n",
       "       10.3979,\n",
       "       3.3335,\n",
       "       4.1306,\n",
       "       3.9875,\n",
       "       4.386,\n",
       "       9.2527,\n",
       "       10.6837,\n",
       "       12.0772,\n",
       "       12.0584,\n",
       "       1.69,\n",
       "       1.4631,\n",
       "       2.31,\n",
       "       4.042,\n",
       "       3.1951,\n",
       "       3.422,\n",
       "       10.6231],\n",
       "      'y': [0.3372,\n",
       "       2.3372,\n",
       "       0.8372,\n",
       "       4.8372,\n",
       "       -0.6974,\n",
       "       2.3718,\n",
       "       0.8163,\n",
       "       0.8372,\n",
       "       1.8372,\n",
       "       0.8372,\n",
       "       1.8372,\n",
       "       0.3372,\n",
       "       0.3025,\n",
       "       2.3372,\n",
       "       0.8372,\n",
       "       -1.2074,\n",
       "       3.3372,\n",
       "       1.858,\n",
       "       0.3372,\n",
       "       3.8372,\n",
       "       -2.2074,\n",
       "       -0.7175,\n",
       "       -2.7173,\n",
       "       -1.2274,\n",
       "       -2.2274,\n",
       "       0.3372,\n",
       "       5.3372,\n",
       "       -3.7173,\n",
       "       -4.7172,\n",
       "       -0.2828,\n",
       "       2.9572,\n",
       "       -1.0012,\n",
       "       1.3121,\n",
       "       1.3121,\n",
       "       3.2295,\n",
       "       3.9198,\n",
       "       2.17,\n",
       "       -0.1378,\n",
       "       -0.1378,\n",
       "       3.9448,\n",
       "       3.2546,\n",
       "       -2.5111,\n",
       "       -0.0975,\n",
       "       -0.9237,\n",
       "       -2.5436,\n",
       "       0.8741,\n",
       "       0.0272,\n",
       "       -0.1998,\n",
       "       5.8741,\n",
       "       5.6472,\n",
       "       4.8002,\n",
       "       -5.3372],\n",
       "      'style': {'annotation': [8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8,\n",
       "        8],\n",
       "       'aid1': [6, 6, 7, 7, 8, 8, 8, 9, 10, 10, 11, 16, 16, 21, 22, 23, 24],\n",
       "       'aid2': [9,\n",
       "        18,\n",
       "        13,\n",
       "        18,\n",
       "        9,\n",
       "        12,\n",
       "        13,\n",
       "        14,\n",
       "        11,\n",
       "        12,\n",
       "        14,\n",
       "        21,\n",
       "        22,\n",
       "        23,\n",
       "        24,\n",
       "        25,\n",
       "        25]}}]}],\n",
       "  'charge': 0,\n",
       "  'props': [{'urn': {'label': 'Compound',\n",
       "     'name': 'Canonicalized',\n",
       "     'datatype': 5,\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'ival': 1}},\n",
       "   {'urn': {'label': 'Compound Complexity',\n",
       "     'datatype': 7,\n",
       "     'implementation': 'E_COMPLEXITY',\n",
       "     'version': '3.4.6.11',\n",
       "     'software': 'Cactvs',\n",
       "     'source': 'xemistry.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'fval': 525}},\n",
       "   {'urn': {'label': 'Count',\n",
       "     'name': 'Hydrogen Bond Acceptor',\n",
       "     'datatype': 5,\n",
       "     'implementation': 'E_NHACCEPTORS',\n",
       "     'version': '3.4.6.11',\n",
       "     'software': 'Cactvs',\n",
       "     'source': 'xemistry.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'ival': 7}},\n",
       "   {'urn': {'label': 'Count',\n",
       "     'name': 'Hydrogen Bond Donor',\n",
       "     'datatype': 5,\n",
       "     'implementation': 'E_NHDONORS',\n",
       "     'version': '3.4.6.11',\n",
       "     'software': 'Cactvs',\n",
       "     'source': 'xemistry.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'ival': 1}},\n",
       "   {'urn': {'label': 'Count',\n",
       "     'name': 'Rotatable Bond',\n",
       "     'datatype': 5,\n",
       "     'implementation': 'E_NROTBONDS',\n",
       "     'version': '3.4.6.11',\n",
       "     'software': 'Cactvs',\n",
       "     'source': 'xemistry.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'ival': 11}},\n",
       "   {'urn': {'label': 'Fingerprint',\n",
       "     'name': 'SubStructure Keys',\n",
       "     'datatype': 16,\n",
       "     'parameters': 'extended 2',\n",
       "     'implementation': 'E_SCREEN',\n",
       "     'version': '3.4.6.11',\n",
       "     'software': 'Cactvs',\n",
       "     'source': 'xemistry.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'binary': '00000371E07B38000000000000000000000000000000000000003C6080000000000000B1F400001E00100000000C0CA19E0637F6F6C81400E01B266364088288293122A009D8203EEC988D2EE2C4F9DB863C2AEED01BCAE827B0D0130E20400142000240004080028400048000000000000000'}},\n",
       "   {'urn': {'label': 'IUPAC Name',\n",
       "     'name': 'Allowed',\n",
       "     'datatype': 1,\n",
       "     'version': '2.6.6',\n",
       "     'software': 'LexiChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.04.19'},\n",
       "    'value': {'sval': 'N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine'}},\n",
       "   {'urn': {'label': 'IUPAC Name',\n",
       "     'name': 'CAS-like Style',\n",
       "     'datatype': 1,\n",
       "     'version': '2.6.6',\n",
       "     'software': 'LexiChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.04.19'},\n",
       "    'value': {'sval': 'N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine'}},\n",
       "   {'urn': {'label': 'IUPAC Name',\n",
       "     'name': 'Markup',\n",
       "     'datatype': 1,\n",
       "     'version': '2.6.6',\n",
       "     'software': 'LexiChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.04.19'},\n",
       "    'value': {'sval': '<I>N</I>-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine'}},\n",
       "   {'urn': {'label': 'IUPAC Name',\n",
       "     'name': 'Preferred',\n",
       "     'datatype': 1,\n",
       "     'version': '2.6.6',\n",
       "     'software': 'LexiChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.04.19'},\n",
       "    'value': {'sval': 'N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine'}},\n",
       "   {'urn': {'label': 'IUPAC Name',\n",
       "     'name': 'Systematic',\n",
       "     'datatype': 1,\n",
       "     'version': '2.6.6',\n",
       "     'software': 'LexiChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.04.19'},\n",
       "    'value': {'sval': 'N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine'}},\n",
       "   {'urn': {'label': 'IUPAC Name',\n",
       "     'name': 'Traditional',\n",
       "     'datatype': 1,\n",
       "     'version': '2.6.6',\n",
       "     'software': 'LexiChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.04.19'},\n",
       "    'value': {'sval': '[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine'}},\n",
       "   {'urn': {'label': 'InChI',\n",
       "     'name': 'Standard',\n",
       "     'datatype': 1,\n",
       "     'version': '1.0.5',\n",
       "     'software': 'InChI',\n",
       "     'source': 'iupac.org',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'sval': 'InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)'}},\n",
       "   {'urn': {'label': 'InChIKey',\n",
       "     'name': 'Standard',\n",
       "     'datatype': 1,\n",
       "     'version': '1.0.5',\n",
       "     'software': 'InChI',\n",
       "     'source': 'iupac.org',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'sval': 'AAKJLRGGTJKAMG-UHFFFAOYSA-N'}},\n",
       "   {'urn': {'label': 'Log P',\n",
       "     'name': 'XLogP3-AA',\n",
       "     'datatype': 7,\n",
       "     'version': '3.0',\n",
       "     'source': 'sioc-ccbg.ac.cn',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'fval': 3.3}},\n",
       "   {'urn': {'label': 'Mass',\n",
       "     'name': 'Exact',\n",
       "     'datatype': 7,\n",
       "     'version': '2.1',\n",
       "     'software': 'PubChem',\n",
       "     'source': 'ncbi.nlm.nih.gov',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'fval': 393.169}},\n",
       "   {'urn': {'label': 'Molecular Formula',\n",
       "     'datatype': 1,\n",
       "     'version': '2.1',\n",
       "     'software': 'PubChem',\n",
       "     'source': 'ncbi.nlm.nih.gov',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'sval': 'C22H23N3O4'}},\n",
       "   {'urn': {'label': 'Molecular Weight',\n",
       "     'datatype': 7,\n",
       "     'version': '2.1',\n",
       "     'software': 'PubChem',\n",
       "     'source': 'ncbi.nlm.nih.gov',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'fval': 393.443}},\n",
       "   {'urn': {'label': 'SMILES',\n",
       "     'name': 'Canonical',\n",
       "     'datatype': 1,\n",
       "     'version': '2.1.5',\n",
       "     'software': 'OEChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'sval': 'COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC'}},\n",
       "   {'urn': {'label': 'SMILES',\n",
       "     'name': 'Isomeric',\n",
       "     'datatype': 1,\n",
       "     'version': '2.1.5',\n",
       "     'software': 'OEChem',\n",
       "     'source': 'openeye.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'sval': 'COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC'}},\n",
       "   {'urn': {'label': 'Topological',\n",
       "     'name': 'Polar Surface Area',\n",
       "     'datatype': 7,\n",
       "     'implementation': 'E_TPSA',\n",
       "     'version': '3.4.6.11',\n",
       "     'software': 'Cactvs',\n",
       "     'source': 'xemistry.com',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'fval': 74.7}},\n",
       "   {'urn': {'label': 'Weight',\n",
       "     'name': 'MonoIsotopic',\n",
       "     'datatype': 7,\n",
       "     'version': '2.1',\n",
       "     'software': 'PubChem',\n",
       "     'source': 'ncbi.nlm.nih.gov',\n",
       "     'release': '2019.01.04'},\n",
       "    'value': {'fval': 393.169}}],\n",
       "  'count': {'heavy_atom': 29,\n",
       "   'atom_chiral': 0,\n",
       "   'atom_chiral_def': 0,\n",
       "   'atom_chiral_undef': 0,\n",
       "   'bond_chiral': 0,\n",
       "   'bond_chiral_def': 0,\n",
       "   'bond_chiral_undef': 0,\n",
       "   'isotope_atom': 0,\n",
       "   'covalent_unit': 1,\n",
       "   'tautomers': -1}},\n",
       " 'rotatable_bond_count': 11,\n",
       " 'shape_fingerprint_3d': None,\n",
       " 'shape_selfoverlap_3d': None,\n",
       " 'tpsa': 74.7,\n",
       " 'undefined_atom_stereo_count': 0,\n",
       " 'undefined_bond_stereo_count': 0,\n",
       " 'volume_3d': None,\n",
       " 'xlogp': 3.3}"
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "c."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:10:12.694332Z",
     "start_time": "2019-05-16T23:10:12.498671Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Annotations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Annotation</th>\n",
       "      <td>[{'SourceName': 'FDA Pharm Classes', 'SourceID...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Page</th>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>TotalPages</th>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Annotations\n",
       "Annotation  [{'SourceName': 'FDA Pharm Classes', 'SourceID...\n",
       "Page                                                        1\n",
       "TotalPages                                                  2"
      ]
     },
     "execution_count": 109,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"\"\"\n",
    "Download on 2019-05-16 at 16:37:15\n",
    "https://pubchem.ncbi.nlm.nih.gov/source/11931#data=Annotations\n",
    "--> Pharmacological Classes --> Download --> JSON\n",
    "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/annotations/heading/JSON/?source=FDA%20Pharm%20Classes&heading=Pharmacological+Classes&page=1&response_type=save&response_basename=PubChemAnnotations_source=FDA%20Pharm%20Classes&heading=Pharmacological+Classes&page=1\n",
    "\"\"\"\n",
    "\n",
    "import json\n",
    "with open('data/raw/PubChemAnnotations_source=FDA Pharm Classes.json') as json_file:  \n",
    "    moa_json = json.load(json_file)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:10:19.499485Z",
     "start_time": "2019-05-16T23:10:18.742934Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Annotations': {'Annotation': [{'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1X0094V6JV',\n",
       "    'Name': 'NAFARELIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/000a5c9f-f66d-4684-a3f6-670664df4691/000a5c9f-f66d-4684-a3f6-670664df4691.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [25077405]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9G34HU7RV0',\n",
       "    'Name': 'EDETIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/00190254-4e2d-4677-ad70-1806f36e8cae/00190254-4e2d-4677-ad70-1806f36e8cae.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6049]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lead Chelating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lead Chelator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-coagulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Coagulation Factor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Chelating Activity',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U4VJ29L7BQ',\n",
       "    'Name': 'METHOXSALEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/00231065-9c8c-4248-a01e-391390cc2fb8/00231065-9c8c-4248-a01e-391390cc2fb8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4114]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Photoabsorption'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Photoactivated Radical Generator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Photosensitizing Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Psoralen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Psoralens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '614OI1Z5WI',\n",
       "    'Name': 'VALPROIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/00abde6d-7fb0-44ec-acc1-fa75135b25fe/00abde6d-7fb0-44ec-acc1-fa75135b25fe.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3121]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Mood Stabilizer'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E6582LOH6V',\n",
       "    'Name': 'FEXOFENADINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/012eece9-434d-400e-bcc3-2e6c6ad15381/012eece9-434d-400e-bcc3-2e6c6ad15381.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H1 Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-1 Receptor Antagonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R63VQ857OT',\n",
       "    'Name': 'AMOXAPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/01413066-0436-4a82-a401-de983db1b728/01413066-0436-4a82-a401-de983db1b728.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2170]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5SEH9X1D1D',\n",
       "    'Name': 'ETHOSUXIMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/016cd8f1-1b58-408e-a958-6e34a25afe68/016cd8f1-1b58-408e-a958-6e34a25afe68.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416907]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CI0FAO63WC',\n",
       "    'Name': 'CEFDINIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/01a1f65d-103b-47fd-b8ca-b572cf05201c/01a1f65d-103b-47fd-b8ca-b572cf05201c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6915944]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3X29ZEJ4R2',\n",
       "    'Name': 'LINAGLIPTIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/023090e5-1439-4185-8240-fc169ebb5cfc/023090e5-1439-4185-8240-fc169ebb5cfc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10096344]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dipeptidyl Peptidase 4 Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dipeptidyl Peptidase 4 Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X4OV71U42S',\n",
       "    'Name': 'PIOGLITAZONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0267d28c-6586-4310-b43d-a7a04bce3379/0267d28c-6586-4310-b43d-a7a04bce3379.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416741]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator Receptor alpha Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator Receptor gamma Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator-activated Receptor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'PPAR alpha'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'PPAR gamma'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazolidinedione'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazolidinediones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '875Y4127EA',\n",
       "    'Name': 'HETASTARCH',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0271ae82-74bd-44a9-94dc-bb1a1fe13b4b/0271ae82-74bd-44a9-94dc-bb1a1fe13b4b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Plasma Volume Expander'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Intravascular Volume'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Osmotic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Starch'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VW78417PU1',\n",
       "    'Name': 'TECHNETIUM TC-99M PENTETATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0277b446-2a93-4297-b7e1-2be5ab3cab53/0277b446-2a93-4297-b7e1-2be5ab3cab53.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73415750]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SPU695OD73',\n",
       "    'Name': 'LODOXAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/02d64a05-90e3-4736-a81d-db43a34e30c6/02d64a05-90e3-4736-a81d-db43a34e30c6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [44564]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Histamine Release',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Mast Cell Stabilizer'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '41X3PWK4O2',\n",
       "    'Name': 'NATEGLINIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/02e04883-ce27-4ac3-9be1-3ad80db4d496/02e04883-ce27-4ac3-9be1-3ad80db4d496.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311309]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glinide'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Potassium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Potassium'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XM03YJ541D',\n",
       "    'Name': 'PRAZOSIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0327bdd2-30ae-427b-90a0-5b7ff5c6d634/0327bdd2-30ae-427b-90a0-5b7ff5c6d634.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4893]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4O4S742ANY',\n",
       "    'Name': 'ESCITALOPRAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/032cb7d4-5c18-4e55-a1cf-818809f3056c/032cb7d4-5c18-4e55-a1cf-818809f3056c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [146570]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '88C55N56UU',\n",
       "    'Name': 'SECRETIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/040b32f1-2205-46fa-b2ba-5ddcf92ba999/040b32f1-2205-46fa-b2ba-5ddcf92ba999.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Secretin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Secretin-class Hormone'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8H8Z5UER66',\n",
       "    'Name': 'LITHIUM CATION',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/041ebf4c-f120-44f4-81be-2969b7a89951/041ebf4c-f120-44f4-81be-2969b7a89951.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [28486]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Mood Stabilizer'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '136H45TB7B',\n",
       "    'Name': 'ALCLOMETASONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/044ac1b4-35bd-47f1-b44b-5fd027a036bc/044ac1b4-35bd-47f1-b44b-5fd027a036bc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311000]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9I628532GX',\n",
       "    'Name': 'PIPERACILLIN ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0494738c-e155-4863-a492-39c1746e5046/0494738c-e155-4863-a492-39c1746e5046.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [43672]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1HRS458QU2',\n",
       "    'Name': 'CLOMIPHENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/04bccbb0-54a7-4f22-9319-d03ac3d9a26d/04bccbb0-54a7-4f22-9319-d03ac3d9a26d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16095356]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Agonist/Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Selective Estrogen Receptor Modulators'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'EOR26LQQ24',\n",
       "    'Name': 'EZETIMIBE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/04e151bd-9b09-4a34-bf1f-577d614ebf49/04e151bd-9b09-4a34-bf1f-577d614ebf49.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [150311]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Cholesterol Absorption',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 11,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Cholesterol',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5997'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dietary Cholesterol Absorption Inhibitor',\n",
       "         'Markup': [{'Start': 8,\n",
       "           'Length': 11,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Cholesterol',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5997'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X7WDT95N5C',\n",
       "    'Name': 'GLIPIZIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/051e1b53-d465-4c92-adf4-eda394fe655d/051e1b53-d465-4c92-adf4-eda394fe655d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3478]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea Compounds'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '84F6U3J2R6',\n",
       "    'Name': 'GADODIAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/053ec088-7d1f-4710-8c9a-83656583bb3b/053ec088-7d1f-4710-8c9a-83656583bb3b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [153921]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F4216019LN',\n",
       "    'Name': 'ALBENDAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/05537274-0dbf-46da-a240-a13fce3cf058/05537274-0dbf-46da-a240-a13fce3cf058.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2082]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antihelminthic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'W2X096QY97',\n",
       "    'Name': 'TRIMETHOBENZAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0580ae82-8d13-447d-8128-680194b73302/0580ae82-8d13-447d-8128-680194b73302.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5577]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiemetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Emesis Suppression'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2T8Q726O95',\n",
       "    'Name': 'LAMIVUDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/05917f95-885c-4fb6-ba88-857263ef0569/05917f95-885c-4fb6-ba88-857263ef0569.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60825]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5UVC90J1LK',\n",
       "    'Name': 'DIATRIZOIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/05a37d39-a849-4d8d-b126-111a3be01248/05a37d39-a849-4d8d-b126-111a3be01248.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2140]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4TI98Z838E',\n",
       "    'Name': 'ESTRADIOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/05bcb951-796c-4bf0-a12f-21d1bd20349f/05bcb951-796c-4bf0-a12f-21d1bd20349f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5757]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estradiol Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '982XCM1FOI',\n",
       "    'Name': 'TOLBUTAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/05bef395-529e-404f-94b6-80c631142bd6/05bef395-529e-404f-94b6-80c631142bd6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5505]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea Compounds'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '144O8QL0L1',\n",
       "    'Name': 'DICLOFENAC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/05d0bff2-cdc1-43ed-82e9-b404c0c13da2/05d0bff2-cdc1-43ed-82e9-b404c0c13da2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3033]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Prostaglandin Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '13Z9HTH115',\n",
       "    'Name': 'ALOSETRON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/05fecc87-225e-4b30-86ab-8de81ba51289/05fecc87-225e-4b30-86ab-8de81ba51289.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2099]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin 3 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin-3 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '971Z4W1S09',\n",
       "    'Name': 'TECHNETIUM TC-99M SESTAMIBI',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/060207d7-a897-46b0-8b90-0eb0785b560a/060207d7-a897-46b0-8b90-0eb0785b560a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [22617237]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H25WJA31XE',\n",
       "    'Name': 'TECHNETIUM TC-99M BICISATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/061229fc-5d35-43c7-bcd7-f3345dded1bc/061229fc-5d35-43c7-bcd7-f3345dded1bc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [131634522]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4965G3J0F5',\n",
       "    'Name': 'SULFACETAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/068ae0c0-9a3c-4cf7-8dd4-4cc5586c86c8/068ae0c0-9a3c-4cf7-8dd4-4cc5586c86c8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5320]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamide Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7XU7A7DROE',\n",
       "    'Name': 'AMPHOTERICIN B',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/069899f4-2549-4d54-b24e-1bd6dc528a62/069899f4-2549-4d54-b24e-1bd6dc528a62.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5280965]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lipid-based Polyene Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polyene Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polyenes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0O72R8RF8A',\n",
       "    'Name': 'AMINO ACIDS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/069ae997-c563-4a30-b6ab-2d4122e058ad/069ae997-c563-4a30-b6ab-2d4122e058ad.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amino Acid Hypertonic Solution'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amino Acids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S79O08V79F',\n",
       "    'Name': 'DALTEPARIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/069caad5-3b82-4783-b5cf-e3ff5bcb70cd/069caad5-3b82-4783-b5cf-e3ff5bcb70cd.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-coagulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Heparin, Low-Molecular-Weight'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Low Molecular Weight Heparin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'V83O1VOZ8L',\n",
       "    'Name': 'ISONIAZID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/06a4643d-8596-4013-b837-8f6b4ac7d000/06a4643d-8596-4013-b837-8f6b4ac7d000.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3767]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimycobacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '030PYR8953',\n",
       "    'Name': 'ROPINIROLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/071b463e-79d7-4f13-8bd1-57128b18a103/071b463e-79d7-4f13-8bd1-57128b18a103.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5095]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonergot Dopamine Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G1GFK9898U',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/07313ff6-c029-4a83-9945-ba4702d3e988/07313ff6-c029-4a83-9945-ba4702d3e988.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1CC1JFE158',\n",
       "    'Name': 'DACTINOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/07339602-8c71-40f5-9318-34d7085c3d52/07339602-8c71-40f5-9318-34d7085c3d52.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [457193]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actinomycin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Synthesis Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5W8JGG2651',\n",
       "    'Name': 'IDURSULFASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/075dbf0b-a03a-4669-9e2f-c3135608c5b9/075dbf0b-a03a-4669-9e2f-c3135608c5b9.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Glucosidases'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X39AL81KEB',\n",
       "    'Name': 'METIPRANOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/075f32da-1224-4014-bcec-007dedafe78d/075f32da-1224-4014-bcec-007dedafe78d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417260]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '68WQQ3N9TI',\n",
       "    'Name': 'IODINATED I-125 SERUM ALBUMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/078c3a6d-0d7b-4e1e-a61f-0530793ac911/078c3a6d-0d7b-4e1e-a61f-0530793ac911.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '475247QF1Z',\n",
       "    'Name': 'EQUINE THYMOCYTE IMMUNE GLOBULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/07b862a2-eb0c-4323-ae71-a58120d7aa63/07b862a2-eb0c-4323-ae71-a58120d7aa63.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lymphocyte Function Alteration'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased T Lymphocyte Destruction'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antibody-Surface Protein Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0G389FZZ9M',\n",
       "    'Name': 'LEVOCARNITINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/07caa9b6-f007-4995-9f08-f75208cf88fa/07caa9b6-f007-4995-9f08-f75208cf88fa.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10917]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Carnitine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Carnitine Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'HSU1C9YRES',\n",
       "    'Name': 'MEDROXYPROGESTERONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/07d31c7f-026a-40ce-8edb-a9ebcec6c879/07d31c7f-026a-40ce-8edb-a9ebcec6c879.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10631]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7S5I7G3JQL',\n",
       "    'Name': 'DEXAMETHASONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/07d729a2-0239-46ec-801d-716d91245c5c/07d729a2-0239-46ec-801d-716d91245c5c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5743]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '23521W1S24',\n",
       "    'Name': 'CLAVULANIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0896b9b4-b496-4a58-9862-0d2de6ec7d80/0896b9b4-b496-4a58-9862-0d2de6ec7d80.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5280980]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta Lactamase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta Lactamase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0CPP32S55X',\n",
       "    'Name': 'DIMERCAPROL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/08b9041b-49c6-4323-87d2-cf56fd5ab7ee/08b9041b-49c6-4323-87d2-cf56fd5ab7ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416686]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Metal Chelating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Metal Chelator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VS041H42XC',\n",
       "    'Name': 'ERGOCALCIFEROL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/096570d2-01c1-4930-b874-391a6b441ce0/096570d2-01c1-4930-b874-391a6b441ce0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5280793]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ergocalciferols'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Provitamin D2 Compound'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6UXW23996M',\n",
       "    'Name': 'CYCLOPHOSPHAMIDE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0a1e7ef2-7bdd-4a6e-b725-5112ec46d65a/0a1e7ef2-7bdd-4a6e-b725-5112ec46d65a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417156]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q573I9DVLP',\n",
       "    'Name': 'LEUCOVORIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0a269c4d-f483-4def-bbf6-1f22aa4586da/0a269c4d-f483-4def-bbf6-1f22aa4586da.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135565456]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folate Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folic Acid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Analogs/Derivatives'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2VF3V7175U',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0a486717-7f1a-44af-b23a-7480568c96b9/0a486717-7f1a-44af-b23a-7480568c96b9.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '72YY86EA29',\n",
       "    'Name': 'COSYNTROPIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0a4ed337-ffb5-498a-953e-20e61050fa40/0a4ed337-ffb5-498a-953e-20e61050fa40.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16133802]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenocorticotropic Hormone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenocorticotropic Hormone'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S46U1CM432',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0a5b680c-18f7-4c04-ba21-7ed70a6b45ed/0a5b680c-18f7-4c04-ba21-7ed70a6b45ed.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'B6E06QE59J',\n",
       "    'Name': 'MEPIVACAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0aa486a7-0e6b-4eb1-b4ec-adf8c8a6a414/0aa486a7-0e6b-4eb1-b4ec-adf8c8a6a414.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416819]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amide Local Anesthetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amides'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N8R9GL539D',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0acf8bbb-ab93-4375-bb77-1e8905a6e725/0acf8bbb-ab93-4375-bb77-1e8905a6e725.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z468598HBV',\n",
       "    'Name': 'PHENTOLAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0b945359-3fd6-44fb-9bd6-bbed842ef6e1/0b945359-3fd6-44fb-9bd6-bbed842ef6e1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5775]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BZ114NVM5P',\n",
       "    'Name': 'MITOXANTRONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0b980944-ded2-4a21-af5b-84cb0b3c4391/0b980944-ded2-4a21-af5b-84cb0b3c4391.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4212]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JR13W81H44',\n",
       "    'Name': 'IOPAMIDOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0baee630-9ae0-4967-ac88-c64b9d3d0e7a/0baee630-9ae0-4967-ac88-c64b9d3d0e7a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [65492]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1L4806J2QF',\n",
       "    'Name': 'ADAPALENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0bb1972f-7348-48b3-abbb-76dd10d6ab25/0bb1972f-7348-48b3-abbb-76dd10d6ab25.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60164]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '80M03YXJ7I',\n",
       "    'Name': 'VALSARTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0c0fd5b0-8dd9-412b-9de4-4c9424fdbfcd/0c0fd5b0-8dd9-412b-9de4-4c9424fdbfcd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60846]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Blocker',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O0ZR1R6RZ2',\n",
       "    'Name': 'BETAXOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0c4597f1-9b0f-4194-9238-d0f800b93fde/0c4597f1-9b0f-4194-9238-d0f800b93fde.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416832]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'HW6NV07QEC',\n",
       "    'Name': 'AMBRISENTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0c49c52d-e6d1-41d1-a34b-bb2e982e45ed/0c49c52d-e6d1-41d1-a34b-bb2e982e45ed.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6918493]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endothelin Receptor Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endothelin Receptor Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3E3V44J4Z9',\n",
       "    'Name': 'TRANYLCYPROMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0c6de249-dd8d-409c-a171-b806eace02a5/0c6de249-dd8d-409c-a171-b806eace02a5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417116]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3QJA87N40S',\n",
       "    'Name': 'GADOXETIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0c88be33-fde0-497d-a526-b1880d1be9d8/0c88be33-fde0-497d-a526-b1880d1be9d8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [25203894]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YKH834O4BH',\n",
       "    'Name': 'EPINEPHRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0cadb5a8-33e6-4584-8476-298c2f498833/0cadb5a8-33e6-4584-8476-298c2f498833.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5816]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '40D3SCR4GZ',\n",
       "    'Name': 'BUPRENORPHINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0cc59de9-b51b-4b4b-a9d6-951721879b4c/0cc59de9-b51b-4b4b-a9d6-951721879b4c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [644073]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Partial Opioid Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Partial Opioid Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '953A26OA1Y',\n",
       "    'Name': 'DORNASE ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0ce444c9-3bf2-4c0e-82e5-6690a7066b6a/0ce444c9-3bf2-4c0e-82e5-6690a7066b6a.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Respiratory Secretion Viscosity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Deoxyribonuclease I'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Human Deoxyribonuclease 1'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Proteins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P9G3CKZ4P5',\n",
       "    'Name': 'GANCICLOVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0d0ea345-6244-4854-8904-97c5db0f8dee/0d0ea345-6244-4854-8904-97c5db0f8dee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135398740]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DNA Polymerase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog Antiviral'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QXS94885MZ',\n",
       "    'Name': 'BIMATOPROST',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0d0edee6-9cb9-483d-9eb3-a23fbcbecbdc/0d0edee6-9cb9-483d-9eb3-a23fbcbecbdc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311027]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R3UK8X3U3D',\n",
       "    'Name': 'MODAFINIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0d10516e-7005-4682-990c-db01325757c7/0d10516e-7005-4682-990c-db01325757c7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76971339]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Sympathetic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sympathomimetic-like Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F8VB5M810T',\n",
       "    'Name': 'TETRACYCLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0d1ca3be-e58a-4566-b68b-5d46b07e25eb/0d1ca3be-e58a-4566-b68b-5d46b07e25eb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54675776]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracycline-class Antimicrobial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tetracycline',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-54675776'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracyclines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9MG78X43ZT',\n",
       "    'Name': 'INDINAVIR ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0d31af53-3f06-4434-8d1f-27bfc4291db1/0d31af53-3f06-4434-8d1f-27bfc4291db1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5362440]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HIV Protease Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protease Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5ASJ6HUZ7D',\n",
       "    'Name': 'DOXEPIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0d69ec36-524d-43d9-a6fa-53ff41c1e2e3/0d69ec36-524d-43d9-a6fa-53ff41c1e2e3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417172]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3S12J47372',\n",
       "    'Name': 'DOBUTAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0e6a1e47-9fee-4cb5-b607-372813d406a5/0e6a1e47-9fee-4cb5-b607-372813d406a5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416960]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6TK1G07BHZ',\n",
       "    'Name': 'POSACONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0ede552c-f857-4c4a-8e90-36e7fa229b57/0ede552c-f857-4c4a-8e90-36e7fa229b57.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [468595]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JU499IS53H',\n",
       "    'Name': 'HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0ee68b54-cc7c-40ec-9484-461ad8e4656f/0ee68b54-cc7c-40ec-9484-461ad8e4656f.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Rotavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rotavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Live'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F7R0FBC1XD',\n",
       "    'Name': 'FACTOR XIII CONCENTRATE (HUMAN)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0ef9ac58-a2e8-4671-b035-5d432136dd00/0ef9ac58-a2e8-4671-b035-5d432136dd00.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Fibrin Polymerization Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Transglutaminases'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q04Q922K9Q',\n",
       "    'Name': 'HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0f20ca29-6b4a-4c76-9c1b-bac551c1ebf2/0f20ca29-6b4a-4c76-9c1b-bac551c1ebf2.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Hepatitis A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hepatitis A Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '41VRH5220H',\n",
       "    'Name': 'PAROXETINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0fadf599-a088-49b9-926d-64ba1a283ebe/0fadf599-a088-49b9-926d-64ba1a283ebe.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [43815]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DZR1ENT301',\n",
       "    'Name': 'CEFTAZIDIME ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0fb531fa-b76e-4885-bf24-d0b433fef89a/0fb531fa-b76e-4885-bf24-d0b433fef89a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73415817]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '90Y4QC304K',\n",
       "    'Name': 'KETOPROFEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0fdf9730-d6eb-4c5e-b301-0af317f6dc62/0fdf9730-d6eb-4c5e-b301-0af317f6dc62.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417112]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J280872D1O',\n",
       "    'Name': 'DESONIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/0fecf808-266e-47ad-979e-32842e3fb414/0fecf808-266e-47ad-979e-32842e3fb414.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311066]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G70B4ETF4S',\n",
       "    'Name': 'EMTRICITABINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1015a777-0d63-4708-a2b1-bcac14d650dc/1015a777-0d63-4708-a2b1-bcac14d650dc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60877]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1306V2B0Q8',\n",
       "    'Name': 'PROPANTHELINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/103b136d-6d4d-49f4-b529-b511318372ce/103b136d-6d4d-49f4-b529-b511318372ce.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4934]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SD6QCT3TSU',\n",
       "    'Name': 'PENTOXIFYLLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/108871e1-6dd1-4cb7-aa79-b3ed240d5500/108871e1-6dd1-4cb7-aa79-b3ed240d5500.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4740]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Viscosity Reducer'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hematologic Activity Alteration'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DCR9Z582X0',\n",
       "    'Name': 'EPOPROSTENOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/10b53b01-3a16-4058-a835-e7dd63912202/10b53b01-3a16-4058-a835-e7dd63912202.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5282411]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostacycline Vasodilator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandins I'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasodilation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'V1L22WVE2S',\n",
       "    'Name': 'ZILEUTON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/10dc4f9f-80e2-4fe1-8bd1-8343f4392390/10dc4f9f-80e2-4fe1-8bd1-8343f4392390.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416699]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': '5-Lipoxygenase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': '5-Lipoxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Leukotriene Production'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'B72HH48FLU',\n",
       "    'Name': 'INFLIXIMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/10e81a90-a86e-4231-b2f1-0fb5892588d5/10e81a90-a86e-4231-b2f1-0fb5892588d5.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tumor Necrosis Factor Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tumor Necrosis Factor Receptor Blocking Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0J48LPH2TH',\n",
       "    'Name': 'HYDROCHLOROTHIAZIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/10e84a9b-c417-4e50-8149-607c61959130/10e84a9b-c417-4e50-8149-607c61959130.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3639]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazide Diuretic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9Y53ZS6I82',\n",
       "    'Name': 'USTILAGO NUDA HORDEI',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1106d4a8-b4f7-4826-b544-94947ef4f863/1106d4a8-b4f7-4826-b544-94947ef4f863.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Standardized Fungal Allergenic Extract'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Histamine Release'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased IgG Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fungal Proteins'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allergens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '502FWN4Q32',\n",
       "    'Name': 'ALISKIREN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/110da013-bc8a-4b64-ab03-09053dc55d39/110da013-bc8a-4b64-ab03-09053dc55d39.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5493444]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Renin Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Renin Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F2NQ468L52',\n",
       "    'Name': 'TECHNETIUM TC-99M MEBROFENIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/11258ac9-5cb1-4548-8f03-6f8370a728da/11258ac9-5cb1-4548-8f03-6f8370a728da.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [11431716]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1C6V77QF41',\n",
       "    'Name': 'CHOLECALCIFEROL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/113cea74-0898-43a2-8301-f15e8764277b/113cea74-0898-43a2-8301-f15e8764277b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5280795]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin D'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin D'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4B33BGI082',\n",
       "    'Name': 'CHOLESTYRAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1147684d-1cb0-485c-87e1-e20bb43467e1/1147684d-1cb0-485c-87e1-e20bb43467e1.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bile Acid Sequestrant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bile-acid Binding Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QX62KLI41N',\n",
       "    'Name': 'CISATRACURIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1147cc2e-5b63-472f-82e5-3c8fb2dcb6bd/1147cc2e-5b63-472f-82e5-3c8fb2dcb6bd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [62887]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Neuromuscular Nondepolarizing Blockade'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nondepolarizing Neuromuscular Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6GNT3Y5LMF',\n",
       "    'Name': 'LEVOFLOXACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/118b156a-0a7a-4b70-92ab-ed397d670c0f/118b156a-0a7a-4b70-92ab-ed397d670c0f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3033924]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolone Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G07GZ97H65',\n",
       "    'Name': 'CLOTRIMAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/11c72e11-21ef-4ada-8250-822ab41f9664/11c72e11-21ef-4ada-8250-822ab41f9664.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2812]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'LUY6P8763W',\n",
       "    'Name': 'HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/11d00f7e-f7af-4dcf-9665-c047766a8b73/11d00f7e-f7af-4dcf-9665-c047766a8b73.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Haemophilus Influenzae B Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Haemophilus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K5BN214699',\n",
       "    'Name': 'NITISINONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/11ed39d5-a594-4d48-83ab-a281017b9c25/11ed39d5-a594-4d48-83ab-a281017b9c25.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [115355]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxyphenylpyruvate Dioxygenase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 21,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxyphenylpyruvate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'multiple-CIDs'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GRZ5RCB1QG',\n",
       "    'Name': 'VENLAFAXINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/12077d34-51a9-422c-bb07-a216907988af/12077d34-51a9-422c-bb07-a216907988af.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417357]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Norepinephrine Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin and Norepinephrine Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'},\n",
       "          {'Start': 14,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '85H0HZU99M',\n",
       "    'Name': 'POVIDONE-IODINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/12218cd6-f36b-4ad8-b5d2-19bf8a5c5ab6/12218cd6-f36b-4ad8-b5d2-19bf8a5c5ab6.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiseptic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Iodine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'NA8320J834',\n",
       "    'Name': 'EPTIFIBATIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1283b785-e27b-4f42-aacb-0413988be594/1283b785-e27b-4f42-aacb-0413988be594.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [448812]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Platelet Aggregation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platelet Aggregation Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3EN3HG4WSW',\n",
       "    'Name': 'PREDNISONE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/129b87f8-4b67-4e57-a1b3-54e3d3f11247/129b87f8-4b67-4e57-a1b3-54e3d3f11247.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0Z5B2CJX4D',\n",
       "    'Name': 'FLUDEOXYGLUCOSE F-18',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/129eb834-4768-4d96-8cd4-8e3e0cc915d8/129eb834-4768-4d96-8cd4-8e3e0cc915d8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [68614]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9081Y98W2V',\n",
       "    'Name': 'TRIPTORELIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/12c82bd9-25f6-453b-a975-a2eb40e773d1/12c82bd9-25f6-453b-a975-a2eb40e773d1.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BO9LE4QFZF',\n",
       "    'Name': 'STAVUDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/12c8e334-2fc6-4bc7-8bc1-e9973eda8fd9/12c8e334-2fc6-4bc7-8bc1-e9973eda8fd9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [18283]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '743QUY4VD8',\n",
       "    'Name': 'HYALURONIDASE RECOMBINANT HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/135218f3-0248-4cf9-b9cb-5a384bfa2f78/135218f3-0248-4cf9-b9cb-5a384bfa2f78.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endoglycosidase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glycoside Hydrolases'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2XLN4Y044H',\n",
       "    'Name': 'REGADENOSON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/13fc0287-0cec-403a-a9ea-65bb693a8870/13fc0287-0cec-403a-a9ea-65bb693a8870.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [44154280]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenosine Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Adenosine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-60961'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenosine Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Adenosine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-60961'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'OF5P57N2ZX',\n",
       "    'Name': 'ALANINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1440156d-cbb6-4b23-8462-a2c72410f492/1440156d-cbb6-4b23-8462-a2c72410f492.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5950]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amino Acid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amino Acids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F089I0511L',\n",
       "    'Name': 'INDAPAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1441126f-a60c-4371-b1df-08f7d793056f/1441126f-a60c-4371-b1df-08f7d793056f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417430]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazide-like Diuretic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CK0N3WH0SR',\n",
       "    'Name': 'PERFLUTREN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/144893b2-e704-44a6-a9c0-e5cad084fc5c/144893b2-e704-44a6-a9c0-e5cad084fc5c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6432]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Contrast Agent for Ultrasound Imaging'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ultrasound Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6KY687524K',\n",
       "    'Name': 'GLIMEPIRIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/146e020e-b349-49b7-a63c-463985e59fe0/146e020e-b349-49b7-a63c-463985e59fe0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3476]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea Compounds'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5688UTC01R',\n",
       "    'Name': 'TRETINOIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/14818fbd-95e1-4d61-b11b-746882958c05/14818fbd-95e1-4d61-b11b-746882958c05.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [444795]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '740T4C525W',\n",
       "    'Name': 'SULFISOXAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1489b329-d7c3-4f12-aad4-5f1bfcaf0963/1489b329-d7c3-4f12-aad4-5f1bfcaf0963.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5344]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamide Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G9O67I0A8Q',\n",
       "    'Name': 'BLATELLA GERMANICA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/14ebe058-543c-4ef2-93fe-c97b36452177/14ebe058-543c-4ef2-93fe-c97b36452177.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Standardized Insect Allergenic Extract'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Histamine Release'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased IgG Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insect Proteins'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allergens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YZI5105V0L',\n",
       "    'Name': 'KETOROLAC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/153d635b-7679-4c01-92c0-2a69c56515a9/153d635b-7679-4c01-92c0-2a69c56515a9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417282]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '34237V843T',\n",
       "    'Name': 'ISOCARBOXAZID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1541a7df-456d-479d-8fed-c185a84ab32f/1541a7df-456d-479d-8fed-c185a84ab32f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3759]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BFE2NBZ7NX',\n",
       "    'Name': 'BESIFLOXACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/15483368-f2bf-491b-ad57-b96e4152317f/15483368-f2bf-491b-ad57-b96e4152317f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10178705]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolone Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'HW3H7D91F6',\n",
       "    'Name': 'PEGADEMASE BOVINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1599f03f-989d-4d46-9741-2a9e94dd1803/1599f03f-989d-4d46-9741-2a9e94dd1803.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenosine Deaminase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bovine Intestinal Adenosine Deaminase'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MHM278SD3E',\n",
       "    'Name': 'MONTELUKAST',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1620ab19-7274-48f8-80c1-8eec386b7055/1620ab19-7274-48f8-80c1-8eec386b7055.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5281040]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Leukotriene Receptor Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Leukotriene Receptor Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S866O45PIG',\n",
       "    'Name': 'BERACTANT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1672ce2e-31f4-4339-877c-a4364e407332/1672ce2e-31f4-4339-877c-a4364e407332.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alveolar Surface Tension Reduction'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Surfactant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Surfactant Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U3P01618RT',\n",
       "    'Name': 'FLUOROURACIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1692752b-d5c3-488a-9521-a3b031078398/1692752b-d5c3-488a-9521-a3b031078398.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3385]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Metabolic Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5Y9QQM372Q',\n",
       "    'Name': 'MENOTROPINS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/16d4a550-7357-43e9-8173-9b924eba101e/16d4a550-7357-43e9-8173-9b924eba101e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '49717AWG6K',\n",
       "    'Name': 'RIBAVIRIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1717d365-828f-44fe-a157-4e3a6ade7d8c/1717d365-828f-44fe-a157-4e3a6ade7d8c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [37542]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog Antiviral'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H645GUL8KJ',\n",
       "    'Name': 'LISDEXAMFETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/17250f8f-ccbf-4d38-9295-e19e073addc5/17250f8f-ccbf-4d38-9295-e19e073addc5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [11597698]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9G64RSX1XD',\n",
       "    'Name': 'CAPTOPRIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/17559bbe-2860-4fb0-9af9-cff81babea40/17559bbe-2860-4fb0-9af9-cff81babea40.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [44093]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin Converting Enzyme Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin-converting Enzyme Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2E1M7F958B',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/175b0f17-d58d-4f06-996f-e50a2ff4b5fd/175b0f17-d58d-4f06-996f-e50a2ff4b5fd.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Conjugate'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'V99T50803M',\n",
       "    'Name': 'SUNITINIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/175e4912-3580-442a-bda0-e9cc4de181e2/175e4912-3580-442a-bda0-e9cc4de181e2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5329102]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O0J6XJN02I',\n",
       "    'Name': 'DUTASTERIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/17cb7480-62f5-4176-8f89-11f3503785ed/17cb7480-62f5-4176-8f89-11f3503785ed.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6918296]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': '5-alpha Reductase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': '5-alpha Reductase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F4TN0IPY37',\n",
       "    'Name': 'BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1814c35e-0bc5-43d6-aea2-2849103bbada/1814c35e-0bc5-43d6-aea2-2849103bbada.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Bordetella Pertussis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pertussis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8GTS82S83M',\n",
       "    'Name': 'DIPHENHYDRAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/183024af-eb41-4b0f-aab3-8d4277548287/183024af-eb41-4b0f-aab3-8d4277548287.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3100]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H1 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-1 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G6317AOI7K',\n",
       "    'Name': 'LEVOBUNOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/18601a5e-e35e-4d0c-b708-a0a637c73333/18601a5e-e35e-4d0c-b708-a0a637c73333.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [39468]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ZJO8CP3Q2A',\n",
       "    'Name': 'FORESKIN KERATINOCYTE (NEONATAL)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/186653c2-07a5-45b1-a608-73dbf043e344/186653c2-07a5-45b1-a608-73dbf043e344.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allogeneic Cultured Cell Scaffold'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tissue Scaffolds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cells, Cultured, Allogeneic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Keratinocytes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '839I73S42A',\n",
       "    'Name': 'LIRAGLUTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1891c503-6e0e-4350-a6f6-851413dda491/1891c503-6e0e-4350-a6f6-851413dda491.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16153050]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'GLP-1 Receptor Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucagon-Like Peptide 1'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucagon-like Peptide-1 (GLP-1) Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Glucagon',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-16132283'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QMS40680K6',\n",
       "    'Name': 'PALIFERMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/18b1236d-4cc0-401b-8751-972a09af9736/18b1236d-4cc0-401b-8751-972a09af9736.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fibroblast Growth Factor 7'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Epithelial Proliferation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Mucocutaneous Epithelial Cell Growth Factor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2436VX1U9B',\n",
       "    'Name': 'IBUTILIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/18b39edd-cd3d-45cc-bcde-000b85254ea6/18b39edd-cd3d-45cc-bcde-000b85254ea6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416681]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G59M7S0WS3',\n",
       "    'Name': 'NITROGLYCERIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/19001e24-cdd1-4708-b47e-aef97171a08c/19001e24-cdd1-4708-b47e-aef97171a08c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4510]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrate Vasodilator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrates'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasodilation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '039LU44I5M',\n",
       "    'Name': 'FLOXURIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1938afc7-49f9-40dc-b88e-a58558c085da/1938afc7-49f9-40dc-b88e-a58558c085da.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5790]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimetabolite'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Deoxyuridine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QHO02LZ4H2',\n",
       "    'Name': 'CHROMIC PHOSPHATE P-32',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/19721a21-faff-41b0-9448-9080cc8227b6/19721a21-faff-41b0-9448-9080cc8227b6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71383]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Therapeutic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7WY7YBI87E',\n",
       "    'Name': 'PHENYLBUTYRIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1972634b-2bac-4e0c-84a5-5f387ca2184e/1972634b-2bac-4e0c-84a5-5f387ca2184e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4775]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ammonium Ion Binding Activity',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Ammonium%20Ion',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-223'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrogen Binding Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N8ZUB7XE0H',\n",
       "    'Name': 'CLOCORTOLONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1994fe84-9320-4bde-9688-b2e6d6411cca/1994fe84-9320-4bde-9688-b2e6d6411cca.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311052]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L6UH7ZF8HC',\n",
       "    'Name': 'RISPERIDONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/19b76195-ff96-4fc1-8e1f-51a5515343d6/19b76195-ff96-4fc1-8e1f-51a5515343d6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5073]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Atypical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'W72I5ZT78Z',\n",
       "    'Name': 'LORACARBEF ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1a21909b-656a-4c07-aac6-af3b3e607f00/1a21909b-656a-4c07-aac6-af3b3e607f00.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284585]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '63937KV33D',\n",
       "    'Name': 'ERYTHROMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1a2657be-6cb6-4573-a1e8-c9449ed5fcfd/1a2657be-6cb6-4573-a1e8-c9449ed5fcfd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [12560]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Sebaceous Gland Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Macrolide'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Macrolide Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Macrolides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WHI7HQ7H85',\n",
       "    'Name': 'URIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1a37e31b-181c-4697-888e-880011e530f3/1a37e31b-181c-4697-888e-880011e530f3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6029]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pyrimidine Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pyrimidines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Analogs/Derivatives'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K94FTS1806',\n",
       "    'Name': 'FLECAINIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1a53a998-c4e6-4498-99a3-8e229fbd373c/1a53a998-c4e6-4498-99a3-8e229fbd373c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417420]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X72RBB02N8',\n",
       "    'Name': 'FELBAMATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1a623e99-5a43-4abf-ae23-5180b0c3fdcf/1a623e99-5a43-4abf-ae23-5180b0c3fdcf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3331]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '673LC5J4LQ',\n",
       "    'Name': 'PENTAMIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1a9925c3-b4ec-4cb6-b7c7-39e23f3a6b55/1a9925c3-b4ec-4cb6-b7c7-39e23f3a6b55.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4735]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiprotozoal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U0JZ726775',\n",
       "    'Name': 'DESIRUDIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1ab85f67-b7c8-4dd1-a777-d393856e3dd0/1ab85f67-b7c8-4dd1-a777-d393856e3dd0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [137528228]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-coagulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Direct Thrombin Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombin Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K1KT5M40JC',\n",
       "    'Name': 'TOSITUMOMAB I-131',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1b19b5b9-9ca0-436b-8db3-f93a5fcb41a4/1b19b5b9-9ca0-436b-8db3-f93a5fcb41a4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD20-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD20-directed Radiotherapeutic Antibody'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '550Z839889',\n",
       "    'Name': 'RUBIDIUM CATION RB-82',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1b6d7314-4e1b-42fe-b7bd-aecdb4bd4164/1b6d7314-4e1b-42fe-b7bd-aecdb4bd4164.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10176083]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '63CZ7GJN5I',\n",
       "    'Name': 'ALLOPURINOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1b8e0378-642c-46a7-a839-208518309d98/1b8e0378-642c-46a7-a839-208518309d98.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135401907]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Xanthine Oxidase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Xanthine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-1188'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Xanthine Oxidase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Xanthine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-1188'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '25N8E57V6T',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1ba13d20-6d96-46a1-8d0b-6b0633073f91/1ba13d20-6d96-46a1-8d0b-6b0633073f91.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '21K6M2I7AG',\n",
       "    'Name': 'INTERFERON GAMMA-1B',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1c6223a5-1163-4421-92ff-e3e081eb21c5/1c6223a5-1163-4421-92ff-e3e081eb21c5.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon gamma'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon-gamma'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TN9BEX005G',\n",
       "    'Name': 'BIVALIRUDIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1c6d7d4b-e05b-477f-b718-13b482917a6b/1c6d7d4b-e05b-477f-b718-13b482917a6b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16129704]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-coagulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Direct Thrombin Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombin Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0MZI008M96',\n",
       "    'Name': 'SALMONELLA TYPHI TY21A LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1c9ce5f9-9128-4eb7-87e5-8fbec72f9f93/1c9ce5f9-9128-4eb7-87e5-8fbec72f9f93.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Salmonella Typhi Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Typhoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C4HQF74XMW',\n",
       "    'Name': 'RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1d0e1457-275e-4940-9a8e-22f9ffcf9696/1d0e1457-275e-4940-9a8e-22f9ffcf9696.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Rabies Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rabies Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z5N076G8YQ',\n",
       "    'Name': 'FIDAXOMICIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1d216218-0828-40dc-8b08-4f8c7555682b/1d216218-0828-40dc-8b08-4f8c7555682b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10034073]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Macrolides'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Macrolide Antibacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'NQX9KB6PCL',\n",
       "    'Name': 'SOMATROPIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1da2170a-c10f-4b65-80c2-92c6cde7bdb7/1da2170a-c10f-4b65-80c2-92c6cde7bdb7.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Human Growth Hormone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Human Growth Hormones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3ZZ5BJ9F2Q',\n",
       "    'Name': 'DIFENOXIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1dbed4c4-16b6-47a1-932d-f6ad6436d6b7/1dbed4c4-16b6-47a1-932d-f6ad6436d6b7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [34328]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antidiarrheal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '762RDY0Y2H',\n",
       "    'Name': 'CLOFARABINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1de8f68d-fbca-4d93-8912-e58430121f3a/1de8f68d-fbca-4d93-8912-e58430121f3a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [119182]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Metabolic Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IW71N46B4Y',\n",
       "    'Name': 'CEFTIBUTEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1e2be5cd-2351-4f62-9323-adbb85ccbc59/1e2be5cd-2351-4f62-9323-adbb85ccbc59.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5282242]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '563KS2PQY5',\n",
       "    'Name': 'LACOSAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1e2fdcb3-34d6-4afa-811d-7a640f20f8cc/1e2fdcb3-34d6-4afa-811d-7a640f20f8cc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [219078]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'W8O17SJF3T',\n",
       "    'Name': 'MEMANTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1e37005e-fce4-4815-a809-02491a5df386/1e37005e-fce4-4815-a809-02491a5df386.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4054]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'NMDA Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'N-methyl-D-aspartate Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 20,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/N-methyl-D-aspartate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-22880'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X4W7ZR7023',\n",
       "    'Name': 'METHYLPREDNISOLONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1e7e9224-bfdb-4d47-89cc-4abff02d4c61/1e7e9224-bfdb-4d47-89cc-4abff02d4c61.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6741]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8Q1PVL543G',\n",
       "    'Name': 'DIPIVEFRIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1eae032c-08c5-4419-8556-a68f4791211e/1eae032c-08c5-4419-8556-a68f4791211e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417345]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic Receptor Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WS821Z52LQ',\n",
       "    'Name': 'TRIAMTERENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1ecee5e5-72ef-4086-b62e-52064d4f960d/1ecee5e5-72ef-4086-b62e-52064d4f960d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5546]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Renal K+ Excretion'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium-sparing Diuretic',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Potassium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Potassium'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E6S1NJ4Y5Q',\n",
       "    'Name': 'CELLULOSE SODIUM PHOSPHATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1f428ede-be17-4ab3-a362-2a2e2be694a3/1f428ede-be17-4ab3-a362-2a2e2be694a3.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Binder'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Chelating Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G8RGG88B68',\n",
       "    'Name': 'PEGINTERFERON ALFA-2B',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1f78ec9f-f1ba-47f2-964d-979e1439132c/1f78ec9f-f1ba-47f2-964d-979e1439132c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon alpha'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'peginterferon alfa-2b'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N7Z035406B',\n",
       "    'Name': 'CILOSTAZOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/1f8626c0-3da3-4ce5-a9ff-53d94cb75404/1f8626c0-3da3-4ce5-a9ff-53d94cb75404.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2754]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 3 Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 3 Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KZ3L01D2PC',\n",
       "    'Name': 'HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/207f5249-c990-4961-acf5-937fc1e503bd/207f5249-c990-4961-acf5-937fc1e503bd.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Rotavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rotavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '60158CV180',\n",
       "    'Name': 'NELARABINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/20ae4208-1827-4955-b554-8dad317f7124/20ae4208-1827-4955-b554-8dad317f7124.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3011155]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Metabolic Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '54348OY1IT',\n",
       "    'Name': 'MALUS DOMESTICA POLLEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/20fdbe39-bf5c-4f24-b21d-eba040ebda8d/20fdbe39-bf5c-4f24-b21d-eba040ebda8d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Standardized Pollen Allergenic Extract'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Histamine Release'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased IgG Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pollen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allergens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '23JE9KDF4R',\n",
       "    'Name': 'POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2144c5dc-670c-4aa2-adb7-ace7fee33b4b/2144c5dc-670c-4aa2-adb7-ace7fee33b4b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Poliovirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Poliovirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QV897JC36D',\n",
       "    'Name': 'BUTORPHANOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/214b1748-2f36-40d0-b61c-38f6c99aa00b/214b1748-2f36-40d0-b61c-38f6c99aa00b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5361092]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Competitive Opioid Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist/Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Partial Opioid Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R4KO0DY52L',\n",
       "    'Name': 'CHLORHEXIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/214ea9da-3305-4186-b7a7-1a693e5f0270/214ea9da-3305-4186-b7a7-1a693e5f0270.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9552079]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Cell Wall Integrity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JGA39ICE2V',\n",
       "    'Name': 'MUROMONAB-CD3',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/21578814-1257-4734-bce4-9d524bf18d29/21578814-1257-4734-bce4-9d524bf18d29.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD3 Blocker Immunosuppressant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD3 Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD3-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Immunologic Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XXE1CET956',\n",
       "    'Name': 'INDOMETHACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/21cf1941-abde-4890-86ae-8a85d1cbf0a3/21cf1941-abde-4890-86ae-8a85d1cbf0a3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3715]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YB12NQZ1YN',\n",
       "    'Name': 'OVINE DIGOXIN IMMUNE FAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/21d3a7d0-1e1a-44e4-892d-197076be98a2/21d3a7d0-1e1a-44e4-892d-197076be98a2.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Digoxin Binding Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '048L81261F',\n",
       "    'Name': 'DEXRAZOXANE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/21d7ff82-98dc-4595-9d99-a23f9547f4ad/21d7ff82-98dc-4595-9d99-a23f9547f4ad.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71384]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytoprotective Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0199MV609F',\n",
       "    'Name': 'GADOTERIDOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/220ad816-09ab-4e3c-b425-513742dcd1f1/220ad816-09ab-4e3c-b425-513742dcd1f1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [131634499]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S56D65XJ9G',\n",
       "    'Name': 'ELTROMBOPAG',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2235b7d8-def9-41cd-8f5a-0efb91a6ccac/2235b7d8-def9-41cd-8f5a-0efb91a6ccac.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135449332]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Megakaryocyte Maturation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Platelet Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombopoiesis Stimulating Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombopoietin Receptor Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombopoietin Receptor Interactions'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WRE554RFEZ',\n",
       "    'Name': 'ROCURONIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/22587473-cb20-4935-adda-87cb6673c364/22587473-cb20-4935-adda-87cb6673c364.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441290]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Neuromuscular Nondepolarizing Blockade'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nondepolarizing Neuromuscular Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G819A456D0',\n",
       "    'Name': 'ABIRATERONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/22db816e-1d4a-4466-9404-3077df8042bd/22db816e-1d4a-4466-9404-3077df8042bd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [132971]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytochrome P450 17A1 Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytochrome P450 17A1 Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6LTE2DNX63',\n",
       "    'Name': 'HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/22e1f56c-c58a-4d00-8402-d2b9f8314647/22e1f56c-c58a-4d00-8402-d2b9f8314647.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Human Papillomavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Papillomavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L16PUN799N',\n",
       "    'Name': 'AMBENONIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/231a39f7-a050-4dc2-9bfb-fc9fbd247b81/231a39f7-a050-4dc2-9bfb-fc9fbd247b81.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2131]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4CNZ27M7RV',\n",
       "    'Name': 'NAFCILLIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2399a954-0e24-4ae9-8ee2-93601517a42f/2399a954-0e24-4ae9-8ee2-93601517a42f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [8982]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E211KPY694',\n",
       "    'Name': 'BOTULINUM TOXIN TYPE A',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/23a21d58-bcb8-48b4-8089-c8c63c45ac3e/23a21d58-bcb8-48b4-8089-c8c63c45ac3e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Acetylcholine Release Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Acetylcholine Release Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RBR61YAJ4V',\n",
       "    'Name': 'WESTERN DIAMONDBACK RATTLESNAKE (CROTALUS ATROX) IMMUNE FAB ANTIVENIN (OVINE)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/23bc5b92-ac90-4ad0-9037-298f74eda8da/23bc5b92-ac90-4ad0-9037-298f74eda8da.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Venom Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8476849N1Y',\n",
       "    'Name': 'RHIZOPUS ARRHIZUS VAR. ARRHIZUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/23ed015c-f217-4fa0-8a2a-91ddfa1878be/23ed015c-f217-4fa0-8a2a-91ddfa1878be.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Standardized Fungal Allergenic Extract'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Histamine Release'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased IgG Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fungal Proteins'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allergens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WP58SVM6R4',\n",
       "    'Name': 'LARONIDASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2403ef2d-98d8-46e7-a55b-5fde34a3d590/2403ef2d-98d8-46e7-a55b-5fde34a3d590.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Glucosidases'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y6UY8OV51T',\n",
       "    'Name': 'TRIOXSALEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/248bf5af-cf58-43b9-b398-f73d3cc7db8a/248bf5af-cf58-43b9-b398-f73d3cc7db8a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5585]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Psoralen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Psoralens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5ZZ84GCW8B',\n",
       "    'Name': 'FORMOTEROL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/24c2cb90-17b2-44be-890c-e8159ee473d7/24c2cb90-17b2-44be-890c-e8159ee473d7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416839]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta2-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6L8OF9XRDC',\n",
       "    'Name': 'FOSAPREPITANT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/24ed9cfa-19d8-4e79-b38c-9160958520e6/24ed9cfa-19d8-4e79-b38c-9160958520e6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135413538]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Neurokinin 1 Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Substance P/Neurokinin-1 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 11,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Substance%20P',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36511'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FYS6T7F842',\n",
       "    'Name': 'ADALIMUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/25406df2-8216-4417-8d72-8ff06732e93c/25406df2-8216-4417-8d72-8ff06732e93c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tumor Necrosis Factor Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tumor Necrosis Factor Receptor Blocking Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'W6KX9E6D8X',\n",
       "    'Name': 'UREA C-13',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/254aa16d-6e99-41de-9e02-de74cf2e45db/254aa16d-6e99-41de-9e02-de74cf2e45db.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [636363]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Carbon Radioisotopes'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Helicobacter pylori Diagnostic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Tracers'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Urea'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '64R4OHP8T0',\n",
       "    'Name': 'HYALURONIDASE, OVINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2595c0f7-c6f2-4205-b082-5405ccb41b83/2595c0f7-c6f2-4205-b082-5405ccb41b83.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endoglycosidase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glycoside Hydrolases'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'LL60K9J05T',\n",
       "    'Name': 'CABERGOLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/25ff952f-0a8f-4494-b95c-28f909c8404b/25ff952f-0a8f-4494-b95c-28f909c8404b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54746]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ergolines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ergot Derivative'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5SKG37872O',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/26047fe6-bbd7-44dc-a949-27d6207f6ea0/26047fe6-bbd7-44dc-a949-27d6207f6ea0.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RJ84Y44811',\n",
       "    'Name': 'QUINAPRIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/260b1973-bc9a-454e-b9c9-f6f079ba7e9b/260b1973-bc9a-454e-b9c9-f6f079ba7e9b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54892]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin Converting Enzyme Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin-converting Enzyme Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '690G0D6V8H',\n",
       "    'Name': 'KETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/26226ebe-71bf-4db5-b184-41db44a39ad2/26226ebe-71bf-4db5-b184-41db44a39ad2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417402]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthesia'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '04XPW8C0FL',\n",
       "    'Name': 'APROTININ',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/26282437-41e9-49ba-8e93-707ca8acc68a/26282437-41e9-49ba-8e93-707ca8acc68a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16130295]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antifibrinolytic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Fibrinolysis'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y45QSO73OB',\n",
       "    'Name': 'STREPTOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2637eb45-0918-44bc-aca9-24862aeb0da4/2637eb45-0918-44bc-aca9-24862aeb0da4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [19649]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycoside Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycosides'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimycobacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TML814419R',\n",
       "    'Name': 'MEFLOQUINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/267e15aa-acad-4088-b963-8a67c5a615f4/267e15aa-acad-4088-b963-8a67c5a615f4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416875]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimalarial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '54EC0SE5PZ',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2692295b-d9e1-4970-a8f3-26cd183f878e/2692295b-d9e1-4970-a8f3-26cd183f878e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7SFC6U2VI5',\n",
       "    'Name': 'CALCITONIN SALMON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/26a533bf-9463-4a3a-8da6-a706f41c56ff/26a533bf-9463-4a3a-8da6-a706f41c56ff.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16133812]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcitonin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcitonin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DOL5F9JD3E',\n",
       "    'Name': 'DELAVIRDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/26d384b6-d004-4321-9f22-82ace978a7d1/26d384b6-d004-4321-9f22-82ace978a7d1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5625]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KHS0AZ4JVK',\n",
       "    'Name': 'BUTALBITAL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/26e5f0b8-3139-4895-b61b-206d0d87c97d/26e5f0b8-3139-4895-b61b-206d0d87c97d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2481]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Barbiturate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Barbiturates'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ZIF514RVZR',\n",
       "    'Name': 'ALBUMIN (HUMAN)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/26f4cb6c-87eb-4c71-84a0-c96ddffa598f/26f4cb6c-87eb-4c71-84a0-c96ddffa598f.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Serum Albumin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Intravascular Volume'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Oncotic Pressure'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Osmotic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serum Albumin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F9NUX55P23',\n",
       "    'Name': 'AZILSARTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/27029df4-49e3-498c-b327-c48b27aff7cd/27029df4-49e3-498c-b327-c48b27aff7cd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135415867]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Type 1 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Blocker',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Blood Pressure'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'COF19H7WBK',\n",
       "    'Name': 'DICLOXACILLIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2747cf1b-482b-4402-840f-a2d1102ac8c9/2747cf1b-482b-4402-840f-a2d1102ac8c9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [18381]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ENR1LLB0FP',\n",
       "    'Name': 'DESMOPRESSIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/274ed7a4-b526-4d91-b050-d02fd3356e21/274ed7a4-b526-4d91-b050-d02fd3356e21.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311065]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Factor VIII Activator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor VIII Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor VIII Concentration'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasopressin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasopressins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N9YNS0M02X',\n",
       "    'Name': 'ACETYLCHOLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/27532a92-9cf8-43ee-a990-492d1be425a1/27532a92-9cf8-43ee-a990-492d1be425a1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [187]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Receptor Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CRS35BZ94Q',\n",
       "    'Name': 'DESFLURANE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/275e2665-f1aa-4579-aa4f-fef0442502cb/275e2665-f1aa-4579-aa4f-fef0442502cb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417327]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthesia'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2M83C4R6ZB',\n",
       "    'Name': 'CALCIUM CATION',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/276040ee-dd62-45de-a7fb-be0777c8fe30/276040ee-dd62-45de-a7fb-be0777c8fe30.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [271]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cations, Divalent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '80061L1WGD',\n",
       "    'Name': 'CIMETIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/27a8c8e7-cfbc-4fcf-a97d-1b4915e4eeed/27a8c8e7-cfbc-4fcf-a97d-1b4915e4eeed.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2756]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-2 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ADN3S497AZ',\n",
       "    'Name': 'MIGLUSTAT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2830e483-e0df-401e-8906-041ab64d30e5/2830e483-e0df-401e-8906-041ab64d30e5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [51634]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucosylceramide Synthase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucosylceramide Synthase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9E338QE28F',\n",
       "    'Name': 'MEPERIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2831e78b-cf23-49ed-8685-7d38bb5c8c24/2831e78b-cf23-49ed-8685-7d38bb5c8c24.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4058]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P89DR4NY54',\n",
       "    'Name': 'ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/288bf2c0-bf56-4c81-9bbd-031473d2e5d1/288bf2c0-bf56-4c81-9bbd-031473d2e5d1.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Antihemophilic Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Factor VIII'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '69G8BD63PP',\n",
       "    'Name': 'BORTEZOMIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/292dbbb1-e566-4558-8d25-c42e24e5ac91/292dbbb1-e566-4558-8d25-c42e24e5ac91.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [387447]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Proteasome Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Proteasome Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'EE92BBP03H',\n",
       "    'Name': 'DILTIAZEM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/29ddb656-e2c2-4ae1-aff4-39b5f5d0828f/29ddb656-e2c2-4ae1-aff4-39b5f5d0828f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [39186]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Channel Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '843CEN85DI',\n",
       "    'Name': 'APRACLONIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2a20c48e-8ddc-4c94-a95a-43ed34791175/2a20c48e-8ddc-4c94-a95a-43ed34791175.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2216]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2M36281008',\n",
       "    'Name': 'ETODOLAC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2a5e1883-e1be-416e-b2d7-b9d3e539860d/2a5e1883-e1be-416e-b2d7-b9d3e539860d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416861]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6S082C9NDT',\n",
       "    'Name': 'TRIMIPRAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2ab61215-4867-4c05-91cc-3591492a10fd/2ab61215-4867-4c05-91cc-3591492a10fd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416955]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2MGG3XW1L2',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2b54ac00-ef68-4de0-ac5a-0ff7f83bf76e/2b54ac00-ef68-4de0-ac5a-0ff7f83bf76e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ZE22NE22F1',\n",
       "    'Name': 'VON WILLEBRAND FACTOR HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2bf86864-25f6-4ee8-89dc-de67010359fa/2bf86864-25f6-4ee8-89dc-de67010359fa.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Platelet Aggregation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'von Willebrand Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '04ZR38536J',\n",
       "    'Name': 'OXALIPLATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2c1dcc66-0668-43f2-8f91-3f3f3c8cd98b/2c1dcc66-0668-43f2-8f91-3f3f3c8cd98b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9887054]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platinum-based Drug'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platinum-containing Compounds',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Platinum',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Platinum'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '04Q9AIZ7NO',\n",
       "    'Name': 'PEMETREXED',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2c34903e-afca-47ca-8e87-1a6b5caaf44a/2c34903e-afca-47ca-8e87-1a6b5caaf44a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135410875]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folate Analog Metabolic Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 6,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Folate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-135398658'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folic Acid Metabolism Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Folic%20Acid',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-135398658'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '34K66TBT99',\n",
       "    'Name': 'PRASUGREL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2c679cd2-3433-4f63-9958-5340b017f2b0/2c679cd2-3433-4f63-9958-5340b017f2b0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417247]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Platelet Aggregation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'P2Y12 Platelet Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'P2Y12 Receptor Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TL2TJE8QTX',\n",
       "    'Name': 'AMINOBENZOIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2c7c1875-521e-48bf-aa87-4f4ffb10ed49/2c7c1875-521e-48bf-aa87-4f4ffb10ed49.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [978]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin B Complex Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin B Complex Member'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q4K217VGA9',\n",
       "    'Name': 'CALFACTANT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2c895a48-d49d-41cd-b09c-c5058bdb0ea1/2c895a48-d49d-41cd-b09c-c5058bdb0ea1.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alveolar Surface Tension Reduction'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Surfactant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Surfactant Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6PNS59HP4Y',\n",
       "    'Name': 'TILUDRONIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2ca0a1da-9ef8-4bb8-8c9b-bc69e8a8ac60/2ca0a1da-9ef8-4bb8-8c9b-bc69e8a8ac60.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60937]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bisphosphonate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diphosphonates'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GNN1DV99GX',\n",
       "    'Name': 'PENICILLAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2d4b6776-b53c-4703-b050-fcf948a8fe44/2d4b6776-b53c-4703-b050-fcf948a8fe44.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5852]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antirheumatic Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'AL805O9OG9',\n",
       "    'Name': 'ORPHENADRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2d742e91-63de-4b9d-ba96-773d8e0c5233/2d742e91-63de-4b9d-ba96-773d8e0c5233.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416765]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Centrally-mediated Muscle Relaxation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Muscle Relaxant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N3RIB7X24K',\n",
       "    'Name': 'IOVERSOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2d8997cf-24b9-4895-8a46-22261cae3a11/2d8997cf-24b9-4895-8a46-22261cae3a11.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3741]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '83LCM6L2BY',\n",
       "    'Name': 'FOMEPIZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2da9a187-9048-454c-99eb-0d4ac60cde2d/2da9a187-9048-454c-99eb-0d4ac60cde2d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3406]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antidote'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ILA426L95O',\n",
       "    'Name': 'AMIFOSTINE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2e23bc7c-81f7-40da-a561-89104acd4ac3/2e23bc7c-81f7-40da-a561-89104acd4ac3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2141]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytoprotective Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Free Radical Scavenging Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M15H03K69B',\n",
       "    'Name': 'PORFIMER',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2e4b55c4-974b-429d-a1a5-0a2e8a734d38/2e4b55c4-974b-429d-a1a5-0a2e8a734d38.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Photoabsorption'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Photoactivated Radical Generator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Photosensitizing Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JY83SHX053',\n",
       "    'Name': 'DEXTRAN 75',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2e739158-a81d-489a-9bd1-b6dbac6524e2/2e739158-a81d-489a-9bd1-b6dbac6524e2.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Plasma Volume Expander'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Intravascular Volume'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Osmotic Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2GT1D0TMX1',\n",
       "    'Name': 'MORICIZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2eda3ec1-be61-4f7c-bc3b-d84bf07cc360/2eda3ec1-be61-4f7c-bc3b-d84bf07cc360.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [34633]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q8BIH59O7H',\n",
       "    'Name': 'ALTRETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2f0d2eb9-cac5-4aa5-8017-d7371094ad72/2f0d2eb9-cac5-4aa5-8017-d7371094ad72.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2123]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FYY3R43WGO',\n",
       "    'Name': 'MINOCYCLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2f173942-70c5-4a59-ace9-20c70137e11c/2f173942-70c5-4a59-ace9-20c70137e11c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54675783]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracycline-class Drug'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracyclines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K7Q1JQR04M',\n",
       "    'Name': 'DINOPROSTONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2f391fcf-3874-47c5-a690-996faeb98705/2f391fcf-3874-47c5-a690-996faeb98705.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5280360]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'HM5641GA6F',\n",
       "    'Name': 'OPRELVEKIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2f8d52d7-ca34-4c89-a7d2-68596b90a9a2/2f8d52d7-ca34-4c89-a7d2-68596b90a9a2.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Megakaryocyte Growth Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombopoietin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9PHQ9Y1OLM',\n",
       "    'Name': 'PREDNISOLONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2f9f0d96-8baa-4795-9fc3-8e37e0333eca/2f9f0d96-8baa-4795-9fc3-8e37e0333eca.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5755]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '864P0921DW',\n",
       "    'Name': 'BROMFENAC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2fa8ac62-dbea-47a2-9bcc-1de62ba02b5c/2fa8ac62-dbea-47a2-9bcc-1de62ba02b5c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60726]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '88463U4SM5',\n",
       "    'Name': 'SULFADOXINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/2fca75ca-202b-4982-acf7-1ec9e3881de5/2fca75ca-202b-4982-acf7-1ec9e3881de5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [17134]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamide'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '69PN84IO1A',\n",
       "    'Name': 'ENALAPRIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/303e3d04-1c4e-43fc-8bd1-7ed08fa547b1/303e3d04-1c4e-43fc-8bd1-7ed08fa547b1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5388962]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin Converting Enzyme Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin-converting Enzyme Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Blood Pressure'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9E01C36A9S',\n",
       "    'Name': 'ETHYNODIOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/309cf58a-3dc6-419d-8be8-77fcaec2f3d8/309cf58a-3dc6-419d-8be8-77fcaec2f3d8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [14687]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6PLQ3CP4P3',\n",
       "    'Name': 'ETOPOSIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/30e52dfa-0779-4409-8dd1-49a04019ad45/30e52dfa-0779-4409-8dd1-49a04019ad45.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [36462]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1B56C968OA',\n",
       "    'Name': 'BECAPLERMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/30ebb9ce-281e-42cd-bf4d-6db375811aa3/30ebb9ce-281e-42cd-bf4d-6db375811aa3.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Platelet-derived Growth Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platelet-Derived Growth Factor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IX503L9WN0',\n",
       "    'Name': 'GANIRELIX',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3132009f-db7c-4a2f-b3b2-e2e8a963b383/3132009f-db7c-4a2f-b3b2-e2e8a963b383.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16130957]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased GnRH Secretion'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '08GY9K1EUO',\n",
       "    'Name': 'RASBURICASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/318bf214-559b-423b-bbbd-c2a1e7388f10/318bf214-559b-423b-bbbd-c2a1e7388f10.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Urate Oxidase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Uric Acid-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MVR3634GX1',\n",
       "    'Name': 'PRIMAQUINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/319c40b8-b9fd-49ad-bd31-aec22865eb4f/319c40b8-b9fd-49ad-bd31-aec22865eb4f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416806]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimalarial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'APG9819VLM',\n",
       "    'Name': 'DARIFENACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/31e3fbe3-eb63-434d-b0c9-75468c48eac3/31e3fbe3-eb63-434d-b0c9-75468c48eac3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [444031]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FXC9231JVH',\n",
       "    'Name': 'CALCITRIOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/31f74a3e-c8b0-4b54-9c03-5ed3121ed038/31f74a3e-c8b0-4b54-9c03-5ed3121ed038.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5280453]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholecalciferol'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin D3 Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6J9BLA949Q',\n",
       "    'Name': 'TESTOLACTONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/322ece11-ef0e-46f8-901f-8a2881e07ad7/322ece11-ef0e-46f8-901f-8a2881e07ad7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [13769]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MNX7R8C5VO',\n",
       "    'Name': 'CARBIDOPA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3262d1ba-4dab-4e2d-8a83-cc9762482875/3262d1ba-4dab-4e2d-8a83-cc9762482875.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [38101]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatic Amino Acid Decarboxylation Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DOPA Decarboxylase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 4,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/DOPA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'multiple-CIDs'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FVF865388R',\n",
       "    'Name': 'DESLORATADINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/32679566-0ee3-4fa9-a94f-7fe24e196c4a/32679566-0ee3-4fa9-a94f-7fe24e196c4a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [124087]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H1 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-1 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WQ29KQ9POT',\n",
       "    'Name': 'GLUCONOLACTONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/32780963-4283-40d6-aa47-4783c53d3a93/32780963-4283-40d6-aa47-4783c53d3a93.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [7027]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calculi Dissolution Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Irrigation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '768M1V522C',\n",
       "    'Name': 'CIDOFOVIR ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3285fbaf-ac4e-44be-b909-4f5b5de691a2/3285fbaf-ac4e-44be-b909-4f5b5de691a2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60613]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DNA Polymerase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5W7SIA7YZW',\n",
       "    'Name': 'LEVONORGESTREL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/328b1ebd-7cb1-40bb-ace3-77568d5e866a/328b1ebd-7cb1-40bb-ace3-77568d5e866a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [13109]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inhibit Ovum Fertilization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin-containing Intrauterine Device'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '556Q0P6PB1',\n",
       "    'Name': 'TECHNETIUM TC-99M SULFUR COLLOID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/32d5ef18-3059-4887-96c8-98b53cdee9bd/32d5ef18-3059-4887-96c8-98b53cdee9bd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76957057]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'T58MSI464G',\n",
       "    'Name': 'ACARBOSE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/333ba4bf-8c0e-4e19-99a9-4aae4df73e83/333ba4bf-8c0e-4e19-99a9-4aae4df73e83.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9811704]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha Glucosidase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Glucosidase Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6YE7PBM15H',\n",
       "    'Name': 'MIDODRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3391f927-b8e6-48c5-9512-0bdd4a88c425/3391f927-b8e6-48c5-9512-0bdd4a88c425.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416942]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5VJA14972G',\n",
       "    'Name': 'ANTIVENIN (LATRODECTUS MACTANS) (EQUINE)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/33e5d282-b69e-43c8-83a3-4b2d7254d371/33e5d282-b69e-43c8-83a3-4b2d7254d371.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Venom Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'HU9DX48N0T',\n",
       "    'Name': 'MYCOPHENOLIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3415eb06-baeb-435e-9c62-29eb6e3e26ae/3415eb06-baeb-435e-9c62-29eb6e3e26ae.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [446541]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimetabolite Immunosuppressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RMW9V5RW38',\n",
       "    'Name': 'TRIFLURIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97f328c6-f9df-4ccd-808d-23c48632164f/97f328c6-f9df-4ccd-808d-23c48632164f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6256]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog Antiviral'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '91Y494NL0X',\n",
       "    'Name': 'BUTENAFINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3432e77e-12df-4f62-a06e-5dd1e3c3fea1/3432e77e-12df-4f62-a06e-5dd1e3c3fea1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2484]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzylamine Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzylamines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6Z5B6HVF6O',\n",
       "    'Name': 'LATANOPROST',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/349f45d8-e01d-4888-be6f-362384ce258c/349f45d8-e01d-4888-be6f-362384ce258c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311221]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'A8910SQJ1U',\n",
       "    'Name': 'SOLIFENACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/34e904a6-de0c-4daf-a0ec-7444c384b218/34e904a6-de0c-4daf-a0ec-7444c384b218.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [154059]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '66Y330CJHS',\n",
       "    'Name': 'HUMAN IMMUNOGLOBULIN G',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/352d1f95-4586-41a2-8c81-4560064d5ae6/352d1f95-4586-41a2-8c81-4560064d5ae6.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antigen Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'AC71R787OV',\n",
       "    'Name': 'COAGULATION FACTOR VIIA RECOMBINANT HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/35352068-88ee-4ad4-a478-4cb650f1f439/35352068-88ee-4ad4-a478-4cb650f1f439.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor IX Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor X Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U5N7SU872W',\n",
       "    'Name': 'MALATHION',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3663371e-c7ad-4050-9c35-249754dbc994/3663371e-c7ad-4050-9c35-249754dbc994.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417266]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FX3WJ41CMX',\n",
       "    'Name': 'PERFLEXANE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3668fe85-6492-45ec-a7c7-5d3afaed91c6/3668fe85-6492-45ec-a7c7-5d3afaed91c6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9639]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Contrast Agent for Ultrasound Imaging'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ultrasound Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M5681Q5F9P',\n",
       "    'Name': 'PITAVASTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/366b85d2-84de-46c6-a894-1d55477f5894/366b85d2-84de-46c6-a894-1d55477f5894.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5282452]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HMG-CoA Reductase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HMG-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 25,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxymethylglutaryl-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JU58VJ6Y3B',\n",
       "    'Name': 'GUANIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/36c4ac0e-7728-4d25-9da7-5deb2f880136/36c4ac0e-7728-4d25-9da7-5deb2f880136.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3520]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Acetylcholine Releasing Agent',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Acetylcholine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-187'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Acetylcholine Activity',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Acetylcholine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-187'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2P471X1Z11',\n",
       "    'Name': 'OMALIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/36db08b7-a485-48e2-b69c-82b431924e28/36db08b7-a485-48e2-b69c-82b431924e28.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-IgE'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased IgE Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'IgE-directed Antibody Interactions'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BGF9MN2HU1',\n",
       "    'Name': 'FENOFIBRIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/36ef818a-ae82-4cd3-a6a6-c2d940235021/36ef818a-ae82-4cd3-a6a6-c2d940235021.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [64929]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator Receptor alpha Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '886U3H6UFF',\n",
       "    'Name': 'CHLOROQUINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/37082802-e154-4f6d-b3e5-2b38d29c05e7/37082802-e154-4f6d-b3e5-2b38d29c05e7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417263]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimalarial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3XMK78S47O',\n",
       "    'Name': 'TESTOSTERONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3777c9c2-a62e-400e-8d3a-a978e0a36ae8/3777c9c2-a62e-400e-8d3a-a978e0a36ae8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6013]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen Receptor Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androstanes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4VX7YNB537',\n",
       "    'Name': 'TACRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/380fe3ed-4fe0-4fc5-a64a-5f043d6c260e/380fe3ed-4fe0-4fc5-a64a-5f043d6c260e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [1935]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2Z07MYW1AZ',\n",
       "    'Name': 'ANASTROZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/38101fa5-761d-4156-99ad-ca74b123b91e/38101fa5-761d-4156-99ad-ca74b123b91e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2187]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '01MI4Q9DI3',\n",
       "    'Name': 'PILOCARPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/38367ca4-039d-4b02-97fd-53b0430d5f49/38367ca4-039d-4b02-97fd-53b0430d5f49.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5910]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Receptor Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N9I9HDB855',\n",
       "    'Name': 'DIHYDROCODEINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/384ecc67-124a-4af0-b736-e968e8c0b3ca/384ecc67-124a-4af0-b736-e968e8c0b3ca.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284543]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S915P5499N',\n",
       "    'Name': 'PLERIXAFOR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/38506a61-5ca6-4df0-846a-dba48a48fdb2/38506a61-5ca6-4df0-846a-dba48a48fdb2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [65015]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hematopoietic Stem Cell Mobilizer'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Hematopoietic Stem Cell Mobilization'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '48SPP0PA9Q',\n",
       "    'Name': 'CEFOTETAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/38587f8f-43c2-4490-b495-2a1186143877/38587f8f-43c2-4490-b495-2a1186143877.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GEB06NHM23',\n",
       "    'Name': 'METOPROLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3860e097-3e1a-4a04-943c-653473421b3c/3860e097-3e1a-4a04-943c-653473421b3c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417235]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '19W019ZDRJ',\n",
       "    'Name': 'CICLOPIROX',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/387a7415-125a-453f-8345-705f7b3d81d7/387a7415-125a-453f-8345-705f7b3d81d7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2749]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased DNA Replication'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Protein Synthesis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased RNA Replication'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Synthesis Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FF28EJQ494',\n",
       "    'Name': 'PROMETHAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3897410d-3cca-4701-ac43-c248153a438b/3897410d-3cca-4701-ac43-c248153a438b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417077]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C291HFX4DY',\n",
       "    'Name': 'NORGESTIMATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3897db6d-1bdd-42f9-b147-bb56f845c7bf/3897db6d-1bdd-42f9-b147-bb56f845c7bf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6540478]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '214IZI85K3',\n",
       "    'Name': 'TRIFLUOPERAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/38995e0d-ba48-4537-af70-8827927b3ae0/38995e0d-ba48-4537-af70-8827927b3ae0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5566]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CS849DUN3M',\n",
       "    'Name': 'ANTI-INHIBITOR COAGULANT COMPLEX',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/38ca4a81-8fca-4c47-aa96-debdb62674ae/38ca4a81-8fca-4c47-aa96-debdb62674ae.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-inhibitor Coagulant Complex'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Reversed Anticoagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N27ADP50ER',\n",
       "    'Name': 'PHOSPHATE ION P-32',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/38e893a0-8e2e-41d3-8650-3e6ac346c1d0/38e893a0-8e2e-41d3-8650-3e6ac346c1d0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [167704]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Therapeutic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C43C467DPE',\n",
       "    'Name': 'CEFTIZOXIME',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/39647cdc-0fa2-4654-8f61-679ca01cbb61/39647cdc-0fa2-4654-8f61-679ca01cbb61.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6533629]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1Y17CTI5SR',\n",
       "    'Name': 'INSULIN HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3a026a80-2d93-4b0d-aacb-3a384140e44b/3a026a80-2d93-4b0d-aacb-3a384140e44b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [118984375]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L3H46UAC61',\n",
       "    'Name': 'METHYCLOTHIAZIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3a259308-c8ee-48fd-a56c-fc008f7f3d4f/3a259308-c8ee-48fd-a56c-fc008f7f3d4f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416653]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazide Diuretic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G32F6EID2H',\n",
       "    'Name': 'ERTAPENEM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3a284691-01c0-418d-99bd-5051532e2b30/3a284691-01c0-418d-99bd-5051532e2b30.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [150610]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Carbapenems'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penem Antibacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KXO2KT9N0G',\n",
       "    'Name': 'PRAVASTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3a33cb38-debc-4793-ab95-1d32c7fac0a9/3a33cb38-debc-4793-ab95-1d32c7fac0a9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54687]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HMG-CoA Reductase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HMG-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 25,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxymethylglutaryl-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7XIY785AZD',\n",
       "    'Name': 'INSULIN GLULISINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3a62d094-71ca-4e2a-a1d0-4423e153dd02/3a62d094-71ca-4e2a-a1d0-4423e153dd02.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16136701]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7I64C51O16',\n",
       "    'Name': 'ZICONOTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3a72b3aa-062d-40b3-9bba-de5d5aa30d45/3a72b3aa-062d-40b3-9bba-de5d5aa30d45.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16158476]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'N-Calcium Channel Receptor Antagonists',\n",
       "         'Markup': [{'Start': 2,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'N-type Calcium Channel Antagonist',\n",
       "         'Markup': [{'Start': 7,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q3JTX2Q7TU',\n",
       "    'Name': 'DIAZEPAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3aa542bc-307c-4db9-8a20-b9c992f2cbbf/3aa542bc-307c-4db9-8a20-b9c992f2cbbf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3016]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'NUV44L116D',\n",
       "    'Name': 'CLOMIPRAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3adae895-cbd3-4841-8872-640e9d3de72e/3adae895-cbd3-4841-8872-640e9d3de72e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2801]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '19O2GP3B7Q',\n",
       "    'Name': 'CLEVIDIPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3ae21155-aa37-4c06-b115-8015be544fcc/3ae21155-aa37-4c06-b115-8015be544fcc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417338]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridine Calcium Channel Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N967BGT6XW',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3b316562-088b-432e-a76e-b189094a6b14/3b316562-088b-432e-a76e-b189094a6b14.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K27005NP0A',\n",
       "    'Name': 'IXABEPILONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3b7d695c-b650-4dd2-9d52-c1ab208820c7/3b7d695c-b650-4dd2-9d52-c1ab208820c7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6445540]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibition'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9YA6SX5S4D',\n",
       "    'Name': 'CEPHRADINE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3b91acd1-6ab5-4530-9f08-df0ab82e4896/3b91acd1-6ab5-4530-9f08-df0ab82e4896.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [38103]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9927MT646M',\n",
       "    'Name': 'BASILIXIMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3bc9f7b9-7faf-47ca-99ea-9992bf41ca39/3bc9f7b9-7faf-47ca-99ea-9992bf41ca39.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin 2 Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin 2 Receptor-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin-2 Receptor Blocking Antibody'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5D06587D6R',\n",
       "    'Name': 'PALONOSETRON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3bd4d2a0-2ffd-4c0d-94de-a2fd10404975/3bd4d2a0-2ffd-4c0d-94de-a2fd10404975.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6337614]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin 3 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin-3 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '768N7QO4KH',\n",
       "    'Name': 'TRYPAN BLUE FREE ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3bed0578-243c-44cc-a0fe-59ac50705ff7/3bed0578-243c-44cc-a0fe-59ac50705ff7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6297]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diagnostic Dye'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dyes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F59P8B75R4',\n",
       "    'Name': 'PENTOSAN POLYSULFATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3c072ae5-224f-4a9e-913f-1a21877d2455/3c072ae5-224f-4a9e-913f-1a21877d2455.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glycosaminoglycan'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glycosaminoglycans'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0K0S2P98ZJ',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3c47f606-fa1f-4d2d-afad-fde54d9b20c7/3c47f606-fa1f-4d2d-afad-fde54d9b20c7.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5SFF1W6677',\n",
       "    'Name': 'CEPHALEXIN ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3c596055-f2e7-4e97-8f19-2b16238976fd/3c596055-f2e7-4e97-8f19-2b16238976fd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [27447]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5TAA004E22',\n",
       "    'Name': 'SARGRAMOSTIM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3c5e420f-3661-452c-b490-3d4a03ef4e46/3c5e420f-3661-452c-b490-3d4a03ef4e46.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Granulocyte Colony-Stimulating Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Granulocyte-Macrophage Colony-Stimulating Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Myeloid Cell Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Leukocyte Growth Factor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '15UQ94PT4P',\n",
       "    'Name': 'DARBEPOETIN ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3c642c0c-11a5-4476-8468-148843af10c4/3c642c0c-11a5-4476-8468-148843af10c4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Erythropoiesis-stimulating Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Erythropoietin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Erythroid Cell Production'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q40X8H422O',\n",
       "    'Name': 'HYDROXOCOBALAMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3c664b08-4c7b-4bcf-bdd8-40fcff9ce582/3c664b08-4c7b-4bcf-bdd8-40fcff9ce582.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [44475014]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antidote'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '91I69L5AY5',\n",
       "    'Name': 'ENFLURANE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3cd92f23-ee05-44a3-bc35-9fe3f9586493/3cd92f23-ee05-44a3-bc35-9fe3f9586493.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417346]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthesia'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G3P28OML5I',\n",
       "    'Name': 'TAMSULOSIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3d053cdb-bfd2-4a30-bbb1-1d52039e10bc/3d053cdb-bfd2-4a30-bbb1-1d52039e10bc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [129211]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6334XMP4KC',\n",
       "    'Name': 'HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3d37e9b0-ca07-494f-a3c0-8a4c5a16434e/3d37e9b0-ca07-494f-a3c0-8a4c5a16434e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Rotavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rotavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Live'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0619F35CGV',\n",
       "    'Name': 'TETRACAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3d3fedd0-3063-4d34-a1eb-22f7c0831a6a/3d3fedd0-3063-4d34-a1eb-22f7c0831a6a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5411]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ester Local Anesthetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Esters'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3Z6FS3IK0K',\n",
       "    'Name': 'CEFACLOR ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3d640155-0413-4d3b-964d-ff1a6b8d67d5/3d640155-0413-4d3b-964d-ff1a6b8d67d5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [51039]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '585NM85KYM',\n",
       "    'Name': 'METHYL AMINOLEVULINATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3e55de1c-5be9-4c35-9f04-75bf4485e854/3e55de1c-5be9-4c35-9f04-75bf4485e854.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [157922]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Porphyrin Precursor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Porphyrinogens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5PE9FDE8GB',\n",
       "    'Name': 'CLONAZEPAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3e569d7d-bdda-40ff-95dd-64c20de454c3/3e569d7d-bdda-40ff-95dd-64c20de454c3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2802]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FQR280JW2N',\n",
       "    'Name': 'HYDROXYAMPHETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3e88bb83-52e9-480a-b84c-c2ba6a9eff29/3e88bb83-52e9-480a-b84c-c2ba6a9eff29.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417306]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic Receptor Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '73B0K5S26A',\n",
       "    'Name': 'BELIMUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3eba8059-0220-4efd-96e3-cb1278c00206/3eba8059-0220-4efd-96e3-cb1278c00206.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased B Lymphocyte Activation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'B Lymphocyte Stimulator-specific Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'B Lymphocyte Stimulator-directed Antibody Interactions'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '364P9RVW4X',\n",
       "    'Name': 'FOSCARNET',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3ec48420-2bda-4476-81e5-f3e836f71e11/3ec48420-2bda-4476-81e5-f3e836f71e11.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3415]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DNA Polymerase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pyrophosphate Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pyrophosphate Analog DNA Polymerase Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TM54L796SN',\n",
       "    'Name': 'HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3ed5b42d-8cfe-482d-8f54-565f5e0679bb/3ed5b42d-8cfe-482d-8f54-565f5e0679bb.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Human Adenovirus Type 7 Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Live'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenovirus Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FKD3DUK39I',\n",
       "    'Name': 'HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3f41b325-d71f-4d29-8bab-c5b5af654771/3f41b325-d71f-4d29-8bab-c5b5af654771.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Human Adenovirus Type 4 Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Live, Unattenuated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenovirus Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J2VZ07J96K',\n",
       "    'Name': 'POLYMYXIN B',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3f5b7cb2-b1f4-4a82-8070-1b1ac9565cae/3f5b7cb2-b1f4-4a82-8070-1b1ac9565cae.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [23649670]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polymyxin-class Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polymyxins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P1QW714R7M',\n",
       "    'Name': 'IMIQUIMOD',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/3f5d6f44-ec2d-4325-b2fe-b17b62835b69/3f5d6f44-ec2d-4325-b2fe-b17b62835b69.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [57469]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Cytokine Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Cytokine Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon Inducers'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3XC8GUZ6CB',\n",
       "    'Name': 'SULFASALAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/405d9519-b178-41a3-ae7f-bea7960466d9/405d9519-b178-41a3-ae7f-bea7960466d9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5339]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminosalicylate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminosalicylic Acids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UH52RJ06IG',\n",
       "    'Name': 'INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/40a1365b-aeb9-4649-a8df-52d04a785703/40a1365b-aeb9-4649-a8df-52d04a785703.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Influenza A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '837RU6905N',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/40ae679e-6b1f-4626-8a52-a4eddf0bc826/40ae679e-6b1f-4626-8a52-a4eddf0bc826.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6X4F561V3W',\n",
       "    'Name': 'UNOPROSTONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/40c40076-4f9e-4221-96f1-069215f6fa52/40c40076-4f9e-4221-96f1-069215f6fa52.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311236]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YBK48BXK30',\n",
       "    'Name': 'TRAZODONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/40e24c39-60a2-439d-81d0-3fbbd8f45b39/40e24c39-60a2-439d-81d0-3fbbd8f45b39.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5533]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P7WI8UL647',\n",
       "    'Name': 'NESIRITIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/419fde75-874c-42bc-8b7d-04c0c6bd12bc/419fde75-874c-42bc-8b7d-04c0c6bd12bc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71308561]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Natriuretic Peptide'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Natriuretic Peptides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '554Z48XN5E',\n",
       "    'Name': 'METHIMAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/41ff6de8-6e65-40b8-a2a3-48861a6a0c0b/41ff6de8-6e65-40b8-a2a3-48861a6a0c0b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [1349907]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thyroid Hormone Synthesis Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thyroid Hormone Synthesis Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P41PML4GHR',\n",
       "    'Name': 'NIZATIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/421e6d8c-d82f-4813-82dc-9c303e81466c/421e6d8c-d82f-4813-82dc-9c303e81466c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4513]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-2 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DTI67O9503',\n",
       "    'Name': 'ALGLUCOSIDASE ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/42207f87-6dc4-4858-91c0-d0927b87271d/42207f87-6dc4-4858-91c0-d0927b87271d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Glucosidases'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Glycogen-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YZI5105V0L_1',\n",
       "    'Name': 'KETOROLAC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/423a1c81-5618-4719-9119-9fb20132e769/423a1c81-5618-4719-9119-9fb20132e769.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417282]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '70HZ18PH24',\n",
       "    'Name': 'ZOLEDRONIC ACID ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/427e935f-b0fa-4f91-ac16-53be6917f514/427e935f-b0fa-4f91-ac16-53be6917f514.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [68740]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bisphosphonate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diphosphonates'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M32RH9MFGP',\n",
       "    'Name': 'DEXMETHYLPHENIDATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/428099c4-9cea-4fe8-944b-d1487f9015d2/428099c4-9cea-4fe8-944b-d1487f9015d2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [154101]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KV2JZ1BI6Z',\n",
       "    'Name': 'PYRIDOXINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4298f3cf-b127-4c7a-83aa-ca60f1353027/4298f3cf-b127-4c7a-83aa-ca60f1353027.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [1054]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin B6 Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin B 6'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Analogs/Derivatives'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5P4DHS6ENR',\n",
       "    'Name': 'BENZONATATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/42b8e446-d8f9-451b-9359-35a647606994/42b8e446-d8f9-451b-9359-35a647606994.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Tracheobronchial Stretch Receptor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-narcotic Antitussive'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9OQO0E343Z',\n",
       "    'Name': 'AMMONIA N-13',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/42dddc9b-c274-433d-8997-6afcdb3cd4d5/42dddc9b-c274-433d-8997-6afcdb3cd4d5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [119432]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4O5J85GJJB',\n",
       "    'Name': 'NETILMICIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/42fe4529-654c-4d29-885f-b34aa4ac1be6/42fe4529-654c-4d29-885f-b34aa4ac1be6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441306]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycoside Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycosides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '46627O600J',\n",
       "    'Name': 'LEVODOPA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/435eee45-2996-4cf6-a768-fa2f358d2249/435eee45-2996-4cf6-a768-fa2f358d2249.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6047]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatic Amino Acid Decarboxylation Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DOPA Decarboxylase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 4,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/DOPA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'multiple-CIDs'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E65RW73PHS',\n",
       "    'Name': 'GADOFOSVESET',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/437069ce-2f27-4857-970c-79ac3bbc875a/437069ce-2f27-4857-970c-79ac3bbc875a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73415770]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RT3Y3QMF8N',\n",
       "    'Name': 'MOLINDONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/43764842-25d6-413a-8430-d3fa08630ec1/43764842-25d6-413a-8430-d3fa08630ec1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416925]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Typical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MQG94M5EEO',\n",
       "    'Name': 'TESAMORELIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/437a3918-7cae-4b57-9c5f-72d19c35fa67/437a3918-7cae-4b57-9c5f-72d19c35fa67.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16137828]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased GHRH Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Growth Hormone Releasing Factor Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '25E79B5CTM',\n",
       "    'Name': 'DENILEUKIN DIFTITOX',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/43884d03-a04e-431a-b9ff-1da41caba322/43884d03-a04e-431a-b9ff-1da41caba322.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD25-directed Cytotoxin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diphtheria Toxin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin-2'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Fusion Proteins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JGH8MYC891',\n",
       "    'Name': 'DROTRECOGIN ALFA (ACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/43d6253c-49af-421d-b73a-f1935613e4e0/43d6253c-49af-421d-b73a-f1935613e4e0.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein C'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Activated Protein C'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '05V02F2KDG',\n",
       "    'Name': 'ROSIGLITAZONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/43fb772b-0245-4763-8138-d0e0d6773db7/43fb772b-0245-4763-8138-d0e0d6773db7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416662]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator Receptor gamma Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator-activated Receptor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'PPAR gamma'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazolidinedione'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazolidinediones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FK894Q51YE',\n",
       "    'Name': 'RABIES VIRUS STRAIN FLURY LEP ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/457700d7-878d-4cc2-b0d8-ecbe5c856ed5/457700d7-878d-4cc2-b0d8-ecbe5c856ed5.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Rabies Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rabies Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'AGG2FN16EV',\n",
       "    'Name': 'SIMVASTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4588f941-2d9d-46a4-b3d6-c306c4fb50f8/4588f941-2d9d-46a4-b3d6-c306c4fb50f8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54454]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HMG-CoA Reductase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HMG-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 25,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxymethylglutaryl-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3B744AG22N',\n",
       "    'Name': 'TECHNETIUM TC-99M EXAMETAZIME',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/458e8676-0c68-4f39-8acc-5d23935192e1/458e8676-0c68-4f39-8acc-5d23935192e1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [11954234]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N12000U13O',\n",
       "    'Name': 'DOXYCYCLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/45a1e5bc-8f07-4125-accf-4d52b2f32d4b/45a1e5bc-8f07-4125-accf-4d52b2f32d4b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54684461]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracycline-class Drug'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracyclines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '10X0709Y6I',\n",
       "    'Name': 'BISACODYL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/45a5a75d-4e1b-46b4-a9ad-69234348ab0b/45a5a75d-4e1b-46b4-a9ad-69234348ab0b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2391]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Large Intestinal Motility'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Stimulant Laxative'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Stimulation Large Intestine Fluid/Electrolyte Secretion'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '59H4FCV1TF',\n",
       "    'Name': 'NEFAZODONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/45d6ddee-369f-4007-9e90-db7ba65f6fa4/45d6ddee-369f-4007-9e90-db7ba65f6fa4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4449]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3OWL53L36A',\n",
       "    'Name': 'MANNITOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/45daa929-1f70-4123-85b1-30f2368d9af5/45daa929-1f70-4123-85b1-30f2368d9af5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6251]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Osmotic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Osmotic Diuretic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '80168379AG',\n",
       "    'Name': 'DOXORUBICIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/45ec1cfe-1efc-47fc-be2c-9c96b0b786f4/45ec1cfe-1efc-47fc-be2c-9c96b0b786f4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [31703]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anthracycline Topoisomerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anthracyclines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0O54ZQ14I9',\n",
       "    'Name': 'AMINOGLUTETHIMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/462e9c13-0233-4aee-b87b-77588ae8563e/462e9c13-0233-4aee-b87b-77588ae8563e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417394]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenal Steroid Synthesis Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenal Steroid Synthesis Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YL5FZ2Y5U1',\n",
       "    'Name': 'METHOTREXATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/464ee144-8f09-4489-aafb-ed49822b647a/464ee144-8f09-4489-aafb-ed49822b647a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [126941]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folate Analog Metabolic Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 6,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Folate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-135398658'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folic Acid Metabolism Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Folic%20Acid',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-135398658'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q8X02027X3',\n",
       "    'Name': 'GEMFIBROZIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/466383cc-e41f-4dad-b18d-ef6f67b1a197/466383cc-e41f-4dad-b18d-ef6f67b1a197.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3463]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator Receptor alpha Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator-activated Receptor alpha Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'PPAR alpha'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UC6VBE7V1Z',\n",
       "    'Name': 'METHADONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/468a3b97-c955-41e6-953a-ab75dd695f0e/468a3b97-c955-41e6-953a-ab75dd695f0e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417353]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'PVI5M0M1GW',\n",
       "    'Name': 'FILGRASTIM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/46b741ec-b2fb-4ba1-a3ee-eb9e87a8b1ba/46b741ec-b2fb-4ba1-a3ee-eb9e87a8b1ba.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Granulocyte Colony-Stimulating Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Granulocyte-Macrophage Colony-Stimulating Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Myeloid Cell Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Leukocyte Growth Factor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N7U69T4SZR',\n",
       "    'Name': 'OLANZAPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/46b7f627-f469-4721-8056-78bee592eddf/46b7f627-f469-4721-8056-78bee592eddf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135398745]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Atypical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ITY7G7Q744',\n",
       "    'Name': 'COCCIDIOIDES IMMITIS SPHERULE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4738cefb-68b1-426f-85e7-0f627727fda4/4738cefb-68b1-426f-85e7-0f627727fda4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Skin Test Antigen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antigens, Fungal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '838F01T721',\n",
       "    'Name': 'PALIPERIDONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4745d6d4-36be-4e6d-a8e6-25f271e0ae55/4745d6d4-36be-4e6d-a8e6-25f271e0ae55.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Atypical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6KIC4BB60G',\n",
       "    'Name': 'HUMAN C1-ESTERASE INHIBITOR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4789f53f-0df3-4f86-be8f-a16bcb5029fa/4789f53f-0df3-4f86-be8f-a16bcb5029fa.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human C1 Esterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Vascular Permeability'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kallikrein Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '77W477J15H',\n",
       "    'Name': 'CHLOROTHIAZIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/479b7a8c-0a4d-4a79-bbbc-27494afa2d59/479b7a8c-0a4d-4a79-bbbc-27494afa2d59.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2720]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazide Diuretic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '21925K482H',\n",
       "    'Name': 'CARISOPRODOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/47a27f39-3029-49d8-857c-e9fdca8f8854/47a27f39-3029-49d8-857c-e9fdca8f8854.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416891]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Centrally-mediated Muscle Relaxation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Muscle Relaxant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O7M2E4264D',\n",
       "    'Name': 'RIMEXOLONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/47cb71a1-53a3-48ec-9597-2f30512e7af5/47cb71a1-53a3-48ec-9597-2f30512e7af5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311412]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6YKS4Y3WQ7',\n",
       "    'Name': 'HYDROCODONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4827c490-d579-4d3a-b5dd-19153e81c1ca/4827c490-d579-4d3a-b5dd-19153e81c1ca.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284569]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H9NOI61UH1',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/488659d3-469e-41c1-a8ef-acd422bcdf61/488659d3-469e-41c1-a8ef-acd422bcdf61.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K2I13DR72L',\n",
       "    'Name': 'GADOPENTETIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4891ad9a-ad57-45a8-b4c8-d3cad1a8712a/4891ad9a-ad57-45a8-b4c8-d3cad1a8712a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [157429]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8I7IO46IVQ',\n",
       "    'Name': 'SAXAGLIPTIN ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/48a2e09c-7dce-4e29-8288-1b721b1a6845/48a2e09c-7dce-4e29-8288-1b721b1a6845.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [11243969]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dipeptidyl Peptidase 4 Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dipeptidyl Peptidase 4 Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '53QOG569E0',\n",
       "    'Name': 'METAPROTERENOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/48b2a1ad-ac44-4851-a095-d220c072a778/48b2a1ad-ac44-4851-a095-d220c072a778.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417071]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta2-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7R4F94TVGY',\n",
       "    'Name': 'CEFPODOXIME',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/48c78b48-9cbc-4ccc-aa5a-28529139e7dc/48c78b48-9cbc-4ccc-aa5a-28529139e7dc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6335986]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '16CHD79MIX',\n",
       "    'Name': 'IOTHALAMIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/491c761d-f427-443b-bbeb-1fa0378334b8/491c761d-f427-443b-bbeb-1fa0378334b8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3737]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q42T66VG0C',\n",
       "    'Name': 'PENICILLIN G',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/49405668-2669-4e08-97d0-f52664d0c2f0/49405668-2669-4e08-97d0-f52664d0c2f0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5904]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '699121PHCA',\n",
       "    'Name': 'DOCETAXEL ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/496d3c1f-e147-40a9-bec3-121b8fc1058a/496d3c1f-e147-40a9-bec3-121b8fc1058a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [148124]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibition'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5XE4NWM740',\n",
       "    'Name': 'MESORIDAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/498e6de5-fd1b-498b-9860-bfd1b6efd09f/498e6de5-fd1b-498b-9860-bfd1b6efd09f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76960490]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3QN8BYN5QF',\n",
       "    'Name': 'FINGOLIMOD',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/49b1483e-7abb-42fb-878f-eadd1c403c4d/49b1483e-7abb-42fb-878f-eadd1c403c4d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [107970]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sphingosine 1-Phosphate Receptor Modulators',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 23,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Sphingosine%201-Phosphate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5283560'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sphingosine 1-phosphate Receptor Modulator',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 23,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Sphingosine%201-phosphate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5283560'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '423W026MA9',\n",
       "    'Name': 'AMCINONIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/49bcf8ab-b2d7-4880-b176-8c03b83c8e30/49bcf8ab-b2d7-4880-b176-8c03b83c8e30.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [443958]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0KB5E5H415',\n",
       "    'Name': 'INFLUENZA A VIRUS A/PERTH/16/2009 (H3N2) LIVE(ATTENUATED) ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/49c01b80-1786-4feb-be19-e6efd63384a8/49c01b80-1786-4feb-be19-e6efd63384a8.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Influenza A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6RZ6XEZ3CR',\n",
       "    'Name': 'CHLORDIAZEPOXIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4a2c1a6d-27a9-439d-aeec-861ab2beeae8/4a2c1a6d-27a9-439d-aeec-861ab2beeae8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2712]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0O977R722D',\n",
       "    'Name': 'OXAMNIQUINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4a4c8296-cb87-40f3-b521-7226597efba1/4a4c8296-cb87-40f3-b521-7226597efba1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76970549]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antihelminthic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KZW0R0686Q',\n",
       "    'Name': 'ETHIODIZED OIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4a6e4fb4-3523-4f6d-b368-e83a0161d783/4a6e4fb4-3523-4f6d-b368-e83a0161d783.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8SSC91326P',\n",
       "    'Name': 'DONEPEZIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4ab589d0-2aac-4777-bb3a-07947ca49f76/4ab589d0-2aac-4777-bb3a-07947ca49f76.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416661]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y0TK0FS77W',\n",
       "    'Name': 'CROMOLYN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4ab6a5bb-146b-4e3b-bd8a-c8b1b89c1aaa/4ab6a5bb-146b-4e3b-bd8a-c8b1b89c1aaa.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2882]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Histamine Release',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Mast Cell Stabilizer'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0J9L7J6V8C',\n",
       "    'Name': 'NEPAFENAC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4acc8ad9-defe-49c3-86fb-1e59ebf9edeb/4acc8ad9-defe-49c3-86fb-1e59ebf9edeb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [151075]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '328VNB72T8',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4ad16af2-a2e2-477e-a496-b5633e97b2c9/4ad16af2-a2e2-477e-a496-b5633e97b2c9.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'I7L8FKN87J',\n",
       "    'Name': 'TUBERCULIN PURIFIED PROTEIN DERIVATIVE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4adf6841-8014-4167-871a-c83404a80ab6/4adf6841-8014-4167-871a-c83404a80ab6.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Skin Test Antigen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tuberculosis Skin Test'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antigens, Bacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '36S3EQV54C',\n",
       "    'Name': 'ESTAZOLAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4afdd845-5a35-4f9a-bc54-bbff8af3ccc1/4afdd845-5a35-4f9a-bc54-bbff8af3ccc1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3261]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0CD5FD6S2M',\n",
       "    'Name': 'FLUOCINOLONE ACETONIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4b914971-9050-4c3b-b86e-44fb9a0549ee/4b914971-9050-4c3b-b86e-44fb9a0549ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6215]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '025P9I542Y',\n",
       "    'Name': 'CYANOCOBALAMIN CO-57',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4c14caf9-4940-4f03-b5f5-bc78bfa9eec4/4c14caf9-4940-4f03-b5f5-bc78bfa9eec4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [122706861]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9266D9P3PQ',\n",
       "    'Name': 'BENDAMUSTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4c1c7bdb-f0bf-4674-9a92-f911b7431546/4c1c7bdb-f0bf-4674-9a92-f911b7431546.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [65628]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '22X328QOC4',\n",
       "    'Name': 'FULVESTRANT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4c366c70-00c1-4197-8b17-5851f5ae1df1/4c366c70-00c1-4197-8b17-5851f5ae1df1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [91800168]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Receptor Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Selective Estrogen Receptor Modulators'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GGD30112WC',\n",
       "    'Name': 'GUANABENZ',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4c4c4442-ce65-4313-94b2-bab35cdfa164/4c4c4442-ce65-4313-94b2-bab35cdfa164.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5702063]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central alpha-2 Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TGJ6YZC4W7',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4c5fbe46-8f33-4e9c-b3c2-efcb4a4a7dd2/4c5fbe46-8f33-4e9c-b3c2-efcb4a4a7dd2.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '494JNQ8L28',\n",
       "    'Name': 'TECHNETIUM TC-99M SUCCIMER',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4c8f26a3-61f4-4553-930c-c39f10e4dab4/4c8f26a3-61f4-4553-930c-c39f10e4dab4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [134694302]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L35JN3I7SJ',\n",
       "    'Name': 'RAMIPRIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4cbe04ad-123a-4b91-af61-f140c650e95b/4cbe04ad-123a-4b91-af61-f140c650e95b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5362129]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin Converting Enzyme Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin-converting Enzyme Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '76W6J0943E',\n",
       "    'Name': 'FLUTAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4ce8e72a-3f3d-44d9-8a89-e1daa1f75ae4/4ce8e72a-3f3d-44d9-8a89-e1daa1f75ae4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3397]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen Receptor Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ASW034S0B8',\n",
       "    'Name': 'ATOMOXETINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4cea1ec9-606a-4eca-a9ca-20fee7f04c4a/4cea1ec9-606a-4eca-a9ca-20fee7f04c4a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54841]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Norepinephrine Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Norepinephrine Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D8L75GM22O',\n",
       "    'Name': 'TECHNETIUM TC-99M RED BLOOD CELLS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4d0229c1-3660-4cc4-99e8-26887ae3385d/4d0229c1-3660-4cc4-99e8-26887ae3385d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8EUL29XUQT',\n",
       "    'Name': 'FLURANDRENOLIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4d3c7c59-619c-44b5-8bcb-c21ead38d775/4d3c7c59-619c-44b5-8bcb-c21ead38d775.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [15209]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5Q768OY0GI',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4e12eb8e-829a-4db1-9d32-afd45475d886/4e12eb8e-829a-4db1-9d32-afd45475d886.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q51BO43MG4',\n",
       "    'Name': 'LEVOTHYROXINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4e23cecf-288f-4a62-a18d-e58f7d50a9d1/4e23cecf-288f-4a62-a18d-e58f7d50a9d1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5819]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'l-Thyroxine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thyroxine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FLV5I5W26R',\n",
       "    'Name': 'HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4ed0d88b-3aae-42d9-bac8-23aaa767a11d/4ed0d88b-3aae-42d9-bac8-23aaa767a11d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Haemophilus Influenzae B Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Haemophilus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N3D6TG58NI',\n",
       "    'Name': 'THIORIDAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4ed2bac1-36ec-4560-ab65-4f3cee8779c0/4ed2bac1-36ec-4560-ab65-4f3cee8779c0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417030]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XZ7BG04GJX',\n",
       "    'Name': 'CEFIXIME ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4ed3d1bb-fccf-42be-b9a2-e47c62fab311/4ed3d1bb-fccf-42be-b9a2-e47c62fab311.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5362065]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D7RD81HE4W',\n",
       "    'Name': 'LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4f03ce05-9ebc-49fb-b5ef-323397699e13/4f03ce05-9ebc-49fb-b5ef-323397699e13.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lymphocyte Function Alteration'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased T Lymphocyte Destruction'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antibody-Surface Protein Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BF4C9Z1J53',\n",
       "    'Name': 'AMANTADINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4f085864-1f8e-4b19-898e-99626a98a561/4f085864-1f8e-4b19-898e-99626a98a561.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2130]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza A M2 Protein Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'M2 Protein Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ZS9CD1I8YE',\n",
       "    'Name': 'BISMUTH CATION',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4f0a1dad-a028-43f1-bc0f-250daa9986f9/4f0a1dad-a028-43f1-bc0f-250daa9986f9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [105143]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bismuth'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bismuth'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6AI06C00GW',\n",
       "    'Name': 'TIZANIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/4f460f5c-814e-48a7-aa64-bf36385f7dcb/4f460f5c-814e-48a7-aa64-bf36385f7dcb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5487]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central alpha-2 Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N21FAR7B4S',\n",
       "    'Name': 'APOMORPHINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/503f1e2d-6e8f-4ecf-a6bf-b99397d89c75/503f1e2d-6e8f-4ecf-a6bf-b99397d89c75.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6005]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopaminergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5D9HAA5Q5S',\n",
       "    'Name': 'SULCONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/50675a42-5588-4e18-b967-2a59d413f28f/50675a42-5588-4e18-b967-2a59d413f28f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416842]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K50N755924',\n",
       "    'Name': 'COLESTIPOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/508dff18-be26-485d-b075-f47a463b3f5f/508dff18-be26-485d-b075-f47a463b3f5f.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bile Acid Sequestrant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bile-acid Binding Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C9R35M8XV6',\n",
       "    'Name': 'HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20,752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5097e548-ad50-4c7c-99ea-e07acc450c00/5097e548-ad50-4c7c-99ea-e07acc450c00.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Haemophilus Influenzae B Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Haemophilus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '51F690397J',\n",
       "    'Name': 'CABAZITAXEL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/50f5447c-ebe2-4432-a8b1-351e37da6084/50f5447c-ebe2-4432-a8b1-351e37da6084.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9854073]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibition'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2GQ1IRY63P',\n",
       "    'Name': 'ATRACURIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/51262468-72ca-49d6-8aa7-9e1645e6639d/51262468-72ca-49d6-8aa7-9e1645e6639d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Neuromuscular Nondepolarizing Blockade'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nondepolarizing Neuromuscular Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2ZM8CX04RZ',\n",
       "    'Name': 'INSULIN GLARGINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/512b55b8-c559-4ba9-8fde-ea596f91b8a3/512b55b8-c559-4ba9-8fde-ea596f91b8a3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [118984454]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q08SIO485D',\n",
       "    'Name': 'PHENPROCOUMON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/51a35b1c-efcc-432e-86d4-05c569e7896c/51a35b1c-efcc-432e-86d4-05c569e7896c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76972520]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin K Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin K Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4M4WE5N2GE',\n",
       "    'Name': 'FLUORIDE ION F-18',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/522d93e3-7ecd-424d-8421-d379726b4918/522d93e3-7ecd-424d-8421-d379726b4918.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10197600]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G10832YT0L',\n",
       "    'Name': 'YERSINIA PESTIS 195/P ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/52db6198-8817-4982-9b02-67b5dc4726a4/52db6198-8817-4982-9b02-67b5dc4726a4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Yersinia Pestis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Plague Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2XQ558L16Z',\n",
       "    'Name': 'BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/52db637e-57ca-47c2-8db1-33868941d3aa/52db637e-57ca-47c2-8db1-33868941d3aa.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Bacillus Calmette-Guerin Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'BCG Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Intravesical Bacillus Calmette-Guerin Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Macrophage Proliferation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Immunologically Active Molecule Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TTD90R31WZ',\n",
       "    'Name': 'INTERFERON BETA-1B',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/52f71e51-9b5a-4663-89f8-5e31e0f33118/52f71e51-9b5a-4663-89f8-5e31e0f33118.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon-beta'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Human Interferon beta'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Proteins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '84319SGC3C',\n",
       "    'Name': 'AMIKACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/530bafa7-5ddc-43d2-a9cb-e7a6401ee384/530bafa7-5ddc-43d2-a9cb-e7a6401ee384.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [37768]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycoside Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycosides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'OYY3447OMC',\n",
       "    'Name': 'PAMIDRONIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/53110260-5f2b-479d-93b0-627583e5bf84/53110260-5f2b-479d-93b0-627583e5bf84.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4674]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bisphosphonate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diphosphonates'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ONW3LB39P7',\n",
       "    'Name': 'MEPENZOLATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/53655aea-3da7-4aa8-8859-3b9d7e6e1a7f/53655aea-3da7-4aa8-8859-3b9d7e6e1a7f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417018]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WYQ7N0BPYC',\n",
       "    'Name': 'ACETYLCYSTEINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/53a3588b-8a35-4e2c-84d3-3825cd9336d7/53a3588b-8a35-4e2c-84d3-3825cd9336d7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [12035]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antidote'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antidote for Acetaminophen Overdose',\n",
       "         'Markup': [{'Start': 13,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Acetaminophen',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-1983'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Respiratory Secretion Viscosity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Glutathione Concentration',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 11,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Glutathione',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-124886'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Mucolytic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Reduction Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0E43V0BB57',\n",
       "    'Name': 'MISOPROSTOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/54622101-1574-4cbb-b680-c6247c233592/54622101-1574-4cbb-b680-c6247c233592.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [134687576]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandin E1 Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandins E, Synthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JCX84Q7J1L',\n",
       "    'Name': 'CELECOXIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/54a0fd65-567e-4c0b-a327-e99c1dcdf488/54a0fd65-567e-4c0b-a327-e99c1dcdf488.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2662]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S65743JHBS',\n",
       "    'Name': 'GEFITINIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/54b163f8-5fdc-4945-8cd8-bac54398e96b/54b163f8-5fdc-4945-8cd8-bac54398e96b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [123631]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '69O5WQQ5TI',\n",
       "    'Name': 'CYCLOBENZAPRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/54e757af-2bdf-4f0f-a53e-e2460df36609/54e757af-2bdf-4f0f-a53e-e2460df36609.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2895]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Centrally-mediated Muscle Relaxation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Muscle Relaxant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L2T84IQI2K',\n",
       "    'Name': 'NALBUPHINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/54f83d1b-ee25-4f80-8009-386f32a2f081/54f83d1b-ee25-4f80-8009-386f32a2f081.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311304]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Competitive Opioid Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist/Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Partial Opioid Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y883P1Z2LT',\n",
       "    'Name': 'ATOVAQUONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/54fc8da3-5024-4913-88eb-9035bc3b46eb/54fc8da3-5024-4913-88eb-9035bc3b46eb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [74989]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimalarial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiprotozoal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7IO5LYA57N',\n",
       "    'Name': 'ROPIVACAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/552cc36e-1b5e-441d-bf2d-0116c5eea084/552cc36e-1b5e-441d-bf2d-0116c5eea084.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [175805]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amide Local Anesthetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amides'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RWM8CCW8GP',\n",
       "    'Name': 'OCTREOTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/55454ebe-c4ec-42c6-81b2-2ea5a1ede4e7/55454ebe-c4ec-42c6-81b2-2ea5a1ede4e7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [448601]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Somatostatin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Somatostatin Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Somatostatin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-16129706'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '304GTH6RNH',\n",
       "    'Name': 'ETONOGESTREL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/558ba2bc-ed04-4199-80f0-a39024a3efee/558ba2bc-ed04-4199-80f0-a39024a3efee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6917715]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YF1K15M17Y',\n",
       "    'Name': 'TEMOZOLOMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/559b61ea-91b6-4be8-8986-4a88ee426f54/559b61ea-91b6-4be8-8986-4a88ee426f54.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5394]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'LKG8494WBH',\n",
       "    'Name': 'BENZYL ALCOHOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/559bd7e4-b52e-44a0-99f0-408ed89eb1bf/559bd7e4-b52e-44a0-99f0-408ed89eb1bf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [244]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pediculicide'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ZL1R02VT79',\n",
       "    'Name': 'RANIBIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/55b9284f-7af7-4cf7-8111-75b8009f601c/55b9284f-7af7-4cf7-8111-75b8009f601c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vascular Endothelial Growth Factor Receptor Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vascular Endothelial Growth Factor-directed Antibody'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vascular Endothelial Growth Factor-directed Antibody Interactions'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X641Y30OA7',\n",
       "    'Name': 'HUMAN BOTULINUM NEUROTOXIN A/B IMMUNE GLOBULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/55c16274-5492-46af-830a-7f387cc12919/55c16274-5492-46af-830a-7f387cc12919.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bacterial Neurotoxin Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antitoxins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VTD58H1Z2X',\n",
       "    'Name': 'DOPAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/55c8ce07-401a-49c0-8788-b3d8c0176b06/55c8ce07-401a-49c0-8788-b3d8c0176b06.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [681]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1UA8E65KDZ',\n",
       "    'Name': 'ALITRETINOIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/56105bb4-b38e-43d2-a649-65fbfc8fe4a5/56105bb4-b38e-43d2-a649-65fbfc8fe4a5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [449171]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '359HUE8FJC',\n",
       "    'Name': 'PENCICLOVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/563f6501-1253-4488-b641-755c53d41e47/563f6501-1253-4488-b641-755c53d41e47.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135398748]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DNA Polymerase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '67M901L9NQ',\n",
       "    'Name': 'AMMONIUM LACTATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/564b2962-07ec-49a9-a28e-c49af866f499/564b2962-07ec-49a9-a28e-c49af866f499.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76958495]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Hydroxy Acid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxy Acids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YO1UK1S598',\n",
       "    'Name': 'ISRADIPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5696ac34-a6c8-4ea9-af6e-15b6bf7a6b07/5696ac34-a6c8-4ea9-af6e-15b6bf7a6b07.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416740]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridine Calcium Channel Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '57F7254B6Q',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/56ce51c4-f81a-4c94-b315-75262cd9c31b/56ce51c4-f81a-4c94-b315-75262cd9c31b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '27O7W4T232',\n",
       "    'Name': 'SPIRONOLACTONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/56d64343-083a-4813-b5c1-22486562d4cc/56d64343-083a-4813-b5c1-22486562d4cc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5833]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aldosterone Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aldosterone Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '52202H034Z',\n",
       "    'Name': 'RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/56fdaa9c-065e-456e-aac0-6aa20f239edf/56fdaa9c-065e-456e-aac0-6aa20f239edf.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Rubella Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rubella Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4NDU154T12',\n",
       "    'Name': 'PROTRIPTYLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/56fe395c-3771-4a82-a4be-d519f8100872/56fe395c-3771-4a82-a4be-d519f8100872.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4976]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6804DJ8Z9U',\n",
       "    'Name': 'CAPECITABINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5756bfe8-ed73-40e9-8ee3-f084f015aaef/5756bfe8-ed73-40e9-8ee3-f084f015aaef.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60953]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Metabolic Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G1LN9045DK',\n",
       "    'Name': 'BUSULFAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/57683734-90ee-44ac-af7d-591cefe8fc7f/57683734-90ee-44ac-af7d-591cefe8fc7f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2478]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VPO7KJ050N',\n",
       "    'Name': 'ILOPERIDONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/579a453b-3ca9-4a36-85a0-0664bdf9deea/579a453b-3ca9-4a36-85a0-0664bdf9deea.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71360]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Atypical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GFO928U8MQ',\n",
       "    'Name': 'DISOPYRAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/57debb44-9353-4183-a38b-2580e1148806/57debb44-9353-4183-a38b-2580e1148806.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416838]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U68WG3173Y',\n",
       "    'Name': 'CARMUSTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/57eb0c2d-d451-4149-8979-9e2f47ad8e76/57eb0c2d-d451-4149-8979-9e2f47ad8e76.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2578]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'EFY6W0M8TG',\n",
       "    'Name': 'LEUPROLIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5808a274-0c06-41e6-b03b-3d7e63aec92a/5808a274-0c06-41e6-b03b-3d7e63aec92a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [657181]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '67P356D8GH',\n",
       "    'Name': 'ACEBUTOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/58494fab-a60b-42ff-b412-c53a0b10a749/58494fab-a60b-42ff-b412-c53a0b10a749.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417432]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q3OKS62Q6X',\n",
       "    'Name': 'BUDESONIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/589e60a9-e536-4204-8a74-8e1a307c0c4f/589e60a9-e536-4204-8a74-8e1a307c0c4f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417139]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z845VHQ61P',\n",
       "    'Name': 'HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/58b15be4-39cd-44f9-8c7c-62f86fe7a6da/58b15be4-39cd-44f9-8c7c-62f86fe7a6da.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Human Papillomavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Papillomavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J0E2756Z7N',\n",
       "    'Name': 'IRBESARTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/58cfe8ce-3bae-4606-b2d5-98125d40a2b0/58cfe8ce-3bae-4606-b2d5-98125d40a2b0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3749]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Blocker',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'LCH760E9T7',\n",
       "    'Name': 'ACITRETIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/58f0b704-2acd-4e93-9b45-1d09922c6ba8/58f0b704-2acd-4e93-9b45-1d09922c6ba8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284513]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L36O5T016N',\n",
       "    'Name': 'RIFAXIMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5908a92d-aae3-4eba-a37f-a6de77c8cffe/5908a92d-aae3-4eba-a37f-a6de77c8cffe.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6436173]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rifamycin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rifamycins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MHJ80W9LRB',\n",
       "    'Name': 'OXAPROZIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5915399a-1c47-4a03-b4e5-c47986a2765e/5915399a-1c47-4a03-b4e5-c47986a2765e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4614]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7C546U4DEN',\n",
       "    'Name': 'DIFLUNISAL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/592d77b6-38c4-4539-b594-832e5692c188/592d77b6-38c4-4539-b594-832e5692c188.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3059]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M2F465ROXU',\n",
       "    'Name': 'ETIDRONIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5936f94c-1715-46cf-be21-daa65faee016/5936f94c-1715-46cf-be21-daa65faee016.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3305]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bisphosphonate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diphosphonates'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '83G67E21XI',\n",
       "    'Name': 'UROKINASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/59537646-9ca6-44f0-bf6d-bac38e580f01/59537646-9ca6-44f0-bf6d-bac38e580f01.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Thrombolysis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombolytic Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FEN504330V',\n",
       "    'Name': 'NADOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/598b1711-e80d-4881-bfca-ddc7f859464e/598b1711-e80d-4881-bfca-ddc7f859464e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417213]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5965120SH1',\n",
       "    'Name': 'MINOXIDIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5992dca4-5c75-40c9-a7e2-76f14dc42995/5992dca4-5c75-40c9-a7e2-76f14dc42995.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4201]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Arteriolar Vasodilation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Arteriolar Vasodilator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '459ROM8M9M',\n",
       "    'Name': 'POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/59d29f50-a3bb-46d8-b09f-c4f7bf7ccfd0/59d29f50-a3bb-46d8-b09f-c4f7bf7ccfd0.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Poliovirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Poliovirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E6GNX3HHTE',\n",
       "    'Name': 'BRIMONIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/59e62877-1dde-48fb-aab5-e4fe2c2a43a1/59e62877-1dde-48fb-aab5-e4fe2c2a43a1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2435]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y5L2157C4J',\n",
       "    'Name': 'TACROLIMUS ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5a03ff93-7d6a-4ed5-9cc7-91822279724d/5a03ff93-7d6a-4ed5-9cc7-91822279724d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [445643]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcineurin Inhibitor Immunosuppressant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcineurin Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3Z6S89TXPW',\n",
       "    'Name': 'PROTEIN C',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5a0d5af2-6ada-4e71-b7c1-eb26f9e3c71f/5a0d5af2-6ada-4e71-b7c1-eb26f9e3c71f.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-coagulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Coagulation Factor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Enzyme Precursors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein C'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z40X7EI2AF',\n",
       "    'Name': 'IOXAGLIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5a4def99-4733-4219-9445-7f06ba8892ba/5a4def99-4733-4219-9445-7f06ba8892ba.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3742]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9013DUQ28K',\n",
       "    'Name': 'ANAKINRA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5a60110d-9e6c-4da8-bf37-a9694382c035/5a60110d-9e6c-4da8-bf37-a9694382c035.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin 1 Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin-1 Receptor Antagonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6702D36OG5',\n",
       "    'Name': 'PARICALCITOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5a8fb11d-9138-471b-b4d4-93357956b399/5a8fb11d-9138-471b-b4d4-93357956b399.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5281104]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholecalciferol'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin D3 Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '13T4O6VMAM',\n",
       "    'Name': 'PIROXICAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5a92bed0-f699-4145-9fed-086a3bb93471/5a92bed0-f699-4145-9fed-086a3bb93471.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54676228]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8HR4QJ6DW8',\n",
       "    'Name': 'MOMETASONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5acb6ee9-ae0a-415e-a62d-5f3f12ab8c2f/5acb6ee9-ae0a-415e-a62d-5f3f12ab8c2f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441335]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FI96A8X663',\n",
       "    'Name': 'RILPIVIRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5aeede14-0bdf-4b0c-897a-be73ffcfd30b/5aeede14-0bdf-4b0c-897a-be73ffcfd30b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6451164]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Nucleoside Reverse Transcriptase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Nucleoside Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0TTZ664R7Z',\n",
       "    'Name': 'PHENOXYBENZAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5b4b5bf6-441b-486f-8329-1a65237cb6a5/5b4b5bf6-441b-486f-8329-1a65237cb6a5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417389]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5S6W795CQM',\n",
       "    'Name': 'NALTREXONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5b5a064f-d010-493f-ae44-3177873acc88/5b5a064f-d010-493f-ae44-3177873acc88.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5360515]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5QZO15J2Z8',\n",
       "    'Name': 'FAMOTIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5bf41e27-ec73-48d2-b689-784d7ce5ad36/5bf41e27-ec73-48d2-b689-784d7ce5ad36.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5702160]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-2 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '313LJP87ET',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5c20d7b7-596d-466a-81e2-5c7b7c7428f9/5c20d7b7-596d-466a-81e2-5c7b7c7428f9.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'A61RXM4375',\n",
       "    'Name': 'BEXAROTENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5c41f268-9dfc-4f8d-9a07-6bcb1f7f2fde/5c41f268-9dfc-4f8d-9a07-6bcb1f7f2fde.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [82146]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '905Z5W3GKH',\n",
       "    'Name': 'THIOTEPA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5c6f28e2-6287-4cfc-a0bd-c023783658e8/5c6f28e2-6287-4cfc-a0bd-c023783658e8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5453]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '15FH07392N',\n",
       "    'Name': 'COAGULATION FACTOR VIIA HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5c80d90e-40e0-4d09-8049-2778c012ac53/5c80d90e-40e0-4d09-8049-2778c012ac53.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor IX Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor X Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'PKK6MUZ20G',\n",
       "    'Name': 'MERCAPTOPURINE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5ca0ada1-57a1-419d-82af-3f2e0fc95b04/5ca0ada1-57a1-419d-82af-3f2e0fc95b04.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [667490]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Metabolic Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R581OT55EA',\n",
       "    'Name': 'PEGLOTICASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5ca4c990-d063-48b2-a0aa-195015737276/5ca4c990-d063-48b2-a0aa-195015737276.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Urate Oxidase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Uric Acid-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '046O35D44R',\n",
       "    'Name': 'PRILOCAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5cd60e14-acde-4e67-9518-1ce8d77d156d/5cd60e14-acde-4e67-9518-1ce8d77d156d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417220]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amide Local Anesthetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amides'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IX6J1063HV',\n",
       "    'Name': 'INDOCYANINE GREEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5cefc8fa-9b1f-4654-aabb-05e8cdba406e/5cefc8fa-9b1f-4654-aabb-05e8cdba406e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5282412]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diagnostic Dye'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dyes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VJT6J7R4TR',\n",
       "    'Name': 'RIFAMPIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5cf0433e-83f2-4b7d-9dd4-36c9caa4f09e/5cf0433e-83f2-4b7d-9dd4-36c9caa4f09e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135398735]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rifamycin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rifamycins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '40S1VHN69B',\n",
       "    'Name': 'BLEOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5d5bcf75-af95-4638-a4c1-31c403308bae/5d5bcf75-af95-4638-a4c1-31c403308bae.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76959350]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytoprotective Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G162GK9U4W',\n",
       "    'Name': 'LEFLUNOMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5d797c44-ea1e-4634-9148-a847093cc651/5d797c44-ea1e-4634-9148-a847093cc651.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3899]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antirheumatic Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X89XV46R07',\n",
       "    'Name': 'TECHNETIUM TC-99M MEDRONATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5e148630-3ff8-4874-bcc3-7fbe231bbc3f/5e148630-3ff8-4874-bcc3-7fbe231bbc3f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [90478980]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UH95VD7V76',\n",
       "    'Name': 'OXACILLIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5e3306ff-f40b-4de9-b90b-0c4e98b5d034/5e3306ff-f40b-4de9-b90b-0c4e98b5d034.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6196]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J6292F8L3D',\n",
       "    'Name': 'HALOPERIDOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5e372020-e1b2-4f97-a7af-2513c3fa14a1/5e372020-e1b2-4f97-a7af-2513c3fa14a1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3559]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Typical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MFZ8I7277D',\n",
       "    'Name': \"MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN\",\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5e775d81-570d-4508-88ae-aac7db519233/5e775d81-570d-4508-88ae-aac7db519233.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Measles Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Measles Vaccine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2679MF687A',\n",
       "    'Name': 'NIACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5ebd3d3b-9a5e-4c13-850d-9147fff333c6/5ebd3d3b-9a5e-4c13-850d-9147fff333c6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [938]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nicotinic Acid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nicotinic Acids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'V27W9254FZ',\n",
       "    'Name': 'CORTISONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5eca17ee-c079-4508-83ba-618c1fbaa1dd/5eca17ee-c079-4508-83ba-618c1fbaa1dd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [222786]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BO76JF850N',\n",
       "    'Name': 'CLIDINIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5ecb4022-1655-478d-93fc-f3c4342b5162/5ecb4022-1655-478d-93fc-f3c4342b5162.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417364]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Parasympathetic Acetylcholine Activity',\n",
       "         'Markup': [{'Start': 26,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Acetylcholine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-187'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'GI Motility Alteration'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Digestive/GI System Activity Alteration'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q573I9DVLP_1',\n",
       "    'Name': 'LEUCOVORIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5edb2236-fcd9-4b97-aab5-7e1494e96aa2/5edb2236-fcd9-4b97-aab5-7e1494e96aa2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135565456]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folate Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Folic Acid'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TZ47U051FI',\n",
       "    'Name': 'DEXTROAMPHETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/5f07f4e0-110c-412d-b624-04a052339e9d/5f07f4e0-110c-412d-b624-04a052339e9d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5826]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1O0600285A',\n",
       "    'Name': 'BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/600e2ed7-6b3d-4748-9431-077038f34183/600e2ed7-6b3d-4748-9431-077038f34183.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Bordetella Pertussis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pertussis Vaccine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'T8C6W1N6NW',\n",
       "    'Name': 'HUMAN ALBUMIN MICROSPHERES',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/614b07fe-719f-4ce4-a8e9-11b2b14db22e/614b07fe-719f-4ce4-a8e9-11b2b14db22e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Contrast Agent for Ultrasound Imaging'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ultrasound Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'LGX9OL562T',\n",
       "    'Name': 'INDIUM IN-111 OXYQUINOLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/61989602-5111-459b-a42b-a13f3bc6c907/61989602-5111-459b-a42b-a13f3bc6c907.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3034762]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'B76N6SBZ8R',\n",
       "    'Name': 'GEMCITABINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6245e916-a38d-4bce-85f9-67f64497e24b/6245e916-a38d-4bce-85f9-67f64497e24b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60750]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Metabolic Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q6U6J48BWY',\n",
       "    'Name': 'IMIGLUCERASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/62c14005-5b1c-4a22-be3c-1cd6026fa7f4/62c14005-5b1c-4a22-be3c-1cd6026fa7f4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucosylceramidase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Glucocerebroside-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3JGY52XJNA',\n",
       "    'Name': 'LUTROPIN ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/62e934db-a83c-48c9-aa93-3fa48da00b77/62e934db-a83c-48c9-aa93-3fa48da00b77.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '382L14738L',\n",
       "    'Name': 'COAGULATION FACTOR IX RECOMBINANT HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/63093813-02de-431e-91d8-d381d9e8a121/63093813-02de-431e-91d8-d381d9e8a121.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'V9EFU16ZIF',\n",
       "    'Name': 'METHYLTESTOSTERONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/632c0fca-f638-43a9-9b56-5c908eb392c6/632c0fca-f638-43a9-9b56-5c908eb392c6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6010]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen Receptor Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androstanes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O4L1XPO44W',\n",
       "    'Name': 'FLUVOXAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/632e076b-aff1-48ed-8e80-ddbce9a58d87/632e076b-aff1-48ed-8e80-ddbce9a58d87.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5324346]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X3P9A5HNYF',\n",
       "    'Name': 'XENON XE-133',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/634fe400-a9e0-4a2e-ab6c-1e93723bb765/634fe400-a9e0-4a2e-ab6c-1e93723bb765.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [66376]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inhalation Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YU55MQ3IZY',\n",
       "    'Name': 'ALPRAZOLAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/63668f8a-0dac-4e8c-8fea-d6f30c2caa4d/63668f8a-0dac-4e8c-8fea-d6f30c2caa4d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2118]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S61K3P7B2V',\n",
       "    'Name': 'PROGUANIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6455f248-86ba-4881-992e-1d80986e44eb/6455f248-86ba-4881-992e-1d80986e44eb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6178111]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimalarial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydrofolate Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dihydrofolate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-136400727'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '32HRV3E3D5',\n",
       "    'Name': 'GRISEOFULVIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/64caf78d-9811-4327-b679-956e06cf129d/64caf78d-9811-4327-b679-956e06cf129d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441140]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Mitosis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibition'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tubulin Inhibiting Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '45E2IPU4MG',\n",
       "    'Name': 'INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6555e280-0b93-4fa2-b391-f8a4058b0079/6555e280-0b93-4fa2-b391-f8a4058b0079.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Influenza B Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '094ZI81Y45',\n",
       "    'Name': 'TAMOXIFEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/65dbfe78-1349-48dd-bfef-973f93e01b75/65dbfe78-1349-48dd-bfef-973f93e01b75.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2733526]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Agonist/Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Selective Estrogen Receptor Modulators'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5BFC8LZ6LQ',\n",
       "    'Name': 'HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/666c3c00-b1b3-4311-ba88-c69afe0f07ae/666c3c00-b1b3-4311-ba88-c69afe0f07ae.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Hepatitis A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hepatitis A Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CHB1QD2QSS',\n",
       "    'Name': 'TEMAZEPAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/66a76b84-434a-4810-be80-04b3b6fd519f/66a76b84-434a-4810-be80-04b3b6fd519f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416735]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TL60C27RLH',\n",
       "    'Name': 'METRELEPTIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/673f46ca-3a82-4df8-91f7-3996cb0110be/673f46ca-3a82-4df8-91f7-3996cb0110be.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Leptin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Analogs/Derivatives'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Leptin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4Q81I59GXC',\n",
       "    'Name': 'MESALAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/67496ebb-450a-4795-a3e8-75a55aba9b6e/67496ebb-450a-4795-a3e8-75a55aba9b6e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4075]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminosalicylate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminosalicylic Acids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C5W04GO61S',\n",
       "    'Name': 'TIOPRONIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/67675034-c776-4f4a-9e10-6d47a6ef4be8/67675034-c776-4f4a-9e10-6d47a6ef4be8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417097]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cystine Disulfide Reduction',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 17,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Cystine%20Disulfide',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-129651947'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'N-substituted Glycines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Reducing and Complexing Thiol'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'OAY8ORS3CQ',\n",
       "    'Name': 'ETHIONAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6767b0c7-7c96-4e41-aca3-730358521025/6767b0c7-7c96-4e41-aca3-730358521025.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2761171]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimycobacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0Y2S3XUQ5H',\n",
       "    'Name': 'BUMETANIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/67b59e83-3e38-436e-a066-5d99979c53da/67b59e83-3e38-436e-a066-5d99979c53da.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2471]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis at Loop of Henle'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Loop Diuretic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7UIT3ZGC8E',\n",
       "    'Name': 'INDIUM IN-111 PENTETATE DISODIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/67e5ecbd-379c-4bc9-87bf-7a6a52922b60/67e5ecbd-379c-4bc9-87bf-7a6a52922b60.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [23724985]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7LKK855W8I',\n",
       "    'Name': 'LETROZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/67f3426d-cbe8-4101-a905-40a8d320d5ee/67f3426d-cbe8-4101-a905-40a8d320d5ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3902]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O5TNM5N07U',\n",
       "    'Name': 'DULOXETINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/67f82d5b-f6cc-4660-b138-163279a0d050/67f82d5b-f6cc-4660-b138-163279a0d050.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60835]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Norepinephrine Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin and Norepinephrine Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'},\n",
       "          {'Start': 14,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5JKY92S7BR',\n",
       "    'Name': 'TIMOLOL ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6809148c-8fca-4060-b3e7-f1af129e54da/6809148c-8fca-4060-b3e7-f1af129e54da.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [33624]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CBZ4BH7TJ1',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6827f7b3-da1a-4aa1-ba1e-b3056159f9f7/6827f7b3-da1a-4aa1-ba1e-b3056159f9f7.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JQZ1L091Y2',\n",
       "    'Name': 'DRONEDARONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/68599cb6-36c1-47aa-a699-bdcef817ef01/68599cb6-36c1-47aa-a699-bdcef817ef01.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [208898]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5YVB0POT2H',\n",
       "    'Name': 'CHLOROPROCAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/691af3be-23af-48aa-bae7-615e3632fb99/691af3be-23af-48aa-bae7-615e3632fb99.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [8612]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ester Local Anesthetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Esters'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S79426A41Z',\n",
       "    'Name': 'FLUPHENAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6930e271-0dae-4459-a403-e59c1b14896d/6930e271-0dae-4459-a403-e59c1b14896d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3372]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8C5Y219Z75',\n",
       "    'Name': 'INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/699a08a8-919a-4aa4-8c76-8f264e64571b/699a08a8-919a-4aa4-8c76-8f264e64571b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Influenza A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RUC37XUP2P',\n",
       "    'Name': 'KANAMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6a14c596-ec40-4efe-b564-17caea01d06e/6a14c596-ec40-4efe-b564-17caea01d06e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416944]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycoside Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycosides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0Y70779M1F',\n",
       "    'Name': 'RIMABOTULINUMTOXINB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6a3f555e-786f-4528-90b1-d52481be58db/6a3f555e-786f-4528-90b1-d52481be58db.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Acetylcholine Release Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Acetylcholine Release Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '367589PJ2C',\n",
       "    'Name': 'MEFENAMIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6a800cbb-9da0-49ca-a7f6-800dde6e5dcb/6a800cbb-9da0-49ca-a7f6-800dde6e5dcb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4044]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F91H02EBWT',\n",
       "    'Name': 'ARFORMOTEROL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6aa44da3-2484-4f9b-808f-496c16e59183/6aa44da3-2484-4f9b-808f-496c16e59183.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3083544]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta2-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'INU8H2KAWG',\n",
       "    'Name': 'FENOLDOPAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6b35eb52-1057-4ae1-bf7d-92aa905cf99e/6b35eb52-1057-4ae1-bf7d-92aa905cf99e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416646]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopaminergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '48W7181FLP',\n",
       "    'Name': 'HUMAN RHO(D) IMMUNE GLOBULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6b6051ec-4481-4e49-863e-08857ce3aba7/6b6051ec-4481-4e49-863e-08857ce3aba7.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endogenous Antigen Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N19A0T0E5J',\n",
       "    'Name': 'PARATHYROID HORMONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6b7769c9-e33e-4af6-a4fe-dada6af3470c/6b7769c9-e33e-4af6-a4fe-dada6af3470c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Parathyroid Hormone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Parathyroid Hormone'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6HT8U7K3AM',\n",
       "    'Name': 'MEQUINOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6bceadeb-b32e-42ce-b5e7-82bd67914e3f/6bceadeb-b32e-42ce-b5e7-82bd67914e3f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9015]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Depigmenting Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Melanin Synthesis Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Melanin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-6325610'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Skin Lightening Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6U90Y1795T',\n",
       "    'Name': 'COAGULATION FACTOR IX HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6bfa7973-8ef6-479c-8cec-2580a4680800/6bfa7973-8ef6-479c-8cec-2580a4680800.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '21MID214D4',\n",
       "    'Name': 'SCHINUS TEREBINTHIFOLIUS POLLEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6c25d374-199b-4b24-aa3e-8579804b24f7/6c25d374-199b-4b24-aa3e-8579804b24f7.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Standardized Pollen Allergenic Extract'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Histamine Release'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased IgG Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pollen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allergens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '458VC51857',\n",
       "    'Name': 'TEGASEROD',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6ca508cd-66b5-4f60-a802-eae69678948d/6ca508cd-66b5-4f60-a802-eae69678948d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135409453]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin 4 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin-4 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E3B2GI648A',\n",
       "    'Name': 'BELATACEPT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6cffd052-fa7a-40df-a868-6d02ecae46ed/6cffd052-fa7a-40df-a868-6d02ecae46ed.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'T Lymphocyte Costimulation Activity Blockade'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Selective T Cell Costimulation Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD80-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD86-directed Antibody Interactions'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5E8K9I0O4U',\n",
       "    'Name': 'CIPROFLOXACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6d1fad30-ff90-417c-8c65-31bfd074aa5c/6d1fad30-ff90-417c-8c65-31bfd074aa5c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2764]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolone Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5JT3N61JSP',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6d4fd88d-f561-4285-b8d0-2418810aeb9a/6d4fd88d-f561-4285-b8d0-2418810aeb9a.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KGZ1SLC28Z',\n",
       "    'Name': 'BECLOMETHASONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6d61e49e-8ca8-4e2c-bbe1-ed7cfe3c1cbd/6d61e49e-8ca8-4e2c-bbe1-ed7cfe3c1cbd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [20469]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SVU4HTP02M',\n",
       "    'Name': 'CHROMATE ION CR-51',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6d8771ac-c661-4f73-ada0-73db7497322e/6d8771ac-c661-4f73-ada0-73db7497322e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3080663]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '70FP3JLY7N',\n",
       "    'Name': 'EDROPHONIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6da0f5c3-bbd6-4446-90ed-6746f0735ba4/6da0f5c3-bbd6-4446-90ed-6746f0735ba4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3202]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1U511HHV4Z',\n",
       "    'Name': 'MEXILETINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6dbb1bbe-a9c2-4838-8921-82b079b98c9a/6dbb1bbe-a9c2-4838-8921-82b079b98c9a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417093]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '30IW36W5B2',\n",
       "    'Name': '4-HYDROXYBUTANOIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6dc84aee-79ca-44a8-9284-c3119827c877/6dc84aee-79ca-44a8-9284-c3119827c877.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10413]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Depressant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Depression'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Organized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0F350BVT6S',\n",
       "    'Name': 'ECHOTHIOPHATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6dd8df24-6635-47f3-a8aa-f41e62813672/6dd8df24-6635-47f3-a8aa-f41e62813672.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10548]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Iodine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7UB4J759TD',\n",
       "    'Name': 'HUMAN VACCINIA VIRUS IMMUNE GLOBULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6e7a7496-9d1a-4e26-84fc-5ac50aca77b9/6e7a7496-9d1a-4e26-84fc-5ac50aca77b9.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Virus Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Virus-specific Hyperimmune Globulins'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '82S8X8XX8H',\n",
       "    'Name': 'RUXOLITINIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6e7af950-f74a-4adf-9255-6abf50573e57/6e7af950-f74a-4adf-9255-6abf50573e57.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [25126798]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z8CBU6KR16',\n",
       "    'Name': 'LOTEPREDNOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6e80d7f1-db31-4fa1-bcd0-dc96548d0bab/6e80d7f1-db31-4fa1-bcd0-dc96548d0bab.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9865442]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'A4YJ7J11TG',\n",
       "    'Name': 'IOXILAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6ebea2d0-9f36-4faa-a40c-97c261273bff/6ebea2d0-9f36-4faa-a40c-97c261273bff.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3743]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L36H50F353',\n",
       "    'Name': 'PODOFILOX',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6f2296a4-cbde-4e50-b0d5-8a792a87ecd4/6f2296a4-cbde-4e50-b0d5-8a792a87ecd4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10607]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Mitosis'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0FRP6G56LD',\n",
       "    'Name': 'BIPERIDEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6f70f65a-bfc6-48d8-b5a7-16e23b1e4e5f/6f70f65a-bfc6-48d8-b5a7-16e23b1e4e5f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2381]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BL03SY4LXB',\n",
       "    'Name': 'NORTRIPTYLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6fdc8f21-48f3-4604-8db9-c0ca363ff9d0/6fdc8f21-48f3-4604-8db9-c0ca363ff9d0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4543]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0P94UQE6SY',\n",
       "    'Name': 'COAGULATION FACTOR X HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/6fe8c3af-36f1-45bf-8830-1f1c955c2ad4/6fe8c3af-36f1-45bf-8830-1f1c955c2ad4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U42B7VYA4P',\n",
       "    'Name': 'CHLORPROMAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/70314cb8-d7db-40a3-b5a7-f0eed8c3d248/70314cb8-d7db-40a3-b5a7-f0eed8c3d248.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2726]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0M3S43XK27',\n",
       "    'Name': 'BENZPHETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/70a07c4b-2250-4e26-8183-c0cce6e50be5/70a07c4b-2250-4e26-8183-c0cce6e50be5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311017]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Appetite Suppression'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Sympathetic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sympathomimetic Amine Anorectic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N0F8P22L1P',\n",
       "    'Name': 'NORFLOXACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/70a4bd80-817e-4fa6-9471-75bf431cc462/70a4bd80-817e-4fa6-9471-75bf431cc462.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4539]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolone Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9JDX055TW1',\n",
       "    'Name': 'DORZOLAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/70d7c6ff-eea4-4d8e-8f3f-7ab2a579dd33/70d7c6ff-eea4-4d8e-8f3f-7ab2a579dd33.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284549]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Carbonic Anhydrase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Carbonic Anhydrase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J177FOW5JL',\n",
       "    'Name': 'FONDAPARINUX',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/70dfc0ee-1ced-425d-b1b4-60935c2413d4/70dfc0ee-1ced-425d-b1b4-60935c2413d4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5282448]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Factor Xa Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Factor Xa Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'W45Z4CJE2J',\n",
       "    'Name': 'INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/70e55824-5c20-45c8-8697-b1354eb6ac99/70e55824-5c20-45c8-8697-b1354eb6ac99.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Influenza B Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X78UG0A0RN',\n",
       "    'Name': 'DASATINIB ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/712b417e-6d84-43d3-9b5b-719f9cd1f65f/712b417e-6d84-43d3-9b5b-719f9cd1f65f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3062316]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '25ADE2236L',\n",
       "    'Name': 'THROMBIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/715d8138-d1c4-4bb6-ada7-2d298f5c3277/715d8138-d1c4-4bb6-ada7-2d298f5c3277.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F93UJX4SWT',\n",
       "    'Name': 'TICARCILLIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/718a4d57-f0fc-4fc2-8cd8-8efa78c00f83/718a4d57-f0fc-4fc2-8cd8-8efa78c00f83.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [36921]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F94OW58Y8V',\n",
       "    'Name': 'AZITHROMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/71a4267c-bb00-4523-95b8-367d8e5d11f5/71a4267c-bb00-4523-95b8-367d8e5d11f5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [131634131]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Macrolide Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Macrolides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9100L32L2N',\n",
       "    'Name': 'METFORMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/71ee8b1c-e6aa-4ca6-aa89-bc4e44c474ee/71ee8b1c-e6aa-4ca6-aa89-bc4e44c474ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4091]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Biguanide'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Biguanides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KI8H7H19WL',\n",
       "    'Name': 'TELITHROMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7221525f-d718-4106-989c-52cb3c98e476/7221525f-d718-4106-989c-52cb3c98e476.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3002190]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ketolide Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ketolides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '70JE2N95KR',\n",
       "    'Name': 'TIGECYCLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/72254acf-2339-41dc-9e07-022c2e974087/72254acf-2339-41dc-9e07-022c2e974087.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54686904]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracycline-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tetracycline',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-54675776'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracyclines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WR2TIP26VS',\n",
       "    'Name': 'ABACAVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/726dd3ad-0388-4b2b-8cde-01889bce1343/726dd3ad-0388-4b2b-8cde-01889bce1343.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441300]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7D0YB67S97',\n",
       "    'Name': 'ABATACEPT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/72e591b5-83a2-4dd0-8f94-77b752e986ef/72e591b5-83a2-4dd0-8f94-77b752e986ef.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Cytokine Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Selective T Cell Costimulation Modulator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Fusion Proteins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CUZ39LUY82',\n",
       "    'Name': 'SILODOSIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/72f4e2ac-4acb-4511-9c57-5cf55a79c0f5/72f4e2ac-4acb-4511-9c57-5cf55a79c0f5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5312125]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XRO4566Q4R',\n",
       "    'Name': 'INTERFERON BETA-1A',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/72f6f4b8-14e7-40a8-a6ac-a8f952792330/72f6f4b8-14e7-40a8-a6ac-a8f952792330.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon-beta'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Human Interferon beta'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Proteins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8GZG754X6M',\n",
       "    'Name': 'GEMTUZUMAB OZOGAMICIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/73645a1b-8c5a-488a-b59c-c35907d0966b/73645a1b-8c5a-488a-b59c-c35907d0966b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD33-directed Cytotoxin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CYS9AKD70P',\n",
       "    'Name': 'ISOFLURANE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/73cb085e-f3ea-433d-8513-83aaee0c0f2b/73cb085e-f3ea-433d-8513-83aaee0c0f2b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417271]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthesia'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XX2MN88N5D',\n",
       "    'Name': 'EFALIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/74005859-8b3c-4d2e-bc93-71c96b2126cb/74005859-8b3c-4d2e-bc93-71c96b2126cb.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antibodies, Monoclonal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD11a-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD11a-directed Humanized IgG1 Antibody'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'HW8W27HTXX',\n",
       "    'Name': 'IODIXANOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/740c4ff7-f3c9-420f-83e1-365d1fba9f65/740c4ff7-f3c9-420f-83e1-365d1fba9f65.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3724]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '295O53K152',\n",
       "    'Name': 'POTASSIUM CATION',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/741dc060-e7d9-4360-91e5-cd576cda3647/741dc060-e7d9-4360-91e5-cd576cda3647.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [813]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Salt'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '61JJC8N5ZK',\n",
       "    'Name': 'PAROMOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/74bbfc11-75b2-428e-9d52-b9a7cd3b7c22/74bbfc11-75b2-428e-9d52-b9a7cd3b7c22.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [165580]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiprotozoal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '56588OP40D',\n",
       "    'Name': 'INTERFERON ALFACON-1',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7517bbaa-0204-4633-a235-545d7c25e677/7517bbaa-0204-4633-a235-545d7c25e677.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon alpha'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon-alpha'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '36780APV5N',\n",
       "    'Name': 'POLYTHIAZIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/751fde75-6036-4f8e-ab13-b5257dd4eda9/751fde75-6036-4f8e-ab13-b5257dd4eda9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416924]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazide Diuretic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L4YEB44I46',\n",
       "    'Name': 'METOCLOPRAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/75a33c93-65d0-4f81-b7f7-709ec263c10e/75a33c93-65d0-4f81-b7f7-709ec263c10e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4168]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine D2 Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine-2 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dopamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-681'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0LVY784C09',\n",
       "    'Name': 'POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/75b4acb5-0438-4ee6-bfea-ea44093f43c6/75b4acb5-0438-4ee6-bfea-ea44093f43c6.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Poliovirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Poliovirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'AVK0I6HY2U',\n",
       "    'Name': 'ABALOPARATIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/76437e6d-c16a-472b-89b1-5352b50c87f9/76437e6d-c16a-472b-89b1-5352b50c87f9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [129626832]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Parathyroid Hormone-Related Peptide Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Parathyroid Hormone-Related Protein'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Analogs/Derivatives'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5Q52X6ICJI',\n",
       "    'Name': 'BENDROFLUMETHIAZIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/76f7ab91-863c-4b06-b6fe-96907810d10f/76f7ab91-863c-4b06-b6fe-96907810d10f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416939]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazide Diuretic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F43I396OIS',\n",
       "    'Name': '.ALPHA.1-PROTEINASE INHIBITOR HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/77022874-286f-48a3-970b-9bdfe390a714/77022874-286f-48a3-970b-9bdfe390a714.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human alpha-1 Proteinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Trypsin Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FKD3DUK39I_1',\n",
       "    'Name': 'HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7720d2fd-ef6a-4061-8ccc-2b005c6963e9/7720d2fd-ef6a-4061-8ccc-2b005c6963e9.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Human Adenovirus Type 4 Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Live'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenovirus Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'AB2794W8KV',\n",
       "    'Name': 'PHENDIMETRAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7729e4a6-e12b-4cc7-ac6d-32635d867621/7729e4a6-e12b-4cc7-ac6d-32635d867621.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [30487]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Appetite Suppression'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Sympathetic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sympathomimetic Amine Anorectic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q46947FE7K',\n",
       "    'Name': 'PEGINTERFERON ALFA-2A',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7743fb12-32a1-4b65-ac5a-adf4976b316d/7743fb12-32a1-4b65-ac5a-adf4976b316d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon alpha'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'peginterferon alfa-2a'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4I8HAB65SZ',\n",
       "    'Name': 'NISOLDIPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/77c5c8ed-89dc-4074-83c5-47981a61be75/77c5c8ed-89dc-4074-83c5-47981a61be75.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416953]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridine Calcium Channel Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Blood Pressure'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '68IQX3T69U',\n",
       "    'Name': 'PROPAFENONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/78068a42-d08e-4456-af7c-5d49e0adcf85/78068a42-d08e-4456-af7c-5d49e0adcf85.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417379]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '003N66TS6T',\n",
       "    'Name': 'RASAGILINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/78264be3-ff30-4dce-b109-67e7ab90f90c/78264be3-ff30-4dce-b109-67e7ab90f90c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3052776]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N0A3Z5XTC6',\n",
       "    'Name': 'TROPICAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/782fb681-0264-4b8e-8133-429462826ec3/782fb681-0264-4b8e-8133-429462826ec3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416840]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9F8QQ6EER1',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7885a8e2-d4a2-4bcd-8b61-c1a662c7cdbd/7885a8e2-d4a2-4bcd-8b61-c1a662c7cdbd.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '62TEY51RR1',\n",
       "    'Name': 'BISMUTH SUBSALICYLATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7890ddc6-0c5f-4ec2-bfe9-6fbc6fdc5d7f/7890ddc6-0c5f-4ec2-bfe9-6fbc6fdc5d7f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [53629521]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bismuth'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bismuth'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '16O34995MB',\n",
       "    'Name': 'IODOHIPPURIC ACID I-131',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/78d94b02-c0b3-45be-8cb7-a58cf8624bb3/78d94b02-c0b3-45be-8cb7-a58cf8624bb3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71800]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '721M9407IY',\n",
       "    'Name': 'PROPYLTHIOURACIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7906e64a-cebf-4fed-89d8-d11f8d28f032/7906e64a-cebf-4fed-89d8-d11f8d28f032.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [657298]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thyroid Hormone Synthesis Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thyroid Hormone Synthesis Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3G6A5W338E',\n",
       "    'Name': 'CAFFEINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7916abfc-53c9-46ce-ab86-00013bc0d10c/7916abfc-53c9-46ce-ab86-00013bc0d10c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2519]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Methylxanthine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Xanthines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'I853LE095B',\n",
       "    'Name': 'TECHNETIUM TC-99M GLUCEPTATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/79435840-9389-426b-9de7-c73644f169fd/79435840-9389-426b-9de7-c73644f169fd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [49800005]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '23HYE36B0I',\n",
       "    'Name': 'VELAGLUCERASE ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/799b98dc-890c-4653-8279-a75f12492f0c/799b98dc-890c-4653-8279-a75f12492f0c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Glucocerebroside-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O1R9FJ93ED',\n",
       "    'Name': 'CEFUROXIME',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/79d6006a-3001-4e0b-9fa1-de536436c9e6/79d6006a-3001-4e0b-9fa1-de536436c9e6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5479529]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R7GV3H6FQ4',\n",
       "    'Name': 'TRIMETHADIONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7a17497d-48ab-4647-8d91-f6b16e7c716e/7a17497d-48ab-4647-8d91-f6b16e7c716e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5576]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WV5EC51866',\n",
       "    'Name': 'SIBUTRAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7a3be4cb-08a8-4ca0-aa64-62f1f47fda6e/7a3be4cb-08a8-4ca0-aa64-62f1f47fda6e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416855]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Appetite Suppression'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dopamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-681'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Norepinephrine Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'},\n",
       "          {'Start': 16,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'},\n",
       "          {'Start': 31,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dopamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-681'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CGS5KI3Q2M',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7ab3ac50-ad30-479b-a6d0-b177206bb249/7ab3ac50-ad30-479b-a6d0-b177206bb249.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '50D9XSG0VR',\n",
       "    'Name': 'MECHLORETHAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7ab8ad85-4e6e-4ab6-b690-d428e92d7f2b/7ab8ad85-4e6e-4ab6-b690-d428e92d7f2b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4033]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ER5I1W795A',\n",
       "    'Name': 'PHENYLACETIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7ab8b813-c88e-4750-93f6-26d305a66c5d/7ab8b813-c88e-4750-93f6-26d305a66c5d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [999]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ammonium Ion Binding Activity',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Ammonium%20Ion',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-223'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrogen Binding Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '92RU3N3Y1O',\n",
       "    'Name': 'DIMETHICONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7adc4ad8-a9f4-46be-82bb-749db23a2fa4/7adc4ad8-a9f4-46be-82bb-749db23a2fa4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Skin Barrier Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R4Z9X1N2ND',\n",
       "    'Name': 'DOFETILIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7af4053b-fea6-4a9f-b56e-ff4b892a648f/7af4053b-fea6-4a9f-b56e-ff4b892a648f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71329]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ULS5I8J03O',\n",
       "    'Name': 'OLSALAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7b0db2c5-7bf0-4371-aebd-5c0db18e2608/7b0db2c5-7bf0-4371-aebd-5c0db18e2608.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [22419]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminosalicylate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminosalicylic Acids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H8A007M585',\n",
       "    'Name': 'TAPENTADOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7b4e512e-f2ca-418a-8de8-5045b4c1b2b0/7b4e512e-f2ca-418a-8de8-5045b4c1b2b0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9838022]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GPV39ZGD8C',\n",
       "    'Name': 'VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7b7a51f6-c7e4-400f-aba3-da6f84610ac0/7b7a51f6-c7e4-400f-aba3-da6f84610ac0.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Varicella Zoster Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Chickenpox Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Herpes Zoster Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Herpes Zoster Vaccine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QIC03ANI02',\n",
       "    'Name': 'FAMCICLOVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7bbaf2f4-f266-4b08-a6b6-9227e31b1f58/7bbaf2f4-f266-4b08-a6b6-9227e31b1f58.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3324]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DNA Polymerase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'DNA Polymerase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JKZ19V908O',\n",
       "    'Name': 'ASENAPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7bbdfc3e-1fd6-4c84-8727-2d79b4869ad5/7bbdfc3e-1fd6-4c84-8727-2d79b4869ad5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416848]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Atypical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '076WHW89TW',\n",
       "    'Name': 'FOLLITROPIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7bd40411-b639-4aea-a57c-1a47315badfc/7bd40411-b639-4aea-a57c-1a47315badfc.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SCK81AMR7R',\n",
       "    'Name': 'THROMBIN ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7bdbacaa-7207-418a-aa70-7709558d32c2/7bdbacaa-7207-418a-aa70-7709558d32c2.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Factor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SML2Y3J35T',\n",
       "    'Name': 'COLCHICINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7bfbb56f-21ec-4100-8ed8-1d5226a3d4cd/7bfbb56f-21ec-4100-8ed8-1d5226a3d4cd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6167]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytochrome P450 3A4 Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'P-Glycoprotein Interactions'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7U75I1278D',\n",
       "    'Name': 'CEFOPERAZONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7c1937be-0fe5-4c14-8b7c-0a80def0fc09/7c1937be-0fe5-4c14-8b7c-0a80def0fc09.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [44187]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YO7261ME24',\n",
       "    'Name': 'CETIRIZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7c313389-1279-4e80-9ff6-01daefae0f93/7c313389-1279-4e80-9ff6-01daefae0f93.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417155]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H1 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-1 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4KV4X8IF6V',\n",
       "    'Name': 'DICYCLOMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7c61bee0-f2e8-45ce-959e-80c15affc500/7c61bee0-f2e8-45ce-959e-80c15affc500.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3042]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KE3U2023NP',\n",
       "    'Name': 'PORACTANT ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7c6ffa98-204f-4260-a60a-31859c8d6f5b/7c6ffa98-204f-4260-a60a-31859c8d6f5b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alveolar Surface Tension Reduction'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Surfactant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Surfactant Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L3JE09KZ2F',\n",
       "    'Name': 'SAQUINAVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7cdfea89-4b99-4a81-8a91-504843d3da73/7cdfea89-4b99-4a81-8a91-504843d3da73.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441243]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HIV Protease Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protease Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'PY4EET359T',\n",
       "    'Name': 'YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7cebe001-7145-4704-8a8d-d08a6a425965/7cebe001-7145-4704-8a8d-d08a6a425965.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Yellow Fever Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Yellow Fever Vaccine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SOA12P041N',\n",
       "    'Name': 'NITAZOXANIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7df89280-455d-4761-bf82-f8ca7ca2f0f4/7df89280-455d-4761-bf82-f8ca7ca2f0f4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [41684]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiprotozoal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1699G8679Z',\n",
       "    'Name': 'SODIUM POLYSTYRENE SULFONATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7e143fd4-4126-40a4-bd58-db80755c614b/7e143fd4-4126-40a4-bd58-db80755c614b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Binder'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Ion Exchange Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8B1QWR724A',\n",
       "    'Name': 'RESERPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7e39d79a-1004-438b-8eba-fea9c54cdd0f/7e39d79a-1004-438b-8eba-fea9c54cdd0f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5770]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamine-depleting Sympatholytic',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Catecholamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-189460'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Sympathetic Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3L5TQ84570',\n",
       "    'Name': 'MECLIZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7eba6bc0-cd7b-4b02-8a42-af7e03af580f/7eba6bc0-cd7b-4b02-8a42-af7e03af580f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417277]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiemetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Emesis Suppression'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UF599785JZ',\n",
       "    'Name': 'FENTANYL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7ebabe3c-20b4-40b2-a07a-50e6951c4971/7ebabe3c-20b4-40b2-a07a-50e6951c4971.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3345]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2W4A77YPAN',\n",
       "    'Name': 'FLUOCINONIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7ef3892c-bd16-4fe8-bcfe-c760c9def452/7ef3892c-bd16-4fe8-bcfe-c760c9def452.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9642]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4L066368AS',\n",
       "    'Name': 'FLUVASTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7f09490e-96f6-436d-82a4-2fadeb11fa75/7f09490e-96f6-436d-82a4-2fadeb11fa75.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416920]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HMG-CoA Reductase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HMG-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 25,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxymethylglutaryl-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '742SXX0ICT',\n",
       "    'Name': 'TADALAFIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7f0fc18f-b4f0-4223-aa8a-6882fe2598f8/7f0fc18f-b4f0-4223-aa8a-6882fe2598f8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [110635]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 5 Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 5 Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y8335394RO',\n",
       "    'Name': 'BUPIVACAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7f36ce58-41f7-4896-a5c2-1ce240b3b316/7f36ce58-41f7-4896-a5c2-1ce240b3b316.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417427]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amide Local Anesthetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amides'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '668Z8C33LU',\n",
       "    'Name': 'REPAGLINIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7f6f4dc2-a805-49d1-a0c1-cd4f1cace155/7f6f4dc2-a805-49d1-a0c1-cd4f1cace155.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [65981]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glinide'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Potassium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Potassium'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '624KN6GM2T',\n",
       "    'Name': 'TEMSIROLIMUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7f745466-5d44-44a5-8aaf-721980347a9e/7f745466-5d44-44a5-8aaf-721980347a9e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6918289]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '30OMY4G3MK',\n",
       "    'Name': 'GUANFACINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7f809ef3-9e9d-432f-a53d-42d709a75c77/7f809ef3-9e9d-432f-a53d-42d709a75c77.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3519]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central alpha-2 Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O7FU5X12W5',\n",
       "    'Name': 'LANTHANUM CATION (3+)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7f960ee2-a29c-417f-bdc0-3aeb37135a9c/7f960ee2-a29c-417f-bdc0-3aeb37135a9c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [104897]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphate Binder'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphate Chelating Activity',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Phosphate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-1061'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '57WA9QZ5WH',\n",
       "    'Name': 'NIMODIPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7fc5dc71-6ddd-4b6e-b799-31fa6ddc5a16/7fc5dc71-6ddd-4b6e-b799-31fa6ddc5a16.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416733]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridine Calcium Channel Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'A14FB57V1D',\n",
       "    'Name': 'GLYCOPYRRONIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/7fefb852-252a-4c3c-8024-ff9da01c94f0/7fefb852-252a-4c3c-8024-ff9da01c94f0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [131634201]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YHP6YLT61T',\n",
       "    'Name': 'PROCHLORPERAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8017f05f-b1ab-4821-a4b7-90912a51b6f2/8017f05f-b1ab-4821-a4b7-90912a51b6f2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4917]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7662KG2R6K',\n",
       "    'Name': 'LUBIPROSTONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8058b473-4f5e-4e0b-afce-31b422abdab8/8058b473-4f5e-4e0b-afce-31b422abdab8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [157920]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Chloride Channel Activator',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Chloride',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-18413378'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Chloride Channel Activators',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Chloride',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-18413378'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8QS6WCL55Z',\n",
       "    'Name': 'HOMATROPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/805ed0d7-df0e-48ea-a5f0-1dee4d95f4f8/805ed0d7-df0e-48ea-a5f0-1dee4d95f4f8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416657]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '46M3EV8HHE',\n",
       "    'Name': 'DIENOGEST',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/809ad6cd-693b-41af-a71c-0c4666975a62/809ad6cd-693b-41af-a71c-0c4666975a62.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [68861]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R420KW629U',\n",
       "    'Name': 'MEPHENYTOIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/819254c7-5a57-42f6-838f-91acda1a1eaf/819254c7-5a57-42f6-838f-91acda1a1eaf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416729]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2BTY8KH53L',\n",
       "    'Name': 'DEFERIPRONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/81feeb72-6660-4f26-bcb9-a23235b075a0/81feeb72-6660-4f26-bcb9-a23235b075a0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2972]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Iron Chelating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Iron Chelator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '31C4KY9ESH',\n",
       "    'Name': 'NITRIC OXIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/826ffea6-5017-4422-9b2b-49b1be3c4758/826ffea6-5017-4422-9b2b-49b1be3c4758.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [145068]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasodilation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasodilator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2XLB86RCW8',\n",
       "    'Name': 'IOTHALAMIC ACID I-125',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/829c531a-259d-4965-83a0-c457714b2fef/829c531a-259d-4965-83a0-c457714b2fef.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [23724932]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7KYV510875',\n",
       "    'Name': 'PIMECROLIMUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/82b782f7-c9b6-42a4-898f-15581374c26a/82b782f7-c9b6-42a4-898f-15581374c26a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6509979]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcineurin Inhibitor Immunosuppressant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcineurin Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q41OR9510P',\n",
       "    'Name': 'MELPHALAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/82ddcc39-e50c-4197-92f4-ac18b896a611/82ddcc39-e50c-4197-92f4-ac18b896a611.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [460612]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R16CO5Y76E',\n",
       "    'Name': 'ASPIRIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/82e04776-4e1d-4a45-8d81-8662176ae54d/82e04776-4e1d-4a45-8d81-8662176ae54d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2244]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Prostaglandin Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WOU1621EEG',\n",
       "    'Name': 'FOSAMPRENAVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/83114572-04d7-443b-98ce-5f2498941876/83114572-04d7-443b-98ce-5f2498941876.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [131536]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HIV Protease Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protease Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DL2R53P963',\n",
       "    'Name': 'COLISTIMETHATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/83252f6a-d48c-4bcf-8af3-ed54684bcfec/83252f6a-d48c-4bcf-8af3-ed54684bcfec.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417237]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polymyxin-class Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polymyxins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '01K63SUP8D',\n",
       "    'Name': 'FLUOXETINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/833d8f09-1e4e-43f5-9dd9-a8c44d378125/833d8f09-1e4e-43f5-9dd9-a8c44d378125.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416962]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BJ4HF6IU1D',\n",
       "    'Name': 'PINDOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/834529c2-d6a8-42fe-8b7a-46e137bdcf7e/834529c2-d6a8-42fe-8b7a-46e137bdcf7e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417103]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '06A33308KH',\n",
       "    'Name': 'STRONTIUM CATION SR-89',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/83b185f5-0d70-4bc0-a494-33fed0da43d4/83b185f5-0d70-4bc0-a494-33fed0da43d4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3083408]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Therapeutic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '293LSV29OL',\n",
       "    'Name': 'INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/840cf2d4-a31d-4825-b152-0a2d7ca33909/840cf2d4-a31d-4825-b152-0a2d7ca33909.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Influenza B Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '43K1W2T1M6',\n",
       "    'Name': 'INTERFERON ALFA-2B',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/848bfd19-93ac-46ef-8266-9c1cd0f37c35/848bfd19-93ac-46ef-8266-9c1cd0f37c35.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon Alfa-2b'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon alpha'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon-alpha'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IWW5FV6NK2',\n",
       "    'Name': 'HEXACHLOROPHENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/84d6f41f-d5e5-481f-b965-84c36f858dbf/84d6f41f-d5e5-481f-b965-84c36f858dbf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3598]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiseptic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7LJ087RS6F',\n",
       "    'Name': 'RILUZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/85189ed3-cee2-40f2-9704-83d58edf7f80/85189ed3-cee2-40f2-9704-83d58edf7f80.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5070]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzothiazole'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzothiazoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7J8897W37S',\n",
       "    'Name': 'DRONABINOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8554cbd3-9711-4c2d-b177-c2b82c9e3803/8554cbd3-9711-4c2d-b177-c2b82c9e3803.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16078]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cannabinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cannabinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9JU12S4YFY',\n",
       "    'Name': 'FLUOXYMESTERONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/85948a66-52ac-4d82-bb4d-584c5a0545df/85948a66-52ac-4d82-bb4d-584c5a0545df.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6446]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen Receptor Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androstanes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2V2JJ0S00T',\n",
       "    'Name': 'JAPANESE ENCEPHALITIS VIRUS STRAIN NAKAYAMA-NIH ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/85a13a63-5815-4330-920e-7ad26fef3182/85a13a63-5815-4330-920e-7ad26fef3182.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Japanese Encephalitis Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Japanese Encephalitis Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7UQ7X4Y489',\n",
       "    'Name': 'TINZAPARIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/85e03e99-364a-4765-8eaa-a956af7af22e/85e03e99-364a-4765-8eaa-a956af7af22e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Heparin, Low-Molecular-Weight'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Low Molecular Weight Heparin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O9U0F09D5X',\n",
       "    'Name': 'DROPERIDOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/860cd69f-6a88-4a38-9a9f-d7a494e7e962/860cd69f-6a88-4a38-9a9f-d7a494e7e962.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3168]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine D2 Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dopamine-2 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dopamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-681'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'HO3OGH5D7I',\n",
       "    'Name': 'NELFINAVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/86421e02-a348-4258-b2d0-b1439068dd73/86421e02-a348-4258-b2d0-b1439068dd73.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [64143]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HIV Protease Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protease Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q153V49P3Z',\n",
       "    'Name': 'ALVIMOPAN ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/865dc9b8-da5a-401b-bd55-76b263f0ac90/865dc9b8-da5a-401b-bd55-76b263f0ac90.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5488548]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'OON1HFZ4BA',\n",
       "    'Name': 'CETRORELIX',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8701c75b-0240-4e39-ac21-0a160a197f30/8701c75b-0240-4e39-ac21-0a160a197f30.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [25074887]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased GnRH Secretion'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '35S93Y190K',\n",
       "    'Name': 'PROCARBAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/87043deb-022d-4308-8cb1-e70498e69cfb/87043deb-022d-4308-8cb1-e70498e69cfb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4915]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '51G6I8B902',\n",
       "    'Name': 'NILUTAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/87c6d683-a616-4681-a59f-05f12c19d7c1/87c6d683-a616-4681-a59f-05f12c19d7c1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4493]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Androgen Receptor Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9J1H7Y9OJV',\n",
       "    'Name': 'EMEDASTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/88c12227-7f87-47d2-b580-89ea7e1bd5f5/88c12227-7f87-47d2-b580-89ea7e1bd5f5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3219]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H1 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-1 Receptor Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K72T3FS567',\n",
       "    'Name': 'ADENOSINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/88ff560b-d590-4690-aec6-317c618f2afa/88ff560b-d590-4690-aec6-317c618f2afa.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60961]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenosine Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Adenosine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-60961'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adenosine Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Adenosine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-60961'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R16CO5Y76E_1',\n",
       "    'Name': 'ASPIRIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/890dd4fd-5fdc-45e8-a38a-bcf005793ef8/890dd4fd-5fdc-45e8-a38a-bcf005793ef8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2244]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Prostaglandin Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platelet Aggregation Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Platelet Aggregation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SI86V6QNEG',\n",
       "    'Name': 'HALCINONIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/893b66bb-2c2f-47d0-803e-2933ddef157b/893b66bb-2c2f-47d0-803e-2933ddef157b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [443943]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U202363UOS',\n",
       "    'Name': 'FENOFIBRATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/898cb14b-c33f-42d9-a248-c84ffaa2a5bd/898cb14b-c33f-42d9-a248-c84ffaa2a5bd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3339]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator Receptor alpha Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Peroxisome Proliferator-activated Receptor alpha Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'PPAR alpha'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XUL93R30K2',\n",
       "    'Name': 'BOSENTAN ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/89a5d38c-979c-4c8f-b041-6a17ffe29dde/89a5d38c-979c-4c8f-b041-6a17ffe29dde.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [104865]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endothelin Receptor Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endothelin Receptor Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ZRP63D75JW',\n",
       "    'Name': 'IDARUBICIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/89fcc500-b0f7-4157-b7ab-599ca7f6e860/89fcc500-b0f7-4157-b7ab-599ca7f6e860.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [42890]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anthracycline Topoisomerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anthracyclines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UT0WHJ4951',\n",
       "    'Name': 'TECHNETIUM TC-99M TEBOROXIME',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8a2bfd05-f9f3-4f3d-a219-f79e3be5cbcf/8a2bfd05-f9f3-4f3d-a219-f79e3be5cbcf.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R43D2573WO',\n",
       "    'Name': 'FOSINOPRIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8a9d6739-3cdb-4851-9efe-901eeba5dec0/8a9d6739-3cdb-4851-9efe-901eeba5dec0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [45357796]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin Converting Enzyme Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin-converting Enzyme Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SJ76Y07H5F',\n",
       "    'Name': 'TRIENTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8b2640f8-5473-49e6-a229-c76ced263e41/8b2640f8-5473-49e6-a229-c76ced263e41.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5565]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Metal Chelating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Metal Chelator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D959AE5USF',\n",
       "    'Name': 'CLOFAZIMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8b4bc81e-dd64-461b-baf3-cce1ca7bb6a2/8b4bc81e-dd64-461b-baf3-cce1ca7bb6a2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2794]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimycobacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '47RRR83SK7',\n",
       "    'Name': 'INTERFERON ALFA-2A',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8b7475b1-dca3-4827-a3a6-2b046cc589df/8b7475b1-dca3-4827-a3a6-2b046cc589df.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon Alfa-2a'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon alpha'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interferon-alpha'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4877X14G4C',\n",
       "    'Name': 'THALLIUM CATION TL-201 (1+)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8c23c0ae-1294-4e26-b42d-873c9b4e5ad5/8c23c0ae-1294-4e26-b42d-873c9b4e5ad5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10130399]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K3GDH6OH08',\n",
       "    'Name': 'DIDANOSINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8c995e80-e806-4556-9252-d64280015e9f/8c995e80-e806-4556-9252-d64280015e9f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135398739]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E47C0NF7LV',\n",
       "    'Name': 'ENOXAPARIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8cb42f7b-ad49-4431-a087-810425233418/8cb42f7b-ad49-4431-a087-810425233418.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Heparin, Low-Molecular-Weight'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Low Molecular Weight Heparin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'PQX0D8J21J',\n",
       "    'Name': 'CETUXIMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8cbd1497-d077-43b4-a9cb-03478f117f30/8cbd1497-d077-43b4-a9cb-03478f117f30.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Epidermal Growth Factor Receptor Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HER1 Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9016E3VB47',\n",
       "    'Name': 'DESERPIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8cf2fc22-7653-4afa-b1bb-f4cc862c79c4/8cf2fc22-7653-4afa-b1bb-f4cc862c79c4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [8550]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamine-depleting Sympatholytic',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Catecholamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-189460'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Sympathetic Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'B2V233XGE7',\n",
       "    'Name': 'MESTRANOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8d18ba36-9656-442f-8bdd-5775ac7352ca/8d18ba36-9656-442f-8bdd-5775ac7352ca.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6291]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '184SNS8VUH',\n",
       "    'Name': 'SULINDAC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8d88a755-ef7f-45a6-bf1d-deeefda83a55/8d88a755-ef7f-45a6-bf1d-deeefda83a55.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76967269]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'B4OB0JHI1X',\n",
       "    'Name': 'PROPARACAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8defb1e8-81f3-4df3-adef-9aaf4e01576c/8defb1e8-81f3-4df3-adef-9aaf4e01576c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4935]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9ZOQ3TZI87',\n",
       "    'Name': 'SORAFENIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8df3b17b-e345-4fea-a0e0-ffba16a1c6c0/8df3b17b-e345-4fea-a0e0-ffba16a1c6c0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [216239]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0Q771797PH',\n",
       "    'Name': 'BUTOCONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8e2a5625-b25f-4f55-b222-3ea86c7e829b/8e2a5625-b25f-4f55-b222-3ea86c7e829b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416915]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5V9KLZ54CY',\n",
       "    'Name': 'VINBLASTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8e9ecedd-199d-4f29-a27e-4a5f4a8f5203/8e9ecedd-199d-4f29-a27e-4a5f4a8f5203.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [13342]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vinca Alkaloid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vinca Alkaloids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'EH28UP18IF',\n",
       "    'Name': 'ISOTRETINOIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8f0619f6-b913-4b08-80bb-bafe364985db/8f0619f6-b913-4b08-80bb-bafe364985db.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5282379]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Retinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8W5C518302',\n",
       "    'Name': 'DAPSONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8f0637f4-da24-45a6-a81f-6fcb7525dc0b/8f0637f4-da24-45a6-a81f-6fcb7525dc0b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2955]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '15G12L5X8K',\n",
       "    'Name': 'GADOBENIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8f136a40-0948-45b5-9d47-11be934f95ba/8f136a40-0948-45b5-9d47-11be934f95ba.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76958774]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X1K54R2P9I',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8f8e394d-8a6a-40ad-88d8-dcb94e8b24b6/8f8e394d-8a6a-40ad-88d8-dcb94e8b24b6.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M312JJ6Z32',\n",
       "    'Name': 'INDIUM IN-111 PENTETREOTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8fb8e567-ac72-42e3-abf5-a68c42dfd7bf/8fb8e567-ac72-42e3-abf5-a68c42dfd7bf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76969012]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VG2QF83CGL',\n",
       "    'Name': 'MELOXICAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8fd39d2c-b078-4ffa-a739-61c11bbd6b2c/8fd39d2c-b078-4ffa-a739-61c11bbd6b2c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54677470]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SY7Q814VUP',\n",
       "    'Name': 'CALCIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/8fe954ee-982f-4eea-b8c2-85eff089dc47/8fe954ee-982f-4eea-b8c2-85eff089dc47.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5460341]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphate Binder'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphate Chelating Activity',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Phosphate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-1061'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '47M74X9YT5',\n",
       "    'Name': 'CLADRIBINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/90192f95-4886-46ee-bc49-1d98cbfa97df/90192f95-4886-46ee-bc49-1d98cbfa97df.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [20279]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Purine Antimetabolite'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D51WO0G0L4',\n",
       "    'Name': 'CLORAZEPIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9068ec07-b287-4679-b159-5e76905be30d/9068ec07-b287-4679-b159-5e76905be30d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417063]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L39WTC366D',\n",
       "    'Name': 'PROCAINAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/90c572b6-5c75-4fbd-8a5c-5558b6d8e1e1/90c572b6-5c75-4fbd-8a5c-5558b6d8e1e1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4913]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'A0JWA85V8F',\n",
       "    'Name': 'ATORVASTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/90d47e95-c77f-46cf-8a64-1ba8a85ef015/90d47e95-c77f-46cf-8a64-1ba8a85ef015.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60823]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HMG-CoA Reductase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HMG-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 25,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxymethylglutaryl-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J06Y7MXW4D',\n",
       "    'Name': 'DEFEROXAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/914be9d6-d569-43a8-852b-d250710752a5/914be9d6-d569-43a8-852b-d250710752a5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2973]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Iron Chelating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Iron Chelator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JU9YAX04C7',\n",
       "    'Name': 'MILRINONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9151d715-eaad-4172-99cc-007973d0f216/9151d715-eaad-4172-99cc-007973d0f216.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4197]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 3 Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 3 Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '40P7XK9392',\n",
       "    'Name': 'FLUMAZENIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/915a4c45-c428-45c1-9d8d-9fcd2be4710a/915a4c45-c428-45c1-9d8d-9fcd2be4710a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3373]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine Antagonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '58TD96H03I',\n",
       "    'Name': 'INDIUM IN-111 CHLORIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/91835db1-954d-4ca6-8b5e-33b993fff7c2/91835db1-954d-4ca6-8b5e-33b993fff7c2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6452255]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J2R869A8YF',\n",
       "    'Name': 'SUCCINYLCHOLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9208f535-ad35-4f57-8f5c-7274d1f9ba78/9208f535-ad35-4f57-8f5c-7274d1f9ba78.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5314]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Depolarizing Neuromuscular Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Neuromuscular Depolarizing Blockade'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q94YYU22B8',\n",
       "    'Name': 'DIETHYLPROPION',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/920f3112-8be3-44bb-9a90-688c64d6214d/920f3112-8be3-44bb-9a90-688c64d6214d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417136]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Appetite Suppression'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Sympathetic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sympathomimetic Amine Anorectic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '414JW8YPVE',\n",
       "    'Name': 'TECHNETIUM TC-99M ALBUMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/92379350-5515-47ec-a755-cd256a949f2e/92379350-5515-47ec-a755-cd256a949f2e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'T34C307W5N',\n",
       "    'Name': 'FORESKIN FIBROBLAST (NEONATAL)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/92512e54-7845-402e-ab36-099b6d5da630/92512e54-7845-402e-ab36-099b6d5da630.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allogeneic Cultured Cell Scaffold'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tissue Scaffolds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cells, Cultured, Allogeneic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fibroblasts'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4M543JVT7G',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/929d5649-16d8-4eab-bda9-07acc90eab4e/929d5649-16d8-4eab-bda9-07acc90eab4e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JZ7EH9T50R',\n",
       "    'Name': 'ELYMUS TRACHYCAULUS POLLEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9382fbbe-1d3f-4a61-8d87-6e39f99e52d5/9382fbbe-1d3f-4a61-8d87-6e39f99e52d5.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Standardized Pollen Allergenic Extract'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Histamine Release'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cell-mediated Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased IgG Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pollen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Allergens'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '004F72P8F4',\n",
       "    'Name': 'BETHANECHOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9388181f-7e4f-404f-859c-7834a8748998/9388181f-7e4f-404f-859c-7834a8748998.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416897]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7M7YKX2N15',\n",
       "    'Name': 'TOPOTECAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/93ab273a-2d01-435b-9525-98f309c83f2b/93ab273a-2d01-435b-9525-98f309c83f2b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60700]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4F4X42SYQ6',\n",
       "    'Name': 'RITUXIMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/93b22ae6-1243-463b-9a26-85ca58628e84/93b22ae6-1243-463b-9a26-85ca58628e84.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD20-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD20-directed Cytolytic Antibody'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y2V2R4W9TQ',\n",
       "    'Name': 'GALLIUM NITRATE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/93c460b1-07e2-459e-940f-5502030c74eb/93c460b1-07e2-459e-940f-5502030c74eb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [61635]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bone Resorption Inhibition'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Resorption Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CM1N99QR1M',\n",
       "    'Name': 'METRIZOIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9419b543-9674-4997-8ed2-59fba225d343/9419b543-9674-4997-8ed2-59fba225d343.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2528]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiographic Contrast Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'X-Ray Contrast Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G4FQ3CKY5R',\n",
       "    'Name': 'ASPARAGINASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9488f452-dda7-4b67-ac46-2388169985f3/9488f452-dda7-4b67-ac46-2388169985f3.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Asparaginase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Asparagine-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'X4W3ENH1CV',\n",
       "    'Name': 'NOREPINEPHRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/94ee9a0d-b663-4bb1-9c9c-0cdbcf1207b6/94ee9a0d-b663-4bb1-9c9c-0cdbcf1207b6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [439260]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catecholamines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DX1U2629QE',\n",
       "    'Name': 'SUCCIMER',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/94f059d3-9dc5-44ec-b6d7-30da71f6b7fc/94f059d3-9dc5-44ec-b6d7-30da71f6b7fc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2724354]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lead Chelating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lead Chelator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '413KH5ZJ73',\n",
       "    'Name': 'ROSUVASTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/95307b4d-e91f-4334-b9b3-a8c8df82240a/95307b4d-e91f-4334-b9b3-a8c8df82240a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [446157]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HMG-CoA Reductase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HMG-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 25,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxymethylglutaryl-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F0XDI6ZL63',\n",
       "    'Name': 'CASPOFUNGIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/95362987-2947-46de-9cc6-5c082b967648/95362987-2947-46de-9cc6-5c082b967648.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16119814]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Echinocandin Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lipopeptides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'A74586SNO7',\n",
       "    'Name': 'CLOPIDOGREL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9545e5f3-77ff-4cb6-8fd4-0ef8cb88ff16/9545e5f3-77ff-4cb6-8fd4-0ef8cb88ff16.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60606]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Platelet Aggregation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'P2Y12 Platelet Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'P2Y12 Receptor Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0NJ98Y462X',\n",
       "    'Name': 'CONIVAPTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/958ac0b3-3dd1-454f-b5b5-528441337e9a/958ac0b3-3dd1-454f-b5b5-528441337e9a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [151171]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antidiuretic Hormone Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasopressin Antagonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3A64E3G5ZO',\n",
       "    'Name': 'BROMOCRIPTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/95c7189f-b943-4c0e-83e3-a7b550e81fbc/95c7189f-b943-4c0e-83e3-a7b550e81fbc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [31101]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ergolines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Ergot Derivative'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '19QM69HH21',\n",
       "    'Name': 'PYRIDOSTIGMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/95c7adb4-2b88-4b21-a703-8ac8ab043944/95c7adb4-2b88-4b21-a703-8ac8ab043944.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4991]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'W46JY43EJR',\n",
       "    'Name': 'SILVER SULFADIAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/95d1b1e4-96d2-4f6d-a809-d51a95387ab6/95d1b1e4-96d2-4f6d-a809-d51a95387ab6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441244]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamide Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonamides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RUM6K67ESG',\n",
       "    'Name': 'TREPROSTINIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/96017ce8-9440-4c75-90ce-fea711e04157/96017ce8-9440-4c75-90ce-fea711e04157.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6918140]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostacycline Vasodilator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Prostaglandins I'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasodilation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TG537D343B',\n",
       "    'Name': 'DESIPRAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9609850a-1cf0-4044-8c2b-47dc8c3e86e1/9609850a-1cf0-4044-8c2b-47dc8c3e86e1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2995]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S8Q36MD2XX',\n",
       "    'Name': 'CANDESARTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/964bdf63-b762-4ccc-830a-0b6e475613b9/964bdf63-b762-4ccc-830a-0b6e475613b9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2541]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Blocker',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YX9162EO3I',\n",
       "    'Name': 'RALOXIFENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/96850c4e-cd31-449d-a89f-a096ea4185ee/96850c4e-cd31-449d-a89f-a096ea4185ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5035]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Agonist/Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Selective Estrogen Receptor Modulators'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XK87D9J012',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/96b4b5fe-5222-44ac-ace1-c489fe3e111a/96b4b5fe-5222-44ac-ace1-c489fe3e111a.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7NFE54O27T',\n",
       "    'Name': 'TOREMIFENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/96b7e439-b53a-4dd1-9fcf-3e914ec2754d/96b7e439-b53a-4dd1-9fcf-3e914ec2754d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3005573]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Agonist/Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Selective Estrogen Receptor Modulators'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R10H71BSWG',\n",
       "    'Name': 'MICAFUNGIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/970f1ea2-8bae-4a91-a3cd-1b5192642b90/970f1ea2-8bae-4a91-a3cd-1b5192642b90.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [477468]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Echinocandin Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lipopeptides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '44RAL3456C',\n",
       "    'Name': 'METHAMPHETAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9712247d-73f8-4739-9b9d-91157b38aa80/9712247d-73f8-4739-9b9d-91157b38aa80.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10836]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amphetamine Anorectic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amphetamines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Appetite Suppression'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Sympathetic Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DQ448MW7KS',\n",
       "    'Name': 'PALIVIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97280012-65a6-4796-8dfa-b48fc0d326b0/97280012-65a6-4796-8dfa-b48fc0d326b0.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antibodies, Monoclonal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fusion Protein Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '38LVP0K73A',\n",
       "    'Name': 'SEVOFLURANE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9733c08d-d1e9-4fdb-937d-e7f4555256f2/9733c08d-d1e9-4fdb-937d-e7f4555256f2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5206]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthesia'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '207ZZ9QZ49',\n",
       "    'Name': 'METHYLPHENIDATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/973d4389-6360-4650-980a-b57c85785223/973d4389-6360-4650-980a-b57c85785223.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417216]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Stimulation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6M3C89ZY6R',\n",
       "    'Name': 'NICOTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97a6cd25-c17e-4c57-ac7a-d6d6395767c2/97a6cd25-c17e-4c57-ac7a-d6d6395767c2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [89594]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Nicotinic Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nicotine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G2B4VE5GH8',\n",
       "    'Name': 'AZTREONAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97ce2ab7-5884-4132-8b33-d7beb8a7fd94/97ce2ab7-5884-4132-8b33-d7beb8a7fd94.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5742832]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monobactam Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monobactams'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q13WX941EF',\n",
       "    'Name': 'EPINASTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97d68f98-0428-4a93-8854-534cde0df610/97d68f98-0428-4a93-8854-534cde0df610.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417173]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic Receptor Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Histamine Release',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H1 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-1 Receptor Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R0TAY3X631',\n",
       "    'Name': 'NORELGESTROMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97daabc9-cb3b-4cbd-8e06-bab1017c3176/97daabc9-cb3b-4cbd-8e06-bab1017c3176.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [62930]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0T2EF4JQTU',\n",
       "    'Name': 'RIMANTADINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97e0565d-4986-4e5e-acd9-4aa0432bd73c/97e0565d-4986-4e5e-acd9-4aa0432bd73c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416869]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza A M2 Protein Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'M2 Protein Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5GRO578KLP',\n",
       "    'Name': 'FLURBIPROFEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/97fb5a76-f16a-4c5d-a248-d9f28ba9c165/97fb5a76-f16a-4c5d-a248-d9f28ba9c165.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416779]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0EB439235F',\n",
       "    'Name': 'TIOTROPIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9855ea2a-3939-4445-99dc-d9dd308e3d82/9855ea2a-3939-4445-99dc-d9dd308e3d82.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5487427]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '873OI62848',\n",
       "    'Name': 'BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/98e654f4-515c-4721-aee1-dc0afbcadc23/98e654f4-515c-4721-aee1-dc0afbcadc23.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Bacillus Anthracis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anthrax Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9X7O8V25IT',\n",
       "    'Name': 'COLLAGENASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/98fd0aec-ae5e-4b49-86bb-2c823f84d074/98fd0aec-ae5e-4b49-86bb-2c823f84d074.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Collagenases'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Collagen-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O408N561GF',\n",
       "    'Name': 'PHENELZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/98feea71-5aff-4314-8a0d-2a40548703cc/98feea71-5aff-4314-8a0d-2a40548703cc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3675]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Monoamine Oxidase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2J57K2523T',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/992b29a2-1b5f-49b8-8757-81d34f5635ae/992b29a2-1b5f-49b8-8757-81d34f5635ae.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6GOW6DWN2A',\n",
       "    'Name': 'OXAZEPAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/996055bc-1cec-4386-b0d0-42e1be9158ff/996055bc-1cec-4386-b0d0-42e1be9158ff.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417330]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RLM74T3Z9D',\n",
       "    'Name': 'GADOVERSETAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/99de9da9-8543-44c8-9b58-c9d17da97819/99de9da9-8543-44c8-9b58-c9d17da97819.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [444013]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L628TT009W',\n",
       "    'Name': 'ISOPROTERENOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/99e4f0c6-0606-47b5-aa63-f25cd6d86641/99e4f0c6-0606-47b5-aa63-f25cd6d86641.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417104]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'O26FZP769L',\n",
       "    'Name': 'LORAZEPAM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9a4a2ded-8284-45a8-bf3a-6b8ce08da26c/9a4a2ded-8284-45a8-bf3a-6b8ce08da26c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416887]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Benzodiazepines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SLF0D9077S',\n",
       "    'Name': 'OXYTETRACYCLINE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9a5763e1-a9f2-4142-882f-e49b2fb53ae7/9a5763e1-a9f2-4142-882f-e49b2fb53ae7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54675779]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracycline-class Antimicrobial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tetracycline',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-54675776'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracyclines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P88XT4IS4D',\n",
       "    'Name': 'PACLITAXEL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9aaa3f8b-9a30-4525-b0d5-833e5e5ba2f9/9aaa3f8b-9a30-4525-b0d5-833e5e5ba2f9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [36314]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibition'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Microtubule Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7673326042',\n",
       "    'Name': 'IRINOTECAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9ab4bb1d-696a-4ca5-950f-5d2d5c71dd1c/9ab4bb1d-696a-4ca5-950f-5d2d5c71dd1c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60838]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Topoisomerase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '423D2T571U',\n",
       "    'Name': 'ETHINYL ESTRADIOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9acd0dbd-e9c9-48a4-83d7-b1f9087a7b99/9acd0dbd-e9c9-48a4-83d7-b1f9087a7b99.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5991]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5W494URQ81',\n",
       "    'Name': 'STREPTOZOCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9ae770a3-dd63-4ba5-ab3a-eb8f265090ff/9ae770a3-dd63-4ba5-ab3a-eb8f265090ff.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [23615975]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CUJ2MVI71Y',\n",
       "    'Name': 'DACLIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9b0b510a-b718-4752-b82f-f1c74c497fa6/9b0b510a-b718-4752-b82f-f1c74c497fa6.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin 2 Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin 2 Receptor-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin-2 Receptor Blocking Antibody'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0G3DE8943Y',\n",
       "    'Name': 'LANREOTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9b1199d7-987f-4bee-99e7-b5462f2354ed/9b1199d7-987f-4bee-99e7-b5462f2354ed.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311220]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Somatostatin Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Somatostatin Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Somatostatin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-16129706'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D2UFC189XF',\n",
       "    'Name': 'MEDRYSONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9b24c842-ff5d-4a3d-8fba-b041fd977c75/9b24c842-ff5d-4a3d-8fba-b041fd977c75.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [247839]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6OEV9DX57Y',\n",
       "    'Name': 'CEFOXITIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9b5057a5-b101-461e-a98e-27fc927f071f/9b5057a5-b101-461e-a98e-27fc927f071f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441199]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H95KBR1GDB',\n",
       "    'Name': 'XENON XE-127',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9b657123-40de-42b0-9319-60a6d0669b69/9b657123-40de-42b0-9319-60a6d0669b69.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [166973]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inhalation Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K0U68Q2TXA',\n",
       "    'Name': 'CORTICOTROPIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9bacf23b-26e7-4052-a9a4-7046b2129a44/9bacf23b-26e7-4052-a9a4-7046b2129a44.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [134687209]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenocorticotropic Hormone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenocorticotropic Hormone'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WIX31ZPX66',\n",
       "    'Name': 'THIOGUANINE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9bb31792-ac17-4840-ba12-d7396db460e4/9bb31792-ac17-4840-ba12-d7396db460e4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2723601]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimetabolite'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K3W1N8YP13',\n",
       "    'Name': 'CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9bdb3f93-732f-44c9-b943-8c39139a118e/9bdb3f93-732f-44c9-b943-8c39139a118e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Clostridium Tetani Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetanus Toxoid'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9LHU78OQFD',\n",
       "    'Name': 'LOVASTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9c04e953-5cf5-4bc2-9ca8-382df858a303/9c04e953-5cf5-4bc2-9ca8-382df858a303.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [53232]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HMG-CoA Reductase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/HMG-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 25,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxymethylglutaryl-CoA',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-445127'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BDF1O1C72E',\n",
       "    'Name': 'NYSTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9c1c68a6-fbf8-4383-9235-c29ffb493df5/9c1c68a6-fbf8-4383-9235-c29ffb493df5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417023]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polyene Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Polyenes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6490C9U457',\n",
       "    'Name': 'PRAZIQUANTEL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9c6bceb6-1b0b-4c36-86d0-3918b440e71c/9c6bceb6-1b0b-4c36-86d0-3918b440e71c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417278]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antihelminthic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ISQ9I6J12J',\n",
       "    'Name': 'LINEZOLID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9d071355-26a2-48fa-8179-8508c45d1c71/9d071355-26a2-48fa-8179-8508c45d1c71.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441401]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Oxazolidinone Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Oxazolidinone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-73949'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Oxazolidinones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z6R9D1D3KJ',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9d189337-ae54-4ed9-a4ea-96f22866dd86/9d189337-ae54-4ed9-a4ea-96f22866dd86.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '50SG953SK6',\n",
       "    'Name': 'MITOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9d58cd01-f870-4698-8c83-1a55c7c76d87/9d58cd01-f870-4698-8c83-1a55c7c76d87.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5746]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DZ854I04ZE',\n",
       "    'Name': 'JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9d6c032f-f686-4cdc-9478-7ca232a5852c/9d6c032f-f686-4cdc-9478-7ca232a5852c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Japanese Encephalitis Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Japanese Encephalitis Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BKJ8M8G5HI',\n",
       "    'Name': 'IMATINIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9d9f4e84-e0b3-407a-bf10-ef69cfd5ef1d/9d9f4e84-e0b3-407a-bf10-ef69cfd5ef1d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5291]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7NNO0D7S5M',\n",
       "    'Name': 'MICONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9da0b738-3b93-4578-a275-3f448c7a6c8d/9da0b738-3b93-4578-a275-3f448c7a6c8d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417079]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'EA6LD1M70M',\n",
       "    'Name': 'MEGESTROL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9e2b8654-df49-4b18-b686-299389fd7a11/9e2b8654-df49-4b18-b686-299389fd7a11.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [19090]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5K0VU709JD',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9e7f02c4-1344-4380-810f-f9a60c9e16fb/9e7f02c4-1344-4380-810f-f9a60c9e16fb.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F64QU97QCR',\n",
       "    'Name': 'DANTROLENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9e9825f0-4884-48df-8eca-889342175cfa/9e9825f0-4884-48df-8eca-889342175cfa.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6914273]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Striated Muscle Contraction'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Striated Muscle Tone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Skeletal Muscle Relaxant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '140QMO216E',\n",
       "    'Name': 'METRONIDAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9ef71064-51c2-477c-b844-6cd39b67edc2/9ef71064-51c2-477c-b844-6cd39b67edc2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4173]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitroimidazole Antimicrobial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Nitroimidazole',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-10701'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitroimidazoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1JQS135EYN',\n",
       "    'Name': 'OXYTOCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9f00aea3-3a97-4298-b2c9-6713c8a03721/9f00aea3-3a97-4298-b2c9-6713c8a03721.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [439302]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Uterine Smooth Muscle Contraction or Tone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Oxytocic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Oxytocin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'W31X2H97FB',\n",
       "    'Name': 'TORSEMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9f020d23-7c7e-448f-87d7-f4c51f18480a/9f020d23-7c7e-448f-87d7-f4c51f18480a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [41781]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis at Loop of Henle'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Loop Diuretic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '12G01I6BBU',\n",
       "    'Name': 'EZOGABINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9f0dc021-b71b-4e67-91b2-641b1cbb590c/9f0dc021-b71b-4e67-91b2-641b1cbb590c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [121892]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Channel Openers'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Potassium Channel Opener'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '46QG38NC4U',\n",
       "    'Name': 'ETHOTOIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9f504de0-0758-41e4-83ca-e3250d9da381/9f504de0-0758-41e4-83ca-e3250d9da381.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417414]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H0DE420U8G',\n",
       "    'Name': 'CHLORZOXAZONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9f878e96-f49c-4343-b672-8612bc2cf126/9f878e96-f49c-4343-b672-8612bc2cf126.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2733]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Centrally-mediated Muscle Relaxation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Muscle Relaxant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4FVB62AFF1',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/9fde8a0a-661f-4b23-9811-f5c1f753a8be/9fde8a0a-661f-4b23-9811-f5c1f753a8be.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1GVO236S58',\n",
       "    'Name': 'HYDROXYETHYL STARCH 130/0.4',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a01db258-190a-4709-b90a-c2a445b3bd1a/a01db258-190a-4709-b90a-c2a445b3bd1a.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Plasma Volume Expander'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Intravascular Volume'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Osmotic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Starch'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'V867Q8X3ZD',\n",
       "    'Name': 'DIETHYLCARBAMAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a0264581-4af3-46d2-8455-78d542e7b2ce/a0264581-4af3-46d2-8455-78d542e7b2ce.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3052]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antihelminthic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'ZZT404XD09',\n",
       "    'Name': 'TIPRANAVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a02f430a-3d9c-4ed2-852c-f670bf4eb8fc/a02f430a-3d9c-4ed2-852c-f670bf4eb8fc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54682461]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'HIV Protease Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protease Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0D3Q044KCA',\n",
       "    'Name': 'GALANTAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a0404dd2-3fb1-41b8-9d2b-8455a9b7e002/a0404dd2-3fb1-41b8-9d2b-8455a9b7e002.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9651]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '884KT10YB7',\n",
       "    'Name': 'RANITIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a043b13b-e2c3-4456-9199-c3f3bf8f125d/a043b13b-e2c3-4456-9199-c3f3bf8f125d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5039]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine H2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histamine-2 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6Z1Y2V4A7M',\n",
       "    'Name': 'ECONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a0d46e0a-40a5-46ab-893a-a5cdd34864cf/a0d46e0a-40a5-46ab-893a-a5cdd34864cf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416712]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1NMA9J598Y',\n",
       "    'Name': 'METAXALONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a105c5b7-ec7b-41de-9863-0c8705e2c54f/a105c5b7-ec7b-41de-9863-0c8705e2c54f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417407]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Centrally-mediated Muscle Relaxation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Muscle Relaxant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D3FM8FA78T',\n",
       "    'Name': 'PRAMLINTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a1a448d2-e27c-4efa-a203-2aef747c3b89/a1a448d2-e27c-4efa-a203-2aef747c3b89.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [70691388]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amylin Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amylin Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4B9XT59T7S',\n",
       "    'Name': 'ZIDOVUDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a1d8d012-e17a-4b51-a1c7-db5f125634ec/a1d8d012-e17a-4b51-a1c7-db5f125634ec.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [35370]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '03V657ZD3V',\n",
       "    'Name': 'METHACHOLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a1ee6be2-eab7-4753-9532-26b5128454c2/a1ee6be2-eab7-4753-9532-26b5128454c2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417370]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Receptor Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C668Q9I33J',\n",
       "    'Name': 'OXICONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a20b9f9a-491f-455e-863e-abb976bc6fdb/a20b9f9a-491f-455e-863e-abb976bc6fdb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5353853]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q20Q21Q62J',\n",
       "    'Name': 'CISPLATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a2428fbb-4140-4469-a495-26af46f9f32b/a2428fbb-4140-4469-a495-26af46f9f32b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [84691]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platinum-based Drug'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platinum-containing Compounds',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Platinum',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Platinum'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'I16QD7X297',\n",
       "    'Name': 'NEOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a2b19c40-a0fd-42ac-87fb-c2ef81d4dd6e/a2b19c40-a0fd-42ac-87fb-c2ef81d4dd6e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [44555449]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycoside Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycosides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QSN5XO8ZSU',\n",
       "    'Name': 'BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a2c8eea5-158a-497d-bf03-20015f7b6e6f/a2c8eea5-158a-497d-bf03-20015f7b6e6f.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Bordetella Pertussis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pertussis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M03GIQ7Z6P',\n",
       "    'Name': 'SINCALIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a2e446c1-3b55-491b-abd3-4491cceb5acf/a2e446c1-3b55-491b-abd3-4491cceb5acf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9833444]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholecystokinin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholecystokinin Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3JB47N2Q2P',\n",
       "    'Name': 'NATALIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a2f3f57a-b886-4235-aab4-17df5f270d58/a2f3f57a-b886-4235-aab4-17df5f270d58.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Integrin Receptor Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Integrin Receptor Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '61746O90DY',\n",
       "    'Name': 'HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a34585ad-af54-4df0-8395-2044d41a9301/a34585ad-af54-4df0-8395-2044d41a9301.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Human Papillomavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Papillomavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9842X06Q6M',\n",
       "    'Name': 'BETAMETHASONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a37955a6-228a-40ea-baf2-7e7ddd38d0bf/a37955a6-228a-40ea-baf2-7e7ddd38d0bf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9782]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7318FJ13YJ',\n",
       "    'Name': 'THIOTHIXENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a3b1c871-0755-4932-a88a-807b66f4609a/a3b1c871-0755-4932-a88a-807b66f4609a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [941651]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Typical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2KH13Z0S0Y',\n",
       "    'Name': 'EPROSARTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a3bcc921-6c86-4e7c-84e8-4c62db9fd20f/a3bcc921-6c86-4e7c-84e8-4c62db9fd20f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5281037]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Blocker',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'OGG85SX4E4',\n",
       "    'Name': 'IMIPRAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a3c76811-1376-418a-9fcf-deb130a22b22/a3c76811-1376-418a-9fcf-deb130a22b22.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3696]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tricyclic Antidepressant'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K3R6ZDH4DU',\n",
       "    'Name': 'DEXTRAN 40',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a4050146-7039-4785-836f-2f046118e2fb/a4050146-7039-4785-836f-2f046118e2fb.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Plasma Volume Expander'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Intravascular Volume'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Osmotic Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'BG3F62OND5',\n",
       "    'Name': 'CARBOPLATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a43d5a0e-12dc-499a-9dc3-8a3024a47e15/a43d5a0e-12dc-499a-9dc3-8a3024a47e15.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10339178]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platinum-based Drug'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Platinum-containing Compounds',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Platinum',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Platinum'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XX73205DH5',\n",
       "    'Name': 'SUCRALFATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a44c0c89-3f46-4140-ab82-453c240af973/a44c0c89-3f46-4140-ab82-453c240af973.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aluminum Complex'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Organometallic Compounds'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'KM2Z91756Z',\n",
       "    'Name': 'RISEDRONIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a47343e7-bbc8-4071-a9b2-9bc97bfae027/a47343e7-bbc8-4071-a9b2-9bc97bfae027.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5245]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bisphosphonate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diphosphonates'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'YO460OQ37K',\n",
       "    'Name': 'VANDETANIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a4a5b17f-dd2b-4417-91cf-98697b8f7230/a4a5b17f-dd2b-4417-91cf-98697b8f7230.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3081361]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CZ5312222S',\n",
       "    'Name': 'NICARDIPINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a4bd9f46-c9bd-42db-9d14-66bbf545f2b4/a4bd9f46-c9bd-42db-9d14-66bbf545f2b4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416670]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium Channel Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridine Calcium Channel Blocker'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydropyridines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L1977Q86S5',\n",
       "    'Name': 'HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a4e1b1d4-0448-489e-9791-140578949842/a4e1b1d4-0448-489e-9791-140578949842.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Rotavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rotavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Live'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '73312P173G',\n",
       "    'Name': 'DIPHENOXYLATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a56e0eaa-463e-4f4c-8201-fc90533efd2f/a56e0eaa-463e-4f4c-8201-fc90533efd2f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [13505]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antidiarrheal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WK2XYI10QM',\n",
       "    'Name': 'IBUPROFEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a5dc1bf1-5f08-4695-9e32-2dd49be56127/a5dc1bf1-5f08-4695-9e32-2dd49be56127.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417148]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cyclooxygenase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Compounds'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nonsteroidal Anti-inflammatory Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'PKI06M3IW0',\n",
       "    'Name': 'RIVASTIGMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a650c15f-8108-4bf9-ba7e-1b593b6144b2/a650c15f-8108-4bf9-ba7e-1b593b6144b2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [77991]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinesterase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '78W62V43DY',\n",
       "    'Name': 'PENBUTOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a69aa684-5000-40d4-9d3b-3b00f655cbc2/a69aa684-5000-40d4-9d3b-3b00f655cbc2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [37464]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '36ITO9SKQJ',\n",
       "    'Name': 'TECHNETIUM TC-99M MERTIATIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a6a5f88f-8a01-454d-93e8-5fd79f8aeddb/a6a5f88f-8a01-454d-93e8-5fd79f8aeddb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76958876]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UAZ6V7728S',\n",
       "    'Name': 'CINACALCET',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a6c9e206-ab65-4dbf-9f94-100da5b5851a/a6c9e206-ab65-4dbf-9f94-100da5b5851a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [156419]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Calcium-sensing Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Calcium-sensing Receptor Sensitivity',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Calcium'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MN3L5RMN02',\n",
       "    'Name': 'CLONIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a6f6ab65-4a42-4009-bb92-ffb294acfc1f/a6f6ab65-4a42-4009-bb92-ffb294acfc1f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2803]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic alpha2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central alpha-2 Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DDA050FCEA',\n",
       "    'Name': 'CENTRUROIDES FAB2 ANTIVENIN (EQUINE)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a6f79b66-f0ab-41fb-9ae3-c3c24ac4307a/a6f79b66-f0ab-41fb-9ae3-c3c24ac4307a.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Venom Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'FTA7XXY4EZ',\n",
       "    'Name': 'PERPHENAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a71af815-28d2-4feb-b2e0-288a047c048b/a71af815-28d2-4feb-b2e0-288a047c048b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4748]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phenothiazines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'N295J34A25',\n",
       "    'Name': 'DROSPIRENONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a73782c4-401a-4dae-8788-03a76fbde55e/a73782c4-401a-4dae-8788-03a76fbde55e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [68873]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z80I64HMNP',\n",
       "    'Name': 'TIAGABINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a7fac803-5b93-4947-b0eb-05fa93a41408/a7fac803-5b93-4947-b0eb-05fa93a41408.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60648]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C045TQL4WP',\n",
       "    'Name': 'PHENTERMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a82ea8fb-55b1-465b-b461-c4bbb5b2f9c8/a82ea8fb-55b1-465b-b461-c4bbb5b2f9c8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4771]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Appetite Suppression'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Sympathetic Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sympathomimetic Amine Anorectic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K9P6MC7092',\n",
       "    'Name': 'OXYBUTYNIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a83d2f20-8286-4737-bf33-769fc536293e/a83d2f20-8286-4737-bf33-769fc536293e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416767]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z8E46IA45W',\n",
       "    'Name': 'TECHNETIUM TC-99M ALBUMIN AGGREGATED',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a85cf204-eb6a-4ae7-b4c9-a68c06e586ce/a85cf204-eb6a-4ae7-b4c9-a68c06e586ce.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '927AH8112L',\n",
       "    'Name': 'NITROFURANTOIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a867fbf2-9fd6-4af8-8756-6890fc5e7b1f/a867fbf2-9fd6-4af8-8756-6890fc5e7b1f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6604200]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrofuran Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrofurans'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0F65R8P09N',\n",
       "    'Name': 'GOSERELIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a87bc880-52c9-4ad2-89b7-4c2e8806f5a9/a87bc880-52c9-4ad2-89b7-4c2e8806f5a9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311128]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WT87C52TJZ',\n",
       "    'Name': 'MOEXIPRIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a8c6fb3a-7daa-478d-88ee-993e703a1f26/a8c6fb3a-7daa-478d-88ee-993e703a1f26.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [91270]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin Converting Enzyme Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin-converting Enzyme Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9HLM53094I',\n",
       "    'Name': 'ANIDULAFUNGIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a8f2968e-7847-4ed9-a1aa-f121bf0571a4/a8f2968e-7847-4ed9-a1aa-f121bf0571a4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [166548]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Echinocandin Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lipopeptides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7WZ1744G86',\n",
       "    'Name': 'MOJAVE RATTLESNAKE (CROTALUS SCUTULATUS) IMMUNE FAB ANTIVENIN (OVINE)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a93e71e4-8fe6-4065-9644-15f38e6e28ff/a93e71e4-8fe6-4065-9644-15f38e6e28ff.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Venom Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenins'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antivenin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '501CFL162R',\n",
       "    'Name': 'HYDROFLUMETHIAZIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a9c8aef0-f35e-47a7-94b7-d5db042bdd17/a9c8aef0-f35e-47a7-94b7-d5db042bdd17.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3647]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazide Diuretic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thiazides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J4T82NDH7E',\n",
       "    'Name': 'ERLOTINIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/a9e7b4b5-92d5-4a7d-b7b6-219606e953d6/a9e7b4b5-92d5-4a7d-b7b6-219606e953d6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [176870]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'XPA88EAP6V',\n",
       "    'Name': 'SPINOSAD',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aa26847d-b284-4545-a85c-7089e9c79adf/aa26847d-b284-4545-a85c-7089e9c79adf.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [17754356]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pediculicide'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4QWG6N8QKH',\n",
       "    'Name': 'HYDROXYCHLOROQUINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aa3a4be7-bd02-460c-8437-3e549770b515/aa3a4be7-bd02-460c-8437-3e549770b515.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417022]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antirheumatic Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C6547J35OD',\n",
       "    'Name': 'RABIES VIRUS STRAIN KISSLING ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aa58134d-9051-4a36-ae31-785c32634e2d/aa58134d-9051-4a36-ae31-785c32634e2d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Rabies Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rabies Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IY90U61Z3S',\n",
       "    'Name': 'ARGATROBAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aa5b29ee-8b21-4652-bca0-7e040a34a909/aa5b29ee-8b21-4652-bca0-7e040a34a909.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [131634738]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-coagulant'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Direct Thrombin Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombin Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '13S1S8SF37',\n",
       "    'Name': 'ZINC CATION',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aa8ec9c3-051e-440d-806b-f1a3f1d2b3ee/aa8ec9c3-051e-440d-806b-f1a3f1d2b3ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [32051]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Copper Absorption Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 6,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Copper',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'Element-Copper'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Copper Ion Absorption',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Copper%20Ion',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-27099'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'L6O3XI777I',\n",
       "    'Name': 'ZANAMIVIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aaaa6af7-0aec-4858-929f-ca3322dbdb48/aaaa6af7-0aec-4858-929f-ca3322dbdb48.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60855]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Neuraminidase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Neuraminidase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'LX1OH63030',\n",
       "    'Name': 'ISOSORBIDE MONONITRATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aab2d492-22ed-4a16-9357-d2943c03fb36/aab2d492-22ed-4a16-9357-d2943c03fb36.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [27661]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrate Vasodilator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrates'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasodilation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IA7306519N',\n",
       "    'Name': 'ISOSORBIDE DINITRATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aaef4237-7beb-4290-b77a-d134344803c4/aaef4237-7beb-4290-b77a-d134344803c4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6883]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrate Vasodilator'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nitrates'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vasodilation'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'A3ULP0F556',\n",
       "    'Name': 'ECULIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/aaf4ef4d-31e9-4bca-b21d-51cea21da46c/aaf4ef4d-31e9-4bca-b21d-51cea21da46c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Complement Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Complement Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S57Y5X1117',\n",
       "    'Name': 'TIOCONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ab0fa59f-108a-4686-8b65-b1015f56b024/ab0fa59f-108a-4686-8b65-b1015f56b024.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417361]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7D96IR0PPM',\n",
       "    'Name': 'PEGASPARGASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ab432071-73b3-437a-b334-0e9201141b8e/ab432071-73b3-437a-b334-0e9201141b8e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Asparaginase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Asparagine-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3M7OB98Y7H',\n",
       "    'Name': 'SILDENAFIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ab47f388-c76f-445f-8c80-99696f665a29/ab47f388-c76f-445f-8c80-99696f665a29.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135398744]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 5 Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Phosphodiesterase 5 Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'CIF6334OLY',\n",
       "    'Name': 'TOLCAPONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ab601d44-1bbb-4e08-b2a7-3ebd2f06363f/ab601d44-1bbb-4e08-b2a7-3ebd2f06363f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4659569]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catechol O-Methyltransferase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Catechol',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-289'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Catechol-O-Methyltransferase Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 8,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Catechol',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-289'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7194H8W3KT',\n",
       "    'Name': 'SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ab871ffd-ad4a-4295-ab5f-b6a94e3c2857/ab871ffd-ad4a-4295-ab5f-b6a94e3c2857.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Salmonella Typhi Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Typhoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'VI Polysaccharide Vaccine, Typhoid'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '57GNO57U7G',\n",
       "    'Name': 'FINASTERIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/abec7f57-731c-4ac7-a34d-c39f831946d7/abec7f57-731c-4ac7-a34d-c39f831946d7.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [57363]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': '5-alpha Reductase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': '5-alpha Reductase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IRH51QN26H',\n",
       "    'Name': 'CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ac1490a1-01e0-466e-99c8-2cf4246a0ccb/ac1490a1-01e0-466e-99c8-2cf4246a0ccb.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Corynebacterium Diphtheriae Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diphtheria Toxoid'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9VXA968E0C',\n",
       "    'Name': 'OXYMORPHONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ac504c29-aacf-457b-91b5-2a536b6ceae0/ac504c29-aacf-457b-91b5-2a536b6ceae0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284604]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GR88G0I6UL',\n",
       "    'Name': 'IPRATROPIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ac7b08f4-c121-44e4-974e-4f6f2759432d/ac7b08f4-c121-44e4-974e-4f6f2759432d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MI340WV90B',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ac7d5de6-b551-4e72-b880-48143fdff3e7/ac7d5de6-b551-4e72-b880-48143fdff3e7.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '59UA429E5G',\n",
       "    'Name': 'GALSULFASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ac83f888-4ec4-413f-8339-5063d4261e52/ac83f888-4ec4-413f-8339-5063d4261e52.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Glucosidases'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2OC4HKD3SF',\n",
       "    'Name': 'TELBIVUDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ac8fa004-8c8a-428d-a7b5-624dc9dd829b/ac8fa004-8c8a-428d-a7b5-624dc9dd829b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [159269]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '27T56C7KK0',\n",
       "    'Name': 'ALGLUCERASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ac9c21af-83ef-451a-bebd-36dbbab4fa5f/ac9c21af-83ef-451a-bebd-36dbbab4fa5f.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucosylceramidase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Glucocerebroside-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z3614QOX8W',\n",
       "    'Name': 'PYRIMETHAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/acb10ace-328c-4087-8e2e-ec0b16619f4d/acb10ace-328c-4087-8e2e-ec0b16619f4d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [4993]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydrofolate Reductase Inhibitor Antimalarial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dihydrofolate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-136400727'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dihydrofolate Reductase Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dihydrofolate',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-136400727'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5R5W9ICI6O',\n",
       "    'Name': 'DEMECLOCYCLINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ad144f71-16f3-47c8-9e69-3c305dcf89ce/ad144f71-16f3-47c8-9e69-3c305dcf89ce.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [54680690]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracycline-class Antimicrobial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 12,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tetracycline',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-54675776'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Tetracyclines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H50H3S3W74',\n",
       "    'Name': 'HISTRELIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ad1626dc-c06f-4936-a960-60d6f65e2019/ad1626dc-c06f-4936-a960-60d6f65e2019.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [25077993]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 30,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-36523'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'C6QE1Q1TKR',\n",
       "    'Name': 'PROCYCLIDINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ad1cd7ff-f2d0-4658-8ec6-65a73def01ed/ad1cd7ff-f2d0-4658-8ec6-65a73def01ed.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416814]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q461L7AK4R',\n",
       "    'Name': 'IOBENGUANE I-131',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ad2f65d1-d410-47c8-b39e-b9b90364975e/ad2f65d1-d410-47c8-b39e-b9b90364975e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71184]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '72G3UY6T4N',\n",
       "    'Name': 'PROTAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ad322834-5337-4f90-867b-81dc5148fdf1/ad322834-5337-4f90-867b-81dc5148fdf1.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Heparin Binding Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Heparin Reversal Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Reversed Anticoagulation Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G42ZU72N5G',\n",
       "    'Name': 'CARBENICILLIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ad900833-456a-4e78-9db9-9fd488f61c95/ad900833-456a-4e78-9db9-9fd488f61c95.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [20824]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'NY22HMQ4BX',\n",
       "    'Name': 'EXEMESTANE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ad9a12eb-98bc-44df-9f18-78b8ea6b3691/ad9a12eb-98bc-44df-9f18-78b8ea6b3691.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60198]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aromatase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'T18F433X4S',\n",
       "    'Name': 'NORETHINDRONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/adb5537a-3c3c-4fde-8012-0794e772ed61/adb5537a-3c3c-4fde-8012-0794e772ed61.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6230]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progesterone Congeners'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6995V82D0B',\n",
       "    'Name': 'EPLERENONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/add9d013-f0fe-4168-9a7e-96dcf8403e95/add9d013-f0fe-4168-9a7e-96dcf8403e95.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [443872]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aldosterone Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aldosterone Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'U188XYD42P',\n",
       "    'Name': 'MOXIFLOXACIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/adddc7a1-2bf2-4b30-9c80-a5aae647a9cc/adddc7a1-2bf2-4b30-9c80-a5aae647a9cc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [152946]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolone Antimicrobial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Quinolones'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0VUA21238F',\n",
       "    'Name': 'LAPATINIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ae21f8d7-2809-4508-97c7-5772e0a614a4/ae21f8d7-2809-4508-97c7-5772e0a614a4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [208908]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q812464R06',\n",
       "    'Name': 'HYDROMORPHONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ae459ce1-5f2d-465e-af16-b291565d53ee/ae459ce1-5f2d-465e-af16-b291565d53ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284570]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6X9OC3H4II',\n",
       "    'Name': 'LOPERAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ae8b5c4c-2e4e-4222-b6f5-bb27f891c015/ae8b5c4c-2e4e-4222-b6f5-bb27f891c015.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3955]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9EM05410Q9',\n",
       "    'Name': 'AMOXICILLIN ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ae9c98f1-deb9-4d84-990a-bfd055609ab6/ae9c98f1-deb9-4d84-990a-bfd055609ab6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [33613]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '98PI200987',\n",
       "    'Name': 'LIDOCAINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/af662d61-2575-4291-9673-562a3e46d8e6/af662d61-2575-4291-9673-562a3e46d8e6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3676]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amide Local Anesthetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Amides'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiarrhythmic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Local Anesthesia'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '64FS3BFH5W',\n",
       "    'Name': 'ERYTHROPOIETIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/af742102-3a46-4069-9864-2899fdec0041/af742102-3a46-4069-9864-2899fdec0041.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Erythropoiesis-stimulating Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Erythropoietin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Erythroid Cell Production'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9Y8NXQ24VQ',\n",
       "    'Name': 'PROPRANOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/af8b4408-d64e-41dd-a878-4be241a1bf71/af8b4408-d64e-41dd-a878-4be241a1bf71.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416802]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SX6K58TVWC',\n",
       "    'Name': 'GLYBURIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/afad7ba8-1e48-4630-8595-be02db0cc7b8/afad7ba8-1e48-4630-8595-be02db0cc7b8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3488]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea Compounds'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'PGV553HXTK',\n",
       "    'Name': 'EQUINE BOTULINUM NEUROTOXIN A/B IMMUNE GLOBULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b00bc83c-d004-4a65-9ccc-7a7099aac505/b00bc83c-d004-4a65-9ccc-7a7099aac505.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bacterial Neurotoxin Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antitoxins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6Q205EH1VU',\n",
       "    'Name': 'VANCOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b044f18c-4112-4afe-8bc1-8f8a4ac04fd5/b044f18c-4112-4afe-8bc1-8f8a4ac04fd5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [14969]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glycopeptide Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glycopeptides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '71M78END5S',\n",
       "    'Name': 'OMEGA-3 FATTY ACIDS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b06f6c81-ee45-4407-81d7-26028bdfd6ed/b06f6c81-ee45-4407-81d7-26028bdfd6ed.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [91618114]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fatty Acids, Omega-3'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Omega-3 Fatty Acid'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'TPY09G7XIR',\n",
       "    'Name': 'FLUORESCEIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b07c6651-466c-4be7-9515-07011bc8b476/b07c6651-466c-4be7-9515-07011bc8b476.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16850]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Diagnostic Dye'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Dyes'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2N4O9L084N',\n",
       "    'Name': 'NABILONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b0860832-3e9d-41a3-b49e-edbf21f6d0e9/b0860832-3e9d-41a3-b49e-edbf21f6d0e9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416882]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cannabinoid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cannabinoids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RE9A0H8OAB',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b088a616-94a9-4841-a30f-eedb9d96e3a9/b088a616-94a9-4841-a30f-eedb9d96e3a9.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'E5B8ND5IPE',\n",
       "    'Name': 'METHOHEXITAL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b158d41f-fafa-45fb-80ae-3601b6a96507/b158d41f-fafa-45fb-80ae-3601b6a96507.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76970591]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Barbiturate'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Barbiturates'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '232HYX66HC',\n",
       "    'Name': 'CAPREOMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b15ff1c3-2164-490c-830f-5234224c6303/b15ff1c3-2164-490c-830f-5234224c6303.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135565061]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimycobacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DL48G20X8X',\n",
       "    'Name': 'SCOPOLAMINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b195a360-f3d3-45e3-af96-b33c02056b80/b195a360-f3d3-45e3-af96-b33c02056b80.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3000322]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anticholinergic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3A189DH42V',\n",
       "    'Name': 'ALEMTUZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b1bcf5fd-0355-49a5-9bb2-23eb3d685f17/b1bcf5fd-0355-49a5-9bb2-23eb3d685f17.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD52-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD52-directed Cytolytic Antibody'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D83282DT06',\n",
       "    'Name': 'FLUCYTOSINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b1bf3b2b-5dff-4134-b87b-2174134f381d/b1bf3b2b-5dff-4134-b87b-2174134f381d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3366]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Analog Antifungal'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '129L90A25N',\n",
       "    'Name': 'HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b1d5950f-0814-413f-a5af-9aed051350c8/b1d5950f-0814-413f-a5af-9aed051350c8.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunoglobulin G'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Passively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Virus Neutralization'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Virus-specific Hyperimmune Globulins'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Immunoglobulins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8NF31401XG',\n",
       "    'Name': 'CARTEOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b24286e9-e36c-4ce9-9863-a4f359134ca9/b24286e9-e36c-4ce9-9863-a4f359134ca9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416824]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4FT78T86XV',\n",
       "    'Name': 'INSULIN DETEMIR',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b2aad6d6-5f17-4ccf-adf3-6ebe2df5e377/b2aad6d6-5f17-4ccf-adf3-6ebe2df5e377.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16137271]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P6YC3EG204',\n",
       "    'Name': 'CYANOCOBALAMIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b2ace55b-3278-4170-98b4-5c250b33bc72/b2ace55b-3278-4170-98b4-5c250b33bc72.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [118701720]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin B 12'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin B12'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '839MOZ74GK',\n",
       "    'Name': 'ANTIHEMOPHILIC FACTOR HUMAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b2b136a0-0d83-4aff-90f5-c95fb4d7acbd/b2b136a0-0d83-4aff-90f5-c95fb4d7acbd.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Antihemophilic Factor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Coagulation Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Blood Coagulation Factors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Factor VIII'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0I55128JYK',\n",
       "    'Name': 'THEOPHYLLINE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b2c91b37-dd51-4998-b779-8e2c92a75b19/b2c91b37-dd51-4998-b779-8e2c92a75b19.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2153]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Methylxanthine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Xanthines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JX8G4WPC8D',\n",
       "    'Name': 'GLUCOSULFONE FREE ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b30bc509-750c-451f-b601-6812a1815641/b30bc509-750c-451f-b601-6812a1815641.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [487090]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimycobacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '724L30Y2QR',\n",
       "    'Name': 'URSODIOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b3ac1093-a390-493a-8a60-032a0566647d/b3ac1093-a390-493a-8a60-032a0566647d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [31401]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bile Acid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Bile Acids and Salts'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'J2D279PEM5',\n",
       "    'Name': 'HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b3bda242-ab47-4ade-a3cb-fb7ea7f250e8/b3bda242-ab47-4ade-a3cb-fb7ea7f250e8.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Human Papillomavirus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Papillomavirus Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GR120KRT6K',\n",
       "    'Name': 'VIGABATRIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b3f1b8d7-aebf-48f0-bd4d-bbae08027582/b3f1b8d7-aebf-48f0-bd4d-bbae08027582.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417154]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D0GX863OA5',\n",
       "    'Name': 'MUPIROCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b3f5d4d1-a4bf-4909-b75e-9075beb5c4b3/b3f5d4d1-a4bf-4909-b75e-9075beb5c4b3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [446596]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'RNA Synthetase Inhibitor Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'RNA Synthetase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '5J49Q6B70F',\n",
       "    'Name': 'VINCRISTINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b42356ba-af1e-49ab-9173-7912aacbc4a2/b42356ba-af1e-49ab-9173-7912aacbc4a2.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5388993]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vinca Alkaloid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vinca Alkaloids'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4MG6O8991R',\n",
       "    'Name': 'RETAPAMULIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b44d58d2-21ae-40d0-ae5c-772b4676f7e8/b44d58d2-21ae-40d0-ae5c-772b4676f7e8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6918462]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'pleuromutilin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pleuromutilin Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Pleuromutilin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-31326'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '022461SR75',\n",
       "    'Name': 'AZFICEL-T',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b44f8506-5dc0-4bbf-a209-993d00e1b50b/b44f8506-5dc0-4bbf-a209-993d00e1b50b.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Autologous Cultured Cell'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cells, Cultured, Autologous'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fibroblasts'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0B535E0BN0',\n",
       "    'Name': 'NEDOCROMIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b45a495f-1575-4a65-96a0-6e7e876c8b0a/b45a495f-1575-4a65-96a0-6e7e876c8b0a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [50294]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Histamine Release',\n",
       "         'Markup': [{'Start': 10,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Histamine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-774'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Mast Cell Stabilizer'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8KOG53Z5EM',\n",
       "    'Name': 'HYALURONIDASE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b4d4972a-21d0-4add-98cd-a08114e9adc2/b4d4972a-21d0-4add-98cd-a08114e9adc2.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Endoglycosidase'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glycoside Hydrolases'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'QUC7NX6WMB',\n",
       "    'Name': 'SERTRALINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b5918e32-030b-41a7-ba15-396822984a3b/b5918e32-030b-41a7-ba15-396822984a3b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [68617]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7C782967RD',\n",
       "    'Name': 'AMPICILLIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b5a379e1-8eb8-4882-9043-b90b2f7449dd/b5a379e1-8eb8-4882-9043-b90b2f7449dd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6249]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillin-class Antibacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 10,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-2349'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penicillins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8C367IY4EY',\n",
       "    'Name': 'BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b60545f5-8a73-4939-b9bd-5dac379b9e67/b60545f5-8a73-4939-b9bd-5dac379b9e67.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Bordetella Pertussis Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pertussis Vaccine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Y41JS2NL6U',\n",
       "    'Name': 'BISOPROLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b61a7cd9-6b2b-4325-a6ea-f51a06d13f53/b61a7cd9-6b2b-4325-a6ea-f51a06d13f53.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416903]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q2OS4303HZ',\n",
       "    'Name': 'HALOFANTRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b61ca544-8135-4e9a-bf83-523675834a60/b61ca544-8135-4e9a-bf83-523675834a60.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416744]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimalarial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VHD28S0H7F',\n",
       "    'Name': '2-MERCAPTOETHANESULFONIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b66aa6f1-8bd7-459a-b2de-661e18b92a50/b66aa6f1-8bd7-459a-b2de-661e18b92a50.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [598]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cytoprotective Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H6EP7W5457',\n",
       "    'Name': 'MANGANESE CATION (2+)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b69ce1c1-69e6-44da-97b4-447c198ae9bc/b69ce1c1-69e6-44da-97b4-447c198ae9bc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [27854]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Magnetic Resonance Contrast Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Paramagnetic Contrast Agent'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z9HK08690W',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b6f200e6-4379-4869-822c-7a90d4eb651c/b6f200e6-4379-4869-822c-7a90d4eb651c.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'JMS50MPO89',\n",
       "    'Name': 'LOSARTAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b70ea939-a14b-45f6-b2e3-fa55c126f1a6/b70ea939-a14b-45f6-b2e3-fa55c126f1a6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3961]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Angiotensin 2 Receptor Blocker',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 13,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Angiotensin%202',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-172198'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '06LU7C9H1V',\n",
       "    'Name': 'LIOTHYRONINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b77bf72c-d6c7-4cce-8887-cea7b03819b3/b77bf72c-d6c7-4cce-8887-cea7b03819b3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5920]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'l-Triiodothyronine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Triiodothyronine'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '320T6RNW1F',\n",
       "    'Name': 'MIFEPRISTONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b7cf15eb-8acc-4833-9d15-50ec7aa0f916/b7cf15eb-8acc-4833-9d15-50ec7aa0f916.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [55245]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestational Hormone Receptor Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Progestin Antagonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'T4Y8ORK057',\n",
       "    'Name': 'TROSPIUM',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b7eefe61-2b26-4c3d-b86f-100522580901/b7eefe61-2b26-4c3d-b86f-100522580901.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284632]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4Q52C550XK',\n",
       "    'Name': 'IBRITUMOMAB TIUXETAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b890741c-eb22-4d88-8c60-135d1ed78d9a/b890741c-eb22-4d88-8c60-135d1ed78d9a.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD20-directed Antibody Interactions'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CD20-directed Radiotherapeutic Antibody'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7I6K9687W5',\n",
       "    'Name': 'INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b9092498-0787-4cb1-a8ac-f6186005ffe6/b9092498-0787-4cb1-a8ac-f6186005ffe6.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Influenza A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '73K4184T59',\n",
       "    'Name': 'DIGOXIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b9360830-91fa-42da-b054-11b49ae700aa/b9360830-91fa-42da-b054-11b49ae700aa.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2724385]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cardiac Glycoside'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cardiac Glycosides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6T84R30KC1',\n",
       "    'Name': 'TRANEXAMIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b9e73b1a-4142-4d37-8b14-cb1ed59608c0/b9e73b1a-4142-4d37-8b14-cb1ed59608c0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5526]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antifibrinolytic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Fibrinolysis'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '1W306TDA6S',\n",
       "    'Name': 'RIFABUTIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/b9f0e144-e0d3-435f-813e-bacfb6cb7043/b9f0e144-e0d3-435f-813e-bacfb6cb7043.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [135415564]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rifamycin Antimycobacterial',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Rifamycin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-6324616'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Rifamycins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7NLV25LOSI',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ba11a085-13bc-4bc3-9ebf-4825322e2b14/ba11a085-13bc-4bc3-9ebf-4825322e2b14.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '50VV3VW0TI',\n",
       "    'Name': 'ATENOLOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/ba2d8f4b-c396-4941-a2e9-e148caa553b1/ba2d8f4b-c396-4941-a2e9-e148caa553b1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416918]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'NQO8R319LY',\n",
       "    'Name': 'DIPHENIDOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bacf6029-8f2e-4f53-a7e3-8ad79f55731e/bacf6029-8f2e-4f53-a7e3-8ad79f55731e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3055]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antiemetic'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Emesis Suppression'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0V5436JAQW',\n",
       "    'Name': 'MIGLITOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bb089c85-9116-46e9-8e17-63f178e882dc/bb089c85-9116-46e9-8e17-63f178e882dc.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [441314]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha Glucosidase Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Glucosidase Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RZD65TSM9U',\n",
       "    'Name': 'AGALSIDASE BETA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bc2d2010-a2f2-4609-8c96-f074c8ec8866/bc2d2010-a2f2-4609-8c96-f074c8ec8866.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'alpha-Glucosidases'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '27618J1N2X',\n",
       "    'Name': 'LEVORPHANOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bc594112-ccbc-41ed-a899-0a8324e2366c/bc594112-ccbc-41ed-a899-0a8324e2366c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5359272]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0G76K8X6C0',\n",
       "    'Name': 'METHSUXIMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bc6fac59-9ae4-48fc-9bdb-7cdf6e4d046b/bc6fac59-9ae4-48fc-9bdb-7cdf6e4d046b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417335]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '82WI2L7Q6E',\n",
       "    'Name': 'DOLASETRON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bcc3f038-edae-4a9f-8f4c-e214a0d7c592/bcc3f038-edae-4a9f-8f4c-e214a0d7c592.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3148]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin 3 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin-3 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '395575MZO7',\n",
       "    'Name': 'PENTOSTATIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bcec4e14-6270-4b95-96dc-95e16a0f7c83/bcec4e14-6270-4b95-96dc-95e16a0f7c83.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [439693]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleic Acid Synthesis Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Nucleoside Metabolic Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'AWV6I5L6H2',\n",
       "    'Name': 'ANTITHROMBIN ALFA',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bcf4745e-dfb8-4d3a-a22d-b98b82b0e843/bcf4745e-dfb8-4d3a-a22d-b98b82b0e843.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Recombinant Antithrombin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Coagulation Factor Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Thrombin Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Factor Xa Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '82VFR53I78',\n",
       "    'Name': 'ARIPIPRAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bd0689ad-9e19-49da-9586-ff07315c0026/bd0689ad-9e19-49da-9586-ff07315c0026.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60795]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Atypical Antipsychotic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'SV0CSG527L',\n",
       "    'Name': 'FLUOROMETHOLONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bdc8f78d-e7de-4669-b03c-892896804d16/bdc8f78d-e7de-4669-b03c-892896804d16.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [9878]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '36B82AMQ7N',\n",
       "    'Name': 'NALOXONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bdd3a73b-4965-465e-b979-eb16b6b4b541/bdd3a73b-4965-465e-b979-eb16b6b4b541.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284596]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9M48M2SF02',\n",
       "    'Name': 'TECHNETIUM TC-99M DEPREOTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/be2168d1-51be-4bd3-94b8-1e651a8cc22b/be2168d1-51be-4bd3-94b8-1e651a8cc22b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [72941733]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '669818346F',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bec8f71f-54f1-4818-9d53-f258262cf18d/bec8f71f-54f1-4818-9d53-f258262cf18d.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R9M4FJE48E',\n",
       "    'Name': 'DALFOPRISTIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bf49de31-72c2-4e7b-8a96-6b0e8ce74729/bf49de31-72c2-4e7b-8a96-6b0e8ce74729.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [6323289]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Streptogramin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Streptogramins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'D8TST4O562',\n",
       "    'Name': 'PANTOPRAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bf5a0695-1c41-411a-94ee-b5944bea521b/bf5a0695-1c41-411a-94ee-b5944bea521b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76958253]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Proton Pump Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Proton Pump Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '58447S8P4L',\n",
       "    'Name': 'MAFENIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bf9f8988-5ae7-4493-99ee-43c3850caea1/bf9f8988-5ae7-4493-99ee-43c3850caea1.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3998]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Methylated Sulfonamide Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Methylated Sulfonamides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '18D0SL7309',\n",
       "    'Name': 'CHLORAMBUCIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bfccb103-93fb-4ecd-979b-abe5978e9bcb/bfccb103-93fb-4ecd-979b-abe5978e9bcb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2708]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WZG3J2MCOL',\n",
       "    'Name': 'GRANISETRON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/bfeeb800-0c36-48ca-b71a-21f6121634a5/bfeeb800-0c36-48ca-b71a-21f6121634a5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284566]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin 3 Receptor Antagonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin-3 Receptor Antagonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '143NQ3779B',\n",
       "    'Name': 'CALCIPOTRIENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c097e4e3-8665-4c9e-ba88-79e44d09d7e0/c097e4e3-8665-4c9e-ba88-79e44d09d7e0.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5288783]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin D'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vitamin D Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9L2KA76MG5',\n",
       "    'Name': 'MONOBENZONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c09eb527-f684-4122-a199-e24591ecb044/c09eb527-f684-4122-a199-e24591ecb044.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [7638]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Depigmenting Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Depigmenting Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Melanin Synthesis Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 7,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Melanin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-6325610'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '58IFB293JI',\n",
       "    'Name': 'VORINOSTAT',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c0d0c03b-e4f3-43b2-8ae8-a9c0f47093f5/c0d0c03b-e4f3-43b2-8ae8-a9c0f47093f5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5311]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histone Deacetylase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Histone Deacetylase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '22Q2CO717B',\n",
       "    'Name': 'INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) LIVE(ATTENUATED) ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c0e0bbc1-b01e-4b18-a645-dace033f28bf/c0e0bbc1-b01e-4b18-a645-dace033f28bf.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Attenuated Influenza A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Attenuated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '901AS54I69',\n",
       "    'Name': 'RAMELTEON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c10b4429-9dd2-4744-a61b-a312d541adb8/c10b4429-9dd2-4744-a61b-a312d541adb8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [208902]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Melatonin Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Melatonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-896'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Melatonin Receptor Agonists',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Melatonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-896'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Z22628B598',\n",
       "    'Name': 'ETOMIDATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c13b9b05-2d5c-4077-ba43-1f2c1f40599b/c13b9b05-2d5c-4077-ba43-1f2c1f40599b.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [667484]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthesia'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'General Anesthetic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IHS69L0Y4T',\n",
       "    'Name': 'CEFAZOLIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c140b71c-1123-4ee2-a7c4-06d6155a773d/c140b71c-1123-4ee2-a7c4-06d6155a773d.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [33255]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporin Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cephalosporins'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '459384H98V',\n",
       "    'Name': 'ZONISAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c157c1c8-e2cc-43a1-aa20-1b4f5df5b7d9/c157c1c8-e2cc-43a1-aa20-1b4f5df5b7d9.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5734]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9L17Y0H71P',\n",
       "    'Name': 'DOTATATE GALLIUM GA-68',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c15a3ad9-9922-461d-b50f-a4bd6401b2e8/c15a3ad9-9922-461d-b50f-a4bd6401b2e8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [131634491]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Positron Emitting Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '26NAK24LS8',\n",
       "    'Name': 'HYDRALAZINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c1637f3b-ba11-4953-9b5d-60ece3eb34db/c1637f3b-ba11-4953-9b5d-60ece3eb34db.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3637]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Arteriolar Vasodilation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Arteriolar Vasodilator'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'P10582JYYK',\n",
       "    'Name': 'REMIFENTANIL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c19eef8c-b48f-440c-9b6f-74ec360de212/c19eef8c-b48f-440c-9b6f-74ec360de212.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [60815]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UX6OWY2V7J',\n",
       "    'Name': 'CODEINE ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c1d6ca29-00e2-4122-8dec-83262562364a/c1d6ca29-00e2-4122-8dec-83262562364a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5284371]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '72W71I16EG',\n",
       "    'Name': 'SERTACONAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c1e65980-8028-4c2d-8a91-2c2eec8763ee/c1e65980-8028-4c2d-8a91-2c2eec8763ee.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417068]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azole Antifungal'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Azoles'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'T2DHJ9645W',\n",
       "    'Name': 'DIFLORASONE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c21a48c4-ab44-42ba-b0ab-a4015ff734ed/c21a48c4-ab44-42ba-b0ab-a4015ff734ed.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [71415]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Corticosteroid Hormone Receptor Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'F38R0JR742',\n",
       "    'Name': 'LUMEFANTRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c261c160-8e57-438c-85a8-f268b8ae6a97/c261c160-8e57-438c-85a8-f268b8ae6a97.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417222]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Antimalarial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '7M19191IKG',\n",
       "    'Name': 'TEDUGLUTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c2716882-f095-43d0-a04a-c293c3ca16fe/c2716882-f095-43d0-a04a-c293c3ca16fe.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [134687068]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'GLP-2 Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucagon-like Peptide-2 (GLP-2) Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Glucagon-Like Peptide 2'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Analogs/Derivatives'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MD6P741W8A',\n",
       "    'Name': 'MARAVIROC',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c280e190-4c95-408c-9f30-30c46d288510/c280e190-4c95-408c-9f30-30c46d288510.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3002977]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'CCR5 Co-receptor Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Chemokine Co-receptor 5 Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'R5H8897N95',\n",
       "    'Name': 'LABETALOL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c286377b-4ff4-4044-aeba-b193f0b5118e/c286377b-4ff4-4044-aeba-b193f0b5118e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3869]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta-Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta-Adrenergic Blocker'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'DL82PE6ANE',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c28e4be0-17f1-4db4-b130-488d728cdab4/c28e4be0-17f1-4db4-b130-488d728cdab4.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'WTM2C3IL2X',\n",
       "    'Name': 'CHLORPROPAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c2af437c-0ecd-4964-afb3-7c84b71fe127/c2af437c-0ecd-4964-afb3-7c84b71fe127.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [2727]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea Compounds'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4LJK511Z86',\n",
       "    'Name': 'GALLIUM CITRATE GA-67',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c2c27fab-2582-46aa-8df8-4efce05f2025/c2c27fab-2582-46aa-8df8-4efce05f2025.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [65430]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '9LT1BRO48Q',\n",
       "    'Name': 'TOLAZAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c2dd2c5f-e051-44c3-b6c1-62b6ec083937/c2dd2c5f-e051-44c3-b6c1-62b6ec083937.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5503]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Sulfonylurea Compounds'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '8YWR746RPQ',\n",
       "    'Name': 'IODIDE ION I-123',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c329978d-e942-490f-bf6f-fb4b0af4734a/c329978d-e942-490f-bf6f-fb4b0af4734a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10220516]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radioactive Diagnostic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Radiopharmaceutical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3E74Y80MEY',\n",
       "    'Name': 'FLAVOXATE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c337157e-43f7-41e6-8624-463c6f8baa2f/c337157e-43f7-41e6-8624-463c6f8baa2f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3354]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Antagonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '6CW7F3G59X',\n",
       "    'Name': 'GABAPENTIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c3630367-1d10-4b28-a78f-1db79c2c99d5/c3630367-1d10-4b28-a78f-1db79c2c99d5.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3446]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Anti-epileptic Agent'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Decreased Central Nervous System Disorganized Electrical Activity'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S2F83W92TK',\n",
       "    'Name': 'PROPOXYPHENE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c37b9cbd-2034-4c2c-adf6-5b94710a1668/c37b9cbd-2034-4c2c-adf6-5b94710a1668.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [10100]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M89N0Q7EQR',\n",
       "    'Name': 'ALDESLEUKIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c3ecf059-d4da-4268-b172-9b0c28149da1/c3ecf059-d4da-4268-b172-9b0c28149da1.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Lymphocyte Activation'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Lymphocyte Cell Production'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Interleukin-2'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Lymphocyte Growth Factor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'EDN2NBH5SS',\n",
       "    'Name': 'LEVALBUTEROL',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c42a8576-8421-40b7-ac45-0fdec2935ca6/c42a8576-8421-40b7-ac45-0fdec2935ca6.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [123600]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Adrenergic beta2-Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'beta2-Adrenergic Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'S62U433RMH',\n",
       "    'Name': 'ZALEPLON',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c43c4afa-9491-45d3-8d0e-2ee194088235/c43c4afa-9491-45d3-8d0e-2ee194088235.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5719]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'gamma-Aminobutyric Acid A Receptor Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 23,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/gamma-Aminobutyric%20Acid',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-119'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'GABA A Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Central Nervous System Depression'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'UM20QQM95Y',\n",
       "    'Name': 'IFOSFAMIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c469fe36-9a27-4f05-8462-88b40f68be07/c469fe36-9a27-4f05-8462-88b40f68be07.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3690]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Activity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Alkylating Drug'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '10T9CSU89I',\n",
       "    'Name': 'TERIPARATIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c46c371f-0078-4531-ae44-655774b4330c/c46c371f-0078-4531-ae44-655774b4330c.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16133850]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Parathyroid Hormone'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Parathyroid Hormone Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '3O44U6XYQK',\n",
       "    'Name': 'NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c4cbf371-4dc0-4ea5-a09a-33904dbcfa8e/c4cbf371-4dc0-4ea5-a09a-33904dbcfa8e.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Meningococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Meningococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'Q20IM7HE75',\n",
       "    'Name': 'IMIPENEM ANHYDROUS',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c4e36959-65f2-47aa-a329-2c92672e22e8/c4e36959-65f2-47aa-a329-2c92672e22e8.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [104838]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Carbapenems'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Penem Antibacterial'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '207SMY3FQT',\n",
       "    'Name': 'VEMURAFENIB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c50f44a1-2678-4095-baa4-67aca5d766ae/c50f44a1-2678-4095-baa4-67aca5d766ae.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [42611257]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Kinase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Protein Kinase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'VZ8RRZ51VK',\n",
       "    'Name': 'TOBRAMYCIN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c5313546-f885-41cb-a29b-92177af4037f/c5313546-f885-41cb-a29b-92177af4037f.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [36294]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycoside Antibacterial'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Aminoglycosides'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '32828355LL',\n",
       "    'Name': 'RABEPRAZOLE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c543d096-c8fc-4302-8d33-938395bd53b3/c543d096-c8fc-4302-8d33-938395bd53b3.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76972072]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Proton Pump Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Proton Pump Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '0C50HW4FO1',\n",
       "    'Name': 'ETRAVIRINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c57015df-3006-4ad9-94d0-291c2fa1ae8e/c57015df-3006-4ad9-94d0-291c2fa1ae8e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [193962]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Nucleoside Analog'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Non-Nucleoside Reverse Transcriptase Inhibitors'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '4SV59689SK',\n",
       "    'Name': 'VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c57f3140-58d1-45f2-b491-d1c6bcab4679/c57f3140-58d1-45f2-b491-d1c6bcab4679.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Live Vaccinia Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Smallpox Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Live'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'GFX7QIS1II',\n",
       "    'Name': 'INSULIN LISPRO',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c580609d-ffad-4513-85f3-ab64aef4dde4/c580609d-ffad-4513-85f3-ab64aef4dde4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [118984450]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Insulin Analog'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'G56VK1HF36',\n",
       "    'Name': 'MILNACIPRAN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c59e5dbc-8831-47b2-a169-d2e73803244e/c59e5dbc-8831-47b2-a169-d2e73803244e.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417385]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Norepinephrine Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin and Norepinephrine Reuptake Inhibitor',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'},\n",
       "          {'Start': 14,\n",
       "           'Length': 14,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Norepinephrine',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-439260'}]}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Serotonin Uptake Inhibitors',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 9,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Serotonin',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-5202'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '2S9ZZM9Q9V',\n",
       "    'Name': 'BEVACIZUMAB',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c5cc3aaa-8ef8-4022-b2ed-8a0085d0d794/c5cc3aaa-8ef8-4022-b2ed-8a0085d0d794.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vascular Endothelial Growth Factor Receptor Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vascular Endothelial Growth Factor-directed Antibody'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vascular Endothelial Growth Factor-directed Antibody Interactions'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'M5DP350VZV',\n",
       "    'Name': 'ETHACRYNIC ACID',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c5fdea4f-06a1-4565-868f-c6869ba6350a/c5fdea4f-06a1-4565-868f-c6869ba6350a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [3278]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Increased Diuresis at Loop of Henle'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Loop Diuretic'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '76I7G6D29C',\n",
       "    'Name': 'MORPHINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c633da78-a69f-4562-8362-a85183d41243/c633da78-a69f-4562-8362-a85183d41243.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [5288826]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Full Opioid Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Opioid Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'K9V0CDQ56E',\n",
       "    'Name': 'CEVIMELINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c657ff6d-4674-4f18-8c7e-57748841a740/c657ff6d-4674-4f18-8c7e-57748841a740.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417326]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Muscarinic Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Cholinergic Receptor Agonist'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'RP4A60D26L',\n",
       "    'Name': 'PENTAZOCINE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c6dd217f-2b26-4828-9407-f3e2c7dff0f4/c6dd217f-2b26-4828-9407-f3e2c7dff0f4.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73416797]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Competitive Opioid Antagonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Partial Opioid Agonist/Antagonist'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Partial Opioid Agonists'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': '19OWO1T3ZE',\n",
       "    'Name': 'ENFUVIRTIDE',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c6df25fd-16d2-48d2-8e7b-dd6d28ff830a/c6df25fd-16d2-48d2-8e7b-dd6d28ff830a.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [16157631]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Fusion Protein Inhibitors'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Human Immunodeficiency Virus 1 Fusion Inhibitor'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'MHG4XW7BIG',\n",
       "    'Name': 'INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c6e5610e-b22a-445e-82bc-2a7dc7b0be96/c6e5610e-b22a-445e-82bc-2a7dc7b0be96.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Influenza A Virus Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Influenza Vaccines'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'IU5QR144QX',\n",
       "    'Name': 'ESTROGENS, CONJUGATED',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c72db578-2dc0-448f-9dff-4fffea18e3fd/c72db578-2dc0-448f-9dff-4fffea18e3fd.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [76965196]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogen Receptor Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Estrogens, Conjugated (USP)'}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'H789N3FKE8',\n",
       "    'Name': 'BACLOFEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c7608e4d-d39f-43a6-a4bd-29bd9bdc41fb/c7608e4d-d39f-43a6-a4bd-29bd9bdc41fb.xml',\n",
       "    'Link': {'ToCompound': {'ByCID': [73417119]}},\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'GABA A Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Mechanisms of Action [MoA]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'GABA B Agonists'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'gamma-Aminobutyric Acid-ergic Agonist',\n",
       "         'Markup': [{'Start': 0,\n",
       "           'Length': 23,\n",
       "           'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/gamma-Aminobutyric%20Acid',\n",
       "           'Type': 'PubChem Internal Link',\n",
       "           'Extra': 'CID-119'}]}]}}]},\n",
       "   {'SourceName': 'FDA Pharm Classes',\n",
       "    'SourceID': 'PYD255827T',\n",
       "    'Name': 'STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN',\n",
       "    'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/forindustry/datastandards/structuredproductlabeling/ucm162549.htm',\n",
       "    'URL': 'https://www.accessdata.fda.gov/spl/data/c7bcd194-55c2-4610-b157-da58c6b816ee/c7bcd194-55c2-4610-b157-da58c6b816ee.xml',\n",
       "    'Data': [{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Established Pharmacologic Class [EPC]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Inactivated Pneumococcal Vaccine'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Physiologic Effects [PE]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Actively Acquired Immunity'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Pneumococcal Vaccines'}]}},\n",
       "     {'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       "      'Name': 'Chemical/Ingredient structural concept [Chemical/Ingredient]',\n",
       "      'Value': {'StringWithMarkup': [{'String': 'Vaccines, Inactivated'}]}}]}],\n",
       "  'Page': 1,\n",
       "  'TotalPages': 2}}"
      ]
     },
     "execution_count": 110,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "moa_json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:15:26.097256Z",
     "start_time": "2019-05-16T23:15:26.016413Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Data</th>\n",
       "      <th>Description</th>\n",
       "      <th>Link</th>\n",
       "      <th>Name</th>\n",
       "      <th>SourceID</th>\n",
       "      <th>SourceName</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [25077405]}}</td>\n",
       "      <td>NAFARELIN</td>\n",
       "      <td>1X0094V6JV</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/000a5c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6049]}}</td>\n",
       "      <td>EDETIC ACID</td>\n",
       "      <td>9G34HU7RV0</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/001902...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [4114]}}</td>\n",
       "      <td>METHOXSALEN</td>\n",
       "      <td>U4VJ29L7BQ</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/002310...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3121]}}</td>\n",
       "      <td>VALPROIC ACID</td>\n",
       "      <td>614OI1Z5WI</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/00abde...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEXOFENADINE</td>\n",
       "      <td>E6582LOH6V</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/012eec...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Data  \\\n",
       "0  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "1  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "2  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "3  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "4  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "\n",
       "                                         Description  \\\n",
       "0  FDA Pharmacologic class is a group of active m...   \n",
       "1  FDA Pharmacologic class is a group of active m...   \n",
       "2  FDA Pharmacologic class is a group of active m...   \n",
       "3  FDA Pharmacologic class is a group of active m...   \n",
       "4  FDA Pharmacologic class is a group of active m...   \n",
       "\n",
       "                                    Link           Name    SourceID  \\\n",
       "0  {'ToCompound': {'ByCID': [25077405]}}      NAFARELIN  1X0094V6JV   \n",
       "1      {'ToCompound': {'ByCID': [6049]}}    EDETIC ACID  9G34HU7RV0   \n",
       "2      {'ToCompound': {'ByCID': [4114]}}    METHOXSALEN  U4VJ29L7BQ   \n",
       "3      {'ToCompound': {'ByCID': [3121]}}  VALPROIC ACID  614OI1Z5WI   \n",
       "4                                    NaN   FEXOFENADINE  E6582LOH6V   \n",
       "\n",
       "          SourceName                                                URL  \n",
       "0  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/000a5c...  \n",
       "1  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/001902...  \n",
       "2  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/002310...  \n",
       "3  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/00abde...  \n",
       "4  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/012eec...  "
      ]
     },
     "execution_count": 123,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "moa_df = pd.DataFrame(moa_json['Annotations']['Annotation'])\n",
    "moa_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 175,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:33:55.555521Z",
     "start_time": "2019-05-16T23:33:55.474601Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Data</th>\n",
       "      <th>Description</th>\n",
       "      <th>Link</th>\n",
       "      <th>Name</th>\n",
       "      <th>SourceID</th>\n",
       "      <th>SourceName</th>\n",
       "      <th>URL</th>\n",
       "      <th>drug_class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [25077405]}}</td>\n",
       "      <td>NAFARELIN</td>\n",
       "      <td>1X0094V6JV</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/000a5c...</td>\n",
       "      <td>Gonadotropin Releasing Hormone Receptor Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6049]}}</td>\n",
       "      <td>EDETIC ACID</td>\n",
       "      <td>9G34HU7RV0</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/001902...</td>\n",
       "      <td>Lead Chelating Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [4114]}}</td>\n",
       "      <td>METHOXSALEN</td>\n",
       "      <td>U4VJ29L7BQ</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/002310...</td>\n",
       "      <td>Photoabsorption</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3121]}}</td>\n",
       "      <td>VALPROIC ACID</td>\n",
       "      <td>614OI1Z5WI</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/00abde...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEXOFENADINE</td>\n",
       "      <td>E6582LOH6V</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/012eec...</td>\n",
       "      <td>Histamine H1 Receptor Antagonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2170]}}</td>\n",
       "      <td>AMOXAPINE</td>\n",
       "      <td>R63VQ857OT</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/014130...</td>\n",
       "      <td>Tricyclic Antidepressant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416907]}}</td>\n",
       "      <td>ETHOSUXIMIDE</td>\n",
       "      <td>5SEH9X1D1D</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/016cd8...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6915944]}}</td>\n",
       "      <td>CEFDINIR</td>\n",
       "      <td>CI0FAO63WC</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/01a1f6...</td>\n",
       "      <td>Cephalosporin Antibacterial</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10096344]}}</td>\n",
       "      <td>LINAGLIPTIN</td>\n",
       "      <td>3X29ZEJ4R2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/023090...</td>\n",
       "      <td>Dipeptidyl Peptidase 4 Inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416741]}}</td>\n",
       "      <td>PIOGLITAZONE</td>\n",
       "      <td>X4OV71U42S</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0267d2...</td>\n",
       "      <td>Peroxisome Proliferator Receptor alpha Agonist</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Data  \\\n",
       "0  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "1  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "2  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "3  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "4  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "5  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "6  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "7  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "8  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "9  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "\n",
       "                                         Description  \\\n",
       "0  FDA Pharmacologic class is a group of active m...   \n",
       "1  FDA Pharmacologic class is a group of active m...   \n",
       "2  FDA Pharmacologic class is a group of active m...   \n",
       "3  FDA Pharmacologic class is a group of active m...   \n",
       "4  FDA Pharmacologic class is a group of active m...   \n",
       "5  FDA Pharmacologic class is a group of active m...   \n",
       "6  FDA Pharmacologic class is a group of active m...   \n",
       "7  FDA Pharmacologic class is a group of active m...   \n",
       "8  FDA Pharmacologic class is a group of active m...   \n",
       "9  FDA Pharmacologic class is a group of active m...   \n",
       "\n",
       "                                    Link           Name    SourceID  \\\n",
       "0  {'ToCompound': {'ByCID': [25077405]}}      NAFARELIN  1X0094V6JV   \n",
       "1      {'ToCompound': {'ByCID': [6049]}}    EDETIC ACID  9G34HU7RV0   \n",
       "2      {'ToCompound': {'ByCID': [4114]}}    METHOXSALEN  U4VJ29L7BQ   \n",
       "3      {'ToCompound': {'ByCID': [3121]}}  VALPROIC ACID  614OI1Z5WI   \n",
       "4                                    NaN   FEXOFENADINE  E6582LOH6V   \n",
       "5      {'ToCompound': {'ByCID': [2170]}}      AMOXAPINE  R63VQ857OT   \n",
       "6  {'ToCompound': {'ByCID': [73416907]}}   ETHOSUXIMIDE  5SEH9X1D1D   \n",
       "7   {'ToCompound': {'ByCID': [6915944]}}       CEFDINIR  CI0FAO63WC   \n",
       "8  {'ToCompound': {'ByCID': [10096344]}}    LINAGLIPTIN  3X29ZEJ4R2   \n",
       "9  {'ToCompound': {'ByCID': [73416741]}}   PIOGLITAZONE  X4OV71U42S   \n",
       "\n",
       "          SourceName                                                URL  \\\n",
       "0  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/000a5c...   \n",
       "1  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/001902...   \n",
       "2  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/002310...   \n",
       "3  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/00abde...   \n",
       "4  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/012eec...   \n",
       "5  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/014130...   \n",
       "6  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/016cd8...   \n",
       "7  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/01a1f6...   \n",
       "8  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/023090...   \n",
       "9  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0267d2...   \n",
       "\n",
       "                                        drug_class  \n",
       "0  Gonadotropin Releasing Hormone Receptor Agonist  \n",
       "1                          Lead Chelating Activity  \n",
       "2                                  Photoabsorption  \n",
       "3                             Anti-epileptic Agent  \n",
       "4                Histamine H1 Receptor Antagonists  \n",
       "5                         Tricyclic Antidepressant  \n",
       "6                             Anti-epileptic Agent  \n",
       "7                      Cephalosporin Antibacterial  \n",
       "8                Dipeptidyl Peptidase 4 Inhibitors  \n",
       "9   Peroxisome Proliferator Receptor alpha Agonist  "
      ]
     },
     "execution_count": 175,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "temp = moa_df.head(10)\n",
    "temp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:18:53.556439Z",
     "start_time": "2019-05-16T23:18:53.551366Z"
    },
    "hidden": true
   },
   "outputs": [],
   "source": [
    "row1 = temp['Data'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:19:05.000179Z",
     "start_time": "2019-05-16T23:19:04.991588Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       " 'Name': 'Established Pharmacologic Class [EPC]',\n",
       " 'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonist',\n",
       "    'Markup': [{'Start': 0,\n",
       "      'Length': 30,\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "      'Type': 'PubChem Internal Link',\n",
       "      'Extra': 'CID-36523'}]}]}}"
      ]
     },
     "execution_count": 142,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "row1[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:18:55.847662Z",
     "start_time": "2019-05-16T23:18:55.834514Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
       " 'Name': 'Mechanisms of Action [MoA]',\n",
       " 'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonists',\n",
       "    'Markup': [{'Start': 0,\n",
       "      'Length': 30,\n",
       "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
       "      'Type': 'PubChem Internal Link',\n",
       "      'Extra': 'CID-36523'}]}]}}"
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "row1[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:21:02.436543Z",
     "start_time": "2019-05-16T23:21:02.428734Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Gonadotropin Releasing Hormone Receptor Agonists'"
      ]
     },
     "execution_count": 145,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "row1[1]['Value']['StringWithMarkup'][0]['String']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:34:48.051970Z",
     "start_time": "2019-05-16T23:34:48.047626Z"
    },
    "hidden": true
   },
   "outputs": [],
   "source": [
    "row1 = temp['Data'][5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 182,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:36:02.844366Z",
     "start_time": "2019-05-16T23:36:02.836909Z"
    },
    "hidden": true
   },
   "outputs": [],
   "source": [
    "def get_moa_class(x):\n",
    "    \"\"\"{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
    " 'Name': 'Established Pharmacologic Class [EPC]',\n",
    " 'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonist',\n",
    "    'Markup': [{'Start': 0,\n",
    "      'Length': 30,\n",
    "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
    "      'Type': 'PubChem Internal Link',\n",
    "      'Extra': 'CID-36523'}]}]}}\n",
    "      \"\"\"\n",
    "    return x['Data'][0]['Value']['StringWithMarkup'][0]['String']\n",
    "def get_moa(x):\n",
    "    \"\"\"{'TOCHeading': {'#TOCHeading': 'Pharmacological Classes'},\n",
    " 'Name': 'Mechanisms of Action [MoA]',\n",
    " 'Value': {'StringWithMarkup': [{'String': 'Gonadotropin Releasing Hormone Receptor Agonists',\n",
    "    'Markup': [{'Start': 0,\n",
    "      'Length': 30,\n",
    "      'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Gonadotropin-Releasing%20Hormone',\n",
    "      'Type': 'PubChem Internal Link',\n",
    "      'Extra': 'CID-36523'}]}]}}\n",
    "      \"\"\"\n",
    "    try:\n",
    "        return x['Data'][1]['Value']['StringWithMarkup'][0]['String']\n",
    "    except IndexError:\n",
    "        return 'MoA not found, try Class'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 183,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:36:11.054010Z",
     "start_time": "2019-05-16T23:36:10.987879Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/opt/conda/lib/python3.6/site-packages/ipykernel_launcher.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/indexing.html#indexing-view-versus-copy\n",
      "  \"\"\"Entry point for launching an IPython kernel.\n"
     ]
    }
   ],
   "source": [
    "temp['moa'] = temp.apply(lambda x : get_moa(x),axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:31:28.444799Z",
     "start_time": "2019-05-16T23:31:28.373939Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/opt/conda/lib/python3.6/site-packages/ipykernel_launcher.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/indexing.html#indexing-view-versus-copy\n",
      "  \"\"\"Entry point for launching an IPython kernel.\n"
     ]
    }
   ],
   "source": [
    "temp['drug_class'] = temp.apply(lambda x : get_moa_class(x),axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 184,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:36:14.497315Z",
     "start_time": "2019-05-16T23:36:14.364757Z"
    },
    "hidden": true,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Data</th>\n",
       "      <th>Description</th>\n",
       "      <th>Link</th>\n",
       "      <th>Name</th>\n",
       "      <th>SourceID</th>\n",
       "      <th>SourceName</th>\n",
       "      <th>URL</th>\n",
       "      <th>drug_class</th>\n",
       "      <th>moa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [25077405]}}</td>\n",
       "      <td>NAFARELIN</td>\n",
       "      <td>1X0094V6JV</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/000a5c...</td>\n",
       "      <td>Gonadotropin Releasing Hormone Receptor Agonist</td>\n",
       "      <td>Gonadotropin Releasing Hormone Receptor Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6049]}}</td>\n",
       "      <td>EDETIC ACID</td>\n",
       "      <td>9G34HU7RV0</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/001902...</td>\n",
       "      <td>Lead Chelating Activity</td>\n",
       "      <td>Lead Chelator</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [4114]}}</td>\n",
       "      <td>METHOXSALEN</td>\n",
       "      <td>U4VJ29L7BQ</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/002310...</td>\n",
       "      <td>Photoabsorption</td>\n",
       "      <td>Photoactivated Radical Generator</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3121]}}</td>\n",
       "      <td>VALPROIC ACID</td>\n",
       "      <td>614OI1Z5WI</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/00abde...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "      <td>Decreased Central Nervous System Disorganized ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEXOFENADINE</td>\n",
       "      <td>E6582LOH6V</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/012eec...</td>\n",
       "      <td>Histamine H1 Receptor Antagonists</td>\n",
       "      <td>Histamine-1 Receptor Antagonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2170]}}</td>\n",
       "      <td>AMOXAPINE</td>\n",
       "      <td>R63VQ857OT</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/014130...</td>\n",
       "      <td>Tricyclic Antidepressant</td>\n",
       "      <td>MoA not found, try Class</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416907]}}</td>\n",
       "      <td>ETHOSUXIMIDE</td>\n",
       "      <td>5SEH9X1D1D</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/016cd8...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "      <td>Decreased Central Nervous System Disorganized ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6915944]}}</td>\n",
       "      <td>CEFDINIR</td>\n",
       "      <td>CI0FAO63WC</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/01a1f6...</td>\n",
       "      <td>Cephalosporin Antibacterial</td>\n",
       "      <td>Cephalosporins</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10096344]}}</td>\n",
       "      <td>LINAGLIPTIN</td>\n",
       "      <td>3X29ZEJ4R2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/023090...</td>\n",
       "      <td>Dipeptidyl Peptidase 4 Inhibitors</td>\n",
       "      <td>Dipeptidyl Peptidase 4 Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416741]}}</td>\n",
       "      <td>PIOGLITAZONE</td>\n",
       "      <td>X4OV71U42S</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0267d2...</td>\n",
       "      <td>Peroxisome Proliferator Receptor alpha Agonist</td>\n",
       "      <td>Peroxisome Proliferator Receptor gamma Agonist</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Data  \\\n",
       "0  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "1  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "2  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "3  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "4  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "5  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "6  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "7  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "8  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "9  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "\n",
       "                                         Description  \\\n",
       "0  FDA Pharmacologic class is a group of active m...   \n",
       "1  FDA Pharmacologic class is a group of active m...   \n",
       "2  FDA Pharmacologic class is a group of active m...   \n",
       "3  FDA Pharmacologic class is a group of active m...   \n",
       "4  FDA Pharmacologic class is a group of active m...   \n",
       "5  FDA Pharmacologic class is a group of active m...   \n",
       "6  FDA Pharmacologic class is a group of active m...   \n",
       "7  FDA Pharmacologic class is a group of active m...   \n",
       "8  FDA Pharmacologic class is a group of active m...   \n",
       "9  FDA Pharmacologic class is a group of active m...   \n",
       "\n",
       "                                    Link           Name    SourceID  \\\n",
       "0  {'ToCompound': {'ByCID': [25077405]}}      NAFARELIN  1X0094V6JV   \n",
       "1      {'ToCompound': {'ByCID': [6049]}}    EDETIC ACID  9G34HU7RV0   \n",
       "2      {'ToCompound': {'ByCID': [4114]}}    METHOXSALEN  U4VJ29L7BQ   \n",
       "3      {'ToCompound': {'ByCID': [3121]}}  VALPROIC ACID  614OI1Z5WI   \n",
       "4                                    NaN   FEXOFENADINE  E6582LOH6V   \n",
       "5      {'ToCompound': {'ByCID': [2170]}}      AMOXAPINE  R63VQ857OT   \n",
       "6  {'ToCompound': {'ByCID': [73416907]}}   ETHOSUXIMIDE  5SEH9X1D1D   \n",
       "7   {'ToCompound': {'ByCID': [6915944]}}       CEFDINIR  CI0FAO63WC   \n",
       "8  {'ToCompound': {'ByCID': [10096344]}}    LINAGLIPTIN  3X29ZEJ4R2   \n",
       "9  {'ToCompound': {'ByCID': [73416741]}}   PIOGLITAZONE  X4OV71U42S   \n",
       "\n",
       "          SourceName                                                URL  \\\n",
       "0  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/000a5c...   \n",
       "1  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/001902...   \n",
       "2  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/002310...   \n",
       "3  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/00abde...   \n",
       "4  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/012eec...   \n",
       "5  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/014130...   \n",
       "6  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/016cd8...   \n",
       "7  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/01a1f6...   \n",
       "8  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/023090...   \n",
       "9  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0267d2...   \n",
       "\n",
       "                                        drug_class  \\\n",
       "0  Gonadotropin Releasing Hormone Receptor Agonist   \n",
       "1                          Lead Chelating Activity   \n",
       "2                                  Photoabsorption   \n",
       "3                             Anti-epileptic Agent   \n",
       "4                Histamine H1 Receptor Antagonists   \n",
       "5                         Tricyclic Antidepressant   \n",
       "6                             Anti-epileptic Agent   \n",
       "7                      Cephalosporin Antibacterial   \n",
       "8                Dipeptidyl Peptidase 4 Inhibitors   \n",
       "9   Peroxisome Proliferator Receptor alpha Agonist   \n",
       "\n",
       "                                                 moa  \n",
       "0   Gonadotropin Releasing Hormone Receptor Agonists  \n",
       "1                                      Lead Chelator  \n",
       "2                   Photoactivated Radical Generator  \n",
       "3  Decreased Central Nervous System Disorganized ...  \n",
       "4                    Histamine-1 Receptor Antagonist  \n",
       "5                           MoA not found, try Class  \n",
       "6  Decreased Central Nervous System Disorganized ...  \n",
       "7                                     Cephalosporins  \n",
       "8                   Dipeptidyl Peptidase 4 Inhibitor  \n",
       "9     Peroxisome Proliferator Receptor gamma Agonist  "
      ]
     },
     "execution_count": 184,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "temp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 185,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:36:26.964722Z",
     "start_time": "2019-05-16T23:36:26.875860Z"
    },
    "hidden": true
   },
   "outputs": [],
   "source": [
    "moa_df['moa'] = moa_df.apply(lambda x : get_moa(x),axis=1)\n",
    "moa_df['drug_class'] = moa_df.apply(lambda x : get_moa_class(x),axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 174,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:33:17.182240Z",
     "start_time": "2019-05-16T23:33:16.947268Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Data</th>\n",
       "      <th>Description</th>\n",
       "      <th>Link</th>\n",
       "      <th>Name</th>\n",
       "      <th>SourceID</th>\n",
       "      <th>SourceName</th>\n",
       "      <th>URL</th>\n",
       "      <th>drug_class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [25077405]}}</td>\n",
       "      <td>NAFARELIN</td>\n",
       "      <td>1X0094V6JV</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/000a5c...</td>\n",
       "      <td>Gonadotropin Releasing Hormone Receptor Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6049]}}</td>\n",
       "      <td>EDETIC ACID</td>\n",
       "      <td>9G34HU7RV0</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/001902...</td>\n",
       "      <td>Lead Chelating Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [4114]}}</td>\n",
       "      <td>METHOXSALEN</td>\n",
       "      <td>U4VJ29L7BQ</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/002310...</td>\n",
       "      <td>Photoabsorption</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3121]}}</td>\n",
       "      <td>VALPROIC ACID</td>\n",
       "      <td>614OI1Z5WI</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/00abde...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEXOFENADINE</td>\n",
       "      <td>E6582LOH6V</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/012eec...</td>\n",
       "      <td>Histamine H1 Receptor Antagonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2170]}}</td>\n",
       "      <td>AMOXAPINE</td>\n",
       "      <td>R63VQ857OT</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/014130...</td>\n",
       "      <td>Tricyclic Antidepressant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416907]}}</td>\n",
       "      <td>ETHOSUXIMIDE</td>\n",
       "      <td>5SEH9X1D1D</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/016cd8...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6915944]}}</td>\n",
       "      <td>CEFDINIR</td>\n",
       "      <td>CI0FAO63WC</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/01a1f6...</td>\n",
       "      <td>Cephalosporin Antibacterial</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10096344]}}</td>\n",
       "      <td>LINAGLIPTIN</td>\n",
       "      <td>3X29ZEJ4R2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/023090...</td>\n",
       "      <td>Dipeptidyl Peptidase 4 Inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416741]}}</td>\n",
       "      <td>PIOGLITAZONE</td>\n",
       "      <td>X4OV71U42S</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0267d2...</td>\n",
       "      <td>Peroxisome Proliferator Receptor alpha Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HETASTARCH</td>\n",
       "      <td>875Y4127EA</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0271ae...</td>\n",
       "      <td>Plasma Volume Expander</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73415750]}}</td>\n",
       "      <td>TECHNETIUM TC-99M PENTETATE</td>\n",
       "      <td>VW78417PU1</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0277b4...</td>\n",
       "      <td>Radioactive Diagnostic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [44564]}}</td>\n",
       "      <td>LODOXAMIDE</td>\n",
       "      <td>SPU695OD73</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/02d64a...</td>\n",
       "      <td>Decreased Histamine Release</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5311309]}}</td>\n",
       "      <td>NATEGLINIDE</td>\n",
       "      <td>41X3PWK4O2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/02e048...</td>\n",
       "      <td>Glinide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [4893]}}</td>\n",
       "      <td>PRAZOSIN</td>\n",
       "      <td>XM03YJ541D</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0327bd...</td>\n",
       "      <td>Adrenergic alpha-Antagonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [146570]}}</td>\n",
       "      <td>ESCITALOPRAM</td>\n",
       "      <td>4O4S742ANY</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/032cb7...</td>\n",
       "      <td>Serotonin Reuptake Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SECRETIN</td>\n",
       "      <td>88C55N56UU</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/040b32...</td>\n",
       "      <td>Secretin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [28486]}}</td>\n",
       "      <td>LITHIUM CATION</td>\n",
       "      <td>8H8Z5UER66</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/041ebf...</td>\n",
       "      <td>Mood Stabilizer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5311000]}}</td>\n",
       "      <td>ALCLOMETASONE</td>\n",
       "      <td>136H45TB7B</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/044ac1...</td>\n",
       "      <td>Corticosteroid</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [43672]}}</td>\n",
       "      <td>PIPERACILLIN ANHYDROUS</td>\n",
       "      <td>9I628532GX</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/049473...</td>\n",
       "      <td>Penicillin-class Antibacterial</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [16095356]}}</td>\n",
       "      <td>CLOMIPHENE</td>\n",
       "      <td>1HRS458QU2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/04bccb...</td>\n",
       "      <td>Estrogen Agonist/Antagonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [150311]}}</td>\n",
       "      <td>EZETIMIBE</td>\n",
       "      <td>EOR26LQQ24</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/04e151...</td>\n",
       "      <td>Decreased Cholesterol Absorption</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3478]}}</td>\n",
       "      <td>GLIPIZIDE</td>\n",
       "      <td>X7WDT95N5C</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/051e1b...</td>\n",
       "      <td>Sulfonylurea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [153921]}}</td>\n",
       "      <td>GADODIAMIDE</td>\n",
       "      <td>84F6U3J2R6</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/053ec0...</td>\n",
       "      <td>Magnetic Resonance Contrast Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2082]}}</td>\n",
       "      <td>ALBENDAZOLE</td>\n",
       "      <td>F4216019LN</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/055372...</td>\n",
       "      <td>Antihelminthic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5577]}}</td>\n",
       "      <td>TRIMETHOBENZAMIDE</td>\n",
       "      <td>W2X096QY97</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0580ae...</td>\n",
       "      <td>Antiemetic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [60825]}}</td>\n",
       "      <td>LAMIVUDINE</td>\n",
       "      <td>2T8Q726O95</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05917f...</td>\n",
       "      <td>Hepatitis B Virus Nucleoside Analog Reverse Tr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2140]}}</td>\n",
       "      <td>DIATRIZOIC ACID</td>\n",
       "      <td>5UVC90J1LK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05a37d...</td>\n",
       "      <td>Radiographic Contrast Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5757]}}</td>\n",
       "      <td>ESTRADIOL</td>\n",
       "      <td>4TI98Z838E</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05bcb9...</td>\n",
       "      <td>Estradiol Congeners</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5505]}}</td>\n",
       "      <td>TOLBUTAMIDE</td>\n",
       "      <td>982XCM1FOI</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05bef3...</td>\n",
       "      <td>Sulfonylurea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>970</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [65430]}}</td>\n",
       "      <td>GALLIUM CITRATE GA-67</td>\n",
       "      <td>4LJK511Z86</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c2c27f...</td>\n",
       "      <td>Radioactive Diagnostic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>971</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5503]}}</td>\n",
       "      <td>TOLAZAMIDE</td>\n",
       "      <td>9LT1BRO48Q</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c2dd2c...</td>\n",
       "      <td>Sulfonylurea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>972</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10220516]}}</td>\n",
       "      <td>IODIDE ION I-123</td>\n",
       "      <td>8YWR746RPQ</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c32997...</td>\n",
       "      <td>Radioactive Diagnostic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>973</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3354]}}</td>\n",
       "      <td>FLAVOXATE</td>\n",
       "      <td>3E74Y80MEY</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c33715...</td>\n",
       "      <td>Cholinergic Muscarinic Antagonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>974</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3446]}}</td>\n",
       "      <td>GABAPENTIN</td>\n",
       "      <td>6CW7F3G59X</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c36303...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>975</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10100]}}</td>\n",
       "      <td>PROPOXYPHENE</td>\n",
       "      <td>S2F83W92TK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c37b9c...</td>\n",
       "      <td>Full Opioid Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>976</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALDESLEUKIN</td>\n",
       "      <td>M89N0Q7EQR</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c3ecf0...</td>\n",
       "      <td>Increased Lymphocyte Activation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>977</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [123600]}}</td>\n",
       "      <td>LEVALBUTEROL</td>\n",
       "      <td>EDN2NBH5SS</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c42a85...</td>\n",
       "      <td>Adrenergic beta2-Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>978</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5719]}}</td>\n",
       "      <td>ZALEPLON</td>\n",
       "      <td>S62U433RMH</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c43c4a...</td>\n",
       "      <td>gamma-Aminobutyric Acid A Receptor Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>979</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3690]}}</td>\n",
       "      <td>IFOSFAMIDE</td>\n",
       "      <td>UM20QQM95Y</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c469fe...</td>\n",
       "      <td>Alkylating Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>980</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [16133850]}}</td>\n",
       "      <td>TERIPARATIDE</td>\n",
       "      <td>10T9CSU89I</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c46c37...</td>\n",
       "      <td>Parathyroid Hormone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>981</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOS...</td>\n",
       "      <td>3O44U6XYQK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c4cbf3...</td>\n",
       "      <td>Inactivated Meningococcal Vaccine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>982</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [104838]}}</td>\n",
       "      <td>IMIPENEM ANHYDROUS</td>\n",
       "      <td>Q20IM7HE75</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c4e369...</td>\n",
       "      <td>Carbapenems</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>983</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [42611257]}}</td>\n",
       "      <td>VEMURAFENIB</td>\n",
       "      <td>207SMY3FQT</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c50f44...</td>\n",
       "      <td>Kinase Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>984</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [36294]}}</td>\n",
       "      <td>TOBRAMYCIN</td>\n",
       "      <td>VZ8RRZ51VK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c53135...</td>\n",
       "      <td>Aminoglycoside Antibacterial</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>985</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [76972072]}}</td>\n",
       "      <td>RABEPRAZOLE</td>\n",
       "      <td>32828355LL</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c543d0...</td>\n",
       "      <td>Proton Pump Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>986</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [193962]}}</td>\n",
       "      <td>ETRAVIRINE</td>\n",
       "      <td>0C50HW4FO1</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c57015...</td>\n",
       "      <td>Human Immunodeficiency Virus 1 Non-Nucleoside ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>987</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF H...</td>\n",
       "      <td>4SV59689SK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c57f31...</td>\n",
       "      <td>Live Vaccinia Virus Vaccine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>988</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [118984450]}}</td>\n",
       "      <td>INSULIN LISPRO</td>\n",
       "      <td>GFX7QIS1II</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c58060...</td>\n",
       "      <td>Insulin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>989</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73417385]}}</td>\n",
       "      <td>MILNACIPRAN</td>\n",
       "      <td>G56VK1HF36</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c59e5d...</td>\n",
       "      <td>Norepinephrine Uptake Inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>990</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BEVACIZUMAB</td>\n",
       "      <td>2S9ZZM9Q9V</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c5cc3a...</td>\n",
       "      <td>Vascular Endothelial Growth Factor Receptor In...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>991</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3278]}}</td>\n",
       "      <td>ETHACRYNIC ACID</td>\n",
       "      <td>M5DP350VZV</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c5fdea...</td>\n",
       "      <td>Increased Diuresis at Loop of Henle</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>992</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5288826]}}</td>\n",
       "      <td>MORPHINE</td>\n",
       "      <td>76I7G6D29C</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c633da...</td>\n",
       "      <td>Full Opioid Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>993</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73417326]}}</td>\n",
       "      <td>CEVIMELINE</td>\n",
       "      <td>K9V0CDQ56E</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c657ff...</td>\n",
       "      <td>Cholinergic Muscarinic Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>994</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416797]}}</td>\n",
       "      <td>PENTAZOCINE</td>\n",
       "      <td>RP4A60D26L</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c6dd21...</td>\n",
       "      <td>Competitive Opioid Antagonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>995</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [16157631]}}</td>\n",
       "      <td>ENFUVIRTIDE</td>\n",
       "      <td>19OWO1T3ZE</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c6df25...</td>\n",
       "      <td>Fusion Protein Inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>996</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H...</td>\n",
       "      <td>MHG4XW7BIG</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c6e561...</td>\n",
       "      <td>Inactivated Influenza A Virus Vaccine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>997</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [76965196]}}</td>\n",
       "      <td>ESTROGENS, CONJUGATED</td>\n",
       "      <td>IU5QR144QX</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c72db5...</td>\n",
       "      <td>Estrogen</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>998</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73417119]}}</td>\n",
       "      <td>BACLOFEN</td>\n",
       "      <td>H789N3FKE8</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c7608e...</td>\n",
       "      <td>GABA A Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>999</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POL...</td>\n",
       "      <td>PYD255827T</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c7bcd1...</td>\n",
       "      <td>Inactivated Pneumococcal Vaccine</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1000 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Data  \\\n",
       "0    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "1    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "2    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "3    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "4    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "5    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "6    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "7    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "8    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "9    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "10   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "11   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "12   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "13   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "14   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "15   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "16   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "17   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "18   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "19   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "20   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "21   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "22   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "23   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "24   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "25   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "26   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "27   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "28   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "29   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "..                                                 ...   \n",
       "970  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "971  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "972  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "973  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "974  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "975  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "976  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "977  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "978  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "979  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "980  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "981  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "982  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "983  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "984  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "985  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "986  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "987  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "988  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "989  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "990  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "991  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "992  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "993  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "994  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "995  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "996  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "997  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "998  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "999  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "\n",
       "                                           Description  \\\n",
       "0    FDA Pharmacologic class is a group of active m...   \n",
       "1    FDA Pharmacologic class is a group of active m...   \n",
       "2    FDA Pharmacologic class is a group of active m...   \n",
       "3    FDA Pharmacologic class is a group of active m...   \n",
       "4    FDA Pharmacologic class is a group of active m...   \n",
       "5    FDA Pharmacologic class is a group of active m...   \n",
       "6    FDA Pharmacologic class is a group of active m...   \n",
       "7    FDA Pharmacologic class is a group of active m...   \n",
       "8    FDA Pharmacologic class is a group of active m...   \n",
       "9    FDA Pharmacologic class is a group of active m...   \n",
       "10   FDA Pharmacologic class is a group of active m...   \n",
       "11   FDA Pharmacologic class is a group of active m...   \n",
       "12   FDA Pharmacologic class is a group of active m...   \n",
       "13   FDA Pharmacologic class is a group of active m...   \n",
       "14   FDA Pharmacologic class is a group of active m...   \n",
       "15   FDA Pharmacologic class is a group of active m...   \n",
       "16   FDA Pharmacologic class is a group of active m...   \n",
       "17   FDA Pharmacologic class is a group of active m...   \n",
       "18   FDA Pharmacologic class is a group of active m...   \n",
       "19   FDA Pharmacologic class is a group of active m...   \n",
       "20   FDA Pharmacologic class is a group of active m...   \n",
       "21   FDA Pharmacologic class is a group of active m...   \n",
       "22   FDA Pharmacologic class is a group of active m...   \n",
       "23   FDA Pharmacologic class is a group of active m...   \n",
       "24   FDA Pharmacologic class is a group of active m...   \n",
       "25   FDA Pharmacologic class is a group of active m...   \n",
       "26   FDA Pharmacologic class is a group of active m...   \n",
       "27   FDA Pharmacologic class is a group of active m...   \n",
       "28   FDA Pharmacologic class is a group of active m...   \n",
       "29   FDA Pharmacologic class is a group of active m...   \n",
       "..                                                 ...   \n",
       "970  FDA Pharmacologic class is a group of active m...   \n",
       "971  FDA Pharmacologic class is a group of active m...   \n",
       "972  FDA Pharmacologic class is a group of active m...   \n",
       "973  FDA Pharmacologic class is a group of active m...   \n",
       "974  FDA Pharmacologic class is a group of active m...   \n",
       "975  FDA Pharmacologic class is a group of active m...   \n",
       "976  FDA Pharmacologic class is a group of active m...   \n",
       "977  FDA Pharmacologic class is a group of active m...   \n",
       "978  FDA Pharmacologic class is a group of active m...   \n",
       "979  FDA Pharmacologic class is a group of active m...   \n",
       "980  FDA Pharmacologic class is a group of active m...   \n",
       "981  FDA Pharmacologic class is a group of active m...   \n",
       "982  FDA Pharmacologic class is a group of active m...   \n",
       "983  FDA Pharmacologic class is a group of active m...   \n",
       "984  FDA Pharmacologic class is a group of active m...   \n",
       "985  FDA Pharmacologic class is a group of active m...   \n",
       "986  FDA Pharmacologic class is a group of active m...   \n",
       "987  FDA Pharmacologic class is a group of active m...   \n",
       "988  FDA Pharmacologic class is a group of active m...   \n",
       "989  FDA Pharmacologic class is a group of active m...   \n",
       "990  FDA Pharmacologic class is a group of active m...   \n",
       "991  FDA Pharmacologic class is a group of active m...   \n",
       "992  FDA Pharmacologic class is a group of active m...   \n",
       "993  FDA Pharmacologic class is a group of active m...   \n",
       "994  FDA Pharmacologic class is a group of active m...   \n",
       "995  FDA Pharmacologic class is a group of active m...   \n",
       "996  FDA Pharmacologic class is a group of active m...   \n",
       "997  FDA Pharmacologic class is a group of active m...   \n",
       "998  FDA Pharmacologic class is a group of active m...   \n",
       "999  FDA Pharmacologic class is a group of active m...   \n",
       "\n",
       "                                       Link  \\\n",
       "0     {'ToCompound': {'ByCID': [25077405]}}   \n",
       "1         {'ToCompound': {'ByCID': [6049]}}   \n",
       "2         {'ToCompound': {'ByCID': [4114]}}   \n",
       "3         {'ToCompound': {'ByCID': [3121]}}   \n",
       "4                                       NaN   \n",
       "5         {'ToCompound': {'ByCID': [2170]}}   \n",
       "6     {'ToCompound': {'ByCID': [73416907]}}   \n",
       "7      {'ToCompound': {'ByCID': [6915944]}}   \n",
       "8     {'ToCompound': {'ByCID': [10096344]}}   \n",
       "9     {'ToCompound': {'ByCID': [73416741]}}   \n",
       "10                                      NaN   \n",
       "11    {'ToCompound': {'ByCID': [73415750]}}   \n",
       "12       {'ToCompound': {'ByCID': [44564]}}   \n",
       "13     {'ToCompound': {'ByCID': [5311309]}}   \n",
       "14        {'ToCompound': {'ByCID': [4893]}}   \n",
       "15      {'ToCompound': {'ByCID': [146570]}}   \n",
       "16                                      NaN   \n",
       "17       {'ToCompound': {'ByCID': [28486]}}   \n",
       "18     {'ToCompound': {'ByCID': [5311000]}}   \n",
       "19       {'ToCompound': {'ByCID': [43672]}}   \n",
       "20    {'ToCompound': {'ByCID': [16095356]}}   \n",
       "21      {'ToCompound': {'ByCID': [150311]}}   \n",
       "22        {'ToCompound': {'ByCID': [3478]}}   \n",
       "23      {'ToCompound': {'ByCID': [153921]}}   \n",
       "24        {'ToCompound': {'ByCID': [2082]}}   \n",
       "25        {'ToCompound': {'ByCID': [5577]}}   \n",
       "26       {'ToCompound': {'ByCID': [60825]}}   \n",
       "27        {'ToCompound': {'ByCID': [2140]}}   \n",
       "28        {'ToCompound': {'ByCID': [5757]}}   \n",
       "29        {'ToCompound': {'ByCID': [5505]}}   \n",
       "..                                      ...   \n",
       "970      {'ToCompound': {'ByCID': [65430]}}   \n",
       "971       {'ToCompound': {'ByCID': [5503]}}   \n",
       "972   {'ToCompound': {'ByCID': [10220516]}}   \n",
       "973       {'ToCompound': {'ByCID': [3354]}}   \n",
       "974       {'ToCompound': {'ByCID': [3446]}}   \n",
       "975      {'ToCompound': {'ByCID': [10100]}}   \n",
       "976                                     NaN   \n",
       "977     {'ToCompound': {'ByCID': [123600]}}   \n",
       "978       {'ToCompound': {'ByCID': [5719]}}   \n",
       "979       {'ToCompound': {'ByCID': [3690]}}   \n",
       "980   {'ToCompound': {'ByCID': [16133850]}}   \n",
       "981                                     NaN   \n",
       "982     {'ToCompound': {'ByCID': [104838]}}   \n",
       "983   {'ToCompound': {'ByCID': [42611257]}}   \n",
       "984      {'ToCompound': {'ByCID': [36294]}}   \n",
       "985   {'ToCompound': {'ByCID': [76972072]}}   \n",
       "986     {'ToCompound': {'ByCID': [193962]}}   \n",
       "987                                     NaN   \n",
       "988  {'ToCompound': {'ByCID': [118984450]}}   \n",
       "989   {'ToCompound': {'ByCID': [73417385]}}   \n",
       "990                                     NaN   \n",
       "991       {'ToCompound': {'ByCID': [3278]}}   \n",
       "992    {'ToCompound': {'ByCID': [5288826]}}   \n",
       "993   {'ToCompound': {'ByCID': [73417326]}}   \n",
       "994   {'ToCompound': {'ByCID': [73416797]}}   \n",
       "995   {'ToCompound': {'ByCID': [16157631]}}   \n",
       "996                                     NaN   \n",
       "997   {'ToCompound': {'ByCID': [76965196]}}   \n",
       "998   {'ToCompound': {'ByCID': [73417119]}}   \n",
       "999                                     NaN   \n",
       "\n",
       "                                                  Name    SourceID  \\\n",
       "0                                            NAFARELIN  1X0094V6JV   \n",
       "1                                          EDETIC ACID  9G34HU7RV0   \n",
       "2                                          METHOXSALEN  U4VJ29L7BQ   \n",
       "3                                        VALPROIC ACID  614OI1Z5WI   \n",
       "4                                         FEXOFENADINE  E6582LOH6V   \n",
       "5                                            AMOXAPINE  R63VQ857OT   \n",
       "6                                         ETHOSUXIMIDE  5SEH9X1D1D   \n",
       "7                                             CEFDINIR  CI0FAO63WC   \n",
       "8                                          LINAGLIPTIN  3X29ZEJ4R2   \n",
       "9                                         PIOGLITAZONE  X4OV71U42S   \n",
       "10                                          HETASTARCH  875Y4127EA   \n",
       "11                         TECHNETIUM TC-99M PENTETATE  VW78417PU1   \n",
       "12                                          LODOXAMIDE  SPU695OD73   \n",
       "13                                         NATEGLINIDE  41X3PWK4O2   \n",
       "14                                            PRAZOSIN  XM03YJ541D   \n",
       "15                                        ESCITALOPRAM  4O4S742ANY   \n",
       "16                                            SECRETIN  88C55N56UU   \n",
       "17                                      LITHIUM CATION  8H8Z5UER66   \n",
       "18                                       ALCLOMETASONE  136H45TB7B   \n",
       "19                              PIPERACILLIN ANHYDROUS  9I628532GX   \n",
       "20                                          CLOMIPHENE  1HRS458QU2   \n",
       "21                                           EZETIMIBE  EOR26LQQ24   \n",
       "22                                           GLIPIZIDE  X7WDT95N5C   \n",
       "23                                         GADODIAMIDE  84F6U3J2R6   \n",
       "24                                         ALBENDAZOLE  F4216019LN   \n",
       "25                                   TRIMETHOBENZAMIDE  W2X096QY97   \n",
       "26                                          LAMIVUDINE  2T8Q726O95   \n",
       "27                                     DIATRIZOIC ACID  5UVC90J1LK   \n",
       "28                                           ESTRADIOL  4TI98Z838E   \n",
       "29                                         TOLBUTAMIDE  982XCM1FOI   \n",
       "..                                                 ...         ...   \n",
       "970                              GALLIUM CITRATE GA-67  4LJK511Z86   \n",
       "971                                         TOLAZAMIDE  9LT1BRO48Q   \n",
       "972                                   IODIDE ION I-123  8YWR746RPQ   \n",
       "973                                          FLAVOXATE  3E74Y80MEY   \n",
       "974                                         GABAPENTIN  6CW7F3G59X   \n",
       "975                                       PROPOXYPHENE  S2F83W92TK   \n",
       "976                                        ALDESLEUKIN  M89N0Q7EQR   \n",
       "977                                       LEVALBUTEROL  EDN2NBH5SS   \n",
       "978                                           ZALEPLON  S62U433RMH   \n",
       "979                                         IFOSFAMIDE  UM20QQM95Y   \n",
       "980                                       TERIPARATIDE  10T9CSU89I   \n",
       "981  NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOS...  3O44U6XYQK   \n",
       "982                                 IMIPENEM ANHYDROUS  Q20IM7HE75   \n",
       "983                                        VEMURAFENIB  207SMY3FQT   \n",
       "984                                         TOBRAMYCIN  VZ8RRZ51VK   \n",
       "985                                        RABEPRAZOLE  32828355LL   \n",
       "986                                         ETRAVIRINE  0C50HW4FO1   \n",
       "987  VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF H...  4SV59689SK   \n",
       "988                                     INSULIN LISPRO  GFX7QIS1II   \n",
       "989                                        MILNACIPRAN  G56VK1HF36   \n",
       "990                                        BEVACIZUMAB  2S9ZZM9Q9V   \n",
       "991                                    ETHACRYNIC ACID  M5DP350VZV   \n",
       "992                                           MORPHINE  76I7G6D29C   \n",
       "993                                         CEVIMELINE  K9V0CDQ56E   \n",
       "994                                        PENTAZOCINE  RP4A60D26L   \n",
       "995                                        ENFUVIRTIDE  19OWO1T3ZE   \n",
       "996  INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H...  MHG4XW7BIG   \n",
       "997                              ESTROGENS, CONJUGATED  IU5QR144QX   \n",
       "998                                           BACLOFEN  H789N3FKE8   \n",
       "999  STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POL...  PYD255827T   \n",
       "\n",
       "            SourceName                                                URL  \\\n",
       "0    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/000a5c...   \n",
       "1    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/001902...   \n",
       "2    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/002310...   \n",
       "3    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/00abde...   \n",
       "4    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/012eec...   \n",
       "5    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/014130...   \n",
       "6    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/016cd8...   \n",
       "7    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/01a1f6...   \n",
       "8    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/023090...   \n",
       "9    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0267d2...   \n",
       "10   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0271ae...   \n",
       "11   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0277b4...   \n",
       "12   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/02d64a...   \n",
       "13   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/02e048...   \n",
       "14   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0327bd...   \n",
       "15   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/032cb7...   \n",
       "16   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/040b32...   \n",
       "17   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/041ebf...   \n",
       "18   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/044ac1...   \n",
       "19   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/049473...   \n",
       "20   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/04bccb...   \n",
       "21   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/04e151...   \n",
       "22   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/051e1b...   \n",
       "23   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/053ec0...   \n",
       "24   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/055372...   \n",
       "25   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0580ae...   \n",
       "26   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05917f...   \n",
       "27   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05a37d...   \n",
       "28   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05bcb9...   \n",
       "29   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05bef3...   \n",
       "..                 ...                                                ...   \n",
       "970  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c2c27f...   \n",
       "971  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c2dd2c...   \n",
       "972  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c32997...   \n",
       "973  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c33715...   \n",
       "974  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c36303...   \n",
       "975  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c37b9c...   \n",
       "976  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c3ecf0...   \n",
       "977  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c42a85...   \n",
       "978  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c43c4a...   \n",
       "979  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c469fe...   \n",
       "980  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c46c37...   \n",
       "981  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c4cbf3...   \n",
       "982  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c4e369...   \n",
       "983  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c50f44...   \n",
       "984  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c53135...   \n",
       "985  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c543d0...   \n",
       "986  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c57015...   \n",
       "987  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c57f31...   \n",
       "988  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c58060...   \n",
       "989  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c59e5d...   \n",
       "990  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c5cc3a...   \n",
       "991  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c5fdea...   \n",
       "992  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c633da...   \n",
       "993  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c657ff...   \n",
       "994  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c6dd21...   \n",
       "995  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c6df25...   \n",
       "996  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c6e561...   \n",
       "997  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c72db5...   \n",
       "998  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c7608e...   \n",
       "999  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c7bcd1...   \n",
       "\n",
       "                                            drug_class  \n",
       "0      Gonadotropin Releasing Hormone Receptor Agonist  \n",
       "1                              Lead Chelating Activity  \n",
       "2                                      Photoabsorption  \n",
       "3                                 Anti-epileptic Agent  \n",
       "4                    Histamine H1 Receptor Antagonists  \n",
       "5                             Tricyclic Antidepressant  \n",
       "6                                 Anti-epileptic Agent  \n",
       "7                          Cephalosporin Antibacterial  \n",
       "8                    Dipeptidyl Peptidase 4 Inhibitors  \n",
       "9       Peroxisome Proliferator Receptor alpha Agonist  \n",
       "10                              Plasma Volume Expander  \n",
       "11                        Radioactive Diagnostic Agent  \n",
       "12                         Decreased Histamine Release  \n",
       "13                                             Glinide  \n",
       "14                        Adrenergic alpha-Antagonists  \n",
       "15                        Serotonin Reuptake Inhibitor  \n",
       "16                                            Secretin  \n",
       "17                                     Mood Stabilizer  \n",
       "18                                      Corticosteroid  \n",
       "19                      Penicillin-class Antibacterial  \n",
       "20                         Estrogen Agonist/Antagonist  \n",
       "21                    Decreased Cholesterol Absorption  \n",
       "22                                        Sulfonylurea  \n",
       "23                Magnetic Resonance Contrast Activity  \n",
       "24                                      Antihelminthic  \n",
       "25                                          Antiemetic  \n",
       "26   Hepatitis B Virus Nucleoside Analog Reverse Tr...  \n",
       "27                         Radiographic Contrast Agent  \n",
       "28                                 Estradiol Congeners  \n",
       "29                                        Sulfonylurea  \n",
       "..                                                 ...  \n",
       "970                       Radioactive Diagnostic Agent  \n",
       "971                                       Sulfonylurea  \n",
       "972                       Radioactive Diagnostic Agent  \n",
       "973                  Cholinergic Muscarinic Antagonist  \n",
       "974                               Anti-epileptic Agent  \n",
       "975                               Full Opioid Agonists  \n",
       "976                    Increased Lymphocyte Activation  \n",
       "977                          Adrenergic beta2-Agonists  \n",
       "978         gamma-Aminobutyric Acid A Receptor Agonist  \n",
       "979                                Alkylating Activity  \n",
       "980                                Parathyroid Hormone  \n",
       "981                  Inactivated Meningococcal Vaccine  \n",
       "982                                        Carbapenems  \n",
       "983                                   Kinase Inhibitor  \n",
       "984                       Aminoglycoside Antibacterial  \n",
       "985                              Proton Pump Inhibitor  \n",
       "986  Human Immunodeficiency Virus 1 Non-Nucleoside ...  \n",
       "987                        Live Vaccinia Virus Vaccine  \n",
       "988                                            Insulin  \n",
       "989                   Norepinephrine Uptake Inhibitors  \n",
       "990  Vascular Endothelial Growth Factor Receptor In...  \n",
       "991                Increased Diuresis at Loop of Henle  \n",
       "992                               Full Opioid Agonists  \n",
       "993                    Cholinergic Muscarinic Agonists  \n",
       "994                     Competitive Opioid Antagonists  \n",
       "995                          Fusion Protein Inhibitors  \n",
       "996              Inactivated Influenza A Virus Vaccine  \n",
       "997                                           Estrogen  \n",
       "998                                    GABA A Agonists  \n",
       "999                   Inactivated Pneumococcal Vaccine  \n",
       "\n",
       "[1000 rows x 8 columns]"
      ]
     },
     "execution_count": 174,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "moa_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 186,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:36:31.314873Z",
     "start_time": "2019-05-16T23:36:31.080535Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Data</th>\n",
       "      <th>Description</th>\n",
       "      <th>Link</th>\n",
       "      <th>Name</th>\n",
       "      <th>SourceID</th>\n",
       "      <th>SourceName</th>\n",
       "      <th>URL</th>\n",
       "      <th>drug_class</th>\n",
       "      <th>moa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [25077405]}}</td>\n",
       "      <td>NAFARELIN</td>\n",
       "      <td>1X0094V6JV</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/000a5c...</td>\n",
       "      <td>Gonadotropin Releasing Hormone Receptor Agonist</td>\n",
       "      <td>Gonadotropin Releasing Hormone Receptor Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6049]}}</td>\n",
       "      <td>EDETIC ACID</td>\n",
       "      <td>9G34HU7RV0</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/001902...</td>\n",
       "      <td>Lead Chelating Activity</td>\n",
       "      <td>Lead Chelator</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [4114]}}</td>\n",
       "      <td>METHOXSALEN</td>\n",
       "      <td>U4VJ29L7BQ</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/002310...</td>\n",
       "      <td>Photoabsorption</td>\n",
       "      <td>Photoactivated Radical Generator</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3121]}}</td>\n",
       "      <td>VALPROIC ACID</td>\n",
       "      <td>614OI1Z5WI</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/00abde...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "      <td>Decreased Central Nervous System Disorganized ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEXOFENADINE</td>\n",
       "      <td>E6582LOH6V</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/012eec...</td>\n",
       "      <td>Histamine H1 Receptor Antagonists</td>\n",
       "      <td>Histamine-1 Receptor Antagonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2170]}}</td>\n",
       "      <td>AMOXAPINE</td>\n",
       "      <td>R63VQ857OT</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/014130...</td>\n",
       "      <td>Tricyclic Antidepressant</td>\n",
       "      <td>MoA not found, try Class</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416907]}}</td>\n",
       "      <td>ETHOSUXIMIDE</td>\n",
       "      <td>5SEH9X1D1D</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/016cd8...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "      <td>Decreased Central Nervous System Disorganized ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [6915944]}}</td>\n",
       "      <td>CEFDINIR</td>\n",
       "      <td>CI0FAO63WC</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/01a1f6...</td>\n",
       "      <td>Cephalosporin Antibacterial</td>\n",
       "      <td>Cephalosporins</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10096344]}}</td>\n",
       "      <td>LINAGLIPTIN</td>\n",
       "      <td>3X29ZEJ4R2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/023090...</td>\n",
       "      <td>Dipeptidyl Peptidase 4 Inhibitors</td>\n",
       "      <td>Dipeptidyl Peptidase 4 Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416741]}}</td>\n",
       "      <td>PIOGLITAZONE</td>\n",
       "      <td>X4OV71U42S</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0267d2...</td>\n",
       "      <td>Peroxisome Proliferator Receptor alpha Agonist</td>\n",
       "      <td>Peroxisome Proliferator Receptor gamma Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HETASTARCH</td>\n",
       "      <td>875Y4127EA</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0271ae...</td>\n",
       "      <td>Plasma Volume Expander</td>\n",
       "      <td>Increased Intravascular Volume</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73415750]}}</td>\n",
       "      <td>TECHNETIUM TC-99M PENTETATE</td>\n",
       "      <td>VW78417PU1</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0277b4...</td>\n",
       "      <td>Radioactive Diagnostic Agent</td>\n",
       "      <td>Radiopharmaceutical Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [44564]}}</td>\n",
       "      <td>LODOXAMIDE</td>\n",
       "      <td>SPU695OD73</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/02d64a...</td>\n",
       "      <td>Decreased Histamine Release</td>\n",
       "      <td>Mast Cell Stabilizer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5311309]}}</td>\n",
       "      <td>NATEGLINIDE</td>\n",
       "      <td>41X3PWK4O2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/02e048...</td>\n",
       "      <td>Glinide</td>\n",
       "      <td>Potassium Channel Antagonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [4893]}}</td>\n",
       "      <td>PRAZOSIN</td>\n",
       "      <td>XM03YJ541D</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0327bd...</td>\n",
       "      <td>Adrenergic alpha-Antagonists</td>\n",
       "      <td>alpha-Adrenergic Blocker</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [146570]}}</td>\n",
       "      <td>ESCITALOPRAM</td>\n",
       "      <td>4O4S742ANY</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/032cb7...</td>\n",
       "      <td>Serotonin Reuptake Inhibitor</td>\n",
       "      <td>Serotonin Uptake Inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SECRETIN</td>\n",
       "      <td>88C55N56UU</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/040b32...</td>\n",
       "      <td>Secretin</td>\n",
       "      <td>Secretin-class Hormone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [28486]}}</td>\n",
       "      <td>LITHIUM CATION</td>\n",
       "      <td>8H8Z5UER66</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/041ebf...</td>\n",
       "      <td>Mood Stabilizer</td>\n",
       "      <td>MoA not found, try Class</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5311000]}}</td>\n",
       "      <td>ALCLOMETASONE</td>\n",
       "      <td>136H45TB7B</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/044ac1...</td>\n",
       "      <td>Corticosteroid</td>\n",
       "      <td>Corticosteroid Hormone Receptor Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [43672]}}</td>\n",
       "      <td>PIPERACILLIN ANHYDROUS</td>\n",
       "      <td>9I628532GX</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/049473...</td>\n",
       "      <td>Penicillin-class Antibacterial</td>\n",
       "      <td>Penicillins</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [16095356]}}</td>\n",
       "      <td>CLOMIPHENE</td>\n",
       "      <td>1HRS458QU2</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/04bccb...</td>\n",
       "      <td>Estrogen Agonist/Antagonist</td>\n",
       "      <td>Selective Estrogen Receptor Modulators</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [150311]}}</td>\n",
       "      <td>EZETIMIBE</td>\n",
       "      <td>EOR26LQQ24</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/04e151...</td>\n",
       "      <td>Decreased Cholesterol Absorption</td>\n",
       "      <td>Dietary Cholesterol Absorption Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3478]}}</td>\n",
       "      <td>GLIPIZIDE</td>\n",
       "      <td>X7WDT95N5C</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/051e1b...</td>\n",
       "      <td>Sulfonylurea</td>\n",
       "      <td>Sulfonylurea Compounds</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [153921]}}</td>\n",
       "      <td>GADODIAMIDE</td>\n",
       "      <td>84F6U3J2R6</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/053ec0...</td>\n",
       "      <td>Magnetic Resonance Contrast Activity</td>\n",
       "      <td>Paramagnetic Contrast Agent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2082]}}</td>\n",
       "      <td>ALBENDAZOLE</td>\n",
       "      <td>F4216019LN</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/055372...</td>\n",
       "      <td>Antihelminthic</td>\n",
       "      <td>MoA not found, try Class</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5577]}}</td>\n",
       "      <td>TRIMETHOBENZAMIDE</td>\n",
       "      <td>W2X096QY97</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/0580ae...</td>\n",
       "      <td>Antiemetic</td>\n",
       "      <td>Emesis Suppression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [60825]}}</td>\n",
       "      <td>LAMIVUDINE</td>\n",
       "      <td>2T8Q726O95</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05917f...</td>\n",
       "      <td>Hepatitis B Virus Nucleoside Analog Reverse Tr...</td>\n",
       "      <td>Human Immunodeficiency Virus Nucleoside Analog...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [2140]}}</td>\n",
       "      <td>DIATRIZOIC ACID</td>\n",
       "      <td>5UVC90J1LK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05a37d...</td>\n",
       "      <td>Radiographic Contrast Agent</td>\n",
       "      <td>X-Ray Contrast Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5757]}}</td>\n",
       "      <td>ESTRADIOL</td>\n",
       "      <td>4TI98Z838E</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05bcb9...</td>\n",
       "      <td>Estradiol Congeners</td>\n",
       "      <td>Estrogen</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5505]}}</td>\n",
       "      <td>TOLBUTAMIDE</td>\n",
       "      <td>982XCM1FOI</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/05bef3...</td>\n",
       "      <td>Sulfonylurea</td>\n",
       "      <td>Sulfonylurea Compounds</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>970</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [65430]}}</td>\n",
       "      <td>GALLIUM CITRATE GA-67</td>\n",
       "      <td>4LJK511Z86</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c2c27f...</td>\n",
       "      <td>Radioactive Diagnostic Agent</td>\n",
       "      <td>Radiopharmaceutical Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>971</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5503]}}</td>\n",
       "      <td>TOLAZAMIDE</td>\n",
       "      <td>9LT1BRO48Q</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c2dd2c...</td>\n",
       "      <td>Sulfonylurea</td>\n",
       "      <td>Sulfonylurea Compounds</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>972</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10220516]}}</td>\n",
       "      <td>IODIDE ION I-123</td>\n",
       "      <td>8YWR746RPQ</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c32997...</td>\n",
       "      <td>Radioactive Diagnostic Agent</td>\n",
       "      <td>Radiopharmaceutical Activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>973</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3354]}}</td>\n",
       "      <td>FLAVOXATE</td>\n",
       "      <td>3E74Y80MEY</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c33715...</td>\n",
       "      <td>Cholinergic Muscarinic Antagonist</td>\n",
       "      <td>Cholinergic Muscarinic Antagonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>974</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3446]}}</td>\n",
       "      <td>GABAPENTIN</td>\n",
       "      <td>6CW7F3G59X</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c36303...</td>\n",
       "      <td>Anti-epileptic Agent</td>\n",
       "      <td>Decreased Central Nervous System Disorganized ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>975</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [10100]}}</td>\n",
       "      <td>PROPOXYPHENE</td>\n",
       "      <td>S2F83W92TK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c37b9c...</td>\n",
       "      <td>Full Opioid Agonists</td>\n",
       "      <td>Opioid Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>976</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALDESLEUKIN</td>\n",
       "      <td>M89N0Q7EQR</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c3ecf0...</td>\n",
       "      <td>Increased Lymphocyte Activation</td>\n",
       "      <td>Increased Lymphocyte Cell Production</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>977</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [123600]}}</td>\n",
       "      <td>LEVALBUTEROL</td>\n",
       "      <td>EDN2NBH5SS</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c42a85...</td>\n",
       "      <td>Adrenergic beta2-Agonists</td>\n",
       "      <td>beta2-Adrenergic Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>978</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5719]}}</td>\n",
       "      <td>ZALEPLON</td>\n",
       "      <td>S62U433RMH</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c43c4a...</td>\n",
       "      <td>gamma-Aminobutyric Acid A Receptor Agonist</td>\n",
       "      <td>GABA A Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>979</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3690]}}</td>\n",
       "      <td>IFOSFAMIDE</td>\n",
       "      <td>UM20QQM95Y</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c469fe...</td>\n",
       "      <td>Alkylating Activity</td>\n",
       "      <td>Alkylating Drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>980</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [16133850]}}</td>\n",
       "      <td>TERIPARATIDE</td>\n",
       "      <td>10T9CSU89I</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c46c37...</td>\n",
       "      <td>Parathyroid Hormone</td>\n",
       "      <td>Parathyroid Hormone Analog</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>981</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOS...</td>\n",
       "      <td>3O44U6XYQK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c4cbf3...</td>\n",
       "      <td>Inactivated Meningococcal Vaccine</td>\n",
       "      <td>Actively Acquired Immunity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>982</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [104838]}}</td>\n",
       "      <td>IMIPENEM ANHYDROUS</td>\n",
       "      <td>Q20IM7HE75</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c4e369...</td>\n",
       "      <td>Carbapenems</td>\n",
       "      <td>Penem Antibacterial</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>983</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [42611257]}}</td>\n",
       "      <td>VEMURAFENIB</td>\n",
       "      <td>207SMY3FQT</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c50f44...</td>\n",
       "      <td>Kinase Inhibitor</td>\n",
       "      <td>Protein Kinase Inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>984</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [36294]}}</td>\n",
       "      <td>TOBRAMYCIN</td>\n",
       "      <td>VZ8RRZ51VK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c53135...</td>\n",
       "      <td>Aminoglycoside Antibacterial</td>\n",
       "      <td>Aminoglycosides</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>985</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [76972072]}}</td>\n",
       "      <td>RABEPRAZOLE</td>\n",
       "      <td>32828355LL</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c543d0...</td>\n",
       "      <td>Proton Pump Inhibitor</td>\n",
       "      <td>Proton Pump Inhibitors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>986</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [193962]}}</td>\n",
       "      <td>ETRAVIRINE</td>\n",
       "      <td>0C50HW4FO1</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c57015...</td>\n",
       "      <td>Human Immunodeficiency Virus 1 Non-Nucleoside ...</td>\n",
       "      <td>Non-Nucleoside Analog</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>987</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF H...</td>\n",
       "      <td>4SV59689SK</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c57f31...</td>\n",
       "      <td>Live Vaccinia Virus Vaccine</td>\n",
       "      <td>Actively Acquired Immunity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>988</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [118984450]}}</td>\n",
       "      <td>INSULIN LISPRO</td>\n",
       "      <td>GFX7QIS1II</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c58060...</td>\n",
       "      <td>Insulin</td>\n",
       "      <td>Insulin Analog</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>989</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73417385]}}</td>\n",
       "      <td>MILNACIPRAN</td>\n",
       "      <td>G56VK1HF36</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c59e5d...</td>\n",
       "      <td>Norepinephrine Uptake Inhibitors</td>\n",
       "      <td>Serotonin and Norepinephrine Reuptake Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>990</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BEVACIZUMAB</td>\n",
       "      <td>2S9ZZM9Q9V</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c5cc3a...</td>\n",
       "      <td>Vascular Endothelial Growth Factor Receptor In...</td>\n",
       "      <td>Vascular Endothelial Growth Factor-directed An...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>991</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [3278]}}</td>\n",
       "      <td>ETHACRYNIC ACID</td>\n",
       "      <td>M5DP350VZV</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c5fdea...</td>\n",
       "      <td>Increased Diuresis at Loop of Henle</td>\n",
       "      <td>Loop Diuretic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>992</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [5288826]}}</td>\n",
       "      <td>MORPHINE</td>\n",
       "      <td>76I7G6D29C</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c633da...</td>\n",
       "      <td>Full Opioid Agonists</td>\n",
       "      <td>Opioid Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>993</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73417326]}}</td>\n",
       "      <td>CEVIMELINE</td>\n",
       "      <td>K9V0CDQ56E</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c657ff...</td>\n",
       "      <td>Cholinergic Muscarinic Agonists</td>\n",
       "      <td>Cholinergic Receptor Agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>994</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73416797]}}</td>\n",
       "      <td>PENTAZOCINE</td>\n",
       "      <td>RP4A60D26L</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c6dd21...</td>\n",
       "      <td>Competitive Opioid Antagonists</td>\n",
       "      <td>Partial Opioid Agonist/Antagonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>995</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [16157631]}}</td>\n",
       "      <td>ENFUVIRTIDE</td>\n",
       "      <td>19OWO1T3ZE</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c6df25...</td>\n",
       "      <td>Fusion Protein Inhibitors</td>\n",
       "      <td>Human Immunodeficiency Virus 1 Fusion Inhibitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>996</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H...</td>\n",
       "      <td>MHG4XW7BIG</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c6e561...</td>\n",
       "      <td>Inactivated Influenza A Virus Vaccine</td>\n",
       "      <td>Actively Acquired Immunity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>997</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [76965196]}}</td>\n",
       "      <td>ESTROGENS, CONJUGATED</td>\n",
       "      <td>IU5QR144QX</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c72db5...</td>\n",
       "      <td>Estrogen</td>\n",
       "      <td>Estrogen Receptor Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>998</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>{'ToCompound': {'ByCID': [73417119]}}</td>\n",
       "      <td>BACLOFEN</td>\n",
       "      <td>H789N3FKE8</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c7608e...</td>\n",
       "      <td>GABA A Agonists</td>\n",
       "      <td>GABA B Agonists</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>999</th>\n",
       "      <td>[{'TOCHeading': {'#TOCHeading': 'Pharmacologic...</td>\n",
       "      <td>FDA Pharmacologic class is a group of active m...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POL...</td>\n",
       "      <td>PYD255827T</td>\n",
       "      <td>FDA Pharm Classes</td>\n",
       "      <td>https://www.accessdata.fda.gov/spl/data/c7bcd1...</td>\n",
       "      <td>Inactivated Pneumococcal Vaccine</td>\n",
       "      <td>Actively Acquired Immunity</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1000 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Data  \\\n",
       "0    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "1    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "2    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "3    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "4    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "5    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "6    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "7    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "8    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "9    [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "10   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "11   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "12   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "13   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "14   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "15   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "16   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "17   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "18   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "19   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "20   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "21   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "22   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "23   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "24   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "25   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "26   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "27   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "28   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "29   [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "..                                                 ...   \n",
       "970  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "971  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "972  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "973  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "974  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "975  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "976  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "977  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "978  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "979  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "980  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "981  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "982  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "983  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "984  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "985  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "986  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "987  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "988  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "989  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "990  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "991  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "992  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "993  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "994  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "995  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "996  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "997  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "998  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "999  [{'TOCHeading': {'#TOCHeading': 'Pharmacologic...   \n",
       "\n",
       "                                           Description  \\\n",
       "0    FDA Pharmacologic class is a group of active m...   \n",
       "1    FDA Pharmacologic class is a group of active m...   \n",
       "2    FDA Pharmacologic class is a group of active m...   \n",
       "3    FDA Pharmacologic class is a group of active m...   \n",
       "4    FDA Pharmacologic class is a group of active m...   \n",
       "5    FDA Pharmacologic class is a group of active m...   \n",
       "6    FDA Pharmacologic class is a group of active m...   \n",
       "7    FDA Pharmacologic class is a group of active m...   \n",
       "8    FDA Pharmacologic class is a group of active m...   \n",
       "9    FDA Pharmacologic class is a group of active m...   \n",
       "10   FDA Pharmacologic class is a group of active m...   \n",
       "11   FDA Pharmacologic class is a group of active m...   \n",
       "12   FDA Pharmacologic class is a group of active m...   \n",
       "13   FDA Pharmacologic class is a group of active m...   \n",
       "14   FDA Pharmacologic class is a group of active m...   \n",
       "15   FDA Pharmacologic class is a group of active m...   \n",
       "16   FDA Pharmacologic class is a group of active m...   \n",
       "17   FDA Pharmacologic class is a group of active m...   \n",
       "18   FDA Pharmacologic class is a group of active m...   \n",
       "19   FDA Pharmacologic class is a group of active m...   \n",
       "20   FDA Pharmacologic class is a group of active m...   \n",
       "21   FDA Pharmacologic class is a group of active m...   \n",
       "22   FDA Pharmacologic class is a group of active m...   \n",
       "23   FDA Pharmacologic class is a group of active m...   \n",
       "24   FDA Pharmacologic class is a group of active m...   \n",
       "25   FDA Pharmacologic class is a group of active m...   \n",
       "26   FDA Pharmacologic class is a group of active m...   \n",
       "27   FDA Pharmacologic class is a group of active m...   \n",
       "28   FDA Pharmacologic class is a group of active m...   \n",
       "29   FDA Pharmacologic class is a group of active m...   \n",
       "..                                                 ...   \n",
       "970  FDA Pharmacologic class is a group of active m...   \n",
       "971  FDA Pharmacologic class is a group of active m...   \n",
       "972  FDA Pharmacologic class is a group of active m...   \n",
       "973  FDA Pharmacologic class is a group of active m...   \n",
       "974  FDA Pharmacologic class is a group of active m...   \n",
       "975  FDA Pharmacologic class is a group of active m...   \n",
       "976  FDA Pharmacologic class is a group of active m...   \n",
       "977  FDA Pharmacologic class is a group of active m...   \n",
       "978  FDA Pharmacologic class is a group of active m...   \n",
       "979  FDA Pharmacologic class is a group of active m...   \n",
       "980  FDA Pharmacologic class is a group of active m...   \n",
       "981  FDA Pharmacologic class is a group of active m...   \n",
       "982  FDA Pharmacologic class is a group of active m...   \n",
       "983  FDA Pharmacologic class is a group of active m...   \n",
       "984  FDA Pharmacologic class is a group of active m...   \n",
       "985  FDA Pharmacologic class is a group of active m...   \n",
       "986  FDA Pharmacologic class is a group of active m...   \n",
       "987  FDA Pharmacologic class is a group of active m...   \n",
       "988  FDA Pharmacologic class is a group of active m...   \n",
       "989  FDA Pharmacologic class is a group of active m...   \n",
       "990  FDA Pharmacologic class is a group of active m...   \n",
       "991  FDA Pharmacologic class is a group of active m...   \n",
       "992  FDA Pharmacologic class is a group of active m...   \n",
       "993  FDA Pharmacologic class is a group of active m...   \n",
       "994  FDA Pharmacologic class is a group of active m...   \n",
       "995  FDA Pharmacologic class is a group of active m...   \n",
       "996  FDA Pharmacologic class is a group of active m...   \n",
       "997  FDA Pharmacologic class is a group of active m...   \n",
       "998  FDA Pharmacologic class is a group of active m...   \n",
       "999  FDA Pharmacologic class is a group of active m...   \n",
       "\n",
       "                                       Link  \\\n",
       "0     {'ToCompound': {'ByCID': [25077405]}}   \n",
       "1         {'ToCompound': {'ByCID': [6049]}}   \n",
       "2         {'ToCompound': {'ByCID': [4114]}}   \n",
       "3         {'ToCompound': {'ByCID': [3121]}}   \n",
       "4                                       NaN   \n",
       "5         {'ToCompound': {'ByCID': [2170]}}   \n",
       "6     {'ToCompound': {'ByCID': [73416907]}}   \n",
       "7      {'ToCompound': {'ByCID': [6915944]}}   \n",
       "8     {'ToCompound': {'ByCID': [10096344]}}   \n",
       "9     {'ToCompound': {'ByCID': [73416741]}}   \n",
       "10                                      NaN   \n",
       "11    {'ToCompound': {'ByCID': [73415750]}}   \n",
       "12       {'ToCompound': {'ByCID': [44564]}}   \n",
       "13     {'ToCompound': {'ByCID': [5311309]}}   \n",
       "14        {'ToCompound': {'ByCID': [4893]}}   \n",
       "15      {'ToCompound': {'ByCID': [146570]}}   \n",
       "16                                      NaN   \n",
       "17       {'ToCompound': {'ByCID': [28486]}}   \n",
       "18     {'ToCompound': {'ByCID': [5311000]}}   \n",
       "19       {'ToCompound': {'ByCID': [43672]}}   \n",
       "20    {'ToCompound': {'ByCID': [16095356]}}   \n",
       "21      {'ToCompound': {'ByCID': [150311]}}   \n",
       "22        {'ToCompound': {'ByCID': [3478]}}   \n",
       "23      {'ToCompound': {'ByCID': [153921]}}   \n",
       "24        {'ToCompound': {'ByCID': [2082]}}   \n",
       "25        {'ToCompound': {'ByCID': [5577]}}   \n",
       "26       {'ToCompound': {'ByCID': [60825]}}   \n",
       "27        {'ToCompound': {'ByCID': [2140]}}   \n",
       "28        {'ToCompound': {'ByCID': [5757]}}   \n",
       "29        {'ToCompound': {'ByCID': [5505]}}   \n",
       "..                                      ...   \n",
       "970      {'ToCompound': {'ByCID': [65430]}}   \n",
       "971       {'ToCompound': {'ByCID': [5503]}}   \n",
       "972   {'ToCompound': {'ByCID': [10220516]}}   \n",
       "973       {'ToCompound': {'ByCID': [3354]}}   \n",
       "974       {'ToCompound': {'ByCID': [3446]}}   \n",
       "975      {'ToCompound': {'ByCID': [10100]}}   \n",
       "976                                     NaN   \n",
       "977     {'ToCompound': {'ByCID': [123600]}}   \n",
       "978       {'ToCompound': {'ByCID': [5719]}}   \n",
       "979       {'ToCompound': {'ByCID': [3690]}}   \n",
       "980   {'ToCompound': {'ByCID': [16133850]}}   \n",
       "981                                     NaN   \n",
       "982     {'ToCompound': {'ByCID': [104838]}}   \n",
       "983   {'ToCompound': {'ByCID': [42611257]}}   \n",
       "984      {'ToCompound': {'ByCID': [36294]}}   \n",
       "985   {'ToCompound': {'ByCID': [76972072]}}   \n",
       "986     {'ToCompound': {'ByCID': [193962]}}   \n",
       "987                                     NaN   \n",
       "988  {'ToCompound': {'ByCID': [118984450]}}   \n",
       "989   {'ToCompound': {'ByCID': [73417385]}}   \n",
       "990                                     NaN   \n",
       "991       {'ToCompound': {'ByCID': [3278]}}   \n",
       "992    {'ToCompound': {'ByCID': [5288826]}}   \n",
       "993   {'ToCompound': {'ByCID': [73417326]}}   \n",
       "994   {'ToCompound': {'ByCID': [73416797]}}   \n",
       "995   {'ToCompound': {'ByCID': [16157631]}}   \n",
       "996                                     NaN   \n",
       "997   {'ToCompound': {'ByCID': [76965196]}}   \n",
       "998   {'ToCompound': {'ByCID': [73417119]}}   \n",
       "999                                     NaN   \n",
       "\n",
       "                                                  Name    SourceID  \\\n",
       "0                                            NAFARELIN  1X0094V6JV   \n",
       "1                                          EDETIC ACID  9G34HU7RV0   \n",
       "2                                          METHOXSALEN  U4VJ29L7BQ   \n",
       "3                                        VALPROIC ACID  614OI1Z5WI   \n",
       "4                                         FEXOFENADINE  E6582LOH6V   \n",
       "5                                            AMOXAPINE  R63VQ857OT   \n",
       "6                                         ETHOSUXIMIDE  5SEH9X1D1D   \n",
       "7                                             CEFDINIR  CI0FAO63WC   \n",
       "8                                          LINAGLIPTIN  3X29ZEJ4R2   \n",
       "9                                         PIOGLITAZONE  X4OV71U42S   \n",
       "10                                          HETASTARCH  875Y4127EA   \n",
       "11                         TECHNETIUM TC-99M PENTETATE  VW78417PU1   \n",
       "12                                          LODOXAMIDE  SPU695OD73   \n",
       "13                                         NATEGLINIDE  41X3PWK4O2   \n",
       "14                                            PRAZOSIN  XM03YJ541D   \n",
       "15                                        ESCITALOPRAM  4O4S742ANY   \n",
       "16                                            SECRETIN  88C55N56UU   \n",
       "17                                      LITHIUM CATION  8H8Z5UER66   \n",
       "18                                       ALCLOMETASONE  136H45TB7B   \n",
       "19                              PIPERACILLIN ANHYDROUS  9I628532GX   \n",
       "20                                          CLOMIPHENE  1HRS458QU2   \n",
       "21                                           EZETIMIBE  EOR26LQQ24   \n",
       "22                                           GLIPIZIDE  X7WDT95N5C   \n",
       "23                                         GADODIAMIDE  84F6U3J2R6   \n",
       "24                                         ALBENDAZOLE  F4216019LN   \n",
       "25                                   TRIMETHOBENZAMIDE  W2X096QY97   \n",
       "26                                          LAMIVUDINE  2T8Q726O95   \n",
       "27                                     DIATRIZOIC ACID  5UVC90J1LK   \n",
       "28                                           ESTRADIOL  4TI98Z838E   \n",
       "29                                         TOLBUTAMIDE  982XCM1FOI   \n",
       "..                                                 ...         ...   \n",
       "970                              GALLIUM CITRATE GA-67  4LJK511Z86   \n",
       "971                                         TOLAZAMIDE  9LT1BRO48Q   \n",
       "972                                   IODIDE ION I-123  8YWR746RPQ   \n",
       "973                                          FLAVOXATE  3E74Y80MEY   \n",
       "974                                         GABAPENTIN  6CW7F3G59X   \n",
       "975                                       PROPOXYPHENE  S2F83W92TK   \n",
       "976                                        ALDESLEUKIN  M89N0Q7EQR   \n",
       "977                                       LEVALBUTEROL  EDN2NBH5SS   \n",
       "978                                           ZALEPLON  S62U433RMH   \n",
       "979                                         IFOSFAMIDE  UM20QQM95Y   \n",
       "980                                       TERIPARATIDE  10T9CSU89I   \n",
       "981  NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOS...  3O44U6XYQK   \n",
       "982                                 IMIPENEM ANHYDROUS  Q20IM7HE75   \n",
       "983                                        VEMURAFENIB  207SMY3FQT   \n",
       "984                                         TOBRAMYCIN  VZ8RRZ51VK   \n",
       "985                                        RABEPRAZOLE  32828355LL   \n",
       "986                                         ETRAVIRINE  0C50HW4FO1   \n",
       "987  VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF H...  4SV59689SK   \n",
       "988                                     INSULIN LISPRO  GFX7QIS1II   \n",
       "989                                        MILNACIPRAN  G56VK1HF36   \n",
       "990                                        BEVACIZUMAB  2S9ZZM9Q9V   \n",
       "991                                    ETHACRYNIC ACID  M5DP350VZV   \n",
       "992                                           MORPHINE  76I7G6D29C   \n",
       "993                                         CEVIMELINE  K9V0CDQ56E   \n",
       "994                                        PENTAZOCINE  RP4A60D26L   \n",
       "995                                        ENFUVIRTIDE  19OWO1T3ZE   \n",
       "996  INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H...  MHG4XW7BIG   \n",
       "997                              ESTROGENS, CONJUGATED  IU5QR144QX   \n",
       "998                                           BACLOFEN  H789N3FKE8   \n",
       "999  STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POL...  PYD255827T   \n",
       "\n",
       "            SourceName                                                URL  \\\n",
       "0    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/000a5c...   \n",
       "1    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/001902...   \n",
       "2    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/002310...   \n",
       "3    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/00abde...   \n",
       "4    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/012eec...   \n",
       "5    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/014130...   \n",
       "6    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/016cd8...   \n",
       "7    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/01a1f6...   \n",
       "8    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/023090...   \n",
       "9    FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0267d2...   \n",
       "10   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0271ae...   \n",
       "11   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0277b4...   \n",
       "12   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/02d64a...   \n",
       "13   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/02e048...   \n",
       "14   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0327bd...   \n",
       "15   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/032cb7...   \n",
       "16   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/040b32...   \n",
       "17   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/041ebf...   \n",
       "18   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/044ac1...   \n",
       "19   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/049473...   \n",
       "20   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/04bccb...   \n",
       "21   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/04e151...   \n",
       "22   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/051e1b...   \n",
       "23   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/053ec0...   \n",
       "24   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/055372...   \n",
       "25   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/0580ae...   \n",
       "26   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05917f...   \n",
       "27   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05a37d...   \n",
       "28   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05bcb9...   \n",
       "29   FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/05bef3...   \n",
       "..                 ...                                                ...   \n",
       "970  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c2c27f...   \n",
       "971  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c2dd2c...   \n",
       "972  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c32997...   \n",
       "973  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c33715...   \n",
       "974  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c36303...   \n",
       "975  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c37b9c...   \n",
       "976  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c3ecf0...   \n",
       "977  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c42a85...   \n",
       "978  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c43c4a...   \n",
       "979  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c469fe...   \n",
       "980  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c46c37...   \n",
       "981  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c4cbf3...   \n",
       "982  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c4e369...   \n",
       "983  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c50f44...   \n",
       "984  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c53135...   \n",
       "985  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c543d0...   \n",
       "986  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c57015...   \n",
       "987  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c57f31...   \n",
       "988  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c58060...   \n",
       "989  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c59e5d...   \n",
       "990  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c5cc3a...   \n",
       "991  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c5fdea...   \n",
       "992  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c633da...   \n",
       "993  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c657ff...   \n",
       "994  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c6dd21...   \n",
       "995  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c6df25...   \n",
       "996  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c6e561...   \n",
       "997  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c72db5...   \n",
       "998  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c7608e...   \n",
       "999  FDA Pharm Classes  https://www.accessdata.fda.gov/spl/data/c7bcd1...   \n",
       "\n",
       "                                            drug_class  \\\n",
       "0      Gonadotropin Releasing Hormone Receptor Agonist   \n",
       "1                              Lead Chelating Activity   \n",
       "2                                      Photoabsorption   \n",
       "3                                 Anti-epileptic Agent   \n",
       "4                    Histamine H1 Receptor Antagonists   \n",
       "5                             Tricyclic Antidepressant   \n",
       "6                                 Anti-epileptic Agent   \n",
       "7                          Cephalosporin Antibacterial   \n",
       "8                    Dipeptidyl Peptidase 4 Inhibitors   \n",
       "9       Peroxisome Proliferator Receptor alpha Agonist   \n",
       "10                              Plasma Volume Expander   \n",
       "11                        Radioactive Diagnostic Agent   \n",
       "12                         Decreased Histamine Release   \n",
       "13                                             Glinide   \n",
       "14                        Adrenergic alpha-Antagonists   \n",
       "15                        Serotonin Reuptake Inhibitor   \n",
       "16                                            Secretin   \n",
       "17                                     Mood Stabilizer   \n",
       "18                                      Corticosteroid   \n",
       "19                      Penicillin-class Antibacterial   \n",
       "20                         Estrogen Agonist/Antagonist   \n",
       "21                    Decreased Cholesterol Absorption   \n",
       "22                                        Sulfonylurea   \n",
       "23                Magnetic Resonance Contrast Activity   \n",
       "24                                      Antihelminthic   \n",
       "25                                          Antiemetic   \n",
       "26   Hepatitis B Virus Nucleoside Analog Reverse Tr...   \n",
       "27                         Radiographic Contrast Agent   \n",
       "28                                 Estradiol Congeners   \n",
       "29                                        Sulfonylurea   \n",
       "..                                                 ...   \n",
       "970                       Radioactive Diagnostic Agent   \n",
       "971                                       Sulfonylurea   \n",
       "972                       Radioactive Diagnostic Agent   \n",
       "973                  Cholinergic Muscarinic Antagonist   \n",
       "974                               Anti-epileptic Agent   \n",
       "975                               Full Opioid Agonists   \n",
       "976                    Increased Lymphocyte Activation   \n",
       "977                          Adrenergic beta2-Agonists   \n",
       "978         gamma-Aminobutyric Acid A Receptor Agonist   \n",
       "979                                Alkylating Activity   \n",
       "980                                Parathyroid Hormone   \n",
       "981                  Inactivated Meningococcal Vaccine   \n",
       "982                                        Carbapenems   \n",
       "983                                   Kinase Inhibitor   \n",
       "984                       Aminoglycoside Antibacterial   \n",
       "985                              Proton Pump Inhibitor   \n",
       "986  Human Immunodeficiency Virus 1 Non-Nucleoside ...   \n",
       "987                        Live Vaccinia Virus Vaccine   \n",
       "988                                            Insulin   \n",
       "989                   Norepinephrine Uptake Inhibitors   \n",
       "990  Vascular Endothelial Growth Factor Receptor In...   \n",
       "991                Increased Diuresis at Loop of Henle   \n",
       "992                               Full Opioid Agonists   \n",
       "993                    Cholinergic Muscarinic Agonists   \n",
       "994                     Competitive Opioid Antagonists   \n",
       "995                          Fusion Protein Inhibitors   \n",
       "996              Inactivated Influenza A Virus Vaccine   \n",
       "997                                           Estrogen   \n",
       "998                                    GABA A Agonists   \n",
       "999                   Inactivated Pneumococcal Vaccine   \n",
       "\n",
       "                                                   moa  \n",
       "0     Gonadotropin Releasing Hormone Receptor Agonists  \n",
       "1                                        Lead Chelator  \n",
       "2                     Photoactivated Radical Generator  \n",
       "3    Decreased Central Nervous System Disorganized ...  \n",
       "4                      Histamine-1 Receptor Antagonist  \n",
       "5                             MoA not found, try Class  \n",
       "6    Decreased Central Nervous System Disorganized ...  \n",
       "7                                       Cephalosporins  \n",
       "8                     Dipeptidyl Peptidase 4 Inhibitor  \n",
       "9       Peroxisome Proliferator Receptor gamma Agonist  \n",
       "10                      Increased Intravascular Volume  \n",
       "11                        Radiopharmaceutical Activity  \n",
       "12                                Mast Cell Stabilizer  \n",
       "13                       Potassium Channel Antagonists  \n",
       "14                            alpha-Adrenergic Blocker  \n",
       "15                         Serotonin Uptake Inhibitors  \n",
       "16                              Secretin-class Hormone  \n",
       "17                            MoA not found, try Class  \n",
       "18            Corticosteroid Hormone Receptor Agonists  \n",
       "19                                         Penicillins  \n",
       "20              Selective Estrogen Receptor Modulators  \n",
       "21            Dietary Cholesterol Absorption Inhibitor  \n",
       "22                              Sulfonylurea Compounds  \n",
       "23                         Paramagnetic Contrast Agent  \n",
       "24                            MoA not found, try Class  \n",
       "25                                  Emesis Suppression  \n",
       "26   Human Immunodeficiency Virus Nucleoside Analog...  \n",
       "27                             X-Ray Contrast Activity  \n",
       "28                                            Estrogen  \n",
       "29                              Sulfonylurea Compounds  \n",
       "..                                                 ...  \n",
       "970                       Radiopharmaceutical Activity  \n",
       "971                             Sulfonylurea Compounds  \n",
       "972                       Radiopharmaceutical Activity  \n",
       "973                 Cholinergic Muscarinic Antagonists  \n",
       "974  Decreased Central Nervous System Disorganized ...  \n",
       "975                                     Opioid Agonist  \n",
       "976               Increased Lymphocyte Cell Production  \n",
       "977                           beta2-Adrenergic Agonist  \n",
       "978                                    GABA A Agonists  \n",
       "979                                    Alkylating Drug  \n",
       "980                         Parathyroid Hormone Analog  \n",
       "981                         Actively Acquired Immunity  \n",
       "982                                Penem Antibacterial  \n",
       "983                          Protein Kinase Inhibitors  \n",
       "984                                    Aminoglycosides  \n",
       "985                             Proton Pump Inhibitors  \n",
       "986                              Non-Nucleoside Analog  \n",
       "987                         Actively Acquired Immunity  \n",
       "988                                     Insulin Analog  \n",
       "989    Serotonin and Norepinephrine Reuptake Inhibitor  \n",
       "990  Vascular Endothelial Growth Factor-directed An...  \n",
       "991                                      Loop Diuretic  \n",
       "992                                     Opioid Agonist  \n",
       "993                       Cholinergic Receptor Agonist  \n",
       "994                  Partial Opioid Agonist/Antagonist  \n",
       "995    Human Immunodeficiency Virus 1 Fusion Inhibitor  \n",
       "996                         Actively Acquired Immunity  \n",
       "997                         Estrogen Receptor Agonists  \n",
       "998                                    GABA B Agonists  \n",
       "999                         Actively Acquired Immunity  \n",
       "\n",
       "[1000 rows x 9 columns]"
      ]
     },
     "execution_count": 186,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "moa_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 191,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:52:29.970282Z",
     "start_time": "2019-05-16T23:52:29.944761Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Data</th>\n",
       "      <th>Description</th>\n",
       "      <th>Link</th>\n",
       "      <th>Name</th>\n",
       "      <th>SourceID</th>\n",
       "      <th>SourceName</th>\n",
       "      <th>URL</th>\n",
       "      <th>drug_class</th>\n",
       "      <th>moa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [Data, Description, Link, Name, SourceID, SourceName, URL, drug_class, moa]\n",
       "Index: []"
      ]
     },
     "execution_count": 191,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "moa_df[moa_df['Name'].str.contains('LINS')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 187,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-16T23:41:01.990382Z",
     "start_time": "2019-05-16T23:41:01.879843Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Data</th>\n",
       "      <th>Description</th>\n",
       "      <th>Link</th>\n",
       "      <th>Name</th>\n",
       "      <th>SourceID</th>\n",
       "      <th>SourceName</th>\n",
       "      <th>URL</th>\n",
       "      <th>drug_class</th>\n",
       "      <th>moa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [Data, Description, Link, Name, SourceID, SourceName, URL, drug_class, moa]\n",
       "Index: []"
      ]
     },
     "execution_count": 187,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drugs_in_common = pd.DataFrame()\n",
    "for drug in lower_drugs:\n",
    "    drugs_in_common = drugs_in_common.append(moa_df[moa_df['Name'].str.contains(drug.upper())])\n",
    "drugs_in_common"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 193,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T00:01:11.068811Z",
     "start_time": "2019-05-17T00:01:10.901503Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>type</th>\n",
       "      <th>groups</th>\n",
       "      <th>atc_codes</th>\n",
       "      <th>categories</th>\n",
       "      <th>inchikey</th>\n",
       "      <th>inchi</th>\n",
       "      <th>description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00001</td>\n",
       "      <td>Lepirudin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>B01AE02</td>\n",
       "      <td>Antithrombins|Fibrinolytic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lepirudin is identical to natural hirudin exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00002</td>\n",
       "      <td>Cetuximab</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>L01XC06</td>\n",
       "      <td>Antineoplastic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Epidermal growth factor receptor binding FAB. ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00003</td>\n",
       "      <td>Dornase alfa</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>R05CB13</td>\n",
       "      <td>Enzymes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Dornase alfa is a biosynthetic form of human d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00004</td>\n",
       "      <td>Denileukin diftitox</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>L01XX29</td>\n",
       "      <td>Antineoplastic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A recombinant DNA-derived cytotoxic protein co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00005</td>\n",
       "      <td>Etanercept</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>L04AB01</td>\n",
       "      <td>Immunosuppressive Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Dimeric fusion protein consisting of the extra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00006</td>\n",
       "      <td>Bivalirudin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>B01AE06</td>\n",
       "      <td>Antithrombins</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Bivalirudin is a synthetic 20 residue peptide ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00007</td>\n",
       "      <td>Leuprolide</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>L02AE02</td>\n",
       "      <td>Antineoplastic Agents, Hormonal|Fertility Agen...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Leuprolide belongs to the general class of dru...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00008</td>\n",
       "      <td>Peginterferon alfa-2a</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>L03AB11</td>\n",
       "      <td>Immunosuppressive Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Human interferon 2a, is a covalent conjugate o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00009</td>\n",
       "      <td>Alteplase</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>B01AD02|S01XA13</td>\n",
       "      <td>Thrombolytic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Human tissue plasminogen activator, purified, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00010</td>\n",
       "      <td>Sermorelin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|withdrawn</td>\n",
       "      <td>H01AC04|V04CD03</td>\n",
       "      <td>Hormone Replacement Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sermorelin acetate is the acetate salt of an a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>DB00011</td>\n",
       "      <td>Interferon alfa-n1</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>L03AB06</td>\n",
       "      <td>Antiviral Agents|Immunologic Factors|Immunosup...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Purified, natural (n is for natural) glycosyla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>DB00012</td>\n",
       "      <td>Darbepoetin alfa</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>B03XA02</td>\n",
       "      <td>Hematinics|Anti-anemic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Human erythropoietin with 2 aa substitutions t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>DB00013</td>\n",
       "      <td>Urokinase</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational|withdrawn</td>\n",
       "      <td>B01AD04</td>\n",
       "      <td>Thrombolytic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low molecular weight form of human urokinase, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>DB00014</td>\n",
       "      <td>Goserelin</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>L02AE03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=BLCLNMBMMGCOAS-URPVMXJPSA-N</td>\n",
       "      <td>InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-3...</td>\n",
       "      <td>Goserelin is a synthetic hormone. In men, it s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>DB00015</td>\n",
       "      <td>Reteplase</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>B01AD07</td>\n",
       "      <td>Fibrinolytic Agents|Thrombolytic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Human tissue plasminogen activator, purified, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>DB00016</td>\n",
       "      <td>Epoetin alfa</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>B03XA01</td>\n",
       "      <td>Hematinics|Anti-anemic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Human erythropoietin (recombinant), produced b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>DB00017</td>\n",
       "      <td>Salmon Calcitonin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>H05BA01</td>\n",
       "      <td>Bone Density Conservation Agents|Antihypercalc...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Synthetic peptide, 32 residues long formulated...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>DB00018</td>\n",
       "      <td>Interferon alfa-n3</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immunosuppressive Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Purified, natural (n is for natural) human int...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>DB00019</td>\n",
       "      <td>Pegfilgrastim</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>L03AA10</td>\n",
       "      <td>Immunosuppressive Agents|Antineutropenic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PEGylated (at N terminus) form of human G-CSF ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>DB00020</td>\n",
       "      <td>Sargramostim</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>L03AA09</td>\n",
       "      <td>Immunosuppressive Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sargramostim is a human recombinant granulocyt...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>DB00021</td>\n",
       "      <td>Secretin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>V04CK01</td>\n",
       "      <td>Diagnostic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This drug is the synthetic form of natural sec...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>DB00022</td>\n",
       "      <td>Peginterferon alfa-2b</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>L03AB10</td>\n",
       "      <td>Immunosuppressive Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Peginterferon alfa-2b is a covalent conjugate ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>DB00023</td>\n",
       "      <td>Asparaginase</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>L01XX02</td>\n",
       "      <td>Antineoplastic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>L-asparagine amidohydrolase from E. coli</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>DB00024</td>\n",
       "      <td>Thyrotropin Alfa</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>V04CJ01</td>\n",
       "      <td>Diagnostic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Thyrotropin alfa is a recombinant form of thyr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>DB00025</td>\n",
       "      <td>Antihemophilic Factor</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>B02BD02</td>\n",
       "      <td>Coagulants|Thrombotic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Human recombinant antihemophilic factor (AHF) ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>DB00026</td>\n",
       "      <td>Anakinra</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>L04AC03</td>\n",
       "      <td>Antirheumatic Agents|Immunosuppressive Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anakinra is a recombinant, nonglycosylated hum...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>DB00027</td>\n",
       "      <td>Gramicidin D</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>R02AB30</td>\n",
       "      <td>Anti-Bacterial Agents|Anti-Infective Agents|An...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gramcidin D is a heterogeneous mixture of thre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>DB00028</td>\n",
       "      <td>Intravenous Immunoglobulin</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>J06BA02|J06BA01</td>\n",
       "      <td>Immunologic Factors|Immunosuppressive Agents|A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Intravenous immunoglobulin (IVIg) is a mixture...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>DB00029</td>\n",
       "      <td>Anistreplase</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>B01AD03</td>\n",
       "      <td>Fibrinolytic Agents|Thrombolytic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Human tissue plasminogen activator, purified, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>DB00030</td>\n",
       "      <td>Insulin Regular</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|experimental|investigational</td>\n",
       "      <td>A10AB01|A10AE05|A10AB04|A10AE04|A10AD05|A10AC0...</td>\n",
       "      <td>Antidiabetic Agents</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Insulin regular is a 51 residue peptide hormon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7729</th>\n",
       "      <td>DB08996</td>\n",
       "      <td>Dimetacrine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=RYQOGSFEJBUZBX-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C20H26N2/c1-20(2)16-10-5-7-12-18(16)2...</td>\n",
       "      <td>Dimetacrine (Istonil, Istonyl, Linostil, Miroi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7730</th>\n",
       "      <td>DB08997</td>\n",
       "      <td>Dexetimide</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=LQQIVYSCPWCSSD-QWVACARCNA-N</td>\n",
       "      <td>InChI=1/C23H26N2O2/c26-21-11-14-23(22(27)24-21...</td>\n",
       "      <td>A muscarinic antagonist that has been used to ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7731</th>\n",
       "      <td>DB08998</td>\n",
       "      <td>Demexiptiline</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=SEDQWOMFMIJKCU-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C18H18N2O/c1-19-12-13-21-20-18-16-8-4...</td>\n",
       "      <td>Demexiptiline (Deparon, Tinoran) is a tricycli...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7732</th>\n",
       "      <td>DB08999</td>\n",
       "      <td>Cyclopentamine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=JWAHBTQSSMYISL-BSIUWKHINA-N</td>\n",
       "      <td>InChI=1/C21H28O2/c1-13(22)20(2)11-9-19-18-6-4-...</td>\n",
       "      <td>Cyclopentamine is a sympathomimetic alkylamine...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7733</th>\n",
       "      <td>DB09000</td>\n",
       "      <td>Cyamemazine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=SLFGIOIONGJGRT-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4...</td>\n",
       "      <td>Cyamemazine (Tercian), also known as cyameprom...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7734</th>\n",
       "      <td>DB09001</td>\n",
       "      <td>Barbexaclone</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>experimental</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Barbexaclone, a salt compound of propylhexedri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7735</th>\n",
       "      <td>DB09002</td>\n",
       "      <td>Cloperastine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=FLNXBVJLPJNOSI-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C20H24ClNO/c21-19-11-9-18(10-12-19)20(...</td>\n",
       "      <td>Cloperastine is a cough suppressant that acts ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7736</th>\n",
       "      <td>DB09003</td>\n",
       "      <td>Clocapramine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=QAZKXHSIKKNOHH-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C28H37ClN4O/c29-24-12-11-23-10-9-22-7...</td>\n",
       "      <td>Clocapramine is an atypical antipsychotic of t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7737</th>\n",
       "      <td>DB09004</td>\n",
       "      <td>Clobutinol</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=KVHHQGIIZCJATJ-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C14H22ClNO/c1-11(10-16(3)4)14(2,17)9-1...</td>\n",
       "      <td>Clobutinol is a cough suppressant that is with...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7738</th>\n",
       "      <td>DB09006</td>\n",
       "      <td>Clinofibrate</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=OGGAHXJZRRGBTK-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C28H36O6/c1-5-26(3,24(29)30)33-22-15-1...</td>\n",
       "      <td>Clinofibrate is a fibrate drug sold and market...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7739</th>\n",
       "      <td>DB09007</td>\n",
       "      <td>Chlorphenoxamine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=KKHPNPMTPORSQE-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-...</td>\n",
       "      <td>Chlorphenoxamine (Phenoxene) is an antihistami...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7740</th>\n",
       "      <td>DB09008</td>\n",
       "      <td>Cephaloridine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=CZTQZXZIADLWOZ-YKHWREDPNA-N</td>\n",
       "      <td>InChI=1/C19H17N3O4S2/c23-14(9-13-5-4-8-27-13)2...</td>\n",
       "      <td>Cephaloridine (or cefaloridine) is a first gen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7741</th>\n",
       "      <td>DB09009</td>\n",
       "      <td>Articaine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=QTGIAADRBBLJGA-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C13H20N2O3S/c1-5-6-14-9(3)12(16)15-10-...</td>\n",
       "      <td>Articaine is a dental local anesthetic. It is ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7742</th>\n",
       "      <td>DB09010</td>\n",
       "      <td>Carmofur</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=AOCCBINRVIKJHY-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-...</td>\n",
       "      <td>Carmofur is a derivative of fluorouracil, and ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7743</th>\n",
       "      <td>DB09012</td>\n",
       "      <td>Carbazochrome</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|investigational|withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Carbazochrome is an antihemorrhagic, or hemost...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7744</th>\n",
       "      <td>DB09013</td>\n",
       "      <td>Befunolol</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>experimental</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=IVSAVFPIVBOGEJ-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C16H23NO4/c1-10(2)17-8-13(19)9-20-14-6...</td>\n",
       "      <td>Befunolol is a beta blocker introduced in 1983...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7745</th>\n",
       "      <td>DB09014</td>\n",
       "      <td>Captodiame</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=IZLPZXSZLLELBJ-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C21H29NS2/c1-4-5-16-23-20-13-11-19(12-...</td>\n",
       "      <td>Captodiame, also known as captodiamine, is an ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7746</th>\n",
       "      <td>DB09015</td>\n",
       "      <td>Potassium Canrenoate</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=JTZQCHFUGHIPDF-IJYBFQDMNA-M</td>\n",
       "      <td>InChI=1/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-...</td>\n",
       "      <td>Potassium canrenoate, the potassium salt of ca...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7747</th>\n",
       "      <td>DB09016</td>\n",
       "      <td>Butriptyline</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Butriptyline is a tricyclic antidepressant whi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7748</th>\n",
       "      <td>DB09017</td>\n",
       "      <td>Brotizolam</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=UMSGKTJDUHERQW-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C15H10BrClN4S/c1-8-19-20-13-7-18-14(9...</td>\n",
       "      <td>Brotizolam is a sedative-hypnotic thienodiazep...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7749</th>\n",
       "      <td>DB09018</td>\n",
       "      <td>Bromopride</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=GIYAQDDTCWHPPL-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19...</td>\n",
       "      <td>Bromopride is a dopamine antagonist with proki...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7750</th>\n",
       "      <td>DB09019</td>\n",
       "      <td>Bromhexine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=OJGDCBLYJGHCIH-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-1...</td>\n",
       "      <td>Bromhexine is an expectorant/mucolytic agent. ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7751</th>\n",
       "      <td>DB09020</td>\n",
       "      <td>Bisacodyl</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=KHOITXIGCFIULA-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11...</td>\n",
       "      <td>Bisacodyl is an organic compound that is used ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7752</th>\n",
       "      <td>DB09021</td>\n",
       "      <td>Benzoctamine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Benzoctamine is a drug that possesses sedative...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7753</th>\n",
       "      <td>DB09022</td>\n",
       "      <td>Benfluorex</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=CJAVTWRYCDNHSM-UHFFFAOYNA-N</td>\n",
       "      <td>InChI=1/C19H20F3NO2/c1-14(12-15-6-5-9-17(13-15...</td>\n",
       "      <td>Benfluorex is an anorectic and hypolipidemic a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7754</th>\n",
       "      <td>DB09023</td>\n",
       "      <td>Benactyzine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>withdrawn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=IVQOFBKHQCTVQV-UHFFFAOYSA-N</td>\n",
       "      <td>InChI=1S/C20H25NO3/c1-3-21(4-2)15-16-24-19(22)...</td>\n",
       "      <td>Benactyzine is an anticholinergic drug used as...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7755</th>\n",
       "      <td>DB09024</td>\n",
       "      <td>Follitropin Alpha</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Follitropin alpha is a human follicle stimulat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7756</th>\n",
       "      <td>DB09026</td>\n",
       "      <td>Aliskiren</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7757</th>\n",
       "      <td>DB09028</td>\n",
       "      <td>Cytisine</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>approved|investigational</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>InChIKey=ANJTVLIZGCUXLD-DTWKUNHWSA-N</td>\n",
       "      <td>InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-...</td>\n",
       "      <td>Cytisine is an alkaloid that is found naturall...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7758</th>\n",
       "      <td>DB09029</td>\n",
       "      <td>Secukinumab</td>\n",
       "      <td>biotech</td>\n",
       "      <td>approved</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A human monoclonal antibody, secukinumab (Cose...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>7759 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     drugbank_id                        name            type  \\\n",
       "0        DB00001                   Lepirudin         biotech   \n",
       "1        DB00002                   Cetuximab         biotech   \n",
       "2        DB00003                Dornase alfa         biotech   \n",
       "3        DB00004         Denileukin diftitox         biotech   \n",
       "4        DB00005                  Etanercept         biotech   \n",
       "5        DB00006                 Bivalirudin         biotech   \n",
       "6        DB00007                  Leuprolide         biotech   \n",
       "7        DB00008       Peginterferon alfa-2a         biotech   \n",
       "8        DB00009                   Alteplase         biotech   \n",
       "9        DB00010                  Sermorelin         biotech   \n",
       "10       DB00011          Interferon alfa-n1         biotech   \n",
       "11       DB00012            Darbepoetin alfa         biotech   \n",
       "12       DB00013                   Urokinase         biotech   \n",
       "13       DB00014                   Goserelin  small molecule   \n",
       "14       DB00015                   Reteplase         biotech   \n",
       "15       DB00016                Epoetin alfa         biotech   \n",
       "16       DB00017           Salmon Calcitonin         biotech   \n",
       "17       DB00018          Interferon alfa-n3         biotech   \n",
       "18       DB00019               Pegfilgrastim         biotech   \n",
       "19       DB00020                Sargramostim         biotech   \n",
       "20       DB00021                    Secretin         biotech   \n",
       "21       DB00022       Peginterferon alfa-2b         biotech   \n",
       "22       DB00023                Asparaginase         biotech   \n",
       "23       DB00024            Thyrotropin Alfa         biotech   \n",
       "24       DB00025       Antihemophilic Factor         biotech   \n",
       "25       DB00026                    Anakinra         biotech   \n",
       "26       DB00027                Gramicidin D         biotech   \n",
       "27       DB00028  Intravenous Immunoglobulin         biotech   \n",
       "28       DB00029                Anistreplase         biotech   \n",
       "29       DB00030             Insulin Regular         biotech   \n",
       "...          ...                         ...             ...   \n",
       "7729     DB08996                 Dimetacrine  small molecule   \n",
       "7730     DB08997                  Dexetimide  small molecule   \n",
       "7731     DB08998               Demexiptiline  small molecule   \n",
       "7732     DB08999              Cyclopentamine  small molecule   \n",
       "7733     DB09000                 Cyamemazine  small molecule   \n",
       "7734     DB09001                Barbexaclone  small molecule   \n",
       "7735     DB09002                Cloperastine  small molecule   \n",
       "7736     DB09003                Clocapramine  small molecule   \n",
       "7737     DB09004                  Clobutinol  small molecule   \n",
       "7738     DB09006                Clinofibrate  small molecule   \n",
       "7739     DB09007            Chlorphenoxamine  small molecule   \n",
       "7740     DB09008               Cephaloridine  small molecule   \n",
       "7741     DB09009                   Articaine  small molecule   \n",
       "7742     DB09010                    Carmofur  small molecule   \n",
       "7743     DB09012               Carbazochrome  small molecule   \n",
       "7744     DB09013                   Befunolol  small molecule   \n",
       "7745     DB09014                  Captodiame  small molecule   \n",
       "7746     DB09015        Potassium Canrenoate  small molecule   \n",
       "7747     DB09016                Butriptyline  small molecule   \n",
       "7748     DB09017                  Brotizolam  small molecule   \n",
       "7749     DB09018                  Bromopride  small molecule   \n",
       "7750     DB09019                  Bromhexine  small molecule   \n",
       "7751     DB09020                   Bisacodyl  small molecule   \n",
       "7752     DB09021                Benzoctamine  small molecule   \n",
       "7753     DB09022                  Benfluorex  small molecule   \n",
       "7754     DB09023                 Benactyzine  small molecule   \n",
       "7755     DB09024           Follitropin Alpha         biotech   \n",
       "7756     DB09026                   Aliskiren         biotech   \n",
       "7757     DB09028                    Cytisine  small molecule   \n",
       "7758     DB09029                 Secukinumab         biotech   \n",
       "\n",
       "                                     groups  \\\n",
       "0                                  approved   \n",
       "1                                  approved   \n",
       "2                                  approved   \n",
       "3                  approved|investigational   \n",
       "4                  approved|investigational   \n",
       "5                  approved|investigational   \n",
       "6                  approved|investigational   \n",
       "7                  approved|investigational   \n",
       "8                                  approved   \n",
       "9                        approved|withdrawn   \n",
       "10                                 approved   \n",
       "11                 approved|investigational   \n",
       "12       approved|investigational|withdrawn   \n",
       "13                                 approved   \n",
       "14                                 approved   \n",
       "15                                 approved   \n",
       "16                 approved|investigational   \n",
       "17                 approved|investigational   \n",
       "18                                 approved   \n",
       "19                 approved|investigational   \n",
       "20                 approved|investigational   \n",
       "21                                 approved   \n",
       "22                                 approved   \n",
       "23                                 approved   \n",
       "24                 approved|investigational   \n",
       "25                                 approved   \n",
       "26                                 approved   \n",
       "27                 approved|investigational   \n",
       "28                                 approved   \n",
       "29    approved|experimental|investigational   \n",
       "...                                     ...   \n",
       "7729                     approved|withdrawn   \n",
       "7730                              withdrawn   \n",
       "7731                               approved   \n",
       "7732                              withdrawn   \n",
       "7733                               approved   \n",
       "7734                           experimental   \n",
       "7735               approved|investigational   \n",
       "7736                               approved   \n",
       "7737                              withdrawn   \n",
       "7738                               approved   \n",
       "7739                              withdrawn   \n",
       "7740                     approved|withdrawn   \n",
       "7741                               approved   \n",
       "7742                              withdrawn   \n",
       "7743     approved|investigational|withdrawn   \n",
       "7744                           experimental   \n",
       "7745               approved|investigational   \n",
       "7746                     approved|withdrawn   \n",
       "7747                               approved   \n",
       "7748                     approved|withdrawn   \n",
       "7749                               approved   \n",
       "7750                               approved   \n",
       "7751                               approved   \n",
       "7752                               approved   \n",
       "7753                              withdrawn   \n",
       "7754                              withdrawn   \n",
       "7755                               approved   \n",
       "7756               approved|investigational   \n",
       "7757               approved|investigational   \n",
       "7758                               approved   \n",
       "\n",
       "                                              atc_codes  \\\n",
       "0                                               B01AE02   \n",
       "1                                               L01XC06   \n",
       "2                                               R05CB13   \n",
       "3                                               L01XX29   \n",
       "4                                               L04AB01   \n",
       "5                                               B01AE06   \n",
       "6                                               L02AE02   \n",
       "7                                               L03AB11   \n",
       "8                                       B01AD02|S01XA13   \n",
       "9                                       H01AC04|V04CD03   \n",
       "10                                              L03AB06   \n",
       "11                                              B03XA02   \n",
       "12                                              B01AD04   \n",
       "13                                              L02AE03   \n",
       "14                                              B01AD07   \n",
       "15                                              B03XA01   \n",
       "16                                              H05BA01   \n",
       "17                                                  NaN   \n",
       "18                                              L03AA10   \n",
       "19                                              L03AA09   \n",
       "20                                              V04CK01   \n",
       "21                                              L03AB10   \n",
       "22                                              L01XX02   \n",
       "23                                              V04CJ01   \n",
       "24                                              B02BD02   \n",
       "25                                              L04AC03   \n",
       "26                                              R02AB30   \n",
       "27                                      J06BA02|J06BA01   \n",
       "28                                              B01AD03   \n",
       "29    A10AB01|A10AE05|A10AB04|A10AE04|A10AD05|A10AC0...   \n",
       "...                                                 ...   \n",
       "7729                                                NaN   \n",
       "7730                                                NaN   \n",
       "7731                                                NaN   \n",
       "7732                                                NaN   \n",
       "7733                                                NaN   \n",
       "7734                                                NaN   \n",
       "7735                                                NaN   \n",
       "7736                                                NaN   \n",
       "7737                                                NaN   \n",
       "7738                                                NaN   \n",
       "7739                                                NaN   \n",
       "7740                                                NaN   \n",
       "7741                                                NaN   \n",
       "7742                                                NaN   \n",
       "7743                                                NaN   \n",
       "7744                                                NaN   \n",
       "7745                                                NaN   \n",
       "7746                                                NaN   \n",
       "7747                                                NaN   \n",
       "7748                                                NaN   \n",
       "7749                                                NaN   \n",
       "7750                                                NaN   \n",
       "7751                                                NaN   \n",
       "7752                                                NaN   \n",
       "7753                                                NaN   \n",
       "7754                                                NaN   \n",
       "7755                                                NaN   \n",
       "7756                                                NaN   \n",
       "7757                                                NaN   \n",
       "7758                                                NaN   \n",
       "\n",
       "                                             categories  \\\n",
       "0                     Antithrombins|Fibrinolytic Agents   \n",
       "1                                 Antineoplastic Agents   \n",
       "2                                               Enzymes   \n",
       "3                                 Antineoplastic Agents   \n",
       "4                              Immunosuppressive Agents   \n",
       "5                                         Antithrombins   \n",
       "6     Antineoplastic Agents, Hormonal|Fertility Agen...   \n",
       "7                              Immunosuppressive Agents   \n",
       "8                                   Thrombolytic Agents   \n",
       "9                            Hormone Replacement Agents   \n",
       "10    Antiviral Agents|Immunologic Factors|Immunosup...   \n",
       "11                        Hematinics|Anti-anemic Agents   \n",
       "12                                  Thrombolytic Agents   \n",
       "13                                                  NaN   \n",
       "14              Fibrinolytic Agents|Thrombolytic Agents   \n",
       "15                        Hematinics|Anti-anemic Agents   \n",
       "16    Bone Density Conservation Agents|Antihypercalc...   \n",
       "17                             Immunosuppressive Agents   \n",
       "18      Immunosuppressive Agents|Antineutropenic Agents   \n",
       "19                             Immunosuppressive Agents   \n",
       "20                                    Diagnostic Agents   \n",
       "21                             Immunosuppressive Agents   \n",
       "22                                Antineoplastic Agents   \n",
       "23                                    Diagnostic Agents   \n",
       "24                         Coagulants|Thrombotic Agents   \n",
       "25        Antirheumatic Agents|Immunosuppressive Agents   \n",
       "26    Anti-Bacterial Agents|Anti-Infective Agents|An...   \n",
       "27    Immunologic Factors|Immunosuppressive Agents|A...   \n",
       "28              Fibrinolytic Agents|Thrombolytic Agents   \n",
       "29                                  Antidiabetic Agents   \n",
       "...                                                 ...   \n",
       "7729                                                NaN   \n",
       "7730                                                NaN   \n",
       "7731                                                NaN   \n",
       "7732                                                NaN   \n",
       "7733                                                NaN   \n",
       "7734                                                NaN   \n",
       "7735                                                NaN   \n",
       "7736                                                NaN   \n",
       "7737                                                NaN   \n",
       "7738                                                NaN   \n",
       "7739                                                NaN   \n",
       "7740                                                NaN   \n",
       "7741                                                NaN   \n",
       "7742                                                NaN   \n",
       "7743                                                NaN   \n",
       "7744                                                NaN   \n",
       "7745                                                NaN   \n",
       "7746                                                NaN   \n",
       "7747                                                NaN   \n",
       "7748                                                NaN   \n",
       "7749                                                NaN   \n",
       "7750                                                NaN   \n",
       "7751                                                NaN   \n",
       "7752                                                NaN   \n",
       "7753                                                NaN   \n",
       "7754                                                NaN   \n",
       "7755                                                NaN   \n",
       "7756                                                NaN   \n",
       "7757                                                NaN   \n",
       "7758                                                NaN   \n",
       "\n",
       "                                  inchikey  \\\n",
       "0                                      NaN   \n",
       "1                                      NaN   \n",
       "2                                      NaN   \n",
       "3                                      NaN   \n",
       "4                                      NaN   \n",
       "5                                      NaN   \n",
       "6                                      NaN   \n",
       "7                                      NaN   \n",
       "8                                      NaN   \n",
       "9                                      NaN   \n",
       "10                                     NaN   \n",
       "11                                     NaN   \n",
       "12                                     NaN   \n",
       "13    InChIKey=BLCLNMBMMGCOAS-URPVMXJPSA-N   \n",
       "14                                     NaN   \n",
       "15                                     NaN   \n",
       "16                                     NaN   \n",
       "17                                     NaN   \n",
       "18                                     NaN   \n",
       "19                                     NaN   \n",
       "20                                     NaN   \n",
       "21                                     NaN   \n",
       "22                                     NaN   \n",
       "23                                     NaN   \n",
       "24                                     NaN   \n",
       "25                                     NaN   \n",
       "26                                     NaN   \n",
       "27                                     NaN   \n",
       "28                                     NaN   \n",
       "29                                     NaN   \n",
       "...                                    ...   \n",
       "7729  InChIKey=RYQOGSFEJBUZBX-UHFFFAOYSA-N   \n",
       "7730  InChIKey=LQQIVYSCPWCSSD-QWVACARCNA-N   \n",
       "7731  InChIKey=SEDQWOMFMIJKCU-UHFFFAOYSA-N   \n",
       "7732  InChIKey=JWAHBTQSSMYISL-BSIUWKHINA-N   \n",
       "7733  InChIKey=SLFGIOIONGJGRT-UHFFFAOYNA-N   \n",
       "7734                                   NaN   \n",
       "7735  InChIKey=FLNXBVJLPJNOSI-UHFFFAOYNA-N   \n",
       "7736  InChIKey=QAZKXHSIKKNOHH-UHFFFAOYSA-N   \n",
       "7737  InChIKey=KVHHQGIIZCJATJ-UHFFFAOYNA-N   \n",
       "7738  InChIKey=OGGAHXJZRRGBTK-UHFFFAOYNA-N   \n",
       "7739  InChIKey=KKHPNPMTPORSQE-UHFFFAOYNA-N   \n",
       "7740  InChIKey=CZTQZXZIADLWOZ-YKHWREDPNA-N   \n",
       "7741  InChIKey=QTGIAADRBBLJGA-UHFFFAOYNA-N   \n",
       "7742  InChIKey=AOCCBINRVIKJHY-UHFFFAOYSA-N   \n",
       "7743                                   NaN   \n",
       "7744  InChIKey=IVSAVFPIVBOGEJ-UHFFFAOYNA-N   \n",
       "7745  InChIKey=IZLPZXSZLLELBJ-UHFFFAOYNA-N   \n",
       "7746  InChIKey=JTZQCHFUGHIPDF-IJYBFQDMNA-M   \n",
       "7747                                   NaN   \n",
       "7748  InChIKey=UMSGKTJDUHERQW-UHFFFAOYSA-N   \n",
       "7749  InChIKey=GIYAQDDTCWHPPL-UHFFFAOYSA-N   \n",
       "7750  InChIKey=OJGDCBLYJGHCIH-UHFFFAOYSA-N   \n",
       "7751  InChIKey=KHOITXIGCFIULA-UHFFFAOYSA-N   \n",
       "7752                                   NaN   \n",
       "7753  InChIKey=CJAVTWRYCDNHSM-UHFFFAOYNA-N   \n",
       "7754  InChIKey=IVQOFBKHQCTVQV-UHFFFAOYSA-N   \n",
       "7755                                   NaN   \n",
       "7756                                   NaN   \n",
       "7757  InChIKey=ANJTVLIZGCUXLD-DTWKUNHWSA-N   \n",
       "7758                                   NaN   \n",
       "\n",
       "                                                  inchi  \\\n",
       "0                                                   NaN   \n",
       "1                                                   NaN   \n",
       "2                                                   NaN   \n",
       "3                                                   NaN   \n",
       "4                                                   NaN   \n",
       "5                                                   NaN   \n",
       "6                                                   NaN   \n",
       "7                                                   NaN   \n",
       "8                                                   NaN   \n",
       "9                                                   NaN   \n",
       "10                                                  NaN   \n",
       "11                                                  NaN   \n",
       "12                                                  NaN   \n",
       "13    InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-3...   \n",
       "14                                                  NaN   \n",
       "15                                                  NaN   \n",
       "16                                                  NaN   \n",
       "17                                                  NaN   \n",
       "18                                                  NaN   \n",
       "19                                                  NaN   \n",
       "20                                                  NaN   \n",
       "21                                                  NaN   \n",
       "22                                                  NaN   \n",
       "23                                                  NaN   \n",
       "24                                                  NaN   \n",
       "25                                                  NaN   \n",
       "26                                                  NaN   \n",
       "27                                                  NaN   \n",
       "28                                                  NaN   \n",
       "29                                                  NaN   \n",
       "...                                                 ...   \n",
       "7729  InChI=1S/C20H26N2/c1-20(2)16-10-5-7-12-18(16)2...   \n",
       "7730  InChI=1/C23H26N2O2/c26-21-11-14-23(22(27)24-21...   \n",
       "7731  InChI=1S/C18H18N2O/c1-19-12-13-21-20-18-16-8-4...   \n",
       "7732  InChI=1/C21H28O2/c1-13(22)20(2)11-9-19-18-6-4-...   \n",
       "7733  InChI=1/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4...   \n",
       "7734                                                NaN   \n",
       "7735  InChI=1/C20H24ClNO/c21-19-11-9-18(10-12-19)20(...   \n",
       "7736  InChI=1S/C28H37ClN4O/c29-24-12-11-23-10-9-22-7...   \n",
       "7737  InChI=1/C14H22ClNO/c1-11(10-16(3)4)14(2,17)9-1...   \n",
       "7738  InChI=1/C28H36O6/c1-5-26(3,24(29)30)33-22-15-1...   \n",
       "7739  InChI=1/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-...   \n",
       "7740  InChI=1/C19H17N3O4S2/c23-14(9-13-5-4-8-27-13)2...   \n",
       "7741  InChI=1/C13H20N2O3S/c1-5-6-14-9(3)12(16)15-10-...   \n",
       "7742  InChI=1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-...   \n",
       "7743                                                NaN   \n",
       "7744  InChI=1/C16H23NO4/c1-10(2)17-8-13(19)9-20-14-6...   \n",
       "7745  InChI=1/C21H29NS2/c1-4-5-16-23-20-13-11-19(12-...   \n",
       "7746  InChI=1/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-...   \n",
       "7747                                                NaN   \n",
       "7748  InChI=1S/C15H10BrClN4S/c1-8-19-20-13-7-18-14(9...   \n",
       "7749  InChI=1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19...   \n",
       "7750  InChI=1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-1...   \n",
       "7751  InChI=1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11...   \n",
       "7752                                                NaN   \n",
       "7753  InChI=1/C19H20F3NO2/c1-14(12-15-6-5-9-17(13-15...   \n",
       "7754  InChI=1S/C20H25NO3/c1-3-21(4-2)15-16-24-19(22)...   \n",
       "7755                                                NaN   \n",
       "7756                                                NaN   \n",
       "7757  InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-...   \n",
       "7758                                                NaN   \n",
       "\n",
       "                                            description  \n",
       "0     Lepirudin is identical to natural hirudin exce...  \n",
       "1     Epidermal growth factor receptor binding FAB. ...  \n",
       "2     Dornase alfa is a biosynthetic form of human d...  \n",
       "3     A recombinant DNA-derived cytotoxic protein co...  \n",
       "4     Dimeric fusion protein consisting of the extra...  \n",
       "5     Bivalirudin is a synthetic 20 residue peptide ...  \n",
       "6     Leuprolide belongs to the general class of dru...  \n",
       "7     Human interferon 2a, is a covalent conjugate o...  \n",
       "8     Human tissue plasminogen activator, purified, ...  \n",
       "9     Sermorelin acetate is the acetate salt of an a...  \n",
       "10    Purified, natural (n is for natural) glycosyla...  \n",
       "11    Human erythropoietin with 2 aa substitutions t...  \n",
       "12    Low molecular weight form of human urokinase, ...  \n",
       "13    Goserelin is a synthetic hormone. In men, it s...  \n",
       "14    Human tissue plasminogen activator, purified, ...  \n",
       "15    Human erythropoietin (recombinant), produced b...  \n",
       "16    Synthetic peptide, 32 residues long formulated...  \n",
       "17    Purified, natural (n is for natural) human int...  \n",
       "18    PEGylated (at N terminus) form of human G-CSF ...  \n",
       "19    Sargramostim is a human recombinant granulocyt...  \n",
       "20    This drug is the synthetic form of natural sec...  \n",
       "21    Peginterferon alfa-2b is a covalent conjugate ...  \n",
       "22             L-asparagine amidohydrolase from E. coli  \n",
       "23    Thyrotropin alfa is a recombinant form of thyr...  \n",
       "24    Human recombinant antihemophilic factor (AHF) ...  \n",
       "25    Anakinra is a recombinant, nonglycosylated hum...  \n",
       "26    Gramcidin D is a heterogeneous mixture of thre...  \n",
       "27    Intravenous immunoglobulin (IVIg) is a mixture...  \n",
       "28    Human tissue plasminogen activator, purified, ...  \n",
       "29    Insulin regular is a 51 residue peptide hormon...  \n",
       "...                                                 ...  \n",
       "7729  Dimetacrine (Istonil, Istonyl, Linostil, Miroi...  \n",
       "7730  A muscarinic antagonist that has been used to ...  \n",
       "7731  Demexiptiline (Deparon, Tinoran) is a tricycli...  \n",
       "7732  Cyclopentamine is a sympathomimetic alkylamine...  \n",
       "7733  Cyamemazine (Tercian), also known as cyameprom...  \n",
       "7734  Barbexaclone, a salt compound of propylhexedri...  \n",
       "7735  Cloperastine is a cough suppressant that acts ...  \n",
       "7736  Clocapramine is an atypical antipsychotic of t...  \n",
       "7737  Clobutinol is a cough suppressant that is with...  \n",
       "7738  Clinofibrate is a fibrate drug sold and market...  \n",
       "7739  Chlorphenoxamine (Phenoxene) is an antihistami...  \n",
       "7740  Cephaloridine (or cefaloridine) is a first gen...  \n",
       "7741  Articaine is a dental local anesthetic. It is ...  \n",
       "7742  Carmofur is a derivative of fluorouracil, and ...  \n",
       "7743  Carbazochrome is an antihemorrhagic, or hemost...  \n",
       "7744  Befunolol is a beta blocker introduced in 1983...  \n",
       "7745  Captodiame, also known as captodiamine, is an ...  \n",
       "7746  Potassium canrenoate, the potassium salt of ca...  \n",
       "7747  Butriptyline is a tricyclic antidepressant whi...  \n",
       "7748  Brotizolam is a sedative-hypnotic thienodiazep...  \n",
       "7749  Bromopride is a dopamine antagonist with proki...  \n",
       "7750  Bromhexine is an expectorant/mucolytic agent. ...  \n",
       "7751  Bisacodyl is an organic compound that is used ...  \n",
       "7752  Benzoctamine is a drug that possesses sedative...  \n",
       "7753  Benfluorex is an anorectic and hypolipidemic a...  \n",
       "7754  Benactyzine is an anticholinergic drug used as...  \n",
       "7755  Follitropin alpha is a human follicle stimulat...  \n",
       "7756                                                NaN  \n",
       "7757  Cytisine is an alkaloid that is found naturall...  \n",
       "7758  A human monoclonal antibody, secukinumab (Cose...  \n",
       "\n",
       "[7759 rows x 9 columns]"
      ]
     },
     "execution_count": 193,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"\"\"\n",
    "Trying: https://github.com/dhimmel/drugbank/blob/gh-pages/data/drugbank.tsv\n",
    "from https://github.com/dhimmel/drugbank\n",
    "\"\"\"\n",
    "db_df = pd.read_table('data/raw/drugbank.tsv',sep='\\t')\n",
    "db_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 206,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-17T00:08:28.641117Z",
     "start_time": "2019-05-17T00:08:28.331402Z"
    },
    "hidden": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>type</th>\n",
       "      <th>groups</th>\n",
       "      <th>atc_codes</th>\n",
       "      <th>categories</th>\n",
       "      <th>inchikey</th>\n",
       "      <th>inchi</th>\n",
       "      <th>description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5230</th>\n",
       "      <td>DB05470</td>\n",
       "      <td>VX-702</td>\n",
       "      <td>small molecule</td>\n",
       "      <td>investigational</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>VX-702 is a small molecule investigational ora...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     drugbank_id    name            type           groups atc_codes  \\\n",
       "5230     DB05470  VX-702  small molecule  investigational       NaN   \n",
       "\n",
       "     categories inchikey inchi  \\\n",
       "5230        NaN      NaN   NaN   \n",
       "\n",
       "                                            description  \n",
       "5230  VX-702 is a small molecule investigational ora...  "
      ]
     },
     "execution_count": 206,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "\n",
    "# db_df[db_df['name'].str.contains('paclitaxel',case=False)]\n",
    "\n",
    "drugs_in_common = pd.DataFrame()\n",
    "for drug in lower_drugs:\n",
    "    drugs_in_common = drugs_in_common.append(db_df[db_df['name'].str.contains(drug,case=False)])\n",
    "drugs_in_common"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## end of failed attempts"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Drug classes by DiSCoVER"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T21:43:12.381576Z",
     "start_time": "2019-05-30T21:43:12.374598Z"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T21:19:21.489766Z",
     "start_time": "2019-05-30T21:19:21.469244Z"
    }
   },
   "outputs": [],
   "source": [
    "drug_annotations = pd.read_csv('moa_annotations/DiSCoVER_drug_annotations.csv',index_col=0)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## making \"gene sets\" (drug sets)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T21:58:18.465874Z",
     "start_time": "2019-05-30T21:58:18.394638Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ccle_drug_name</th>\n",
       "      <th>ccle_target</th>\n",
       "      <th>gdsc_drug_name</th>\n",
       "      <th>gdsc_synonyms</th>\n",
       "      <th>gdsc_target</th>\n",
       "      <th>gdsc_target_pathway</th>\n",
       "      <th>ctrp_drug_name</th>\n",
       "      <th>ctrp_target</th>\n",
       "      <th>ctrp_target_description</th>\n",
       "      <th>synonyms</th>\n",
       "      <th>targets</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>(5z)-7-oxozeaenol</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>(5Z)-7-Oxozeaenol</td>\n",
       "      <td>5Z-7-Oxozeaenol, LL-Z1640-2</td>\n",
       "      <td>TAK1</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>5Z-7-Oxozeaenol; LL-Z1640-2; (5Z)-7-Oxozeaenol</td>\n",
       "      <td>TAK1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16-beta-bromoandrosterone</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>16-beta-bromoandrosterone</td>\n",
       "      <td>NONE</td>\n",
       "      <td>dehydroepiandrosterone (DHEA) analog</td>\n",
       "      <td>16-beta-bromoandrosterone</td>\n",
       "      <td>NONE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1s,3r-rsl-3</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>1S,3R-RSL-3</td>\n",
       "      <td>GPX4</td>\n",
       "      <td>synthetic lethal with HRAS in engineered cells...</td>\n",
       "      <td>1S,3R-RSL-3</td>\n",
       "      <td>GPX4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3-cl-ahpc</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>3-Cl-AHPC</td>\n",
       "      <td>NR0B2</td>\n",
       "      <td>binder of nuclear receptor SHP</td>\n",
       "      <td>3-Cl-AHPC</td>\n",
       "      <td>NR0B2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5-fluorouracil</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>5-Fluorouracil</td>\n",
       "      <td>5-FU</td>\n",
       "      <td>Antimetabolite (DNA &amp; RNA)</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>5-FU; 5-Fluorouracil</td>\n",
       "      <td>Antimetabolite (DNA &amp; RNA)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>968</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>968</td>\n",
       "      <td>GLS</td>\n",
       "      <td>inhibitor of glutaminase</td>\n",
       "      <td>968</td>\n",
       "      <td>GLS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a-443654</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>A-443654</td>\n",
       "      <td>KIN001-139</td>\n",
       "      <td>AKT1; AKT2; AKT3</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>A-443654; KIN001-139</td>\n",
       "      <td>AKT2; AKT1; AKT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a-770041</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>A-770041</td>\n",
       "      <td>KIN001-111</td>\n",
       "      <td>LCK; FYN</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>KIN001-111; A-770041</td>\n",
       "      <td>FYN; LCK</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a-804598</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>A-804598</td>\n",
       "      <td>P2RX7</td>\n",
       "      <td>inhibitor of purinergic receptor P2X</td>\n",
       "      <td>A-804598</td>\n",
       "      <td>P2RX7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aa-cocf3</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AA-COCF3</td>\n",
       "      <td>FAAH; PLA2G4A; PLA2G4B; PLA2G4C; PLA2G4D</td>\n",
       "      <td>inhibitor of cytosolic phospholipase A2; inhib...</td>\n",
       "      <td>AA-COCF3</td>\n",
       "      <td>PLA2G4A; FAAH; PLA2G4C; PLA2G4D; PLA2G4B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abiraterone</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>abiraterone</td>\n",
       "      <td>CYP17A1</td>\n",
       "      <td>inhibitor of 17 alpha-hydroxylase and C17,20 l...</td>\n",
       "      <td>abiraterone</td>\n",
       "      <td>CYP17A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-199</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ABT-199</td>\n",
       "      <td>BCL2</td>\n",
       "      <td>inhibitor of BCL2</td>\n",
       "      <td>ABT-199</td>\n",
       "      <td>BCL2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>BCL2; BCL2L1; BCL2L2</td>\n",
       "      <td>inhibitor of BCL2, BCL-xL, and BCL-W</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>BCL2; BCL2L2; BCL2L1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ac55649</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AC55649</td>\n",
       "      <td>RARB</td>\n",
       "      <td>agonist of retinoic acid receptor beta</td>\n",
       "      <td>AC55649</td>\n",
       "      <td>RARB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aew541</th>\n",
       "      <td>AEW541</td>\n",
       "      <td>IGF1R</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AEW541</td>\n",
       "      <td>IGF1R</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>afatinib</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Afatinib</td>\n",
       "      <td>BIBW2992, Tovok, Gilotrif</td>\n",
       "      <td>ERBB2; EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>EGFR; ERBB2</td>\n",
       "      <td>inhibitor of EGFR and HER2</td>\n",
       "      <td>Gilotrif; Afatinib; Tovok; BIBW2992; afatinib</td>\n",
       "      <td>ERBB2; EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>agk-2</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AGK-2</td>\n",
       "      <td>SIRT2</td>\n",
       "      <td>inhibitor of sirtuin 2</td>\n",
       "      <td>AGK-2</td>\n",
       "      <td>SIRT2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aica ribonucleotide</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AICA Ribonucleotide</td>\n",
       "      <td>AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole...</td>\n",
       "      <td>AMPK agonist</td>\n",
       "      <td>Metabolism</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AICA Ribonucleotide; N1-(b-D-Ribofuranosyl)-5-...</td>\n",
       "      <td>AMPK agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>akt inhibitor viii</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AKT inhibitor VIII</td>\n",
       "      <td>Akti-1/2</td>\n",
       "      <td>AKT1; AKT2; AKT3</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Akti-1/2; AKT inhibitor VIII</td>\n",
       "      <td>AKT2; AKT1; AKT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alectinib</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>CH5424802, CH 542802, Alecensa</td>\n",
       "      <td>ALK</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>CH5424802; Alectinib; Alecensa; CH 542802</td>\n",
       "      <td>ALK</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>alisertib</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "      <td>inhibitor of aurora kinases A and B</td>\n",
       "      <td>alisertib</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib:navitoclax (2:1 mol/mol)</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>alisertib:navitoclax (2:1 mol/mol)</td>\n",
       "      <td>AURKA; AURKB; BCL2; BCL2L1; BCL2L2</td>\n",
       "      <td>inhibitor of aurora kinases A and B;inhibitor ...</td>\n",
       "      <td>alisertib:navitoclax (2:1 mol/mol)</td>\n",
       "      <td>BCL2; BCL2L2; BCL2L1; AURKA; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alvocidib</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>alvocidib</td>\n",
       "      <td>CDK1; CDK2; CDK4; CDK6</td>\n",
       "      <td>inhibitor of cyclin-dependent kinases</td>\n",
       "      <td>alvocidib</td>\n",
       "      <td>CDK1; CDK4; CDK6; CDK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>am-580</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AM-580</td>\n",
       "      <td>RARA</td>\n",
       "      <td>agonist of retinoic acid receptor alpha</td>\n",
       "      <td>AM-580</td>\n",
       "      <td>RARA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>amuvatinib</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Amuvatinib</td>\n",
       "      <td>MP470, MP 470, MP-470</td>\n",
       "      <td>KIT; PDGFRA; FLT3</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>MP470; MP-470; MP 470; Amuvatinib</td>\n",
       "      <td>PDGFRA; KIT; FLT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>apicidin</td>\n",
       "      <td>HDAC1; HDAC2; HDAC3; HDAC6; HDAC8</td>\n",
       "      <td>inhibitor of HDAC1, HDAC2, HDAC3, HDAC6, and H...</td>\n",
       "      <td>apicidin</td>\n",
       "      <td>HDAC8; HDAC1; HDAC3; HDAC2; HDAC6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ar-42</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AR-42</td>\n",
       "      <td>HDAC-42, AR 42, AR42</td>\n",
       "      <td>HDAC1</td>\n",
       "      <td>Chromatin histone acetylation</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>HDAC-42; AR 42; AR-42; AR42</td>\n",
       "      <td>HDAC1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>as601245</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AS601245</td>\n",
       "      <td>NONE</td>\n",
       "      <td>JNK1; JNK2; JNK2</td>\n",
       "      <td>JNK and p38 signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AS601245</td>\n",
       "      <td>JNK1; JNK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>as605240</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AS605240</td>\n",
       "      <td>KIN001-173, AS-605240</td>\n",
       "      <td>PI3Kgamma</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AS605240; KIN001-173; AS-605240</td>\n",
       "      <td>PI3Kgamma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>at-406</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>AT-406</td>\n",
       "      <td>XIAP</td>\n",
       "      <td>SMAC mimetic; inhibitor of inhibitor of apopto...</td>\n",
       "      <td>AT-406</td>\n",
       "      <td>XIAP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-680</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>VX-680</td>\n",
       "      <td>AURKA; AURKB; AURKC</td>\n",
       "      <td>inhibitor of aurora kinases</td>\n",
       "      <td>VX-680</td>\n",
       "      <td>AURKA; AURKC; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>VX-702</td>\n",
       "      <td>VX702, VX 702</td>\n",
       "      <td>p38</td>\n",
       "      <td>JNK and p38 signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>VX702; VX-702; VX 702</td>\n",
       "      <td>p38</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>way-362450</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WAY-362450</td>\n",
       "      <td>NR1H4</td>\n",
       "      <td>agonist of farnesoid X receptor</td>\n",
       "      <td>WAY-362450</td>\n",
       "      <td>NR1H4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wee1 inhibitor</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Wee1 Inhibitor</td>\n",
       "      <td>681640, Wee1 Inhibitor</td>\n",
       "      <td>WEE1; CHEK1</td>\n",
       "      <td>Cell cycle</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>681640; Wee1 Inhibitor</td>\n",
       "      <td>CHEK1; WEE1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wh-4-023</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WH-4-023</td>\n",
       "      <td>KIN001-112</td>\n",
       "      <td>SRC; LCK</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>KIN001-112; WH-4-023</td>\n",
       "      <td>LCK; SRC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>whi-p97</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WHI-P97</td>\n",
       "      <td>AC1L1GQE, KIN001-055</td>\n",
       "      <td>JAK3</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WHI-P97; KIN001-055; AC1L1GQE</td>\n",
       "      <td>JAK3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wp1130</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WP1130</td>\n",
       "      <td>UCHL5; USP14; USP5; USP9X</td>\n",
       "      <td>inhibitor of the deubiquitinase activity of US...</td>\n",
       "      <td>WP1130</td>\n",
       "      <td>USP5; UCHL5; USP14; USP9X</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz-1-84</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WZ-1-84</td>\n",
       "      <td>KIN001-123</td>\n",
       "      <td>BMX</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WZ-1-84; KIN001-123</td>\n",
       "      <td>BMX</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz3105</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WZ3105</td>\n",
       "      <td>NONE</td>\n",
       "      <td>SRC; ROCK2; NTRK2; FLT3; IRAK1; others</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WZ3105</td>\n",
       "      <td>ROCK2; NTRK2; SRC; others; IRAK1; FLT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz4002</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WZ4002</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>inhibitor of EGFR targeting T790M resistance</td>\n",
       "      <td>WZ4002</td>\n",
       "      <td>EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz8040</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>WZ8040</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>inhibitor of EGFR targeting T790M resistance</td>\n",
       "      <td>WZ8040</td>\n",
       "      <td>EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xav939</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XAV939</td>\n",
       "      <td>NVP-XAV939, XAV-939, XAV 939</td>\n",
       "      <td>TNKS1; TNKS2</td>\n",
       "      <td>WNT signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XAV939; XAV 939; XAV-939; NVP-XAV939</td>\n",
       "      <td>TNKS2; TNKS1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xl765</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XL765</td>\n",
       "      <td>MTOR; PIK3CA; PIK3CB; PIK3CD; PIK3CG; PRKDC</td>\n",
       "      <td>inhibitor of mTOR and PI3K kinase acitivities</td>\n",
       "      <td>XL765</td>\n",
       "      <td>PRKDC; PIK3CA; MTOR; PIK3CB; PIK3CG; PIK3CD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd11-85h</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD11-85h</td>\n",
       "      <td>NONE</td>\n",
       "      <td>BRSK2; FLT4; MARK4; PRKCD; RET; SPRK1</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD11-85h</td>\n",
       "      <td>PRKCD; FLT4; SPRK1; RET; BRSK2; MARK4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd13-2</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD13-2</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RIPK1</td>\n",
       "      <td>Apoptosis regulation</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD13-2</td>\n",
       "      <td>RIPK1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd14-99</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD14-99</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ALK; CDK7; LTK; others</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD14-99</td>\n",
       "      <td>ALK; LTK; others; CDK7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd15-27</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD15-27</td>\n",
       "      <td>NONE</td>\n",
       "      <td>CAMK2</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD15-27</td>\n",
       "      <td>CAMK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd8-85</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD8-85</td>\n",
       "      <td>ERK5-IN-1</td>\n",
       "      <td>ERK5; BET</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD8-85; ERK5-IN-1</td>\n",
       "      <td>ERK5; BET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd8-92</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD8-92</td>\n",
       "      <td>XMD 8-92</td>\n",
       "      <td>MAPK7</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>XMD8-92; XMD 8-92</td>\n",
       "      <td>MAPK7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>y-39983</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Y-39983</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ROCK</td>\n",
       "      <td>Cytoskeleton</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Y-39983</td>\n",
       "      <td>ROCK</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>yk-4-279</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>YK-4-279</td>\n",
       "      <td>YK 4-279</td>\n",
       "      <td>RNA helicase A</td>\n",
       "      <td>Other</td>\n",
       "      <td>YK 4-279</td>\n",
       "      <td>DHX9; ERG; ETV1</td>\n",
       "      <td>inhibitor of RNA helicase A (RHA) binding to E...</td>\n",
       "      <td>YK-4-279; YK 4-279</td>\n",
       "      <td>RNA helicase A; DHX9; ERG; ETV1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>yl54</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>YL54</td>\n",
       "      <td>NONE</td>\n",
       "      <td>stapled helical peptide</td>\n",
       "      <td>YL54</td>\n",
       "      <td>NONE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ym201636</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>YM201636</td>\n",
       "      <td>YM-201636, YM 201636</td>\n",
       "      <td>PYKFYVE</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>YM201636; YM 201636; YM-201636</td>\n",
       "      <td>PYKFYVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>z-llnle-cho</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Z-LLNle-CHO</td>\n",
       "      <td>Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1</td>\n",
       "      <td>gamma-secretase</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Gamma-Secretase Inhibitor 1; Z-L-Norleucine-CH...</td>\n",
       "      <td>gamma-secretase</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zd-6474</th>\n",
       "      <td>ZD-6474</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ZD-6474</td>\n",
       "      <td>EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zebularine</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>zebularine</td>\n",
       "      <td>DNMT1</td>\n",
       "      <td>inhibitor of DNA methyltransferases</td>\n",
       "      <td>zebularine</td>\n",
       "      <td>DNMT1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zg-10</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ZG-10</td>\n",
       "      <td>NONE</td>\n",
       "      <td>JNK1</td>\n",
       "      <td>JNK and p38 signaling</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ZG-10</td>\n",
       "      <td>JNK1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zibotentan</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Zibotentan</td>\n",
       "      <td>ZD4054, ZD-4054</td>\n",
       "      <td>Endothelin-1 receptor (EDNRA)</td>\n",
       "      <td>Other</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>Zibotentan; ZD4054; ZD-4054</td>\n",
       "      <td>Endothelin-1 receptor (EDNRA)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zm447439</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ZM447439</td>\n",
       "      <td>ZM-447439, ZM 447439</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "      <td>Mitosis</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ZM447439; ZM 447439; ZM-447439</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zstk474</th>\n",
       "      <td>NONE</td>\n",
       "      <td>NONE</td>\n",
       "      <td>ZSTK474</td>\n",
       "      <td>KIN001-167, ZSTK-474, ZSTK 474</td>\n",
       "      <td>PI3K (class 1)</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>ZSTK474</td>\n",
       "      <td>PIK3CB; PIK3CD; PIK3CG</td>\n",
       "      <td>inhibitor of PI3K catalytic subunits beta, del...</td>\n",
       "      <td>ZSTK-474; ZSTK 474; ZSTK474; KIN001-167</td>\n",
       "      <td>PI3K (class 1); PIK3CB; PIK3CG; PIK3CD</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>715 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                   ccle_drug_name ccle_target  \\\n",
       "drug                                                            \n",
       "(5z)-7-oxozeaenol                            NONE        NONE   \n",
       "16-beta-bromoandrosterone                    NONE        NONE   \n",
       "1s,3r-rsl-3                                  NONE        NONE   \n",
       "3-cl-ahpc                                    NONE        NONE   \n",
       "5-fluorouracil                               NONE        NONE   \n",
       "968                                          NONE        NONE   \n",
       "a-443654                                     NONE        NONE   \n",
       "a-770041                                     NONE        NONE   \n",
       "a-804598                                     NONE        NONE   \n",
       "aa-cocf3                                     NONE        NONE   \n",
       "abiraterone                                  NONE        NONE   \n",
       "abt-199                                      NONE        NONE   \n",
       "abt-737                                      NONE        NONE   \n",
       "ac55649                                      NONE        NONE   \n",
       "aew541                                     AEW541       IGF1R   \n",
       "afatinib                                     NONE        NONE   \n",
       "agk-2                                        NONE        NONE   \n",
       "aica ribonucleotide                          NONE        NONE   \n",
       "akt inhibitor viii                           NONE        NONE   \n",
       "alectinib                                    NONE        NONE   \n",
       "alisertib                                    NONE        NONE   \n",
       "alisertib:navitoclax (2:1 mol/mol)           NONE        NONE   \n",
       "alvocidib                                    NONE        NONE   \n",
       "am-580                                       NONE        NONE   \n",
       "amuvatinib                                   NONE        NONE   \n",
       "apicidin                                     NONE        NONE   \n",
       "ar-42                                        NONE        NONE   \n",
       "as601245                                     NONE        NONE   \n",
       "as605240                                     NONE        NONE   \n",
       "at-406                                       NONE        NONE   \n",
       "...                                           ...         ...   \n",
       "vx-680                                       NONE        NONE   \n",
       "vx-702                                       NONE        NONE   \n",
       "way-362450                                   NONE        NONE   \n",
       "wee1 inhibitor                               NONE        NONE   \n",
       "wh-4-023                                     NONE        NONE   \n",
       "whi-p97                                      NONE        NONE   \n",
       "wp1130                                       NONE        NONE   \n",
       "wz-1-84                                      NONE        NONE   \n",
       "wz3105                                       NONE        NONE   \n",
       "wz4002                                       NONE        NONE   \n",
       "wz8040                                       NONE        NONE   \n",
       "xav939                                       NONE        NONE   \n",
       "xl765                                        NONE        NONE   \n",
       "xmd11-85h                                    NONE        NONE   \n",
       "xmd13-2                                      NONE        NONE   \n",
       "xmd14-99                                     NONE        NONE   \n",
       "xmd15-27                                     NONE        NONE   \n",
       "xmd8-85                                      NONE        NONE   \n",
       "xmd8-92                                      NONE        NONE   \n",
       "y-39983                                      NONE        NONE   \n",
       "yk-4-279                                     NONE        NONE   \n",
       "yl54                                         NONE        NONE   \n",
       "ym201636                                     NONE        NONE   \n",
       "z-llnle-cho                                  NONE        NONE   \n",
       "zd-6474                                   ZD-6474        EGFR   \n",
       "zebularine                                   NONE        NONE   \n",
       "zg-10                                        NONE        NONE   \n",
       "zibotentan                                   NONE        NONE   \n",
       "zm447439                                     NONE        NONE   \n",
       "zstk474                                      NONE        NONE   \n",
       "\n",
       "                                         gdsc_drug_name  \\\n",
       "drug                                                      \n",
       "(5z)-7-oxozeaenol                     (5Z)-7-Oxozeaenol   \n",
       "16-beta-bromoandrosterone                          NONE   \n",
       "1s,3r-rsl-3                                        NONE   \n",
       "3-cl-ahpc                                          NONE   \n",
       "5-fluorouracil                           5-Fluorouracil   \n",
       "968                                                NONE   \n",
       "a-443654                                       A-443654   \n",
       "a-770041                                       A-770041   \n",
       "a-804598                                           NONE   \n",
       "aa-cocf3                                           NONE   \n",
       "abiraterone                                        NONE   \n",
       "abt-199                                            NONE   \n",
       "abt-737                                            NONE   \n",
       "ac55649                                            NONE   \n",
       "aew541                                             NONE   \n",
       "afatinib                                       Afatinib   \n",
       "agk-2                                              NONE   \n",
       "aica ribonucleotide                 AICA Ribonucleotide   \n",
       "akt inhibitor viii                   AKT inhibitor VIII   \n",
       "alectinib                                     Alectinib   \n",
       "alisertib                                          NONE   \n",
       "alisertib:navitoclax (2:1 mol/mol)                 NONE   \n",
       "alvocidib                                          NONE   \n",
       "am-580                                             NONE   \n",
       "amuvatinib                                   Amuvatinib   \n",
       "apicidin                                           NONE   \n",
       "ar-42                                             AR-42   \n",
       "as601245                                       AS601245   \n",
       "as605240                                       AS605240   \n",
       "at-406                                             NONE   \n",
       "...                                                 ...   \n",
       "vx-680                                             NONE   \n",
       "vx-702                                           VX-702   \n",
       "way-362450                                         NONE   \n",
       "wee1 inhibitor                           Wee1 Inhibitor   \n",
       "wh-4-023                                       WH-4-023   \n",
       "whi-p97                                         WHI-P97   \n",
       "wp1130                                             NONE   \n",
       "wz-1-84                                         WZ-1-84   \n",
       "wz3105                                           WZ3105   \n",
       "wz4002                                             NONE   \n",
       "wz8040                                             NONE   \n",
       "xav939                                           XAV939   \n",
       "xl765                                              NONE   \n",
       "xmd11-85h                                     XMD11-85h   \n",
       "xmd13-2                                         XMD13-2   \n",
       "xmd14-99                                       XMD14-99   \n",
       "xmd15-27                                       XMD15-27   \n",
       "xmd8-85                                         XMD8-85   \n",
       "xmd8-92                                         XMD8-92   \n",
       "y-39983                                         Y-39983   \n",
       "yk-4-279                                       YK-4-279   \n",
       "yl54                                               NONE   \n",
       "ym201636                                       YM201636   \n",
       "z-llnle-cho                                 Z-LLNle-CHO   \n",
       "zd-6474                                            NONE   \n",
       "zebularine                                         NONE   \n",
       "zg-10                                             ZG-10   \n",
       "zibotentan                                   Zibotentan   \n",
       "zm447439                                       ZM447439   \n",
       "zstk474                                         ZSTK474   \n",
       "\n",
       "                                                                        gdsc_synonyms  \\\n",
       "drug                                                                                    \n",
       "(5z)-7-oxozeaenol                                         5Z-7-Oxozeaenol, LL-Z1640-2   \n",
       "16-beta-bromoandrosterone                                                        NONE   \n",
       "1s,3r-rsl-3                                                                      NONE   \n",
       "3-cl-ahpc                                                                        NONE   \n",
       "5-fluorouracil                                                                   5-FU   \n",
       "968                                                                              NONE   \n",
       "a-443654                                                                   KIN001-139   \n",
       "a-770041                                                                   KIN001-111   \n",
       "a-804598                                                                         NONE   \n",
       "aa-cocf3                                                                         NONE   \n",
       "abiraterone                                                                      NONE   \n",
       "abt-199                                                                          NONE   \n",
       "abt-737                                                                          NONE   \n",
       "ac55649                                                                          NONE   \n",
       "aew541                                                                           NONE   \n",
       "afatinib                                                    BIBW2992, Tovok, Gilotrif   \n",
       "agk-2                                                                            NONE   \n",
       "aica ribonucleotide                 AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole...   \n",
       "akt inhibitor viii                                                           Akti-1/2   \n",
       "alectinib                                              CH5424802, CH 542802, Alecensa   \n",
       "alisertib                                                                        NONE   \n",
       "alisertib:navitoclax (2:1 mol/mol)                                               NONE   \n",
       "alvocidib                                                                        NONE   \n",
       "am-580                                                                           NONE   \n",
       "amuvatinib                                                      MP470, MP 470, MP-470   \n",
       "apicidin                                                                         NONE   \n",
       "ar-42                                                            HDAC-42, AR 42, AR42   \n",
       "as601245                                                                         NONE   \n",
       "as605240                                                        KIN001-173, AS-605240   \n",
       "at-406                                                                           NONE   \n",
       "...                                                                               ...   \n",
       "vx-680                                                                           NONE   \n",
       "vx-702                                                                  VX702, VX 702   \n",
       "way-362450                                                                       NONE   \n",
       "wee1 inhibitor                                                 681640, Wee1 Inhibitor   \n",
       "wh-4-023                                                                   KIN001-112   \n",
       "whi-p97                                                          AC1L1GQE, KIN001-055   \n",
       "wp1130                                                                           NONE   \n",
       "wz-1-84                                                                    KIN001-123   \n",
       "wz3105                                                                           NONE   \n",
       "wz4002                                                                           NONE   \n",
       "wz8040                                                                           NONE   \n",
       "xav939                                                   NVP-XAV939, XAV-939, XAV 939   \n",
       "xl765                                                                            NONE   \n",
       "xmd11-85h                                                                        NONE   \n",
       "xmd13-2                                                                          NONE   \n",
       "xmd14-99                                                                         NONE   \n",
       "xmd15-27                                                                         NONE   \n",
       "xmd8-85                                                                     ERK5-IN-1   \n",
       "xmd8-92                                                                      XMD 8-92   \n",
       "y-39983                                                                          NONE   \n",
       "yk-4-279                                                                     YK 4-279   \n",
       "yl54                                                                             NONE   \n",
       "ym201636                                                         YM-201636, YM 201636   \n",
       "z-llnle-cho                           Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1   \n",
       "zd-6474                                                                          NONE   \n",
       "zebularine                                                                       NONE   \n",
       "zg-10                                                                            NONE   \n",
       "zibotentan                                                            ZD4054, ZD-4054   \n",
       "zm447439                                                         ZM-447439, ZM 447439   \n",
       "zstk474                                                KIN001-167, ZSTK-474, ZSTK 474   \n",
       "\n",
       "                                                               gdsc_target  \\\n",
       "drug                                                                         \n",
       "(5z)-7-oxozeaenol                                                    TAK1    \n",
       "16-beta-bromoandrosterone                                             NONE   \n",
       "1s,3r-rsl-3                                                           NONE   \n",
       "3-cl-ahpc                                                             NONE   \n",
       "5-fluorouracil                                  Antimetabolite (DNA & RNA)   \n",
       "968                                                                   NONE   \n",
       "a-443654                                                  AKT1; AKT2; AKT3   \n",
       "a-770041                                                          LCK; FYN   \n",
       "a-804598                                                              NONE   \n",
       "aa-cocf3                                                              NONE   \n",
       "abiraterone                                                           NONE   \n",
       "abt-199                                                               NONE   \n",
       "abt-737                                                               NONE   \n",
       "ac55649                                                               NONE   \n",
       "aew541                                                                NONE   \n",
       "afatinib                                                       ERBB2; EGFR   \n",
       "agk-2                                                                 NONE   \n",
       "aica ribonucleotide                                           AMPK agonist   \n",
       "akt inhibitor viii                                        AKT1; AKT2; AKT3   \n",
       "alectinib                                                              ALK   \n",
       "alisertib                                                             NONE   \n",
       "alisertib:navitoclax (2:1 mol/mol)                                    NONE   \n",
       "alvocidib                                                             NONE   \n",
       "am-580                                                                NONE   \n",
       "amuvatinib                                               KIT; PDGFRA; FLT3   \n",
       "apicidin                                                              NONE   \n",
       "ar-42                                                                HDAC1   \n",
       "as601245                                                  JNK1; JNK2; JNK2   \n",
       "as605240                                                         PI3Kgamma   \n",
       "at-406                                                                NONE   \n",
       "...                                                                    ...   \n",
       "vx-680                                                                NONE   \n",
       "vx-702                                                                 p38   \n",
       "way-362450                                                            NONE   \n",
       "wee1 inhibitor                                                 WEE1; CHEK1   \n",
       "wh-4-023                                                          SRC; LCK   \n",
       "whi-p97                                                               JAK3   \n",
       "wp1130                                                                NONE   \n",
       "wz-1-84                                                                BMX   \n",
       "wz3105                              SRC; ROCK2; NTRK2; FLT3; IRAK1; others   \n",
       "wz4002                                                                NONE   \n",
       "wz8040                                                                NONE   \n",
       "xav939                                                        TNKS1; TNKS2   \n",
       "xl765                                                                 NONE   \n",
       "xmd11-85h                            BRSK2; FLT4; MARK4; PRKCD; RET; SPRK1   \n",
       "xmd13-2                                                              RIPK1   \n",
       "xmd14-99                                            ALK; CDK7; LTK; others   \n",
       "xmd15-27                                                             CAMK2   \n",
       "xmd8-85                                                          ERK5; BET   \n",
       "xmd8-92                                                              MAPK7   \n",
       "y-39983                                                               ROCK   \n",
       "yk-4-279                                                    RNA helicase A   \n",
       "yl54                                                                  NONE   \n",
       "ym201636                                                           PYKFYVE   \n",
       "z-llnle-cho                                                gamma-secretase   \n",
       "zd-6474                                                               NONE   \n",
       "zebularine                                                            NONE   \n",
       "zg-10                                                                 JNK1   \n",
       "zibotentan                                   Endothelin-1 receptor (EDNRA)   \n",
       "zm447439                                                      AURKA; AURKB   \n",
       "zstk474                                                     PI3K (class 1)   \n",
       "\n",
       "                                              gdsc_target_pathway  \\\n",
       "drug                                                                \n",
       "(5z)-7-oxozeaenol                                  Other, kinases   \n",
       "16-beta-bromoandrosterone                                    NONE   \n",
       "1s,3r-rsl-3                                                  NONE   \n",
       "3-cl-ahpc                                                    NONE   \n",
       "5-fluorouracil                                              Other   \n",
       "968                                                          NONE   \n",
       "a-443654                                      PI3K/MTOR signaling   \n",
       "a-770041                                           Other, kinases   \n",
       "a-804598                                                     NONE   \n",
       "aa-cocf3                                                     NONE   \n",
       "abiraterone                                                  NONE   \n",
       "abt-199                                                      NONE   \n",
       "abt-737                                                      NONE   \n",
       "ac55649                                                      NONE   \n",
       "aew541                                                       NONE   \n",
       "afatinib                                           EGFR signaling   \n",
       "agk-2                                                        NONE   \n",
       "aica ribonucleotide                                    Metabolism   \n",
       "akt inhibitor viii                            PI3K/MTOR signaling   \n",
       "alectinib                                           RTK signaling   \n",
       "alisertib                                                    NONE   \n",
       "alisertib:navitoclax (2:1 mol/mol)                           NONE   \n",
       "alvocidib                                                    NONE   \n",
       "am-580                                                       NONE   \n",
       "amuvatinib                                         Other, kinases   \n",
       "apicidin                                                     NONE   \n",
       "ar-42                               Chromatin histone acetylation   \n",
       "as601245                                    JNK and p38 signaling   \n",
       "as605240                                      PI3K/MTOR signaling   \n",
       "at-406                                                       NONE   \n",
       "...                                                           ...   \n",
       "vx-680                                                       NONE   \n",
       "vx-702                                      JNK and p38 signaling   \n",
       "way-362450                                                   NONE   \n",
       "wee1 inhibitor                                         Cell cycle   \n",
       "wh-4-023                                           Other, kinases   \n",
       "whi-p97                                            Other, kinases   \n",
       "wp1130                                                       NONE   \n",
       "wz-1-84                                            Other, kinases   \n",
       "wz3105                                                      Other   \n",
       "wz4002                                                       NONE   \n",
       "wz8040                                                       NONE   \n",
       "xav939                                              WNT signaling   \n",
       "xl765                                                        NONE   \n",
       "xmd11-85h                                                   Other   \n",
       "xmd13-2                                      Apoptosis regulation   \n",
       "xmd14-99                                                    Other   \n",
       "xmd15-27                                           Other, kinases   \n",
       "xmd8-85                                                     Other   \n",
       "xmd8-92                                            Other, kinases   \n",
       "y-39983                                              Cytoskeleton   \n",
       "yk-4-279                                                    Other   \n",
       "yl54                                                         NONE   \n",
       "ym201636                                                    Other   \n",
       "z-llnle-cho                                                 Other   \n",
       "zd-6474                                                      NONE   \n",
       "zebularine                                                   NONE   \n",
       "zg-10                                       JNK and p38 signaling   \n",
       "zibotentan                                                  Other   \n",
       "zm447439                                                  Mitosis   \n",
       "zstk474                                       PI3K/MTOR signaling   \n",
       "\n",
       "                                                        ctrp_drug_name  \\\n",
       "drug                                                                     \n",
       "(5z)-7-oxozeaenol                                                 NONE   \n",
       "16-beta-bromoandrosterone                    16-beta-bromoandrosterone   \n",
       "1s,3r-rsl-3                                                1S,3R-RSL-3   \n",
       "3-cl-ahpc                                                    3-Cl-AHPC   \n",
       "5-fluorouracil                                                    NONE   \n",
       "968                                                                968   \n",
       "a-443654                                                          NONE   \n",
       "a-770041                                                          NONE   \n",
       "a-804598                                                      A-804598   \n",
       "aa-cocf3                                                      AA-COCF3   \n",
       "abiraterone                                                abiraterone   \n",
       "abt-199                                                        ABT-199   \n",
       "abt-737                                                        ABT-737   \n",
       "ac55649                                                        AC55649   \n",
       "aew541                                                            NONE   \n",
       "afatinib                                                      afatinib   \n",
       "agk-2                                                            AGK-2   \n",
       "aica ribonucleotide                                               NONE   \n",
       "akt inhibitor viii                                                NONE   \n",
       "alectinib                                                         NONE   \n",
       "alisertib                                                    alisertib   \n",
       "alisertib:navitoclax (2:1 mol/mol)  alisertib:navitoclax (2:1 mol/mol)   \n",
       "alvocidib                                                    alvocidib   \n",
       "am-580                                                          AM-580   \n",
       "amuvatinib                                                        NONE   \n",
       "apicidin                                                      apicidin   \n",
       "ar-42                                                             NONE   \n",
       "as601245                                                          NONE   \n",
       "as605240                                                          NONE   \n",
       "at-406                                                          AT-406   \n",
       "...                                                                ...   \n",
       "vx-680                                                          VX-680   \n",
       "vx-702                                                            NONE   \n",
       "way-362450                                                  WAY-362450   \n",
       "wee1 inhibitor                                                    NONE   \n",
       "wh-4-023                                                          NONE   \n",
       "whi-p97                                                           NONE   \n",
       "wp1130                                                          WP1130   \n",
       "wz-1-84                                                           NONE   \n",
       "wz3105                                                            NONE   \n",
       "wz4002                                                          WZ4002   \n",
       "wz8040                                                          WZ8040   \n",
       "xav939                                                            NONE   \n",
       "xl765                                                            XL765   \n",
       "xmd11-85h                                                         NONE   \n",
       "xmd13-2                                                           NONE   \n",
       "xmd14-99                                                          NONE   \n",
       "xmd15-27                                                          NONE   \n",
       "xmd8-85                                                           NONE   \n",
       "xmd8-92                                                           NONE   \n",
       "y-39983                                                           NONE   \n",
       "yk-4-279                                                      YK 4-279   \n",
       "yl54                                                              YL54   \n",
       "ym201636                                                          NONE   \n",
       "z-llnle-cho                                                       NONE   \n",
       "zd-6474                                                           NONE   \n",
       "zebularine                                                  zebularine   \n",
       "zg-10                                                             NONE   \n",
       "zibotentan                                                        NONE   \n",
       "zm447439                                                          NONE   \n",
       "zstk474                                                        ZSTK474   \n",
       "\n",
       "                                                                    ctrp_target  \\\n",
       "drug                                                                              \n",
       "(5z)-7-oxozeaenol                                                          NONE   \n",
       "16-beta-bromoandrosterone                                                  NONE   \n",
       "1s,3r-rsl-3                                                                GPX4   \n",
       "3-cl-ahpc                                                                 NR0B2   \n",
       "5-fluorouracil                                                             NONE   \n",
       "968                                                                         GLS   \n",
       "a-443654                                                                   NONE   \n",
       "a-770041                                                                   NONE   \n",
       "a-804598                                                                  P2RX7   \n",
       "aa-cocf3                               FAAH; PLA2G4A; PLA2G4B; PLA2G4C; PLA2G4D   \n",
       "abiraterone                                                             CYP17A1   \n",
       "abt-199                                                                    BCL2   \n",
       "abt-737                                                    BCL2; BCL2L1; BCL2L2   \n",
       "ac55649                                                                    RARB   \n",
       "aew541                                                                     NONE   \n",
       "afatinib                                                            EGFR; ERBB2   \n",
       "agk-2                                                                     SIRT2   \n",
       "aica ribonucleotide                                                        NONE   \n",
       "akt inhibitor viii                                                         NONE   \n",
       "alectinib                                                                  NONE   \n",
       "alisertib                                                          AURKA; AURKB   \n",
       "alisertib:navitoclax (2:1 mol/mol)           AURKA; AURKB; BCL2; BCL2L1; BCL2L2   \n",
       "alvocidib                                                CDK1; CDK2; CDK4; CDK6   \n",
       "am-580                                                                     RARA   \n",
       "amuvatinib                                                                 NONE   \n",
       "apicidin                                      HDAC1; HDAC2; HDAC3; HDAC6; HDAC8   \n",
       "ar-42                                                                      NONE   \n",
       "as601245                                                                   NONE   \n",
       "as605240                                                                   NONE   \n",
       "at-406                                                                     XIAP   \n",
       "...                                                                         ...   \n",
       "vx-680                                                      AURKA; AURKB; AURKC   \n",
       "vx-702                                                                     NONE   \n",
       "way-362450                                                                NR1H4   \n",
       "wee1 inhibitor                                                             NONE   \n",
       "wh-4-023                                                                   NONE   \n",
       "whi-p97                                                                    NONE   \n",
       "wp1130                                                UCHL5; USP14; USP5; USP9X   \n",
       "wz-1-84                                                                    NONE   \n",
       "wz3105                                                                     NONE   \n",
       "wz4002                                                                     EGFR   \n",
       "wz8040                                                                     EGFR   \n",
       "xav939                                                                     NONE   \n",
       "xl765                               MTOR; PIK3CA; PIK3CB; PIK3CD; PIK3CG; PRKDC   \n",
       "xmd11-85h                                                                  NONE   \n",
       "xmd13-2                                                                    NONE   \n",
       "xmd14-99                                                                   NONE   \n",
       "xmd15-27                                                                   NONE   \n",
       "xmd8-85                                                                    NONE   \n",
       "xmd8-92                                                                    NONE   \n",
       "y-39983                                                                    NONE   \n",
       "yk-4-279                                                        DHX9; ERG; ETV1   \n",
       "yl54                                                                       NONE   \n",
       "ym201636                                                                   NONE   \n",
       "z-llnle-cho                                                                NONE   \n",
       "zd-6474                                                                    NONE   \n",
       "zebularine                                                                DNMT1   \n",
       "zg-10                                                                      NONE   \n",
       "zibotentan                                                                 NONE   \n",
       "zm447439                                                                   NONE   \n",
       "zstk474                                                  PIK3CB; PIK3CD; PIK3CG   \n",
       "\n",
       "                                                              ctrp_target_description  \\\n",
       "drug                                                                                    \n",
       "(5z)-7-oxozeaenol                                                                NONE   \n",
       "16-beta-bromoandrosterone                        dehydroepiandrosterone (DHEA) analog   \n",
       "1s,3r-rsl-3                         synthetic lethal with HRAS in engineered cells...   \n",
       "3-cl-ahpc                                              binder of nuclear receptor SHP   \n",
       "5-fluorouracil                                                                   NONE   \n",
       "968                                                          inhibitor of glutaminase   \n",
       "a-443654                                                                         NONE   \n",
       "a-770041                                                                         NONE   \n",
       "a-804598                                         inhibitor of purinergic receptor P2X   \n",
       "aa-cocf3                            inhibitor of cytosolic phospholipase A2; inhib...   \n",
       "abiraterone                         inhibitor of 17 alpha-hydroxylase and C17,20 l...   \n",
       "abt-199                                                             inhibitor of BCL2   \n",
       "abt-737                                          inhibitor of BCL2, BCL-xL, and BCL-W   \n",
       "ac55649                                        agonist of retinoic acid receptor beta   \n",
       "aew541                                                                           NONE   \n",
       "afatinib                                                   inhibitor of EGFR and HER2   \n",
       "agk-2                                                          inhibitor of sirtuin 2   \n",
       "aica ribonucleotide                                                              NONE   \n",
       "akt inhibitor viii                                                               NONE   \n",
       "alectinib                                                                        NONE   \n",
       "alisertib                                         inhibitor of aurora kinases A and B   \n",
       "alisertib:navitoclax (2:1 mol/mol)  inhibitor of aurora kinases A and B;inhibitor ...   \n",
       "alvocidib                                       inhibitor of cyclin-dependent kinases   \n",
       "am-580                                        agonist of retinoic acid receptor alpha   \n",
       "amuvatinib                                                                       NONE   \n",
       "apicidin                            inhibitor of HDAC1, HDAC2, HDAC3, HDAC6, and H...   \n",
       "ar-42                                                                            NONE   \n",
       "as601245                                                                         NONE   \n",
       "as605240                                                                         NONE   \n",
       "at-406                              SMAC mimetic; inhibitor of inhibitor of apopto...   \n",
       "...                                                                               ...   \n",
       "vx-680                                                    inhibitor of aurora kinases   \n",
       "vx-702                                                                           NONE   \n",
       "way-362450                                            agonist of farnesoid X receptor   \n",
       "wee1 inhibitor                                                                   NONE   \n",
       "wh-4-023                                                                         NONE   \n",
       "whi-p97                                                                          NONE   \n",
       "wp1130                              inhibitor of the deubiquitinase activity of US...   \n",
       "wz-1-84                                                                          NONE   \n",
       "wz3105                                                                           NONE   \n",
       "wz4002                                   inhibitor of EGFR targeting T790M resistance   \n",
       "wz8040                                   inhibitor of EGFR targeting T790M resistance   \n",
       "xav939                                                                           NONE   \n",
       "xl765                                   inhibitor of mTOR and PI3K kinase acitivities   \n",
       "xmd11-85h                                                                        NONE   \n",
       "xmd13-2                                                                          NONE   \n",
       "xmd14-99                                                                         NONE   \n",
       "xmd15-27                                                                         NONE   \n",
       "xmd8-85                                                                          NONE   \n",
       "xmd8-92                                                                          NONE   \n",
       "y-39983                                                                          NONE   \n",
       "yk-4-279                            inhibitor of RNA helicase A (RHA) binding to E...   \n",
       "yl54                                                          stapled helical peptide   \n",
       "ym201636                                                                         NONE   \n",
       "z-llnle-cho                                                                      NONE   \n",
       "zd-6474                                                                          NONE   \n",
       "zebularine                                        inhibitor of DNA methyltransferases   \n",
       "zg-10                                                                            NONE   \n",
       "zibotentan                                                                       NONE   \n",
       "zm447439                                                                         NONE   \n",
       "zstk474                             inhibitor of PI3K catalytic subunits beta, del...   \n",
       "\n",
       "                                                                             synonyms  \\\n",
       "drug                                                                                    \n",
       "(5z)-7-oxozeaenol                      5Z-7-Oxozeaenol; LL-Z1640-2; (5Z)-7-Oxozeaenol   \n",
       "16-beta-bromoandrosterone                                   16-beta-bromoandrosterone   \n",
       "1s,3r-rsl-3                                                               1S,3R-RSL-3   \n",
       "3-cl-ahpc                                                                   3-Cl-AHPC   \n",
       "5-fluorouracil                                                   5-FU; 5-Fluorouracil   \n",
       "968                                                                               968   \n",
       "a-443654                                                         A-443654; KIN001-139   \n",
       "a-770041                                                         KIN001-111; A-770041   \n",
       "a-804598                                                                     A-804598   \n",
       "aa-cocf3                                                                     AA-COCF3   \n",
       "abiraterone                                                               abiraterone   \n",
       "abt-199                                                                       ABT-199   \n",
       "abt-737                                                                       ABT-737   \n",
       "ac55649                                                                       AC55649   \n",
       "aew541                                                                         AEW541   \n",
       "afatinib                                Gilotrif; Afatinib; Tovok; BIBW2992; afatinib   \n",
       "agk-2                                                                           AGK-2   \n",
       "aica ribonucleotide                 AICA Ribonucleotide; N1-(b-D-Ribofuranosyl)-5-...   \n",
       "akt inhibitor viii                                       Akti-1/2; AKT inhibitor VIII   \n",
       "alectinib                                   CH5424802; Alectinib; Alecensa; CH 542802   \n",
       "alisertib                                                                   alisertib   \n",
       "alisertib:navitoclax (2:1 mol/mol)                 alisertib:navitoclax (2:1 mol/mol)   \n",
       "alvocidib                                                                   alvocidib   \n",
       "am-580                                                                         AM-580   \n",
       "amuvatinib                                          MP470; MP-470; MP 470; Amuvatinib   \n",
       "apicidin                                                                     apicidin   \n",
       "ar-42                                                     HDAC-42; AR 42; AR-42; AR42   \n",
       "as601245                                                                     AS601245   \n",
       "as605240                                              AS605240; KIN001-173; AS-605240   \n",
       "at-406                                                                         AT-406   \n",
       "...                                                                               ...   \n",
       "vx-680                                                                         VX-680   \n",
       "vx-702                                                          VX702; VX-702; VX 702   \n",
       "way-362450                                                                 WAY-362450   \n",
       "wee1 inhibitor                                                 681640; Wee1 Inhibitor   \n",
       "wh-4-023                                                         KIN001-112; WH-4-023   \n",
       "whi-p97                                                 WHI-P97; KIN001-055; AC1L1GQE   \n",
       "wp1130                                                                         WP1130   \n",
       "wz-1-84                                                           WZ-1-84; KIN001-123   \n",
       "wz3105                                                                         WZ3105   \n",
       "wz4002                                                                         WZ4002   \n",
       "wz8040                                                                         WZ8040   \n",
       "xav939                                           XAV939; XAV 939; XAV-939; NVP-XAV939   \n",
       "xl765                                                                           XL765   \n",
       "xmd11-85h                                                                   XMD11-85h   \n",
       "xmd13-2                                                                       XMD13-2   \n",
       "xmd14-99                                                                     XMD14-99   \n",
       "xmd15-27                                                                     XMD15-27   \n",
       "xmd8-85                                                            XMD8-85; ERK5-IN-1   \n",
       "xmd8-92                                                             XMD8-92; XMD 8-92   \n",
       "y-39983                                                                       Y-39983   \n",
       "yk-4-279                                                           YK-4-279; YK 4-279   \n",
       "yl54                                                                             YL54   \n",
       "ym201636                                               YM201636; YM 201636; YM-201636   \n",
       "z-llnle-cho                         Gamma-Secretase Inhibitor 1; Z-L-Norleucine-CH...   \n",
       "zd-6474                                                                       ZD-6474   \n",
       "zebularine                                                                 zebularine   \n",
       "zg-10                                                                           ZG-10   \n",
       "zibotentan                                                Zibotentan; ZD4054; ZD-4054   \n",
       "zm447439                                               ZM447439; ZM 447439; ZM-447439   \n",
       "zstk474                                       ZSTK-474; ZSTK 474; ZSTK474; KIN001-167   \n",
       "\n",
       "                                                                        targets  \n",
       "drug                                                                             \n",
       "(5z)-7-oxozeaenol                                                          TAK1  \n",
       "16-beta-bromoandrosterone                                                  NONE  \n",
       "1s,3r-rsl-3                                                                GPX4  \n",
       "3-cl-ahpc                                                                 NR0B2  \n",
       "5-fluorouracil                                       Antimetabolite (DNA & RNA)  \n",
       "968                                                                         GLS  \n",
       "a-443654                                                       AKT2; AKT1; AKT3  \n",
       "a-770041                                                               FYN; LCK  \n",
       "a-804598                                                                  P2RX7  \n",
       "aa-cocf3                               PLA2G4A; FAAH; PLA2G4C; PLA2G4D; PLA2G4B  \n",
       "abiraterone                                                             CYP17A1  \n",
       "abt-199                                                                    BCL2  \n",
       "abt-737                                                    BCL2; BCL2L2; BCL2L1  \n",
       "ac55649                                                                    RARB  \n",
       "aew541                                                                    IGF1R  \n",
       "afatinib                                                            ERBB2; EGFR  \n",
       "agk-2                                                                     SIRT2  \n",
       "aica ribonucleotide                                                AMPK agonist  \n",
       "akt inhibitor viii                                             AKT2; AKT1; AKT3  \n",
       "alectinib                                                                   ALK  \n",
       "alisertib                                                          AURKA; AURKB  \n",
       "alisertib:navitoclax (2:1 mol/mol)           BCL2; BCL2L2; BCL2L1; AURKA; AURKB  \n",
       "alvocidib                                                CDK1; CDK4; CDK6; CDK2  \n",
       "am-580                                                                     RARA  \n",
       "amuvatinib                                                    PDGFRA; KIT; FLT3  \n",
       "apicidin                                      HDAC8; HDAC1; HDAC3; HDAC2; HDAC6  \n",
       "ar-42                                                                     HDAC1  \n",
       "as601245                                                             JNK1; JNK2  \n",
       "as605240                                                              PI3Kgamma  \n",
       "at-406                                                                     XIAP  \n",
       "...                                                                         ...  \n",
       "vx-680                                                      AURKA; AURKC; AURKB  \n",
       "vx-702                                                                      p38  \n",
       "way-362450                                                                NR1H4  \n",
       "wee1 inhibitor                                                      CHEK1; WEE1  \n",
       "wh-4-023                                                               LCK; SRC  \n",
       "whi-p97                                                                    JAK3  \n",
       "wp1130                                                USP5; UCHL5; USP14; USP9X  \n",
       "wz-1-84                                                                     BMX  \n",
       "wz3105                                   ROCK2; NTRK2; SRC; others; IRAK1; FLT3  \n",
       "wz4002                                                                     EGFR  \n",
       "wz8040                                                                     EGFR  \n",
       "xav939                                                             TNKS2; TNKS1  \n",
       "xl765                               PRKDC; PIK3CA; MTOR; PIK3CB; PIK3CG; PIK3CD  \n",
       "xmd11-85h                                 PRKCD; FLT4; SPRK1; RET; BRSK2; MARK4  \n",
       "xmd13-2                                                                   RIPK1  \n",
       "xmd14-99                                                 ALK; LTK; others; CDK7  \n",
       "xmd15-27                                                                  CAMK2  \n",
       "xmd8-85                                                               ERK5; BET  \n",
       "xmd8-92                                                                   MAPK7  \n",
       "y-39983                                                                    ROCK  \n",
       "yk-4-279                                        RNA helicase A; DHX9; ERG; ETV1  \n",
       "yl54                                                                       NONE  \n",
       "ym201636                                                                PYKFYVE  \n",
       "z-llnle-cho                                                     gamma-secretase  \n",
       "zd-6474                                                                    EGFR  \n",
       "zebularine                                                                DNMT1  \n",
       "zg-10                                                                      JNK1  \n",
       "zibotentan                                        Endothelin-1 receptor (EDNRA)  \n",
       "zm447439                                                           AURKA; AURKB  \n",
       "zstk474                                  PI3K (class 1); PIK3CB; PIK3CG; PIK3CD  \n",
       "\n",
       "[715 rows x 11 columns]"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_annotations = drug_annotations.fillna('NONE')\n",
    "drug_annotations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T21:43:47.932955Z",
     "start_time": "2019-05-30T21:43:47.927705Z"
    }
   },
   "outputs": [],
   "source": [
    "# Unique targets\n",
    "all_targs = []\n",
    "for targs in drug_annotations['targets'].fillna('NONE'):\n",
    "    for targ in targs.split('; '):\n",
    "        all_targs.append(targ)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T21:46:35.682868Z",
     "start_time": "2019-05-30T21:46:35.670571Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[' PDGFRA',\n",
       " 'ABCG2',\n",
       " 'ABL',\n",
       " 'ABL(T315I)',\n",
       " 'ABL1',\n",
       " 'ACAT1',\n",
       " 'ACER1',\n",
       " 'ACER2',\n",
       " 'ACER3',\n",
       " 'ADCK4',\n",
       " 'ADORA2A',\n",
       " 'AHR',\n",
       " 'AKT1',\n",
       " 'AKT2',\n",
       " 'AKT3',\n",
       " 'ALK',\n",
       " 'ALK4',\n",
       " 'ALK5',\n",
       " 'AMPK agonist',\n",
       " 'ANPEP',\n",
       " 'APH1A',\n",
       " 'AR',\n",
       " 'ARAF',\n",
       " 'ARF1',\n",
       " 'ARFGAP1',\n",
       " 'ARG1',\n",
       " 'ARG2',\n",
       " 'ASAH1',\n",
       " 'ASAH2',\n",
       " 'ASAH2B',\n",
       " 'ATM',\n",
       " 'ATP1A1',\n",
       " 'ATP1A2',\n",
       " 'ATP1A3',\n",
       " 'ATP1A4',\n",
       " 'ATP1B1',\n",
       " 'ATP1B2',\n",
       " 'ATP1B3',\n",
       " 'ATP1B4',\n",
       " 'ATP5L2',\n",
       " 'ATP6V0A1',\n",
       " 'ATR',\n",
       " 'AURKA',\n",
       " 'AURKB',\n",
       " 'AURKC',\n",
       " 'AXL',\n",
       " 'Amyloid beta20',\n",
       " 'Amyloid beta40',\n",
       " 'Angiopoietin-1 receptor',\n",
       " 'Anthracycline',\n",
       " 'Antimetabolite',\n",
       " 'Antimetabolite (DNA & RNA)',\n",
       " 'Autophagy inducer',\n",
       " 'BAX',\n",
       " 'BCL-W',\n",
       " 'BCL-XL',\n",
       " 'BCL2',\n",
       " 'BCL2L1',\n",
       " 'BCL2L10',\n",
       " 'BCL2L2',\n",
       " 'BCR',\n",
       " 'BCR-ABL',\n",
       " 'BET',\n",
       " 'BIRC5',\n",
       " 'BMX',\n",
       " 'BRAF',\n",
       " 'BRD2',\n",
       " 'BRD3',\n",
       " 'BRD4',\n",
       " 'BRDT',\n",
       " 'BRSK2',\n",
       " 'BTK',\n",
       " 'Biguanide agent',\n",
       " 'CA9',\n",
       " 'CAMK2',\n",
       " 'CAPN1',\n",
       " 'CASP3',\n",
       " 'CASP6',\n",
       " 'CASP7',\n",
       " 'CCNB1',\n",
       " 'CDC25A',\n",
       " 'CDC25B',\n",
       " 'CDC25C',\n",
       " 'CDK1',\n",
       " 'CDK1,CDK2,CDK5,CDK7,CDK9',\n",
       " 'CDK16',\n",
       " 'CDK17',\n",
       " 'CDK2',\n",
       " 'CDK4',\n",
       " 'CDK5',\n",
       " 'CDK5R1',\n",
       " 'CDK6',\n",
       " 'CDK7',\n",
       " 'CDK9',\n",
       " 'CDKL5',\n",
       " 'CERK',\n",
       " 'CERS1',\n",
       " 'CERS2',\n",
       " 'CERS3',\n",
       " 'CERS4',\n",
       " 'CERS5',\n",
       " 'CERS6',\n",
       " 'CHEK1',\n",
       " 'CHEK2',\n",
       " 'CLK1',\n",
       " 'CLK4',\n",
       " 'CLTA',\n",
       " 'CLTB',\n",
       " 'CLTC',\n",
       " 'CLTCL1',\n",
       " 'CMPK1',\n",
       " 'CNR2',\n",
       " 'CPT1A',\n",
       " 'CRBN',\n",
       " 'CSF1R',\n",
       " 'CSNK1D',\n",
       " 'CSNK1E',\n",
       " 'CSNK2A1',\n",
       " 'CSNK2A2',\n",
       " 'CTSL1',\n",
       " 'CUL1',\n",
       " 'CXCR2',\n",
       " 'CYP17A1',\n",
       " 'DAPK3',\n",
       " 'DCLK1',\n",
       " 'DDR1',\n",
       " 'DHFR',\n",
       " 'DHX9',\n",
       " 'DIABLO',\n",
       " 'DNA alkylating agent',\n",
       " 'DNA crosslinker',\n",
       " 'DNAPK',\n",
       " 'DNM1',\n",
       " 'DNMT1',\n",
       " 'DOT1L',\n",
       " 'DPP4',\n",
       " 'DRD2',\n",
       " 'Dihydrofolate reductase (DHFR)',\n",
       " 'EGFR',\n",
       " 'EGLN1',\n",
       " 'EHMT1',\n",
       " 'EHMT2',\n",
       " 'EIF2A',\n",
       " 'EIF4A2',\n",
       " 'EIF4E',\n",
       " 'EIF4G1',\n",
       " 'EP300',\n",
       " 'EPHA2',\n",
       " 'EPHB4',\n",
       " 'ERBB2',\n",
       " 'ERG',\n",
       " 'ERK1',\n",
       " 'ERK2',\n",
       " 'ERK5',\n",
       " 'ESR1',\n",
       " 'ESR2',\n",
       " 'ETV1',\n",
       " 'EZH2',\n",
       " 'Endothelin-1 receptor (EDNRA)',\n",
       " 'Ephrins',\n",
       " 'F2R',\n",
       " 'FAAH',\n",
       " 'FAK',\n",
       " 'FAK2',\n",
       " 'FASN',\n",
       " 'FGFR',\n",
       " 'FGFR1',\n",
       " 'FGFR2',\n",
       " 'FGFR3',\n",
       " 'FLT1',\n",
       " 'FLT3',\n",
       " 'FLT4',\n",
       " 'FNTA',\n",
       " 'FNTB',\n",
       " 'FXR',\n",
       " 'FYN',\n",
       " 'Farnesyl-transferase (FNTA)',\n",
       " 'G9a and GLP methyltransferases',\n",
       " 'GLS',\n",
       " 'GPER1',\n",
       " 'GPX4',\n",
       " 'GS',\n",
       " 'GSK3A',\n",
       " 'GSK3B',\n",
       " 'HDAC',\n",
       " 'HDAC inhibitor Class I',\n",
       " 'HDAC,RAR',\n",
       " 'HDAC1',\n",
       " 'HDAC1 ',\n",
       " 'HDAC1-10',\n",
       " 'HDAC2',\n",
       " 'HDAC3',\n",
       " 'HDAC6',\n",
       " 'HDAC8',\n",
       " 'HIF-PH',\n",
       " 'HIPK2',\n",
       " 'HMGCR',\n",
       " 'HMGCS1',\n",
       " 'HNF4A',\n",
       " 'HRH2',\n",
       " 'HSP90',\n",
       " 'HSP90AA1',\n",
       " 'HSP90B1',\n",
       " 'HSPA1A',\n",
       " 'HSPA1B',\n",
       " 'HSPA1L',\n",
       " 'IDH1',\n",
       " 'IGF1R',\n",
       " 'IIa',\n",
       " 'IIb',\n",
       " 'IKBKB',\n",
       " 'IKBKE',\n",
       " 'IKK',\n",
       " 'IKK1',\n",
       " 'IKK2',\n",
       " 'IKKB',\n",
       " 'INSR',\n",
       " 'IR',\n",
       " 'IRAK1',\n",
       " 'ITK',\n",
       " 'IV',\n",
       " 'Induces reactive oxygen species',\n",
       " 'JAK1',\n",
       " 'JAK2',\n",
       " 'JAK3',\n",
       " 'JNK',\n",
       " 'JNK1',\n",
       " 'JNK2',\n",
       " 'JNK3',\n",
       " 'KDM1A',\n",
       " 'KDM3A',\n",
       " 'KDM4A',\n",
       " 'KDM4B',\n",
       " 'KDM4C',\n",
       " 'KDM4D',\n",
       " 'KDM6A',\n",
       " 'KDM6B',\n",
       " 'KDR',\n",
       " 'KEAP1',\n",
       " 'KIF11',\n",
       " 'KIT',\n",
       " 'KLF5',\n",
       " 'KPNB1',\n",
       " 'KSP',\n",
       " 'L3MBTL3',\n",
       " 'LAP3',\n",
       " 'LCK',\n",
       " 'LDHA',\n",
       " 'LDHB',\n",
       " 'LDHC',\n",
       " 'LOK',\n",
       " 'LRRK2',\n",
       " 'LTK',\n",
       " 'LXR',\n",
       " 'LYPLA1',\n",
       " 'MAP2K1',\n",
       " 'MAP2K2',\n",
       " 'MAP3K8',\n",
       " 'MAP4K2',\n",
       " 'MAPK1',\n",
       " 'MAPK10',\n",
       " 'MAPK11',\n",
       " 'MAPK14',\n",
       " 'MAPK7',\n",
       " 'MAPK8',\n",
       " 'MAPK9',\n",
       " 'MARK4',\n",
       " 'MCL1',\n",
       " 'MDM2',\n",
       " 'MDM4',\n",
       " 'MEK',\n",
       " 'MEK1',\n",
       " 'MEK2',\n",
       " 'MEK5',\n",
       " 'MEN1',\n",
       " 'MET',\n",
       " 'MGMT',\n",
       " 'MPS1',\n",
       " 'MTOR',\n",
       " 'MTORC1',\n",
       " 'MTORC2',\n",
       " 'MYH1',\n",
       " 'MYH2',\n",
       " 'Microtubule destabiliser',\n",
       " 'Microtubule stabiliser',\n",
       " 'N-myristoyltransferase 1/2',\n",
       " 'NAE',\n",
       " 'NAE1',\n",
       " 'NAMPT',\n",
       " 'NAMPT ',\n",
       " 'NCEH1',\n",
       " 'NCSTN',\n",
       " 'NFE2L2',\n",
       " 'NONE',\n",
       " 'NOTCH1',\n",
       " 'NPEPPS',\n",
       " 'NPM1',\n",
       " 'NR0B2',\n",
       " 'NR1D1',\n",
       " 'NR1H4',\n",
       " 'NR3C1',\n",
       " 'NTRK1',\n",
       " 'NTRK2',\n",
       " 'NTRK3',\n",
       " 'P2RX7',\n",
       " 'PAK1',\n",
       " 'PAK4',\n",
       " 'PARP1',\n",
       " 'PARP2',\n",
       " 'PB1',\n",
       " 'PDE4A',\n",
       " 'PDE4B',\n",
       " 'PDE4D',\n",
       " 'PDE5A',\n",
       " 'PDGFR',\n",
       " 'PDGFRA',\n",
       " 'PDGFRB',\n",
       " 'PDK1 (PDPK1)',\n",
       " 'PDK2',\n",
       " 'PI3K (Class 1)',\n",
       " 'PI3K (class 1)',\n",
       " 'PI3Kalpha',\n",
       " 'PI3Kbeta',\n",
       " 'PI3Kdelta',\n",
       " 'PI3Kgamma',\n",
       " 'PICK1',\n",
       " 'PIK3CA',\n",
       " 'PIK3CB',\n",
       " 'PIK3CD',\n",
       " 'PIK3CG',\n",
       " 'PIM1',\n",
       " 'PIM3',\n",
       " 'PKC',\n",
       " 'PKCB',\n",
       " 'PKM',\n",
       " 'PLA2G4A',\n",
       " 'PLA2G4B',\n",
       " 'PLA2G4C',\n",
       " 'PLA2G4D',\n",
       " 'PLAUR',\n",
       " 'PLD1',\n",
       " 'PLD2',\n",
       " 'PLK1',\n",
       " 'PLK2',\n",
       " 'PLK3',\n",
       " 'POLA1',\n",
       " 'PPARdelta',\n",
       " 'PPARgamma',\n",
       " 'PPID',\n",
       " 'PPK',\n",
       " 'PPM1D',\n",
       " 'PPP2CA',\n",
       " 'PPP3CA',\n",
       " 'PPP3CB',\n",
       " 'PPP3CC',\n",
       " 'PPP3R1',\n",
       " 'PPP3R2',\n",
       " 'PRKCB',\n",
       " 'PRKCD',\n",
       " 'PRKDC',\n",
       " 'PSEN1',\n",
       " 'PSENEN',\n",
       " 'PSMB1',\n",
       " 'PSMB2',\n",
       " 'PSMB5',\n",
       " 'PSMD1',\n",
       " 'PSMD2',\n",
       " 'PTGS2',\n",
       " 'PTK2',\n",
       " 'PTP4A3',\n",
       " 'PYKFYVE',\n",
       " 'Procaspase-3',\n",
       " 'Procaspase-7',\n",
       " 'Proteasome',\n",
       " 'Pyrimidine antimetabolite',\n",
       " 'RAC1',\n",
       " 'RAC2',\n",
       " 'RAC3',\n",
       " 'RAD51',\n",
       " 'RAF',\n",
       " 'RAF1',\n",
       " 'RARA',\n",
       " 'RARB',\n",
       " 'RARG',\n",
       " 'RASAL1',\n",
       " 'RET',\n",
       " 'RHOA',\n",
       " 'RIPK1',\n",
       " 'RNA Polymerase 1',\n",
       " 'RNA helicase A',\n",
       " 'ROCK',\n",
       " 'ROCK1',\n",
       " 'ROCK2',\n",
       " 'RON',\n",
       " 'RORA',\n",
       " 'RORC',\n",
       " 'ROS1',\n",
       " 'RPS6KB2',\n",
       " 'RRM1',\n",
       " 'RSK',\n",
       " 'RSK2',\n",
       " 'RTK',\n",
       " 'RXRA',\n",
       " 'RXRB',\n",
       " 'RXRG',\n",
       " 'Retinioic X receptor (RXR) agonist',\n",
       " 'Retinoic acid ',\n",
       " 'S1PR1',\n",
       " 'S1PR2',\n",
       " 'S1PR3',\n",
       " 'S6K1',\n",
       " 'SCARB1',\n",
       " 'SERCA',\n",
       " 'SGK2',\n",
       " 'SGK3',\n",
       " 'SHP-1 (PTPN6)',\n",
       " 'SHP-2 (PTPN11)',\n",
       " 'SIRT1',\n",
       " 'SIRT2',\n",
       " 'SKP1',\n",
       " 'SLC5A1',\n",
       " 'SLC7A11',\n",
       " 'SMARCA2',\n",
       " 'SMARCA4',\n",
       " 'SMO',\n",
       " 'SPHK1',\n",
       " 'SPRK1',\n",
       " 'SPTLC1',\n",
       " 'SPTLC2',\n",
       " 'SPTLC3',\n",
       " 'SRC',\n",
       " 'SRD5A2',\n",
       " 'STAT3',\n",
       " 'STK33',\n",
       " 'SYK',\n",
       " 'TACC3',\n",
       " 'TAK',\n",
       " 'TAK1',\n",
       " 'TASP1',\n",
       " 'TBK1',\n",
       " 'TEC',\n",
       " 'TERT',\n",
       " 'TGFBR1',\n",
       " 'TIAM1',\n",
       " 'TIE2',\n",
       " 'TIE2,AXL',\n",
       " 'TNKS',\n",
       " 'TNKS1',\n",
       " 'TNKS2',\n",
       " 'TOP1',\n",
       " 'TOP2',\n",
       " 'TOP2A',\n",
       " 'TOP2B',\n",
       " 'TP53',\n",
       " 'TRAIL receptor agonist',\n",
       " 'TRCB',\n",
       " 'TRIO',\n",
       " 'TRPC6',\n",
       " 'TRPV4',\n",
       " 'TSPO',\n",
       " 'TTK',\n",
       " 'TUBB1',\n",
       " 'TXN',\n",
       " 'TYMS',\n",
       " 'UBA1',\n",
       " 'UCHL5',\n",
       " 'UGCG',\n",
       " 'USP10',\n",
       " 'USP13',\n",
       " 'USP14',\n",
       " 'USP5',\n",
       " 'USP7',\n",
       " 'USP9X',\n",
       " 'VCP',\n",
       " 'VDAC1',\n",
       " 'VDAC2',\n",
       " 'VDR',\n",
       " 'VEGFR',\n",
       " 'VEGFR1',\n",
       " 'VEGFR2',\n",
       " 'VEGFR3',\n",
       " 'VEGFR3/FLT4',\n",
       " 'WEE1',\n",
       " 'WRN',\n",
       " 'XIAP',\n",
       " 'XPO1',\n",
       " 'YES1',\n",
       " 'c-FGR',\n",
       " 'c-MET',\n",
       " 'dsDNA break induction',\n",
       " 'gamma-secretase',\n",
       " 'not defined',\n",
       " 'others',\n",
       " 'p38',\n",
       " 'p38alpha',\n",
       " 'p38beta']"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_targs = sorted(list(set(all_targs)))\n",
    "unique_targs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T21:53:33.893809Z",
     "start_time": "2019-05-30T21:53:33.821800Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ccle_drug_name</th>\n",
       "      <th>ccle_target</th>\n",
       "      <th>gdsc_drug_name</th>\n",
       "      <th>gdsc_synonyms</th>\n",
       "      <th>gdsc_target</th>\n",
       "      <th>gdsc_target_pathway</th>\n",
       "      <th>ctrp_drug_name</th>\n",
       "      <th>ctrp_target</th>\n",
       "      <th>ctrp_target_description</th>\n",
       "      <th>synonyms</th>\n",
       "      <th>targets</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>(5z)-7-oxozeaenol</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>(5Z)-7-Oxozeaenol</td>\n",
       "      <td>5Z-7-Oxozeaenol, LL-Z1640-2</td>\n",
       "      <td>TAK1</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5Z-7-Oxozeaenol; LL-Z1640-2; (5Z)-7-Oxozeaenol</td>\n",
       "      <td>TAK1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16-beta-bromoandrosterone</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>16-beta-bromoandrosterone</td>\n",
       "      <td>NaN</td>\n",
       "      <td>dehydroepiandrosterone (DHEA) analog</td>\n",
       "      <td>16-beta-bromoandrosterone</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1s,3r-rsl-3</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1S,3R-RSL-3</td>\n",
       "      <td>GPX4</td>\n",
       "      <td>synthetic lethal with HRAS in engineered cells...</td>\n",
       "      <td>1S,3R-RSL-3</td>\n",
       "      <td>GPX4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3-cl-ahpc</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3-Cl-AHPC</td>\n",
       "      <td>NR0B2</td>\n",
       "      <td>binder of nuclear receptor SHP</td>\n",
       "      <td>3-Cl-AHPC</td>\n",
       "      <td>NR0B2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5-fluorouracil</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5-Fluorouracil</td>\n",
       "      <td>5-FU</td>\n",
       "      <td>Antimetabolite (DNA &amp; RNA)</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5-FU; 5-Fluorouracil</td>\n",
       "      <td>Antimetabolite (DNA &amp; RNA)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>968</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>968</td>\n",
       "      <td>GLS</td>\n",
       "      <td>inhibitor of glutaminase</td>\n",
       "      <td>968</td>\n",
       "      <td>GLS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a-443654</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A-443654</td>\n",
       "      <td>KIN001-139</td>\n",
       "      <td>AKT1; AKT2; AKT3</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A-443654; KIN001-139</td>\n",
       "      <td>AKT2; AKT1; AKT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a-770041</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A-770041</td>\n",
       "      <td>KIN001-111</td>\n",
       "      <td>LCK; FYN</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>KIN001-111; A-770041</td>\n",
       "      <td>FYN; LCK</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a-804598</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A-804598</td>\n",
       "      <td>P2RX7</td>\n",
       "      <td>inhibitor of purinergic receptor P2X</td>\n",
       "      <td>A-804598</td>\n",
       "      <td>P2RX7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aa-cocf3</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AA-COCF3</td>\n",
       "      <td>FAAH; PLA2G4A; PLA2G4B; PLA2G4C; PLA2G4D</td>\n",
       "      <td>inhibitor of cytosolic phospholipase A2; inhib...</td>\n",
       "      <td>AA-COCF3</td>\n",
       "      <td>PLA2G4A; FAAH; PLA2G4C; PLA2G4D; PLA2G4B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abiraterone</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>abiraterone</td>\n",
       "      <td>CYP17A1</td>\n",
       "      <td>inhibitor of 17 alpha-hydroxylase and C17,20 l...</td>\n",
       "      <td>abiraterone</td>\n",
       "      <td>CYP17A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-199</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ABT-199</td>\n",
       "      <td>BCL2</td>\n",
       "      <td>inhibitor of BCL2</td>\n",
       "      <td>ABT-199</td>\n",
       "      <td>BCL2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>abt-737</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>BCL2; BCL2L1; BCL2L2</td>\n",
       "      <td>inhibitor of BCL2, BCL-xL, and BCL-W</td>\n",
       "      <td>ABT-737</td>\n",
       "      <td>BCL2; BCL2L2; BCL2L1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ac55649</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AC55649</td>\n",
       "      <td>RARB</td>\n",
       "      <td>agonist of retinoic acid receptor beta</td>\n",
       "      <td>AC55649</td>\n",
       "      <td>RARB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aew541</th>\n",
       "      <td>AEW541</td>\n",
       "      <td>IGF1R</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AEW541</td>\n",
       "      <td>IGF1R</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>afatinib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Afatinib</td>\n",
       "      <td>BIBW2992, Tovok, Gilotrif</td>\n",
       "      <td>ERBB2; EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>EGFR; ERBB2</td>\n",
       "      <td>inhibitor of EGFR and HER2</td>\n",
       "      <td>Gilotrif; Afatinib; Tovok; BIBW2992; afatinib</td>\n",
       "      <td>ERBB2; EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>agk-2</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AGK-2</td>\n",
       "      <td>SIRT2</td>\n",
       "      <td>inhibitor of sirtuin 2</td>\n",
       "      <td>AGK-2</td>\n",
       "      <td>SIRT2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aica ribonucleotide</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AICA Ribonucleotide</td>\n",
       "      <td>AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole...</td>\n",
       "      <td>AMPK agonist</td>\n",
       "      <td>Metabolism</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AICA Ribonucleotide; N1-(b-D-Ribofuranosyl)-5-...</td>\n",
       "      <td>AMPK agonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>akt inhibitor viii</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AKT inhibitor VIII</td>\n",
       "      <td>Akti-1/2</td>\n",
       "      <td>AKT1; AKT2; AKT3</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Akti-1/2; AKT inhibitor VIII</td>\n",
       "      <td>AKT2; AKT1; AKT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alectinib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>CH5424802, CH 542802, Alecensa</td>\n",
       "      <td>ALK</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CH5424802; Alectinib; Alecensa; CH 542802</td>\n",
       "      <td>ALK</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>alisertib</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "      <td>inhibitor of aurora kinases A and B</td>\n",
       "      <td>alisertib</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alisertib:navitoclax (2:1 mol/mol)</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>alisertib:navitoclax (2:1 mol/mol)</td>\n",
       "      <td>AURKA; AURKB; BCL2; BCL2L1; BCL2L2</td>\n",
       "      <td>inhibitor of aurora kinases A and B;inhibitor ...</td>\n",
       "      <td>alisertib:navitoclax (2:1 mol/mol)</td>\n",
       "      <td>BCL2; BCL2L2; BCL2L1; AURKA; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>alvocidib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>alvocidib</td>\n",
       "      <td>CDK1; CDK2; CDK4; CDK6</td>\n",
       "      <td>inhibitor of cyclin-dependent kinases</td>\n",
       "      <td>alvocidib</td>\n",
       "      <td>CDK1; CDK4; CDK6; CDK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>am-580</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AM-580</td>\n",
       "      <td>RARA</td>\n",
       "      <td>agonist of retinoic acid receptor alpha</td>\n",
       "      <td>AM-580</td>\n",
       "      <td>RARA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>amuvatinib</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Amuvatinib</td>\n",
       "      <td>MP470, MP 470, MP-470</td>\n",
       "      <td>KIT; PDGFRA; FLT3</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MP470; MP-470; MP 470; Amuvatinib</td>\n",
       "      <td>PDGFRA; KIT; FLT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>apicidin</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>apicidin</td>\n",
       "      <td>HDAC1; HDAC2; HDAC3; HDAC6; HDAC8</td>\n",
       "      <td>inhibitor of HDAC1, HDAC2, HDAC3, HDAC6, and H...</td>\n",
       "      <td>apicidin</td>\n",
       "      <td>HDAC8; HDAC1; HDAC3; HDAC2; HDAC6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ar-42</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AR-42</td>\n",
       "      <td>HDAC-42, AR 42, AR42</td>\n",
       "      <td>HDAC1</td>\n",
       "      <td>Chromatin histone acetylation</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HDAC-42; AR 42; AR-42; AR42</td>\n",
       "      <td>HDAC1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>as601245</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AS601245</td>\n",
       "      <td>NaN</td>\n",
       "      <td>JNK1; JNK2; JNK2</td>\n",
       "      <td>JNK and p38 signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AS601245</td>\n",
       "      <td>JNK1; JNK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>as605240</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AS605240</td>\n",
       "      <td>KIN001-173, AS-605240</td>\n",
       "      <td>PI3Kgamma</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AS605240; KIN001-173; AS-605240</td>\n",
       "      <td>PI3Kgamma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>at-406</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AT-406</td>\n",
       "      <td>XIAP</td>\n",
       "      <td>SMAC mimetic; inhibitor of inhibitor of apopto...</td>\n",
       "      <td>AT-406</td>\n",
       "      <td>XIAP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-680</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>VX-680</td>\n",
       "      <td>AURKA; AURKB; AURKC</td>\n",
       "      <td>inhibitor of aurora kinases</td>\n",
       "      <td>VX-680</td>\n",
       "      <td>AURKA; AURKC; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>vx-702</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>VX-702</td>\n",
       "      <td>VX702, VX 702</td>\n",
       "      <td>p38</td>\n",
       "      <td>JNK and p38 signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>VX702; VX-702; VX 702</td>\n",
       "      <td>p38</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>way-362450</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WAY-362450</td>\n",
       "      <td>NR1H4</td>\n",
       "      <td>agonist of farnesoid X receptor</td>\n",
       "      <td>WAY-362450</td>\n",
       "      <td>NR1H4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wee1 inhibitor</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Wee1 Inhibitor</td>\n",
       "      <td>681640, Wee1 Inhibitor</td>\n",
       "      <td>WEE1; CHEK1</td>\n",
       "      <td>Cell cycle</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>681640; Wee1 Inhibitor</td>\n",
       "      <td>CHEK1; WEE1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wh-4-023</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WH-4-023</td>\n",
       "      <td>KIN001-112</td>\n",
       "      <td>SRC; LCK</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>KIN001-112; WH-4-023</td>\n",
       "      <td>LCK; SRC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>whi-p97</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WHI-P97</td>\n",
       "      <td>AC1L1GQE, KIN001-055</td>\n",
       "      <td>JAK3</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WHI-P97; KIN001-055; AC1L1GQE</td>\n",
       "      <td>JAK3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wp1130</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WP1130</td>\n",
       "      <td>UCHL5; USP14; USP5; USP9X</td>\n",
       "      <td>inhibitor of the deubiquitinase activity of US...</td>\n",
       "      <td>WP1130</td>\n",
       "      <td>USP5; UCHL5; USP14; USP9X</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz-1-84</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WZ-1-84</td>\n",
       "      <td>KIN001-123</td>\n",
       "      <td>BMX</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WZ-1-84; KIN001-123</td>\n",
       "      <td>BMX</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz3105</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WZ3105</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SRC; ROCK2; NTRK2; FLT3; IRAK1; others</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WZ3105</td>\n",
       "      <td>ROCK2; NTRK2; SRC; others; IRAK1; FLT3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz4002</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WZ4002</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>inhibitor of EGFR targeting T790M resistance</td>\n",
       "      <td>WZ4002</td>\n",
       "      <td>EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wz8040</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WZ8040</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>inhibitor of EGFR targeting T790M resistance</td>\n",
       "      <td>WZ8040</td>\n",
       "      <td>EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xav939</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XAV939</td>\n",
       "      <td>NVP-XAV939, XAV-939, XAV 939</td>\n",
       "      <td>TNKS1; TNKS2</td>\n",
       "      <td>WNT signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XAV939; XAV 939; XAV-939; NVP-XAV939</td>\n",
       "      <td>TNKS2; TNKS1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xl765</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XL765</td>\n",
       "      <td>MTOR; PIK3CA; PIK3CB; PIK3CD; PIK3CG; PRKDC</td>\n",
       "      <td>inhibitor of mTOR and PI3K kinase acitivities</td>\n",
       "      <td>XL765</td>\n",
       "      <td>PRKDC; PIK3CA; MTOR; PIK3CB; PIK3CG; PIK3CD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd11-85h</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD11-85h</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRSK2; FLT4; MARK4; PRKCD; RET; SPRK1</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD11-85h</td>\n",
       "      <td>PRKCD; FLT4; SPRK1; RET; BRSK2; MARK4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd13-2</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD13-2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RIPK1</td>\n",
       "      <td>Apoptosis regulation</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD13-2</td>\n",
       "      <td>RIPK1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd14-99</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD14-99</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALK; CDK7; LTK; others</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD14-99</td>\n",
       "      <td>ALK; LTK; others; CDK7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd15-27</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD15-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CAMK2</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD15-27</td>\n",
       "      <td>CAMK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd8-85</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD8-85</td>\n",
       "      <td>ERK5-IN-1</td>\n",
       "      <td>ERK5; BET</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD8-85; ERK5-IN-1</td>\n",
       "      <td>ERK5; BET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>xmd8-92</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD8-92</td>\n",
       "      <td>XMD 8-92</td>\n",
       "      <td>MAPK7</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>XMD8-92; XMD 8-92</td>\n",
       "      <td>MAPK7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>y-39983</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Y-39983</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ROCK</td>\n",
       "      <td>Cytoskeleton</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Y-39983</td>\n",
       "      <td>ROCK</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>yk-4-279</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>YK-4-279</td>\n",
       "      <td>YK 4-279</td>\n",
       "      <td>RNA helicase A</td>\n",
       "      <td>Other</td>\n",
       "      <td>YK 4-279</td>\n",
       "      <td>DHX9; ERG; ETV1</td>\n",
       "      <td>inhibitor of RNA helicase A (RHA) binding to E...</td>\n",
       "      <td>YK-4-279; YK 4-279</td>\n",
       "      <td>RNA helicase A; DHX9; ERG; ETV1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>yl54</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>YL54</td>\n",
       "      <td>NaN</td>\n",
       "      <td>stapled helical peptide</td>\n",
       "      <td>YL54</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ym201636</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>YM201636</td>\n",
       "      <td>YM-201636, YM 201636</td>\n",
       "      <td>PYKFYVE</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>YM201636; YM 201636; YM-201636</td>\n",
       "      <td>PYKFYVE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>z-llnle-cho</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Z-LLNle-CHO</td>\n",
       "      <td>Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1</td>\n",
       "      <td>gamma-secretase</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gamma-Secretase Inhibitor 1; Z-L-Norleucine-CH...</td>\n",
       "      <td>gamma-secretase</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zd-6474</th>\n",
       "      <td>ZD-6474</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ZD-6474</td>\n",
       "      <td>EGFR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zebularine</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>zebularine</td>\n",
       "      <td>DNMT1</td>\n",
       "      <td>inhibitor of DNA methyltransferases</td>\n",
       "      <td>zebularine</td>\n",
       "      <td>DNMT1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zg-10</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ZG-10</td>\n",
       "      <td>NaN</td>\n",
       "      <td>JNK1</td>\n",
       "      <td>JNK and p38 signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ZG-10</td>\n",
       "      <td>JNK1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zibotentan</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zibotentan</td>\n",
       "      <td>ZD4054, ZD-4054</td>\n",
       "      <td>Endothelin-1 receptor (EDNRA)</td>\n",
       "      <td>Other</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zibotentan; ZD4054; ZD-4054</td>\n",
       "      <td>Endothelin-1 receptor (EDNRA)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zm447439</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ZM447439</td>\n",
       "      <td>ZM-447439, ZM 447439</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "      <td>Mitosis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ZM447439; ZM 447439; ZM-447439</td>\n",
       "      <td>AURKA; AURKB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zstk474</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ZSTK474</td>\n",
       "      <td>KIN001-167, ZSTK-474, ZSTK 474</td>\n",
       "      <td>PI3K (class 1)</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>ZSTK474</td>\n",
       "      <td>PIK3CB; PIK3CD; PIK3CG</td>\n",
       "      <td>inhibitor of PI3K catalytic subunits beta, del...</td>\n",
       "      <td>ZSTK-474; ZSTK 474; ZSTK474; KIN001-167</td>\n",
       "      <td>PI3K (class 1); PIK3CB; PIK3CG; PIK3CD</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>715 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                   ccle_drug_name ccle_target  \\\n",
       "drug                                                            \n",
       "(5z)-7-oxozeaenol                             NaN         NaN   \n",
       "16-beta-bromoandrosterone                     NaN         NaN   \n",
       "1s,3r-rsl-3                                   NaN         NaN   \n",
       "3-cl-ahpc                                     NaN         NaN   \n",
       "5-fluorouracil                                NaN         NaN   \n",
       "968                                           NaN         NaN   \n",
       "a-443654                                      NaN         NaN   \n",
       "a-770041                                      NaN         NaN   \n",
       "a-804598                                      NaN         NaN   \n",
       "aa-cocf3                                      NaN         NaN   \n",
       "abiraterone                                   NaN         NaN   \n",
       "abt-199                                       NaN         NaN   \n",
       "abt-737                                       NaN         NaN   \n",
       "ac55649                                       NaN         NaN   \n",
       "aew541                                     AEW541       IGF1R   \n",
       "afatinib                                      NaN         NaN   \n",
       "agk-2                                         NaN         NaN   \n",
       "aica ribonucleotide                           NaN         NaN   \n",
       "akt inhibitor viii                            NaN         NaN   \n",
       "alectinib                                     NaN         NaN   \n",
       "alisertib                                     NaN         NaN   \n",
       "alisertib:navitoclax (2:1 mol/mol)            NaN         NaN   \n",
       "alvocidib                                     NaN         NaN   \n",
       "am-580                                        NaN         NaN   \n",
       "amuvatinib                                    NaN         NaN   \n",
       "apicidin                                      NaN         NaN   \n",
       "ar-42                                         NaN         NaN   \n",
       "as601245                                      NaN         NaN   \n",
       "as605240                                      NaN         NaN   \n",
       "at-406                                        NaN         NaN   \n",
       "...                                           ...         ...   \n",
       "vx-680                                        NaN         NaN   \n",
       "vx-702                                        NaN         NaN   \n",
       "way-362450                                    NaN         NaN   \n",
       "wee1 inhibitor                                NaN         NaN   \n",
       "wh-4-023                                      NaN         NaN   \n",
       "whi-p97                                       NaN         NaN   \n",
       "wp1130                                        NaN         NaN   \n",
       "wz-1-84                                       NaN         NaN   \n",
       "wz3105                                        NaN         NaN   \n",
       "wz4002                                        NaN         NaN   \n",
       "wz8040                                        NaN         NaN   \n",
       "xav939                                        NaN         NaN   \n",
       "xl765                                         NaN         NaN   \n",
       "xmd11-85h                                     NaN         NaN   \n",
       "xmd13-2                                       NaN         NaN   \n",
       "xmd14-99                                      NaN         NaN   \n",
       "xmd15-27                                      NaN         NaN   \n",
       "xmd8-85                                       NaN         NaN   \n",
       "xmd8-92                                       NaN         NaN   \n",
       "y-39983                                       NaN         NaN   \n",
       "yk-4-279                                      NaN         NaN   \n",
       "yl54                                          NaN         NaN   \n",
       "ym201636                                      NaN         NaN   \n",
       "z-llnle-cho                                   NaN         NaN   \n",
       "zd-6474                                   ZD-6474        EGFR   \n",
       "zebularine                                    NaN         NaN   \n",
       "zg-10                                         NaN         NaN   \n",
       "zibotentan                                    NaN         NaN   \n",
       "zm447439                                      NaN         NaN   \n",
       "zstk474                                       NaN         NaN   \n",
       "\n",
       "                                         gdsc_drug_name  \\\n",
       "drug                                                      \n",
       "(5z)-7-oxozeaenol                     (5Z)-7-Oxozeaenol   \n",
       "16-beta-bromoandrosterone                           NaN   \n",
       "1s,3r-rsl-3                                         NaN   \n",
       "3-cl-ahpc                                           NaN   \n",
       "5-fluorouracil                           5-Fluorouracil   \n",
       "968                                                 NaN   \n",
       "a-443654                                       A-443654   \n",
       "a-770041                                       A-770041   \n",
       "a-804598                                            NaN   \n",
       "aa-cocf3                                            NaN   \n",
       "abiraterone                                         NaN   \n",
       "abt-199                                             NaN   \n",
       "abt-737                                             NaN   \n",
       "ac55649                                             NaN   \n",
       "aew541                                              NaN   \n",
       "afatinib                                       Afatinib   \n",
       "agk-2                                               NaN   \n",
       "aica ribonucleotide                 AICA Ribonucleotide   \n",
       "akt inhibitor viii                   AKT inhibitor VIII   \n",
       "alectinib                                     Alectinib   \n",
       "alisertib                                           NaN   \n",
       "alisertib:navitoclax (2:1 mol/mol)                  NaN   \n",
       "alvocidib                                           NaN   \n",
       "am-580                                              NaN   \n",
       "amuvatinib                                   Amuvatinib   \n",
       "apicidin                                            NaN   \n",
       "ar-42                                             AR-42   \n",
       "as601245                                       AS601245   \n",
       "as605240                                       AS605240   \n",
       "at-406                                              NaN   \n",
       "...                                                 ...   \n",
       "vx-680                                              NaN   \n",
       "vx-702                                           VX-702   \n",
       "way-362450                                          NaN   \n",
       "wee1 inhibitor                           Wee1 Inhibitor   \n",
       "wh-4-023                                       WH-4-023   \n",
       "whi-p97                                         WHI-P97   \n",
       "wp1130                                              NaN   \n",
       "wz-1-84                                         WZ-1-84   \n",
       "wz3105                                           WZ3105   \n",
       "wz4002                                              NaN   \n",
       "wz8040                                              NaN   \n",
       "xav939                                           XAV939   \n",
       "xl765                                               NaN   \n",
       "xmd11-85h                                     XMD11-85h   \n",
       "xmd13-2                                         XMD13-2   \n",
       "xmd14-99                                       XMD14-99   \n",
       "xmd15-27                                       XMD15-27   \n",
       "xmd8-85                                         XMD8-85   \n",
       "xmd8-92                                         XMD8-92   \n",
       "y-39983                                         Y-39983   \n",
       "yk-4-279                                       YK-4-279   \n",
       "yl54                                                NaN   \n",
       "ym201636                                       YM201636   \n",
       "z-llnle-cho                                 Z-LLNle-CHO   \n",
       "zd-6474                                             NaN   \n",
       "zebularine                                          NaN   \n",
       "zg-10                                             ZG-10   \n",
       "zibotentan                                   Zibotentan   \n",
       "zm447439                                       ZM447439   \n",
       "zstk474                                         ZSTK474   \n",
       "\n",
       "                                                                        gdsc_synonyms  \\\n",
       "drug                                                                                    \n",
       "(5z)-7-oxozeaenol                                         5Z-7-Oxozeaenol, LL-Z1640-2   \n",
       "16-beta-bromoandrosterone                                                         NaN   \n",
       "1s,3r-rsl-3                                                                       NaN   \n",
       "3-cl-ahpc                                                                         NaN   \n",
       "5-fluorouracil                                                                   5-FU   \n",
       "968                                                                               NaN   \n",
       "a-443654                                                                   KIN001-139   \n",
       "a-770041                                                                   KIN001-111   \n",
       "a-804598                                                                          NaN   \n",
       "aa-cocf3                                                                          NaN   \n",
       "abiraterone                                                                       NaN   \n",
       "abt-199                                                                           NaN   \n",
       "abt-737                                                                           NaN   \n",
       "ac55649                                                                           NaN   \n",
       "aew541                                                                            NaN   \n",
       "afatinib                                                    BIBW2992, Tovok, Gilotrif   \n",
       "agk-2                                                                             NaN   \n",
       "aica ribonucleotide                 AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole...   \n",
       "akt inhibitor viii                                                           Akti-1/2   \n",
       "alectinib                                              CH5424802, CH 542802, Alecensa   \n",
       "alisertib                                                                         NaN   \n",
       "alisertib:navitoclax (2:1 mol/mol)                                                NaN   \n",
       "alvocidib                                                                         NaN   \n",
       "am-580                                                                            NaN   \n",
       "amuvatinib                                                      MP470, MP 470, MP-470   \n",
       "apicidin                                                                          NaN   \n",
       "ar-42                                                            HDAC-42, AR 42, AR42   \n",
       "as601245                                                                          NaN   \n",
       "as605240                                                        KIN001-173, AS-605240   \n",
       "at-406                                                                            NaN   \n",
       "...                                                                               ...   \n",
       "vx-680                                                                            NaN   \n",
       "vx-702                                                                  VX702, VX 702   \n",
       "way-362450                                                                        NaN   \n",
       "wee1 inhibitor                                                 681640, Wee1 Inhibitor   \n",
       "wh-4-023                                                                   KIN001-112   \n",
       "whi-p97                                                          AC1L1GQE, KIN001-055   \n",
       "wp1130                                                                            NaN   \n",
       "wz-1-84                                                                    KIN001-123   \n",
       "wz3105                                                                            NaN   \n",
       "wz4002                                                                            NaN   \n",
       "wz8040                                                                            NaN   \n",
       "xav939                                                   NVP-XAV939, XAV-939, XAV 939   \n",
       "xl765                                                                             NaN   \n",
       "xmd11-85h                                                                         NaN   \n",
       "xmd13-2                                                                           NaN   \n",
       "xmd14-99                                                                          NaN   \n",
       "xmd15-27                                                                          NaN   \n",
       "xmd8-85                                                                     ERK5-IN-1   \n",
       "xmd8-92                                                                      XMD 8-92   \n",
       "y-39983                                                                           NaN   \n",
       "yk-4-279                                                                     YK 4-279   \n",
       "yl54                                                                              NaN   \n",
       "ym201636                                                         YM-201636, YM 201636   \n",
       "z-llnle-cho                           Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1   \n",
       "zd-6474                                                                           NaN   \n",
       "zebularine                                                                        NaN   \n",
       "zg-10                                                                             NaN   \n",
       "zibotentan                                                            ZD4054, ZD-4054   \n",
       "zm447439                                                         ZM-447439, ZM 447439   \n",
       "zstk474                                                KIN001-167, ZSTK-474, ZSTK 474   \n",
       "\n",
       "                                                               gdsc_target  \\\n",
       "drug                                                                         \n",
       "(5z)-7-oxozeaenol                                                    TAK1    \n",
       "16-beta-bromoandrosterone                                              NaN   \n",
       "1s,3r-rsl-3                                                            NaN   \n",
       "3-cl-ahpc                                                              NaN   \n",
       "5-fluorouracil                                  Antimetabolite (DNA & RNA)   \n",
       "968                                                                    NaN   \n",
       "a-443654                                                  AKT1; AKT2; AKT3   \n",
       "a-770041                                                          LCK; FYN   \n",
       "a-804598                                                               NaN   \n",
       "aa-cocf3                                                               NaN   \n",
       "abiraterone                                                            NaN   \n",
       "abt-199                                                                NaN   \n",
       "abt-737                                                                NaN   \n",
       "ac55649                                                                NaN   \n",
       "aew541                                                                 NaN   \n",
       "afatinib                                                       ERBB2; EGFR   \n",
       "agk-2                                                                  NaN   \n",
       "aica ribonucleotide                                           AMPK agonist   \n",
       "akt inhibitor viii                                        AKT1; AKT2; AKT3   \n",
       "alectinib                                                              ALK   \n",
       "alisertib                                                              NaN   \n",
       "alisertib:navitoclax (2:1 mol/mol)                                     NaN   \n",
       "alvocidib                                                              NaN   \n",
       "am-580                                                                 NaN   \n",
       "amuvatinib                                               KIT; PDGFRA; FLT3   \n",
       "apicidin                                                               NaN   \n",
       "ar-42                                                                HDAC1   \n",
       "as601245                                                  JNK1; JNK2; JNK2   \n",
       "as605240                                                         PI3Kgamma   \n",
       "at-406                                                                 NaN   \n",
       "...                                                                    ...   \n",
       "vx-680                                                                 NaN   \n",
       "vx-702                                                                 p38   \n",
       "way-362450                                                             NaN   \n",
       "wee1 inhibitor                                                 WEE1; CHEK1   \n",
       "wh-4-023                                                          SRC; LCK   \n",
       "whi-p97                                                               JAK3   \n",
       "wp1130                                                                 NaN   \n",
       "wz-1-84                                                                BMX   \n",
       "wz3105                              SRC; ROCK2; NTRK2; FLT3; IRAK1; others   \n",
       "wz4002                                                                 NaN   \n",
       "wz8040                                                                 NaN   \n",
       "xav939                                                        TNKS1; TNKS2   \n",
       "xl765                                                                  NaN   \n",
       "xmd11-85h                            BRSK2; FLT4; MARK4; PRKCD; RET; SPRK1   \n",
       "xmd13-2                                                              RIPK1   \n",
       "xmd14-99                                            ALK; CDK7; LTK; others   \n",
       "xmd15-27                                                             CAMK2   \n",
       "xmd8-85                                                          ERK5; BET   \n",
       "xmd8-92                                                              MAPK7   \n",
       "y-39983                                                               ROCK   \n",
       "yk-4-279                                                    RNA helicase A   \n",
       "yl54                                                                   NaN   \n",
       "ym201636                                                           PYKFYVE   \n",
       "z-llnle-cho                                                gamma-secretase   \n",
       "zd-6474                                                                NaN   \n",
       "zebularine                                                             NaN   \n",
       "zg-10                                                                 JNK1   \n",
       "zibotentan                                   Endothelin-1 receptor (EDNRA)   \n",
       "zm447439                                                      AURKA; AURKB   \n",
       "zstk474                                                     PI3K (class 1)   \n",
       "\n",
       "                                              gdsc_target_pathway  \\\n",
       "drug                                                                \n",
       "(5z)-7-oxozeaenol                                  Other, kinases   \n",
       "16-beta-bromoandrosterone                                     NaN   \n",
       "1s,3r-rsl-3                                                   NaN   \n",
       "3-cl-ahpc                                                     NaN   \n",
       "5-fluorouracil                                              Other   \n",
       "968                                                           NaN   \n",
       "a-443654                                      PI3K/MTOR signaling   \n",
       "a-770041                                           Other, kinases   \n",
       "a-804598                                                      NaN   \n",
       "aa-cocf3                                                      NaN   \n",
       "abiraterone                                                   NaN   \n",
       "abt-199                                                       NaN   \n",
       "abt-737                                                       NaN   \n",
       "ac55649                                                       NaN   \n",
       "aew541                                                        NaN   \n",
       "afatinib                                           EGFR signaling   \n",
       "agk-2                                                         NaN   \n",
       "aica ribonucleotide                                    Metabolism   \n",
       "akt inhibitor viii                            PI3K/MTOR signaling   \n",
       "alectinib                                           RTK signaling   \n",
       "alisertib                                                     NaN   \n",
       "alisertib:navitoclax (2:1 mol/mol)                            NaN   \n",
       "alvocidib                                                     NaN   \n",
       "am-580                                                        NaN   \n",
       "amuvatinib                                         Other, kinases   \n",
       "apicidin                                                      NaN   \n",
       "ar-42                               Chromatin histone acetylation   \n",
       "as601245                                    JNK and p38 signaling   \n",
       "as605240                                      PI3K/MTOR signaling   \n",
       "at-406                                                        NaN   \n",
       "...                                                           ...   \n",
       "vx-680                                                        NaN   \n",
       "vx-702                                      JNK and p38 signaling   \n",
       "way-362450                                                    NaN   \n",
       "wee1 inhibitor                                         Cell cycle   \n",
       "wh-4-023                                           Other, kinases   \n",
       "whi-p97                                            Other, kinases   \n",
       "wp1130                                                        NaN   \n",
       "wz-1-84                                            Other, kinases   \n",
       "wz3105                                                      Other   \n",
       "wz4002                                                        NaN   \n",
       "wz8040                                                        NaN   \n",
       "xav939                                              WNT signaling   \n",
       "xl765                                                         NaN   \n",
       "xmd11-85h                                                   Other   \n",
       "xmd13-2                                      Apoptosis regulation   \n",
       "xmd14-99                                                    Other   \n",
       "xmd15-27                                           Other, kinases   \n",
       "xmd8-85                                                     Other   \n",
       "xmd8-92                                            Other, kinases   \n",
       "y-39983                                              Cytoskeleton   \n",
       "yk-4-279                                                    Other   \n",
       "yl54                                                          NaN   \n",
       "ym201636                                                    Other   \n",
       "z-llnle-cho                                                 Other   \n",
       "zd-6474                                                       NaN   \n",
       "zebularine                                                    NaN   \n",
       "zg-10                                       JNK and p38 signaling   \n",
       "zibotentan                                                  Other   \n",
       "zm447439                                                  Mitosis   \n",
       "zstk474                                       PI3K/MTOR signaling   \n",
       "\n",
       "                                                        ctrp_drug_name  \\\n",
       "drug                                                                     \n",
       "(5z)-7-oxozeaenol                                                  NaN   \n",
       "16-beta-bromoandrosterone                    16-beta-bromoandrosterone   \n",
       "1s,3r-rsl-3                                                1S,3R-RSL-3   \n",
       "3-cl-ahpc                                                    3-Cl-AHPC   \n",
       "5-fluorouracil                                                     NaN   \n",
       "968                                                                968   \n",
       "a-443654                                                           NaN   \n",
       "a-770041                                                           NaN   \n",
       "a-804598                                                      A-804598   \n",
       "aa-cocf3                                                      AA-COCF3   \n",
       "abiraterone                                                abiraterone   \n",
       "abt-199                                                        ABT-199   \n",
       "abt-737                                                        ABT-737   \n",
       "ac55649                                                        AC55649   \n",
       "aew541                                                             NaN   \n",
       "afatinib                                                      afatinib   \n",
       "agk-2                                                            AGK-2   \n",
       "aica ribonucleotide                                                NaN   \n",
       "akt inhibitor viii                                                 NaN   \n",
       "alectinib                                                          NaN   \n",
       "alisertib                                                    alisertib   \n",
       "alisertib:navitoclax (2:1 mol/mol)  alisertib:navitoclax (2:1 mol/mol)   \n",
       "alvocidib                                                    alvocidib   \n",
       "am-580                                                          AM-580   \n",
       "amuvatinib                                                         NaN   \n",
       "apicidin                                                      apicidin   \n",
       "ar-42                                                              NaN   \n",
       "as601245                                                           NaN   \n",
       "as605240                                                           NaN   \n",
       "at-406                                                          AT-406   \n",
       "...                                                                ...   \n",
       "vx-680                                                          VX-680   \n",
       "vx-702                                                             NaN   \n",
       "way-362450                                                  WAY-362450   \n",
       "wee1 inhibitor                                                     NaN   \n",
       "wh-4-023                                                           NaN   \n",
       "whi-p97                                                            NaN   \n",
       "wp1130                                                          WP1130   \n",
       "wz-1-84                                                            NaN   \n",
       "wz3105                                                             NaN   \n",
       "wz4002                                                          WZ4002   \n",
       "wz8040                                                          WZ8040   \n",
       "xav939                                                             NaN   \n",
       "xl765                                                            XL765   \n",
       "xmd11-85h                                                          NaN   \n",
       "xmd13-2                                                            NaN   \n",
       "xmd14-99                                                           NaN   \n",
       "xmd15-27                                                           NaN   \n",
       "xmd8-85                                                            NaN   \n",
       "xmd8-92                                                            NaN   \n",
       "y-39983                                                            NaN   \n",
       "yk-4-279                                                      YK 4-279   \n",
       "yl54                                                              YL54   \n",
       "ym201636                                                           NaN   \n",
       "z-llnle-cho                                                        NaN   \n",
       "zd-6474                                                            NaN   \n",
       "zebularine                                                  zebularine   \n",
       "zg-10                                                              NaN   \n",
       "zibotentan                                                         NaN   \n",
       "zm447439                                                           NaN   \n",
       "zstk474                                                        ZSTK474   \n",
       "\n",
       "                                                                    ctrp_target  \\\n",
       "drug                                                                              \n",
       "(5z)-7-oxozeaenol                                                           NaN   \n",
       "16-beta-bromoandrosterone                                                   NaN   \n",
       "1s,3r-rsl-3                                                                GPX4   \n",
       "3-cl-ahpc                                                                 NR0B2   \n",
       "5-fluorouracil                                                              NaN   \n",
       "968                                                                         GLS   \n",
       "a-443654                                                                    NaN   \n",
       "a-770041                                                                    NaN   \n",
       "a-804598                                                                  P2RX7   \n",
       "aa-cocf3                               FAAH; PLA2G4A; PLA2G4B; PLA2G4C; PLA2G4D   \n",
       "abiraterone                                                             CYP17A1   \n",
       "abt-199                                                                    BCL2   \n",
       "abt-737                                                    BCL2; BCL2L1; BCL2L2   \n",
       "ac55649                                                                    RARB   \n",
       "aew541                                                                      NaN   \n",
       "afatinib                                                            EGFR; ERBB2   \n",
       "agk-2                                                                     SIRT2   \n",
       "aica ribonucleotide                                                         NaN   \n",
       "akt inhibitor viii                                                          NaN   \n",
       "alectinib                                                                   NaN   \n",
       "alisertib                                                          AURKA; AURKB   \n",
       "alisertib:navitoclax (2:1 mol/mol)           AURKA; AURKB; BCL2; BCL2L1; BCL2L2   \n",
       "alvocidib                                                CDK1; CDK2; CDK4; CDK6   \n",
       "am-580                                                                     RARA   \n",
       "amuvatinib                                                                  NaN   \n",
       "apicidin                                      HDAC1; HDAC2; HDAC3; HDAC6; HDAC8   \n",
       "ar-42                                                                       NaN   \n",
       "as601245                                                                    NaN   \n",
       "as605240                                                                    NaN   \n",
       "at-406                                                                     XIAP   \n",
       "...                                                                         ...   \n",
       "vx-680                                                      AURKA; AURKB; AURKC   \n",
       "vx-702                                                                      NaN   \n",
       "way-362450                                                                NR1H4   \n",
       "wee1 inhibitor                                                              NaN   \n",
       "wh-4-023                                                                    NaN   \n",
       "whi-p97                                                                     NaN   \n",
       "wp1130                                                UCHL5; USP14; USP5; USP9X   \n",
       "wz-1-84                                                                     NaN   \n",
       "wz3105                                                                      NaN   \n",
       "wz4002                                                                     EGFR   \n",
       "wz8040                                                                     EGFR   \n",
       "xav939                                                                      NaN   \n",
       "xl765                               MTOR; PIK3CA; PIK3CB; PIK3CD; PIK3CG; PRKDC   \n",
       "xmd11-85h                                                                   NaN   \n",
       "xmd13-2                                                                     NaN   \n",
       "xmd14-99                                                                    NaN   \n",
       "xmd15-27                                                                    NaN   \n",
       "xmd8-85                                                                     NaN   \n",
       "xmd8-92                                                                     NaN   \n",
       "y-39983                                                                     NaN   \n",
       "yk-4-279                                                        DHX9; ERG; ETV1   \n",
       "yl54                                                                        NaN   \n",
       "ym201636                                                                    NaN   \n",
       "z-llnle-cho                                                                 NaN   \n",
       "zd-6474                                                                     NaN   \n",
       "zebularine                                                                DNMT1   \n",
       "zg-10                                                                       NaN   \n",
       "zibotentan                                                                  NaN   \n",
       "zm447439                                                                    NaN   \n",
       "zstk474                                                  PIK3CB; PIK3CD; PIK3CG   \n",
       "\n",
       "                                                              ctrp_target_description  \\\n",
       "drug                                                                                    \n",
       "(5z)-7-oxozeaenol                                                                 NaN   \n",
       "16-beta-bromoandrosterone                        dehydroepiandrosterone (DHEA) analog   \n",
       "1s,3r-rsl-3                         synthetic lethal with HRAS in engineered cells...   \n",
       "3-cl-ahpc                                              binder of nuclear receptor SHP   \n",
       "5-fluorouracil                                                                    NaN   \n",
       "968                                                          inhibitor of glutaminase   \n",
       "a-443654                                                                          NaN   \n",
       "a-770041                                                                          NaN   \n",
       "a-804598                                         inhibitor of purinergic receptor P2X   \n",
       "aa-cocf3                            inhibitor of cytosolic phospholipase A2; inhib...   \n",
       "abiraterone                         inhibitor of 17 alpha-hydroxylase and C17,20 l...   \n",
       "abt-199                                                             inhibitor of BCL2   \n",
       "abt-737                                          inhibitor of BCL2, BCL-xL, and BCL-W   \n",
       "ac55649                                        agonist of retinoic acid receptor beta   \n",
       "aew541                                                                            NaN   \n",
       "afatinib                                                   inhibitor of EGFR and HER2   \n",
       "agk-2                                                          inhibitor of sirtuin 2   \n",
       "aica ribonucleotide                                                               NaN   \n",
       "akt inhibitor viii                                                                NaN   \n",
       "alectinib                                                                         NaN   \n",
       "alisertib                                         inhibitor of aurora kinases A and B   \n",
       "alisertib:navitoclax (2:1 mol/mol)  inhibitor of aurora kinases A and B;inhibitor ...   \n",
       "alvocidib                                       inhibitor of cyclin-dependent kinases   \n",
       "am-580                                        agonist of retinoic acid receptor alpha   \n",
       "amuvatinib                                                                        NaN   \n",
       "apicidin                            inhibitor of HDAC1, HDAC2, HDAC3, HDAC6, and H...   \n",
       "ar-42                                                                             NaN   \n",
       "as601245                                                                          NaN   \n",
       "as605240                                                                          NaN   \n",
       "at-406                              SMAC mimetic; inhibitor of inhibitor of apopto...   \n",
       "...                                                                               ...   \n",
       "vx-680                                                    inhibitor of aurora kinases   \n",
       "vx-702                                                                            NaN   \n",
       "way-362450                                            agonist of farnesoid X receptor   \n",
       "wee1 inhibitor                                                                    NaN   \n",
       "wh-4-023                                                                          NaN   \n",
       "whi-p97                                                                           NaN   \n",
       "wp1130                              inhibitor of the deubiquitinase activity of US...   \n",
       "wz-1-84                                                                           NaN   \n",
       "wz3105                                                                            NaN   \n",
       "wz4002                                   inhibitor of EGFR targeting T790M resistance   \n",
       "wz8040                                   inhibitor of EGFR targeting T790M resistance   \n",
       "xav939                                                                            NaN   \n",
       "xl765                                   inhibitor of mTOR and PI3K kinase acitivities   \n",
       "xmd11-85h                                                                         NaN   \n",
       "xmd13-2                                                                           NaN   \n",
       "xmd14-99                                                                          NaN   \n",
       "xmd15-27                                                                          NaN   \n",
       "xmd8-85                                                                           NaN   \n",
       "xmd8-92                                                                           NaN   \n",
       "y-39983                                                                           NaN   \n",
       "yk-4-279                            inhibitor of RNA helicase A (RHA) binding to E...   \n",
       "yl54                                                          stapled helical peptide   \n",
       "ym201636                                                                          NaN   \n",
       "z-llnle-cho                                                                       NaN   \n",
       "zd-6474                                                                           NaN   \n",
       "zebularine                                        inhibitor of DNA methyltransferases   \n",
       "zg-10                                                                             NaN   \n",
       "zibotentan                                                                        NaN   \n",
       "zm447439                                                                          NaN   \n",
       "zstk474                             inhibitor of PI3K catalytic subunits beta, del...   \n",
       "\n",
       "                                                                             synonyms  \\\n",
       "drug                                                                                    \n",
       "(5z)-7-oxozeaenol                      5Z-7-Oxozeaenol; LL-Z1640-2; (5Z)-7-Oxozeaenol   \n",
       "16-beta-bromoandrosterone                                   16-beta-bromoandrosterone   \n",
       "1s,3r-rsl-3                                                               1S,3R-RSL-3   \n",
       "3-cl-ahpc                                                                   3-Cl-AHPC   \n",
       "5-fluorouracil                                                   5-FU; 5-Fluorouracil   \n",
       "968                                                                               968   \n",
       "a-443654                                                         A-443654; KIN001-139   \n",
       "a-770041                                                         KIN001-111; A-770041   \n",
       "a-804598                                                                     A-804598   \n",
       "aa-cocf3                                                                     AA-COCF3   \n",
       "abiraterone                                                               abiraterone   \n",
       "abt-199                                                                       ABT-199   \n",
       "abt-737                                                                       ABT-737   \n",
       "ac55649                                                                       AC55649   \n",
       "aew541                                                                         AEW541   \n",
       "afatinib                                Gilotrif; Afatinib; Tovok; BIBW2992; afatinib   \n",
       "agk-2                                                                           AGK-2   \n",
       "aica ribonucleotide                 AICA Ribonucleotide; N1-(b-D-Ribofuranosyl)-5-...   \n",
       "akt inhibitor viii                                       Akti-1/2; AKT inhibitor VIII   \n",
       "alectinib                                   CH5424802; Alectinib; Alecensa; CH 542802   \n",
       "alisertib                                                                   alisertib   \n",
       "alisertib:navitoclax (2:1 mol/mol)                 alisertib:navitoclax (2:1 mol/mol)   \n",
       "alvocidib                                                                   alvocidib   \n",
       "am-580                                                                         AM-580   \n",
       "amuvatinib                                          MP470; MP-470; MP 470; Amuvatinib   \n",
       "apicidin                                                                     apicidin   \n",
       "ar-42                                                     HDAC-42; AR 42; AR-42; AR42   \n",
       "as601245                                                                     AS601245   \n",
       "as605240                                              AS605240; KIN001-173; AS-605240   \n",
       "at-406                                                                         AT-406   \n",
       "...                                                                               ...   \n",
       "vx-680                                                                         VX-680   \n",
       "vx-702                                                          VX702; VX-702; VX 702   \n",
       "way-362450                                                                 WAY-362450   \n",
       "wee1 inhibitor                                                 681640; Wee1 Inhibitor   \n",
       "wh-4-023                                                         KIN001-112; WH-4-023   \n",
       "whi-p97                                                 WHI-P97; KIN001-055; AC1L1GQE   \n",
       "wp1130                                                                         WP1130   \n",
       "wz-1-84                                                           WZ-1-84; KIN001-123   \n",
       "wz3105                                                                         WZ3105   \n",
       "wz4002                                                                         WZ4002   \n",
       "wz8040                                                                         WZ8040   \n",
       "xav939                                           XAV939; XAV 939; XAV-939; NVP-XAV939   \n",
       "xl765                                                                           XL765   \n",
       "xmd11-85h                                                                   XMD11-85h   \n",
       "xmd13-2                                                                       XMD13-2   \n",
       "xmd14-99                                                                     XMD14-99   \n",
       "xmd15-27                                                                     XMD15-27   \n",
       "xmd8-85                                                            XMD8-85; ERK5-IN-1   \n",
       "xmd8-92                                                             XMD8-92; XMD 8-92   \n",
       "y-39983                                                                       Y-39983   \n",
       "yk-4-279                                                           YK-4-279; YK 4-279   \n",
       "yl54                                                                             YL54   \n",
       "ym201636                                               YM201636; YM 201636; YM-201636   \n",
       "z-llnle-cho                         Gamma-Secretase Inhibitor 1; Z-L-Norleucine-CH...   \n",
       "zd-6474                                                                       ZD-6474   \n",
       "zebularine                                                                 zebularine   \n",
       "zg-10                                                                           ZG-10   \n",
       "zibotentan                                                Zibotentan; ZD4054; ZD-4054   \n",
       "zm447439                                               ZM447439; ZM 447439; ZM-447439   \n",
       "zstk474                                       ZSTK-474; ZSTK 474; ZSTK474; KIN001-167   \n",
       "\n",
       "                                                                        targets  \n",
       "drug                                                                             \n",
       "(5z)-7-oxozeaenol                                                          TAK1  \n",
       "16-beta-bromoandrosterone                                                   NaN  \n",
       "1s,3r-rsl-3                                                                GPX4  \n",
       "3-cl-ahpc                                                                 NR0B2  \n",
       "5-fluorouracil                                       Antimetabolite (DNA & RNA)  \n",
       "968                                                                         GLS  \n",
       "a-443654                                                       AKT2; AKT1; AKT3  \n",
       "a-770041                                                               FYN; LCK  \n",
       "a-804598                                                                  P2RX7  \n",
       "aa-cocf3                               PLA2G4A; FAAH; PLA2G4C; PLA2G4D; PLA2G4B  \n",
       "abiraterone                                                             CYP17A1  \n",
       "abt-199                                                                    BCL2  \n",
       "abt-737                                                    BCL2; BCL2L2; BCL2L1  \n",
       "ac55649                                                                    RARB  \n",
       "aew541                                                                    IGF1R  \n",
       "afatinib                                                            ERBB2; EGFR  \n",
       "agk-2                                                                     SIRT2  \n",
       "aica ribonucleotide                                                AMPK agonist  \n",
       "akt inhibitor viii                                             AKT2; AKT1; AKT3  \n",
       "alectinib                                                                   ALK  \n",
       "alisertib                                                          AURKA; AURKB  \n",
       "alisertib:navitoclax (2:1 mol/mol)           BCL2; BCL2L2; BCL2L1; AURKA; AURKB  \n",
       "alvocidib                                                CDK1; CDK4; CDK6; CDK2  \n",
       "am-580                                                                     RARA  \n",
       "amuvatinib                                                    PDGFRA; KIT; FLT3  \n",
       "apicidin                                      HDAC8; HDAC1; HDAC3; HDAC2; HDAC6  \n",
       "ar-42                                                                     HDAC1  \n",
       "as601245                                                             JNK1; JNK2  \n",
       "as605240                                                              PI3Kgamma  \n",
       "at-406                                                                     XIAP  \n",
       "...                                                                         ...  \n",
       "vx-680                                                      AURKA; AURKC; AURKB  \n",
       "vx-702                                                                      p38  \n",
       "way-362450                                                                NR1H4  \n",
       "wee1 inhibitor                                                      CHEK1; WEE1  \n",
       "wh-4-023                                                               LCK; SRC  \n",
       "whi-p97                                                                    JAK3  \n",
       "wp1130                                                USP5; UCHL5; USP14; USP9X  \n",
       "wz-1-84                                                                     BMX  \n",
       "wz3105                                   ROCK2; NTRK2; SRC; others; IRAK1; FLT3  \n",
       "wz4002                                                                     EGFR  \n",
       "wz8040                                                                     EGFR  \n",
       "xav939                                                             TNKS2; TNKS1  \n",
       "xl765                               PRKDC; PIK3CA; MTOR; PIK3CB; PIK3CG; PIK3CD  \n",
       "xmd11-85h                                 PRKCD; FLT4; SPRK1; RET; BRSK2; MARK4  \n",
       "xmd13-2                                                                   RIPK1  \n",
       "xmd14-99                                                 ALK; LTK; others; CDK7  \n",
       "xmd15-27                                                                  CAMK2  \n",
       "xmd8-85                                                               ERK5; BET  \n",
       "xmd8-92                                                                   MAPK7  \n",
       "y-39983                                                                    ROCK  \n",
       "yk-4-279                                        RNA helicase A; DHX9; ERG; ETV1  \n",
       "yl54                                                                        NaN  \n",
       "ym201636                                                                PYKFYVE  \n",
       "z-llnle-cho                                                     gamma-secretase  \n",
       "zd-6474                                                                    EGFR  \n",
       "zebularine                                                                DNMT1  \n",
       "zg-10                                                                      JNK1  \n",
       "zibotentan                                        Endothelin-1 receptor (EDNRA)  \n",
       "zm447439                                                           AURKA; AURKB  \n",
       "zstk474                                  PI3K (class 1); PIK3CB; PIK3CG; PIK3CD  \n",
       "\n",
       "[715 rows x 11 columns]"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_annotations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T21:58:38.078398Z",
     "start_time": "2019-05-30T21:58:38.062088Z"
    }
   },
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "'str' object has no attribute 'str'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-55-9d6bf15fd7fe>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mdrug_annotations\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mloc\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'(5z)-7-oxozeaenol'\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m'targets'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mstr\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mcontains\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;31mAttributeError\u001b[0m: 'str' object has no attribute 'str'"
     ]
    }
   ],
   "source": [
    "drug_annotations.loc['(5z)-7-oxozeaenol','targets'].str.contains()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T22:06:20.528767Z",
     "start_time": "2019-05-30T22:06:20.520391Z"
    }
   },
   "outputs": [],
   "source": [
    "def drug_targets_gene(row,gene):\n",
    "    return row[['targets']].str.contains(gene,case=False)['targets']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-30T22:33:24.800858Z",
     "start_time": "2019-05-30T22:33:24.795075Z"
    }
   },
   "outputs": [],
   "source": [
    "def find_drugs_from_gene(df,gene):\n",
    "    df = df[df.apply(lambda x: x[['targets']].str.contains(gene,case=False),axis=1)['targets']]\n",
    "    \n",
    "    all_drugs = []\n",
    "    for drugs in df['synonyms'].fillna('NONE'):\n",
    "        for drug in drugs.split('; '):\n",
    "            all_drugs.append(drug.lower())\n",
    "    unique_drugs = sorted(list(set(all_drugs)))\n",
    "    return unique_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 174,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:14:45.955792Z",
     "start_time": "2019-05-31T17:14:45.949069Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['pi3k',\n",
       " 'mtor',\n",
       " 'akt',\n",
       " 'p53',\n",
       " 'bet',\n",
       " 'aurora',\n",
       " 'cdk',\n",
       " 'chk',\n",
       " 'ezh2',\n",
       " 'hdac',\n",
       " 'bcl2',\n",
       " 'tgf',\n",
       " 'parp',\n",
       " 'shh',\n",
       " 'wnt',\n",
       " 'gabra',\n",
       " 'lmx']"
      ]
     },
     "execution_count": 174,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "genes_of_interest =\"\"\"pi3k\n",
    "mTOR\n",
    "AKT\n",
    "p53\n",
    "BET\n",
    "Aurora\n",
    "CDK\n",
    "CHK\n",
    "EZH2\n",
    "HDAC\n",
    "BCL2\n",
    "TGF\n",
    "PARP\n",
    "SHH\n",
    "WNT\n",
    "GABRA\n",
    "Lmx\"\"\".lower().split('\\n')\n",
    "genes_of_interest"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 175,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:14:46.823851Z",
     "start_time": "2019-05-31T17:14:46.818754Z"
    }
   },
   "outputs": [],
   "source": [
    "def list2str(lista):\n",
    "    return \"; \".join(lista)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 176,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:14:57.528558Z",
     "start_time": "2019-05-31T17:14:47.546051Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>description</th>\n",
       "      <th>drugs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>pi3k</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"pi3k\"</td>\n",
       "      <td>ak-55409; as-605240; as605240; azd 6482; azd-6...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mtor</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"mtor\"</td>\n",
       "      <td>a-1065-5; ay-22989; azd-8055; azd8055; bez235;...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>akt</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"akt\"</td>\n",
       "      <td>a-443654; akt inhibitor viii; akti-1/2; at7867...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>p53</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"p53\"</td>\n",
       "      <td>pifithrin-mu; prima-1; prima-1-met; rita; sch-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bet</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"bet\"</td>\n",
       "      <td>ak-55409; avagacestat; azd 6482; azd-6482; azd...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aurora</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"aurora\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cdk</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"cdk\"</td>\n",
       "      <td>al-39256; alvocidib; at-7519; at7519; brd-k307...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chk</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"chk\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ezh2</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"ezh2\"</td>\n",
       "      <td>brd-k42260513; brd-k51831558; brd1835</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>hdac</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"hdac\"</td>\n",
       "      <td>apicidin; ar 42; ar-42; ar42; belinostat; brd-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bcl2</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"bcl2\"</td>\n",
       "      <td>abt 263; abt-199; abt-263; abt-737; abt263; al...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tgf</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"tgf\"</td>\n",
       "      <td>ly-2157299; sb-431542; sb-525334</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>parp</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"parp\"</td>\n",
       "      <td>lynparza; abt 888; abt-888; abt888; ag-014699...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>shh</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"shh\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wnt</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"wnt\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gabra</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"gabra\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lmx</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"lmx\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            description  \\\n",
       "pi3k      Drugs (and synonyms) which target gene \"pi3k\"   \n",
       "mtor      Drugs (and synonyms) which target gene \"mtor\"   \n",
       "akt        Drugs (and synonyms) which target gene \"akt\"   \n",
       "p53        Drugs (and synonyms) which target gene \"p53\"   \n",
       "bet        Drugs (and synonyms) which target gene \"bet\"   \n",
       "aurora  Drugs (and synonyms) which target gene \"aurora\"   \n",
       "cdk        Drugs (and synonyms) which target gene \"cdk\"   \n",
       "chk        Drugs (and synonyms) which target gene \"chk\"   \n",
       "ezh2      Drugs (and synonyms) which target gene \"ezh2\"   \n",
       "hdac      Drugs (and synonyms) which target gene \"hdac\"   \n",
       "bcl2      Drugs (and synonyms) which target gene \"bcl2\"   \n",
       "tgf        Drugs (and synonyms) which target gene \"tgf\"   \n",
       "parp      Drugs (and synonyms) which target gene \"parp\"   \n",
       "shh        Drugs (and synonyms) which target gene \"shh\"   \n",
       "wnt        Drugs (and synonyms) which target gene \"wnt\"   \n",
       "gabra    Drugs (and synonyms) which target gene \"gabra\"   \n",
       "lmx        Drugs (and synonyms) which target gene \"lmx\"   \n",
       "\n",
       "                                                    drugs  \n",
       "pi3k    ak-55409; as-605240; as605240; azd 6482; azd-6...  \n",
       "mtor    a-1065-5; ay-22989; azd-8055; azd8055; bez235;...  \n",
       "akt     a-443654; akt inhibitor viii; akti-1/2; at7867...  \n",
       "p53     pifithrin-mu; prima-1; prima-1-met; rita; sch-...  \n",
       "bet     ak-55409; avagacestat; azd 6482; azd-6482; azd...  \n",
       "aurora                                                     \n",
       "cdk     al-39256; alvocidib; at-7519; at7519; brd-k307...  \n",
       "chk                                                        \n",
       "ezh2                brd-k42260513; brd-k51831558; brd1835  \n",
       "hdac    apicidin; ar 42; ar-42; ar42; belinostat; brd-...  \n",
       "bcl2    abt 263; abt-199; abt-263; abt-737; abt263; al...  \n",
       "tgf                      ly-2157299; sb-431542; sb-525334  \n",
       "parp     lynparza; abt 888; abt-888; abt888; ag-014699...  \n",
       "shh                                                        \n",
       "wnt                                                        \n",
       "gabra                                                      \n",
       "lmx                                                        "
      ]
     },
     "execution_count": 176,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list_of_drugs_per_genes = pd.DataFrame()\n",
    "for gene in genes_of_interest:\n",
    "    list_of_drugs_per_genes.loc[gene,'description']=f'Drugs (and synonyms) which target gene \"{gene}\"'\n",
    "    list_of_drugs_per_genes.loc[gene,'drugs'] = list2str(list(find_drugs_from_gene(drug_annotations,gene)))\n",
    "list_of_drugs_per_genes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:14:57.547801Z",
     "start_time": "2019-05-31T17:14:57.530698Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>description</th>\n",
       "      <th>drugs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>pi3k</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"pi3k\"</td>\n",
       "      <td>ak-55409; as-605240; as605240; azd 6482; azd-6...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mtor</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"mtor\"</td>\n",
       "      <td>a-1065-5; ay-22989; azd-8055; azd8055; bez235;...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>akt</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"akt\"</td>\n",
       "      <td>a-443654; akt inhibitor viii; akti-1/2; at7867...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>p53</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"p53\"</td>\n",
       "      <td>pifithrin-mu; prima-1; prima-1-met; rita; sch-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bet</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"bet\"</td>\n",
       "      <td>ak-55409; avagacestat; azd 6482; azd-6482; azd...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>aurora</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"aurora\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>cdk</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"cdk\"</td>\n",
       "      <td>al-39256; alvocidib; at-7519; at7519; brd-k307...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chk</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"chk\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ezh2</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"ezh2\"</td>\n",
       "      <td>brd-k42260513; brd-k51831558; brd1835</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>hdac</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"hdac\"</td>\n",
       "      <td>apicidin; ar 42; ar-42; ar42; belinostat; brd-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bcl2</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"bcl2\"</td>\n",
       "      <td>abt 263; abt-199; abt-263; abt-737; abt263; al...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tgf</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"tgf\"</td>\n",
       "      <td>ly-2157299; sb-431542; sb-525334</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>parp</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"parp\"</td>\n",
       "      <td>lynparza; abt 888; abt-888; abt888; ag-014699...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>shh</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"shh\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>wnt</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"wnt\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gabra</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"gabra\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lmx</th>\n",
       "      <td>Drugs (and synonyms) which target gene \"lmx\"</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pi3k+mtor+akt</th>\n",
       "      <td>Drugs (and synonyms) which target genes pi3k, ...</td>\n",
       "      <td>ak-55409; as-605240; as605240; azd 6482; azd-6...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                     description  \\\n",
       "pi3k               Drugs (and synonyms) which target gene \"pi3k\"   \n",
       "mtor               Drugs (and synonyms) which target gene \"mtor\"   \n",
       "akt                 Drugs (and synonyms) which target gene \"akt\"   \n",
       "p53                 Drugs (and synonyms) which target gene \"p53\"   \n",
       "bet                 Drugs (and synonyms) which target gene \"bet\"   \n",
       "aurora           Drugs (and synonyms) which target gene \"aurora\"   \n",
       "cdk                 Drugs (and synonyms) which target gene \"cdk\"   \n",
       "chk                 Drugs (and synonyms) which target gene \"chk\"   \n",
       "ezh2               Drugs (and synonyms) which target gene \"ezh2\"   \n",
       "hdac               Drugs (and synonyms) which target gene \"hdac\"   \n",
       "bcl2               Drugs (and synonyms) which target gene \"bcl2\"   \n",
       "tgf                 Drugs (and synonyms) which target gene \"tgf\"   \n",
       "parp               Drugs (and synonyms) which target gene \"parp\"   \n",
       "shh                 Drugs (and synonyms) which target gene \"shh\"   \n",
       "wnt                 Drugs (and synonyms) which target gene \"wnt\"   \n",
       "gabra             Drugs (and synonyms) which target gene \"gabra\"   \n",
       "lmx                 Drugs (and synonyms) which target gene \"lmx\"   \n",
       "pi3k+mtor+akt  Drugs (and synonyms) which target genes pi3k, ...   \n",
       "\n",
       "                                                           drugs  \n",
       "pi3k           ak-55409; as-605240; as605240; azd 6482; azd-6...  \n",
       "mtor           a-1065-5; ay-22989; azd-8055; azd8055; bez235;...  \n",
       "akt            a-443654; akt inhibitor viii; akti-1/2; at7867...  \n",
       "p53            pifithrin-mu; prima-1; prima-1-met; rita; sch-...  \n",
       "bet            ak-55409; avagacestat; azd 6482; azd-6482; azd...  \n",
       "aurora                                                            \n",
       "cdk            al-39256; alvocidib; at-7519; at7519; brd-k307...  \n",
       "chk                                                               \n",
       "ezh2                       brd-k42260513; brd-k51831558; brd1835  \n",
       "hdac           apicidin; ar 42; ar-42; ar42; belinostat; brd-...  \n",
       "bcl2           abt 263; abt-199; abt-263; abt-737; abt263; al...  \n",
       "tgf                             ly-2157299; sb-431542; sb-525334  \n",
       "parp            lynparza; abt 888; abt-888; abt888; ag-014699...  \n",
       "shh                                                               \n",
       "wnt                                                               \n",
       "gabra                                                             \n",
       "lmx                                                               \n",
       "pi3k+mtor+akt  ak-55409; as-605240; as605240; azd 6482; azd-6...  "
      ]
     },
     "execution_count": 177,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list_of_drugs_per_genes.loc['pi3k+mtor+akt','description']='Drugs (and synonyms) which target genes pi3k, mtor, or akt'\n",
    "list_of_drugs_per_genes.loc['pi3k+mtor+akt','drugs'] = '; '.join(list_of_drugs_per_genes.loc[['pi3k','mtor','akt'],'drugs'])\n",
    "list_of_drugs_per_genes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T15:53:47.305606Z",
     "start_time": "2019-05-31T15:53:47.285258Z"
    }
   },
   "outputs": [],
   "source": [
    "# DataFrame to GMT file (https://software.broadinstitute.org/cancer/software/gsea/wiki/index.php/Data_formats#Gene_Set_Database_Formats)\n",
    "with open('results/drug_sets.gmt', 'w') as file:\n",
    "    for set_name in list_of_drugs_per_genes.index:\n",
    "        if len(list_of_drugs_per_genes.loc[set_name,\"drugs\"])>0:\n",
    "            file.write(f'{set_name}\\t{list_of_drugs_per_genes.loc[set_name,\"description\"]}\\t')\n",
    "            file.write('\\t'.join(list_of_drugs_per_genes.loc[set_name,\"drugs\"].split('; ')))\n",
    "            file.write('\\n')\n",
    "        "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Using GSEA oneach subgroup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 187,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:30:01.294880Z",
     "start_time": "2019-05-31T17:30:01.282855Z"
    },
    "genepattern": {
     "name": "Login",
     "server": "https://cloud.genepattern.org/gp",
     "type": "auth"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7784faeeb2404f969e913f81969dbca2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPAuthWidget()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Requires GenePattern Notebook: pip install genepattern-notebook\n",
    "import gp\n",
    "import genepattern\n",
    "\n",
    "# Username and password removed for security reasons.\n",
    "genepattern.display(genepattern.session.register(\"https://cloud.genepattern.org/gp\", \"\", \"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "ssGSEA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 188,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:30:01.861777Z",
     "start_time": "2019-05-31T17:30:01.413646Z"
    },
    "genepattern": {
     "description": "Performs single sample GSEA Projection",
     "name": "ssGSEAProjection",
     "param_values": {
      "combine.mode": null,
      "gene.set.selection": null,
      "gene.sets.database.files": null,
      "gene.symbol.column": null,
      "input.gct.file": null,
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "min.gene.set.size": null,
      "output.file.prefix": null,
      "sample.normalization.method": null,
      "weighting.exponent": null
     },
     "type": "task"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d1addd8ff9d145a8a544a4f490f015b3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d17614a243c444689b2acc415a76b4b8",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPJobWidget(job_number=128710)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ssgseaprojection_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')\n",
    "ssgseaprojection_job_spec = ssgseaprojection_task.make_job_spec()\n",
    "ssgseaprojection_job_spec.set_parameter(\"input.gct.file\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run4700401478737654863.tmp/pdx_drug_scores.gct\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"output.file.prefix\", \"\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.sets.database.files\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run1103852253694045308.tmp/drug_sets.gmt\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.symbol.column\", \"Name\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.set.selection\", \"ALL\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"sample.normalization.method\", \"none\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"weighting.exponent\", \"0.75\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"combine.mode\", \"combine.add\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(ssgseaprojection_task)\n",
    "\n",
    "\n",
    "job128710 = gp.GPJob(genepattern.session.get(0), 128710)\n",
    "genepattern.display(job128710)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## G3"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "HDAC and PI3k"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 192,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:30:04.368540Z",
     "start_time": "2019-05-31T17:30:03.658048Z"
    },
    "genepattern": {
     "description": "Gene Set Enrichment Analysis",
     "name": "GSEA",
     "param_values": {
      "alt.delim": null,
      "chip.platform.file": null,
      "collapse.dataset": null,
      "collapsing.mode.for.probe.sets.with.more.than.one.match": null,
      "create.gcts": null,
      "create.svgs": null,
      "create.zip": null,
      "dev.mode": null,
      "expression.dataset": null,
      "gene.list.ordering.mode": null,
      "gene.list.sorting.mode": null,
      "gene.sets.database": null,
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "make.detailed.gene.set.report": null,
      "max.gene.set.size": null,
      "median.for.class.metrics": null,
      "metric.for.ranking.genes": null,
      "min.gene.set.size": null,
      "normalization.mode": null,
      "number.of.markers": null,
      "number.of.permutations": null,
      "omit.features.with.no.symbol.match": null,
      "output.file.name": null,
      "permutation.type": null,
      "phenotype.labels": null,
      "plot.graphs.for.the.top.sets.of.each.phenotype": null,
      "random.seed": null,
      "randomization.mode": null,
      "save.random.ranked.lists": null,
      "scoring.scheme": null,
      "selected.gene.sets": null,
      "target.profile": null
     },
     "type": "task"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9e4a099804674bffaba764bd9fc565bb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "927958fa8f734761a5286233f6c4c619",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPJobWidget(job_number=128671)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "gsea_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')\n",
    "gsea_job_spec = gsea_task.make_job_spec()\n",
    "gsea_job_spec.set_parameter(\"expression.dataset\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run4589296313022428825.tmp/pdx_drug_scores.gct\")\n",
    "gsea_job_spec.set_parameter(\"gene.sets.database\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run2251284024402984396.tmp/drug_sets.gmt\")\n",
    "gsea_job_spec.set_parameter(\"number.of.permutations\", \"1000\")\n",
    "gsea_job_spec.set_parameter(\"phenotype.labels\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run7323026098850613025.tmp/G3.cls\")\n",
    "gsea_job_spec.set_parameter(\"target.profile\", \"\")\n",
    "gsea_job_spec.set_parameter(\"collapse.dataset\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"permutation.type\", \"phenotype\")\n",
    "gsea_job_spec.set_parameter(\"chip.platform.file\", \"\")\n",
    "gsea_job_spec.set_parameter(\"scoring.scheme\", \"weighted\")\n",
    "gsea_job_spec.set_parameter(\"metric.for.ranking.genes\", \"Signal2Noise\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.sorting.mode\", \"real\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.ordering.mode\", \"descending\")\n",
    "gsea_job_spec.set_parameter(\"max.gene.set.size\", \"500\")\n",
    "gsea_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "gsea_job_spec.set_parameter(\"collapsing.mode.for.probe.sets.with.more.than.one.match\", \"Max_probe\")\n",
    "gsea_job_spec.set_parameter(\"normalization.mode\", \"meandiv\")\n",
    "gsea_job_spec.set_parameter(\"randomization.mode\", \"no_balance\")\n",
    "gsea_job_spec.set_parameter(\"omit.features.with.no.symbol.match\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"make.detailed.gene.set.report\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"median.for.class.metrics\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"number.of.markers\", \"100\")\n",
    "gsea_job_spec.set_parameter(\"plot.graphs.for.the.top.sets.of.each.phenotype\", \"20\")\n",
    "gsea_job_spec.set_parameter(\"random.seed\", \"timestamp\")\n",
    "gsea_job_spec.set_parameter(\"save.random.ranked.lists\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"create.svgs\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"selected.gene.sets\", \"\")\n",
    "gsea_job_spec.set_parameter(\"output.file.name\", \"<expression.dataset_basename>.zip\")\n",
    "gsea_job_spec.set_parameter(\"alt.delim\", \"\")\n",
    "gsea_job_spec.set_parameter(\"create.zip\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"create.gcts\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"dev.mode\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"job.memory\", \"8 Gb\")\n",
    "gsea_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "gsea_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "gsea_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(gsea_task)\n",
    "\n",
    "job128671 = gp.GPJob(genepattern.session.get(0), 128671)\n",
    "genepattern.display(job128671)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "G4"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "nfkb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 191,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:30:03.654911Z",
     "start_time": "2019-05-31T17:30:02.961811Z"
    },
    "genepattern": {
     "description": "Gene Set Enrichment Analysis",
     "name": "GSEA",
     "param_values": {
      "alt.delim": null,
      "chip.platform.file": null,
      "collapse.dataset": null,
      "collapsing.mode.for.probe.sets.with.more.than.one.match": null,
      "create.gcts": null,
      "create.svgs": null,
      "create.zip": null,
      "dev.mode": null,
      "expression.dataset": null,
      "gene.list.ordering.mode": null,
      "gene.list.sorting.mode": null,
      "gene.sets.database": null,
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "make.detailed.gene.set.report": null,
      "max.gene.set.size": null,
      "median.for.class.metrics": null,
      "metric.for.ranking.genes": null,
      "min.gene.set.size": null,
      "normalization.mode": null,
      "number.of.markers": null,
      "number.of.permutations": null,
      "omit.features.with.no.symbol.match": null,
      "output.file.name": null,
      "permutation.type": null,
      "phenotype.labels": null,
      "plot.graphs.for.the.top.sets.of.each.phenotype": null,
      "random.seed": null,
      "randomization.mode": null,
      "save.random.ranked.lists": null,
      "scoring.scheme": null,
      "selected.gene.sets": null,
      "target.profile": null
     },
     "type": "task"
    }
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1110f373bd0e4fdd817280c8cc450485",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7e85b03f388448ff9ff705a794f2fa2a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPJobWidget(job_number=128673)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "gsea_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')\n",
    "gsea_job_spec = gsea_task.make_job_spec()\n",
    "gsea_job_spec.set_parameter(\"expression.dataset\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run796413082341766210.tmp/pdx_drug_scores.gct\")\n",
    "gsea_job_spec.set_parameter(\"gene.sets.database\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run7684167559180190881.tmp/drug_sets.gmt\")\n",
    "gsea_job_spec.set_parameter(\"number.of.permutations\", \"1000\")\n",
    "gsea_job_spec.set_parameter(\"phenotype.labels\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run137917282661286220.tmp/G4.cls\")\n",
    "gsea_job_spec.set_parameter(\"target.profile\", \"\")\n",
    "gsea_job_spec.set_parameter(\"collapse.dataset\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"permutation.type\", \"phenotype\")\n",
    "gsea_job_spec.set_parameter(\"chip.platform.file\", \"\")\n",
    "gsea_job_spec.set_parameter(\"scoring.scheme\", \"weighted\")\n",
    "gsea_job_spec.set_parameter(\"metric.for.ranking.genes\", \"Signal2Noise\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.sorting.mode\", \"real\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.ordering.mode\", \"descending\")\n",
    "gsea_job_spec.set_parameter(\"max.gene.set.size\", \"500\")\n",
    "gsea_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "gsea_job_spec.set_parameter(\"collapsing.mode.for.probe.sets.with.more.than.one.match\", \"Max_probe\")\n",
    "gsea_job_spec.set_parameter(\"normalization.mode\", \"meandiv\")\n",
    "gsea_job_spec.set_parameter(\"randomization.mode\", \"no_balance\")\n",
    "gsea_job_spec.set_parameter(\"omit.features.with.no.symbol.match\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"make.detailed.gene.set.report\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"median.for.class.metrics\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"number.of.markers\", \"100\")\n",
    "gsea_job_spec.set_parameter(\"plot.graphs.for.the.top.sets.of.each.phenotype\", \"20\")\n",
    "gsea_job_spec.set_parameter(\"random.seed\", \"timestamp\")\n",
    "gsea_job_spec.set_parameter(\"save.random.ranked.lists\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"create.svgs\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"selected.gene.sets\", \"\")\n",
    "gsea_job_spec.set_parameter(\"output.file.name\", \"<expression.dataset_basename>.zip\")\n",
    "gsea_job_spec.set_parameter(\"alt.delim\", \"\")\n",
    "gsea_job_spec.set_parameter(\"create.zip\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"create.gcts\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"dev.mode\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"job.memory\", \"8 Gb\")\n",
    "gsea_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "gsea_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "gsea_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(gsea_task)\n",
    "\n",
    "job128673 = gp.GPJob(genepattern.session.get(0), 128673)\n",
    "genepattern.display(job128673)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "SHH"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 189,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:30:02.641343Z",
     "start_time": "2019-05-31T17:30:01.864606Z"
    },
    "genepattern": {
     "description": "Gene Set Enrichment Analysis",
     "name": "GSEA",
     "param_values": {
      "alt.delim": null,
      "chip.platform.file": null,
      "collapse.dataset": null,
      "collapsing.mode.for.probe.sets.with.more.than.one.match": null,
      "create.gcts": null,
      "create.svgs": null,
      "create.zip": null,
      "dev.mode": null,
      "expression.dataset": null,
      "gene.list.ordering.mode": null,
      "gene.list.sorting.mode": null,
      "gene.sets.database": null,
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "make.detailed.gene.set.report": null,
      "max.gene.set.size": null,
      "median.for.class.metrics": null,
      "metric.for.ranking.genes": null,
      "min.gene.set.size": null,
      "normalization.mode": null,
      "number.of.markers": null,
      "number.of.permutations": null,
      "omit.features.with.no.symbol.match": null,
      "output.file.name": null,
      "permutation.type": null,
      "phenotype.labels": null,
      "plot.graphs.for.the.top.sets.of.each.phenotype": null,
      "random.seed": null,
      "randomization.mode": null,
      "save.random.ranked.lists": null,
      "scoring.scheme": null,
      "selected.gene.sets": null,
      "target.profile": null
     },
     "type": "task"
    }
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "33e39e4fb990488da3a9fca8a52a90fe",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9ccc833f7da546a6b4e43a96cfaa0849",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPJobWidget(job_number=128672)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "gsea_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')\n",
    "gsea_job_spec = gsea_task.make_job_spec()\n",
    "gsea_job_spec.set_parameter(\"expression.dataset\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run204511326019200245.tmp/pdx_drug_scores.gct\")\n",
    "gsea_job_spec.set_parameter(\"gene.sets.database\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run1263190161821396616.tmp/drug_sets.gmt\")\n",
    "gsea_job_spec.set_parameter(\"number.of.permutations\", \"1000\")\n",
    "gsea_job_spec.set_parameter(\"phenotype.labels\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run6866766001543375916.tmp/SHH.cls\")\n",
    "gsea_job_spec.set_parameter(\"target.profile\", \"\")\n",
    "gsea_job_spec.set_parameter(\"collapse.dataset\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"permutation.type\", \"phenotype\")\n",
    "gsea_job_spec.set_parameter(\"chip.platform.file\", \"\")\n",
    "gsea_job_spec.set_parameter(\"scoring.scheme\", \"weighted\")\n",
    "gsea_job_spec.set_parameter(\"metric.for.ranking.genes\", \"Signal2Noise\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.sorting.mode\", \"real\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.ordering.mode\", \"descending\")\n",
    "gsea_job_spec.set_parameter(\"max.gene.set.size\", \"500\")\n",
    "gsea_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "gsea_job_spec.set_parameter(\"collapsing.mode.for.probe.sets.with.more.than.one.match\", \"Max_probe\")\n",
    "gsea_job_spec.set_parameter(\"normalization.mode\", \"meandiv\")\n",
    "gsea_job_spec.set_parameter(\"randomization.mode\", \"no_balance\")\n",
    "gsea_job_spec.set_parameter(\"omit.features.with.no.symbol.match\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"make.detailed.gene.set.report\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"median.for.class.metrics\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"number.of.markers\", \"100\")\n",
    "gsea_job_spec.set_parameter(\"plot.graphs.for.the.top.sets.of.each.phenotype\", \"20\")\n",
    "gsea_job_spec.set_parameter(\"random.seed\", \"timestamp\")\n",
    "gsea_job_spec.set_parameter(\"save.random.ranked.lists\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"create.svgs\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"selected.gene.sets\", \"\")\n",
    "gsea_job_spec.set_parameter(\"output.file.name\", \"<expression.dataset_basename>.zip\")\n",
    "gsea_job_spec.set_parameter(\"alt.delim\", \"\")\n",
    "gsea_job_spec.set_parameter(\"create.zip\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"create.gcts\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"dev.mode\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"job.memory\", \"8 Gb\")\n",
    "gsea_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "gsea_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "gsea_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(gsea_task)\n",
    "\n",
    "job128672 = gp.GPJob(genepattern.session.get(0), 128672)\n",
    "genepattern.display(job128672)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T16:03:24.768638Z",
     "start_time": "2019-05-31T16:03:24.745806Z"
    }
   },
   "source": [
    "SSH+p53"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 193,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:30:05.107077Z",
     "start_time": "2019-05-31T17:30:04.373787Z"
    },
    "genepattern": {
     "description": "Gene Set Enrichment Analysis",
     "name": "GSEA",
     "param_values": {
      "alt.delim": null,
      "chip.platform.file": null,
      "collapse.dataset": null,
      "collapsing.mode.for.probe.sets.with.more.than.one.match": null,
      "create.gcts": null,
      "create.svgs": null,
      "create.zip": null,
      "dev.mode": null,
      "expression.dataset": null,
      "gene.list.ordering.mode": null,
      "gene.list.sorting.mode": null,
      "gene.sets.database": null,
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "make.detailed.gene.set.report": null,
      "max.gene.set.size": null,
      "median.for.class.metrics": null,
      "metric.for.ranking.genes": null,
      "min.gene.set.size": null,
      "normalization.mode": null,
      "number.of.markers": null,
      "number.of.permutations": null,
      "omit.features.with.no.symbol.match": null,
      "output.file.name": null,
      "permutation.type": null,
      "phenotype.labels": null,
      "plot.graphs.for.the.top.sets.of.each.phenotype": null,
      "random.seed": null,
      "randomization.mode": null,
      "save.random.ranked.lists": null,
      "scoring.scheme": null,
      "selected.gene.sets": null,
      "target.profile": null
     },
     "type": "task"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "10b615a4d0b546a1a78d655fb005a1b4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "65b29a26ff03414db59392545557490e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPJobWidget(job_number=128674)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "gsea_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00072')\n",
    "gsea_job_spec = gsea_task.make_job_spec()\n",
    "gsea_job_spec.set_parameter(\"expression.dataset\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run8032620094729877808.tmp/pdx_drug_scores.gct\")\n",
    "gsea_job_spec.set_parameter(\"gene.sets.database\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run6215004688199059296.tmp/drug_sets.gmt\")\n",
    "gsea_job_spec.set_parameter(\"number.of.permutations\", \"1000\")\n",
    "gsea_job_spec.set_parameter(\"phenotype.labels\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run7191742514002045121.tmp/SHH%20p53.cls\")\n",
    "gsea_job_spec.set_parameter(\"target.profile\", \"\")\n",
    "gsea_job_spec.set_parameter(\"collapse.dataset\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"permutation.type\", \"phenotype\")\n",
    "gsea_job_spec.set_parameter(\"chip.platform.file\", \"\")\n",
    "gsea_job_spec.set_parameter(\"scoring.scheme\", \"weighted\")\n",
    "gsea_job_spec.set_parameter(\"metric.for.ranking.genes\", \"Signal2Noise\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.sorting.mode\", \"real\")\n",
    "gsea_job_spec.set_parameter(\"gene.list.ordering.mode\", \"descending\")\n",
    "gsea_job_spec.set_parameter(\"max.gene.set.size\", \"500\")\n",
    "gsea_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "gsea_job_spec.set_parameter(\"collapsing.mode.for.probe.sets.with.more.than.one.match\", \"Max_probe\")\n",
    "gsea_job_spec.set_parameter(\"normalization.mode\", \"meandiv\")\n",
    "gsea_job_spec.set_parameter(\"randomization.mode\", \"no_balance\")\n",
    "gsea_job_spec.set_parameter(\"omit.features.with.no.symbol.match\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"make.detailed.gene.set.report\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"median.for.class.metrics\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"number.of.markers\", \"100\")\n",
    "gsea_job_spec.set_parameter(\"plot.graphs.for.the.top.sets.of.each.phenotype\", \"20\")\n",
    "gsea_job_spec.set_parameter(\"random.seed\", \"timestamp\")\n",
    "gsea_job_spec.set_parameter(\"save.random.ranked.lists\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"create.svgs\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"selected.gene.sets\", \"\")\n",
    "gsea_job_spec.set_parameter(\"output.file.name\", \"<expression.dataset_basename>.zip\")\n",
    "gsea_job_spec.set_parameter(\"alt.delim\", \"\")\n",
    "gsea_job_spec.set_parameter(\"create.zip\", \"true\")\n",
    "gsea_job_spec.set_parameter(\"create.gcts\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"dev.mode\", \"false\")\n",
    "gsea_job_spec.set_parameter(\"job.memory\", \"8 Gb\")\n",
    "gsea_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "gsea_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "gsea_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(gsea_task)\n",
    "\n",
    "job128674 = gp.GPJob(genepattern.session.get(0), 128674)\n",
    "genepattern.display(job128674)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 190,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:30:02.957761Z",
     "start_time": "2019-05-31T17:30:02.644642Z"
    },
    "genepattern": {
     "name": "HeatMapViewer",
     "param_values": {
      "dataset": null,
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null
     },
     "type": "task"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7b73d3d262714260965d9cd8075fe95e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8cb712e997ef4073abe22d595747c1b4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPJobWidget(job_number=128712)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "heatmapviewer_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')\n",
    "heatmapviewer_job_spec = heatmapviewer_task.make_job_spec()\n",
    "heatmapviewer_job_spec.set_parameter(\"dataset\", \"https://cloud.genepattern.org/gp/jobResults/128710/pdx_drug_scores.PROJ.gct\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(heatmapviewer_task)\n",
    "\n",
    "job128712 = gp.GPJob(genepattern.session.get(0), 128712)\n",
    "genepattern.display(job128712)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 194,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:48:59.334396Z",
     "start_time": "2019-05-31T17:48:55.825857Z"
    },
    "genepattern": {
     "description": "Performs single sample GSEA Projection",
     "name": "ssGSEAProjection",
     "param_values": {
      "combine.mode": null,
      "gene.set.selection": null,
      "gene.sets.database.files": [
       "https://cloud.genepattern.org/gp/users/edjuaro/tmp/run3287674282713104112.tmp/drug_sets.gmt"
      ],
      "gene.symbol.column": null,
      "input.gct.file": [
       "https://cloud.genepattern.org/gp/users/edjuaro/tmp/run996970999154832720.tmp/g3_test.gct"
      ],
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "min.gene.set.size": "2",
      "output.file.prefix": null,
      "sample.normalization.method": null,
      "weighting.exponent": null
     },
     "type": "task"
    }
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "acd54de150904598a74af7015a662bbe",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ssgseaprojection_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')\n",
    "ssgseaprojection_job_spec = ssgseaprojection_task.make_job_spec()\n",
    "ssgseaprojection_job_spec.set_parameter(\"input.gct.file\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run996970999154832720.tmp/g3_test.gct\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"output.file.prefix\", \"\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.sets.database.files\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run3287674282713104112.tmp/drug_sets.gmt\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.symbol.column\", \"Name\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.set.selection\", \"ALL\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"sample.normalization.method\", \"none\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"weighting.exponent\", \"0.75\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"combine.mode\", \"combine.add\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(ssgseaprojection_task)\n",
    "\n",
    "job128723 = gp.GPJob(genepattern.session.get(0), 128723)\n",
    "genepattern.display(job128723)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 195,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:49:43.867432Z",
     "start_time": "2019-05-31T17:49:43.560471Z"
    },
    "genepattern": {
     "description": "A configurable heat map viewer that provides users with several options for manipulating and visualizing array-based data",
     "name": "HeatMapViewer",
     "param_values": {
      "dataset": [
       "https://cloud.genepattern.org/gp/jobResults/128723/g3_test.PROJ.gct"
      ],
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null
     },
     "type": "task"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c298f44b508846208b58b3f816fbabad",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "heatmapviewer_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')\n",
    "heatmapviewer_job_spec = heatmapviewer_task.make_job_spec()\n",
    "heatmapviewer_job_spec.set_parameter(\"dataset\", \"https://cloud.genepattern.org/gp/jobResults/128723/g3_test.PROJ.gct\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(heatmapviewer_task)\n",
    "\n",
    "\n",
    "job128724 = gp.GPJob(genepattern.session.get(0), 128724)\n",
    "genepattern.display(job128724)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 200,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T18:03:04.663238Z",
     "start_time": "2019-05-31T18:03:04.216435Z"
    },
    "genepattern": {
     "description": "Performs single sample GSEA Projection",
     "name": "ssGSEAProjection",
     "param_values": {
      "combine.mode": null,
      "gene.set.selection": null,
      "gene.sets.database.files": [
       "https://cloud.genepattern.org/gp/users/edjuaro/tmp/run5267445165661688137.tmp/drug_sets.gmt"
      ],
      "gene.symbol.column": null,
      "input.gct.file": [
       "https://cloud.genepattern.org/gp/users/edjuaro/tmp/run8637938324048559706.tmp/g4_scores.gct"
      ],
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "min.gene.set.size": "2",
      "output.file.prefix": null,
      "sample.normalization.method": null,
      "weighting.exponent": null
     },
     "type": "task"
    }
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "744e5ebb45384bb68743abffea79ecea",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ssgseaprojection_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')\n",
    "ssgseaprojection_job_spec = ssgseaprojection_task.make_job_spec()\n",
    "ssgseaprojection_job_spec.set_parameter(\"input.gct.file\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run8637938324048559706.tmp/g4_scores.gct\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"output.file.prefix\", \"\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.sets.database.files\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run5267445165661688137.tmp/drug_sets.gmt\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.symbol.column\", \"Name\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.set.selection\", \"ALL\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"sample.normalization.method\", \"none\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"weighting.exponent\", \"0.75\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"combine.mode\", \"combine.add\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(ssgseaprojection_task)\n",
    "\n",
    "\n",
    "job128728 = gp.GPJob(genepattern.session.get(0), 128728)\n",
    "genepattern.display(job128728)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 197,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:56:55.620817Z",
     "start_time": "2019-05-31T17:56:52.144146Z"
    },
    "genepattern": {
     "description": "A configurable heat map viewer that provides users with several options for manipulating and visualizing array-based data",
     "name": "HeatMapViewer",
     "param_values": {
      "dataset": [
       "https://cloud.genepattern.org/gp/jobResults/128728/g4_scores.PROJ.gct"
      ],
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null
     },
     "type": "task"
    }
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5eb037f6f8ac4e11aa519cf622f4f17b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "heatmapviewer_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')\n",
    "heatmapviewer_job_spec = heatmapviewer_task.make_job_spec()\n",
    "heatmapviewer_job_spec.set_parameter(\"dataset\", \"https://cloud.genepattern.org/gp/jobResults/128728/g4_scores.PROJ.gct\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(heatmapviewer_task)\n",
    "\n",
    "\n",
    "job128731 = gp.GPJob(genepattern.session.get(0), 128731)\n",
    "genepattern.display(job128731)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 201,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T18:03:31.713362Z",
     "start_time": "2019-05-31T18:03:31.272260Z"
    },
    "genepattern": {
     "description": "Performs single sample GSEA Projection",
     "name": "ssGSEAProjection",
     "param_values": {
      "combine.mode": null,
      "gene.set.selection": null,
      "gene.sets.database.files": [
       "https://cloud.genepattern.org/gp/users/edjuaro/tmp/run6734891911716975173.tmp/drug_sets.gmt"
      ],
      "gene.symbol.column": null,
      "input.gct.file": [
       "https://cloud.genepattern.org/gp/users/edjuaro/tmp/run4685508474058790569.tmp/SHH_scores.gct"
      ],
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null,
      "min.gene.set.size": "2",
      "output.file.prefix": null,
      "sample.normalization.method": null,
      "weighting.exponent": null
     },
     "type": "task"
    }
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "70c7fe96b40646e7ac887b30c661cbfe",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ssgseaprojection_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.analysis:00270')\n",
    "ssgseaprojection_job_spec = ssgseaprojection_task.make_job_spec()\n",
    "ssgseaprojection_job_spec.set_parameter(\"input.gct.file\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run4685508474058790569.tmp/SHH_scores.gct\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"output.file.prefix\", \"\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.sets.database.files\", \"https://cloud.genepattern.org/gp/users/edjuaro/tmp/run6734891911716975173.tmp/drug_sets.gmt\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.symbol.column\", \"Name\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"gene.set.selection\", \"ALL\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"sample.normalization.method\", \"none\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"weighting.exponent\", \"0.75\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"min.gene.set.size\", \"2\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"combine.mode\", \"combine.add\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "ssgseaprojection_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(ssgseaprojection_task)\n",
    "\n",
    "\n",
    "job128729 = gp.GPJob(genepattern.session.get(0), 128729)\n",
    "genepattern.display(job128729)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 199,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-05-31T17:57:24.600845Z",
     "start_time": "2019-05-31T17:57:24.288191Z"
    },
    "genepattern": {
     "description": "A configurable heat map viewer that provides users with several options for manipulating and visualizing array-based data",
     "name": "HeatMapViewer",
     "param_values": {
      "dataset": [
       "https://cloud.genepattern.org/gp/jobResults/128729/SHH_scores.PROJ.gct"
      ],
      "job.cpuCount": null,
      "job.memory": null,
      "job.queue": null,
      "job.walltime": null
     },
     "type": "task"
    }
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "fe9039a523604197b50119f2ceff9e3c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "GPTaskWidget(lsid='urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "heatmapviewer_task = gp.GPTask(genepattern.session.get(0), 'urn:lsid:broad.mit.edu:cancer.software.genepattern.module.visualizer:00010')\n",
    "heatmapviewer_job_spec = heatmapviewer_task.make_job_spec()\n",
    "heatmapviewer_job_spec.set_parameter(\"dataset\", \"https://cloud.genepattern.org/gp/jobResults/128729/SHH_scores.PROJ.gct\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.memory\", \"2 Gb\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.queue\", \"gpbeta-default\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.cpuCount\", \"1\")\n",
    "heatmapviewer_job_spec.set_parameter(\"job.walltime\", \"02:00:00\")\n",
    "genepattern.display(heatmapviewer_task)\n",
    "\n",
    "\n",
    "job128730 = gp.GPJob(genepattern.session.get(0), 128730)\n",
    "genepattern.display(job128730)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
